<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006569.pub5" GROUP_ID="SCHIZ" ID="844906090713124077" MERGED_FROM="" MODIFIED="2016-10-18 13:48:21 +0100" MODIFIED_BY="Claire Irving" REVIEW_NO="" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2016-10-18 13:48:15 +0100" MODIFIED_BY="Claire Irving">
<TITLE>Aripiprazole versus other atypical antipsychotics for schizophrenia</TITLE>
<CONTACT MODIFIED="2016-10-18 13:48:15 +0100" MODIFIED_BY="Claire Irving"><PERSON ID="32212196170187591241091215150732" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tao</FIRST_NAME><LAST_NAME>Suo</LAST_NAME><POSITION>Associate Chief Physician</POSITION><EMAIL_1>simonsuo@aliyun.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Surgery, Institute of General Surgery</DEPARTMENT><ORGANISATION>Zhongshan Hospital, Fudan University</ORGANISATION><ADDRESS_1>180 Fenglin Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 21 64041990-2365</PHONE_1><FAX_1>+86 21 64038472</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-10-18 13:48:15 +0100" MODIFIED_BY="Claire Irving"><PERSON ID="13633700785170654037090923140503" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Priya</FIRST_NAME><LAST_NAME>Khanna</LAST_NAME><POSITION>Consultant Psychiatrist</POSITION><EMAIL_1>priya40@gmail.com</EMAIL_1><EMAIL_2>priya.khanna@nhs.net</EMAIL_2><ADDRESS><DEPARTMENT>Rehabilitation and Recovery, Adult Psychiatry</DEPARTMENT><ORGANISATION>Northumberland, Tyne and Wear NHS Foundation Trust</ORGANISATION><CITY>Newcastle</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="32212196170187591241091215150732" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tao</FIRST_NAME><LAST_NAME>Suo</LAST_NAME><POSITION>Associate Chief Physician</POSITION><EMAIL_1>simonsuo@aliyun.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Surgery, Institute of General Surgery</DEPARTMENT><ORGANISATION>Zhongshan Hospital, Fudan University</ORGANISATION><ADDRESS_1>180 Fenglin Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 21 64041990-2365</PHONE_1><FAX_1>+86 21 64038472</FAX_1></ADDRESS></PERSON><PERSON ID="87F1AFC682E26AA20078D4E6A8FF088C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Katja</FIRST_NAME><LAST_NAME>Komossa</LAST_NAME><POSITION>Psychiatric Consultant</POSITION><EMAIL_1>Katja.Komossa@usz.ch</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry and Psychotherapy</DEPARTMENT><ORGANISATION>University Hospital of Zurich</ORGANISATION><ADDRESS_1>Culmannstrasse 8</ADDRESS_1><CITY>Zurich</CITY><ZIP>CH-8091</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>0041 (0) 44 255 5280</PHONE_1><FAX_1>0041 (0) 44 255 4408</FAX_1></ADDRESS></PERSON><PERSON ID="39898063044387319466111027134526" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Huaixing</FIRST_NAME><LAST_NAME>Ma</LAST_NAME><POSITION>Graduate Student</POSITION><EMAIL_1>ma.huaixing@zs-hospital.sh.cn</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medical Oncology</DEPARTMENT><ORGANISATION>Zhongshan Hospital, Fudan University</ORGANISATION><CITY>Shanghai</CITY><COUNTRY CODE="CN">China</COUNTRY></ADDRESS></PERSON><PERSON ID="11852B3682E26AA201DC7B3E1C938991" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Christine</FIRST_NAME><LAST_NAME>Rummel-Kluge</LAST_NAME><POSITION>Research Fellow</POSITION><EMAIL_1>Christine.rummel-kluge@medizin.uni-leipzig.de</EMAIL_1><ADDRESS><DEPARTMENT>Clinic and Outpatient Clinic of Psychiatry and Psychotherapy</DEPARTMENT><ORGANISATION>University of Leipzig</ORGANISATION><ADDRESS_1>Semmelweisstrasse 10</ADDRESS_1><CITY>Leipzig</CITY><ZIP>04103</ZIP><REGION>Saxony</REGION><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49-34-1972-4493</PHONE_1><FAX_1>+49-34-1972-4599</FAX_1></ADDRESS></PERSON><PERSON ID="1184F66B82E26AA201DC7B3E7E3084DF" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Hany</FIRST_NAME><MIDDLE_INITIALS>G</MIDDLE_INITIALS><LAST_NAME>El-Sayeh</LAST_NAME><POSITION>Consultant Psychiatrist</POSITION><EMAIL_1>hany.el-sayeh@nhs.net</EMAIL_1><ADDRESS><DEPARTMENT>Harrogate District Hospital</DEPARTMENT><ORGANISATION>Tees, Esk &amp; Wear Valleys NHS Foundation Trust</ORGANISATION><ADDRESS_1>Briary Wing</ADDRESS_1><ADDRESS_2>Lancaster Park Road</ADDRESS_2><CITY>Harrogate</CITY><ZIP>HG2 7SX</ZIP><REGION>North Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 01423 553424</PHONE_1></ADDRESS></PERSON><PERSON ID="D3501EE082E26AA20080535F42019853" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Stefan</FIRST_NAME><LAST_NAME>Leucht</LAST_NAME><POSITION>Vice-chairman</POSITION><EMAIL_1>Stefan.Leucht@lrz.tum.de</EMAIL_1><MOBILE_PHONE>+49 151 270 42590</MOBILE_PHONE><ADDRESS><DEPARTMENT>Klinik und Poliklinik für Psychiatrie und Psychotherapie</DEPARTMENT><ORGANISATION>Technische Universität München Klinikum rechts der Isar</ORGANISATION><ADDRESS_1>Ismaninger Straße 22</ADDRESS_1><CITY>München</CITY><ZIP>81675</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49-89-4140 ext: 4249</PHONE_1><FAX_1>+49-89-4140-4888</FAX_1></ADDRESS></PERSON><PERSON ID="258C268D82E26AA2000C5DBBFFD4E447" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Jun</FIRST_NAME><LAST_NAME>Xia</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>Jun.Xia@nottingham.ac.uk</EMAIL_1><EMAIL_2>jun-xia@review-solutions.cn</EMAIL_2><ADDRESS><DEPARTMENT>Cochrane Schizophrenia Group</DEPARTMENT><ORGANISATION>The University of Nottingham</ORGANISATION><ADDRESS_1>Institute of Mental Health</ADDRESS_1><ADDRESS_2>University of Nottingham Innovation Park, Triumph Road,</ADDRESS_2><CITY>Nottingham</CITY><ZIP>NG7 2TU</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 113 8550686</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-02-16 07:49:50 +0000" MODIFIED_BY="Huaixing Ma">
<UP_TO_DATE>
<DATE DAY="24" MONTH="6" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="5" MONTH="11" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="7" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2009"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2016-10-18 13:38:01 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2016-10-18 13:38:01 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="10" YEAR="2016"/>
<DESCRIPTION>
<P>Feedback received and authors have amended data input for a mental state outcome (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>). Data have changed and result is now significant, but overall conclusions of review remain unchanged. See <LINK REF="FBK-01" TYPE="FEEDBACK">Feedback 1</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-10-18 11:38:28 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-10-18 11:38:28 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="10" YEAR="2013"/>
<DESCRIPTION>
<P>No overall change to conclusions.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-10-18 11:38:27 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>New search run in November 2012. Trials assessed and new data added to review (162 new trials), but no changes to overall conclusions.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-06-26 11:00:32 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="10" YEAR="2012"/>
<DESCRIPTION>
<P>New search and data added, no major changes to conclusions.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-06-26 11:00:28 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>This is a major update, eight new trials have been included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-03-14 14:57:49 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-07-04 15:53:09 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2013-06-25 16:04:38 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-03-14 15:19:00 +0000" MODIFIED_BY="[Empty name]">
<NAME>Psychiatrische Klinik, Klinikum rechts der Isar, TU Mü nchen, Freistaat Bayern</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-09-11 20:02:03 +0100" MODIFIED_BY="[Empty name]">
<NAME>Nottingham Healthcare NHS Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-09-11 20:02:33 +0100" MODIFIED_BY="[Empty name]">
<NAME>University of Nottingham</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-06-25 16:04:38 +0100" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Schizophrenia Group</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2013-07-04 15:53:09 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2013-07-04 15:53:09 +0100" MODIFIED_BY="[Empty name]">
<NAME>Bundesministerium für Bildung und Forschung, Nr FKZ: 01KG 0606, GZ: GF-GFKG01100506</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-06-25 16:04:45 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute of Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This project is supported by the NIHR&#8217;s 2012 Cochrane Review Incentive Scheme.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-10-18 13:37:08 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">Aripiprazole versus other atypical antipsychotics</TITLE>
<SUMMARY_BODY MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>In many countries in the industrialised world there has been a huge growth in the prescription of medication for people with mental health problems, taken orally as a tablet or by injection. Atypical and second generation antipsychotic drugs have become ever more popular, because they are thought to help people with mental health problems who do not respond quite so well to initial treatment. These newer drugs hold the promise of both reducing symptoms, such as hearing voices or seeing things, and reducing problematic side effects, such as sleepiness, weight gain, and shaking.</P>
<P>However, there is little research and comparison of the ways in which drugs differ from one another. This review examines the effectiveness of aripiprazole with other new antipsychotics.<BR/>
<BR/>Originally the review included 12 research trials. After an update search carried out in November 2012, 162 trials were added. Most of these trials were from China and although new data were added to the review, overall conclusions did not change. The review now has five comparisons with aripiprazole being compared with clozapine, olanzapine, quetiapine, risperidone and ziprasidone.</P>
<P>For people with schizophrenia it may be important to know that aripiprazole may not be as good or effective as olanzapine but that it has less side effects. Aripiprazole is similar in effectiveness to risperidone and somewhat better than ziprasidone. Aripiprazole had less side- effects than olanzapine and risperidone (such as weight gain, sleepiness, heart problems, shaking and increased cholesterol levels). Aripiprazole was not as good as ziprasidone for dealing with restlessness or people&#8217;s inability to sit still. Comparison with other antipsychotic drugs as a group showed that people preferred taking aripiprazole. However, people with schizophrenia as well as mental health professionals and policy makers should know that the evidence is limited and mostly of low or very low quality. More trials and research is required, including on outcomes such as: quality of life; the views of service users and carers; and patient preference.</P>
<P>This plain language summary has been written by a consumer from Rethink Mental Illness, Benjamin Gray. Email: ben.gray@rethink.org</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-10-24 15:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first-line drug treatments for people with schizophrenia. In this review, we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-07-30 11:12:55 +0100" MODIFIED_BY="[Empty name]">
<P>To review the effects of aripiprazole compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychoses.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-07-09 10:39:03 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Schizophrenia Group Trials Register (November 2012), inspected references of all identified studies for further trials and contacted relevant pharmaceutical companies, drug approval agencies and authors of trials for additional information.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-10-24 15:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>We included all randomised clinical trials (RCTs) comparing aripiprazole (oral) with oral and parenteral forms of amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone or zotepine for people with schizophrenia or schizophrenia-like psychoses.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-06-26 14:06:16 +0100" MODIFIED_BY="[Empty name]">
<P>We extracted data independently. For dichotomous data we calculated risk ratios (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a random-effects model. Where possible, we calculated illustrative comparative risks for primary outcomes. For continuous data, we calculated mean differences (MD), again based on a random-effects model. We assessed risk of bias for each included study and used GRADE approach to rate quality of evidence.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-10-24 15:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>We now have included 174 trials involving 17,244 participants. Aripiprazole was compared with clozapine, quetiapine, risperidone, ziprasidone and olanzapine. The overall number of participants leaving studies early was 30% to 40%, limiting validity (no differences between groups).</P>
<P>When compared with clozapine, there were no significant differences for global state (no clinically significant response, n = 2132, 29 RCTs, <I>low quality evidence</I>); mental state (BPRS, n = 426, 5 RCTs, <I>very low quality evidence</I>); or leaving the study early for any reason (n = 240, 3 RCTs, <I>very low quality evidence</I>). Quality of life score using the WHO-QOL-100 scale demonstrated significant difference, favouring aripiprazole (n = 132, 2 RCTs, RR 2.59 CI 1.43 to 3.74, <I>very low quality evidence</I>). General extrapyramidal symptoms (EPS) were no different between groups (n = 520, 8 RCTs,<I> very low quality evidence</I>). No study reported general functioning or service use.</P>
<P>When compared with quetiapine, there were no significant differences for global state (n = 991, 12 RCTs, <I>low quality evidence</I>); mental state (PANSS positive symptoms, n = 583, 7 RCTs, <I>very low quality evidence</I>); leaving the study early for any reason (n = 168, 2 RCTs, <I>very low quality evidence</I>), or general EPS symptoms (n = 348, 4 RCTs, <I>very low quality evidence</I>). Results were significantly in favour of aripiprazole for quality of life (WHO-QOL-100 total score, n = 100, 1 RCT, MD 2.60 CI 1.31 to 3.89, <I>very low quality evidence</I>). No study reported general functioning or service use.</P>
<P>When compared with risperidone, there were no significant differences for global state (n = 6381, 80 RCTs, <I>low quality evidence</I>); or leaving the study early for any reason (n = 1239, 12 RCTs, <I>very low quality evidence</I>). Data were significantly in favour of aripiprazole for improvement in mental state using the BPRS (n = 570, 5 RCTs, MD 1.33 CI 2.24 to 0.42, <I>very low quality evidence</I>); with higher adverse effects seen in participants receiving risperidone of general EPS symptoms (n = 2605, 31 RCTs, RR 0.39 CI 0.31 to 0.50, <I>low quality evidence</I>). No study reported general functioning, quality of life or service use.</P>
<P>When compared with ziprasidone, there were no significant differences for global state (n = 442, 6 RCTs, <I>very low quality evidence</I>); mental state using the BPRS (n = 247, 1 RCT, <I>very low quality evidence</I>); or leaving the study early for any reason (n = 316, 2 RCTs, <I>very low quality evidence</I>). Weight gain was significantly greater in people receiving aripiprazole (n = 232, 3 RCTs, RR 4.01 CI 1.10 to 14.60, <I>very low quality evidence</I>). No study reported general functioning, quality of life or service use.</P>
<P>When compared with olanzapine, there were no significant differences for global state (n = 1739, 11 RCTs, <I>very low quality evidence</I>); mental state using PANSS (n = 1500, 11 RCTs, <I>very low quality evidence</I>); or quality of life using the GQOLI-74 scale (n = 68, 1 RCT, <I>very low quality of evidence</I>). Significantly more people receiving aripiprazole left the study early due to any reason (n = 2331, 9 RCTs, RR 1.15 CI 1.05 to 1.25, <I>low quality evidence</I>) and significantly more people receiving olanzapine gained weight (n = 1538, 9 RCTs, RR 0.25 CI 0.15 to 0.43, <I>very low quality evidence</I>). None of the included studies provided outcome data for the comparisons of 'service use' or 'general functioning'.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>Information on all comparisons is of limited quality, is incomplete and problematic to apply clinically. The quality of the evidence is all low or very low. Aripiprazole is an antipsychotic drug with an important adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerge from ongoing larger, independent pragmatic trials.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-10-18 13:37:08 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-11-13 16:46:23 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>Schizophrenia is usually a chronic and disabling psychiatric disorder, which afflicts approximately one per cent of the population worldwide, affecting  male and female patients in similar proportions. The annual incidence of schizophrenia averages 15 per 100,000 population  and the risk of developing the illness over one's lifetime averages 0.7% (<LINK REF="REF-Tandon-2008" TYPE="REFERENCE">Tandon 2008</LINK>). Its typical manifestations include  'positive' symptoms such as fixed, false beliefs (delusions) and perceptions without cause (hallucinations), 'negative' symptoms such as apathy and lack of drive, disorganisation of behaviour and thought, and catatonic symptoms such as mannerisms and bizarre posturing (<LINK REF="REF-Carpenter-1994" TYPE="REFERENCE">Carpenter 1994</LINK>). The degree of suffering and disability is considerable with 80% to 90% of those affected not working (<LINK REF="REF-Marvaha-2004" TYPE="REFERENCE">Marvaha 2004</LINK>) and up to 10% dying prematurely (<LINK REF="REF-Tsuang-1978" TYPE="REFERENCE">Tsuang 1978</LINK>). In the age group of 15 to 44 years, schizophrenia is among the top 10 leading causes of disease-related disability in the world (<LINK REF="REF-WHO-2001" TYPE="REFERENCE">WHO 2001</LINK>). Conventional antipsychotic drugs, such as chlorpromazine and haloperidol, have traditionally been used as first line antipsychotics for people with schizophrenia (<LINK REF="REF-Kane-1993" TYPE="REFERENCE">Kane 1993</LINK>). The introduction and subsequent use of clozapine in the United States of America identified that clozapine seemed to be more effective, and was associated with fewer movement disorders than existing agents such as chlorpromazine (<LINK REF="REF-Kane-1988" TYPE="REFERENCE">Kane 1988</LINK>). These results boosted the development and marketing of new/second/atypical generation antipsychotics (SGAs).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>There is no good definition of what constitutes an atypical/second generation antipsychotic, but they were initially said to differ from older generation drugs in that they did not cause movement disorders (catalepsy) in rats at clinically effective doses (<LINK REF="REF-Arnt-1998" TYPE="REFERENCE">Arnt 1998</LINK>). The terms new or second generation to describe clozapine, a very old drug, are equally poor descriptors. According to treatment guidelines (<LINK REF="REF-APA-2004" TYPE="REFERENCE">APA 2004</LINK>; <LINK REF="REF-Gaebel-2006" TYPE="REFERENCE">Gaebel 2006</LINK>), SGAs include drugs such as amisulpride, aripiprazole, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone and zotepine. It is unclear whether some old and inexpensive compounds such as sulpiride, perazine or even low-dose chlorpromazine, have similar properties (<LINK REF="REF-M_x00f6_ller-2000" TYPE="REFERENCE">Möller 2000</LINK>). High expectations were raised for these SGAs as regards their alleged superiority in a number of areas such as compliance, cognitive functioning, negative symptoms, movement disorders, quality of life and efficacy in treatment-resistant schizophrenia.</P>
</INTERVENTION>
<THEORY MODIFIED="2013-11-13 16:46:23 +0000" MODIFIED_BY="[Empty name]">
<P>Aripiprazole is said to be the prototype of a new and third generation of antipsychotics; the so called dopamine-serotonin system stabilisers. It is reported to exert its antipsychotic effects by acting as a partial agonist at D2 dopamine and 5-HT1a serotonin receptors and as an agonist at 5-HT2 serotonin receptors. It has been postulated that through the above receptor site actions, and hence dopamine and serotonin system stabilisation, a partial D2 agonist would be able to act as an antagonist in pathways where an abundance of dopamine was producing psychosis, yet it would stimulate receptors as an agonist at sites in which low dopaminergic tone would produce adverse effects (e.g. areas mediating motor movement and prolactin release (<LINK REF="REF-Rivas_x002d_Vasquez-2003" TYPE="REFERENCE">Rivas-Vasquez 2003</LINK>)). Aripiprazole, however, also has an affinity to other receptors including D3, D4, 5-HT2c, 5HT7, alpha-1 adrenergic and histamine receptors. This may explain adverse effects associated with this compound such as somnolence, headache, gastrointestinal upset and light headedness (<LINK REF="REF-FDA-2002" TYPE="REFERENCE">FDA 2002</LINK>). The recommended target dose for aripiprazole is 10-15 mg per day (dose range 10-30 mg/day). Phase III trials were initially conducted in Japan in 1995 and the drug was granted Approved Status by the FDA (USA) on the 15 November 2002 for the treatment of schizophrenia. Aripiprazole has since been licensed in most countries worldwide.</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>The debate as to how far the second generation antipsychotic drugs improve these outcomes compared to conventional antipsychotics continues (<LINK REF="REF-Duggan-2005" TYPE="REFERENCE">Duggan 2005</LINK>) and results from recent studies were sobering (<LINK REF="REF-Jones-2006" TYPE="REFERENCE">Jones 2006</LINK>; <LINK REF="REF-Lieberman-2005" TYPE="REFERENCE">Lieberman 2005</LINK>). Nevertheless, in some parts of the world, particularly  in western industrialised countries, SGAs have become the mainstay of treatment. Second generation antipsychotics also differ in terms of their costs. Amisulpride and risperidone, for example, are already generic in many countries. Therefore, the question as to whether they differ from each other in their clinical efficacy becomes increasingly important. In this review we aim to summarise evidence from randomised controlled trials comparing aripiprazole with other SGAs. This  acts as a continuum to the comparisons previously published by <LINK REF="REF-EL_x002d_Sayeh-2006" TYPE="REFERENCE">EL-Sayeh 2006</LINK>, <LINK REF="REF-Leucht-2008" TYPE="REFERENCE">Leucht 2008</LINK> and  <LINK REF="REF-Komossa-2009" TYPE="REFERENCE">Komossa 2009</LINK>.</P>
<P>This review was published in early 2013 with a vast number of Chinese studies in awaiting classification, thus we have updated it again in June 2013.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-06-25 16:17:42 +0100" MODIFIED_BY="[Empty name]">
<P>To review the effects of aripiprazole compared with other second generation/atypical antipsychotics for people with schizophrenia.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>We included both open and double-blinded, randomised controlled trials. We included open trials as we felt that important data that could potentially have an impact on the results might otherwise be overlooked. Where a trial was described as "double-blind" but it was only implied that the study was randomised, we included these trials in a sensitivity analysis. If there was no substantive difference within primary outcomes (see <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>) when these 'implied randomisation' studies were added, then we included these in the final analysis. If there was a substantive difference, we only used clearly randomised trials and described the results of the sensitivity analysis in the text. We excluded quasi-randomised studies, such as those allocating by using alternate days of the week.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-06-25 16:17:42 +0100" MODIFIED_BY="[Empty name]">
<P>We included people with schizophrenia and other types of schizophrenia-like psychosis (e.g. schizophreniform and schizoaffective disorders), irrespective of the diagnostic criteria used. There is no clear evidence that the schizophrenia-like psychoses are caused by fundamentally different disease processes or require different treatment approaches (<LINK REF="REF-Carpenter-1994" TYPE="REFERENCE">Carpenter 1994</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-06-25 16:17:42 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Aripiprazole</HEADING>
<P>Any oral form of application, any dose.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Other new/atypical antipsychotic drugs</HEADING>
<P>These include amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone, zotepine: any oral or parenteral form of application, any dose.</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>We grouped outcomes into the short term (up to 12 weeks), medium term (13-26 weeks) and long term (over 26 weeks).</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">1. Global state</HEADING>
<P>No clinically important response - as defined by the individual studies (e.g. global impression less than much improved or less than 50% reduction on a rating scale) - medium term</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. General functioning</HEADING>
<P>No clinically important change in general functioning - medium term</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Adverse effects</HEADING>
<P>Clinically important specific adverse effects - medium term</P>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>1. Global state</B>
</P>
<P>1.1 No clinically important change in global state (as defined by individual studies)<BR/>1.2 Relapse (as defined by the individual studies)</P>
<P>
<B>2. Mental state</B>
</P>
<P>2.1 No clinically important change in general mental state score<BR/>2.2 Average endpoint general mental score<BR/>2.3 Average change in general mental state score<BR/>2.4 No clinically important change in specific symptoms (positive symptoms of schizophrenia, negative symptoms of schizophrenia)<BR/>2.5 Average endpoint specific symptom score<BR/>2.6 Average change in specific symptom score</P>
<P>
<B>3. Leaving the studies early</B>
</P>
<P>3.1 Any reason, adverse events, inefficacy of treatment</P>
<P>
<B>4. Quality of life/satisfaction with treatment</B>
</P>
<P>4.1 No clinically important change in general quality of life<BR/>4.2 Average endpoint general quality of life score<BR/>4.3 Average change in general quality of life score</P>
<P>
<B>5. General functioning</B>
</P>
<P>5.1 No clinically important change in general functioning,- short and long term<BR/>5.2 Average endpoint general functioning score<BR/>5.3 Average change in general functioning score</P>
<SUBSECTION>
<HEADING LEVEL="5">6. Cognitive functioning</HEADING>
<P>6.1 No clinically important change in overall cognitive functioning<BR/>6.2 Average endpoint of overall cognitive functioning score<BR/>6.3 Average change of overall cognitive functioning score</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Service use</HEADING>
<P>7.1 Number of patients hospitalised</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Adverse effects</HEADING>
<P>8.1 Number of participants with at least one adverse effect<BR/>8.2 Clinically important specific adverse effects (cardiac effects, death, movement disorders, prolactin increase and associated effects, weight gain, effects on white blood cell count), short and long term<BR/>8.3 Average endpoint in specific adverse effects<BR/>8.4 Average change in specific adverse effects</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. 'Summary of findings' table</HEADING>
<P>We used the GRADE approach to interpret findings (<LINK REF="REF-Sch_x00fc_nemann-2008" TYPE="REFERENCE">Schünemann 2008</LINK>) and used the GRADE profiler to import data from Review Manager (RevMan) to create 'Summary of findings' tables. These tables provide outcome-specific information concerning the overall quality of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rated as important to patient-care and decision making. We selected the following main outcomes for inclusion in the 'Summary of findings' tables.</P>
<OL>
<LI>Global state</LI>
<LI>Mental state</LI>
<LI>Leaving the study early</LI>
<LI>Quality of Life</LI>
<LI>Adverse effects</LI>
<LI>General functioning</LI>
<LI>Service use</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>No language restriction was applied within the limitations of the search tools.</P>
<ELECTRONIC_SEARCHES MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Update search</HEADING>
<P>We searched the Cochrane Schizophrenia Group Trials Register (5 November 2012) using the phrase:</P>
<P>[ ( (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in title, abstract or index terms of REFERENCE) or ( (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in interventions of STUDY)]</P>
<P>The Cochrane Schizophrenia Group&#8217;s Trials Register is compiled by systematic searches of major databases, handsearches of journals and conference proceedings (see <A HREF="http://szg.cochrane.org/cszg-specialised-register">Group Module</A>). Incoming trials are assigned to relevant existing or new review titles.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Previous electronic search</HEADING>
<P>Please see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-06-25 22:55:00 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Reference searching</HEADING>
<P>We inspected the reference lists of all studies identified in the search for more trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Personal contact</HEADING>
<P>Where possible, we contacted the first author of each included study for missing information.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Drug companies</HEADING>
<P>We contacted the manufacturers of all atypical antipsychotics included for additional data in the 2011 update.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>For previous data collection and analysis methods please see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<STUDY_SELECTION MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>Review author TS inspected the reports for this update. TS resolved any doubts by discussion with other review authors, and where there was still doubt, TS acquired the full article for further inspection. Once the full articles were obtained, TS decided whether the studies met the review criteria. Twenty per cent of the references were randomly checked by HXM for reliability. Any disagreements were resolved by discussion. For any persistent disagreement, TS sought further information from authors of studies and added these trials to the list of those awaiting assessment. (See also <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> for detailed flow chart of the selection process).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-10-24 15:28:30 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Extraction</HEADING>
<P>For this update, TS and HXM extracted data from included studies. If data were presented only in graphs and figures, TS and HXM extracted data whenever possible. When further information was necessary, TS contacted authors of studies in order to obtain missing data or for clarification. If studies were multicentre, where possible, TS extracted data relevant to each component centre separately.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Management</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Forms</HEADING>
<P>We extracted data onto standard, simple forms.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Scale-derived data</HEADING>
<P>We included continuous data from rating scales only if:<BR/>a. the psychometric properties of the measuring instrument have been described in a peer-reviewed journal (<LINK REF="REF-Marshall-2000" TYPE="REFERENCE">Marshall 2000</LINK>); and<BR/>b. the measuring instrument has not been written or modified by one of the trialists for that particular trial.</P>
<P>Ideally, the measuring instrument should either be i. a self-report or ii. completed by an independent rater or relative (not the therapist). We realise that this is not often reported clearly; we have noted whether or not this is the case in <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.3 Endpoint versus change data</HEADING>
<P>There are advantages of both endpoint and change data. Change data can remove a component of between-person variability from the analysis. On the other hand, calculation of change needs two assessments (baseline and endpoint), which can be difficult in unstable and difficult to measure conditions such as schizophrenia. We decided primarily to use endpoint data, and only use change data if the former were not available. We combined endpoint and change data in the analysis as we used mean differences (MD) rather than standardised mean differences (SMD) throughout (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, Chapter 9.4.5.2).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.4 Skewed data</HEADING>
<P>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non-parametric data, we aimed to apply the following standards to all data before inclusion:</P>
<P>a) standard deviations (SDs) and means are reported in the paper or obtainable from the authors;</P>
<P>b) when a scale starts from the finite number zero, the SD, when multiplied by two, is less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution (<LINK REF="REF-Altman-1996" TYPE="REFERENCE">Altman 1996</LINK>));</P>
<P>c) if a scale started from a positive value (such as the Positive and Negative Syndrome Scale (PANSS, (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>)), which can have values from 30 to 210), we modified the calculation described above to take the scale starting point into account. In these cases skew is present if 2 SD &gt; (S-S min), where S is the mean score and S min is the minimum score.</P>
<P>Endpoint scores on scales often have a finite start and end point and these rules can be applied. We entered skewed endpoint data from studies of fewer than 200 participants in as other data within the data and analyses tables rather than into an analysis. Skewed data pose less of a problem when looking at mean if the sample size is large; we entered such endpoint data into syntheses.</P>
<P>When continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to tell whether data are skewed or not; we entered skewed change data into analyses regardless of the size of study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.5 Common measure</HEADING>
<P>To facilitate comparison between trials, we intended to convert variables that can be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.6 Conversion of continuous to binary</HEADING>
<P>Where possible, we made efforts to convert outcome measures to dichotomous data. This can be done by identifying cut-off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there is a 50% reduction in a scale-derived score such as the Brief Psychiatric Rating Scale (BPRS, <LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>) or the PANSS (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>), this could be considered as a clinically significant response (<LINK REF="REF-Leucht-2005a" TYPE="REFERENCE">Leucht 2005a</LINK>; <LINK REF="REF-Leucht-2005" TYPE="REFERENCE">Leucht 2005</LINK>). If data based on these thresholds were not available, we used the primary cut-off presented by the original authors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.7 Direction of graphs</HEADING>
<P>Where possible, we entered data in such a way that the area to the left of the line of no effect indicated a favourable outcome for aripiprazole.</P>
</SUBSECTION>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>For this update, review author TS worked independently by using criteria described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) to assess trial quality. This new set of criteria is based on evidence of associations between overestimate of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting.</P>
<P>Where inadequate details of randomisation and other characteristics of trials were provided we contacted the authors of the studies in order to obtain additional information.</P>
<P>We have noted the level of risk of bias in both the text of the review and in the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>; <LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>; <LINK REF="SOF-05" TYPE="SOF">Summary of findings table 5</LINK>.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Binary data</HEADING>
<P>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI). It has been shown that RR is more intuitive (<LINK REF="REF-Boissel-1999" TYPE="REFERENCE">Boissel 1999</LINK>) than odds ratios and that odds ratios tend to be interpreted as RR by clinicians (<LINK REF="REF-Deeks-2000" TYPE="REFERENCE">Deeks 2000</LINK>). The Number Needed to Treat/Harm (NNT/H) statistic with its CI is intuitively attractive to clinicians but is problematic both in its accurate calculation in meta-analyses and interpretation (<LINK REF="REF-Hutton-2009" TYPE="REFERENCE">Hutton 2009</LINK>). For binary data presented in the 'Summary of findings' tables, where possible, we calculated illustrative comparative risks.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Continuous data</HEADING>
<P>For continuous outcomes, we estimated the mean difference (MD) between groups. We would prefer not to calculate effect size measures (standardised mean difference (SMD). However, if scales of very considerable similarity were used, we presumed there was a small difference in measurement, and we calculated effect size and transformed the effect back to the units of one or more of the specific instruments.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Cluster trials</HEADING>
<P>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice), but analysis and pooling of clustered data poses problems. Authors often fail to account for intra-class correlation in clustered studies, leading to a 'unit of analysis' error (<LINK REF="REF-Divine-1992" TYPE="REFERENCE">Divine 1992</LINK>) whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated. This causes type I errors (<LINK REF="REF-Bland-1997" TYPE="REFERENCE">Bland 1997</LINK>; <LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>).</P>
<P>No cluster-randomised trials were identified in our search; however, if reviews in the future include such trials, where clustering is not accounted for in primary studies, we will present data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, we will seek to contact first authors of such studies to obtain intra-class correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>). Where clustering is been incorporated into the analysis of primary studies, we will present these data as if from a non cluster-randomised study, but adjust for the clustering effect.</P>
<P>We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC [Design effect = 1+(m-1)*ICC] (<LINK REF="REF-Donner-2002" TYPE="REFERENCE">Donner 2002</LINK>). If the ICC was not reported it was assumed to be 0.1 (<LINK REF="REF-Ukoumunne-1999" TYPE="REFERENCE">Ukoumunne 1999</LINK>).</P>
<P>If, in future updates of this review cluster trials are identified, cluster studies will be appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies would be possible using the generic inverse variance technique.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Cross-over trials</HEADING>
<P>A major concern of cross-over trials is the carry-over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase the participants can differ systematically from their initial state despite a wash-out phase. For the same reason cross-over trials are not appropriate if the condition of interest is unstable (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). As both effects are very likely in severe mental illness, if we encountered such trials, we planned only to use data of the first phase of cross-over studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Studies with multiple treatment groups</HEADING>
<P>Where a study involves more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. If data were binary, we simply added these and combined them within the two-by-two table. If data were continuous, we combined data following the formula in section 7.7.3.8 (Combining groups) of the <I>Cochrane Handbook for Systemic reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Where the additional treatment arms were not relevant, we did not reproduce these data.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Overall loss of credibility</HEADING>
<P>At some degree of loss of follow-up, data must lose credibility (<LINK REF="REF-Xia-2009" TYPE="REFERENCE">Xia 2009</LINK>). Although high rates of premature discontinuation are a major problem in this field, we felt that it was unclear which degree of attrition leads to a high degree of bias. We, therefore, did not exclude outcomes on the basis of the percentage of participants completing them. However, we addressed the attrition problem in all parts of the review, including the abstract. For this purpose, we calculated, presented and commented on frequency statistics (overall rates of leaving the studies early in all studies and comparators pooled and their ranges). We assumed that the people who discontinued the studies for any reason did not show any response to the treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Binary</HEADING>
<P>We presented data on a 'once-randomised-always-analyse' basis (an intention-to-treat (ITT) analysis). We undertook a sensitivity analysis to test how prone the primary outcomes are to change when data only from people who complete the study to that point are compared with the ITTanalysis using the above assumptions.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Continuous</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Attrition</HEADING>
<P>In the case of continuous outcomes, we preferred to use ITT results, but if not available we used completer data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Standard deviations</HEADING>
<P>If SDs were not reported, we first tried to obtain the missing values from the authors. If not available, where there are missing measures of variance for continuous data, but an exact standard error (SE) and CIs available for group means, and either a P value or T value available for differences in mean, we can calculate them according to the rules described in the <I>Cochrane Handbook for Systemic reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>): When only the SE is reported, SDs are calculated by the formula SD = SE* square root (n). Chapters 7.7.3 and 16.1.3 of the <I>Cochrane Handbook for Systemic reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) present detailed formulae for estimating SDs from P values, T or F values, CIs, ranges or other statistics. If these formulae do not apply, we would have calculated the SDs according to a validated imputation method, which is based on the SDs of the other included studies (<LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>). Although some of these imputation strategies can introduce error, the alternative would be to exclude a given study&#8217;s outcome and thus to lose information. We nevertheless would have examined the validity of the imputations in a sensitivity analysis excluding imputed values, had we imputed any values.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.3 Last observation carried forward</HEADING>
<P>We anticipated that in many studies the method of last observation carried forward (LOCF) would be employed within the study report. As with all methods of imputation to deal with missing data, LOCF introduces uncertainty about the reliability of the results (<LINK REF="REF-Leucht-2007" TYPE="REFERENCE">Leucht 2007</LINK>). We nevertheless used LOCF data being aware that many results are the product of LOCF assumptions.</P>
</SUBSECTION>
</SUBSECTION>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Clinical heterogeneity</HEADING>
<P>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations which we had not predicted would arise. When such situations or participant groups arose, we discussed these fully.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Methodological heterogeneity</HEADING>
<P>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise. When such methodological outliers arose, we discussed these fully.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Statistical heterogeneity</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Visual inspection</HEADING>
<P>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Employing the I<SUP>2</SUP> statistic</HEADING>
<P>We investigated heterogeneity between studies by considering the I<SUP>2 </SUP>method alongside the ChI<SUP>2</SUP> P value. The I<SUP>2 </SUP>provides an estimate of the percentage of inconsistency thought to be due to chance (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). The importance of the observed value of I<SUP>2 </SUP>depends on i. magnitude and direction of effects and ii. strength of evidence for heterogeneity (e.g. P value from ChI<SUP>2</SUP> test, or a confidence interval for I<SUP>2</SUP>). An I<SUP>2 </SUP>estimate greater than or equal to around 50% accompanied by a statistically significant ChI<SUP>2</SUP> statistic was interpreted as evidence of substantial levels of heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for heterogeneity (<LINK TAG="SUBGROUP_ANALYSIS" TYPE="SECTION">Subgroup analysis and investigation of heterogeneity</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-06-25 16:17:42 +0100" MODIFIED_BY="[Empty name]">
<P>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). These are described in Section 10 of the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small-study effects. We did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots were possible, we sought statistical advice in their interpretation.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>We understand that there is no closed argument for preference for use of fixed-effect or random-effects models. The random-effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random-effects model takes into account differences between studies even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random-effects model: it puts added weight onto small studies, which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. Where possible, for both dichotomous and continuous data we used the random-effects model for data synthesis.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Subgroup analyses - only primary outcomes</HEADING>
<P>We did not anticipate any subgroup analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Investigation of heterogeneity</HEADING>
<P>If inconsistency was high, we reported this. First, we investigated whether data had been entered correctly. Second, if data were correct, we visually inspected the graph and successively removed outlying studies to see if homogeneity was restored. For this review we decided that should this occur with data contributing to the summary finding of no more than around 10% of the total weighting, we would present data. If not, then we did not pool data and discussed relevant issues. We know of no supporting research for this 10% cut-off, but we used prediction intervals as an alternative to this unsatisfactory state.<BR/>
<BR/>When unanticipated clinical or methodological heterogeneity was obvious, we simply stated hypotheses regarding these for future reviews or versions of this review. We did not anticipate undertaking analyses relating to these.</P>
</SUBSECTION>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Implication of randomisation</HEADING>
<P>We aimed to include trials in a sensitivity analysis if they were described in some way so as to imply randomisation. For the primary outcomes, we included these studies and, if there was no substantive difference when the implied randomised studies were added to those with better description of randomisation, then we entered all data from these studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Assumptions for lost binary data</HEADING>
<P>Where assumptions had to be made regarding people lost to follow-up (see <LINK TAG="MISSING_DATA" TYPE="SECTION">Dealing with missing data</LINK>), we compared the findings of the primary outcomes when we used our assumptions and when we used data only from people who completed the study to that point. If there was a substantial difference, we reported results and discussed them, but continued to employ our assumption.</P>
<P>Where assumptions had to be made regarding missing SDs data (see <LINK TAG="MISSING_DATA" TYPE="SECTION">Dealing with missing data</LINK>), we compared the findings of the primary outcomes when we used our assumptions and when we used data only from people who completed the study to that point. A sensitivity analysis was undertaken to test how prone results were to change when completer-only data only were compared to the imputed data using the above assumption. If there was a substantial difference, we reported results and discussed them, but continued to employ our assumption.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Risk of bias</HEADING>
<P>We analysed the effects of excluding trials that were judged to be at high risk of bias across one or more of the domains of randomisation (implied as randomised with no further details available): allocation concealment, blinding and outcome reporting for the meta-analysis of the primary outcome. If the exclusion of trials at high risk of bias did not substantially alter the direction of effect or the precision of the effect estimates, then we included data from these trials in the analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Imputed values</HEADING>
<P>We planned to undertake a sensitivity analysis to assess the effects of including data from trials where we used imputed values for ICC in calculating the design effect in cluster randomised trials. However, no cluster-randomised trials were identified for this update.</P>
<P>In future updates, if cluster randomised trials are included we will undertake sensitivity analyses. If we note substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed above, we will not pool data from the excluded trials with the other trials contributing to the outcome, but present them separately.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Skewed data</HEADING>
<P>We planned sensitivity analyses a priori for examining the change in the robustness of the sensitivity to including studies with potentially skewed data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Comparator dose</HEADING>
<P>A recent report showed that some of the comparisons of atypical antipsychotics may have been biased by using inappropriate comparator doses (<LINK REF="REF-Heres-2006" TYPE="REFERENCE">Heres 2006</LINK>). We, therefore, also analysed whether the exclusion of studies with inappropriate comparator doses changed the results of the primary outcome and the general mental state.</P>
<P>Comparator doses were considered inappropriate where they exceeded BNF and Martindale recommended maximum doses (<LINK REF="REF-BNF-2013" TYPE="REFERENCE">BNF 2013</LINK>; <LINK REF="REF-Martindale-2013" TYPE="REFERENCE">Martindale 2013</LINK>).</P>
<UL>
<LI>Aripiprazole: usual maintenance dose of 15 mg daily; range 10 to 15 mg once daily; maximum dose 30 mg daily.</LI>
<LI>Clozapine: usual dose 200 to 450 mg daily; maximum dose 900 mg daily.</LI>
<LI>Quetiapine: usual range 300 to 450 mg daily in two divided doses; maximum dose 750 mg daily.</LI>
<LI>Risperidone: usual dose 4 mg daily; maximum dose 50 mg every two weeks.</LI>
<LI>Ziprasidone: (oral) 20 mg twice daily, increased if necessary up to maximum 80 mg twice daily; usual maintenance dose 20 mg twice daily; (intramuscular (IM) for acute agitation) 10 to 20 mg as required; maximum dose 40 mg daily for three consecutive days (to switch to oral therapy as soon as possible).</LI>
<LI>Olanzapine: usual range 5 to 20 mg daily; maximum dose 20 mg daily.</LI>
</UL>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-10-18 13:37:08 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>For a substantive description of studies please see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> tables.</P>
<SEARCH_RESULTS MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Original search (2005/2007)</HEADING>
<P>The first search yielded 3620 reports of which 28 were closely inspected. After excluding 22 studies, six publications on four trials and two comparisons could be included: aripiprazole versus olanzapine (two) and aripiprazole versus risperidone (two) (<LINK REF="REF-Komossa-2009" TYPE="REFERENCE">Komossa 2009</LINK>) (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Updated search (November 2011)</HEADING>
<P>The search we undertook for the first update of the review (<LINK REF="REF-Khanna-2013" TYPE="REFERENCE">Khanna 2013</LINK>) identified 618 further results and, after close inspection, we included eight more studies; making a total of 12 studies altogether. We excluded 38 trials, added 216 trials to 'Studies awaiting classification' (due to the need for translation or data extraction) and 16 trials to 'Ongoing studies' category (<LINK REF="REF-Khanna-2013" TYPE="REFERENCE">Khanna 2013</LINK>) (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Updated search (November 2012)</HEADING>
<P>The 2012 updated search for this current version of the review yielded 215 new citations; 209 full-text articles were assessed for eligibility, and ultimately 162 studies (from 167 references) were included. The total amount of included studies in this current review is 174 (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>The 174 included studies randomised 17,244 participants with the diagnosis of schizophrenia or schizoaffective disorder. All studies were described as randomised. We included both double blind and open label studies. Many were sponsored by pharmaceutical companies with some pecuniary interest in the result.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Length of studies</HEADING>
<P>One trial was only five days long. The vast majority were short term with a duration of three to eight weeks. Seven medium-term studies ranged from 20 to 26 weeks, and long-term studies from 28 weeks to two years.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Setting</HEADING>
<P>Studies reported inpatient and outpatient settings; the vast majority of studies were undertaken in China, where, it seems, aripiprazole is being heavily marketed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Participants</HEADING>
<P>Participants were diagnosed with varying diagnostic criteria; Diagnostic Statistical Manual version 4 (DSM-IV); clinical diagnosis (or no mention). The vast majority of participants in included studies were diagnosed using the Chinese Classification of Mental Disorders (CCMD-3). Participants were usually relatively chronically ill with mean ages in the late thirties.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Study size</HEADING>
<P>The sample size varied from n = 40 (<LINK REF="STD-Zhang-2008b" TYPE="STUDY">Zhang 2008b</LINK>) to n = 1599 (<LINK REF="STD-Tandon-2006" TYPE="STUDY">Tandon 2006</LINK>) people.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.1 Aripiprazole</HEADING>
<P>Doses ranged between 2.5 to 30 mg/day.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.2 Control drugs</HEADING>
<P>Other atypical drugs, namely olanzapine, risperidone, ziprasidone and quetiapine were used as controls. As some studies did not elucidate doses it can only be presumed that therapeutic doses were employed.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">6.1 Leaving the study early</HEADING>
<P>Thirty-five studies reported on participants leaving the study early due to any reason.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.2 Rating scales</HEADING>
<P>Details of scales that provided usable data are shown below. Reasons for exclusion of data from other instruments are given under 'Outcomes' in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="6">6.2.1 Global state scales</HEADING>
<P>6.2.1.1 Clinical Global Impression Scale - CGI Scale (<LINK REF="REF-Guy-1976" TYPE="REFERENCE">Guy 1976</LINK>)<BR/>This is used to assess both severity of illness and clinical improvement, by comparing the conditions of the person standardised against other people with the same diagnosis. A seven-point scoring system is used with low scores showing decreased severity and/or overall improvement.</P>
<P>6.2.1.2 Investigator's Assessment Questionnaire - IAQ (<LINK REF="REF-Tandon-2005" TYPE="REFERENCE">Tandon 2005</LINK>)<BR/>The IAQ is a quantifiable clinical tool that can provide detailed information regarding common safety, efficacy and tolerability concerns that patients experience while taking antipsychotics. It has been shown to highly correlate with time to study discontinuation which is a common measure of effectiveness.</P>
<P>6.2.1.3 Arizona Sexual Experience Scale - ASEX (<LINK REF="REF-McGahuey-2000" TYPE="REFERENCE">McGahuey 2000</LINK>)<BR/>This is a brief scale for self-rating of sexual function. It has five items and is rated in five steps. Possible scores range from five to 30 with higher scores indicating more sexual dysfunction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.2 Mental state scales</HEADING>
<P>6.2.2.1 Positive and Negative Syndrome Scale - PANSS (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>)<BR/>This schizophrenia scale has 30 items, each of which can be defined on a seven-point scoring system varying from one - absent to seven - extreme. It can be divided into three sub scales for measuring the severity of general psychopathology, positive symptoms (PANSS-P), and negative symptoms (PANSS-N). A low score indicates lesser severity.</P>
<P>6.2.2.2 Positive and Negative Syndrome Scale-Excited Component - PANSS-EC (<LINK REF="REF-Chaichan-2008" TYPE="REFERENCE">Chaichan 2008</LINK>)<BR/>The PANSS-EC scale is derived as a sub scale of PANSS and is a simple scale used to measure the degree of agitation. The scale consists of five items (poor impulse control, tension, hostility, uncooperativeness, excitement), each being ranked from one to seven giving a potential maximum score of 35 points.</P>
<P>6.2.2.3 Brief Psychiatric Rating Scale &#8211; BPRS (<LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>)<BR/>This consists of 18 to 24 items (depending on the version) each rated on a scale from one (absent) to seven (extreme).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.3 Adverse effects scales</HEADING>
<P>6.2.3.1 Abnormal Involuntary Movement Scale - AIMS (<LINK REF="REF-Guy-1976" TYPE="REFERENCE">Guy 1976</LINK>)<BR/>This scale has been used to assess tardive dyskinesia, a long-term, drug-induced movement disorder and short-term movement disorders such as tremor.</P>
<P>6.2.3.2 Simpson Angus Scale - SAS (<LINK REF="REF-Simpson-1970" TYPE="REFERENCE">Simpson 1970</LINK>)<BR/>This 10-item scale (with a scoring system of zero to four on each item) measures drug-induced parkinsonism, a short-term drug-induced movement disorder. A low score indicates low levels of parkinsonism.</P>
<P>6.2.3.3 Barnes Akathisia Scale - BAS (<LINK REF="REF-Barnes-1989" TYPE="REFERENCE">Barnes 1989</LINK>)<BR/>The scale comprises items rating the observable, restless movements that characterise akathisia, a subjective awareness of restlessness, and any distress associated with the condition. These items are rated from zero (normal) to three (severe). In addition, there is an item for rating global severity (from zero (absent) to five (severe)). A low score indicates low levels of akathisia.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.4 Quality of Life</HEADING>
<P>6.2.4.1 Euro-QoL-5D - EQ-5D (<LINK REF="REF-Jelsma-2001" TYPE="REFERENCE">Jelsma 2001</LINK>)<BR/>The EuroQoL-5D is a generic preference based measure of health-related quality of life. It has five domains which are mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression, each having three short questions. The EQ-5D Utility score assesses all five items on a scale of zero to one, where zero represents worst possible health and one represents perfect health. The EQ-5D Health Dimension Scale assesses each item on three possible scores where one is the best and three the worst score.</P>
<P>6.2.4.2 Quality of Life Scale &#8211; QLS (<LINK REF="REF-Heinrichs-1984" TYPE="REFERENCE">Heinrichs 1984</LINK>)<BR/>Quality of Life Scale (QLS), a 21-item scale divided into four domains including Interpersonal relations, Instrumental role, Intrapsychic foundations and common objects/activities scored on a seven-point scale with lowest score indicating severe dysfunction.</P>
<P>6.2.4.3 Impact of Weight on Quality of Life - IwQOL-Lite (<LINK REF="REF-Kolotkin-2002" TYPE="REFERENCE">Kolotkin 2002</LINK>)<BR/>This is a survey instrument that is used to quantitatively assess an individual's perception of how their weight affects their day-to-day life. This instrument is especially valuable to obesity researchers, clinicians, psychologists, medical device and/or pharmaceutical companies seeking to validate the effectiveness of their treatments for obesity using metrics that go beyond the physical measurements of weight loss.</P>
<P>6.2.4.4 World Health Organisation Quality of Life Scale (WHOQoL-Bref, <LINK REF="REF-O_x0027_Carroll-2000" TYPE="REFERENCE">O'Carroll 2000</LINK>)<BR/>The WHOQoL-Bref is a 26-item self-report comprising satisfaction with health, psychological functioning, social relationships and environmental opportunities. Each item is scored on a five-point scale from one (poor) to five (worse). The Chinese version of the WHOQoL scale, the generic quality of life inventory (GQOLI-74), was also used in included Chinese studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.1 Global state scales</HEADING>
<P>6.2.1.1 Clinical Global Impression Scale - CGI Scale (<LINK REF="REF-Guy-1976" TYPE="REFERENCE">Guy 1976</LINK>)<BR/>This is used to assess both severity of illness and clinical improvement, by comparing the conditions of the person standardised against other people with the same diagnosis. A seven-point scoring system is used with low scores showing decreased severity and/or overall improvement.</P>
<P>6.2.1.2 Investigator's Assessment Questionnaire - IAQ (<LINK REF="REF-Tandon-2005" TYPE="REFERENCE">Tandon 2005</LINK>)<BR/>The IAQ is a quantifiable clinical tool that can provide detailed information regarding common safety, efficacy and tolerability concerns that patients experience while taking antipsychotics. It has been shown to highly correlate with time to study discontinuation which is a common measure of effectiveness.</P>
<P>6.2.1.3 Arizona Sexual Experience Scale - ASEX (<LINK REF="REF-McGahuey-2000" TYPE="REFERENCE">McGahuey 2000</LINK>)<BR/>This is a brief scale for self-rating of sexual function. It has five items and is rated in five steps. Possible scores range from five to 30 with higher scores indicating more sexual dysfunction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.2 Mental state scales</HEADING>
<P>6.2.2.1 Positive and Negative Syndrome Scale - PANSS (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>)<BR/>This schizophrenia scale has 30 items, each of which can be defined on a seven-point scoring system varying from one - absent to seven - extreme. It can be divided into three sub scale for measuring the severity of general psychopathology, positive symptoms (PANSS-P), and negative symptoms (PANSS-N). A low score indicates lesser severity.</P>
<P>6.2.2.2 Positive and Negative Syndrome Scale-Excited Component - PANSS-EC (<LINK REF="REF-Chaichan-2008" TYPE="REFERENCE">Chaichan 2008</LINK>)<BR/>The PANSS-EC scale is derived as a sub scale of PANSS and is a simple scale used to measure the degree of agitation. The scale consists of five items (poor impulse control, tension, hostility, uncooperativeness, excitement) each being ranked from one to seven giving a potential maximum score of 35 points.</P>
<P>6.2.2.3 Brief Psychiatric Rating Scale &#8211; BPRS (<LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>)<BR/>This consists of 18 to 24 items (depending on the version) each rated on a scale from one (absent) to seven (extreme).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.3 Adverse effects scales</HEADING>
<P>6.2.3.1 Abnormal Involuntary Movement Scale - AIMS (<LINK REF="REF-Guy-1976" TYPE="REFERENCE">Guy 1976</LINK>)<BR/>This scale has been used to assess tardive dyskinesia, a long-term, drug-induced movement disorder and short-term movement disorders such as tremor.</P>
<P>6.2.3.2 Simpson Angus Scale - SAS (<LINK REF="REF-Simpson-1970" TYPE="REFERENCE">Simpson 1970</LINK>)<BR/>This 10-item scale (with a scoring system of zero to four on each item) measures drug-induced parkinsonism, a short-term drug-induced movement disorder. A low score indicates low levels of parkinsonism.</P>
<P>6.2.3.3 Barnes Akathisia Scale - BAS (<LINK REF="REF-Barnes-1989" TYPE="REFERENCE">Barnes 1989</LINK>)<BR/>The scale comprises items rating the observable, restless movements that characterise akathisia, a subjective awareness of restlessness, and any distress associated with the condition. These items are rated from zero (normal) to three (severe). In addition, there is an item for rating global severity (from zero (absent) to five (severe)). A low score indicates low levels of akathisia.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.2.4 Quality of Life</HEADING>
<P>6.2.4.1 Euro-QoL-5D - EQ-5D (<LINK REF="REF-Jelsma-2001" TYPE="REFERENCE">Jelsma 2001</LINK>)<BR/>The EuroQoL-5D is a generic preference based measure of health-related quality of life. It has five domains which are mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression, each having three short questions. The EQ-5D Utility score assesses all five items on a scale of zero to one, where zero represents worst possible health and one represents perfect health. The EQ-5D Health Dimension Scale assesses each item on three possible scores where one is the best and three the worst score.</P>
<P>6.2.4.2 Quality of Life Scale &#8211; QLS (<LINK REF="REF-Heinrichs-1984" TYPE="REFERENCE">Heinrichs 1984</LINK>)<BR/>Quality of Life Scale (QLS), a 21-item scale divided into four domains including Interpersonal relations, Instrumental role, Intrapsychic foundations and common objects/activities scored on a seven-point scale with lowest score indicating severe dysfunction.</P>
<P>6.2.4.3 Impact of Wieght on Quality of Life - IwQOL-Lite (<LINK REF="REF-Kolotkin-2002" TYPE="REFERENCE">Kolotkin 2002</LINK>)<BR/>This is a survey instrument that is used to quantitatively assess an individual's perception of how their weight affects their day-to-day life. This instrument is especially valuable to obesity researchers, clinicians, psychologists, medical device and/or pharmaceutical companies seeking to validate the effectiveness of their treatments for obesity using metrics that go beyond the physical measurements of weight loss.</P>
<P>6.2.4.4 World Health Organization Quality of Life Scale (WHOQoL-Bref, <LINK REF="REF-O_x0027_Carroll-2000" TYPE="REFERENCE">O'Carroll 2000</LINK>)</P>
<P>The WHOQoL-Bref is a 26-item self-report comprising satisfaction with health, psychological functioning, social relationships and environmental opportunities. Each item is scored on a five-point scale from one (poor) to five (worse). The Chinese version of the WHOQoL scale, the generic quality of life inventory (GQOLI-74), was also used in included Chinese studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.3 Adverse effects</HEADING>
<P>Adverse effects were mainly recorded in open interviews. In addition, continuous data were provided for weight, QTc time and cholesterol levels.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4 Missing outcomes</HEADING>
<P>No information was provided on the number of people hospitalised or global functioning. This can be an important and useful measure of the efficacy of medications being used. Also, not one study reported on functional outcomes, such as living skills, ability to live independently or employment. These trials clearly are more explanatory than pragmatic, focusing on whether in ideal circumstances aripiprazole has an effect rather than whether it would be useful in everyday routine care (<LINK REF="REF-Thorpe-2009" TYPE="REFERENCE">Thorpe 2009</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-10-24 15:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>There are a total of 79 excluded studies in this 2012 update. The most common reason for exclusion was because of lack of randomisation (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Awaiting classification</HEADING>
<P>Four studies are awaiting assessment (<LINK REF="STD-Wang-2006f" TYPE="STUDY">Wang 2006f</LINK>; <LINK REF="STD-Zhao-2006a" TYPE="STUDY">Zhao 2006a</LINK>; <LINK REF="STD-Zheng-XR-2008" TYPE="STUDY">Zheng XR 2008</LINK>; <LINK REF="STD-_x9676__x5efa__x9752__x002c_-2007" TYPE="STUDY">&#38518;&#24314;&#38738;, 2007</LINK>). Three of these were because of inconsistent reporting of denominators. Since we were unable to get clarification from the authors, we decided to leave these trials in <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> until further information becomes available. Please refer to <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK> for further details.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>There are 16 studies in this category (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>). There appeared to be much ongoing research activity in 2005 but completed studies have not yet been identified. We have contacted authors for current information but have received no updates.</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>For details please refer to the 'Risk of bias' table for each study and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK> and <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK> for the graphic overview.</P>
<ALLOCATION MODIFIED="2013-10-24 15:14:18 +0100" MODIFIED_BY="[Empty name]">
<P>The vast majority of included studies were rated as an 'unclear' risk of bias. Eighteen trials were rated as a 'low' risk of bias and described randomisation methods in some detail (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). Three of these used computer-generated voice recognition systems. It remained unclear whether there was a risk of bias. Only one study described the method of allocation concealment - by means of a sealed envelope (<LINK REF="STD-Wei-2006" TYPE="STUDY">Wei 2006</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>Only 11 included studies were described as double blind (<LINK REF="STD-Chen-2007a" TYPE="STUDY">Chen 2007a</LINK>; <LINK REF="STD-Du-2006" TYPE="STUDY">Du 2006</LINK>; <LINK REF="STD-Feng-2006" TYPE="STUDY">Feng 2006</LINK>; <LINK REF="STD-Fleischhacker-2008" TYPE="STUDY">Fleischhacker 2008</LINK>; <LINK REF="STD-Guo-2006" TYPE="STUDY">Guo 2006</LINK>; <LINK REF="STD-Kane-2009" TYPE="STUDY">Kane 2009</LINK>; <LINK REF="STD-Kinon-2004" TYPE="STUDY">Kinon 2004</LINK>; <LINK REF="STD-McQuade-2004" TYPE="STUDY">McQuade 2004</LINK>; <LINK REF="STD-Potkin-2003" TYPE="STUDY">Potkin 2003</LINK>; <LINK REF="STD-Xu-2010" TYPE="STUDY">Xu 2010</LINK>; <LINK REF="STD-Zimbroff-2007" TYPE="STUDY">Zimbroff 2007</LINK>). <LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK> and <LINK REF="STD-Potkin-2003" TYPE="STUDY">Potkin 2003</LINK> described using identical capsules for blinding. <LINK REF="STD-Zimbroff-2007" TYPE="STUDY">Zimbroff 2007</LINK> used double dummy administration of medication. The other studies did not provide any information on the blinding procedure. No study examined whether blinding was effective. Six studies were open label (<LINK REF="STD-Chen-2009" TYPE="STUDY">Chen 2009</LINK>; <LINK REF="STD-Kern-2006" TYPE="STUDY">Kern 2006</LINK>; <LINK REF="STD-Kerwin-2007" TYPE="STUDY">Kerwin 2007</LINK>; <LINK REF="STD-Tandon-2006" TYPE="STUDY">Tandon 2006</LINK>; <LINK REF="STD-Wlodzmierz-2006" TYPE="STUDY">Wlodzmierz 2006</LINK>; <LINK REF="STD-Wolf-2007" TYPE="STUDY">Wolf 2007</LINK>), and two described single-blinding (<LINK REF="STD-Zhang-2009a" TYPE="STUDY">Zhang 2009a</LINK>; <LINK REF="STD-Zhu-2005" TYPE="STUDY">Zhu 2005</LINK>). We found that the adverse effect profiles of examined compounds are quite different which may have made blinding difficult. We therefore conclude that the risk of bias for objective outcomes (e.g. death or laboratory values) was low but there was considerable risk of bias for subjective outcomes.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>In two studies the rates of participants leaving the study early were higher than 30% (<LINK REF="STD-McQuade-2004" TYPE="STUDY">McQuade 2004</LINK>; <LINK REF="STD-Potkin-2003" TYPE="STUDY">Potkin 2003</LINK>); in <LINK REF="STD-McQuade-2004" TYPE="STUDY">McQuade 2004</LINK> it was as high as 72%. Overall attrition was about 35% to 40%. Last observation carried forward (LOCF) method to account for participants leaving the study early was used in studies that made clear attrition numbers, which we now know to be a far from ideal assumption (<LINK REF="REF-Leucht-2007" TYPE="REFERENCE">Leucht 2007</LINK>). Only <LINK REF="STD-McQuade-2004" TYPE="STUDY">McQuade 2004</LINK>, however, analysed the study completers in a secondary analysis assuming that a participant who left the study prematurely would not have had a change of condition if he/she had stayed in the study. This assumption can also be misleading. The majority of new data from Chinese studies states no incomplete data - therefore, this domain is largely rated across studies as a 'low' risk of bias. Twenty-eight studies did not mention or make explicit any participants lost through attrition, and so were rated as an 'unclear' risk of bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>In terms of selective reporting there was a high risk of bias in the majority of included studies. Overall, only 13 studies rated as a 'low' risk of bias, and only one rated as 'unclear', meaning that the remainder of the 174 included studies (160) were rated at a 'high' risk of bias with not all recorded outcomes reported. Six studies reported only adverse events that occurred in at least 5% to 10% of participants (<LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>; <LINK REF="STD-Fleischhacker-2008" TYPE="STUDY">Fleischhacker 2008</LINK>; <LINK REF="STD-Kane-2009" TYPE="STUDY">Kane 2009</LINK>; <LINK REF="STD-Potkin-2003" TYPE="STUDY">Potkin 2003</LINK>; <LINK REF="STD-Zimbroff-2007" TYPE="STUDY">Zimbroff 2007</LINK>). By this procedure rare, but important adverse events, can be missed. <LINK REF="STD-Kinon-2004" TYPE="STUDY">Kinon 2004</LINK> reported adverse effects that occurred in at least 1% of patients. <LINK REF="STD-McQuade-2004" TYPE="STUDY">McQuade 2004</LINK> did not report on the PANSS positive sub score despite having recorded it. See funnel plots for the primary outcome of no clinically significant response (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>; <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>), where distrubution of studies is relatively symmetrical, except for comparison 5.1 (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>), perhaps owing to less included studies.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-06-25 16:17:42 +0100" MODIFIED_BY="[Empty name]">
<P>Many included studies were sponsored by the manufacturer of aripiprazole or the comparator drug. There is evidence that pharmaceutical companies may be selective in reporting the benefits and disadvantages of their own compounds (<LINK REF="REF-Heres-2006" TYPE="REFERENCE">Heres 2006</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-10-18 13:37:08 +0100" MODIFIED_BY="[Empty name]">
<P>We used risk ratios (RR) for dichotomous data and mean differences (MD) for continuous data, with their respective 95% confidence intervals (CIs) throughout.</P>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 1: ARIPIPRAZOLE versus CLOZAPINE</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1.1 Global state: 1. No clinically significant response (as defined by the original studies)</HEADING>
<P>Data demonstrate there was no difference between groups (29 RCTs, n = 2132, RR 1.05 CI 0.87 to 1.27, <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.2 Mental state: 1. Specific - binary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.2.1 Anxiety and agitation</HEADING>
<P>In the short term, there was significant favour (P = 0.01) for clozapine with higher levels of anxiety seen in participants receiving aripiprazole (11 RCTs, n = 732, RR 2.62 CI 1.21 to 5.70), however, with a slight degree of heterogeneity (ChI<SUP>2</SUP> = 13.34; df = 10; P = 0.21; I<SUP>2</SUP> = 25%). Data demonstrate no difference between groups at medium term (1 RCT, n = 90). Data for levels of agitation at short term demonstrated no difference between groups (1 RCT, n = 60, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.3 Mental state: 2. Average endpoint scores of various scales (short term, up to 12 weeks, high = poor)</HEADING>
<P>Data for all scales demonstrated no significant difference, including the BPRS (5 RCTs, n = 426); PANSS (23 RCTs, n = 1638), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 61.84; df = 22; P = 0.0; I<SUP>2</SUP> = 64%); and SANS (1 RCT, n = 50, <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.4 Mental state: 3. Average endpoint scores of various scales (medium term, 12 to 26 weeks, high = poor)</HEADING>
<P>When using PANSS, data from 3 RCTs significantly favoured (P = 0.0004) aripiprazole (n = 236, MD -5.41 CI -8.42 to -2.41, <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.5 Mental state: 4. Average endpoint scores of various scales (skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.6 Mental state: 5. Specific - average endpoint positive score (PANSS, high = poor)</HEADING>
<P>Overall, there was no difference between groups at both short and medium term (22 RCTs, n = 1523, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>), however there was considerable heterogeneity present (ChI<SUP>2</SUP> = 74.67; df = 21; P = 0.00001; I<SUP>2</SUP> = 72%).</P>
<P>By short term, data indicate no significant difference between groups (19 RCTs, n = 1287), however. considerable heterogeneity was present (ChI<SUP>2</SUP> = 66.47; df = 18; P = 0.00001; I<SUP>2</SUP> = 73%). Again, by the medium term, data indicate no significant difference between groups (3 RCTs, n = 236), however there was considerable heterogeneity present (ChI<SUP>2</SUP> = 5.87; df = 2; P = 0.05; I<SUP>2</SUP> = 66%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.7 Mental state: 6. Specific - average endpoint negative score (PANSS, high = poor)</HEADING>
<P>Overall, there was no significant difference between aripiprazole between short term and medium term (23 RCTs, n = 1640), however considerable heterogeneity was present (ChI<SUP>2</SUP> = 114.66; df = 22; P = 0.0001; I<SUP>2</SUP> = 81%).</P>
<P>Short-term data indicate no significant difference between groups (20 RCTs, n = 1404), however there was considerable heterogeneity present (ChI<SUP>2</SUP> = 51.61; df = 19; P = 0.0001; I<SUP>2</SUP> = 63%). Medium-term data significantly favoured aripiprazole (3 RCTs, n = 236, MD -3.24 CI -5.82 to -0.67, <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>), however with considerable heterogeneity (ChI<SUP>2</SUP> = 15.99; df = 2; P = 0.0003; I<SUP>2</SUP> = 87%)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.8 Mental state: 7. Specific - average endpoint general psychopathological score (PANSS, high = poor )</HEADING>
<P>Overall, data indicate no significant difference between groups (19 RCTs, n = 1330, <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Data indicate a significant difference (P = 0.02) favouring aripiprazole at medium term (3 RCTs, n = 236 MD -1.89 CI -3.45 to -0.34).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.9 Mental state: 8. Specific - average total score decreased rate (PANSS, low = poor)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.9.1 By up to 12 weeks</HEADING>
<P>Data in one small study indicate no significant difference between groups (1 RCT, n = 118, <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.10 Mental state: 9. Specific - average positive score decreased rate (PANSS, low = poor)</HEADING>
<P>Short-term data in one small study indicate no significant difference between groups (1 RCT, n = 118, <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.11 Leaving the study early</HEADING>
<P>Data demonstrate no significant difference between groups when leaving the study for any reasons (3 RCTs, n = 240, <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). This was also the case for adverse events (3 RCTs, n = 212) and due to 'economic issues' (1 RCT, n = 120).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.12 Quality of life: 1a. Average scores (short term, up to 12 weeks, WHO-QOL-100, low = poor)</HEADING>
<P>Data demonstrate statistical significance (P = 0.0001) in favour of aripiprazole in two small RCTs (n = 132, MD 2.59 CI 1.43 to 3.74, <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>). On the physical health component, data demonstrate statistical significance (P = 0.01) in favour of aripiprazole in two small RCTs (n = 132, MD 7.73 CI 1.51 to 13.94), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 6.04; df = 1; P = 0.014; I<SUP>2</SUP> = 83%). Again, mental health component data demonstrate statistical significance (P = 0.0001) in favour of aripiprazole in two small RCTs (n = 132, MD 9.21 CI 4.74 to 13.68), however there was considerable heterogeneity present (ChI<SUP>2</SUP> = 2.31; df = 1; P = 0.13; I<SUP>2</SUP> = 57%). Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of aripiprazole for the spiritual support component (1 RCT, n = 72, MD 6.61 CI 4.25 to 8.97), and for external environment (P = 0.0001) (3 RCTs, n = 248, MD 13.82 CI 8.69 to 18.94) again with considerable heterogeneity present (ChI<SUP>2</SUP> = 7.63; df = 2; P = 0.02; I<SUP>2</SUP> = 74%).<BR/>Data demonstrate no statistical significance for social function (2 RCTs, n = 132) again with considerable heterogeneity present (ChI<SUP>2</SUP> = 23.23; df = 1; P = 0.00001; I<SUP>2</SUP> = 96%) or independence (1 RCT, n = 72).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.13 Quality of life: 1b. Average scores (medium term, 12 to 24 weeks, WHO-QOL-100, low = poor)</HEADING>
<P>The endpoint score demonstrated statistical significance (P = 0.00001) in favour of aripiprazole (2 RCTs, n = 176, MD 2.75 CI 1.98 to 3.53, <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). Data demonstrate statistical significance in the physical health component (P = 0.04) in favour of aripiprazole (3 RCTs, n = 256, MD 4.89 CI 0.22 to 9.56), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 33.90; df = 2; P = 0.00001; I<SUP>2</SUP> = 94%). Mental health data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (3 RCTs, n = 256, MD 7.39 CI 5.26 to 9.53), again with considerable heterogeneity present (ChI<SUP>2</SUP> = 2.6; df = 2; P = 0.27; I<SUP>2</SUP> = 23%). This was also the case for social function with significant favour (P = 0.0008) of aripiprazole (3 RCTs, n = 256, MD 6.68 CI 2.79 to 10.56), again with considerable heterogeneity present (ChI<SUP>2</SUP> = 13.19; df = 2; P = 0.001; I<SUP>2</SUP> = 85%). Data in two small studies demonstrate statistical significance (P = 0.00001) in favour of aripiprazole for the independence component (2 RCTs, n = 176, MD 6.71 CI 4.76 to 8.66). Data demonstrate no significant difference between groups for material life (1 RCT, n = 80) and spiritual support (2 RCTs, n = 176).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.14 Quality of life: 2. Average endpoint general quality of life score (GQOLI - 74, low = poor)</HEADING>
<P>Physical health data from one small RCT demonstrate statistical significance (P = 0.01) in favour of aripiprazole ( n = 120, MD 7.70 CI 2.95 to 12.45, <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). Data for social function from one small RCT demonstrate statistical significance (P = 0.0002) in favour of aripiprazole (n = 120, MD 6.60 CI 3.15 to 10.05). Data from one small RCT demonstrate statistical significance (P = 0.0002) in favour of aripiprazole for environmental area (n = 90, MD 11.50 CI 5.55 to 17.45) and independence (P = 0.0003) in favour of aripiprazole (n = 90, MD 6.16 CI 2.84 to 9.48). No significant difference was found for: total GQOLI score (1 RCT, n = 114); mental health data (1 RCT, n = 120); and material life (1 RCT, n = 120)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.15 Adverse effects:1. At least one adverse effect, non-specific</HEADING>
<P>Data demonstrate statistical significance (P = 0.02) in favour of aripiprazole, with more people receiving clozapine experiencing at least one adverse effect (7 RCTs, n = 574, RR 0.67 CI 0.48 to 0.95, <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 18.17; df = 7; P = 0.01; I<SUP>2</SUP> = 61%). There was no significant difference between groups in the short term for: epilepsy (1 RCT, n = 60); abnormal liver function (5 RCTs, n = 364); stuffy nose (3 RCTs, n = 258); sweating (1 RCT, n = 74); urinary retention (2 RCTs, n = 132); and urinary incontinence (2 RCTs, n = 120).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.16 Adverse effects: 2. Cardiac effects</HEADING>
<P>Overall, less cardiac effects were seen in people receiving aripiprazole compared with clozapine.</P>
<P>Significant results were found in the short term for abnormal ECG (P = 0.00001), with less occurrences found in people receiving aripiprazole (12 RCTs, n = 921, RR 0.38 CI 0.29 to 0.51, <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>). Data were also significantly in favour of aripiprazole (P = 0.0003) for short-term general adverse cardiac events (1 RCT, n = 62, RR 0.32 CI 0.17 to 0.60). QTc prolongation was significantly in favour (P = 0.001) of aripiprazole in both the short (4 RCTs, n = 334, RR 0.16 CI 0.05 to 0.49) and medium (P = 0.03) term (1 RCT, n = 90, RR 0.05 CI 0.00 to 0.79), as well as tachycardia (P = 0.00001) in the short term (15 RCTs, n = 1104, RR 0.29 CI 0.22 to 0.38). There was no significant difference between groups for a short-term decrease in blood pressure (3 RCTs, n = 194); and medium-term tachycardia (1 RCT, n = 60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.17 Adverse effects: 3. Central/peripheral nervous system</HEADING>
<P>Data showing a decrease in activity from one small RCT demonstrate statistical significance (P = 0.0002) in favour of aripiprazole at short term (n = 120, RR 0.21 CI 0.10 to 0.48, <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>). This was also the case for blurred vision (P = 0.003) (6 RCTs, n = 472, RR 0.29 CI 0.12 to 0.66) with slight heterogeneity present (ChI<SUP>2</SUP> = 9.11; df = 5; P = 0.105; I<SUP>2</SUP> = 45%). Dizziness was also seen significantly more at short term (P = 0.05) in people receiving clozapine (9 RCTs, n = 698, RR 0.60 CI 0.36 to 1.00). Data from one small RCT for general vegetative nervous system adverse reaction demonstrate statistical significance (P = 0.01) in favour of aripiprazole (n = 62, RR 0.48 CI 0.27 to 0.84) by short term. Other short-term CNS adverse effects that were significantly in favour of aripiprazole include; hyper-salivation (P = 0.00001) (16 RCTs, n = 1074, RR 0.06 CI 0.03 to 0.10); memory decline (P = 0.04) (1 RCT n = 80, RR 0.13 CI 0.02 to 0.95); sedation (P = 0.02) (n = 80, RR 0.03 CI 0.00 to 0.52); and somnolence (P = 0.00001) (21 RCTs, n = 1492, RR 0.15 CI 0.09 to 0.24), with slight heterogeneity present (ChI<SUP>2</SUP> = 35.6; df = 20; P = 0.02; I<SUP>2</SUP> = 44%).</P>
<P>Data significantly favoured clozapine at medium term for: headache (P = 0.03) (16 RCTs, n = 1102, RR 2.28 CI 1.07 to 4.86), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 45.69; df = 15; P = 0.0001; I<SUP>2</SUP> = 67%); and insomnia (P = 0.00001) (14 RCTs, n = 990, RR 5.62 CI 2.90 to 10.91).</P>
<P>There was no difference between groups in the short term for: increase in activity (1 RCT, n = 48); fatigue (4 RCTs, n = 300); general CNS adverse reaction (1 RCT, n = 62); irritability (2 RCTs, n = 120); as well as insomnia at medium term (1 RCT, n = 90); and headache at medium term (1 RCT, n = 90).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.18 Adverse effects: 4. Extrapyramidal effects</HEADING>
<P>No significant difference was found between groups at short term for the following outcomes: general EPS (8 RCTs, n = 520); tardive dyskinesia (1 RCT, n = 72). For medium-term outcomes, the following demonstrated no significant difference: akathisia (1 RCT, n = 80); dystonia (1 RCT, n = 80); spasmodic torticollis (1 RCT, n = 80); and tremor (1 RCT, n = 80, <LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>).</P>
<P>The only homogenous data that demonstrate statistical significance (P = 0.01) was in favour of clozapine for the outcome of dystonia at short term (5 RCTs, n = 374, RR 3.24 CI 1.29 to 8.12). All other data either presented no significant difference between groups, or no difference with varying degrees of heterogeneity. The latter include short-term data for akathisia, with no significant difference between groups (13 RCTs, n = 916, RR 1.21 CI 0.54 to 2.68) with considerable heterogeneity present (ChI<SUP>2</SUP> = 25.43; df = 12; P = 0.01; I<SUP>2</SUP> = 53%). Data for tremor at short term demonstrated no significant difference between groups (6 RCTs, n = 460, RR 1.99 CI 0.72 to 5.48) with slight heterogeneity present (ChI<SUP>2</SUP> = 7.17; df = 5; P = 0.208; I<SUP>2</SUP> = 30%). This was the same for use of antiparkinson medication in the short term (2 RCTs, n = 140, RR 2.84 CI 0.07 to 117.07) with considerable heterogeneity present (ChI<SUP>2</SUP> = 6.94; df = 1; P = 0.008; I<SUP>2</SUP> = 86%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.19 Adverse effects: 5. Gastrointestinal</HEADING>
<P>No significant difference was found in the short term for: general gastrointestinal adverse reaction (2 RCTs, n = 130); and indigestion (1 RCT, n = 60). Data for dry mouth at short term also demonstrated no significant difference between groups (4 RCTs, n = 268, RR 0.64 CI 0.08 to 5.38) with substantial heterogeneity present (ChI<SUP>2</SUP> = 13.3; df = 3; P = 0.004; I<SUP>2</SUP> = 77%). This was also true for nausea/vomiting (10 RCTs, n = 790, RR 1.55 CI 0.71 to 3.38) again with heterogeneity present (ChI<SUP>2</SUP> = 17.01; df = 9; P = 0.05; I<SUP>2</SUP> = 47%, <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>).</P>
<P>Data were significantly in favour of clozapine for abdominal discomfort or pain at short term (P = 0.03) (2 RCTs. n = 132, RR 10.21 CI 1.32 to 79.12). Short-term data for constipation demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (19 RCTs, n = 1390, RR 0.15 CI 0.08 to 0.31) with substantial heterogeneity present (ChI<SUP>2</SUP> = 74.05; df = 18; P = 0.0; I<SUP>2</SUP> = 76%). Remaing data for medium-term outcomes were in favour of aripiprazole, with significantly less instances of constipation (P = 0.007) (1 RCT, n = 90, RR 0.02 CI 0.00 to 0.36) and hyper-salivation (P = 0.005) (1 RCT, n = 90, RR 0.02 CI 0.00 to 0.29).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.20 Adverse effects: 6. Haematological</HEADING>
<P>All data for this outcome were homogenous and statistically significant in favour of aripiprazole, including abnormal blood routine in the short term (P = 0.007) (5 RCTs, n = 368, RR 0.16 CI 0.04 to 0.60, <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>); and leucopenia in the short term (P = 0.002) (10 RCTs, n = 726, RR 0.21 CI 0.08 to 0.56). Abnormal blood routine in the medium term also demonstrates statistical significance (P = 0.008) in favour of aripiprazole (2 RCTs, n = 152, RR 0.32 CI 0.14 to 0.75).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.21 Adverse effects: 7. Hormonal (short term, up to 12 weeks)</HEADING>
<P>Data for lactation or menstrual changes demonstrate statistical significance (P = 0.003) in favour of aripiprazole (3 RCTs, n = 214, RR 0.11 CI 0.03 to 0.47, <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.22 Adverse effects: 8a. Metabolic - binary measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.22.1 Blood glucose - increased (short term, up to 12 weeks)</HEADING>
<P>Data demonstrate statistical significance (P = 0.0002) in favour of aripiprazole (5 RCTs, n = 410, RR 0.12 CI 0.04 to 0.37, <LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.2 C-peptide (short term, up to 12 weeks)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.01) in favour of aripiprazole (1 RCT, n = 60, RR 0.03 CI 0.00 to 0.45).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.3 Decrease appetite (short term, up to 12 weeks)</HEADING>
<P>Data demonstrate statistical significance (P = 0.01) in favour of aripiprazole (2 RCTs, n = 130, RR 0.07 CI 0.01 to 0.54).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.4 Postural hypotension (short term, up to 12 weeks)</HEADING>
<P>Data demonstrate statistical significance (P = 0.001) in favour of aripiprazole (5 RCTs, n = 344, RR 0.16 CI 0.07 to 0.39).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.5 PRL- increase (short term, up to 12 weeks)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.04) in favour of aripiprazole (1 RCT, n = 48, RR 0.05 CI 0.00 to 0.82).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.6 Weight gain (short term, up to 12 weeks)</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (18 RCTs, n = 1318, RR 0.13 CI 0.08 to 0.22).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.7 Blood glucose - increased (medium term, 12 to 24 weeks)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 90).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.8 Decreased appetite (medium term, 12 to 24 weeks)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.05) in favour of aripiprazole (n = 90, RR 0.06 CI 0.00 to 0.99).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.22.9 Weight gain (medium term, 12 to 24 weeks)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.009) in favour of aripiprazole (n = 90, RR 0.02 CI 0.00 to 0.39, <LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.23 Adverse effects: 8b. Metabolic - continuous measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.23.1 Blood glucose - FPG in HbA1c normal group (in mmol/L</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 36).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.23.2 Blood glucose - FPG in HbA1c abnormal group (in mmol/L)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 19).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.23.3 Blood glucose - PBG in HbA1c normal group (in mmol/L)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 36).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.23.4 Blood glucose - PBG in HbA1c abnormal group (in mmol/L)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (1 RCT, n = 19, MD -1.90 CI -2.63 to -1.17).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.23.5 Blood glucose - FPG average endpoint (in mmol/L)</HEADING>
<P>Data demonstrate statistical significance (P = 0.0009) in favour of aripiprazole (2 RCTs, n = 134, MD -0.52 CI -0.83 to -0.22).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.23.6 Blood glucose - C-peptide average endpoint (in mg/dlmmol/L)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.05) in favour of aripiprazole (1 RCT, n = 60, MD -0.72 CI -1.45 to 0.01).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.23.7 Weight gain - average endpoint level (in kg)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 74, <LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.24 Cost-effectiveness analysis (skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 2: ARIPIPRAZOLE versus QUETIAPINE</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">2.1 Global state: 1. No clinically significant response (as defined by original studies)</HEADING>
<P>Data demonstrate no significant difference between groups (12 RCTs, n = 991, <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.2 Global state: 2 a. Average endpoint total score (short term, up to 12 weeks, high = poor)</HEADING>
<P>Data for the CGI demonstrate no significant difference between groups (1 RCT, n = 80, <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). This was also the case for PANSS (10 RCTs, n = 831), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 21.14; df = 9; P = 0.012; I<SUP>2</SUP> = 57%). Data from the BPRS from one small RCT demonstrate statistical significance (P = 0.007) in favour of aripiprazole (1 RCT, n = 80, MD -2.63 CI -4.55 to -0.71).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.3 Global state: 2b. Average endpoint scale score (medium term, 12 to 24 weeks, high = poor)</HEADING>
<P>Data for PANSS demonstrate no significant difference between groups (1 RCT, n = 100, <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.4 Global state: 3. Average endpoint SI score (CGI, high = poor)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.4.1 Up to 12 weeks - short term</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 108, <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.5 Mental state: 2a. Specific - binary outcomes</HEADING>
<P>There was no significant difference between groups in the short term for: agitation (5 RCTs, n = 423); anxiety (2 RCTs, n = 168); and depression (1 RCT, n = 108, <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>). This was also the case for agitation at medium term (1 RCT, n = 100).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.6 Mental state: 3. Specific - average endpoint positive score (PANSS, high = poor)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.6.1 By up to 12 weeks - short term</HEADING>
<P>Short-term data demonstrate no significant difference between groups (7 RCTs, n = 583, <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>) with substantial heterogeneity present (ChI<SUP>2</SUP> = 20.25; df = 6; P = 0.002; I<SUP>2</SUP> = 70%). Medium term data, again, demonstrate no significant difference between groups (1 RCT, n = 100).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.7 Mental state: 4. Specific - average endpoint negative score (PANSS, high = poor)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.7.1 Up to 12 weeks - short term</HEADING>
<P>Short-term data demonstrate no significant difference between groups using PANSS negative score (6 RCTs, n = 443, <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>); this is also the case for medium-term data (1 RCT, n = 100).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.8 Mental state: 5. Specific - average endpoint general pathological score (PANSS, high = poor )</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.8.1 Up to 12 weeks - short term</HEADING>
<P>Short-term data for PANSS pathological score demonstrate no significant difference between groups (10 RCTs, n = 831, <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>) with substantial heterogeneity present (ChI<SUP>2</SUP> = 83.29; df = 9; P = 0.00001; I<SUP>2</SUP> = 89%). Medium-term data also demonstrate no significant difference between groups (1 RCT, n = 100).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.9 Mental state: 6. Average scores of various scales (skewed)</HEADING>
<P>All data for the various scales are skewed and are best inspected by viewing <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.10 Leaving the study early</HEADING>
<P>All data for leaving the study early showed no significant difference between groups: any reason (2 RCTs, n = 168); because of no effect (1 RCT, n = 108); early discharge (1 RCT, n = 60); early treatment termination (2 RCTs, n = 168); violation of test scheme (1 RCT, n = 108); and withdrawal of informed consent (1 RCT, n = 108, <LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.11 Quality of life: Average score (medium term, 12 to 24 weeks, WHO-QOL-100, low = poor)</HEADING>
<P>The majority of data from a single study are significantly in favour of aripiprazole for a better outcome using this scale, including; total score (P = 0.0001) (1 RCT, n = 100, MD 2.60 CI 1.31 to 3.89); physical health (P = 0.00001) (1 RCT, n = 100, MD 6.00 CI 4.38 to 7.62); mental health (P = 0.00001) (1 RCT, n = 100, MD 9.10 CI 5.92 to 12.28); social function (P = 0.00001) (1 RCT, n = 100, MD 5.60 CI 3.33 to 7.87); environmental area (P = 0.0001) (1 RCT, n = 100, MD 11.50 CI 5.86 to 17.14); and independence (P = 0.0001) (1 RCT, n = 100, MD 6.20 CI 3.05 to 9.35, <LINK REF="CMP-002.11" TYPE="ANALYSIS">Analysis 2.11</LINK>). Data for spiritual pillar demonstrate no significant difference between groups (1 RCT, n = 100).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.12 Adverse effects: 1. At least one adverse effect</HEADING>
<P>For non-specific adverse effects, data demonstrate no significant difference between groups (3 RCTs, n = 258). All other data also demonstrated no significant difference, including: abnormal urinary test results (1 RCT, n = 108); abnormal liver function (8 RCTs, n = 658); stuffy nose (2 RCTs, n = 188); sweating (1 RCT, n = 70); urine routine abnormal (1 RCT, n = 80, <LINK REF="CMP-002.12" TYPE="ANALYSIS">Analysis 2.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.13 Adverse effects: 2. Cardiac effects (short term, up to 12 weeks)</HEADING>
<P>Data for tachycardia demonstrate statistical significance (P = 0.003) in favour of aripiprazole (8 RCTs, n = 643, RR 0.35 CI 0.18 to 0.69). All other data demonstrate no significant difference between groups: abnormal ECG (6 RCTs, n = 528); decrease in blood pressure (4 RCTs, n = 348); and QTc prolongation (3 RCTs, n = 225, <LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.14 Adverse effects: 3a. Central nervous system</HEADING>
<P>No significant difference was found between groups in the short term for the following outcomes: blurred vision (6 RCTs, n = 521); dizziness (8 RCTs, n = 671); headache (5 RCTs, n = 436) with substantial heterogeneity present (ChI<SUP>2</SUP> = 13.42; df = 4; P = 0.009; I<SUP>2</SUP> = 70%); and insomnia (7 RCTs, n = 591). There was no difference at medium term for: dizziness (1 RCT, n = 100); insomnia (1 RCT, n = 100); or somnolence (1 RCT, n = 100, <LINK REF="CMP-002.14" TYPE="ANALYSIS">Analysis 2.14</LINK>).</P>
<P>Data at short term for somnolence demonstrate statistical significance (P = 0.01) in favour of aripiprazole (9 RCTs, n = 731, RR 0.34 CI 0.15 to 0.77) with heterogeneity present (ChI<SUP>2</SUP> = 18.37; df = 8; P = 0.019; I<SUP>2</SUP> = 56%). Medium-term data for headache demonstrate statistical significance (P = 0.03) in favour of quetiapine (1 RCT, n = 100, RR 9.00 CI 1.18 to 48.42).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.15 Adverse effects: 4. Various extrapyramidal symptoms (short term, up to 12 weeks)</HEADING>
<P>All data demonstrated no significant difference between groups for akathisia (7 RCTs, n = 571, <LINK REF="CMP-002.15" TYPE="ANALYSIS">Analysis 2.15</LINK>); dystonia (2 RCTs, n = 145); general EPS (4 RCTs, n = 348); and tremor (4 RCTs, n = 343).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.16 Adverse effects: 5. Gastrointestinal</HEADING>
<P>Data were significantly in favour of aripiprazole in the shot term from constipation (P = 0.005) (7 RCTs, n = 591, RR 0.38 CI 0.19 to 0.75, <LINK REF="CMP-002.16" TYPE="ANALYSIS">Analysis 2.16</LINK>); dry mouth (P = 0.0007) (7 RCTs, n = 611, RR 0.23 CI 0.10 to 0.53); and in the medium term for dry mouth (P = 0.009) (1 RCT, n = 100, RR 0.11 CI 0.01 to 0.84). Data were significantly in favour of quetiapine in the short term for: nausea/ vomiting (P = 0.004) (7 RCTs, n = 611, RR 2.68 CI 1.36 to 5.26).There was no significant difference at medium term for nausea/vomiting (1 RCT, n = 100).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.17 Adverse effects: 6. Haematological</HEADING>
<P>Data demonstrate no significant difference in the short term for abnormal blood routine (1 RCT, n = 85, <LINK REF="CMP-002.17" TYPE="ANALYSIS">Analysis 2.17</LINK>) and leucopenia (2 RCTs, n = 140).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.18 Adverse effects: 7. Hormonal - binary measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.18.1 Menstrual disorder (short term, up to 12 weeks)</HEADING>
<P>There was no significant difference between groups for menstrual disorder at both short term (6 RCTs, n = 518) and medium term (1 RCT, n = 100, <LINK REF="CMP-002.18" TYPE="ANALYSIS">Analysis 2.18</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.19 Adverse effects: 8a. Metabolic - binary measures</HEADING>
<P>At short term, there was no significant difference between groups for a decrease in appetite (4 RCTs, n = 328) and lactation (5 RCTs, n = 383). Medium data were also not significant for weight gain (1 RCT, n = 100). Data were significantly in favour of aripiprazole in the short term for weight gain (P = 0.01) (10 RCTs, n = 823, RR 0.45 CI 0.24 to 0.85) and at medium term for decreased appetite (P = 0.05) (1 RCT, n = 100, RR 0.13 CI 0.02 to 0.96, <LINK REF="CMP-002.19" TYPE="ANALYSIS">Analysis 2.19</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.20 Adverse effects: 8b.Metabolic - continuous measure</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.03) in favour of aripiprazole for cholesterol TC average endpoint level (in mmol/L) (1 RCT, n = 180, MD -0.19 CI -0.36 to -0.02, <LINK REF="CMP-002.20" TYPE="ANALYSIS">Analysis 2.20</LINK>). However, all other data demonstrated no significant difference between groups.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 3: ARIPIPRAZOLE versus RISPERIDONE</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">3.1 Global state: 1.No clinically significant response (as defined by the original studies)</HEADING>
<P>Data are equivocal at short term, demonstrating no significant difference between groups (80 RCTs, n = 6381, RR 1.08 CI 0.96 to 1.21, <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.2 Global state: 2. Average endpoint total score (short term, up to 12 weeks, CGI, high = poor)</HEADING>
<P>Data demonstrate statistical significance (P = 0.006) in favour of risperidone (2 RCTs, n = 196, MD 0.35 CI 0.09 to 0.61, <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.3 Global state: 3.Average CGI subscale scores (short term, up to 12 weeks, high = poor)</HEADING>
<P>CGI-EI data demonstrate statistical significance (P = 0.006) in favour of risperidone (1 RCT, n = 120, MD 0.50 CI 0.14 to 0.86, <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>), and CGI-SI data demonstrate statistical significance (P = 0.006) in favour of risperidone (1 RCT, n = 120, MD 0.40 CI 0.12 to 0.68).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.4 Global state average endpoint of various scales (skewed)</HEADING>
<P>All data are skewed and are best inspected by viewing <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.5 Mental state: 1. Specific - binary outcomes (short term, up to 12 weeks)</HEADING>
<P>Data for anxiety demonstrate statistical significance (P = 0.01) in favour of risperidone (9 RCTs, n = 744, RR 1.81 CI 1.12 to 2.94, <LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>); however all other data are equivocal, demonstrating no difference between groups, including for agitation/excitement (26 RCTs, n = 2038) and irritability (1 RCT, n = 100).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.6 Mental state: 2a. Average endpoint scale score (short term, up to 12 weeks, high = poor)</HEADING>
<P>Data at short term for BPRS demonstrate statistical significance (P = 0.004) in favour of aripiprazole (5 RCTs, n = 570, MD -1.33 CI -2.24 to -0.42, <LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>), as were data for PANSS short term which showed a risk reduction by 0.8 on the PANSS scale favouring aripiprazole group (77 RCTs, n = 5733, MD -0.80 95% CI -1.58 to -0.02, <LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>). However, all other data show no significant difference between groups: PANSS medium term (1 RCT, n = 50) and SANS medium term (1 RCT, n = 50).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.7 Mental state: 3. Specific - average endpoint positive score (PANSS, high = poor)</HEADING>
<P>Data are equivocal at both short and medium term, demonstrating no significant difference between groups (40 RCTs, n = 3205, MD 0.02 CI -0.37 to 0.41, <LINK REF="CMP-003.07" TYPE="ANALYSIS">Analysis 3.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.8 Mental state: 4. Specific - average endpoint negative score (PANSS, high = poor)</HEADING>
<P>Data demonstrate statistical significance (P = 0.001) in favour of aripiprazole at short term (37 RCTs, n = 2976, MD -0.64 CI -1.04 to -0.25, <LINK REF="CMP-003.08" TYPE="ANALYSIS">Analysis 3.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.9 Mental state: 5. Specific - average endpoint general psychopathological score (PANSS, high = poor)</HEADING>
<P>Data are equivocal at both short and medium term, demonstrating no significant difference between groups (58 RCTs, n = 4243, MD -0.25 CI -0.71 to 0.20, <LINK REF="CMP-003.09" TYPE="ANALYSIS">Analysis 3.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.10 Mental state: 6. PANSS average score decreased rate (short term, up to 12 weeks, low = poor)</HEADING>
<P>Data for total scale score decreased rate demonstrate statistical significance (P = 0.03) in favour of aripiprazole (3 RCTs, n = 219, MD 3.06 CI 0.24 to 5.87, <LINK REF="CMP-003.10" TYPE="ANALYSIS">Analysis 3.10</LINK>). All other data demonstrate no significant difference between groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.11 Mental state: 7. BPRS total score decreased rate (short term, up to 12 weeks, high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 132, MD -2.97 CI -6.61 to 0.67, <LINK REF="CMP-003.11" TYPE="ANALYSIS">Analysis 3.11</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.12 Mental state: 8. General - average total score (PANSS, high = poor)</HEADING>
<P>Data from two RCTs demonstrate no significant difference between groups at short term (2 RCTs, n = 372, MD 1.50 CI -2.96 to 5.96, <LINK REF="CMP-003.12" TYPE="ANALYSIS">Analysis 3.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.13 Mental state: 9. Average scores of various scale (skewed)</HEADING>
<P>All data for this outcome are skewed, and are best inspected by viewing <LINK REF="CMP-003.13" TYPE="ANALYSIS">Analysis 3.13</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.14 Leaving the study early</HEADING>
<P>All data for leaving the study early demonstrate no significant difference between groups, including leaving for any reason (12 RCTs, n = 1239, <LINK REF="CMP-003.14" TYPE="ANALYSIS">Analysis 3.14</LINK>); progressive disease (2 RCTs, n = 188); incomplete data (1 RCT, n = 180); adverse effects (9 RCTs, n = 1272); and no effect of study drug (5 RCTs, n = 681).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.15 Adverse effects: 1. At least one adverse effect, non-specific</HEADING>
<P>With more non-specific adverse effects seen with people receiving risperidone, data demonstrate statistical significance (P = 0.0002) in favour of aripiprazole (28 RCTs, n = 2361, RR 0.81 CI 0.73 to 0.91, <LINK REF="CMP-003.15" TYPE="ANALYSIS">Analysis 3.15</LINK>). Generally, data demonstrated no significant difference between groups, including hyper-salivation (7 RCTs, n = 554), and sweating (4 RCTs, n = 278).<BR/>
<BR/>Data demonstrate statistical significance (P = 0.003) in favour of aripiprazole for abnormal liver function (29 RCTs, n = 2300, RR 0.63 CI 0.46 to 0.86) and sexual desire change (P = 0.0001) (8 RCTs, n = 614, RR 0.11 CI 0.04 to 0.30).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.16 Adverse effects: 2a.Cardiac effects (short term, up to 12 weeks)</HEADING>
<P>Data for tachycardia demonstrate statistical significance (P = 0.02) in favour of aripiprazole (49 RCTs, n = 3835, RR 0.76 CI 0.61 to 0.96, <LINK REF="CMP-003.16" TYPE="ANALYSIS">Analysis 3.16</LINK>). All other data are equivocal, demonstrating no significant difference between groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.17 Adverse effects: 2b. Cardiac - QTc change from baseline (in ms)</HEADING>
<P>Data demonstrate statistical significance (P = 0.005) in favour of aripiprazole (2 RCTs, n = 383, MD -7.19 CI -12.19 to -2.19, <LINK REF="CMP-003.17" TYPE="ANALYSIS">Analysis 3.17</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.18 Adverse effects: 3. Central nervous system (short term, up to 12 weeks)</HEADING>
<P>The majority of data are equivocal, demonstrating no difference between groups. Data for headache demonstrate statistical significance (P = 0.01) in favour of risperidone (20 RCTs, n = 1505, RR 1.91 CI 1.31 to 2.78, <LINK REF="CMP-003.18" TYPE="ANALYSIS">Analysis 3.18</LINK>). Data from one small RCT demonstrate statistical significance (P = 0.04) in favour of aripiprazole for decrease in memory, with higher instances seen in people receiving risperidone (1 RCT, n = 60, RR 0.22 CI 0.05 to 0.94).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.19 Adverse effects: 3a. Endocrine - Prolactin - average change (ng/mL)</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (2 RCTs, n = 383, MD -54.71 CI -60.06 to -49.36, <LINK REF="CMP-003.19" TYPE="ANALYSIS">Analysis 3.19</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.20 Adverse effects: 3b. Endocrine - Prolactin - associated</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of aripiprazole for abnormally high prolactin value (1 RCT, n = 301, RR 0.04 CI 0.02 to 0.08, <LINK REF="CMP-003.20" TYPE="ANALYSIS">Analysis 3.20</LINK>). Data demonstrate no significant difference between groups for dysmenorrhoea (1 RCT, n = 91).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.21 Adverse effects:4.Various extrapyramidal symptoms (short term, up to 12 weeks)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.21.1 Akathisia</HEADING>
<P>Data demonstrate statistical significance of aripiprazole for: akathisia (P = 0.00001) (42 RCTs, n = 3501, RR 0.60 CI 0.48 to 0.74, <LINK REF="CMP-003.21" TYPE="ANALYSIS">Analysis 3.21</LINK>); tremor (P = 0.00001) (36 RCTs, n = 2799, RR 0.35 CI 0.27 to 0.45); dystonia (P = 0.00001) (32 RCTs, n = 2640, RR 0.35 CI 0.25 to 0.49); and EPS (P = 0.00001) (31 RCTs, n = 2605, RR 0.39 CI 0.31 to 0.50) with slight heterogeneity present (ChI<SUP>2</SUP> = 53.91; df = 30; P = 0.005; I<SUP>2</SUP> = 44%). All other data demonstrate no difference between groups for parkinsonism (1 RCT, n = 301); use of antiparkinson medication (1 RCT, n = 83); tremor (2 RCTs, n = 391).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.22 Adverse effects: 4b. Extrapyramidal - average score</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.22.1 Abnormal Involuntary Movement Scale (high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 383, MD -0.25 CI -1.24 to 0.75, <LINK REF="CMP-003.22" TYPE="ANALYSIS">Analysis 3.22</LINK>) with considerable heterogeneity present (ChI<SUP>2</SUP> = 3.09; df = 1; P = 0.079; I<SUP>2</SUP> = 68%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.22.2 Barnes Akathisia Scale (high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 383, MD -0.11 CI -0.49 to 0.27) with slight heterogeneity present (ChI<SUP>2</SUP> = 1.98; df = 1; P = 0.16; I<SUP>2</SUP> = 49%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.22.3 Simpson-Angus Scale (high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 383, MD -0.70 CI -2.22 to 0.82) with substantial heterogeneity present (ChI<SUP>2</SUP> = 5.11; df = 1; P = 0.024; I<SUP>2</SUP> = 80%).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.23 Adverse effects: 5. Gastrointestinal</HEADING>
<P>Data for constipation (27 RCTs, n = 2067) and dry mouth (33 RCTs, n = 2658) are equivocal, demonstrating no significant difference between groups (<LINK REF="CMP-003.23" TYPE="ANALYSIS">Analysis 3.23</LINK>). For nausea and vomiting data demonstrate statistical significance (P = 0.00001) in favour of risperidone (28 RCTs, n = 2180, RR 1.84 CI 1.31 to 2.56).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.24 Adverse effects: 6. Haematological</HEADING>
<P>All data demonstrate no difference between groups for abnormal blood routine (6 RCTs, n = 515, <LINK REF="CMP-003.24" TYPE="ANALYSIS">Analysis 3.24</LINK>); leucopenia (1 RCT, n = 60) and abnormal blood lipids (1 RCT, n = 80).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.25 Adverse effects: 7a. Metabolic - binary measures (short term, up to 12 weeks)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.25.1 Appetite - decrease</HEADING>
<P>Data demonstrate statistical significance (P = 0.05) in favour of aripiprazole (2 RCTs, n = 204, RR 0.26 CI 0.07 to 1.03, <LINK REF="CMP-003.25" TYPE="ANALYSIS">Analysis 3.25</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.2 Blood glucose- increase</HEADING>
<P>Data demonstrate statistical significance (P = 0.02) in favour of aripiprazole (5 RCTs, n = 358, RR 0.28 CI 0.09 to 0.82).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.3 Endocrine disorder</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (9 RCTs, n = 642, RR 0.07 CI 0.03 to 0.17).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.4 Lactation</HEADING>
<P>Data demonstrate statistical significance (P = 0.01) in favour of aripiprazole (3 RCTs, n = 216, RR 0.11 CI 0.02 to 0.60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.5 Menstrual disorder/lactation</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (29 RCTs, n = 2278, RR 0.10 CI 0.06 to 0.16).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.6 Menstrual disorder or sexual function change</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 68).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.7 Menstrual disorder</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (9 RCTs, n = 655, RR 0.13 CI 0.06 to 0.27).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.8 Skin symptoms</HEADING>
<P>Data demonstrate statistical significance (P = 0.02) in favour of aripiprazole (9 RCTs, n = 778, RR 0.32 CI 0.12 to 0.86).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.9 PRL-increase</HEADING>
<P>Data demonstrate statistical significance (P = 0.002) in favour of aripiprazole (3 RCTs, n = 184, RR 0.07 CI 0.01 to 0.38).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.10 Obesity</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 72).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.11 Vaginal bleeding</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 72).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.12 Weight gain</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (58 RCTs, n = 4623, RR 0.22 CI 0.17 to 0.29).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.25.13 Weight loss</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 101)</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.26 Adverse effects: 7b. Metabolic - continuous measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.26.1 Endpoint average weight (in kg)</HEADING>
<P>Data demonstrate statistical significance (P = 0.02) in favour of aripiprazole (5 RCTs, n = 465, MD -2.30 CI -4.17 to -0.44, <LINK REF="CMP-003.26" TYPE="ANALYSIS">Analysis 3.26</LINK>), however with substantial heterogeneity present (ChI<SUP>2</SUP> = 37.17; df = 4; P = 0.0; I<SUP>2</SUP> = 89%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.2 Weight change from baseline (in kg)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (1 RCT, n = 100, MD -1.50 CI -1.84 to -1.16).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.3 Average endpoint BMI of male participants (in kg/m2)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.003) in favour of aripiprazole (1 RCT, n = 60, MD -2.46 CI -4.08 to -0.84).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.4 Average endpoint BMI of female participants (in kg/m2)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 124, MD -1.47 CI -3.55 to 0.60) with substantial heterogeneity between groups (ChI<SUP>2</SUP> = 4.32; df = 1; P = 0.038; I<SUP>2</SUP> = 77%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.5 Average endpoint blood glucose of female participants (in mmol/L)</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of risperidone (1 RCT, n = 60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.6 Average endpoint blood glucose of male participants (in mmol/L)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.7 Average endpoint blood glucose FBG (in mg/dL)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.8 Average endpoint cholesterol - TC of female participants (in mmol/L)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.03) in favour of aripiprazole (1 RCT, n = 60, MD -0.51 CI -0.96 to -0.06).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.9 Average endpoint cholesterol - TC of male participants (in mmol/L)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.05) in favour of aripiprazole (1 RCT, n = 60, MD -0.48 CI -0.96 to 0.00).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.10 Average endpoint cholesterol - TC level (in mmol/L)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 240).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.11 Average endpoint cholesterol - TG level (in mmol/L)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.12 Average endpoint cholesterol - LDL level (in mmol/L)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 240).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.26.13 Average endpoint waistline (in cm)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.003) in favour of aripiprazole (1 RCT, n = 180, MD -3.30 CI -5.47 to -1.13).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.27. Adverse effect: 7c. Metabolic - continuous measures</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.01) in favour of aripiprazole for change in cholesterol from baseline (1 RCT, n = 83, MD -22.30 CI -39.69 to -4.91, <LINK REF="CMP-003.27" TYPE="ANALYSIS">Analysis 3.27</LINK>). Remaining data demonstrate no significant difference between groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.28 Adverse effect: 8. required additional drug combination</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.28.1 Benzodiazepines</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 138, RR 1.07 CI 0.73 to 1.58, <LINK REF="CMP-003.28" TYPE="ANALYSIS">Analysis 3.28</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.28.2 Benzhexol</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.04) in favour of aripiprazole (1 RCT, n = 69, RR 0.34 CI 0.12 to 0.93).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.28.3 Benzhexol/propranolol</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 69, RR 1.11 CI 0.45 to 2.72).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.29 Adverse effects: 9.TESS score (short term, up to 12 weeks, high = poor)</HEADING>
<P>Data demonstrate statistical significance (P = 0.006) in favour of aripiprazole (4 RCTs, n = 250, MD -1.34 CI -2.3 to -0.39, <LINK REF="CMP-003.29" TYPE="ANALYSIS">Analysis 3.29</LINK>), however with substantial heterogeneity present (ChI<SUP>2</SUP> = 48.54; df = 3; P = 0.00001; I<SUP>2</SUP> = 94%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.30 Adverse effects: 10. TESS score (skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-003.30" TYPE="ANALYSIS">Analysis 3.30</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.31 Adverse effects: 11. weight gain (skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-003.31" TYPE="ANALYSIS">Analysis 3.31</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.32 Cognitive functioning: 1. Specific - average endpoint total score</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.32.1 Short term, up to 12 weeks, WMS, low = poor</HEADING>
<P>Data demonstrate no significant difference between groups for both WMS (1 RCT, n = 72, <LINK REF="CMP-003.32" TYPE="ANALYSIS">Analysis 3.32</LINK>) and WAIS-RC (1 RCT, n = 72).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.33 Cost-effectiveness analysis (skewed)</HEADING>
<P>All data for this outcome are skewed and are best viewed by inspecting <LINK REF="CMP-003.33" TYPE="ANALYSIS">Analysis 3.33</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 4: ARIPIPRAZOLE versus ZIPRASIDONE</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">4.1 Global state: 1. No clinically significant response (as defined by the original studies)</HEADING>
<P>Short term data demonstrate no significant difference between groups (6 RCTs, n = 442, RR 0.97 CI 0.62 to 1.52, <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.2 Global state: 2. Average endpoint CGI-GI score (short term, up to 12 weeks, high = poor)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.001) in favour of aripiprazole (1 RCT, n = 86, MD -3.93 CI -6.32 to -1.54, <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.3 Global state: 3. Average change score (CGI-S, decline = best)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 247, MD -0.03 CI -0.28 to 0.22, <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.4 Mental state: 1. Average endpoint total score (short term, up to 12 weeks, high = poor)</HEADING>
<P>PANSS data demonstrate no significant difference between groups (7 RCTs, n = 689, <LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>), neither do BPRS data (1 RCT, n = 247). However, SANS data demonstrate statistical significance (P = 0.02) in favour of aripiprazole (3 RCTs, n = 238, MD -1.39 CI -2.56 to -0.22).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.5 Mental state: 2. Specific - binary outcomes (up to 12 weeks - short term)</HEADING>
<P>There was no significant difference between groups for anxiety (1 RCT, n = 86) or agitation (2 RCTs, n = 150, <LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.6 Mental state: 3. Specific - average endpoint PANSS subscale scores (short term, high = poor)</HEADING>
<P>There was no significant difference between groups for positive symptom score (2 RCTs, n = 146); negative symptom scores (4 RCTs, n = 272); and general pathology scores (5 RCTs, n = 382, <LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>.)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.7 Mental state: 4. Average endpoint scores of various scales (skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.8 Leaving the study early</HEADING>
<P>All data for leaving study early were equivocal, demonstrating no significant difference between groups (<LINK REF="CMP-004.08" TYPE="ANALYSIS">Analysis 4.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.9 Adverse effects:1.At least one adverse effect, non-specific</HEADING>
<P>Data demonstrate statistical significance (P = 0.0001) in favour of ziprasidone for sexual function change (2 RCTs, n = 172, RR 8.00 CI 2.96 to 21.65, <LINK REF="CMP-004.09" TYPE="ANALYSIS">Analysis 4.9</LINK>); all other data for adverse effects were equivocal.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.10 Adverse effects: 2.Cardiac effects (short term, up to 12 weeks)</HEADING>
<P>All data for cardiac effects are equivocal and demonstrate no difference between groups (<LINK REF="CMP-004.10" TYPE="ANALYSIS">Analysis 4.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.11 Adverse effects: 3. Central/ peripheral nervous system</HEADING>
<P>Data for dizziness demonstrate statistical significance (P = 0.002) in favour of ziprasidone (5 RCTs, n = 376, RR 3.24 CI 1.57 to 6.70, <LINK REF="CMP-004.11" TYPE="ANALYSIS">Analysis 4.11</LINK>), as well as data for insomnia (P = 0.02) (5 RCTs, n = 382, RR 2.93 CI 1.17 to 7.30), however with slight heterogeneity present (ChI<SUP>2</SUP> = 7.38; df = 4; P = 0.117; I<SUP>2</SUP> = 46%). All other data are equivocal, demonstrating no significant difference between groups, including for headache (2 RCTs, n = 150); blurred vision (1 RCT, n = 84) and somnolence (4 RCTs, n = 296).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.12 Adverse effects: 4. Various extrapyramidal symptoms (short term, up to 12 weeks)</HEADING>
<P>All data were equivocal, demonstrating no difference between groups (<LINK REF="CMP-004.12" TYPE="ANALYSIS">Analysis 4.12</LINK>), including dystonia (1 RCT, n = 84); tremor (2 RCTs, n = 152) and use of anti-Parkinson drugs (2 RCTs, n = 140) with substantial heterogeneity present (ChI<SUP>2</SUP> = 6.94; df = 1; P = 0.008; I<SUP>2</SUP> = 86%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.13 Adverse effects: 5. Gastrointestinal (short term, up to 12 weeks)</HEADING>
<P>Again, all data were equivocal, demonstrating no difference between groups (<LINK REF="CMP-004.13" TYPE="ANALYSIS">Analysis 4.13</LINK>), including: constipation (3 RCTs, n = 230); dry mouth (4 RCTs, n = 296); hyper-salivation (1 RCT, n = 86) and nausea/vomiting (6 RCTs, n = 442).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.14 Adverse effects: 6. Haematological</HEADING>
<P>Data for leucopenia demonstrate no significant difference between groups (2 RCTs, n = 140, <LINK REF="CMP-004.14" TYPE="ANALYSIS">Analysis 4.14</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.15 Adverse effects: 7. Hormonal</HEADING>
<P>Data for menstrual disorder demonstrate no significant difference between groups (6 RCTs, n = 538, <LINK REF="CMP-004.15" TYPE="ANALYSIS">Analysis 4.15</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.16 Adverse effects: 8a. Metabolic - binary measures</HEADING>
<P>All data were equivocal, demonstrating no difference between groups, including appetite decrease (2 RCTs, n = 152, <LINK REF="CMP-004.16" TYPE="ANALYSIS">Analysis 4.16</LINK>)) with substantial heterogeneity present (ChI<SUP>2</SUP> = 4.04; df = 1; P = 0.045; I<SUP>2</SUP> = 75%); abnormal blood routine (1 RCT, n = 85); lactation (1 RCT, n = 66); and weight gain (3 RCTs, n = 232).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4.17 Adverse effects: 8b. Metabolic - continuous measures</HEADING>
<P>Most data were equivocal, demonstrating no difference between groups; however, data for HDL demonstrate statistical significance (P = 0.04) in favour of aripiprazole (1 RCT, n = 180, MD 0.10 CI 0.01 to 0.19) and data for waistline average endpoint level (in cm) demonstrate statistical significance (P = 0.0004) in favour of aripiprazole (1 RCT, n = 180, MD -3.40 CI -5.29 to -1.51 <LINK REF="CMP-004.17" TYPE="ANALYSIS">Analysis 4.17</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 5: ARIPIPRAZOLE versus OLANZAPINE</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">5.1 Global state: 1. No clinically significant response (as defined by the original studies)</HEADING>
<P>Data are equivocal at short term (10 RCTs, n = 1422) and medium term (1 RCT, n = 317), demonstrating no significant difference between groups (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.2 Global state: 2. Not responded (decline in PANSS of 30% or more)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.2.1 By up to 12 weeks (short term)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.04) in favour of olanzapine at short term (1 RCT, n = 566, RR 1.16 CI 1.01 to 1.34, <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>) and long term (P = 0.05) (1 RCT, n = 566, RR 1.13 CI 1.0 to 1.27).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.3 Global state: 3. Remission not achieved (as defined in the study)</HEADING>
<P>Data demonstrate no significant difference between groups at short term (1 RCT, n = 566, <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of olanzapine by long term (1 RCT, n = 566, RR 1.38 CI 1.23 to 1.56).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.4 Global state: 4. Average endpoint EI score (CGI, high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups at short term (2 RCTs, n = 180, <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.5 Global state: 5. Average endpoint CGI score decreased rate (short term, low = poor)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 60, <LINK REF="CMP-005.05" TYPE="ANALYSIS">Analysis 5.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.6 Global state: 6. Average change score (CGI-S, decline = best)</HEADING>
<P>Data demonstrate no significant difference between groups at long term (1 RCT, n = 566, <LINK REF="CMP-005.06" TYPE="ANALYSIS">Analysis 5.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.7 Global state: 7. Improvement (CGI-I, high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups (1 RCT, n = 566, <LINK REF="CMP-005.07" TYPE="ANALYSIS">Analysis 5.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.8 Mental state: 1. General - average total score (PANSS, high = poor)</HEADING>
<P>Data are equivocal, demonstrating no significant difference between groups at short term (11 RCTs, n = 1500, <LINK REF="CMP-005.08" TYPE="ANALYSIS">Analysis 5.8</LINK>) and medium term (2 RCTs, n = 139). Data from one small RCT demonstrate statistical significance (P = 0.04) in favour of olanzapine (1 RCT, n = 566, MD 4.20 CI 0.10 to 8.3) in the long term.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.9 Mental state: 2. Average endpoint scale score (SANS, high = poor)</HEADING>
<P>Data demonstrate no significant difference between groups at short term (1 RCT, n = 89, <LINK REF="CMP-005.09" TYPE="ANALYSIS">Analysis 5.9</LINK>) and long term (1 RCT, n = 48).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.10 Mental state: 3. average endpoint score (PANSS, skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-005.10" TYPE="ANALYSIS">Analysis 5.10</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.11 Mental state: 4. Specific - average endpoint positive score (PANSS, high = poor)</HEADING>
<P>Overall, data from all time frames demonstrate statistical significance (P = 0.01) in favour of olanzapine (7 RCTs, n = 1043, MD 0.71 CI 0.17 to 1.26, <LINK REF="CMP-005.11" TYPE="ANALYSIS">Analysis 5.11</LINK>). Data are equivocal at short term, demonstrating no significant difference between groups (5 RCTs, n = 429) with slight heterogeneity between groups (ChI<SUP>2</SUP> = 6.26; df = 4; P = 0.181; I<SUP>2</SUP> = 36%). Data demonstrate no significant difference at medium term (1 RCT, n = 48) or long term (1 RCT, n = 566).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.12 Mental state: 5. Specific - average endpoint negative subscale score (PANSS, high = poor)</HEADING>
<P>At both short and medium term, data demonstrate no significant difference between group (6 RCTs, n = 967, <LINK REF="CMP-005.12" TYPE="ANALYSIS">Analysis 5.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.13 Mental state: 6. Specific - average endpoint general pathological score (PANSS, high = poor)</HEADING>
<P>At both short and medium term, data demonstrate no significant difference between groups (8 RCTs, n = 642, <LINK REF="CMP-005.13" TYPE="ANALYSIS">Analysis 5.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.14 Mental state: 7. Specific - binary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.14.1 Anxiety - labelled as" adverse effect"</HEADING>
<P>Data demonstrate no significant difference between groups for anxiety (2 RCTs, n = 778, <LINK REF="CMP-005.14" TYPE="ANALYSIS">Analysis 5.14</LINK>) or exacerbation of schizophrenia (2 RCTs, n = 778). Data from one small RCT demonstrate statistical significance (P = 0.04) in favour of aripiprazole for depression (1 RCT, n = 566, RR 0.27 CI 0.08 to 0.95).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.15 Mental state: 8. Average various scale scores decreased rate (skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-005.15" TYPE="ANALYSIS">Analysis 5.15</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.16 Adverse effects: 1. At least one adverse effect</HEADING>
<P>For non-specific adverse effects, data demonstrate no significant difference between groups (1 RCT, n = 75, <LINK REF="CMP-005.16" TYPE="ANALYSIS">Analysis 5.16</LINK>). For endocrine dyscrasia, data from one small RCT demonstrate statistical significance (P = 0.01) in favour of aripiprazole (1 RCT, n = 80, RR 0.08 CI 0.01 to 0.61); and for high prolactin level (P = 0.001) (1 RCT, n = 317, RR 0.27 CI 0.12 to 0.60). Remaining data are equivocal and demonstrate no difference between groups, including skin reaction (1 RCT, n = 89); and liver function abnormality  (5 RCTs, n = 348).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.17 Adverse effects: 2. Cardiac effects</HEADING>
<P>All data are equivocal and demonstrate no difference between groups for abnormal ECG (2 RCTs, n = 121); decrease in blood pressure (1 RCT, n = 89); QTc prolongation (3 RCTs, n = 618) and tachycardia (5 RCTs, n = 339).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.18 Adverse effects: 3a. Cardiac - QTc change from baseline (in ms)</HEADING>
<P>Data from one RCT demonstrate no significant difference between groups (1 RCT, n = 317, <LINK REF="CMP-005.18" TYPE="ANALYSIS">Analysis 5.18</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.19 Adverse effects: 3b. Central/ peripheral nervous system</HEADING>
<P>Data from two RCTs demonstrate statistical significance (P = 0.0001) in favour of aripiprazole for levels of sedation (2 RCTs, n = 883, RR 0.37 CI 0.23 to 0.60) and data from one small RCT demonstrate statistical significance (P = 0.05) in favour of aripiprazole for headache/dizziness (1 RCT, n = 89, RR 0.29 CI 0.09 to 1.00, <LINK REF="CMP-003.19" TYPE="ANALYSIS">Analysis 3.19</LINK>). All other data are equivocal and demonstrate no difference between groups, including dizziness (6 RCTs, n = 1057); blurred vision (1 RCT, n = 75); fatigue (3 RCTs, n = 721) and insomnia (7 RCTs, n = 1141), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 13.87; df = 6; P = 0.031; I<SUP>2</SUP> = 57%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.20 Adverse effects: 4. Endocrine - Prolactin - average increase</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.0001) in favour of aripiprazole (1 RCT, n = 566, MD -8.89 CI -12.96 to -4.82, <LINK REF="CMP-005.20" TYPE="ANALYSIS">Analysis 5.20</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.21 Adverse effects: 5. Extrapyramidal - various</HEADING>
<P>All data are equivocal and demonstrate no difference between groups, including: tremor (1 RCT, n = 61); EPS (4 RCTs, n = 667); and parkinsonism (3 RCTs, n = 618). Data for akathisia are equivocal, demonstrating no significant difference between groups (6 RCTs, n = 1320, <LINK REF="CMP-005.21" TYPE="ANALYSIS">Analysis 5.21</LINK>), however with considerable heterogeneity present (ChI<SUP>2</SUP> = 19.45; df = 6; P = 0.003; I<SUP>2</SUP> = 69%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.22 Adverse effects: 6. Gastrointestinal</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.03) in favour of aripiprazole for abdominal pain (1 RCT, n = 566, RR 2.96 CI 1.09 to 8.03). All remaining data are equivocal and demonstrate no significant difference between groups, including: dry mouth (5 RCTs, n = 854); constipation (6 RCTs, n = 443) and nausea/vomiting (6 RCTs, n = 948, <LINK REF="CMP-005.22" TYPE="ANALYSIS">Analysis 5.22</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.23 Adverse effects: 7. Hormonal</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.23.1 Menstrual changes</HEADING>
<P>Data are equivocal and demonstrate no significant difference between groups (3 RCTs, n = 198, <LINK REF="CMP-005.23" TYPE="ANALYSIS">Analysis 5.23</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.24 Adverse effects: 8a. Metabolic - binary measures</HEADING>
<P>Data demonstrate statistical significance (P = 0.001) in favour of aripiprazole for blood glucose increase (3 RCTs, n = 227, RR 0.12 CI 0.03 to 0.44); for abnormally high cholesterol level (P = 0.0001) (1 RCT, n = 223, RR 0.32 CI 0.19 to 0.54, <LINK REF="CMP-005.24" TYPE="ANALYSIS">Analysis 5.24</LINK>); and weight gain (P = 0.00001) (9 RCTs, n = 1538, RR 0.25 CI 0.15 to 0.43). All remaining data demonstrate no significant difference between groups for appetite increase (2 RCTs, n = 655); lactation (1 RCT, n = 60) and PRL increase (1 RCT, n = 89).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.25 Adverse effects: 8b. Metabolic - continuous measures (high = poor)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.25.1 Weight - average endpoint level (in kg)</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (3 RCTs, n = 242, MD -7.43 CI -9.21 to -5.65, <LINK REF="CMP-005.25" TYPE="ANALYSIS">Analysis 5.25</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.25.2 Weight gain - change from baseline (in kg)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 656), however with substantial heterogeneity present (ChI<SUP>2</SUP> = 6.31; df = 1; P = 0.012; I<SUP>2</SUP> = 84%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.25.3 Cholesterol - change from baseline (in mg/dL)</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (2 RCTs, n = 789, MD -15.37 CI -21.62 to -9.11).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.25.4 Cholesterol - TC average endpoint level (in mmol/L)</HEADING>
<P>Data demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (2 RCTs, n = 182, MD -1.00 CI -1.44 to -0.56).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.25.5 Cholesterol - TG average endpoint level (in mmol/L</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (1 RCT, n = 102, MD -1.00 CI -1.31 to -0.69).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.25.6 Blood glucose - PBG average endpoint level (in mg/dL)</HEADING>
<P>Data from one small RCT demonstrate statistical significance (P = 0.00001) in favour of aripiprazole (1 RCT, n = 60, MD -0.95 CI -1.27 to -0.63).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.25.7 Glucose - change from baseline (in mg/dl)</HEADING>
<P>Data demonstrate no significant difference between groups (2 RCTs, n = 883).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.26 Adverse effects: average endpoint scale scores (TESS, skewed)</HEADING>
<P>All data for this outcome are skewed and are best inspected by viewing <LINK REF="CMP-005.26" TYPE="ANALYSIS">Analysis 5.26</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.27 Leaving the study early</HEADING>
<P>Data for leaving for any reason from one small RCT demonstrate statistical significance (P = 0.002) in favour of olanzapine (9 RCTs, n = 2331, RR 1.15 CI 1.05 to 1.25, <LINK REF="CMP-005.27" TYPE="ANALYSIS">Analysis 5.27</LINK>); statistical significance was also found in inefficacy (P = 0.003) in favour of olanzapine (4 RCTs, n = 1352, RR 1.81 CI 1.23 to 2.67). Remaining reasons for leaving the study early demonstrated no significant difference between groups, including adverse event (4 RCTs, n = 1352); early discharge (1 RCT, n = 60); medication non-compliance (1 RCT, n = 255); and death (1 RCT, n = 214).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.28 Quality of life: 1. Average endpoint general quality of life score (GQOLI-74, low = poor)</HEADING>
<P>All data are equivocal and demonstrate no difference between groups (<LINK REF="CMP-005.28" TYPE="ANALYSIS">Analysis 5.28</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 6: ARIPIPRAZOLE versus OLANZAPINE (acutely agitated people - all data by five days)</HEADING>
<P>One study was included in this category.</P>
<SUBSECTION>
<HEADING LEVEL="4">6.1 Global state</HEADING>
<P>An improvement was defined as reduction in the Brief Psychiatric Rating Scale (BPRS). There was no significant difference in the two groups (n = 471, MD -0.18, CI -0.79 to 0.43, <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6.2 Mental state</HEADING>
<P>There was no significant difference reported in participants on aripiprazole and olanzapine in agitation level (defined as at least  40% reduction in PANSS-EC (n = 604, RR 0.92, CI 0.76 to 1.12). No significant difference was noted in agitation (n = 578, RR 0.25, CI 0.05 to 1.17); anxiety (n = 604, RR 0.93, CI 0.40 to 2.17) and exacerbation of schizophrenia (n = 604, RR 5.13, CI 0.25 to 106.49, <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>). All such outcomes were labelled as &#8220;adverse effects&#8221; in the published report.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6.3 Leaving the study early</HEADING>
<P>Both groups were similar in the number of participants leaving the study early due to adverse effects (n = 604, RR 0.68 CI 0.12 to 4.07, <LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6.4 Adverse effects</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">6.4.1 Central nervous system</HEADING>
<P>No significant difference was reported between administering aripiprazole or olanzapine in acutely agitated patients with regards to CNS side effects of dizziness (n = 578, RR 0.29, CI 0.06 to 1.36); sedation (n = 578, RR 0.71, CI 0.23 to 2.22); insomnia (n = 604, RR 1.60, CI 0.87 to 2.94) and somnolence (n = 578, RR 0.14, CI 0.02 to 1.15). Participants on aripiprazole reported more headaches (n = 578, RR 2.43, CI 1.02 to 5.77) and lethargy (n = 578, RR 1.33, CI 0.30 to 5.90, <LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4.2 Endocrine system - increase in average levels of prolactin</HEADING>
<P>People allocated aripiprazole reported significantly lower (P = 0.00001) prolactin level increase compared with participants given olanzapine (n = 604, MD -15.76, CI -19.18 to -12.34, <LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4.3 Extrapyramidal side effects</HEADING>
<P>Participants in both groups experienced similar rates of akathisia (n = 604, RR 1.43, CI 0.79 to 2.56) and parkinsonian symptoms (n = 604, 1 RCT, RR 1.71 CI 0.41 to 7.10, <LINK REF="CMP-006.06" TYPE="ANALYSIS">Analysis 6.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4.4 Extrapyramidal symptoms</HEADING>
<P>Extrapyramidal symptoms were also reported by using scales where higher score represents a poor outcome. There was no significant difference between groups when assessed using Barnes Akathisia scale (n = 604, MD 0.07, CI -0.24 to 0.38) or Simpson Angus scale (n = 604, MD -0.05, CI -0.13 to 0.03, <LINK REF="CMP-006.07" TYPE="ANALYSIS">Analysis 6.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4.5 Gastrointestinal side effects</HEADING>
<P>Both groups reported similar occurrence of dry mouth (n = 578, RR 1.00, CI 0.20 to 4.91) and twice the number of participants on olanzapine reported nausea/dyspepsia (n = 578, RR 0.50, CI 0.09 to 2.71, <LINK REF="CMP-006.08" TYPE="ANALYSIS">Analysis 6.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4.6 Metabolic side effects- increase in triglyceride levels</HEADING>
<P>These results favoured patients on aripiprazole significantly (P = 0.00001) (n = 604, MD -35.62, CI -49.25 to -21.99, <LINK REF="CMP-006.09" TYPE="ANALYSIS">Analysis 6.9</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">COMPARISON 7. ARIPIPRAZOLE versus OTHER ANTIPSYCHOTIC DRUGS</HEADING>
<P>We used data from three studies for this comparison. In all three studies aripiprazole was compared with any one of several new generation antipsychotic drugs.</P>
<SUBSECTION>
<HEADING LEVEL="4">7.1 Global state: 1. No change as defined by the original study (measured by IAQ)</HEADING>
<P>
<LINK REF="STD-Kerwin-2007" TYPE="STUDY">Kerwin 2007</LINK> showed an improvement in global state in energy (n = 523, 1 RCT, RR 0.69 CI 0.56 to 0.84); mood (n = 523, 1 RCT, RR 0.77 CI 0.65 to 0.92); negative symptoms (n = 523, 1 RCT, RR 0.82 CI 0.68 to 0.99); somnolence (n = 523, 1 RCT, RR 0.80 CI 0.69 to 0.93) and weight gain (n = 523, 1 RCT, RR 0.84 CI 0.76 to 0.94) when aripiprazole was used but no significant difference was noted in cognition (n = 523, 1 RCT, <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.2 Global state: 2. Change in sexual dysfunction (measured by ASEX)</HEADING>
<P>No significant difference was seen in the two groups (n = 85, 1 RCT, <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.3 Mental state: 1. Binary outcomes</HEADING>
<P>No significant difference was noted in anxiety (n = 1361, 2 RCTs); "schizophrenia" (n = 548, 1 RCT) and psychotic disorder (n = 2881, 3 RCTs). Participants on aripiprazole experienced slightly less agitation (n = 548, 1 RCT, RR 2.64 CI 0.96 to 7.23, <LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.4 Medication preference (study medication worse than or equal to previous medication)</HEADING>
<P>People reported aripiprazole being better in the short term (n = 446, 1 RCT, RR 0.67 CI 0.49 to 0.91) and medium term (n = 330, 1 RCT, RR 0.39 CI 0.25 to 0.61). Carers, however, reported no difference in the two groups both in the short (n = 121, 1 RCT) and medium term (n = 80, 1 RCT, <LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.5 Quality of life: 1. Unsatisfactory response (Health dimension scale)</HEADING>
<P>Fewer participants reported an unsatisfactory response on the health dimension scale when using aripiprazole (n = 329, 1 RCT, RR 0.29 CI 0.13 to 0.66, <LINK REF="CMP-007.05" TYPE="ANALYSIS">Analysis 7.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.6 Quality of life: 2. Average change in Quality of Life score (high is better)</HEADING>
<P>The results favoured other antipsychotics (n = 326, 1 RCT, MD 6.20 CI 3.08 to 9.32, <LINK REF="CMP-007.06" TYPE="ANALYSIS">Analysis 7.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.7 Quality of life: 3. Average EQ-5D utility score (high is better)</HEADING>
<P>No significant difference was noted in the two groups (n = 329, 1 RCT, <LINK REF="CMP-007.07" TYPE="ANALYSIS">Analysis 7.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.8 Quality of life: 4a. Weight-related score - no meaningful change (measured by Impact of Weight on Quality of Life (IWQoL-Lite))</HEADING>
<P>No significant difference was noted in the two groups when weight was measured in binary scale (n = 327, 1 RCT, <LINK REF="CMP-007.08" TYPE="ANALYSIS">Analysis 7.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.9 Quality of life: 4b. Weight-related score (measured by Impact of Weight on Quality of Life (IWQoL-Lite))</HEADING>
<P>No significant difference was noted in the two groups for average change in weight in the short term (n = 443, 1 RCT) and medium term (n = 328, 1 RCT, <LINK REF="CMP-007.09" TYPE="ANALYSIS">Analysis 7.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.10 Leaving the study early</HEADING>
<P>No significant difference was noted in the participants who left the study early in the three groups for any reason (n = 2908, 3 RCTs, RR 0.97 CI 0.78 to 1.19); administrative reasons (n = 833, 1 RCT, RR 0.80 CI 0.00 to 1.84); death (n = 555, 1 RCT, RR 0.48 CI 0.04 to 5.23); inefficacy (n = 2908, 3 RCTs, RR 0.94 CI 0.45 to 1.96); lost to follow-up (n = 1388, 2 RCTs, RR 0.85 CI 0.34 to 2.13); no longer meets criteria (n = 1388, 2 RCTs, RR 0.65 CI 0.16 to 2.63); other (n = 1388, 2 RCTs, RR 0.62 CI 0.10 to 3.80); compliance issues (n = 1388, 2 RCTs, RR 1.10 CI 0.53 to 2.32) and pregnancy (n = 555, 1 RCT, RR 0.95 CI 0.14 to 6.73). More participants in the aripiprazole group left due to adverse events (n = 2908, 3 RCTs, RR 1.40 CI 1.11 to 1.76). Fewer participants in the aripiprazole group withdrew from the study (n = 2908, 3 RCTs, RR 0.48 CI 0.36 to 0.66, <LINK REF="CMP-007.10" TYPE="ANALYSIS">Analysis 7.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.11 Adverse effects - 1. At least one side effect</HEADING>
<P>Participants taking other antipsychotics reported this slightly more (n = 2333, 2 RCTs, RR 1.14 CI 1.05 to 1.23, <LINK REF="CMP-007.11" TYPE="ANALYSIS">Analysis 7.11</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.12 Adverse effects - 2. Central nervous system</HEADING>
<P>No significant difference was noted in sleep disorder (n = 813, 1 RCT, RR 1.79 CI 0.78 to 4.10) and fatigue (n = 548, 1 RCT, RR 0.59 CI 0.27 to 1.28). A larger number of participants on aripiprazole reported insomnia (n = 2881, 3 RCTs, RR 2.09 CI 1.65 to 2.66) and headache (n = 2881, 3 RCTs, RR 1.47 CI 1.09 to 1.99). Fewer participants on aripiprazole reported somnolence (n = 2881, 3 RCTs, RR 0.52 CI 0.39 to 0.71, <LINK REF="CMP-007.12" TYPE="ANALYSIS">Analysis 7.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.13 Adverse effects - 3a. Endocrine system - increase in prolactin level</HEADING>
<P>Significantly fewer participants on aripiprazole reported an increased prolactin level (n = 548, 1 RCT, RR 0.31 CI 0.23 to 0.41, <LINK REF="CMP-007.13" TYPE="ANALYSIS">Analysis 7.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.14 Adverse effects - 3b. Endocrine system - change in prolactin level from baseline</HEADING>
<P>The results favoured aripiprazole (n = 94, 1 RCT, MD -8.60 CI -19.14 to 1.94, <LINK REF="CMP-007.14" TYPE="ANALYSIS">Analysis 7.14</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.15 Adverse effects - 4. Extrapyramidal symptoms (EPS)</HEADING>
<P>The results did not favour any of the comparison groups with a large confidence interval (n = 2881, 3 RCTs, RR 1.02 CI 0.09 to 11.09, <LINK REF="CMP-007.15" TYPE="ANALYSIS">Analysis 7.15</LINK>) and prohibitively high heterogeneity (97%). It is unclear why <LINK REF="STD-Tandon-2006" TYPE="STUDY">Tandon 2006</LINK> causes this and removal of this study results in homogeneity being restored.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.16 Adverse effects - 5. Gastrointestinal</HEADING>
<P>A significantly larger number of people given aripiprazole reported symptoms of nausea (n = 2881, 3 RCTs, RR 3.13 CI 2.12 to 4.61, <LINK REF="CMP-007.16" TYPE="ANALYSIS">Analysis 7.16</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.17 Adverse effects - 6a. Metabolic - binary measures</HEADING>
<P>Significantly fewer people allocated aripiprazole reported 7% or more weight gain in the medium term (n = 330, 1 RCT, RR 0.35 CI 0.19 to 0.64); average weight gain (n = 548, 1 RCT, RR 0.11 CI 0.03 to 0.37); total cholesterol increase (n = 269, 1 RCT, RR 0.75 CI 0.62 to 0.91) and low-density lipoprotein (LDL) increase (n = 268, 1 RCT, RR 0.65 CI 0.51 to 0.84). We found no significant difference in either group in high-density lipoprotein (HDL) increase (n = 269, 1 RCT, RR 0.87 CI 0.61 to 1.22); triglyceride increase (n = 267, 1 RCT, RR O.80 CI 0.64 to 1.00) and increase in fasting glucose (n = 236, 1 RCT, RR 0.95 CI 0.62 to1.47). A greater number of people given aripiprazole reported 7% or more of weight loss in the medium term (n = 330, 1 RCT, RR 1.75 CI 0.97 to 3.19, <LINK REF="CMP-007.17" TYPE="ANALYSIS">Analysis 7.17</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7.18 Adverse effects - 6b. Metabolic - continuous measures</HEADING>
<P>Aripiprazole was favoured for no risk of weight gain (n = 537, 1 RCT, MD -2.70 CI -3.68 to -1.72); weight change from baseline (n = 441, 1 RCT, MD short term -2.48 CI -3.30 to -1.66; n = 327, 1 RCT, MD medium term -3.74 CI -4.65 to -2.83); and change in fasting cholesterol (n = 262, 1 RCT, MD -9.70 CI -16.07 to -3.33). There was no difference reported in change in fasting glucose (n = 229, 1 RCT, MD -1.90 CI -5.78 to 1.98, <LINK REF="CMP-007.18" TYPE="ANALYSIS">Analysis 7.18</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">8. SENSITIVITY ANALYSIS</HEADING>
<P>We planned to undertake a sensitivity analysis for the primary outcomes of interest of (i) no clinically important response (as defined by each study); (ii) general functioning; and (iii) clinically important specific adverse effects. No study, however, reported data for the outcome of general functioning. For sensitivity analysis of 'comparator dose', we tested outcome of (i) no clinically important response (as defined by each study); and (ii) general mental state.</P>
<SUBSECTION>
<HEADING LEVEL="4">8.1 Implication of randomisation</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">8.1.1 Aripiprazole versus Clozapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.1.1.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant differences between groups after removing studies from meta-analysis that only implied randomisation (n = 322, 4 RCTs, RR 1.04 CI 0.76 to 1.44).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.1.1.2 Adverse effects - clinically important specific adverse effects</HEADING>
<P>Few studies provided data at medium term for any clinically important adverse effects; for EPS effects, only one study (<LINK REF="STD-Li-2007" TYPE="STUDY">Li 2007</LINK>) provided relevant data. This study only implied randomisation, therefore after removing this study from data and analysis, there were no data left to compare. However, at short term, there remained no significant differences between groups after removing studies from meta-analysis that only implied randomisation for the outcome of 'general EPS' (n = 60, 1 RCT, RR 1.50 CI 0.27 to 8.34). When implied randomised studies were removed from the outcome of akathisia, there was significantly greater instances (P = 0.002) in people receiving aripiprazole (n = 180, 2 RCTs, RR 4.99 CI 1.78 to 14.00).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.1.2 Aripiprazole versus Quetiapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.1.2.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant differences between groups after removing studies from meta-analysis that only implied randomisation (n = 108, 1 RCT, RR 1.00 CI 0.26 to 3.79).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.1.2.2 Adverse effects - clinically important specific adverse effects</HEADING>
<P>All adverse data reported are for the short term; there remained no significant differences between groups after removing studies from meta-analysis that only implied randomisation for the outcome of akathisia (n = 108, 1 RCT, RR 2.00 CI 0.19 to 21.41). This was also the case for tremor (n = 108, 1 RCT, RR 0.33 CI 0.01 to 8.01). Remaining studies in other outcomes of dystonia and general EPS were all implied as randomised; therefore, the removal of these studies left us with no data to compare.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.1.3 Aripiprazole versus Risperidone</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.1.3.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant differences between groups after removing studies from meta-analysis that only implied randomisation (n = 703, 7 RCTs, RR 1.29 CI 0.87 to 1.92).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.1.3.2 Adverse effects - clinically important specific adverse effects</HEADING>
<P>All adverse data reported are for the short term; data were no longer statistically significant in favour of aripiprazole for akathisia after removing studies from the meta-analysis that only implied randomisation (n = 293, 4 RCTs, RR 0.93 CI 0.45 to 1.90), this was also the case for tremor (n = 210, 3 RCTs, RR 0.61 CI 0.30 to 1.23). Data were still statistically significant (P = 0.003, albeit slightly lower in the level of significance) in favour of aripiprazole for the outcome of dystonia after the removal of implied randomised studies from meta-analysis (n = 210, 3 RCTs, RR 0.17 CI 0.05 to 0.56), as well as for general EPS (n = 367, 4 RCTs, RR 0.53 CI 0.35 to 0.80). All data for tremor and parkinsonism were from implied randomised studies, which left no data to compare after removal.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.1.4 Aripiprazole versus Ziprasidone</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.1.4.1 Global state: no clinically important response (as defined by the individual studies)</HEADING>
<P>All studies reporting this outcome were implied as randomised; therefore, there were no data left to compare once they were removed from the meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.1.4.2 Adverse effects - clinically important specific adverse effects</HEADING>
<P>All adverse data reported are for the short term; data remained equivocal for akathisia after removing implied randomised studies (n = 253, 1 RCT, RR 1.26 CI 0.48 to 3.27). Data for all other various EPS outcomes, including dystonia, tremor, use of antiparkinson medication and general EPS effects, were reported by implied randomised studies, leaving no data to compare once removed from analysis.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.1.5 Aripiprazole versus Olanzapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.1.5.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant differences between groups after removing studies from meta-analysis that only implied randomisation (n = 778, 2 RCTs, RR 1.00 CI 0.82 to 1.23).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.1.5.2 Adverse effects - clinically important specific adverse effects</HEADING>
<P>Data proved statistically significant (P = 0.05) in favour of olanzapine for akathisia after removing implied randomised studies from meta-analysis (n = 75, 1 RCT, RR 16.68 CI 1.01 to 276.65), while data for remaining extrapyramidal effects (tremor, EPS, parkinsonism) were from implied randomised studies, leaving no data to compare.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.1.6 Aripiprazole versus Olanzapine (acutely agitated)</HEADING>
<P>The one study included in this comparison only implied randomisation, therefore there were no data left to compare.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.1.7 Aripiprazole versus Other antipsychotic drugs</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.1.7.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>The one study included in this outcome only implied randomisation, therefore there were no data left to compare.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.1.7.2 Adverse effects - clinically important specific adverse effects</HEADING>
<P>For the outcome of akathisia, after removing the two studies that implied randomisation, only one study (with higher methodological quality) was left to compare (<LINK REF="STD-Tandon-2006" TYPE="STUDY">Tandon 2006</LINK>), which eliminated the heterogeneity present and found statistical significance (P = 0.00001) in favour of aripiprazole over other antipsychotic drugs (n = 1520, 1 RCT, RR 0.17 CI 0.12 to 0.22).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8.2 Assumptions for lost binary data</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">8.2.1 Aripiprazole versus Clozapine</HEADING>
<P>Only one study for this comparison did not report all data. <LINK REF="STD-Yu-2006" TYPE="STUDY">Yu 2006</LINK> reported the loss of n = 5 participants; however it was not clear to which group these participants belonged.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.2.2 Aripiprazole versus Quetiapine</HEADING>
<P>No included studies reported losses for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.2.3 Aripiprazole versus Risperidone</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.2.3.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no difference in the estimate of effect when completer-only data were pooled at short term (79 RCTs, n = 6245, RR 1.12 CI 0.98 to 1.28).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.2.4 Aripiprazole versus Ziprasidone</HEADING>
<P>No included studies reported losses for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.2.5 Aripiprazole versus Olanzapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.2.5.1 Global state: no clinically significant response (as defined by the individual studies</HEADING>
<P>There remained no difference in the estimate of effect when completer-only data were pooled in the short and medium term combined (11 RCTs, n = 1558, RR 1.04 CI 0.93 to 1.16).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.2.6 Aripiprazole versus Olanzapine (acutely agitated)</HEADING>
<P>The one study included in this comparison did not report losses for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.2.7 Aripiprazole versus Other antipsychotic drugs</HEADING>
<P>No included studies reported losses for this comparison.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8.3 Risk of bias</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">8.3.1 Aripiprazole versus Clozapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.3.1.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant differences between groups after removing studies from meta-analysis that rated as a 'high' risk on one or more of the risk of bias domains (n = 90, 1 RCT, RR 0.91 CI 0.32 to 2.62).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.3.1.2 General functioning: no clinically important change in general functioning</HEADING>
<P>No included study reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.3.1.3 Adverse effects - clinically important specific adverse effects</HEADING>
<P>For extrapyramidal effects, all studies rated as a 'high' risk on one or more of the risk of bias domains, leaving no data to compare for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.3.2 Aripiprazole versus Quetiapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.3.2.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>All studies rated as a 'high' risk on one or more of the risk of bias domains, leaving no data to compare for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.3.2.2 General functioning: no clinically important change in general functioning</HEADING>
<P>No included study reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.3.2.3 Adverse effects - clinically important specific adverse effects</HEADING>
<P>All studies rated as a 'high' risk on one or more of the risk of bias domains, leaving no data to compare for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.3.3 Aripiprazole versus Risperidone</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.3.3.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant differences between groups after removing studies from meta-analysis that rated as a 'high' risk on one or more of the risk of bias domains (n = 465, 6 RCTs, RR 1.27 CI 0.69 to 2.31).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.3.3.2 General functioning: no clinically important change in general functioning</HEADING>
<P>No included study reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.3.3.3 Adverse effects - clinically important specific adverse effects</HEADING>
<P>All adverse data reported are for the short term; data were no longer statistically significant in favour of aripiprazole for akathisia after removing studies that rated as a 'high' risk on one or more of the risk of bias domains (n = 161, 2 RCTs, RR 0.59 CI 0.14 to 2.55), this was also the case for tremor (n = 161, 2 RCTs, RR 0.20 CI 0.04 to 1.14), and dystonia (n = 161, 2 RCTs, RR 0.17 CI 0.59 to 4.21). However, data were still statistically significant (P = 0.0001) in favour of aripiprazole for general EPS (n = 284, 4 RCTs, RR 0.29 CI 0.16 to 0.51). All data for tremor and parkinsonism were rated as 'high' risk on one or more of the risk of bias domains, which left no data to compare after removal.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.3.4 Aripiprazole versus Ziprasidone</HEADING>
<P>All studies providing data for all primary outcomes rated as a 'high' risk on one or more of the risk of bias domains, leaving no data to compare for this outcome in a sensitivity analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.3.5 Aripiprazole versus Olanzapine</HEADING>
<P>All studies providing data for all primary outcomes rated as a 'high' risk on one or more of the risk of bias domains, leaving no data to compare for this outcome in a sensitivity analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.3.6 Aripiprazole versus Olanzapine (acutely agitated)</HEADING>
<P>The one study included in this comparison rated as a 'high' risk on one or more of the risk of bias domains, therefore there were no data left to compare.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.3.7 Aripiprazole versus Other antipsychotic drugs</HEADING>
<P>Again, all studies providing data for all primary outcomes rated as a 'high' risk on one or more of the risk of bias domains, leaving no data to compare for this outcome in a sensitivity analysis.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8.4 Imputed values</HEADING>
<P>No values were imputed for intra-class correlation coefficients (ICC), since we included no cluster randomised trials in meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8.5 Skewed data</HEADING>
<P>All skewed data have been presented separately in tables within data and analyses, therefore a sensitivity analysis was not possible via meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8.6 Comparator dose</HEADING>
<P>Not all studies reported mean doses and standard deviations; therefore, this sensitivity analysis has been undertaken with the dose values made available, taking predominantly ranges into account.</P>
<SUBSECTION>
<HEADING LEVEL="5">8.6.1 Aripiprazole versus Clozapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.6.1.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>There remained no significant difference between groups when removing two studies (<LINK REF="STD-Li-2007" TYPE="STUDY">Li 2007</LINK>; <LINK REF="STD-Yu-2007" TYPE="STUDY">Yu 2007</LINK>) that compared doses of aripiprazole that exceeded BNF recommendations to lower doses of clozapine (27 RCTs, n = 1978, RR 1.08 CI 0.88 to 1.32).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.6.1.2 General mental state (BPRS/ PANSS)</HEADING>
<P>At short term, none of the five studies rating mental state using the BPRS (endpoint scores) used inappropriate comparator doses, therefore there were no differences between results. Using the PANSS at short term, after removing the two studies (<LINK REF="STD-Li-2007" TYPE="STUDY">Li 2007</LINK>; <LINK REF="STD-Yu-2007" TYPE="STUDY">Yu 2007</LINK>) that compared doses of aripiprazole that exceeded BNF recommendations to lower doses of clozapine, there was still no significant difference between groups, (23 RCTs, n = 1484, MD 0.55 CI -0.53 to 1.63), however the degree of heterogeneity was reduced from I<SUP>2</SUP> = 64% (P = 0.0001) to I<SUP>2</SUP> = 44% (P = 0.02). At medium term, three studies provided data using PANSS used comparisons within the recommended doses.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.6.2 Aripiprazole versus Quetiapine</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">8.6.2.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>Three studies exceeded recommended doses of clozapine, each employing a maximum dose of 800 mg daily (<LINK REF="STD-Chen-2009" TYPE="STUDY">Chen 2009</LINK>; <LINK REF="STD-Li-2007b" TYPE="STUDY">Li 2007b</LINK>; <LINK REF="STD-Luo-2008" TYPE="STUDY">Luo 2008</LINK>). There was no difference in the estimate of the effect when these studies were excluded from meta-analysis (9 RCTs, n = 801, RR 0.91 CI 0.59 to 1.14)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.6.2.2 General mental state (BPRS/ PANSS)</HEADING>
<P>No studies provided data for general average endpoint scores using either the BPRS or PANSS.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.6.3 Aripiprazole versus Risperidone</HEADING>
<P>The majority of studies used a range with a maximum of 6 mg daily risperidone, which exceeds the 4 mg BNF recommendation.</P>
<SUBSECTION>
<HEADING LEVEL="6">8.6.3.1 Global state: no clinically significant response (as defined by the individual studies)</HEADING>
<P>After excluding 70 studies with a range of 1 to 6 mg risperidone, there remained no difference between groups (9 RCTs, n = 727, RR 1.14 CI 0.76 to 1.71).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">8.6.3.2 General mental state (BPRS/ PANSS)</HEADING>
<P>For average endpoint mental state in the short term using BPRS, after excluding four of the five studies providing data, there was no longer significant favour for aripiprazole, instead showing no difference between groups (1 RCT, n = 68, MD 2.30 CI -1.17 to 5.77) and removing all heterogeneity. For PANSS in the short term, after removing 69 studies that used a higher than recommended dose of risperidone, results still demonstrated no difference (8 RCTs, n = 659, MD -0.50 CI -2.09 to 1.09s), however all heterogeneity was removed.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.6.4 Aripiprazole versus Ziprasidone</HEADING>
<P>None of the included studies for the outcomes of interest used inappropriate comparator doses; therefore, there were no studies to exclude.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.6.5 Aripiprazole versus Olanzapine</HEADING>
<P>None of the included studies for the outcomes of interest used inappropriate comparator doses; therefore, there were no studies to exclude.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.6.6 Aripiprazole versus Olanzapine (acutely agitated)</HEADING>
<P>The one study included in this comparison did not use any inappropriate comparator doses, therefore there was no difference in results.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8.6.7 Aripiprazole versus Other antipsychotic drugs</HEADING>
<P>Of the three studies included in this outcome, <LINK REF="STD-Kerwin-2007" TYPE="STUDY">Kerwin 2007</LINK> used higher than recommended doses of risperidone and quetiapine; however, this study did not provide data for the outcomes of interest, therefore there were no difference between results.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>Many trials were sponsored by the manufacturers of aripiprazole or the comparator agent manufacturers. In a blinded analysis of abstracts it has been shown that pharmaceutical companies emphasize positive aspects of their compounds (<LINK REF="REF-Heres-2006" TYPE="REFERENCE">Heres 2006</LINK>). Every result, without exception, therefore, must be viewed with this in mind.</P>
<SUMMARY_OF_RESULTS MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1. COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE</HEADING>
<P>Thirty-nine studies fell into this category, please see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. Data are generally of poor quality and we found no data on indices including service use or global functioning. Overall, inclusion of new Chinese studies gave us much more data for this comparison. Quality of life outcomes, more often than not, significantly favoured use of aripiprazole over clozapine. However, there was no difference between the use of either drug for the primary outcome of clinically significant response in global state. Largely, people were at significantly less risk of adverse effects when receiving aripiprazole (<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>; <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>), but greater risk of central nervous system (CNS) adverse effects such as headache and insomnia than people receiving clozapine (<LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>), Extrapyramidal effects (EPS) were largely equivocal between groups. Data were heterogeneous as regards EPS, which may well be attributable to the differing doses employed between studies - as some used low doses (between 5 to 20 mg aripiprazole versus 5 to 500 mg clozapine) of either drugs, and some used slightly higher (10 to 30 mg aripiprazole versus 50 to 270 mg clozapine). Evidence from 11 studies (n = 732) does suggest that people receiving aripiprazole had a greater risk of experiencing anxiety in the short term (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE</HEADING>
<P>Fifteen studies provided data for this comparison, please see <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; again, the inclusion of new Chinese studies gave us data for this comparison, which was lacking in the previous version of this review. The quality of the data were generally 'low' to 'very low', due to poor outcome reporting and methodological quality. There were, again, no data for service use; only one study reported data using any quality of life scale, which significantly favoured use of aripiprazole in six out of the seven components measured. Further larger scale, high-quality trials are needed in order to reach any confident conclusions for this outcome. The evidence from 12 included studies (n = 991) suggest no significant difference between the two drugs in terms of clinically significant response. Adverse effect data do suggest a greater risk of tachycardia in people receiving quetiapine (<LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>), as well as dry mouth, constipation (<LINK REF="CMP-002.16" TYPE="ANALYSIS">Analysis 2.16</LINK>) and weight gain (<LINK REF="CMP-002.19" TYPE="ANALYSIS">Analysis 2.19</LINK>). However, nausea and vomiting was more common in people receiving aripiprazole (<LINK REF="CMP-002.16" TYPE="ANALYSIS">Analysis 2.16</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE</HEADING>
<P>Eighty studies (n = 6381) report data for the primary outcome of clinically significant response for this important comparison. Risperidone, now off-licence, is inexpensive and widely accessible; aripiprazole is not. Data are, again, of limited quality (randomisation and concealment methods being unclear, <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>), however, this current update search has provided data that were lacking in the previous version of this review, including global functioning, and economic analyses; however, service use data are still missing. The majority of reported data are short term; adverse effects were selectively reported and studies were often sponsored by pharmaceutical companies.</P>
<P>For global outcomes there were no convincing differences between the two drugs (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>, <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>, <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>, <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>). Binary mental state data were largely equivocal, with the exception of anxiety, which was significantly higher in people receiving aripiprazole (<LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>). Scale data for mental state favoured aripiprazole using the BPRS and PANSS average endpoint negative score (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>; <LINK REF="CMP-003.08" TYPE="ANALYSIS">Analysis 3.8</LINK>). As regards adverse effects, the only convincing data were for tachycardia (<LINK REF="CMP-003.16" TYPE="ANALYSIS">Analysis 3.16</LINK>) and abnormal liver function (<LINK REF="CMP-003.15" TYPE="ANALYSIS">Analysis 3.15</LINK>) in risperidone. Risperidone also carried greater risk of metabolic adverse effects (<LINK REF="CMP-003.25" TYPE="ANALYSIS">Analysis 3.25</LINK>) including weight gain, menstrual disorder and lactation. General EPS, akathisia, tremor and dystonia were all significantly higher in people receiving risperidone than aripiprazole (<LINK REF="CMP-003.21" TYPE="ANALYSIS">Analysis 3.21</LINK>). Again, headache (<LINK REF="CMP-003.18" TYPE="ANALYSIS">Analysis 3.18</LINK>), and nausea and vomiting were significantly more prominent in people receiving aripiprazole (<LINK REF="CMP-003.23" TYPE="ANALYSIS">Analysis 3.23</LINK>). Both drugs may cause movement disorders and about one third of people allocated aripiprazole used antiparkinsonian drugs (<LINK REF="CMP-003.21" TYPE="ANALYSIS">Analysis 3.21</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. COMPARISON 4. ARIPIPRAZOLE versus ZIPRASIDONE</HEADING>
<P>The addition of new Chinese studies gave us an additional 15 studies to add to the previous one in this comparison. Ziprasidone is a major competitor of aripiprazole but data are of limited quality (<LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>), and there are still no data for service use. Data are all short term (four weeks).</P>
<P>There really does seem to be very little suggestion of differences in global state, attrition (about one third of people left in a matter of a few weeks) and mental state; however, there was greater improvement noted using SANS in people receiving aripiprazole in three RCTs (n = 238).</P>
<P>As regards adverse effects, there were largely no clear differences between groups; however, people receiving aripiprazole were significantly more likely to show signs of dizziness and insomnia (<LINK REF="CMP-004.11" TYPE="ANALYSIS">Analysis 4.11</LINK>) as well as weight gain (<LINK REF="CMP-004.16" TYPE="ANALYSIS">Analysis 4.16</LINK>). There is a need for better trials providing clear information for all interested in the care of people with schizophrenia who have access to these drugs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE</HEADING>
<P>Nineteen studies reported data for this comparison, see <LINK REF="SOF-05" TYPE="SOF">Summary of findings table 5</LINK>. Data are generally of poor quality and we found no data on indices including service use or global functioning. The inclusion of new Chinese studies gave data for quality of life outcomes (one RCT), which were lacking in the previous version of this review. The studies, although randomised and blinded, lack clarity on how both were carried out. Some studies were sponsored by pharmaceutical companies and adverse effects were seemingly selectively reported.</P>
<P>Even with the addition of new studies, global state outcomes show no clear differences between the drugs and the various measures of mental state did not clearly point to an advantage of one drug over another. The only significant findings from PANSS showed greater improvement in positive symptoms over each short, medium and long term combined (<LINK REF="CMP-005.11" TYPE="ANALYSIS">Analysis 5.11</LINK>). Approaching 50% of people left these studies for any reason (<LINK REF="CMP-005.27" TYPE="ANALYSIS">Analysis 5.27</LINK>) which may be a reflection of study design.</P>
<P>Regarding adverse effects, extrapyramidal side effects did not appear to be  a major problem. Weight gain appears to be olanzapine&#8217;s major shortcoming when compared with aripiprazole (<LINK REF="CMP-005.24" TYPE="ANALYSIS">Analysis 5.24</LINK>). This is important as there were significantly smaller mean increase of cholesterol levels from baseline in the aripiprazole group than in people allocated olanzapine (<LINK REF="CMP-005.25" TYPE="ANALYSIS">Analysis 5.25</LINK>). Few people like gain weight or to be exposed to risks resulting from higher cholesterol levels. Olanzapine seemed to have a higher sedative effect on people in two randomised trials (<LINK REF="CMP-005.19" TYPE="ANALYSIS">Analysis 5.19</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">6. COMPARISON 6. ARIPIPRAZOLE versus OLANZAPINE (in acutely agitated patients)</HEADING>
<P>These results were based on a single five-day trial but with nearly 500 participants. This comparison was included to comply with the protocol of this review but, in retrospect, we feel would be best in a separate review and are pleased to see that this is underway (<LINK REF="REF-Pagadala-2009" TYPE="REFERENCE">Pagadala 2009</LINK>). Overall, the results suggest that the two drugs may be of some use in the acute situation but data are few, not of high quality, undertaken by those with a pecuniary interest in the findings, and do not have a comparison group of other more widely used treatments for acute agitation thought due to serious mental illness.</P>
<P>Very few (0.83%) participants left the study early with numbers being similar in both groups. This very low figure may reflect the coercive nature of the treatment and that people were not free to leave. This is an observation and is not meant as criticism as this too may reflect real-world practice.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">7. COMPARISON 7. ARIPIPRAZOLE versus OTHER ANTIPSYCHOTIC DRUGS</HEADING>
<P>The studies were randomised but no concealment methods were clarified. We do think the comparison of aripiprazole with any one of several new generation antipsychotic drugs is practical and reflects real-world practice. One of the studies reported quality of life measures, which we feel gives a fresh dimension to the comparison. Although some attempts were made to incorporate clinically important issues, the overall quality of evidence remains low.</P>
<P>Many general measures did improve with aripiprazole although there was not any difference for sexual dysfunction. Several measures of mental state did not improve although evidence of limited quality did show some advantage of aripiprazole for negative symptoms. This latter finding is important and should be replicated in a study independent of industry conflicts of interest.</P>
<P>We are not sure why people with schizophrenia reported aripiprazole being preferred when their carers did not (<LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>). This could be a chance finding. Despite this expression of preference, about one third of participants left the trial early. Perhaps this is reflective of a vote of lack of confidence for the trial design rather than the drug itself.</P>
<P>It is good that quality of life is now recorded as a matter of routine in these studies but not good that it is measured by many scales that are problematic to interpret. Partly as a result of this, we are unsure of the effects of aripiprazole on quality of life compared with several of its competitors.</P>
<P>Aripiprazole is not free of adverse effects but there may be slightly less overall than with the other drugs. Nausea may be a problem (<LINK REF="CMP-007.16" TYPE="ANALYSIS">Analysis 7.16</LINK>) but weight gain less problematic than other drugs.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1. Completeness</HEADING>
<P>Randomised evidence is available for only five out of eight possible comparisons of aripiprazole with other second generation antipsychotic drugs, although three studies compared aripiprazole with other atypical antipsychotics grouped together. Overall, evidence is incomplete. We do not have any good data on the implications of the use of aripiprazole on use of services from trials and we do think that 'admission' is a key outcome for people with schizophrenia. There are also very few economic data, which could be most important in this area.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Applicability</HEADING>
<P>In terms of applicability, we highlight that most included studies were 'efficacy' studies. Large and simple, pragmatic, real-world effectiveness studies are not available, greatly limiting external validity (<LINK REF="REF-Thorpe-2009" TYPE="REFERENCE">Thorpe 2009</LINK>).</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-07-09 12:02:54 +0100" MODIFIED_BY="[Empty name]">
<P>All studies were randomised and double blind or open label, but details were rarely presented. It is therefore unclear whether randomisation and blinding, where mentioned, were really appropriately done. The high number of participants leaving studies early (between 30% to 40% overall) must call into question the credibility of the findings (<LINK REF="REF-Xia-2007" TYPE="REFERENCE">Xia 2007</LINK>) because, once a person is lost to follow-up outcomes become a matter of assumption. Three long-term studies were available but in a chronic, often life-long, disorder such as schizophrenia it is important that many more participants are followed up for longer. Overall, we considered the quality of evidence to be 'medium' at best with a moderate risk of bias.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-07-09 12:05:51 +0100" MODIFIED_BY="[Empty name]">
<P>It is possible that some important information may have been excluded during the review process due to human error or information not being available. New data from 162 Chinese studies that were previously awaiting assessment did not substantially change the findings of the first review, however they have given us more comparisons and increased precision whilst not clearly effecting overall quality of data.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>An earlier Cochrane review compared aripiprazole with any other antipsychotic drugs (<LINK REF="REF-EL_x002d_Sayeh-2006" TYPE="REFERENCE">EL-Sayeh 2006</LINK>). In this past review authors combined olanzapine and risperidone as one group of 'atypical antipsychotic' drugs. A subsequent review comparing aripiprazole with other atypical antipsychotics was also published (<LINK REF="REF-Komossa-2009" TYPE="REFERENCE">Komossa 2009</LINK>) where the authors concluded that aripiprazole was not much different from other second generation antipsychotic drugs. This current update again concludes that aripiprazole was similar to other atypical antipsychotic drugs but we have found some evidence of it being better tolerated than its competitors.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-07-09 12:09:11 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. For people with schizophrenia</HEADING>
<P>For people with schizophrenia, it may be important to know that aripiprazole may be slightly less effective than olanzapine, but is less associated with adverse effects such as weight gain, cholesterol and prolactin increase and sedation. Aripiprazole's efficacy seems to be similar to that of risperidone, but certain movement disorders, cholesterol and prolactin increase may occur less frequently when taking aripiprazole. Aripiprazole may also be slightly better than ziprasidone with no clear differences apparent in adverse effects. When compared to other atypical antipsychotics as a group, people allocated to aripiprazole preferred its use. However, effects on quality of life were similar and carers found the two groups to be similar.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. For clinicians</HEADING>
<P>Clinicians should know that randomised evidence of the effects of aripiprazole compared with other second generation antipsychotic drugs is only available for a few drugs. Aripiprazole does not seem dogged by the problems of weight gain and raised prolactin. As with many antipsychotic drugs, it may, however, cause some extrapyramidal effects. More studies are needed to clarify the role of aripiprazole compared to other second generation antipsychotic drugs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. For managers/policy makers</HEADING>
<P>Data that are relevant for policy makers such as service utilisation, functioning in society or costs are not available. We therefore find it difficult to make recommendations for decision makers.</P>
</SUBSECTION>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. General</HEADING>
<P>Outcome reporting remains insufficient in antipsychotic drug trials. Strict adherence to the <A HREF="http://www.consortstatement.org">CONSORT</A> statement (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>) would make such studies much more informative. Making all data available would set this compound far ahead of its competitors (<A HREF="http://alltrials.net">ALLTRIALS</A>). Increasingly healthcare sub-specialities are gaining universal agreement on core outcomes to be reported within all trials (<A HREF="http://www.comet-initiative.org/">COMET</A>). This would greatly reduce disaggregation of data and add to the power of reviews such as this.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Specific</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Reviews</HEADING>
<P>Many interesting and potentially informative trials have had to be excluded as they are not of direct relevance to this review. Suggestions for their use within reviews are given in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Trials</HEADING>
<P>There is much room for further, better, randomised trials comparing aripiprazole with other second generation antipsychotic drugs. Comparisons with amisulpride, sertindole and zotepine are currently missing. We present a suggestion in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> recognising that much goes into design and conduct of such a large study that cannot be captured in a table.</P>
</SUBSECTION>
</SUBSECTION>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-01-02 13:17:33 +0000" MODIFIED_BY="[Empty name]">
<P>We would like to thank all members of the Cochrane Schizophrenia Group editorial base for their editorial assistance, and Ben Gray for writing the plain language summary. The Cochrane Schizophrenia Group provides and maintains a standard template of text for the methods section of their reviews. We have used this and adapted it so it is relevant for this review.</P>
<P>We would like to acknowledge and thank Werner Kissling, Heike Hunger, Sandra Schwaz and Franziska Schmid for their contributions in previous versions of this review.</P>
<P>We thank Heather Maxwell for copy editing this review, her skill in this area is greatly appreciated.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-11-18 10:34:43 +0000" MODIFIED_BY="[Empty name]">
<P>Tao Suo - none known.<BR/>Priya Khanna - none known.<BR/>Katja Komossa - none known.<BR/>Huai-xing Ma - none know.*<BR/>Stefan Leucht - has received honoraria for lectures from Abbvie, Astra Zeneca, BristolMyersSquibb, ICON, EliLilly, Janssen, Johnson &amp; Johnson, Roche, SanofiAventis, Lundbeck and Pfizer; honoraria for consulting/advisory boards from Roche, EliLilly, Medavante, BristolMyersSquibb, Alkermes, Janssen, Johnson &amp; Johnson and Lundbeck. EliLilly has provided medication for a study with Stefan Leucht as primary investigator.<BR/>Christine Rummel - has received lecture honoraria and travel grants to attend scientific meetings from AstraZenca, JanssenCilag, EliLilly and Pfizer.<BR/>Heike Hunger - none known.<BR/>Sandra Schwarz - none known.<BR/>Hany George El-Sayeh - none known.<BR/>Jun Xia - none known.*</P>
<P>* no conflict of interest but authors work for a professional review company that received an incentive to complete this update (see also <LINK TAG="SOURCES_OF_SUPPORT" TYPE="SECTION">Sources of support</LINK>).</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-01-02 13:16:36 +0000" MODIFIED_BY="[Empty name]">
<P>Tao Suo - study selection (2012 update), data extraction, report writing.<BR/>Priya Khanna - study selection (2011 update), data extraction, report writing.<BR/>Katja Komossa - protocol development, searching, study selection, data extraction, report writing.<BR/>Huai-xing Ma - study selection (2012 update), data extraction, report writing.<BR/>Stefan Leucht - protocol development, searching, study selection, data extraction, report writing.<BR/>Hany George El Sayeh - protocol development, 2011 update - help with write up.<BR/>Jun Xia - help with study selection (2012 update), data extraction, report writing.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-07-15 21:21:32 +0100" MODIFIED_BY="[Empty name]">
<P>The review was slightly adapted to new formatting and functions available in Review Manager 5, notably the 'Risk of bias' tables. In the first version of this review, we planned to undertake a sensitivity analysis and exclude studies with 'inappropriate comparator doses'; however, this was not defined. In the current review, we have defined this in the <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK> section.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2013-06-25 16:17:42 +0100" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-10-18 13:48:21 +0100" MODIFIED_BY="Claire Irving">
<STUDIES MODIFIED="2013-11-04 16:55:07 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-11-04 16:53:51 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-An-2008" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="An 2008" YEAR="">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ai C-Q, Chen S-M</AU>
<TI>Comparison study in the treatment of schizophrenia between aripiprazole and clozapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>1</NO>
<PG>53-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676738"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676737"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bai-2007" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Bai 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bai S-X, Yan L, Ding X-M</AU>
<TI>Comparative study on the efficacy of aripiprazole and clozapine in treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#27695;&#27694;&#24179;&#23545;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30103;&#25928;&#21450;&#23545;&#24515;&#30005;&#22270;&#24433;&#21709;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#20020;&#24202;&#23454;&#29992;&#21307;&#23398;</SO>
<YR>2007</YR>
<VL>1</VL>
<NO>4</NO>
<PG>39-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676740"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676739"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bai-2009" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Bai 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#30333;&#21073;&#25991;</AU>
<TI>ziprasidone and aripiprazole in the treatment of schizophrenia] Google Translate</TI>
<TO>&#40784;&#25289;&#35199;&#37230;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350; [</TO>
<SO>&#38738;&#23707;&#21307;&#33647;&#21355;&#29983;</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>3</NO>
<PG>199-200</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676742"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676741"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ban-2008" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Ban 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ban N, Cui J-B</AU>
<TI>Analysis of the efficacy of aripiprazole and quetiapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30827;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#20998;&#26512;</TO>
<SO>Occupation and Health [&#32844;&#19994;&#19982;&#20581;&#24247;]</SO>
<YR>2008</YR>
<VL>24</VL>
<NO>3</NO>
<PG>292-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676744"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676743"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2007" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chan 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chan HY, Lin WW, Lin SK, Hwang TJ, Su TP, Chiang SC, et al</AU>
<TI>Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: A randomized trial</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2007</YR>
<VL>68</VL>
<NO>1</NO>
<PG>29-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676746"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hwang TJ, Chan HY, Lin WW, Lin SK, Hwu HG, Cheng MY, et al</AU>
<TI>Aripiprazole versus risperidone in the treatment of acutely relapsed patients with schizophrenia in Taiwan: a randomized controlled trial</TI>
<SO>Journal of the European College of Neuropsychopharmacology</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>Suppl 3</NO>
<PG>S497</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676747"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676745"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chang-2007" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chang S</AU>
<TI>A control study of aripiprazole vs. risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>4</NO>
<PG>335-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676749"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676748"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2006" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen H, Liu Z, Gong J, Chen H, Hu D, Wang D</AU>
<TI>Comparative study of therapeutic effects between aripiprazole and risperidone on schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shanghai Medical and Pharmaceutical Journal [&#19978;&#28023;&#21307;&#33647;]</SO>
<YR>2006</YR>
<VL>27</VL>
<NO>9</NO>
<PG>404-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676751"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676750"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2007a" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#38472;&#39134;, &#29579;&#32418;&#33395;, &#26446;&#24503;&#21647;, &#21608;&#20445;&#21355;, &#31243;&#22827;&#33521;</AU>
<TI>Aripiprazole, quetiapine treatment of female episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#12289;&#21945;&#30827;&#24179;&#27835;&#30103;&#22899;&#24615;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>6</NO>
<PG>381-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676753"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676752"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2008a" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#38663;&#38647;, &#40644;&#33395;</AU>
<TI>Aripiprazole and risperidone in the treatment of female schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Modern Research of Integrated Chinese and Western Medicine [&#29616;&#20195;&#20013;&#35199;&#21307;&#32467;&#21512;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>35</NO>
<PG>5454-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676755"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676754"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2009" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#32418;&#33521;, &#24352;&#37094;, &#20184;&#36814;&#26149;, &#23395;&#28023;&#23792;, &#36153;&#29605;, &#40644;&#38597;&#21335;</AU>
<TI>Aripiprazole and quetiapine in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21945;&#30827;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>1</NO>
<PG>53-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676757"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676756"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2009a" MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#36828;&#23725;, &#40644;&#25991;&#27494;, &#21494;&#37995;&#27494;</AU>
<TI>Comparative study between aripiprazole and olanzapine in the treatment of agitated schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#20276;&#28608;&#36234;&#30340;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>4</NO>
<PG>261-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676759"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676758"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2010" MODIFIED="2013-09-26 12:10:09 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-09-26 12:10:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#38472;&#24179;&#21195;, &#32599;&#24314;&#24904;, &#21016;&#26691;&#33459;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia in the clinical control study] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>17</NO>
<PG>2249-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676761"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676760"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2010a" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2010a" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#24681;&#27665;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia starting] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>17</NO>
<PG>2180-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676763"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676762"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2009" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Cheng 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#31243;&#24179;, &#29579;&#22825;&#40857;, &#38472;&#32418;&#20809;, &#21776;&#40527;, &#21608;&#26690;&#26126;</AU>
<TI>Ziprasidone and Aripiprazole in the treatment of schizophrenia with predominantly negative symptoms</TI>
<TO>&#40784;&#25289;&#35199;&#37230;&#19982;&#38463;&#31435;&#21617;&#21777;&#27835;&#30103;&#20197;&#38452;&#24615;&#30151;&#29366;&#20026;&#20027;&#30340;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of the Xianning Medical College [&#26032;&#20065;&#21307;&#23398;&#38498;&#23398;&#25253;]</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>2</NO>
<PG>106-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676765"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676764"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-CuiMeng-2008" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="CuiMeng 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>CuiMeng</AU>
<TI>Compare the aripiprazole with risperidone to treat schizophrenia disease</TI>
<TO>&#21033;&#22521;&#37230;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;120&#20363;&#31934;&#31070;&#20998;&#35010;&#30151;&#25928;&#26524;&#23545;&#27604;&#20998;&#26512;</TO>
<SO>Journal of the Mudanjiang Medical College</SO>
<YR>2008</YR>
<VL>29</VL>
<NO>3</NO>
<PG>20-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676767"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676766"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dai-2005" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Dai 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dai J-P, Zhao Z-H, Liu G-X</AU>
<TI>Comparison of efficacy and safety of aripiprazole and quetiapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#33287;&#22862;&#30827;&#24179;&#27835;&#30274;&#31934;&#31070;&#20998;&#35010;&#30309;&#30274;&#25928;&#21644;&#23433;&#20840;&#24615;&#27604;&#36611;</TO>
<SO>Chinese Journal of Behavioral Medical Science [&#20013;&#22269;&#34892;&#20026;&#21307;&#23398;&#31185;&#23398;]</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>8</NO>
<PG>712-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676769"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676768"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dai-2006" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Dai 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dai T</AU>
<TI>A comparison of schizophrenia with aripiprazole and risperidone</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of the Datong Medical College</SO>
<YR>2006</YR>
<VL>26</VL>
<NO>1</NO>
<PG>14-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676771"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676770"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deng-2008" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Deng 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#37011;&#20811;&#25991;, &#24352;&#27704;&#31119;, &#24352;&#28023;&#39118;</AU>
<TI>Effects were compared aripiprazole in the treatment of elderly schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#32769;&#24180;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#23545;&#27604;&#35266;&#23519;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>1</NO>
<PG>28-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676773"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676772"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deng-2008a" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Deng 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#37011;&#21326;, &#36213;&#26757;&#31168;</AU>
<TI>Control study of domestic aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#22269;&#20135;&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of the Youjiang Medical College for Nationalities</SO>
<YR>2008</YR>
<VL>5</VL>
<PG>755-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676775"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676774"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ding-2007" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Ding 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#19969;&#27704;&#32418;, &#21608;&#24198;&#28023;, &#37011;&#37329;&#33521;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#29616;&#20195;&#21307;&#29983;</SO>
<YR>2007</YR>
<VL>45</VL>
<NO>17</NO>
<PG>87</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676777"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676776"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Du-2006" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Du 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Du B, Zhao S-M, Tian G-Q</AU>
<TI>Study on effects of aripiprazole on serum prolactin level and body weight</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#34880;&#28165;&#20652;&#20083;&#32032;&#21450;&#20307;&#37325;&#30340;&#24433;&#21709;</TO>
<SO>Chinese General Practice [&#20013;&#22269;&#20840;&#31185;&#21307;&#23398;]</SO>
<YR>2006</YR>
<VL>9</VL>
<NO>13</NO>
<PG>1065-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676779"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676778"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fan-2005" MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]" NAME="Fan 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fan W-L, Yu C-M, Wen J-S</AU>
<TI>Efficacy analysis of aripiprazole and clozapine in the treatment of schizophrenia</TI>
<SO>Journal of North Sichuan Medical College</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>4</NO>
<PG>377-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676781"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676780"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fan-2010" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Fan 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#33539;&#25991;&#28572;, &#20313;&#25104;&#27665;, &#26446;&#27491;&#21457;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350; [</TO>
<SO>&#35199;&#37096;&#21307;&#23398;</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>6</NO>
<PG>1051-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676783"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676782"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feng-2006" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Feng 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feng Y, Yan X, Zhao Z</AU>
<TI>The clinical study on aripiprazole and risperidone in trea tment of first-onset schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30103;&#25928;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>4</NO>
<PG>418-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676785"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676784"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fleischhacker-2008" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Fleischhacker 2008" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>BMS</AU>
<TI>A multicenter, double-blind, randomized, comparative study of aripiprazole and olanzapine in the treatment of patients with acute schizophrenia</TI>
<SO>Clinical Study Report CN138003</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676787"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676786"/><IDENTIFIER TYPE="CTG" VALUE="CN138-003"/><IDENTIFIER TYPE="ISRCTN" VALUE="NCT00712686"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fu-2009" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Fu 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#20613;&#28145;&#30465;,&#26417;&#33735;&#33491;,&#37101;&#25991;&#21191;,&#21016;&#19968;&#21596;,&#20052;&#32988;&#23431;</AU>
<TI>Comparative study of Aripiprazole with risperidone in the treatment of adolescent patients with first episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#38738;&#23569;&#24180;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Qiqihar Medical College [&#40784;&#40784;&#21704;&#23572;&#21307;&#23398;&#38498;&#23398;&#25253;]</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>8</NO>
<PG>905-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676789"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676788"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ge-2009" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Ge 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#34945;&#32431;&#29618;</AU>
<TI>Quetiapine and aripiprazole in the treatment control study of first-episode schizophrenia] Google Translate</TI>
<TO>&#21945;&#30827;&#24179;&#21644;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#29616;&#20195;&#33647;&#29289;&#24212;&#29992;</SO>
<YR>2009</YR>
<VL>2</VL>
<NO>3</NO>
<PG>71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676791"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676790"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ge-2010" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Ge 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#33883;&#28113;&#21531;, &#29579;&#26149;&#33395;, &#26417;&#20025;</AU>
<TI>Aripiprazole and quetiapine in the treatment of women with schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21945;&#30827;&#24179;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350; [</TO>
<SO>Chinese General Practice [&#20013;&#22269;&#20840;&#31185;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>13</VL>
<NO>5</NO>
<PG>46-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676793"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676792"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2006" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Guo 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo X-F, Chen J-D, Zhao J-P</AU>
<TI>A randomized and double-blind controlled clinical trial of aripiprazole in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30274;&#31934;&#31070;&#20998;&#35010;&#30309;&#30340;&#38568;&#27231;&#38617;&#30450;&#23565;&#29031;&#35430;&#39511;</TO>
<SO>Journal of Clinical Research</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>5</NO>
<PG>716-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676795"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676794"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2005" MODIFIED="2013-09-28 14:29:18 +0100" MODIFIED_BY="[Empty name]" NAME="Han 2005" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Han P, Zhang Y-H, Zhang C-Z</AU>
<TI>Quality of life in schizophrenics treated with aripiprazole or clozapine</TI>
<SO>Chinese Journal of Rehabilitation Theory and Practice</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>12</NO>
<PG>995-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676797"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-28 14:29:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Han P, Zhang Y-H, Zhang Y-Q</AU>
<TI>A controlled study of schizophrenia treated with aripiprazole and clozapine</TI>
<SO>Chinese Journal of Rehabilitation Theory and Practice [&#20013;&#22269;&#24247;&#22797;&#29702;&#35770;&#19982;&#23454;&#36341;]</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>10</NO>
<PG>853-4</PG>
<IDENTIFIERS MODIFIED="2013-09-28 14:29:18 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676798"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676796"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2007" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Han 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Han Y, Li Y, Ren C</AU>
<TI>Clinical effect of the domestic olanzapine and aripiprazole in the treatment of schizophrenia</TI>
<TO>&#22269;&#20135;&#22885;&#27694;&#24179;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>15</VL>
<NO>1</NO>
<PG>28-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676800"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676799"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2007a" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Han 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#38889;&#38634;&#23792;, &#33539;&#36830;&#26757;</AU>
<TI>Aripiprazole and risperidone in the treatment of clinical studies of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#32500;&#24605;&#36890;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#30740;&#31350;</TO>
<SO>Journal of Practical Medical Techniques [&#23454;&#29992;&#21307;&#25216;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>31</NO>
<PG>4298-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676802"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676801"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-2010" MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Hu 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#32993;&#20122;&#28248;, &#23828;&#28851;&#21916;, &#20110;&#27994;&#29611;, &#23828;&#40527;, &#31206;&#39062;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Tianjin Pharmacy</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>1</NO>
<PG>41-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676804"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676803"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2009" MODIFIED="2013-09-26 12:25:42 +0100" MODIFIED_BY="[Empty name]" NAME="Huang 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-09-26 12:25:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#40644;&#27827;&#20142;, &#29579;&#26690;&#39321;</AU>
<TI>A comparative study in earlier schizophrenic patients treated with aripiprazole and risperidone</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#26089;&#26399;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#21644;&#23433;&#20840;&#24615;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#21307;&#33647;&#25351;&#21335;</SO>
<YR>2009</YR>
<VL>7</VL>
<NO>16</NO>
<PG>15-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676806"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676805"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ji-2007" MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]" NAME="Ji 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ji D-C, Yu C-X, Sun Y-J, Huang M, Huang Q</AU>
<TI>A study of aripiprazole and risperidone in treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>4</NO>
<PG>261-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676808"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676807"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiang-2009" MODIFIED="2013-10-24 15:38:48 +0100" MODIFIED_BY="[Empty name]" NAME="Jiang 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-10-24 15:38:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiang G, Luo J</AU>
<TI>Aripiprazole and clozapine in treatment refractory schizophrenia randomized controlled study] Google Translate</TI>
<SO>Chongqing Medical Journal</SO>
<YR>2009</YR>
<VL>38</VL>
<NO>1</NO>
<PG>87-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676810"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676809"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jie-2008" MODIFIED="2013-10-24 15:38:57 +0100" MODIFIED_BY="[Empty name]" NAME="Jie 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-10-24 15:38:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jie R, Wang G</AU>
<TI>Aripiprazole and clozapine treatment of schizophrenia with predominantly negative symptoms</TI>
<SO>Sichuan Mental Health</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>2</NO>
<PG>107-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676812"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676811"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kane-2009" MODIFIED="2013-09-27 20:52:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kane 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ascher-Svanum H, Stensland MD, Peng X, Faries DE, Stauffer VL, Osuntokun OO, et al</AU>
<TI>Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>1</NO>
<PG>115-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676814"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer V, Watson SB</AU>
<TI>A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia</TI>
<SO>Biological Psychiatry</SO>
<YR>2008</YR>
<VL>63</VL>
<NO>7 Suppl</NO>
<PG>289S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676815"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer V, Watson SB</AU>
<TI>A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia</TI>
<SO>Proceedings of the 63rd Annual Convention of the Society of Biological Psychiatry</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676816"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-27 20:52:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer VL, Watson SB, et al</AU>
<TI>A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2009</YR>
<VL>70</VL>
<NO>4</NO>
<PG>572-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676817"/><IDENTIFIER TYPE="MEDLINE" VALUE="19323965"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osuntokun O, Kane JM, Kryzhanovskaya LA, Xu W, Stauffer V, Watson SB</AU>
<TI>A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia</TI>
<SO>International Journal of Neuropsychopharmacology</SO>
<YR>2008</YR>
<VL>11</VL>
<NO>Suppl 1</NO>
<PG>153</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676818"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Watson SB, Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer V</AU>
<TI>A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia</TI>
<SO>Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676819"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676813"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kern-2006" MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]" NAME="Kern 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kern RS, Green MF, Cornblatt BA, Owen JR, McQuade RD, Carson WH, et al</AU>
<TI>The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine</TI>
<SO>Psychopharmacology</SO>
<YR>2006</YR>
<VL>187</VL>
<NO>3</NO>
<PG>312-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676821"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676820"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerwin-2007" MODIFIED="2013-09-27 20:55:07 +0100" MODIFIED_BY="[Empty name]" NAME="Kerwin 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beuzen JN, L'Italien G, Hanssens L, Marcus RN, McQuade RD, Carson WH</AU>
<TI>Changes in prolactin levels and arizona sexual experience scale (ASEX) scores among patients switched from risperidone to aripiprazole in the schizophrenia trial of aripiprazole (STAR) study</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>421-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676823"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blonde L, Kan HJ, Gutterman EM, L'Italien GJ, Kim MS, Hanssens L, et al</AU>
<TI>Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2008</YR>
<VL>69</VL>
<NO>5</NO>
<PG>741-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676824"/><IDENTIFIER TYPE="MEDLINE" VALUE="18435564"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanssens L, L&#8217; Italien G, McQuade R, Iwamoto T, Pans M</AU>
<TI>Evaluation of quality of life in community-treated schizophrenic patients: a naturalistic, open-label study comparing aripiprazole to standard-of-care (Schizophrenia Trial of aripiprazole: STAR study)</TI>
<SO>European Psychiatry</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>Suppl 1</NO>
<PG>S99</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676825"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanssens L, L'Italien G, Marcus RN, McQuade RD, Carson WH, Beuzen JN</AU>
<TI>Reasons for switching from previous therapy and preference of medication in the large, randomized, naturalistic schizophrenia trial of aripiprazole (STAR)</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>432</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676826"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-27 20:55:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, et al</AU>
<TI>A multi centre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of aripiprazole: (STAR) study</TI>
<SO>European Psychiatry</SO>
<YR>2007</YR>
<VL>22</VL>
<NO>7</NO>
<PG>433-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676827"/><IDENTIFIER TYPE="MEDLINE" VALUE="17555947"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, et al</AU>
<TI>A multi centre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenic Trial of aripiprazole: (STAR) study</TI>
<SO>Wiadomosci Psychiatryczne</SO>
<YR>2008</YR>
<VL>11</VL>
<NO>2</NO>
<PG>105-19</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676828"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>King D, Knapp M, Thomas P, Razzouk D, Loze JY, Kan HJ, et al</AU>
<TI>Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: Star study</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>2</NO>
<PG>365-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676829"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kolotkin RL, Corey-Lisle PK, Crosby RD, Kan HJ, McQuade RD</AU>
<TI>Changes in weight and weight-related quality of life in a multi centre, randomized trial of aripiprazole versus standard of care</TI>
<SO>European Psychiatry</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>8</NO>
<PG>561-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676830"/><IDENTIFIER TYPE="MEDLINE" VALUE="18374544"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>L'Italien G, Hanssens L, Kan HJ, Baker RA, Marcus RN, McQuade RD, et al</AU>
<TI>Metabolic effects of aripiprazole versus olanzapine, quetiapine, or risperidone (the STAR trial)</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>439</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676831"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>L'Italien GJ, Blonde L, Hanssens L, McQuade R</AU>
<TI>Prevalence of diabetes/cardiovascular risk factors among schizophrenia patients treated with atypical antipsychotics in a multicenter, randomized, naturalistic, open-label study (Schizophrenia Trial of aripiprazole: STAR study)</TI>
<SO>Diabetes</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>Suppl 1</NO>
<PG>A538</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676832"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>L'ltalien GJ, Hanssens L, Marcus RN, McQuade RD</AU>
<TI>Evidence of antipsychotic treatment selection based on metabolic risk factors among community-based schizophrenia patients (The STAR Trial)</TI>
<SO>Proceedings of the 160th Annual Meeting of the American Psychiatric Association; 2007 May 19-24; San Diego, CA</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676833"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Millet B</AU>
<TI>A multicenter, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients (Schizophrenia Trial of aripiprazole - STAR)</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676834"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor D, Hanssens L, Loze J-Y, Pans M, L'Italien G, Marcus RN</AU>
<TI>Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study</TI>
<SO>European Psychiatry</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>5</NO>
<PG>336-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676835"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676822"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kinon-2004" MODIFIED="2013-09-27 21:00:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kinon 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Eli Lilly and Company</AU>
<TI>Olanzapine versus aripiprazole in the treatment of acutely ill patients with schizophrenia</TI>
<SO>Eli Lilly and Company Clinical Trial Registry</SO>
<YR>2004</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676837"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-27 21:00:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J</AU>
<TI>Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia</TI>
<SO>Journal of Clinical Psychopharmacology</SO>
<YR>2008</YR>
<VL>28</VL>
<NO>6</NO>
<PG>601-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676838"/><IDENTIFIER TYPE="MEDLINE" VALUE="19011427"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Stauffer V, Kinon B, Kollack-Walker S, Chen L, Sniadecki J</AU>
<TI>Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia</TI>
<SO>Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676839"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676836"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuang-2006" MODIFIED="2013-09-28 14:39:31 +0100" MODIFIED_BY="[Empty name]" NAME="Kuang 2006" YEAR="2006, 2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuang L-P, Xue Z-M</AU>
<TI>A controlled study on compliance of schizophrenia treated with aripirazole and clozapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#27835;&#30103;&#20381;&#20174;&#24615;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Clinical Psychology[&#20013;&#22269;&#20020;&#24202;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>4</NO>
<PG>426-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676841"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-28 14:39:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuang L-P</AU>
<TI>A controlled study on quality of life of schizophrenia treated with aripiprazole and clozapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#24433;&#21709;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese Civil Administration[&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>9</NO>
<PG>690-1</PG>
<IDENTIFIERS MODIFIED="2013-09-28 14:39:31 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676842"/><IDENTIFIER MODIFIED="2013-09-28 14:39:31 +0100" MODIFIED_BY="Heather Maxwell" TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676840"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2006" MODIFIED="2013-09-28 14:39:46 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-09-28 14:39:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li G-R, Lu P-X, Li Y-D</AU>
<TI>A comparative study of aripiprazole and risperidone in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2006</YR>
<VL>19</VL>
<NO>3</NO>
<PG>196-7</PG>
<IDENTIFIERS MODIFIED="2013-09-28 14:39:46 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676844"/><IDENTIFIER MODIFIED="2013-09-28 14:39:46 +0100" MODIFIED_BY="Heather Maxwell" TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676843"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2006a" MODIFIED="2013-09-28 14:40:04 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-09-28 14:40:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Li L-X, Lian H-T</AU>
<TI>A comparative study of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>9</NO>
<PG>723-4</PG>
<IDENTIFIERS MODIFIED="2013-09-28 14:40:04 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676846"/><IDENTIFIER MODIFIED="2013-09-28 14:40:04 +0100" MODIFIED_BY="Heather Maxwell" TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676845"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li M, Wu N, Li Y-F</AU>
<TI>Comparative study of influence of aripiprazole on life quality in schizophrenic patients</TI>
<SO>Chinese Journal of Health Psychology</SO>
<YR>2007</YR>
<VL>15</VL>
<NO>10</NO>
<PG>956-7.[MEDLINE:]</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676848"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676847"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007a" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007a" YEAR="">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#29618;, &#29579;&#20426;&#36229;</AU>
<TI>Aripiprazole and clozapine on quality of life of patients with schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>15</NO>
<PG>1939-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676850"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li Q, Li G, Li G</AU>
<TI>Effects of aripiprazole and clozapine on life quality of schizophrenics</TI>
<SO>Journal of Clinical Psychosomatic Diseases</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>5</NO>
<PG>404-6.[MEDLINE: ]</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676851"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676849"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007b" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#26446;&#32654;&#33457;, &#21525;&#20255;, &#37026;&#31168;&#23071;</AU>
<TI>Aripiprazole and quetiapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21945;&#30827;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#21307;&#24072;&#36827;&#20462;&#26434;&#24535;</SO>
<YR>2007</YR>
<VL>30</VL>
<NO>11A</NO>
<PG>49-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676853"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676852"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007c" MODIFIED="2013-09-27 21:03:03 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007c" YEAR="2007">
<REFERENCE MODIFIED="2013-09-27 21:03:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li H</AU>
<TI>Comparison of efficacy and safety of aripiprazole and ziprasidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#40784;&#25289;&#35199;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#27604;&#36739;</TO>
<SO>International Medicine and Health Guidance News [&#22269;&#38469;&#21307;&#33647;&#21355;&#29983;&#23548;&#25253;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>11</NO>
<PG>77-9</PG>
<IDENTIFIERS MODIFIED="2013-09-27 21:03:03 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676855"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676854"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007d" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007d" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li C, Deng L, Feng W</AU>
<TI>Control studies of domestic aripiprazole vs. risperidone in the treatment of schizophrenia</TI>
<TO>&#22269;&#20135;&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>2</NO>
<PG>100-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676857"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676856"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2009" MODIFIED="2013-11-04 16:48:53 +0000" MODIFIED_BY="[Empty name]" NAME="Li 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:48:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#26446;&#26195;&#33521;, &#21016;&#29734;</AU>
<TI>Aripiprazole and clozapine treatment of schizophrenia control study of efficacy and safety] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30103;&#25928;&#19982;&#23433;&#20840;&#24615;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#29976;&#32899;&#31185;&#25216;</SO>
<YR>2009</YR>
<VL>25</VL>
<NO>16</NO>
<PG>135-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676859"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676858"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2009a" MODIFIED="2013-11-04 16:49:02 +0000" MODIFIED_BY="[Empty name]" NAME="Li 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:49:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26446;&#20195;&#31168;, &#38472;&#27874;, &#19969;&#38745;&#21326;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia compared] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#23545;&#27604;</TO>
<SO>Baotou Medical Journal</SO>
<YR>2009</YR>
<VL>33</VL>
<NO>1</NO>
<PG>13-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676861"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676860"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2009b" MODIFIED="2013-11-04 16:49:11 +0000" MODIFIED_BY="[Empty name]" NAME="Li 2009b" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:49:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#26446;&#26195;&#21326;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#23454;&#29992;&#21307;&#33647;</SO>
<YR>2009</YR>
<VL>4</VL>
<NO>18</NO>
<PG>166-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676863"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676862"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lian-2008" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Lian 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#36830;&#26641;&#22862;, &#26519;&#24503;&#39062;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#29616;&#20195;&#21307;&#29983;</SO>
<YR>2008</YR>
<VL>46</VL>
<NO>14</NO>
<PG>91-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676865"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676864"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang-2008" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Liang 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26753;&#20339;, &#38518;&#24314;&#38738;, &#24247;&#32418;</AU>
<TI>Compliance control study of aripiprazole and risperidone in the treatment of patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#20381;&#20174;&#24615;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Guangxi Medical Journal</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>1</NO>
<PG>30-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676867"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676866"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2006" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Liu S, Ren C, Song X</AU>
<TI>Comparative study between aripiprazole and clozapine in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>658-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676869"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676868"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2006a" MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu W, Yang K, Zuo X</AU>
<TI>A control study on aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#27966;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>4</NO>
<PG>420-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676871"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676870"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2007" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu B</AU>
<TI>A control study on aripiprazole vs. clozapine in the treatment of refractory schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>6</NO>
<PG>500-1, 507</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676873"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676872"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2008" MODIFIED="2013-11-04 16:49:21 +0000" MODIFIED_BY="[Empty name]" NAME="Liu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-11-04 16:49:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Liu J, Ren J, Wang Y</AU>
<TI>Aripiprazole and clozapine treatment episode schizophrenia</TI>
<SO>&#20013;&#22269;&#23454;&#29992;&#21307;&#33647;</SO>
<YR>2008</YR>
<VL>3</VL>
<NO>4</NO>
<PG>55-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676875"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676874"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2008a" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Liu W, Zhang X</AU>
<TI>A comparative study of ziprasidone and aripiprazole in the treatment of schizophrenia with predominantly negative symptoms</TI>
<TO>&#40784;&#25289;&#35199;&#37230;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#20197;&#38452;&#24615;&#30151;&#29366;&#20026;&#20027;&#30340;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>16</VL>
<NO>2</NO>
<PG>124-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676877"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676876"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2008b" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2008b" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21016;&#20174;&#25935;</AU>
<TI>Aripiprazole for schizophrenia patients with psychiatric symptoms and quality of life impact</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30340;&#31934;&#31070;&#30151;&#29366;&#21450;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#21307;&#33647;&#23548;&#25253;</SO>
<YR>2008</YR>
<VL>5</VL>
<NO>19</NO>
<PG>110-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676879"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676878"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2008c" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2008c" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#21016;&#20255;&#38155;, &#24352;&#21355;&#25935;</AU>
<TI>Aripiprazole and risperidone in the treatment of refractory schizophrenia Efficacy</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30103;&#25928;&#35266;&#23519;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>3</NO>
<PG>224-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676881"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676880"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2008d" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2008d" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21016;&#23781;&#23896;, &#37079;&#26195;&#26126;, &#26446;&#20029;&#39062;</AU>
<TI>Aripiprazole and risperidone in the treatment episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Medical Journal of Metallurgical Industry [&#20013;&#22269;&#20918;&#37329;&#24037;&#19994;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>25</VL>
<NO>3</NO>
<PG>276-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676883"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676882"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2009" MODIFIED="2013-11-04 16:49:32 +0000" MODIFIED_BY="[Empty name]" NAME="Liu 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:49:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#21016;&#23071;, &#26446;&#27946;&#33521;</AU>
<TI>Aripiprazole and olanzapine schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22885;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>5</NO>
<PG>339-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676885"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676884"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2009a" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#21016;&#24535;&#19996;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Medical Theory and Practice</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>9</NO>
<PG>1072-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676887"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676886"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2009b" MODIFIED="2013-11-04 16:49:38 +0000" MODIFIED_BY="[Empty name]" NAME="Liu 2009b" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:49:38 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21016;&#26122;, &#26417;&#24576;&#36713;, &#36213;&#21220;, &#35885;&#26435;</AU>
<TI>Aripiprazole and quetiapine in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21945;&#30827;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>1</NO>
<PG>42-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676889"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676888"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2010" MODIFIED="2013-11-04 16:49:44 +0000" MODIFIED_BY="[Empty name]" NAME="Liu 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:49:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21016;&#21321;&#20848;, &#24352;&#39321;&#20113;, &#26647;&#20811;&#28165;, &#26705;&#25991;&#21326;, &#24352;&#24422;&#24658;, &#30000;&#26690;&#24179;, et al</AU>
<TI>Clozapine, risperidone and aripiprazole adverse drug reactions cost - effectiveness analysis] Google Translate</TI>
<TO>&#27695;&#27694;&#24179;&#12289;&#21033;&#22521;&#37230;&#21644;&#38463;&#31435;&#21708;&#21777;&#33647;&#29289;&#19981;&#33391;&#21453;&#24212;&#25104;&#26412;-&#25928;&#26524;&#20998;&#26512;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2010</YR>
<VL>18</VL>
<NO>6</NO>
<PG>646-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676891"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676890"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-X-2007" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Li X 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#26446;&#26342;, &#29579;&#33805;, &#23044;&#28059;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1064, 1067</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676893"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676892"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lou-2007" MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Lou 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lou T, Li N, Wu X-Y, Wang C-S</AU>
<TI>Effect of aripiprazole on late-onset schizophrenia and cognitive function</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#26202;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#35266;&#23519;&#21450;&#20854;&#23545;&#35748;&#30693;&#21151;&#33021;&#30340;&#24433;&#21709;</TO>
<SO>Chinese New Drugs Journal [&#20013;&#22269;&#26032;&#33647;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>20</NO>
<PG>1709-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676895"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676894"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luo-2008" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Luo 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luo X, An B-F</AU>
<TI>Comparison of quetiapine and aripiprazole in the treatment of first episode schizophrenia</TI>
<TO>&#22862;&#30827;&#24179;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>3</NO>
<PG>191-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676897"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676896"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luo-2009" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Luo 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#32599;&#26469;&#20852;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia efficacy analysis</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30103;&#25928;&#20998;&#26512;</TO>
<SO>&#24403;&#20195;&#21307;&#23398;</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>170</NO>
<PG>101-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676899"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676898"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lv-2007" MODIFIED="2013-09-28 14:58:36 +0100" MODIFIED_BY="[Empty name]" NAME="Lv 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-09-28 14:58:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lv T-H, Jin C-X</AU>
<TI>A comparative study on aripiprazole and risperidone in the treatment of schizophrenic patients</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>5</NO>
<PG>181-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676901"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676900"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2009" MODIFIED="2013-11-04 16:49:55 +0000" MODIFIED_BY="[Empty name]" NAME="Ma 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:49:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#40635;&#26174;&#23047;, &#21346;&#21916;&#37329;, &#37049;&#26195;&#21326;</AU>
<TI>Aripiprazole and olanzapine in negative symptoms in schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22885;&#27694;&#24179;&#27835;&#30103;&#20197;&#38452;&#24615;&#30151;&#29366;&#20026;&#20027;&#30340;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>China Pharmaceuticals [&#20013;&#22283;&#34277;&#26989;]</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>23</NO>
<PG>59-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676903"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676902"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2009a" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Ma 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#39532;&#24544;&#26234;, &#38472;&#26149;&#27494;</AU>
<TI>Efficacy of aripiprazole and risperidone in the treatment of early schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#26089;&#26399;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#35266;&#23519;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>6</NO>
<PG>643-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676905"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676904"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mai-2005" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Mai 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mai G-Y, Cai G-H, Huang J-M</AU>
<TI>Comparative study on the effect of aripiprazole and risperidone on schizophrenia</TI>
<SO>Chinese Journal of Rehabilitation [&#20013;&#22283;&#24247;&#24489;]</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>3</NO>
<PG>184-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676907"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676906"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mao-2010" MODIFIED="2013-11-04 16:50:05 +0000" MODIFIED_BY="[Empty name]" NAME="Mao 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:50:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#27611;&#26143;, &#21016;&#27946;&#31179;, &#38472;&#29577;&#36745;</AU>
<TI>Olanzapine and aripiprazole in the treatment of refractory schizophrenia control study of 70 cases] Google Translate</TI>
<TO>&#22885;&#27694;&#24179;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;70&#20363;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>11</NO>
<PG>1365-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676909"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676908"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McQuade-2004" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="McQuade 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Abou Gharbia N, McQuade R, Jody D, Kujawa M, Carson W, Iwamoto T, et al</AU>
<TI>Comparative study of the long-term effects of aripiprazole and olanzapine treatment on body weight</TI>
<SO>Proceedings of the Thematic Conference of the World Psychiatric Association on "Treatments in Psychiatry: An Update"; 2004 Nov 10-13; Florence, Italy</SO>
<YR>2004</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676911"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blonde L, Ray S, Corey-Lisle PK, Cislo PR, L'Italien G</AU>
<TI>The risk of new-onset type 2 diabetes and coronary heart disease in chronic schizophrenic patients treated with aripiprazole and olanzapine</TI>
<SO>Journal of the European College of Neuropsychopharmacology</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>Suppl 3</NO>
<PG>S275</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676912"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jody D, McQuade RD, Kujawa M, Carson W, Iwamoto T, Archibald D, et al</AU>
<TI>Long-term weight effects of aripiprazole versus olanzapine</TI>
<SO>Schizophrenia Research</SO>
<YR>2004</YR>
<VL>67</VL>
<NO>1</NO>
<PG>187</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676913"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>McQuade RD, Jody D, Kujawa MJ, Carson WH, Iwamoto T, Archibald DG, et al</AU>
<TI>Long-term weight effects of aripiprazole versus olanzapine</TI>
<SO>Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco, California, USA</SO>
<YR>2003</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676914"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McQuade RD, Kujawa M, Saha AR, Ingenito GG, Ali MW, Luo X, et al</AU>
<TI>Aripiprazole for long-term maintenance treatment of schizophrenia</TI>
<SO>Schizophrenia Research</SO>
<YR>2003</YR>
<VL>60</VL>
<NO>1</NO>
<PG>295</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676915"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, et al</AU>
<TI>A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2004</YR>
<VL>65</VL>
<NO>Suppl 18</NO>
<PG>47-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676916"/><IDENTIFIER TYPE="MEDLINE" VALUE="15600384"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, et al</AU>
<TI>A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2004</YR>
<VL>65</VL>
<NO>Suppl 18</NO>
<PG>47-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676917"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer JM, Rosenblatt LC, Kim E, Baker RA, Whitehead R</AU>
<TI>The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2009</YR>
<VL>70</VL>
<NO>3</NO>
<PG>318-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676918"/><IDENTIFIER TYPE="MEDLINE" VALUE="19192469"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676910"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mu-2008" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Mu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#31302;&#24503;&#20891;, &#29579;&#40857;&#38182;, &#29579;&#24013;</AU>
<TI>Domestic aripiprazole and risperidone in the treatment of female schizophrenia</TI>
<TO>&#22269;&#20135;&#38463;&#31435;&#21708;&#21777;&#21644;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>23</NO>
<PG>2781, 2783</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676920"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676919"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mu-2010" MODIFIED="2013-11-04 16:50:26 +0000" MODIFIED_BY="[Empty name]" NAME="Mu 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:50:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#27792;&#24535;&#24378;, &#26472;&#39034;&#33521;, &#26446;&#24380;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia compared] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#23545;&#27604;</TO>
<SO>Medical Information</SO>
<YR>2010</YR>
<VL>3</VL>
<PG>641-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676922"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676921"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pan-2007" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Pan 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pan G</AU>
<TI>A controlled study of aripiprazole and risperdal in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>15</VL>
<NO>4</NO>
<PG>363-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676924"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676923"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peng-2007" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Peng 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peng X, Huang Y, Liu X-Y</AU>
<TI>A clinical analysis of aripiprazole and quetiapine in treatment of first episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30827;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#20998;&#26512;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>5</NO>
<PG>329-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676926"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676925"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peng-2007a" MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]" NAME="Peng 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peng Z-Y, Mao W-L</AU>
<TI>Comparative study between aripiprazole and clozapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of the Gannan Medical College [&#36195;&#21335;&#21307;&#23398;&#38498;&#23398;&#25253;]</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>2</NO>
<PG>237-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676928"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676927"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Potkin-2003" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Potkin 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Potkin SG, Kujawa M, Carson WH, Saha AR, Ali M, Ingenito G</AU>
<TI>Aripiprazole and risperidone versus placebo in schizophrenia and schizoaffective disorder</TI>
<SO>Schizophrenia Research</SO>
<YR>2003</YR>
<VL>60</VL>
<PG>300</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676930"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, et al</AU>
<TI>Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2003</YR>
<VL>60</VL>
<NO>7</NO>
<PG>681-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676931"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676929"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pu-2007" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Pu 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Pu S-B, Liang J-X, Zhang W-S</AU>
<TI>The comparison of blood prolactin and body index in the female patients with psychosis treated by aripiprazole and risperidone</TI>
<TO>&#38463;&#31435;&#27966;&#21777;&#19982;&#21033;&#22521;&#37230;&#23545;&#22899;&#24615;&#24739;&#32773;&#34880;&#28165;&#20652;&#20083;&#32032;&#21450;&#20307;&#22411;&#25351;&#25968;&#24433;&#21709;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>5</NO>
<PG>163-4, 7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676933"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676932"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qian-2009" MODIFIED="2013-11-04 16:50:36 +0000" MODIFIED_BY="[Empty name]" NAME="Qian 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:50:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#38065;&#25991;&#32988;</AU>
<TI>Aripiprazole and olanzapine treatment of female control study of patients with schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22885;&#27694;&#24179;&#23545;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#27835;&#30103;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20853;&#22242;&#21307;&#23398;</SO>
<YR>2009</YR>
<VL>1</VL>
<NO>19</NO>
<PG>28-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676935"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676934"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qin-2008" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Qin 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#31206;&#29233;&#29618;, &#26446;&#25935;, &#32997;&#29233;&#33805;</AU>
<TI>Aripiprazole and risperidone in the treatment of chronic schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>4</NO>
<PG>284, 300</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676937"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676936"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qu-2009" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Qu 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26354;&#19975;&#20161;</AU>
<TI>The comparison for effect of treating schizophrenia with aripiprazole and risperidone</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;120&#20363;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#27604;</TO>
<SO>Chinese Journal of Ethnomedicine and Ethnopharmacy</SO>
<YR>2009</YR>
<VL>6</VL>
<PG>33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676939"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676938"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shan-2008" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Shan 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shan H</AU>
<TI>A controlled study of aripiprazole vs. risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>2</NO>
<PG>119-20, 133</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676941"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676940"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shuai-2008" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Shuai 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shuai H</AU>
<TI>Evaluating the effect and safety of aripirazole and risperidone</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#30103;&#25928;&#21450;&#23433;&#20840;&#24615;&#35780;&#20215;</TO>
<SO>&#20013;&#22269;&#29616;&#20195;&#21307;&#33647;&#26434;&#24535;</SO>
<YR>2008</YR>
<VL>10</VL>
<NO>2</NO>
<PG>35-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676943"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676942"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2008" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Song 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#23435;&#33395;&#33805;</AU>
<TI>Comparative analysis of aripiprazole and risperidone in the treatment of female schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#20998;&#26512;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>1</NO>
<PG>34-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676945"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676944"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2009" MODIFIED="2013-11-04 16:50:46 +0000" MODIFIED_BY="[Empty name]" NAME="Song 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:50:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#23435;&#38271;&#24800;</AU>
<TI>Aripiprazole Comparative Study of Risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777; &#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#27604;&#30740;&#31350;</TO>
<SO>Journal of Medical Forum [&#21307;&#33647;&#35770;&#22363;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>19</NO>
<PG>67-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676947"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676946"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2010" MODIFIED="2013-11-04 16:50:54 +0000" MODIFIED_BY="[Empty name]" NAME="Song 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:50:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#23435;&#33459;</AU>
<TI>Olanzapine and aripiprazole in the treatment of schizophrenia] Google Translate</TI>
<TO>&#22885;&#27694;&#24179;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>8</NO>
<PG>970, 986</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676949"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676948"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Su-2007" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Su 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26647;&#23567;&#32418;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>5</NO>
<PG>313-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676951"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676950"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Su-2008" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Su 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Su Q, Huang H-R, Gao A-Q, Huang D</AU>
<TI>A comparative study of olanzapine and aripiprazole in treatment of schizophrenia</TI>
<TO>&#22885;&#27694;&#24179;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>6</NO>
<PG>409-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676953"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676952"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2006" MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]" NAME="Sun 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun Q, Guo H, Liu Y</AU>
<TI>Effect of aripiprazole on coginiton function in patients with schizophrenic</TI>
<TO>&#22885;&#27966;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#35748;&#30693;&#21151;&#33021;&#30340;&#24433;&#21709;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>4</NO>
<PG>424-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676955"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676954"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2009" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Sun 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#23385;&#19996;, &#27743;&#29748;&#26222;, &#26446;&#24314;&#38155;, &#26446;&#34183;, &#26472;&#32769;&#34382;</AU>
<TI>Control study on aripiprazole in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#21147;&#21708;&#21777;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>7</NO>
<PG>774-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676957"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676956"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2009a" MODIFIED="2013-11-04 16:51:05 +0000" MODIFIED_BY="[Empty name]" NAME="Sun 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:51:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#23385;&#24503;&#29983;, &#23609;&#28949;&#26032;</AU>
<TI>Quetiapine and aripiprazole in the treatment of schizophrenia] Google Translate</TI>
<TO>&#22862;&#30827;&#24179;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>12</NO>
<PG>1416-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676959"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676958"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tandon-2006" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Tandon 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riera L, Hu R, Stock E, Nyilas M, Torbeyns A, Borian F, et al</AU>
<TI>Broad effectiveness trial with aripiprazole</TI>
<SO>Schizophrenia Research</SO>
<YR>2004</YR>
<VL>67</VL>
<NO>1</NO>
<PG>157</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676961"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tandon R, Marcus RN, Stock EG, Riera LC, Kostic D, Pans M, et al</AU>
<TI>A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With aripiprazole (BETA)</TI>
<SO>Schizophrenia Research</SO>
<YR>2006</YR>
<VL>84</VL>
<NO>1</NO>
<PG>77-89</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676962"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676960"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2006" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Tang 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tang Q, Lai G, Zhang J</AU>
<TI>Aripiprazole and risperidone in the treatment of female schizophrenics</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shanghai Archives of Psychiatry [&#19978;&#28023;&#31934;&#31070;&#21307;&#23398;] [&#19978;&#28023;&#31934;&#31070;&#37291;&#23416;]</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>1</NO>
<PG>30-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676964"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676963"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2007" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Tang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tang C-G, Wang R-C</AU>
<TI>Comparison of efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#30340;&#30103;&#25928;&#21644;&#23433;&#20840;&#24615;&#27604;&#36739;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>17</NO>
<PG>727-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676966"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676965"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2010" MODIFIED="2013-11-04 16:51:13 +0000" MODIFIED_BY="[Empty name]" NAME="Tang 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:51:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Tang Q</AU>
<TI>Aripiprazole and risperidone in the treatment efficacy of first-episode schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#35266;&#23519;</TO>
<SO>Chinese Journal of Pharmaco Epidemiology [&#33647;&#29289;&#27969;&#34892;&#30149;&#23398;&#26434;&#24535;]</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>1</NO>
<PG>13-4, 20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676968"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676967"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2010a" MODIFIED="2013-11-04 16:51:19 +0000" MODIFIED_BY="[Empty name]" NAME="Tang 2010a" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:51:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21776;&#38745;, &#38472;&#38081;&#23439;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>17</NO>
<PG>2243-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676970"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676969"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tao-2008" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Tao 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tao S-W, Chen Q, Yang C, Pan R-D, Pan T-W, Li L, et al</AU>
<TI>A comparison of the effects on lipid metabolic among four different atypical antipsychotic agents</TI>
<TO>4&#31181;&#38750;&#20856;&#22411;&#25239;&#31934;&#31070;&#30149;&#33647;&#29289;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#33026;&#20195;&#35874;&#30340;&#24433;&#21709;</TO>
<SO>Journal of the Youjiang Medical College for Nationalities</SO>
<YR>2008</YR>
<VL>6</VL>
<PG>927-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676972"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676971"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tong-2007" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Tong 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tong J, Yang Z</AU>
<TI>Control study of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>1</NO>
<PG>7-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676974"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676973"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tu-2009" MODIFIED="2013-11-04 16:51:29 +0000" MODIFIED_BY="[Empty name]" NAME="Tu 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:51:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#28034;&#22269;&#21644;, &#32993;&#26377;&#24179;, &#21608;&#23398;&#20799;</AU>
<TI>Aripiprazole (Booz Qing) and risperidone in the treatment of schizophrenia in the clinical control study] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;(&#21338;&#24605;&#28165;)&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Jiangxi Medical Journal [&#27743;&#35199;&#21307;&#33647;]</SO>
<YR>2009</YR>
<VL>44</VL>
<NO>8</NO>
<PG>799-800</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676976"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676975"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2005" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang R, Liu Y, Ning Z</AU>
<TI>A controlled study of aripiprazole vs clozapine in the treatment of first-episode schizophrenia</TI>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>4</NO>
<PG>301-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676978"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676977"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang G-P, Xie R, Pei G-X, Zhang Y-L</AU>
<TI>Comparative study between aripiprazole and clozapine in the treatment of patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#30340;&#20020;&#24202;&#24212;&#29992;&#65288;&#19968;&#65289;&#8212;&#8212;&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>1</NO>
<PG>44-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676980"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676979"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006a" MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang Y, Sun F, Zhang Z</AU>
<TI>Observation of therapeutic effect of aripiprazole in the treatment schizophrenic patients</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#35266;&#23519;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>4</NO>
<PG>427-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676982"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676981"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006b" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006b" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang G-P</AU>
<TI>Effect of aripiprazole on quality of life of schizophrenic patients</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>6</NO>
<PG>360-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676984"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676983"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006c" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006c" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang H, Wang Y, Lu L</AU>
<TI>A comparative study between aripiprazole and risperidone in the treatment of chronic schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>650-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676986"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676985"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006d" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006d" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang D, Li Y, Feng Y</AU>
<TI>A controlled study of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>4</NO>
<PG>245-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676988"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676987"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang D</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>17</NO>
<PG>751</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676990"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676989"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007a" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang L-Z, Weng J-Z, Zhuo Z-M</AU>
<TI>Comparative study on aripiprazole and risperidone in treatment of female schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#35199;&#37096;&#21307;&#23398;</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>1</NO>
<PG>42-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676992"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676991"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007d" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2007d" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#29579;&#23398;&#28392;, &#21016;&#23439;</AU>
<TI>A force of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#21147;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22806;&#20581;&#24247;&#25991;&#25688; [&#21307;&#33647;&#23398;&#21002;]</SO>
<YR>2007</YR>
<VL>4</VL>
<NO>11</NO>
<PG>44</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676994"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676993"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007e" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2007e" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#29579;&#22269;&#23500;</AU>
<TI>Aripiprazole in the treatment of schizophrenia clinical observation</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#20020;&#24202;&#35266;&#23519;</TO>
<SO>Journal of the Changzhi Medical College</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>2</NO>
<PG>110-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676996"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676995"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2008" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang Y-C, Wang J-L, Yuan J-M</AU>
<TI>A controlled study of effect on schizophrenia serum prolactin level aripiprazole</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#34880;&#28165;&#20652;&#20083;&#32032;&#30340;&#24433;&#21709;</TO>
<SO>&#20013;&#22269;&#23454;&#29992;&#21307;&#33647;</SO>
<YR>2008</YR>
<VL>3</VL>
<NO>21</NO>
<PG>38-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2676998"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676997"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2008c" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2008c" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#29579;&#22825;&#40857;, &#31243;&#24179;, &#38472;&#32418;&#20809;, &#21776;&#40527;, &#21608;&#26690;&#26126;</AU>
<TI>Ziprasidone treatment of schizophrenia with predominantly negative symptoms</TI>
<TO>&#40784;&#25289;&#35199;&#37230;&#27835;&#30103;&#20197;&#38452;&#24615;&#30151;&#29366;&#20026;&#20027;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>3</NO>
<PG>206-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677000"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2676999"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2009" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#29579;&#33538;&#33805;</AU>
<TI>New antipsychotic drug aripiprazole on glucose metabolism and glycosylated hemoglobin</TI>
<TO>&#26032;&#22411;&#25239;&#31934;&#31070;&#30149;&#33647;&#29289;&#38463;&#31435;&#21708;&#21777;&#23545;&#31958;&#20195;&#35874;&#24433;&#21709;&#21450;&#19982;&#31958;&#21270;&#34880;&#32418;&#34507;&#30333;&#30340;&#20851;&#31995;</TO>
<SO>Hebei Medical Journal</SO>
<YR>2009</YR>
<VL>31</VL>
<NO>14</NO>
<PG>1752-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677002"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677001"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2006" MODIFIED="2013-09-28 13:53:34 +0100" MODIFIED_BY="[Empty name]" NAME="Wei 2006" YEAR="2010">
<REFERENCE MODIFIED="2013-09-28 13:53:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#38889;&#26641;&#21326;</AU>
<TI>Aripiprazole and quetiapine in the treatment of schizophrenia control study of women] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30827;&#24179;&#27835;&#30103;&#22899;&#24615;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>22</VL>
<NO>5</NO>
<PG>511-6</PG>
<IDENTIFIERS MODIFIED="2013-09-28 13:53:34 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677004"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wei S-Z, Tang Q-S, Xu Z-N, Ruan X-J, Lu B</AU>
<TI>A randomized, double blind, double dummy parallel controlled study in the female first-episode schizophrenia treated with aripiprazole and quetiapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30827;&#24179;&#27835;&#30103;&#22899;&#24615;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#38543;&#26426;&#12289;&#21452;&#30450;&#12289;&#21452;&#27169;&#25311;&#24179;&#34892;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Nervous and Mental Diseases</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>6</NO>
<PG>511-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677005"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677003"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2007" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wei 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#39759;&#26376;&#29618;, &#38889;&#40527;, &#39759;&#26149;&#39321;</AU>
<TI>Control study of aripiprazole and clozapine in schizophrenia affect the quality of life in patients with</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#24433;&#21709;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>2</NO>
<PG>80-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677007"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677006"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2009" MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wei 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#39759;&#20029;&#38686;, &#21016;&#20256;&#20891;, &#26472;&#27874;, &#23828;&#23439;&#32500;</AU>
<TI>Olanzapine A Leekpai azole treatment of schizophrenia</TI>
<TO>&#22885;&#27694;&#24179;&#19982;&#38463;&#31435;&#27966;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#23454;&#29992;&#21307;&#33647;</SO>
<YR>2009</YR>
<VL>4</VL>
<NO>16</NO>
<PG>166-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677009"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677008"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wen-2009" MODIFIED="2013-09-28 13:54:23 +0100" MODIFIED_BY="[Empty name]" NAME="Wen 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-09-28 13:54:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#25991;&#21551;&#29748;, &#40644;&#36828;&#20809;, &#39532;&#38745;&#23665;</AU>
<TI>aripiprazole and risperidone in the treatment of female controlled study of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#35266;&#23519;</TO>
<SO>Guangdong Medical Journal [&#24191;&#19996;&#21307;&#23398;]</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>6</NO>
<PG>987-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677011"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677010"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wen-2009a" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Wen 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#25991;&#23478;&#26494;, &#22799;&#21335;, &#32993;&#26195;&#20029;</AU>
<TI>Comparison of aripiprazole and risperidone in the treatment of female schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of the North Sichuan Medical College</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>4</NO>
<PG>342-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677013"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677012"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wlodzmierz-2006" MODIFIED="2013-11-04 16:51:49 +0000" MODIFIED_BY="[Empty name]" NAME="Wlodzmierz 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sanchez R, Kostic D, Stock E, Torbeyns AF, Kerselaers W, Nyilas M, et al</AU>
<TI>Aripiprazole vs olanzapine in patients with acutely relapsing or chronic, stable schizophrenia: A 52-week open-label extension study</TI>
<SO>Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677015"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-11-04 16:51:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wlodzimierz CK, Marcus RN, Torbeyns A, Nyilas M, McQuade RD</AU>
<TI>Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine</TI>
<SO>Psychopharmacology</SO>
<YR>2006</YR>
<VL>189</VL>
<NO>2</NO>
<PG>259-66</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677016"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677014"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolf-2007" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Wolf 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Beuzen J-N, Pans M, Modell S, Hagens P, McQuade R, Iwamato T, et al</AU>
<TI>Broad effectiveness trial with aripiprazole in Europe Eu-Beta</TI>
<SO>Proceedings of the 13th Congress of the Association of European Psychiatrists; 2005 Apr 2-6; Munich, Germany</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677018"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Beuzen J-N, Pans M, Modell S, Hagens P, McQuade R, Iwamoto T, et al</AU>
<TI>Naturalistic study of aripiprazole treatment</TI>
<SO>Proceedings of the XIII World Congress of Psychiatry; 2005 Sep 10-15; Cairo, Egypt</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677019"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Beuzen J-N, Schirr K, Pans M, Hagens P, Kostic D, Carson W, et al</AU>
<TI>Effectiveness of aripiprazole in a naturalistic setting: a European multicenter study</TI>
<SO>Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677020"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wolf J, Janssen F, Lublin H, Salokangas RKR, Allain H, Smeraldi E, et al</AU>
<TI>A prospective, multi centre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with aripiprazole in Europe (EU-BETA)</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>2007</YR>
<VL>23</VL>
<NO>10</NO>
<PG>2313-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677021"/><IDENTIFIER TYPE="MEDLINE" VALUE="17706003"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677017"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2008" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Wu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu S, Liu H-Y, Huo X-P</AU>
<TI>A comparative study of aripiprazole and risperidone in the treamtment of senile schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#32769;&#24180;&#26399;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>15</NO>
<PG>1723-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677023"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677022"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xiao-2007" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Xiao 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Xiao G-C, Wang D-P, Huang G-P</AU>
<TI>Comparative study on the clinical effect and the life quality of schizophrenic patients treated with aripiprazol and clozepine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30103;&#25928;&#21450;&#29983;&#27963;&#36136;&#37327;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#21307;&#30103;&#21069;&#27839;</SO>
<YR>2007</YR>
<VL>1</VL>
<NO>2</NO>
<PG>28-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677025"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677024"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xie-2008" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Xie 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#35874;&#26032;&#24180;, &#33298;&#20154;&#20061;, &#38054;&#26691;&#26691;</AU>
<TI>Aripiprazole and risperidone in the treatment of male schizophrenia efficacy and sexual function</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21450;&#21033;&#22521;&#37230;&#27835;&#30103;&#30007;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#21450;&#23545;&#24615;&#21151;&#33021;&#30340;&#24433;&#21709;</TO>
<SO>Hunan Medical Journal</SO>
<YR>2008</YR>
<VL>25</VL>
<NO>6</NO>
<PG>1111-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677027"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677026"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xie-2010" MODIFIED="2013-11-04 16:52:20 +0000" MODIFIED_BY="[Empty name]" NAME="Xie 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:52:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#35874;&#26681;&#29983;, &#36213;&#26032;&#34174;, &#38065;&#22269;&#24179;, &#21556;&#29577;&#32418;, &#32993;&#24198;&#33452;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#39044;&#38450;&#21307;&#23398;&#26434;&#24535;</SO>
<YR>2010</YR>
<VL>11</VL>
<NO>2</NO>
<PG>190-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677029"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677028"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xu-2007" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Xu 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#24464;&#32654;&#21220;</AU>
<TI>Aripiprazole and clozapine treatment of schizophrenia analysis</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#20998;&#26512;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>6</NO>
<PG>548-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677031"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677030"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xu-2010" MODIFIED="2013-11-04 16:52:27 +0000" MODIFIED_BY="[Empty name]" NAME="Xu 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:52:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#24464;&#31584;, &#26446;&#26397;, &#29579;&#24935;&#33459;, &#26446;&#21326;&#33459;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia randomized double-blind controlled study] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#38543;&#26426;&#21452;&#30450;&#23545;&#29031;&#30740;&#31350; [</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2010</YR>
<VL>20</VL>
<NO>1</NO>
<PG>35-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677033"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677032"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yan-2007" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Yan 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38414;&#32654;&#33521;, &#21016;&#26041;&#33721;, &#20167;&#29233;&#29611;</AU>
<TI>Aripiprazole impact on the quality of life of patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#30149;&#20154;&#29983;&#27963;&#36136;&#37327;&#24433;&#21709;&#30340;&#30740;&#31350;</TO>
<SO>&#23478;&#24237;&#25252;&#22763;</SO>
<YR>2007</YR>
<VL>5</VL>
<NO>11C</NO>
<PG>15-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677035"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677034"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yan-2008" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Yan 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38379;&#20964;&#23071;, &#21016;&#38634;&#23792;</AU>
<TI>Aripiprazole and risperidone in the treatment of children with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#20799;&#31461;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#21307;&#23398;&#25991;&#25688; [&#20799;&#31185;&#23398;]</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>6</NO>
<PG>465-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677037"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677036"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yan-2008a" MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Yan 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38379;&#23453;&#26124;</AU>
<TI>Aripiprazole and clozapine treatment of refractory schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#35266;&#23519;</TO>
<SO>Chinese Journal of Misdiagnostics [&#20013;&#22269;&#35823;&#35786;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>18</NO>
<PG>4304-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677039"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677038"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yan-2010" MODIFIED="2013-11-04 16:52:37 +0000" MODIFIED_BY="[Empty name]" NAME="Yan 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:52:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26191;&#26690;&#33805;, &#26417;&#24535;&#38654;, &#19969;&#23506;&#26149;, &#26472;&#26149;&#38675;</AU>
<TI>Aripiprazole and risperidone in patients with first-episode schizophrenia comparative efficacy and safety study] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21033;&#22521;&#37230;&#23545;&#39318;&#21457;&#20998;&#35010;&#30151;&#24739;&#32773;&#30103;&#25928;&#21450;&#23433;&#20840;&#24615;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#24403;&#20195;&#21307;&#33647;</SO>
<YR>2010</YR>
<VL>17</VL>
<NO>22</NO>
<PG>37-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677041"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677040"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2006" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang L, Yang K, Yao X</AU>
<TI>A comparative between aripiprazole and clozapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#27604;&#36739;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2006</YR>
<VL>19</VL>
<NO>2</NO>
<PG>92-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677043"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677042"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2007" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Yang T-R, Song B-L, Yuan C-Q</AU>
<TI>Control study of aripiprazole and clozapine in treatment of patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30340;&#30103;&#25928;&#27604;&#36739;</TO>
<SO>&#35199;&#37096;&#21307;&#23398;</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>2</NO>
<PG>234-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677045"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677044"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang J, Zhu G-H, Xie J</AU>
<TI>A comparative study of ziprasidone and aripiprazole in the treatment of schizophrenia</TI>
<TO>&#40784;&#25289;&#35199;&#37230;&#19982;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>23</NO>
<PG>2760-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677047"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677046"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008a" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang X, Deng H, Wen W</AU>
<TI>Study of aripiprazole in treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;30&#20363;</TO>
<SO>China Pharmaceuticals [&#20013;&#22283;&#34277;&#26989;]</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>5</NO>
<PG>52-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677049"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677048"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008b" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2008b" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>a&#26472;&#33635;</AU>
<TI>Aripiprazole in the treatment of female schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#22269;&#29616;&#20195;&#21307;&#29983;</SO>
<YR>2008</YR>
<VL>46</VL>
<NO>13</NO>
<PG>100-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677051"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677050"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2009" MODIFIED="2013-11-04 16:52:45 +0000" MODIFIED_BY="[Empty name]" NAME="Yang 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:52:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26472;&#26149;&#24378;, &#26446;&#23453;&#29664;</AU>
<TI>Aripiprazole and olanzapine on body weight, blood glucose control study effects of] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22885;&#27694;&#24179;&#23545;&#20307;&#36136;&#37327;&#12289;&#34880;&#31958;&#24433;&#21709;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>5</NO>
<PG>339-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677053"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677052"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ye-2005" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Ye 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ye X-R, Xia X-L</AU>
<TI>A comparative study between aripiprazole and risperidone in treatment of first-onset schizophrenia</TI>
<SO>Medical Journal of National Defending Forces in Southwest China</SO>
<YR>2005</YR>
<VL>15</VL>
<NO>6</NO>
<PG>616-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677055"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677054"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ye-2005a" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Ye 2005a" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ye C-W, Pan D-J, Ni X-J, Pan J-L, Zhu G-D</AU>
<TI>Controlled study between aripiprazole and olanzapine on schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22885;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Modern Research of Integrated Chinese and Western Medicine [&#29616;&#20195;&#20013;&#35199;&#21307;&#32467;&#21512;&#26434;&#24535;]</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>24</NO>
<PG>3199-200</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677057"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677056"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yi-2007" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yi 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Yi F, Zhen D L-L, Wang J-L, Xu L-F, Yang G-P</AU>
<TI>A comparative study of blood2glucose metabolism between aripiprazole and clozapine in treatment of patientswith schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#34880;&#31958;&#20195;&#35874;&#30340;&#24433;&#21709;</TO>
<SO>Journal of Clinical Psychological Medicine [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>4</NO>
<PG>253</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677059"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677058"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2006" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yu 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu C-X, Ji D-C, Yuan H</AU>
<TI>The study of clinical efficacy of aripiprazole in the treatment for refractory schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#35266;&#23519;</TO>
<SO>Shandong Jingshen Yixue</SO>
<YR>2006</YR>
<VL>19</VL>
<NO>4</NO>
<PG>263-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677061"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677060"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2006a" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yu 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu L</AU>
<TI>Effects of aripiprazole vs. clozapine on body weight and blood sugar levels of schizophrenics</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#20307;&#37325;&#21450;&#34880;&#31958;&#30340;&#24433;&#21709;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>6</NO>
<PG>422-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677063"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677062"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2007" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yu 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu L, Li B</AU>
<TI>A control study of aripirazole and clozapine in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>2</NO>
<PG>115-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677065"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677064"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2008" MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]" NAME="Yu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#20110;&#27704;&#28059;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>19</NO>
<PG>2267, 2269</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677067"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677066"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2009" MODIFIED="2013-11-04 16:52:56 +0000" MODIFIED_BY="[Empty name]" NAME="Yu 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:52:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#20313;&#29790;&#39640;</AU>
<TI>Aripiprazole and clozapine in the treatment of chronic schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Liaoning</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>4</NO>
<PG>211-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677069"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677068"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-ZG-2007" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Yu ZG 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#20313;&#24535;&#21018;, &#21016;&#37329;&#40527;/&#32487;&#40857;, &#21016;&#20891;</AU>
<TI>Controlled clinical studies of aripiprazole and clozapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#20020;&#24202;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1066-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677071"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677070"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2006" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Zhang Y, Li G, An B</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#32500;&#24605;&#36890;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>635-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677073"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677072"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2006a" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Y, Gao G, Zhang Q</AU>
<TI>A comparative study of aripiprazole versus olanzapine in the treatment of chronic schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22885;&#27694;&#24179;&#27835;&#30103;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>4</NO>
<PG>429-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677075"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677074"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2007" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang R-X, Cai Y-F, Zhao L-G</AU>
<TI>A comparative study of EKG changed by aripiprazole and clozapine in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#30149;&#20154;&#24515;&#30005;&#22270;&#24433;&#21709;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1016, 1018</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677077"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677076"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2007a" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Y, Zhang H, Gu W</AU>
<TI>A control study of aripiprazole in the treatment of childhood schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#20799;&#31461;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>2</NO>
<PG>122-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677079"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677078"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2007b" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Z-L, Xiao X-Y, Nie B</AU>
<TI>Clinical control study of aripiprazole and risperidone in the treatment of first- episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Modern Medicine and Health [&#29616;&#20195;&#21307;&#33647;&#21355;&#29983;]</SO>
<YR>2007</YR>
<VL>23</VL>
<NO>4</NO>
<PG>494-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677081"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677080"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang J</AU>
<TI>Comparative investigation on aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#20998;&#26512;</TO>
<SO>Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][&#40778;&#40778;&#21704;&#29246;&#37291;&#23416;&#38498;&#23416;&#22577;]</SO>
<YR>2008</YR>
<VL>29</VL>
<NO>13</NO>
<PG>1542-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677083"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677082"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008a" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#25391;&#19996;</AU>
<TI>Controlled clinical observation of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#20020;&#24202;&#23545;&#29031;&#35266;&#23519;</TO>
<SO>Guangzhou Medical Journal</SO>
<YR>2008</YR>
<VL>39</VL>
<NO>3</NO>
<PG>52-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677085"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677084"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008b" MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2008b" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#32988;&#21033;, &#30427;&#27665;&#29983;, &#26446;&#27704;&#24378;, &#26446;&#25391;&#23431;</AU>
<TI>Comparison of the efficacy of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#27604;&#36739;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>20</NO>
<PG>2386, 2435</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677087"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677086"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2009" MODIFIED="2013-11-04 16:53:06 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:53:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#24352;&#33395;&#29734;, &#20110;&#25391;&#19996;</AU>
<TI>Aripiprazole and clozapine in treatment refractory schizophrenia comparative observation] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30103;&#25928;&#27604;&#36739;&#35266;&#23519;</TO>
<SO>People's Military Surgeon [&#20154;&#27665;&#20891;&#21307;]</SO>
<YR>2009</YR>
<VL>52</VL>
<NO>12</NO>
<PG>822-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677089"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677088"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2009a" MODIFIED="2013-11-04 16:53:15 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:53:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#19996;&#21355;, &#29976;&#26223;&#26792;, &#39640;&#23384;&#21451;, &#27573;&#24800;&#23792;</AU>
<TI>Aripiprazole and risperidone on glucose and lipid] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#23545;&#34880;&#31958;&#12289;&#34880;&#33026;&#30340;&#24433;&#21709;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>5</NO>
<PG>343-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677091"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677090"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2009b" MODIFIED="2013-11-04 16:53:20 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang 2009b" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:53:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#28789;&#23077;, &#24352;&#37329;&#20809;, &#24352;&#29645;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Baotou Medical College [&#21253;&#38957;&#37291;&#23416;&#38498;&#23416;&#22577;]</SO>
<YR>2009</YR>
<VL>25</VL>
<NO>6</NO>
<PG>41-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677093"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677092"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2010" MODIFIED="2013-11-04 16:53:26 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:53:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#24352;&#21551;&#26519;, &#32735;&#27743;</AU>
<TI>Aripiprazole and clozapine in treatment refractory schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>West China Medical Journal [&#21326;&#35199;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>6</NO>
<PG>1033-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677095"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677094"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2010a" MODIFIED="2013-11-04 16:53:34 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang 2010a" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:53:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#29577;&#28165;, &#29579;&#24425;&#33805;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia comparative analysis of 100 cases] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;100&#20363;&#30340;&#23545;&#27604;&#20998;&#26512;</TO>
<SO>Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [&#23454;&#29992;&#24515;&#33041;&#32954;&#34880;&#31649;&#30149;&#26434;&#24535;]</SO>
<YR>2010</YR>
<VL>18</VL>
<NO>6</NO>
<PG>762</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677097"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677096"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2006" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhao 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao L, Wang M, Wang B</AU>
<TI>A controlled study of aripiprazole versus quetiapine in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30340;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>663-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677099"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677098"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2007" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhao 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao S-M, Du B, Li K-Q</AU>
<TI>A comparative study of aripiprazole versus risperdal in patients with schizophrenia</TI>
<TO>&#22885;&#27966;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#20020;&#24202;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>5</NO>
<PG>195-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677101"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677100"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhi-2005" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhi 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhi S-L</AU>
<TI>Comparison study of aripiprazole and risperidone on schizophrenia</TI>
<SO>Modern Jorunal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>21</NO>
<PG>2787-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677103"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677102"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2007" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhou 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#21608;&#24179;, &#21016;&#32852;&#29734;</AU>
<TI>Aripiprazole and clozapine treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>2</NO>
<PG>126-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677105"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677104"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2007a" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhou 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21608;&#20255;&#19996;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia control observation</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#35266;&#23519;</TO>
<SO>Journal of the Youjiang Medical College for Nationalities</SO>
<YR>2007</YR>
<VL>29</VL>
<NO>3</NO>
<PG>384-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677107"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677106"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2007b" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhou 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21608;&#38632;&#26519;</AU>
<TI>Aripiprazole impact on the quality of life in patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>5</NO>
<PG>354, 356</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677109"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677108"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2008" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhou 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#21608;&#21191;, &#38472;&#38634;&#33459;, &#26519;&#21191;, &#21016;&#21191;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>2</NO>
<PG>139-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677111"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677110"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2005" MODIFIED="2013-09-28 14:23:46 +0100" MODIFIED_BY="[Empty name]" NAME="Zhu 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-09-28 14:23:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zhu P-J, Cheng Z-E, Zhang J, Zhu P-L, Zhan X-M</AU>
<TI>Clinical study of therapeutic effects of aripiprazole in treatment of patients with schizophrenia</TI>
<SO>Chinese Journal of Clinical Pharmacology and Therapeutics</SO>
<YR>2005</YR>
<VL>10</VL>
<NO>10</NO>
<PG>1194-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677113"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu P-L, Zhu P-J, Chen Z-E, Zhang J, Zhan X-M, Li Q-Z</AU>
<TI>Treatment of 40 cases of schizophrenia with aripiprazole</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;40&#20363;</TO>
<SO>Herald of Medicine [&#21307;&#33647;&#23548;&#25253;] [&#37291;&#34277;&#23566;&#22577;]</SO>
<YR>2006</YR>
<VL>25</VL>
<NO>6</NO>
<PG>536-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677114"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677112"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2008" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zhu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#26417;&#28385;&#36830;, &#28504;&#22823;&#27941;, &#21346;&#33308;&#39134;</AU>
<TI>A Leekpai azole quetiapine controlled study for the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#27966;&#21777;&#19982;&#21945;&#30827;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine [&#23454;&#29992;&#20013;&#35199;&#21307;&#32467;&#21512;&#20020;&#24202;]</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>1</NO>
<PG>9-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677116"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677115"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2010" MODIFIED="2013-11-04 16:53:51 +0000" MODIFIED_BY="[Empty name]" NAME="Zhu 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:53:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26417;&#36920;&#28330;</AU>
<TI>Risperidone and olanzapine and aripiprazole on cognitive function in chronic schizophrenia] Google Translate</TI>
<TO>&#22885;&#27694;&#24179;&#21644;&#21033;&#22521;&#37230;&#21450;&#38463;&#31435;&#21708;&#21777;&#23545;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#35748;&#30693;&#21151;&#33021;&#30340;&#24433;&#21709;</TO>
<SO>&#20013;&#21326;&#20020;&#24202;&#21307;&#24072;&#26434;&#24535;(&#30005;&#23376;&#29256;)</SO>
<YR>2010</YR>
<VL>4</VL>
<NO>9</NO>
<PG>1709-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677118"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677117"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zimbroff-2007" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zimbroff 2007" YEAR="">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Pfizer</AU>
<TI>A study comparing the efficacy and safety of ziprasidone and aripiprazole for the treatment of schizophrenia or schizoaffective disorder in hospitalized patients</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677120"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zimbroff D, Warrington L, Loebel A, Yang R, Siu C</AU>
<TI>Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: A randomized, double-blind, 4-week study</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2007</YR>
<VL>22</VL>
<NO>6</NO>
<PG>363-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677121"/><IDENTIFIER TYPE="MEDLINE" VALUE="17917555"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677119"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zou-2006" MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]" NAME="Zou 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Zou K-Q, Jiang Q-L, Wang D</AU>
<TI>Comparative study on effects of aripiprazole and clozapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#30340;&#20020;&#24202;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>&#20013;&#21326;&#29616;&#20195;&#20869;&#31185;&#23398;&#26434;&#24535;</SO>
<YR>2006</YR>
<VL>3</VL>
<NO>1</NO>
<PG>17-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677123"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677122"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-11-04 16:55:07 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ai-2008" MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" NAME="Ai 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ai C-Q, Chen S-M</AU>
<TI>Comparison study in the treatment of schizophrenia between aripiprazole and clozapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>1</NO>
<PG>53-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677125"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677124"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Allen-2007" MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" NAME="Allen 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allen M, Talbott S, Eudicone J, McQuade R, Pikalov A</AU>
<TI>Similar rates of agitation, anxiety and insomnia in sedating and non-sedating antipsychotics: evaluating clinical trial results with aripiprazole, haloperidol and olanzapine</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>418</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677127"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677126"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anon-2008" MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" NAME="Anon 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Anon</AU>
<TI>Effectiveness of antipsychotic combination with psychosocial intervention on outcome of patients with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677129"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677128"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bao-2007" MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" NAME="Bao 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bao L-Y, Wang K-M</AU>
<TI>The effectiveness of aripiprazole combined with clonazepam treated with agitation in schizophrenia</TI>
<TO>&#38463; &#31435; &#21708; &#21777; &#21512; &#29992; &#27695; &#30813; &#35199; &#27886; &#27835; &#30103; &#31934; &#31070; &#20998; &#35010; &#30151; &#20852; &#22859; &#30151; &#29366; &#30103; &#25928; &#20998; &#26512;</TO>
<SO>Medical Journal of Chinese People's Health</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>3</NO>
<PG>198-200</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677131"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677130"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bergman-2007" MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" NAME="Bergman 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bergman M, Friedman JI, Stawarz K, Bowman A, Siever L, Cavagna M, et al</AU>
<TI>A double blind placebo controlled study of guanfacine adjunctive treatment to atypical antipsychotics for cognitive dysfunction in schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677133"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677132"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bristol_x002d_Myers-2006" MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" NAME="Bristol-Myers 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bristol-Myers Squibb, Otsuka America Pharmaceutical</AU>
<TI>A multicenter, randomized, double-blind, placebo-controlled, 16 week study of aripiprazole used as dual therapy in the treatment of patients with chronic stable schizophrenia or schizoaffective disorder demonstrating an inadequate response to quetiapine or risperidone monotherapy</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677135"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677134"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carson-2000" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Carson 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carson WH, Kane JM, Ali M, Dunbar GC, Ingenito G</AU>
<TI>Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2000</YR>
<VL>10</VL>
<NO>Suppl 3</NO>
<PG>S309</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677137"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677136"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Casey-2003" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Casey 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Casey D, L'Italien G, Waldeck R, Cislo P, Carson W</AU>
<TI>Metabolic syndrome comparison between olanzapine, aripiprazole, and placebo</TI>
<SO>Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17&#8211; 22; San Francisco, California, USA</SO>
<YR>2003</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677139"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677138"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2005" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen J-D, Zhao J-P, Li L-H, Guo X-F, Zhai J-G, Wang C-Y, et al</AU>
<TI>A multi centre, randomised and double-blind controlled trial of aripiprazole in treatment of schizophrenia</TI>
<SO>Chinese Journal of New Drugs and Clinical Remedies</SO>
<YR>2005</YR>
<VL>11</VL>
<PG>845-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677141"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677140"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2007" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen J, Zhou Y, Zha X-Y</AU>
<TI>A comparative study of aripiprazole and clozapine in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>2</NO>
<PG>97-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677143"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677142"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2008" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen Q-S, Li Y-H, Qu L-J</AU>
<TI>A comparative study of aripiprazole and risperidone in the treatment of the first episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>5</NO>
<PG>394-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677145"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677144"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-LJ-2010" MODIFIED="2013-11-04 16:54:05 +0000" MODIFIED_BY="[Empty name]" NAME="Chen LJ 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:54:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#33673;&#26230;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia compared] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#27604;&#20998;&#26512;</TO>
<SO>&#24403;&#20195;&#21307;&#23398;</SO>
<YR>2010</YR>
<VL>16</VL>
<NO>4</NO>
<PG>140-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677147"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677146"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-YH-2010" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Chen YH 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38472;&#27704;&#32418;</AU>
<TI>Aripiprazole and risperidone in the treatment of female schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Shanxi Clinical Medicine</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>9B</NO>
<PG>1232-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677149"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677148"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colombo-2008" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Colombo 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colombo GL, Caruggi M, Di Matteo S, Rossi A</AU>
<TI>An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia</TI>
<SO>Neuropsychiatric Disease and Treatment</SO>
<YR>2008</YR>
<VL>4</VL>
<NO>5</NO>
<PG>967-76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677151"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677150"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cornblatt-2002" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Cornblatt 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cornblatt B, Kern RS, Carson WH, Stock E, Ali M, Ingenito G, et al</AU>
<TI>Neurocognitive effects of aripiprazole versus olanzapine in patients with stable psychosis</TI>
<SO>Schizophrenia Research</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>3 Suppl 1</NO>
<PG>27</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677153"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677152"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fawzi-2009" MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" NAME="Fawzi 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi M, Fawzi M Jr</AU>
<TI>Aripiprazole, olanzapine and olanzapine-clomipramine combination in schizophrenia with obsessive-compulsive symptoms</TI>
<SO>World Psychiatry</SO>
<YR>2009</YR>
<VL>8</VL>
<NO>Suppl 1</NO>
<PG>NRS5.4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677155"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677154"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fleischhacker-2008a" MODIFIED="2013-09-28 14:43:58 +0100" MODIFIED_BY="[Empty name]" NAME="Fleischhacker 2008a" YEAR="2008">
<REFERENCE MODIFIED="2013-09-28 14:43:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fleischhacker W, Heikkinen ME, Olie JP, Dewaele P, McQuade R, Hennicken D, et al</AU>
<TI>Long-term effect on weight of aripiprazole-clozapine in schizophrenia patients with suboptimal response on clozapine</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2008</YR>
<VL>18</VL>
<PG>S447</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677157"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Markovic O</AU>
<TI>A multicenter, comparative, randomized, double-blind, placebo controlled study on the effect on weight of adjunctive treatment with aripiprazole in patients with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677158"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677156"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geng-2009" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Geng 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#32831;&#23506;&#26494;, &#21016;&#33635;&#33465;, &#36793;&#36763;&#19985;, &#33487;&#31168;&#33593;, &#23828;&#26149;&#38738;, &#33931;&#40857;, et al</AU>
<TI>Comparative study of the effects of ariplprazole and risoeridone on the therapeutic effect and patients&#8217;weight in patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#30103;&#25928;&#19982;&#20307;&#37325;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Hebei Medical Journal</SO>
<YR>2009</YR>
<VL>31</VL>
<NO>4</NO>
<PG>407-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677160"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677159"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guan-2007" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Guan 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guan H-Y, Wang K-Q, Jiang L, Geng H-S, Li Q-X, Liu Z-R, et al</AU>
<TI>A controlled study of efficacy between aripiprazole and risperidone in the treatment of patients with</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>4</NO>
<PG>241-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677162"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677161"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-HF-2010" MODIFIED="2013-11-04 16:54:16 +0000" MODIFIED_BY="[Empty name]" NAME="Han HF 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:54:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#38889;&#24800;&#33452;</AU>
<TI>Second generation of psychiatric drugs 3 cost of the treatment of schizophrenia] Google Translate</TI>
<TO>3&#31181;&#20108;&#20195;&#31934;&#31070;&#30149;&#33647;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#25104;&#26412;&#20998;&#26512;</TO>
<SO>Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][&#40778;&#40778;&#21704;&#29246;&#37291;&#23416;&#38498;&#23416;&#22577;]</SO>
<YR>2010</YR>
<VL>31</VL>
<NO>9</NO>
<PG>1379-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677164"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677163"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hatta-2009" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Hatta 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hatta K, Sato K, Hamakawa H, Takebayashi H, Kimura N, Ochi S, et al</AU>
<TI>Effectiveness of second-generation antipsychotics with acute-phase schizophrenia</TI>
<SO>Schizophrenia Research</SO>
<YR>2009</YR>
<VL>113</VL>
<NO>1</NO>
<PG>49-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677166"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677165"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Henderson-2009" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Henderson 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Henderson DC, Fan X, Copeland PM, Borba CP, Freudenreich O, Evins AE, et al</AU>
<TI>Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients</TI>
<SO>Journal of Clinical Psychopharmacology</SO>
<YR>2009</YR>
<VL>29</VL>
<NO>2</NO>
<PG>165-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677168"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Roussel JJ, Machon DA, Henderson DC</AU>
<TI>A placebo-controlled, cross-over trial of aripiprazole added to obese olanzapine-treated patients with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677169"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677167"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2008" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Huang 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang X, Du W, Xue S, Tong Z, Jiang Z</AU>
<TI>Clinical efficacy of aripiprazole and risperidone in treating schizophrenia and their influence</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#30103;&#25928;&#21450;&#23545;&#34880;&#28165;&#20652;&#20083;&#32032;&#30340;&#24433;&#21709;</TO>
<SO>&#33647;&#29289;&#19981;&#33391;&#21453;&#24212;&#26434;&#24535;</SO>
<YR>2008</YR>
<VL>10</VL>
<NO>2</NO>
<PG>77-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677171"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677170"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janssen-2005" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Janssen 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Janssen F</AU>
<TI>A comparative, randomized, open-label, multicenter study on the efficacy and safety of switch treatment with aripiprazole in schizophrenic out-patients who are experiencing insufficient efficacy with risperidone and/or safety and tolerability issues, while on risperidone</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677173"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677172"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiang-2007" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Jiang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiang Y-H, Shen Z-X</AU>
<TI>A comparison between the therapeutic effects of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#27604;&#36739;</TO>
<SO>Herald of Medicine [&#21307;&#33647;&#23548;&#25253;] [&#37291;&#34277;&#23566;&#22577;]</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>10</NO>
<PG>1147-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677175"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677174"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ju-2009" MODIFIED="2013-11-04 16:54:25 +0000" MODIFIED_BY="[Empty name]" NAME="Ju 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:54:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#38816;&#24247;, &#36153;&#29605;, &#23395;&#21355;&#19996;, &#39640;&#36816;&#20848;</AU>
<TI>Comparative analysis of aripiprazole and risperidone in the treatment of schizophrenia negative emotions</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#36127;&#24615;&#24773;&#32490;&#30340;&#27604;&#36739;&#20998;&#26512;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>1</NO>
<PG>39-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677177"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677176"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2006" MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kim YS</AU>
<TI>A double-blind randomized placebo controlled study of aripiprazole augmentation for clozapine-treated patients with refractory schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677179"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677178"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2009" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kim C-Y</AU>
<TI>A multi-center, randomized, open, treatment-switching study from orally administered antipsychotic monotherapy in the treatment of chronic schizophrenic and schizoaffective patients</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677181"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kim CY, Chung S, Lee JN, Kwon JS, Kim DH, Kim CE, et al</AU>
<TI>A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>4</NO>
<PG>181-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677182"/><IDENTIFIER TYPE="MEDLINE" VALUE="19451828"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677180"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lan-2008" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Lan 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lan T, Chiu H, Hu T, Huang H, Wu B, Tuan Y</AU>
<TI>Prolactin level as an indicator to clinical psychopathological severity in aripiprazole treated schizophrenia</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2008</YR>
<VL>18</VL>
<PG>S440</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677184"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677183"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007e" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007e" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li A-F, Yao J-X, Liao X-H</AU>
<TI>A controlled study of domestic aripiprazole and clozapine in the treatment of refractory schizophrenia</TI>
<TO>&#22269;&#20135;&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>5</NO>
<PG>165-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677186"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677185"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007f" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2007f" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li D, Yu L-B, Zha Z-Q</AU>
<TI>A comparative study on quality of life of female schizophrenics treated with aripiprazole</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>5</NO>
<PG>170-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677188"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677187"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang-2005" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Liang 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Liang S</AU>
<TI>A multi-center, randomized, double-blind study, comparing with risperidone, to evaluate the efficacy and safety of aripiprazole in the treatment of patients with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677190"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677189"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-C-2010" MODIFIED="2013-11-04 16:54:36 +0000" MODIFIED_BY="[Empty name]" NAME="Li C 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-04 16:54:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26446;&#36229;, &#26446;&#24935;&#23077;, &#21016;&#24425;&#31168;</AU>
<TI>Aripiprazole and clozapine in the treatment of schizophrenia were] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#21644;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#20020;&#24202;&#23545;&#29031;&#20998;&#26512;</TO>
<SO>Acta Medicinae Sinica [&#21326;&#22799;&#21307;&#23398;]</SO>
<YR>2010</YR>
<VL>23</VL>
<NO>4</NO>
<PG>391-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677192"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677191"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liemburg-2011" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Liemburg 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liemburg E, Aleman A, Bous J, Hollander K, Knegtering H</AU>
<TI>An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being</TI>
<SO>Pharmacopsychiatry</SO>
<YR>2011</YR>
<VL>44</VL>
<NO>3</NO>
<PG>109-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677194"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677193"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-2006" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Lin 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lin C</AU>
<TI>A controlIed study of aripiprazole and risperidone in treatment of first-episode schizophrenia</TI>
<TO>&#21338;&#24605;&#28165;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>660-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677196"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677195"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-Y-2009" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Lin Y 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26519;&#20113;, &#27754;&#23389;&#39745;, &#28201;&#36798;&#27665;, &#40644;&#33322;</AU>
<TI>Control study of aripiprazole and clozapine in the treatment of the negative symptoms of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#38452;&#24615;&#30151;&#29366;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>1</NO>
<PG>38-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677198"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677197"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2007a" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu G, Cai Y</AU>
<TI>A comparison study on the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Modern Hospital</SO>
<YR>2007</YR>
<VL>7</VL>
<NO>8</NO>
<PG>36-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677200"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677199"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2007b" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu L, Xinag H</AU>
<TI>Compared effect and safety analysis of aripiprazole in late-onset schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#26202;&#21457;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#23545;&#29031;&#20998;&#26512;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>3</NO>
<PG>142-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677202"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677201"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-XH-2009" MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Liu XH 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#21016;&#26195;&#32418;, &#26446;&#21355;&#20891;, &#23395;&#30922;</AU>
<TI>Clinical comparison of aripiprazole and risperidone in the treatment of female schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#27604;&#36739;</TO>
<SO>Sichuan Mental Health [&#22235;&#24029;&#31934;&#31070;&#21355;&#29983;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>2</NO>
<PG>115-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677204"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677203"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2008" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Lu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#21346;&#33395;&#26149;, &#26446;&#25196;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013;&#22269;&#27665;&#24247;&#21307;&#23398;]</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>23</NO>
<PG>2804</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677206"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677205"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lv-2006" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Lv 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lv X-M, Jia Z-L, Liu C-J</AU>
<TI>Effect of aripiprazole on body weight and blood glucose in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#20307;&#37325;&#21450;&#34880;&#31958;&#30340;&#24433;&#21709;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2006</YR>
<VL>19</VL>
<NO>3</NO>
<PG>181-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677208"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677207"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2007" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Ma 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ma Q, Lian H-T, Li L-X</AU>
<TI>A study of aripiprazole combined with clozapine in refractory schizophrenia</TI>
<TO>&#38463; &#31435; &#21708; &#21777; &#21512; &#24182; &#27695; &#27694; &#24179; &#27835; &#30103; &#38590; &#27835; &#24615; &#31934; &#31070; &#20998; &#35010; &#30151;</TO>
<SO>Medical Journal of Chinese People's Health [&#20013; &#22269; &#27665; &#24247; &#21307; &#23398; ]</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1046, 1048</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677210"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677209"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2009b" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Ma 2009b" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#39532;&#38383;&#32988;, &#39532;&#29618;, &#24352;&#28113;&#33459;</AU>
<TI>Comparative study on aripiprazole and risperidone in the treatment of female patients with schizophrenics</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#27604;&#20998;&#26512;</TO>
<SO>&#23454;&#29992;&#33647;&#29289;&#19982;&#20020;&#24202;</SO>
<YR>2009</YR>
<VL>12</VL>
<NO>2</NO>
<PG>77-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677212"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677211"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Medori-2008" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Medori 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Medori R, Wapenaar R, De Arce R, Rouillon F, Gaebel W, Cordes J, et al</AU>
<TI>Relapse prevention and effectiveness in schizophrenia of risperidone long-acting injectable (rlai) versus quetiapine or aripiprazole</TI>
<SO>Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677214"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677213"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Millar-2008" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Millar 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Millar H, Felter C, Landsberg W</AU>
<TI>The effects of aripiprazole in combination with clozapine: patient functioning results from a double-blind, 16-week study in patients with schizophrenia (CN138-170)</TI>
<SO>Journal of Psychopharmacology</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>5</NO>
<PG>A17</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677216"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677215"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mortimer-2004" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Mortimer 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mortimer AMP</AU>
<TI>Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia</TI>
<SO>Evidence-Based Mental Health</SO>
<YR>2004</YR>
<VL>7</VL>
<NO>2</NO>
<PG>41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677218"/><IDENTIFIER TYPE="MEDLINE" VALUE="15107337"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677217"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mossner-2009" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Mossner 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mossner R, Schuhmacher A, Kuhn KU, Cvetanovska G, Rujescu D, Zill P, et al</AU>
<TI>Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia</TI>
<SO>Pharmacogenetics and Genomics</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>1</NO>
<PG>91-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677220"/><IDENTIFIER TYPE="MEDLINE" VALUE="18849890"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677219"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Namey-2006" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Namey 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Namey LB, Henderson DC</AU>
<TI>Aripiprazole for clozapine associated medical morbidity</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677222"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677221"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newcomer-2006" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Newcomer 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Newcomer JW, L'Italien G, Vester-Blokland, McQuade RD, Carson WH, Marcus RN</AU>
<TI>Improvement of non-hdl cholesterol levels among patients randomized to aripiprazole versus olanzapine</TI>
<SO>Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677224"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677223"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newcomer-2008" MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" NAME="Newcomer 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newcomer JW, Meyer JM, Baker RA, Eudicone JM, Pikalov A, Vester-Blokland E, et al</AU>
<TI>Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine</TI>
<SO>Schizophrenia Research</SO>
<YR>2008</YR>
<VL>106</VL>
<NO>2-3</NO>
<PG>300-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677226"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677225"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newcomer-2008c" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Newcomer 2008c" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newcomer JW, Meyer JM, Baker RA, Eudicone JM, Pikalov A, Vester-Blokland E, et al</AU>
<TI>Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine</TI>
<SO>Schizophrenia Research</SO>
<YR>2008</YR>
<VL>106</VL>
<NO>2-3</NO>
<PG>300-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677228"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677227"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pae-2009a" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Pae 2009a" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pae CU, Serretti A, Chiesa A, Mandelli L, Lee C, Kim J, et al</AU>
<TI>Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>8</NO>
<PG>562-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677230"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677229"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ray-2004" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Ray 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ray S, Corey-Lisle PK, Cislo PR, L'Italien G, Weiden P</AU>
<TI>An economic evaluation of aripiprazole compared to olanzapine based on metabolic side-effect profile</TI>
<SO>Journal of the European College of Neuropsychopharmacology</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>Suppl 3</NO>
<PG>S279</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677232"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677231"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Remington-2009" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Remington 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Remington G</AU>
<TI>Refractory schizophrenia: Adding aripiprazole to clozapine reduces negative but not overall symptoms</TI>
<SO>Evidence-Based Mental Health</SO>
<YR>2009</YR>
<VL>12</VL>
<NO>2</NO>
<PG>51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677234"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677233"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schreiner-2009" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Schreiner 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Schreiner A, De Arce R, Eding E, Marques-Teixeira J, Milanova V, Rancans E, et al</AU>
<TI>Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)</TI>
<SO>Proceedings of the 9th World Congress of Biological Psychiatry; 2009 Jun 28-Jul 2; Paris, France</SO>
<YR>2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677236"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677235"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shen-2006" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Shen 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shen J-Q, Shi J-F</AU>
<TI>A controlled study on aripiprazole and risperidone in the treatment of schizophrenic patients</TI>
<TO>&#38463;&#31435;&#27966;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#38376;&#35786;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#20020;&#24202;&#30740;&#31350;</TO>
<SO>Chinese Journal of Modern Applied Pharmacy</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>7</NO>
<PG>714-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677238"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677237"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shim-2006" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Shim 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shim JC, Kelly DL, Jung DU, Seo YS, Kim YH, Conley RR</AU>
<TI>Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemia</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>Suppl 4</NO>
<PG>S405</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677240"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677239"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2006a" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Sun 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun F, Dong R, Wang Y</AU>
<TI>A randomized control study aripiprazole in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#38543;&#26426;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>642-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677242"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677241"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-P-2009" MODIFIED="2013-11-04 16:54:53 +0000" MODIFIED_BY="[Empty name]" NAME="Sun P 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:54:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#23385;&#40527;, &#23731;&#33521;, &#24352;&#27491;&#24609;, &#24352;&#27589;&#33993;, &#24464;&#19968;&#23792;</AU>
<TI>Quetiapine, aripiprazole treatment efficacy in patients with acute schizophrenia] Google Translate</TI>
<TO>&#21945;&#30827;&#24179;&#12289;&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#24613;&#24615;&#26399;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30103;&#25928;&#35266;&#23519;</TO>
<SO>Shandong Archives of Psychiatry [&#23665;&#19996;&#31934;&#31070;&#21307;&#23398;]</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>5</NO>
<PG>381-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677244"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677243"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takeuchi-2008" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Takeuchi 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takeuchi H, Suzuki T, Uchida H, Nakajima S, Nomura K, Kikuchi T, et al</AU>
<TI>A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering</TI>
<SO>Journal of Clinical Psychopharmacology</SO>
<YR>2008</YR>
<VL>28</VL>
<NO>5</NO>
<PG>540-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677246"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677245"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Talbott-2007" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Talbott 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Talbott S, Buckley P, Eudicone J, McQuade R, Van-Tran Q</AU>
<TI>Akathisia in schizophrenia patients treated with aripiprazole, haloperidol, or olanzapine-analyses of the first 12 weeks of three double-blind, long-term trials</TI>
<SO>Proceedings of the 11th International Congress on Schizophrenia Research; 2007 Mar 28-Apr 1; Colorado Springs, Colorado, USA</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677248"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677247"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-2007" MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Taylor 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor D</AU>
<TI>Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia</TI>
<SO>Evidence-Based Mental Health</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>3</NO>
<PG>76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677250"/><IDENTIFIER TYPE="MEDLINE" VALUE="17652558"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677249"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006e" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006e" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang X-Q, Zhou H-X, Zhang Y-L, Wang H-Y, Gao T-X, Xie P-L</AU>
<TI>Clinical study of aripiprazole and risperidone in treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#20020;&#24202;&#30740;&#31350;</TO>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>2</NO>
<PG>108-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677252"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677251"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007b" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang K-Q, Guan H-Y, Jiang L, Geng H-S, Li Q-X, Liu Z-R, et al</AU>
<TI>A controlled study of effect on serum prolactin level between aripiprazole and risperidone</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#23545;&#34880;&#28165;&#20652;&#20083;&#32032;&#27700;&#24179;&#30340;&#24433;&#21709;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>3</NO>
<PG>154-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677254"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677253"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007c" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2007c" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang Y, Chen T</AU>
<TI>Non - classical antipsychotic drugs for schizophrenia: cost - minimization analysis on 3 schemes</TI>
<TO>3&#31181;&#38750;&#32463;&#20856;&#25239;&#31934;&#31070;&#30149;&#33647;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#26368;&#23567;&#25104;&#26412;&#20998;&#26512;</TO>
<SO>China Pharmacy [&#20013;&#22283;&#34277;&#25151;]</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>32</NO>
<PG>2487-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677256"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677255"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watts-2006a" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Watts 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Watts KL, Wilson H, Tang T</AU>
<TI>Estimating and reducing the cardiovascular risk of patients with schizophrenia drugs from lipid measures and ischemic electrocardiographic changes</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677258"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677257"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xu-2008" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Xu 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xu M, Zheng G-X</AU>
<TI>Comparative study of aripiprazole and risperidone for schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Jilin Medical Journal</SO>
<YR>2008</YR>
<VL>29</VL>
<NO>19</NO>
<PG>1629-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677260"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677259"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2007a" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang W, Liu X-Q, Li X-W</AU>
<TI>A ramdomized controlled clinical study of aripiprazole in the treatment of childhood schizophrenia</TI>
<TO>&#38463;&#31435;&#21617;&#21777;&#27835;&#30103;&#20799;&#31461;&#31934;&#31070;&#20998;&#35010;&#30151;&#22810;&#20013;&#24515;&#38543;&#26426;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Hunan Medical Journal</SO>
<YR>2007</YR>
<VL>24</VL>
<NO>6</NO>
<PG>942-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677262"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677261"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2007b" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang S, Gao S, Wu X</AU>
<TI>A control study of aripiprazole vs. clozapine in the treatment of refractory schizophrenia</TI>
<SO>Journal of Clinical Psychosomatic Diseases</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>1</NO>
<PG>15-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677264"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677263"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2007a" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Yu 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu L</AU>
<TI>Comparative study of aripiprazole and risperidone in the treatment of female schizophrenias</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#22899;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>15</VL>
<NO>10</NO>
<PG>948-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677266"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677265"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeng-2006" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Zeng 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeng D-Z, Chen K-Q, Hu Z-D</AU>
<TI>Influence of aripiprazole on life quality of the patients with schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;</TO>
<SO>Chinese Journal of Rehabilitation [&#20013;&#22283;&#24247;&#24489;]</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>4</NO>
<PG>288</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677268"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677267"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2006b" MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2006b" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang X-L, Cui Y-Z, Yang X-S</AU>
<TI>Controlled study on aripiprazole in the treatment of schizophrenic patients who has response to clozapine</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#26367;&#25442;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Medical Journal of Chinese Civil Administration</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>9</NO>
<PG>753-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677270"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677269"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-F-2009" MODIFIED="2013-11-04 16:55:07 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang F 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-11-04 16:55:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#24070;, &#29066;&#26118;&#27494;</AU>
<TI>Aripiprazole and quetiapine in the treatment control study of first-episode schizophrenia] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30827;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>11</NO>
<PG>299-300</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677272"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677271"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-RK-2008" MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang RK 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#20161;&#20975;, &#20184;&#23398;&#20975;, &#29579;&#24314;&#21033;, &#24352;&#26149;&#40527;</AU>
<TI>Aripiprazole and clozapine in the treatment of refractory schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#38590;&#27835;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][&#40778;&#40778;&#21704;&#29246;&#37291;&#23416;&#38498;&#23416;&#22577;]</SO>
<YR>2008</YR>
<VL>29</VL>
<NO>14</NO>
<PG>1703-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677274"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677273"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-XL-2007" MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang XL 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#24352;&#23567;&#32838;, &#40644;&#29486;&#24179;, &#21346;&#21451;&#27426;</AU>
<TI>Aripiprazole and risperidone in the treatment of schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Fujian Medical Journal [&#31119;&#24314;&#21307;&#33647;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>29</VL>
<NO>6</NO>
<PG>117-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677276"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677275"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-GW-2009" MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Zhao GW 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#36213;&#36149;&#25991;</AU>
<TI>Aripiprazole and risperidone on serum prolactin levels] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#23545;&#34880;&#28165;&#20652;&#20083;&#32032;&#27700;&#24179;&#30340;&#24433;&#21709; [</TO>
<SO>Medical Journal of Liaoning</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>4</NO>
<PG>221-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677278"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677277"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-JY-2009" MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Zhao JY 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#36213;&#26230;&#23195;, &#37101;&#32032;&#33465;, &#29579;&#26032;&#21451;</AU>
<TI>A control study on effect of domestic aripiprazole and clozapine in treatment of schizophrenia</TI>
<TO>&#22269;&#20135;&#38463;&#31435;&#21708;&#21777;&#19982;&#27695;&#27694;&#24179;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#21450;&#23433;&#20840;&#24615;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Occupation and Health [&#32844;&#19994;&#19982;&#20581;&#24247;]</SO>
<YR>2009</YR>
<VL>25</VL>
<NO>6</NO>
<PG>666-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677280"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677279"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhe-2007" MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Zhe 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Zhe J, Shi X-Y, Tan T-C, Liu W-X, Tao P-Y, Wang J, et al</AU>
<TI>Comparative study of aripiprazole and risperidone in treatment of late onset schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#26202;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Linchuang Jingshen Yixue Zazhi [&#20020;&#24202;&#31934;&#31070;&#21307;&#23398;&#26434;&#24535;]</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>5</NO>
<PG>327-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677282"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677281"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhi-2010" MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" NAME="Zhi 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#25903;&#32988;&#21033;</AU>
<TI>aripiprazole and risperidone in the treatment of schizophrenia compared efficacy] Google Translate</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30103;&#25928;&#23545;&#27604; [</TO>
<SO>China Pharmaceuticals [&#20013;&#22283;&#34277;&#26989;]</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>1</NO>
<PG>52-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677284"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677283"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006f" MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2006f" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang H, Wang Y, Lu L</AU>
<TI>A comparative study between aripiprazole and risperidone in the treatment of chronic schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#21033;&#22521;&#37230;&#27835;&#30103;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>650-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677286"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677285"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2006a" MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]" NAME="Zhao 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:56:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao L, Wang M, Wang B</AU>
<TI>A controlled study of aripiprazole versus quetiapine in the treatment of first-episode schizophrenia</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#19982;&#22862;&#30340;&#24179;&#27835;&#30103;&#39318;&#21457;&#31934;&#31070;&#20998;&#35010;&#30151;&#23545;&#29031;&#30740;&#31350;</TO>
<SO>Chinese Journal of Health Psychology [&#20013;&#22269;&#20581;&#24247;&#24515;&#29702;&#23398;&#26434;&#24535;]</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>6</NO>
<PG>663-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677288"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677287"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zheng-XR-2008" MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]" NAME="Zheng XR 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:56:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#37073;&#23389;&#33635;</AU>
<TI>Aripiprazole in the treatment of schizophrenia, efficacy and safety analysis</TI>
<TO>&#38463;&#31435;&#21708;&#21777;&#27835;&#30103;&#31934;&#31070;&#20998;&#35010;&#30151;&#30340;&#30103;&#25928;&#19982;&#23433;&#20840;&#24615;&#20998;&#26512;</TO>
<SO>Modern Practical Medicine</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>6</NO>
<PG>457-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677290"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677289"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x9676__x5efa__x9752__x002c_-2007" MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]" NAME="&#38518;&#24314;&#38738;, 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:56:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>&#38518;&#24314;&#38738;, &#26753;&#20339;, &#26366;&#24378;, &#24247;&#32418;</AU>
<TI>A controlled study on compliance of schizophrenia treated with aripiprazole and risperidone</TI>
<SO>Proceedings of the 8th National Academic Congress of CSP with the Regional Meeting of the WPA; 2007 Sep 20-23; Shanghai</SO>
<YR>2007</YR>
<PG>334</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677292"/><IDENTIFIER TYPE="MEDLINE" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677291"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2013-09-28 15:03:17 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bristol_x002d_Myers-2009" MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" NAME="Bristol-Myers 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bristol-Myers Squibb</AU>
<TI>Metabolic abnormalities - OPT</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677294"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677293"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eli-Lilly-2003" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Eli Lilly 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Eli Lilly and Company</AU>
<TI>Study of olanzapine vs aripiprazole in the treatment of schizophrenia</TI>
<SO>Eli Lilly and Company Clinical Trial Registry</SO>
<YR>2003</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677296"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677295"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Essock-2002" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Essock 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Essock SM, Covell NH, Carbuto M, Bielen K, Jabbour B, Saltz BL et al</AU>
<TI>Effectiveness of switching antipsychotic medications</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2002</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677298"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677297"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glorioso-2005" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Glorioso 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Glorioso DK, Jeste DV</AU>
<TI>Metabolic effects of newer antipsychotics in older patients</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677300"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677299"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanssens-2007" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Hanssens 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hanssens L</AU>
<TI>A 16-Week, multicenter, randomized, open-label study to assess the effects of aripiprazole versus other atypical antipsychotics in the treatment of schizophrenic patients with metabolic syndrome</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677302"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677301"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-2006" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Johnson 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC</AU>
<TI>A 2-year, prospective, blinded-rater, open-label, active-controlled, multicenter, randomized study of long-term efficacy and effectiveness comparing risperdal® consta® and abilify® (aripiprazole) in adults with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677304"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677303"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lehrer-2008" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Lehrer 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lehrer DS, Jewell M</AU>
<TI>Best event schizophrenia trial--a randomized double-blind trial of aripiprazole and risperidone in schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677306"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677305"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-2009" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="Lin 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lin C-C</AU>
<TI>Identification and treatment response prediction of antipsychotic-related metabolic syndrome</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677308"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677307"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Livingston-2007" MODIFIED="2013-09-28 15:03:17 +0100" MODIFIED_BY="[Empty name]" NAME="Livingston 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-09-28 15:03:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Livingston M, Stroup TS, McEvoy JP, Rojas I, Gamel N, Glick I, et al</AU>
<TI>Clinical management of metabolic problems in patients with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677310"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677309"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCormack-2006" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="McCormack 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>McCormack J, Robinson D, Tobias K, Petrides G, Robinson D, Sevy S, et al</AU>
<TI>Preventing morbidity in first episode schizophrenia, part II</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677312"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677311"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McEvoy-2007" MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" NAME="McEvoy 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>McEvoy JP</AU>
<TI>Metabolic signatures and biomarkers for aripiprazole</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677314"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677313"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montoya-2006" MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]" NAME="Montoya 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Montoya D, Blizard R, Buckley PF, Holman T, Kerr J, Miller DD, et al</AU>
<TI>Preventing relapse: oral antipsychotics compared to injectables: evaluating efficacy (PROACTIVE)</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677316"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677315"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schweiger-2005" MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]" NAME="Schweiger 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Schweiger J, Flavin K, Rosen B, Spies A, Newcomer JW, Haupt D</AU>
<TI>Changes in adiposity and metabolic measures during medication switches to aripiprazole from other atypical antipsychotics</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677318"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677317"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stroup-2007" MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]" NAME="Stroup 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stroup TS, McEvoy JP, Swartz MS, Hamer RM, Perkins DO, Lieberman JA</AU>
<TI>Comparison of antipsychotics for metabolic problems (CAMP): a NIMH schizophrenia trials network study</TI>
<SO>Clinical Schizophrenia and Related Psychoses</SO>
<YR>2007</YR>
<VL>1</VL>
<NO>1</NO>
<PG>69-72</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677320"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677319"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swartz-2008b" MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]" NAME="Swartz 2008b" YEAR="2008">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Swartz M, Stroup TS, McEvoy JP, Rojas IA</AU>
<TI>Comparison of optimal antipsychotic treatments for adults with schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677322"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677321"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vontur-2005" MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]" NAME="Vontur 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Vontur MG, Lopez J, Woolsey MD, Maples NL, Velligan DI</AU>
<TI>Do patients taking aripiprazole learn more in vocational skills training than patients taking olanzapine?</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2677324"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2677323"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-11-04 16:55:53 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-11-04 16:55:39 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Altman-1996" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Altman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Bland JM</AU>
<TI>Detecting skewness from summary information</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>313</VL>
<PG>1200</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APA-2004" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="APA 2004" TYPE="BOOK_SECTION">
<AU>American Psychiatric Association</AU>
<TI>Practice guidelines for the treatment of patients with schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2004</YR>
<PG>1-114</PG>
<EN>2nd</EN>
<PB>American Psychiatric Publishing, Inc</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arnt-1998" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Arnt 1998" TYPE="JOURNAL_ARTICLE">
<AU>Arnt J, Skarsfeldt T</AU>
<TI>Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence</TI>
<SO>Neuropsychopharmacology</SO>
<YR>1998</YR>
<VL>18</VL>
<PG>63-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barnes-1989" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Barnes 1989" TYPE="JOURNAL_ARTICLE">
<AU>Barnes TR</AU>
<TI>A rating scale for drug-induced akathisia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1989</YR>
<VL>154</VL>
<PG>672-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belgamwar-2011" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Belgamwar 2011" TYPE="COCHRANE_REVIEW">
<AU>Belgamwar Ravindra B, El-Sayeh Hany George G</AU>
<TI>Aripiprazole versus placebo for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>8</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006622.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bhattacharjee-2008" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Bhattacharjee 2008" TYPE="COCHRANE_REVIEW">
<AU>Bhattacharjee J, El-Sayeh Hany George G</AU>
<TI>Aripiprazole versus typical antipsychotic drugs for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>3</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006617.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bland-1997" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Bland 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bland JM, Kerry SM</AU>
<TI>Statistics notes. Trials randomised in clusters</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-BNF-2013" MODIFIED="2013-07-15 21:18:41 +0100" MODIFIED_BY="[Empty name]" NAME="BNF 2013" TYPE="OTHER">
<TI>British National Formulary (BNF)</TI>
<SO>http://www.bnf.org/bnf/index.htm</SO>
<YR>accessed June/July 2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boissel-1999" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Boissel 1999" TYPE="JOURNAL_ARTICLE">
<AU>Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, Boutitie F, et al</AU>
<TI>The problem of therapeutic efficacy indices.3. Comparison of the indices and their use</TI>
<SO>Therapie</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>4</NO>
<PG>405-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carpenter-1994" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Carpenter 1994" TYPE="JOURNAL_ARTICLE">
<AU>Carpenter WT Jr, Buchanan RW</AU>
<TI>Schizophrenia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>330</VL>
<PG>681-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chaichan-2008" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Chaichan 2008" TYPE="JOURNAL_ARTICLE">
<AU>Chaichan W</AU>
<TI>Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p. r. n. medication</TI>
<SO>Journal of Psychiatric Practice</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>2</NO>
<PG>105-13</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="18360196"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cipriani-2009" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Cipriani 2009" TYPE="COCHRANE_REVIEW">
<AU>Cipriani A, Boso M, Barbui C</AU>
<TI>Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006324.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2000" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 2000" TYPE="CONFERENCE_PROC">
<AU>Deeks J</AU>
<TI>Issues in the selection for meta-analyses of binary data</TI>
<SO>Proceeding of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa</SO>
<YR>2000</YR>
<PB>Cochrane Collaboration</PB>
<CY>Cape Town</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Divine-1992" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Divine 1992" TYPE="JOURNAL_ARTICLE">
<AU>Divine GW, Brown JT, Frazer LM</AU>
<TI>The unit of analysis error in studies about physicians' patient care behavior</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1992</YR>
<VL>7</VL>
<PG>623-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2002" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Donner 2002" TYPE="JOURNAL_ARTICLE">
<AU>Donner A, Klar N</AU>
<TI>Issues in the meta-analysis of cluster randomized trials</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>2971-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duggan-2005" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Duggan 2005" TYPE="COCHRANE_REVIEW">
<AU>Duggan L, Dardennes R, El-Dosoky A, Fenton M, Indran S, Rathbone J</AU>
<TI>Olanzapine for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD001359.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey-Smith G, Schneider M, Minder CSO</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>13</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EL_x002d_Sayeh-2006" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="EL-Sayeh 2006" TYPE="COCHRANE_REVIEW">
<AU>El-Sayeh HG, Morganti C</AU>
<TI>Aripiprazole for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>2</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD004578.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FDA-2002" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="FDA 2002" TYPE="OTHER">
<AU>U. S. Federal Drug Administration CDER</AU>
<TI>Abilify (aripiprazole) tablets, medical review</TI>
<SO>www.fda.gov/cder/foi/nda/2002/21-436_Abilify.htm 2002</SO>
<YR>(accessed 18 August 2006)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2006" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Furukawa 2006" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N</AU>
<TI>Imputing missing standard deviations in meta-analyses can provide accurate results</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2006</YR>
<VL>59</VL>
<PG>7-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gaebel-2006" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Gaebel 2006" TYPE="OTHER">
<AU>Gaebel W, Falkai P, Weinmann S, Wobrock T</AU>
<TI>Treatment guidelines for schizophrenia</TI>
<TO>Behandlungsleitlinie Schizophrenie</TO>
<SO>Steinkopf</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gulliford-1999" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Gulliford 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gulliford MC, Ukoumunne OC, Chinn S</AU>
<TI>Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1999</YR>
<VL>149</VL>
<PG>876-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guy-1976" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Guy 1976" TYPE="BOOK">
<AU>Guy U</AU>
<SO>ECDEU assessment manual for psychopharmacology</SO>
<YR>1976</YR>
<PB>National Institute of Mental Health</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heinrichs-1984" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Heinrichs 1984" TYPE="JOURNAL_ARTICLE">
<AU>Heinrichs DW, Hanlon TE, Carpenter WT Jr</AU>
<TI>The quality of life scale: An instrument for rating the schizophrenic deficit syndrome</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>3</NO>
<PG>388-98</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="6474101"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Heres-2006" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Heres 2006" TYPE="JOURNAL_ARTICLE">
<AU>Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S</AU>
<TI>Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>163</VL>
<PG>185-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hutton-2009" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Hutton 2009" TYPE="JOURNAL_ARTICLE">
<AU>Hutton JL</AU>
<TI>Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials</TI>
<SO>British Journal of Haematology</SO>
<YR>2009</YR>
<VL>146</VL>
<NO>1</NO>
<PG>27-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jelsma-2001" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Jelsma 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jelsma J, Mhundwa K, De Weerdt W, De Cock P, Chimera J, Chivaura V</AU>
<TI>The reliability of the Shona version of the EQ-5D</TI>
<SO>Central African Journal of Medicine</SO>
<YR>2001</YR>
<VL>47</VL>
<NO>1</NO>
<PG>8-13</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="11961858"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jones-2006" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Jones 2006" TYPE="JOURNAL_ARTICLE">
<AU>Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al</AU>
<TI>Randomized controlled trial of the effect on quality of life</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2006</YR>
<VL>63</VL>
<PG>1079-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kane-1988" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Kane 1988" TYPE="JOURNAL_ARTICLE">
<AU>Kane JM, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group</AU>
<TI>Clozapine for the treatment of treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1988</YR>
<VL>45</VL>
<PG>789-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kane-1993" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Kane 1993" TYPE="JOURNAL_ARTICLE">
<AU>Kane JM</AU>
<TI>Treatment programme and long-term outcome in chronic schizophrenia</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1993</YR>
<VL>46</VL>
<PG>585-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kay-1986" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Kay 1986" TYPE="BOOK">
<AU>Kay SR, Opler LA, Fiszbein A</AU>
<SO>Positive and Negative Syndrome Scale (PANSS) Manual</SO>
<YR>1986</YR>
<PB>Multi-Health Systems</PB>
<CY>North Tonawanda (NY)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kolotkin-2002" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Kolotkin 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kolotkin RL, Crosby RD</AU>
<TI>Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample</TI>
<SO>Quality of Life Research</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>2</NO>
<PG>157-71</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="12018739"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2005" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2005" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R</AU>
<TI>What does the PANSS mean?</TI>
<SO>Schizophrenia Research</SO>
<YR>2005</YR>
<VL>79</VL>
<PG>231-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2005a" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2005a" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R</AU>
<TI>Clinical implications of brief psychiatric rating scale scores</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>187</VL>
<PG>366-71</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="16199797"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2007" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2007" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Engel RR, Bauml J, Davis JM</AU>
<TI>Is the superior efficacy of new generation antipsychotics an artifact of LOCF?</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>1</NO>
<PG>183-91</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="16905632"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2008" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2008" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, et al</AU>
<TI>A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2009</YR>
<VL>166</VL>
<NO>2</NO>
<PG>152-63</PG>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1176/appi.ajp.2008.08030368"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lieberman-2005" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Lieberman 2005" TYPE="JOURNAL_ARTICLE">
<AU>Liebermann JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al</AU>
<TI>Effectiveness of antipsychotic drugs in patients with chronic schizophrenia</TI>
<SO>New England Journal of Medicine</SO>
<YR>2005</YR>
<VL>353</VL>
<PG>1209-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maayan-2011" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Maayan 2011" TYPE="COCHRANE_PROTOCOL">
<AU>Maayan N, Soares-Weiser K, Xia J, Adams CE</AU>
<TI>Antipsychotic combinations for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>2</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD009005"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Marshall-2000" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Marshall 2000" TYPE="JOURNAL_ARTICLE">
<AU>Marshall M, Lockwood A, Adams C, Bradley C, Joy C, Fenton M</AU>
<TI>Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>176</VL>
<PG>249-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Martindale-2013" MODIFIED="2013-07-15 21:18:48 +0100" MODIFIED_BY="[Empty name]" NAME="Martindale 2013" TYPE="OTHER">
<TI>Martindale: the complete drug reference</TI>
<SO>http://www.medicinescomplete.com/mc/martindale/current/</SO>
<YR>accessed June/ July 2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marvaha-2004" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Marvaha 2004" TYPE="JOURNAL_ARTICLE">
<AU>Marvaha S, Johnson S</AU>
<TI>Schizophrenia and employment - a review</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>2004</YR>
<VL>39</VL>
<PG>337-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McGahuey-2000" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="McGahuey 2000" TYPE="JOURNAL_ARTICLE">
<AU>McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al</AU>
<TI>The Arizona Sexual Experience Scale (ASEX): reliability and validity</TI>
<SO>Journal of Sex &amp; Marital Therapy</SO>
<YR>2000</YR>
<VL>26</VL>
<NO>1</NO>
<PG>25-40</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="10693114"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman D</AU>
<TI>The CONSORT Statement: revised recommendations for improving the quality of reports of parallel- group randomized trials</TI>
<SO>JAMA</SO>
<YR>2001</YR>
<VL>285</VL>
<PG>1987-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mukundan-2010" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Mukundan 2010" TYPE="COCHRANE_REVIEW">
<AU>Mukundan A, Faulkner G, Cohn T, Remington G</AU>
<TI>Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>12</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006629.pub2"/><IDENTIFIER TYPE="OTHER" VALUE="CD006629"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-M_x00f6_ller-2000" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Möller 2000" TYPE="JOURNAL_ARTICLE">
<AU>Möller HJ</AU>
<TI>New assessment of atypical antipsychotics</TI>
<TO>Aktuelle bewertung neuer/atypischer neuroleptika</TO>
<SO>Nervenarzt</SO>
<YR>2000</YR>
<VL>71</VL>
<PG>329-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Carroll-2000" MODIFIED="2013-11-04 16:55:39 +0000" MODIFIED_BY="[Empty name]" NAME="O'Carroll 2000" TYPE="JOURNAL_ARTICLE">
<AU>O'Carroll RE, Smith K, Couston M, Cossar JA, Hayes PC</AU>
<TI>A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation</TI>
<SO>Quality of Life Research</SO>
<YR>2000</YR>
<VL>9</VL>
<PG>121-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Overall-1962" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Overall 1962" TYPE="JOURNAL_ARTICLE">
<AU>Overall JE, Gorham DR</AU>
<TI>The brief psychiatric rating scale</TI>
<SO>Psychological Reports</SO>
<YR>1962</YR>
<VL>10</VL>
<PG>799-812</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pagadala-2009" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Pagadala 2009" TYPE="COCHRANE_PROTOCOL">
<AU>Pagadala B, Jayaram Mahesh B, Mitra L</AU>
<TI>Aripiprazole for psychosis-induced aggression or agitation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD008074"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rivas_x002d_Vasquez-2003" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Rivas-Vasquez 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rivas-Vasquez RA</AU>
<TI>Aripiprazole: A novel antipsychotic with dopamine stabilising properties</TI>
<SO>Professional Psychology</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>1</NO>
<PG>108-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rust-1989" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Rust 1989" TYPE="BOOK">
<AU>Rust J, Golombok S</AU>
<SO>Modern Psychometrics</SO>
<YR>1989</YR>
<PB>Routledge</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2008" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Schünemann 2008" TYPE="BOOK_SECTION">
<AU>Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al</AU>
<TI>Chapter 12: Interpreting results and drawing conclusions</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PG>359-83</PG>
<ED>Higgins JPT, Green S</ED>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simpson-1970" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Simpson 1970" TYPE="JOURNAL_ARTICLE">
<AU>Simpson EN, Angus JWF</AU>
<TI>A rating scale for extrapyramidal adverse effects</TI>
<SO>Acta Psychiatrica Scandinavica Supplementum</SO>
<YR>1970</YR>
<VL>212</VL>
<PG>11-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tandon-2005" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Tandon 2005" TYPE="JOURNAL_ARTICLE">
<AU>Tandon R, Devellis RF, Han J, Li H, Frangou S, Dursun S, et al</AU>
<TI>Validation of the investigator's assessment questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder</TI>
<SO>Psychiatry Research</SO>
<YR>2005</YR>
<VL>136</VL>
<NO>2-3</NO>
<PG>211-21</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="16115690"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tandon-2008" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Tandon 2008" TYPE="JOURNAL_ARTICLE">
<AU>Tandon R, Keshavan MS, Nasralllah HA</AU>
<TI>Schizophrenia, "just the facts"What we know in 2008.2. Epidemiology and etiology</TI>
<SO>Schizophrenia Research</SO>
<YR>2008</YR>
<VL>102</VL>
<PG>1-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thorpe-2009" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Thorpe 2009" TYPE="JOURNAL_ARTICLE">
<AU>Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al</AU>
<TI>A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2009</YR>
<VL>62</VL>
<NO>5</NO>
<PG>464-75</PG>
<IDENTIFIERS><IDENTIFIER TYPE="PUBMED" VALUE="19348971"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tsuang-1978" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Tsuang 1978" TYPE="JOURNAL_ARTICLE">
<AU>Tsuang MT</AU>
<TI>Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1978</YR>
<VL>35</VL>
<PG>153-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ukoumunne-1999" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Ukoumunne 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ</AU>
<TI>Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review</TI>
<SO>Health Technology Assessment</SO>
<YR>1999</YR>
<VL>3</VL>
<NO>5</NO>
<PG>iii-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whitehead-2002" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Whitehead 2002" TYPE="COCHRANE_REVIEW">
<AU>Whitehead C, Moss S, Cardno A, Lewis G</AU>
<TI>Antidepressants for people with both schizophrenia and depression</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>2</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD002305"/><IDENTIFIER TYPE="PUBMED" VALUE="12076447"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WHO-2001" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2001" TYPE="BOOK">
<AU>WHO</AU>
<SO>The World Health Report 2001 - Mental Health: New Understanding, New Hope</SO>
<YR>2001</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Xia-2007" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Xia 2007" TYPE="CONFERENCE_PROC">
<AU>Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al</AU>
<TI>The Leeds Outcomes Stakeholders Survey (LOSS) study</TI>
<SO>Proceedings of the 15th Cochrane Colloquium, Sao Paulo, 23-27 October 2007</SO>
<YR>2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Xia-2009" MODIFIED="2013-06-25 15:54:31 +0100" MODIFIED_BY="[Empty name]" NAME="Xia 2009" TYPE="JOURNAL_ARTICLE">
<AU>Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al</AU>
<TI>Loss to outcomes stakeholder survey: the LOSS study</TI>
<SO>Psychiatric Bulletin</SO>
<YR>2009</YR>
<VL>33</VL>
<NO>7</NO>
<PG>254-7</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-11-04 16:55:53 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Khanna-2013" MODIFIED="2013-11-04 16:55:53 +0000" MODIFIED_BY="Heather Maxwell" NAME="Khanna 2013" TYPE="COCHRANE_REVIEW">
<AU>Khanna P, Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, El-Sayeh HG, et al</AU>
<TI>Aripiprazole versus other atypical antipsychotics for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-09-29 15:20:11 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER MODIFIED="2013-09-29 15:20:11 +0100" MODIFIED_BY="Heather Maxwell" TYPE="DOI" VALUE="10.1002/14651858.CD006569.pub4"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Komossa-2009" MODIFIED="2013-10-01 10:42:34 +0100" MODIFIED_BY="[Empty name]" NAME="Komossa 2009" TYPE="COCHRANE_REVIEW">
<AU>Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, et al</AU>
<TI>Aripiprazole versus other atypical antipsychotics for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006569.pub3"/><IDENTIFIER TYPE="PUBMED" VALUE="19821375"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-07-09 11:02:54 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-10-24 15:37:38 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-10-24 15:37:38 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-09-28 16:21:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-An-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. No further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:03:05 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis:schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 78.<BR/>Age: not reported.<BR/>Gender: not reported.<BR/>History: duration of illness not reported, age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:03:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 41.<BR/>2. Clozapine: Dose range: 25-500 mg/day. Mean dose: not reported. N = 37.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:21:15 +0100" MODIFIED_BY="[Empty name]">
<P>Globlal state:PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: &#8805; 50%, improved: &#8805; 20%, no effect: &lt; 20%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:09:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bai-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:08:46 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 118.<BR/>Age: 20&#65374;50 years, aripiprazole group, mean = (32 ± 11) years; clozapine group, mean= (32 ± 13) years.</P>
<P>Gender: aripiprazole group: 34 male, 25 female; clozapine group: 38 male, 21 female.<BR/>History: aripiprazole group: 1&#65374;36 months, mean = (22 ± 5) months; clozapine group: 1&#65374;36 months, mean = (20 ± 7) months. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:09:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (20 ± 5) mg/day. N = 59.<BR/>2. Clozapine: Dose range: 50-650 mg/day. Mean dose: (450 ± 125) mg/day. N = 59.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:09:09 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (markedly improved: &gt; 60%, improved: 40%-60%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score.</P>
<P>Adverse events.</P>
<P>Unable to use:</P>
<P>Mental state: PANSS anxiety subscale score - unvalidated subscale.</P>
<P>Cognitive functioning: PANSS cognitive factor subscale score - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:21:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bai-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:09:59 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (32.1 ± 7.1) years; ziprasidone group: mean = (31.8 ± 7.1) years.</P>
<P>Gender: not reported.<BR/>History: aripiprazole group: mean= (5.5 ± 2.2) years; ziprasidone group: mean = (5.6 ± 2.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:10:12 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean= (15.8 ± 5.1) mg/day. N = 30.<BR/>2. Ziprasidone: Dose range: 20-140 mg/day. Mean= (88.7 ± 12.6) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:21:26 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:21:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ban-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:11:32 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 35 or more.<BR/>N = 80.<BR/>Age: aripiprazole group, 16&#65374;45 years. mean= (29 ± 8.8) years; quetiapine group, 18-45 years, mean = (30 ± 2.7) years.</P>
<P>Gender: aripiprazole group: 17 male, 23 female; quetiapine group: 21 male, 19 female.<BR/>History: aripiprazole group: mean = (1.2 ± 1.0) months; clozapine group: mean = (0.9 ± 1.1) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:11:46 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: (11.8 ± 3.4) mg/day. N = 40.<BR/>2. Quetiapine: Dose range: 50-750 mg/day. Mean dose: (544.8 ± 83.8) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:21:37 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: no clinically significant improvement.</P>
<P>Mental state: BPRS total score.</P>
<P>Adverse effects.<BR/>
</P>
<P>Unable to use -<BR/>BPRS anxiety-depression subscale score, BPRS thought disorder subscale score, BPRS activation subscale score, BPRS hostile subscale score - subscales are unvalidated.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:32:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chan-2007">
<CHAR_METHODS MODIFIED="2013-09-28 17:32:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, permuted block randomisation stratified by centre.<BR/>Blindness: double, identical capsules.<BR/>Duration: four weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:18:58 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: (DSM-IV) schizophrenia (N = 80) or schizoaffective disorder (N = 3), acute relapse. PANSS total score of 60 or more.<BR/>N = 83.<BR/>Age: 18-65 years (mean aripiprazole = 35.2 years, mean risperidone = 35.1 years).<BR/>Gender: 45 M, 38 F.<BR/>History: duration of illness not reported, age at onset not reported.<BR/>Setting: inpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:16:04 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: fixed dose: 15 mg/day. N = 49.<BR/>2. Risperidone: fixed dose: 6 mg/day. N = 34.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early: any reason, adverse events, inefficacy. <BR/>Global state: CGI. <BR/>Mental state: PANSS total score, PANSS positive sub score, PANSS negative sub score. <BR/>Adverse effects: at least one adverse effect, cardiac effects (QTc), extrapyramidal adverse effects (use of antiparkinson medication, extrapyramidal symptoms, AIMS, BAS, SAS), cholesterol increase, glucose elevation, prolactin increase, weight. </P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:20:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chang-2007">
<CHAR_METHODS MODIFIED="2013-09-28 16:19:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:20:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 100.<BR/>Age: aripiprazole group: 18&#65374;48 years. mean= (29.5 ± 11.7) years; risperidone group: 16&#65374;60 years, mean = (29.3 ± 10.6) years.</P>
<P>Gender: aripiprazole group: 29 male, 21 female; risperidone group: 28 male, 22 female.<BR/>History: aripiprazole group: 1 month&#65374;10 years, mean = (6.4 ± 1.5) years; risperidone group: 1.5 months&#65374;13 years, mean = (6.3 ± 1.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:20:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 50.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose:not reported. N = 50.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:20:48 +0100" MODIFIED_BY="[Empty name]">
<P>Globlal state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%- 75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score,PANSS general pathological subscale score, irritability- labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:22:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2006">
<CHAR_METHODS MODIFIED="2013-09-28 16:22:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: two weeks wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:22:24 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 101.<BR/>Age: aripiprazole group: 16&#65374;60 years. mean = (28.6 ± 12.9) years; risperidone group: 17&#65374;59 years, mean = (25.4 ± 7.7) years.</P>
<P>Gender: aripiprazole group: 19 male, 32 female; risperidone group: 26 male, 24 female.<BR/>History: aripiprazole group: 1.4&#65374;240 months, mean = (23.3 ± 43.2) months; risperidone group: 1.7&#65374;108 months, mean = (23.3 ± 37.1) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:22:38 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean = (15.9 ± 4.0) mg/day. N = 51.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.3 ± 1.1) mg/day. N = 50.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:22:48 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI-SI score, CGI-EI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:24:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2007a">
<CHAR_METHODS MODIFIED="2013-09-28 16:23:27 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: six months.<BR/>Design: parallel.<BR/>Location: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:24:00 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 100.<BR/>Age: not reported.<BR/>Gender: not reported.<BR/>History: 1&#65374;6 months, mean = (2.8 ± 1.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:24:09 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 50.<BR/>2. Quetiapine: Dose range: 100-600 mg/day. Mean dose: not reported. N = 50.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:24:27 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%- 80%, improved: 30%-50%, no effect: &lt; 30%); CGI-SI total score.</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. agitation-labelled as "adverse effect".</P>
<P>Life of quality: WHO-QOL-100.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, blood glucose, electrolyte, ECG, liver function (deficient data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:26:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2008a">
<CHAR_METHODS MODIFIED="2013-09-28 16:25:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:26:07 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (32.5 ± 9.3) years; risperidone group: mean = (33.2 ± 8.0) years.</P>
<P>Gender: 60 female.<BR/>History: aripiprazole group: mean = (3.6 ± 1.3) years; risperidone group: mean = (3. 9 ± 1.5) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:26:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean = (18. 6 ±7. 4)) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4. 3 ±1. 3) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:26:32 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, excitement labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:28:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2009">
<CHAR_METHODS MODIFIED="2013-09-28 16:27:54 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: open.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:28:25 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>
</P>
<P>Age: aripiprazole group: 18&#65374;58 years; mean = (25.63 ± 7.9) years; quetiapine group: 18&#65374;55 years; mean = (29.4 ± 9.5) years.</P>
<P>Gender: aripiprazole group: 18 male, 12 female; quetiapine group: 17 male, 13 female.<BR/>History: aripiprazole group: 3 months&#65374;5 years, mean = (2.39 ± 1.8) years; quetiapine group: 3 months&#65374;5 years, mean = (3.2 ± 1.6) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:28:36 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Quetiapine: Dose range: 100-800 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:28:51 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>Mental state: SANS subscale score - unvalidated subscale.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:31:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2009a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.</P>
<P>Blindness: unclear.<BR/>Duration: 3&#65374;7 days wash-out period + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:30:41 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more, Excited subscales (PEC) of 14 or more.<BR/>N = 75.<BR/>Age: aripiprazole group: mean = 38.4 years; olanzapine group: mean = 37.1 years.</P>
<P>Gender: aripiprazole group: 25 male, 15 female; olanzapine group: 22 male, 13 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:30:53 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 40.<BR/>2. Olanzapine: Dose range: 5-20 mg/day. Mean dose: not reported. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:31:18 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-75%, no effect: &lt; 50%).</P>
<P>Mental state: PANSS total score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Mental state: PANSS PEC subscale score - unvalidated.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:36 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:32:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2010">
<CHAR_METHODS MODIFIED="2013-09-28 16:32:11 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:31:54 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 64.<BR/>Age: aripiprazole group 18&#65374;50 years, mean = (22.35 ± 7.15) years; risperidone group 18&#65374;49 years, mean = (22.25 ± 9.55) years.</P>
<P>Gender: aripiprazole group: 14 male, 18 female; risperidone group: 17 male, 15 female.<BR/>History: aripiprazole group 1 month&#65374;10 years; risperidone group 1 month&#65374;9 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:32:34 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (19.4 ± 2.1) mg/day. N = 32.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (2.7 ± 0.7)mg/day. N = 32.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:32:47 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:37:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2010a">
<CHAR_METHODS MODIFIED="2013-09-28 16:36:24 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:36:43 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 120.<BR/>Age: 18&#65374;60 years, aripiprazole group mean= (31.8 ±7.9) years; risperidone group mean = (32.5 ± 6.8) years.</P>
<P>Gender: aripiprazole group: 24 male, 36 female; risperidone group: 26 male, 34 female.<BR/>History: aripiprazole group: mean = (11.2 ± 6.1) months; risperidone group: mean= (11.8 ± 6.9) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:36:52 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 60.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 60.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:37:15 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:38:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:38:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more, SANS of 60 or more.<BR/>N = 86.<BR/>Age: aripiprazole group: mean = (29.35 ± 7.6) years; ziprasidone group: mean= (30.28 ± 8.1) years.</P>
<P>Gender: aripiprazole group: 25 male, 18 female; ziprasidone group: 26 male, 17 female.<BR/>History: aripiprazole group: mean = (5.23 ± 2.81) years; ziprasidone group: mean = (5.16 ± 2.6) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:38:24 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean = (11.7 ± 1.2) mg/day. N = 43.<BR/>2. Ziprasidone: Dose range: 20-120 mg/day. Mean = (86.26 ± 10.2) mg/day. N = 43.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:38:44 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. SANS total score score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:39:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-CuiMeng-2008">
<CHAR_METHODS MODIFIED="2013-09-28 16:39:11 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:39:35 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 120.<BR/>Age: aripiprazole group: 18&#65374;64 years, mean = (25.2 ± 7.5) years; risperidone group: 18&#65374;65 years, mean = (25 ± 8) years.</P>
<P>Gender: aripiprazole group: 40 male, 20 female; risperidone group: 36 male, 24 female.<BR/>History: aripiprazole group 1&#65374;55 months, mean = (22 ± 12) months; risperidone group 1&#65374;55 months, mean = (22 ± 13) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:39:49 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 60.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 60.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score.</P>
<P>Adverse effects: TESS score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:41:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dai-2005">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:40:38 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more, CGI of 4 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: 18&#65374;58 years. mean = (31 ± 8) years; quetiapine group: 19&#65374;57 years, mean = (32 ± 9) years.</P>
<P>Gender: aripiprazole group: 20 male, 20 female; quetiapine group: 21 male, 19 female.<BR/>History: aripiprazole group: 1 month&#65374;10 years, mean = (5.9 ± 3) years; clozapine group: 1 month&#65374;9 years, mean = (5 ± 3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:40:52 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: (23.3 ± 3.1) mg/day. N = 40.<BR/>2. Quetiapine: Dose range: 75-700 mg/day. Mean dose: (565 ± 85) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:41:06 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25). CGI average endpoint scale score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:42:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dai-2006">
<CHAR_METHODS MODIFIED="2013-09-28 16:41:35 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.</P>
<P>Duration: eight weeks.</P>
<P>Design: parallel.</P>
<P>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:42:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.</P>
<P>N = 80.</P>
<P>Age: aripiprazole group: 24&#65374;58 years, mean = 31 years; risperidone group: not reported.</P>
<P>Gender: aripiprazole group: 28 male, 12 female; risperidone group: 24 male, 16 female.</P>
<P>History: aripiprazole group: 1 month&#65374;8 years, mean = 6.4 years; risperidone group: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:42:11 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 40.</P>
<P>2. Risperidone: Dose range: 5-20 mg/day. Mean dose: not reported. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:42:19 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (markedly improved: &#8805;70%, improved: 40%-70%, no effect: &lt; 40%).</P>
<P>Mental state: PANSS total score.</P>
<P>Adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:43:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deng-2008">
<CHAR_METHODS MODIFIED="2013-09-28 16:42:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:42:56 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 50.<BR/>Age: mean = (63.5 ± 2.3) years; risperidone group: mean = (65.2 ± 2.7) years.</P>
<P>Gender: aripiprazole group: 17 male, 8 female; risperidone group: 15 male, 10 female.<BR/>History: aripiprazole group: mean= (3.7 ± 2.4) years; risperidone group: mean=(5.2 ± 1.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:43:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 25.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 25.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:43:28 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: &#8805;50%, improved: &#8805;25%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:45:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deng-2008a">
<CHAR_METHODS MODIFIED="2013-09-28 16:44:24 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:44:47 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 90.<BR/>Age: aripiprazole group: mean= (25 ± 5. 2) years; risperidone group: mean = (29 ± 4. 2) years.</P>
<P>Gender: aripiprazole group: 25 male, 20 female; risperidone group: 23 male, 22 female.<BR/>History: aripiprazole group: mean = (1.3 ± 1.1) years; risperidone group: mean = (1.5 ± 1.0) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:44:54 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 45.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose: not reported. N = 45.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:45:03 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-74%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:46:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ding-2007">
<CHAR_METHODS MODIFIED="2013-09-28 16:45:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:46:08 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 35 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;56 years, mean = (28.6 ± 3.7) years; risperidone group: 19&#65374;55 years, mean = (28.1 ± 5.6) years.</P>
<P>Gender: aripiprazole group: 13 male, 17 female; risperidone group: 14 male, 16 female.<BR/>History: aripiprazole group: 1 month&#65374;3 years, mean = (1.4 ± 0.5) years. risperidone group: 1 month&#65374;3 years, mean = (1.3 ± 0.6) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:46:18 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:46:32 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: anxiety - labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:47:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Du-2006">
<CHAR_METHODS MODIFIED="2013-09-28 16:46:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: double.<BR/>Duration: one week wash-out period + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:47:00 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 65.<BR/>Age: aripiprazole group: 18&#65374;65 years, mean = (29 ± 9) years; risperidone group: 18&#65374;60 years, mean = (31.1 ± 9.7) years.</P>
<P>Gender: not reported.<BR/>History: 1 month &#65374;20 years, mean= (6.8 ± 8.4) years; risperidone group: 1 month &#65374;23 years, mean= (7.3 ± 8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:47:12 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (21 ± 6.2) mg/day. N = 33.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.5 ± 1) mg/day. N = 32.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse effects: level of PRL, weight.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:53:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fan-2005">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:52:56 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 72.<BR/>Age: aripiprazole group, mean = (32 ± 10.2) years; clozapine group: mean = (31 ± 10.8) years.</P>
<P>Gender: aripiprazole group: 19 male, 13 female; clozapine group: 20 male, 12 female.<BR/>History:aripiprazole group: mean = (6.6 ± 3.3) years; clozapine group: mean = (6.4 ± 3.2 ) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:53:20 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (15.68 ± 6.42) mg/day. N = 36.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean = (211 ± 31.82) mg/day. N = 36.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:53:32 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects: central nervous system (somnolence ) extrapyramidal side-effects, weight gain, postural hypotension, tardive dyskinesia, constipation,endocrine (menstrual disorder), ECG abnormal (Q-Tc prolongation), change of blood routine.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:37 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:54:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fan-2010">
<CHAR_METHODS MODIFIED="2013-09-28 16:54:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:54:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 19&#65374;60 years, mean = (33.5 ± 6.9) years; risperidone group: 18&#65374;60 years, mean = (32.7 ± 8.1) years.</P>
<P>Gender: aripiprazole group: 17 male, 13 female; risperidone group: 18 male, 12 female.<BR/>History: aripiprazole group: 1&#65374;146 months, mean = (6.3 ± 5.7) years; risperidone group: 1&#65374;160 months, mean = (6.9 ± 6.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:54:46 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: (22.5 ± 6.6)mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: (4.5 ± 1.4)mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:54:57 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 16:56:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feng-2006">
<CHAR_METHODS MODIFIED="2013-09-28 16:55:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: double.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 16:56:01 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 69.<BR/>Age: 18&#65374;55 years.</P>
<P>Gender: not reported.<BR/>History: &lt; 1 year. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:56:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (22.68 ± 4.91) mg/day. N = 35.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.94 ± 1.43) mg/day. N = 34.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 16:56:28 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%). CGI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-30 17:07:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fleischhacker-2008">
<CHAR_METHODS MODIFIED="2013-09-28 17:32:28 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: double, no further details.<BR/>Duration: 52 weeks (first six weeks observed).<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-30 17:07:33 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: (DSM-IV) acute schizophrenia, PANSS of 60 or more.<BR/>N = 703.<BR/>Age: 18-65 years.<BR/>Gender: M, F.<BR/>History: duration of illness not reported, age at onset not reported.<BR/>Setting: in- and out-patient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 16:59:12 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: flexible dose. Allowed dose range: 15-30 mg/day. N = 355.<BR/>2. Olanzapine: flexible dose. Allowed dose range: 10-20 mg/day. N = 348.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-30 17:07:33 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early: any reason.<BR/>Global state: CGI.<BR/>Mental state: PANSS total score, MADRS.<BR/>Quality of life/satisfaction with treatment: Quality of Life Enjoyment and Satisfaction Questionnaire, Medication adherence scale.<BR/>Adverse effects: open interviews, EPS (SAS, AIMS, BAS), cardiac effects (ECG), weight gain (BMI).</P>
<P>Unable to use -<BR/>Adverse event outcomes (no data, interim report)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-30 17:07:33 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:01:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fu-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:01:06 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 69.<BR/>Age: 12&#65374;18 years, aripiprazole group: mean = (16.9 ± 3.4) years; risperidone group: mean = (15.6 ± 5.7) years.</P>
<P>Gender: aripiprazole group: 20 male, 13 female; risperidone group: 21 male, 15 female.<BR/>History: aripiprazole group: mean = (4.7 ± 2.9) years; risperidone group: mean= (5.2 ± 3.5) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:01:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean = (16.5 ± 3) mg/day. N = 33.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean = (3.6 ± 1) mg/day. N = 36.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:01:48 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &gt; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS total score decreased rate, "agitation" labelled as adverse effect.</P>
<P>Drug combination.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:07:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ge-2009">
<CHAR_METHODS MODIFIED="2013-09-28 17:06:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:07:45 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>
</P>
<P>Age: 18&#65374;40 years, aripiprazole group: mean = (22.1 ± 5.9) years; quetiapine group: mean = (24.8 ± 7.2) years.</P>
<P>Gender: Not reported.<BR/>History: aripiprazole group: mean = (1.1 ± 0.7) years; quetiapine group: mean = (1.3 ± 0.7) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:07:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Initial dose: 5 mg/day. Mean = (25.5 ± 1.8) mg/day. N = 40.<BR/>2. Quetiapine: Initial dose: 100mg/day. Mean = (425 ± 27) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:08:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ge-2010">
<CHAR_METHODS MODIFIED="2013-09-28 17:08:05 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:08:23 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>
</P>
<P>Age: 16&#65374;55 years, aripiprazole group: mean = (30 ± 2.4) years; quetiapine group: mean = (31 ± 3.2) years.</P>
<P>Gender: 80 female.<BR/>History: &lt; 3 years, aripiprazole group: not reported; quetiapine group: 3 months&#65374;3 years, mean = (2.05 ± 0.5) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:08:33 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 2.5-30 mg/day. Mean dose: not reported. N = 40.<BR/>2. Quetiapine: Dose range: 50-600 mg/day. Mean dose: not reported. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:08:44 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score, anxiety- labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:09:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guo-2006">
<CHAR_METHODS MODIFIED="2013-09-28 17:09:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: double.<BR/>Duration: 3-7 days wash-out period + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:09:15 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more. BPRS of 35 or more.<BR/>N = 38.<BR/>Age: aripiprazole group: mean = (28.9 ± 7.3) years; risperidone group: mean= (27.7 ± 8.4) years.</P>
<P>Gender: aripiprazole group: 11 male, 7 female; risperidone group: 14 male, 6 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:09:32 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 18.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose: not reported. N = 20.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:09:50 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score. BPRS total score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-24 15:35:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2005">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:10:18 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 70.<BR/>Age: 18&#65374;60 years, mean aripiprazole group = (27 ± 6) years; mean clozapine group = (29 ± 8) years.</P>
<P>Gender: aripiprazole group: 18 male, 17 female; clozapine group: 19 male, 16 female.<BR/>History: aripiprazole group, mean = (1.5 ± 2) years; clozapine group: mean = (1.7 ± 2 ) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:10:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 35.<BR/>2. Clozapine: Dose range: 25-450 mg/day. Mean dose: not reported. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-24 15:35:10 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects: Central nervous system (dizziness, headache,insomnia, somnolence), extrapyramidal side-effects, gastrointestinal (constipation, salivate), weight gain, blood glucose increase, blood routine abnormal, change of ECG (Q-T abnormal).</P>
<P>Unable to use -<BR/>Adverse effects: TESS score (no data), EEG, laboratory tests (urine routine, hepatorenal function) and use of Benzodiazepines azoles or Artane (no data).</P>
<P>Mental state: PANSS anxiety subscale score - unvalidates subscale.</P>
<P>Cognitive function: PANSS cognitive factor subscale score - subscale unvalidated.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:12:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:11:57 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 61.<BR/>Age: aripiprazole group: mean = (31.0 ± 10.1) years; olanzapine group: mean = (29.9 ± 9.3) years.</P>
<P>Gender: aripiprazole group: 14 male, 16 female; olanzapine group: 14 male, 17 female.<BR/>History: aripiprazole group: mean = (5.89 ± 1.1) years; olanzapine group: mean= (6.26 ± 1.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:12:18 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (20.8 ± 3.1) mg/day . N = 30.<BR/>2. Olanzapine: Dose range: 5-20 mg/day. Mean dose = (13.6 ± 2.7) mg/day. N = 31.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:12:22 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: markedly improved, improved, slight improved, no effect.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:13:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2007a">
<CHAR_METHODS MODIFIED="2013-09-28 17:12:57 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:13:27 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 86.<BR/>Age: aripiprazole group: 16&#65374;61 years. mean = (25.7 ± 7.9) years; risperidone group: 16&#65374;62 years, mean = (26.9 ± 8.4) years.</P>
<P>Gender: aripiprazole group: 19 male, 24 female; risperidone group: 20 male, 23 female.<BR/>History: aripiprazole group:1 month&#65374;10 years, mean = (4.8 ± 2.6) years; risperidone group: 1 month&#65374;9 years, mean = (4.6 ± 2.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:13:35 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: (15.3 ± 3.2) mg/day. N = 43.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: (3.8 ± 1.6) mg/day. N = 43<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:13:46 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-75%, no effect: &lt; 50%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -</P>
<P>Mental state: PANSS subscale score decreased rate - unvalidated subscales.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-24 15:35:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hu-2010">
<CHAR_METHODS MODIFIED="2013-10-24 15:35:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 50.<BR/>Age: aripiprazole group 18&#65374;56 years, mean = (28.9 ± 4.6) years; risperidone group 16&#65374;58 years, mean = (30.1 ± 5.2) years.</P>
<P>Gender: aripiprazole group: 13 male, 12 female; risperidone group: 12 male, 13 female.<BR/>History: aripiprazole group: 1 month&#65374;5 years, mean = (3.6 ± 2.1) years; risperidone group: 2 months&#65374;5.2 years, mean = (3.8 ± 2.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:15:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 25.<BR/>2. Risperidone: Dose range: 2-8 mg/day. Mean dose: not reported. N = 25.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-24 15:35:37 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:38 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:16:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2009">
<CHAR_METHODS MODIFIED="2013-09-28 17:15:55 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:16:25 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score = 50.<BR/>N = 60.<BR/>Age: 16&#65374; 55 years, aripiprazole group mean = (30.90 ± 11.05) years; risperidone group mean = (29.55 ± 12.35) years.</P>
<P>Gender: aripiprazole group: 12 male, 18 female; risperidone group: 13 male, 17 female.<BR/>History: aripiprazole group: mean = (4.5 ± 6.9) months; risperidone group mean = (5.7 ± 8.7) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose:not reported. N = 30.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:16:49 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Leaving the study early.</P>
<P>Adverse effects: the average endpoint score of BMI, blood glucose, TCHO, TG, PRL, LEP.</P>
<P>Unable to use -</P>
<P>Mental state: PANSS total score (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:20:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ji-2007">
<CHAR_METHODS MODIFIED="2013-09-28 17:19:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and patient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:19:54 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 64.<BR/>Age: aripiprazole group: 18&#65374;58 years, mean = (32.8 ± 6.2) years; risperidone group: 17&#65374;59 years, mean = (30.6 ± 7.8) years.</P>
<P>Gender: aripiprazole group: 19 male, 13 female; risperidone group: 18 male, 14 female.<BR/>History: aripiprazole group: 1 month&#65374;9 years, mean = (4.2 ± 3.9) years; risperidone group: 1 month&#65374;11 years, mean = (5.2 ± 3.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:20:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (15 ± 5) mg/ day. N = 32.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.2 ± 1.8) mg/ day. N = 32.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:20:14 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score, anxiety-labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:21:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiang-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: not reported, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:20:44 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 80.<BR/>Age: Aripiprazole group: 18&#65374;56 years, mean = (33 ± 6) years; Clozapine group: 18&#65374;57 years, mean = (35 ± 5.7) years.<BR/>Gender: aripiprazole group: 26 female, 14 male; clozapine group: 27 male, 13 female.<BR/>History: aripiprazole group: 2&#65374;8 years, mean =(5 ± 3.2) years; clozapine group: 2&#65374;15years, mean =(5.7 ± 4.1) years. Age at onset not reported.<BR/>Setting: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:20:57 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (23.5 ± 1.4) mg/d. N = 40.<BR/>2. Clozapine: Dose range: 25-500 mg/day. Mean = (400 ± 14.2) mg/d. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:21:02 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:21:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jie-2008">
<CHAR_METHODS MODIFIED="2013-09-28 17:21:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:21:40 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), PANSS of 60 or more, SANS of 60 or more.<BR/>N = 50.<BR/>Age: aripiprazole group: 18&#65374;50 years, mean = (25.7 ± 5.8) years; clozapine group: 18&#65374;57 years, mean = (27.85 ± 5.75) years.<BR/>Gender: aripiprazole group: 16 male, 9 female; clozapine group: 15 male, 10 female.<BR/>History: aripiprazole group: 1&#65374;10 years, mean = (4.15 ± 3.14) years; clozapine group: 1&#65374;11years, mean = (4.18 ± 3.15) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:21:50 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean = (13.5 ± .8) mg/d. N = 25.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean = (385.5 ± 75.5) mg/d. N = 25.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:21:59 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 80%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects: TESS total score.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:10:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kane-2009">
<CHAR_METHODS MODIFIED="2013-09-29 11:10:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: double, no further details.<BR/>Duration: 28 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:24:14 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: (DSM-IV) schizophrenia catatonic (n = 3), disorganised (n = 29), paranoid (n = 464), undifferentiated (n = 62), residual (n = 6), missing (n = 2), PANSS total score of &#8805; 75, minimum of &#8805; 4 PANSS positive items, score of &#8805; 4 on CGI-S, score of &#8805; 3 on CGI-I.<BR/>N = 566.<BR/>Age: 18-65 years. Mean for males 38 years.<BR/>Gender: 384 M, 182 F.<BR/>History: duration of illness not reported, mean (SD) previous episodes 7.7 (8.0).<BR/>Setting: inpatient and outpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:24:40 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 15- 30 mg/day, N = 285.<BR/>2. Olanzapine: 10-20 mg/day. N = 281.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early.<BR/>Global state: CGI.<BR/>Mental state: PANSS total score.<BR/>Adverse effects: EPSE (SAS, AIMS, BAS), laboratory results- lipids, glucose, increase in prolactin level, sedation, weight gain and others.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:13:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kern-2006">
<CHAR_METHODS MODIFIED="2013-09-29 11:13:59 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, 1:1 ratio.<BR/>Blindness: open label, no further details.<BR/>Duration: 26 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:25:15 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: (DSM-IV) schizophrenia or schizo-affective disorder.<BR/>N = 255.<BR/>Age: 18-65 years.<BR/>Gender: 109 M, 60 F.<BR/>History: duration of illness not reported.<BR/>Setting: outpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:25:27 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 15- 30 mg/day, N = 128.<BR/>2. Olanzapine: 10-15 mg/day. N = 127.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early. <BR/>
</P>
<P>Unable to use -<BR/>Cognitive function: CVLT, BVRT-R, WCST, Trail Making A and B, Verbal Fluency, Letter-Number Sequencing, Grooved Pegboard Test, CPT-IP (no usable data). <BR/>Mental state: PANSS total score (used as co-variate, no usable data). </P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]">
<P>Study compared the neuro-cognitive effects of medications. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-30 17:08:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kerwin-2007">
<CHAR_METHODS MODIFIED="2013-09-29 11:11:26 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, computer generated 1: 1.<BR/>Blindness: open label.<BR/>Duration: 26 weeks.<BR/>Design: parallel, naturalistic.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-30 17:08:58 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM IV).</P>
<P>N = 271.<BR/>Age: 18-65 years (mean about 38 years).<BR/>Gender: M and F.<BR/>History: duration of illness not reported, age at onset not reported.<BR/>Setting: community or hospital-based outpatient centre. .<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:29:43 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 10-30 mg/day (mean-18.7 mg). N = 284.<BR/>2. Standard care: olanzapine 5-20 mg/day (mean 12.5 mg); N = 75, risperidone 2-16 mg/day (mean-4.6 mg); N = 81, quetiapine100-800 mg/day (mean-386.8 mg); N = 110.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]">
<P>IAQ, Leaving the study early: any reason, adverse events, inefficacy.<BR/>Global state: CGI (data not usable) ASEX.<BR/>Quality of life: QLS, IWQoL-Lite, EQ-5D.<BR/>Adverse effects: at least one adverse effect, extrapyramidal adverse effects, cholesterol increase, fasting triglycerides abnormalities, glucose elevation, prolactin increase, weight change.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-30 17:06:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kinon-2004">
<CHAR_METHODS MODIFIED="2013-09-29 11:12:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random (1: 1), no further details.<BR/>Blindness: double, no further details.<BR/>Duration: 5 days.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:33:13 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, schizoaffective disorder or schizophreniform disorder.</P>
<P>N = 604.<BR/>Age 18-55 years.<BR/>Gender: male/female.<BR/>History: duration of illness not reported, acutely ill.<BR/>Setting: originally inpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:33:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 15-30 mg/day, mean 19.26 mg (SD 5.46). N = 298.<BR/>2. Olanzapine: 20 mg/day, mean 19.97 mg (SD 0.27). N = 306.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]">
<P>Agitation symptoms: PANSS-EC. <BR/>Leaving the study early: any reason, adverse events, inefficacy. <BR/>Global state: CGI. <BR/>Mental state: PANSS total score, BPRS. <BR/>Adverse effects: at least one adverse effect, cardiac effects (QTc), extrapyramidal adverse effects (use of antiparkinson medication, extrapyramidal symptom (BAS, SAS-modified), cholesterol increase, glucose elevation, prolactin increase, weight, <BR/>Other measures: GANI, DAI-10, ACES. </P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-30 17:06:31 +0100" MODIFIED_BY="[Empty name]">
<P>Lorazepam was used as required throughout the study. Data were not made available for other scales used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-28 17:35:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuang-2006">
<CHAR_METHODS MODIFIED="2013-09-28 17:34:32 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 17:34:51 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), BPRS of 35 or more.<BR/>N = 120.<BR/>Age: aripiprazole group: 18&#65374;60 years, mean = (32 ± 9) years, clozapine group: 18&#65374;60 years, mean = (31 ± 10) years.<BR/>Gender: aripiprazole group: 32 male, 24 female; clozapine group: 32 male, 24 female.<BR/>History: aripiprazole group: mean = (6 ± 2.1) months; clozapine group: mean = (5 ± 2.3) months. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 17:35:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (20 ± 5) mg/day. N = 60.<BR/>2. Clozapine: Dose range: 75-600 mg/day. Mean = (550 ± 50) mg/day. N = 60.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-28 17:35:10 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: BPRS score.</P>
<P>Leaving the study early.</P>
<P>Quality of life: GQOLI-74 (material life, physical health, mental health, social function).</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-24 15:36:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2006">
<CHAR_METHODS MODIFIED="2013-10-24 15:36:00 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:03:09 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 70.<BR/>Age: aripiprazole group: 22&#65374;43 years, mean = (32.83 ± 9. 42) years; risperidone group: 20&#65374;42 years, mean = (33. 64 ± 7. 26) years.</P>
<P>Gender: aripiprazole group: 18 male, 17 female; risperidone group: 20 male, 15 female.<BR/>History: aripiprazole group: 1&#65374;3 months, mean= (2.14 ± 0.87) months; risperidone group: 1&#65374;3 months, mean= (2.15 ± 0.97) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:05:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 35.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 35.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-24 15:36:16 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score. agitation-labelled as "adverse effect".</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-24 15:36:17 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-24 15:36:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2006a">
<CHAR_METHODS MODIFIED="2013-10-24 15:36:35 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:10:12 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 76.<BR/>Age: aripiprazole group: 18&#65374;59 years. mean = (8. 6 ± 8. 7) years; risperidone group: 20&#65374;58 years, mean = (29. 8 ± 9. 3) years.</P>
<P>Gender: aripiprazole group: 20 male, 18 female; risperidone group: 21 male, 17 female.<BR/>History: aripiprazole group: 1 month&#65374;13 years, mean = 6.5 years; risperidone group: 2 months&#65374;12 years, mean = 7.2 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:10:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (18.3 ± 4.2) mg/day. N=38.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.1 ± 1.2) mg/day. N=38.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-24 15:36:40 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score, anxiety- labelled as "adverse effect", excitement/agitation-labelled as "adverse effect".</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:39 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:12:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: not reported, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:11:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: mean = (28.9 ± 13.1) years; clozapine group: mean = (30.2 ± 12.5) years.</P>
<P>Gender: aripiprazole group: 22 male, 18 female; clozapine group: 23 male, 17 female.<BR/>History: aripiprazole group: mean = (7.3 ± 4.1) months; clozapine group: mean = (7.4 ± 4.2) months. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:11:49 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-60 mg/day. Mean = (21.1 ± 6.6) mg/day. N = 40.<BR/>2. Clozapine: Dose range: 75-500 mg/day. Mean = (301 ± 115.2) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:12:37 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects: extrapyramidal side-effects (akathisia, tremor, dystonia, spasmodic torticollis).</P>
<P>Quality of life: WHO-QOL-100.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:04:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007a">
<CHAR_METHODS MODIFIED="2013-09-29 11:04:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: unclear.<BR/>Duration: six months.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:13:20 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (25.1 ± 6.8) years; clozapine group: mean = (26.4 ± 6.2) years.<BR/>Gender: aripiprazole group: 13 male, 17 female; clozapine group: 15 male, 15 female.<BR/>History: 2 years or less. aripiprazole group: mean = (5.7 ± 4.3) months; clozapine group, mean= (6.5 ± 4.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:13:28 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 15-30 mg/day. Mean dose:not reported. N = 30.<BR/>2. Clozapine: Dose range: 200-350 mg/day. Mean dose:not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:13:33 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathology subscale score, anxiety - labelled as "adverse effect''.</P>
<P>Quality of life: WHOQOL100.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:14:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007b">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:14:00 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>
</P>
<P>Age: aripiprazole group: 18&#65374;50 years. mean = (24.4 ± 13.9) years; quetiapine group: 18-48 years, mean = (27.2 ± 8.4) years.</P>
<P>Gender: aripiprazole group: 17 male, 13 female; quetiapine group: 17 male, 13 female.<BR/>History: aripiprazole group: 3 months&#65374;5 years, mean= (2.8 ± 2.2) years; quetiapine group: 3 months&#65374;5 years, mean= (2.6 ± 2.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N=30.<BR/>2. Quetiapine: Dose range: 100-800 mg/day. Mean dose: not reported. N=30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:14:10 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, menstrual disorder, lactation, weight gain, EEG, ECG, blood routine, urine routine, hepatorenal function, use of benzhexol, benzodiazepine and propranolol (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:04:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007c">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:14:48 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 84.<BR/>Age: aripiprazole group: 15&#65374;62 years. mean = (29.4 ± 11.2) years; ziprasidone group: 18-60 years, mean = (28.3 ± 10.1) years.</P>
<P>Gender: aripiprazole group: 18 male, 24 female; ziprasidone group: 20 male, 22 female.<BR/>History: aripiprazole group: 1 month&#65374;12 years, mean = 5.6 years; ziprasidone group: 2 months&#65374;13 years, mean = 6.1 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:15:01 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (25 ± 5) mg/day. N = 42.<BR/>2. Ziprasidone: Dose range: 20-160 mg/day. Mean = (120 ± 40) mg/day. N = 42.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:04:52 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Leaving the study early: no patient.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, EEG, weight, use of alprazolam, propranolol and anticholinergic medication (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:16:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007d">
<CHAR_METHODS MODIFIED="2013-09-29 10:15:33 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: 1&#65374;2 weeks wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:15:54 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 120.<BR/>Age: aripiprazole group: 16&#65374;60 years. mean = (28. 4 ± 9. 1) years; risperidone group: 17&#65374;56 years, mean = (29. 6 ± 8. 3) years.</P>
<P>Gender: aripiprazole group: 28 male, 32 female; risperidone group: 46 male, 14 female.<BR/>History: aripiprazole group: mean = (2.3 ± 1.8) months; risperidone group: mean = (2.4 ± 1.6) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:16:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 60.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 60.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:16:49 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI-SI, CGI-GI.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score. agitation-labelled as "adverse effect".</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, renal function, PRL, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:18:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2009">
<CHAR_METHODS MODIFIED="2013-09-29 10:17:12 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:17:28 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 60.<BR/>Age: aripiprazole group: 15&#65374;50 years, mean = (26. 9 ± 10. 1) years, clozapine group: 15&#65374;45 years, mean = (25. 5 ± 9. 3) years.<BR/>Gender: aripiprazole group: 18 male, 12 female; clozapine group: 20 male, 10 female .<BR/>History: aripiprazole group: 2 months&#65374;10 years, mean = (7.1 ± 5.12) years; clozapine group: 2 months&#65374;13 years, mean = (7.8 ± 6.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:17:35 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Clozapine: Dose range: 50-475 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:18:00 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score,PANSS general pathological subscale score.</P>
<P>Adverse effects: TESS total score(no data), central nervous system (somnolence, dizziness, headache,insomnia), extrapyramidal side-effects (akathisia), gastrointestinal (constipation, salivate), weight gain, blood glucose increase, blood routine abnormal, change of ECG, tachycardia, appetite decrease.<BR/>
</P>
<P>Unable to use -<BR/>Adverse effects: Laboratory tests (urine routine, hepatorenal function), use of alprazolam, propranolol and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:19:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2009a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:19:04 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), BPRS total score of 20 or more.<BR/>N = 60.<BR/>
</P>
<P>Age: aripiprazole group: mean = (28.6 ± 6.49) years; risperidone group: mean = (29.13 ± 8.61) years.</P>
<P>Gender: aripiprazole group: 16 male, 14 female; risperidone group: 17 male, 13 female.<BR/>History: aripiprazole group: mean = (2.17 ± 4.82) years; risperidone group: mean = (3.22 ± 6.71) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:19:13 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose:not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose:not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:19:20 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: BPRS total score.</P>
<P>Adverse effects</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:20:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2009b">
<CHAR_METHODS MODIFIED="2013-09-29 10:19:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:20:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 15&#65374;45 years, mean = (25.3 ± 10.2) years; risperidone group: 17&#65374;50 years, mean = (28.3 ± 1.2) years.</P>
<P>Gender: aripiprazole group: 14 male, 16 female; risperidone group: 15 male, 15 female.<BR/>History: aripiprazole group: 1 month&#65374;2 years, mean = (1.1 ± 0.8) years; risperidone group: 2 months&#65374;2 years, mean = (1.2 ± 0.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:20:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (25.3 ± 5.1) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean = (3.9 ± 1.7) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:20:25 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:21:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-X-2007">
<CHAR_METHODS MODIFIED="2013-09-29 10:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: 3&#65374;7 days wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:21:08 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 71.<BR/>Age: aripiprazole group: mean = (38.1 ± 8.6) years; risperidone group: mean = (36.3 ± 10.2) years.</P>
<P>Gender: aripiprazole group: 25 male, 11 female; risperidone group: 22 male, 13 female.<BR/>History: aripiprazole group: mean = (6.4 ± 3.9) years; risperidone group: mean = (5.9 ± 4.0) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:21:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 36.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 35.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:21:30 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. agitation-labelled as "adverse effect".</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:22:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lian-2008">
<CHAR_METHODS MODIFIED="2013-09-29 10:21:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:22:13 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 86.<BR/>Age: aripiprazole group: 21&#65374;53 years, mean = 38.1 years; risperidone group: 23&#65374;56 years, mean = 37.6 years.</P>
<P>Gender: aripiprazole group: 27 male, 16 female; risperidone group: 30 male, 13 female.<BR/>History: aripiprazole group: 2 months&#65374;8 years, mean = 4.5 years; risperidone group: 2 months&#65374;10 years, mean = 4.6 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:22:28 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 43.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 43.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:22:37 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (excellent: &#8805; 60%, improved: &#8805; 40%, no effect: &lt; 40%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood and urine routines, liver function, ECG (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:23:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang-2008">
<CHAR_METHODS MODIFIED="2013-09-29 10:23:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: not reported, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:23:21 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 120.<BR/>Age: aripiprazole group 18&#65374;60 years, mean = (24. 9 ± 10. 7) years; risperidone group 18&#65374;58 years, mean = (26. 5 ± 9. 2) years.</P>
<P>Gender: aripiprazole group: 32 male, 28 female; risperidone group: 31 male, 29 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:23:38 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = 18.7 mg/day. N = 60.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean = 4.8 mg/day. N = 60.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:23:54 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score. agitation labelled as "adverse effect".</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, use of benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:25:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:24:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole: 15&#65374;45 years, mean = (25.3 ± 10.2) years; clozapine: 17&#65374;50 years, mean = (28.3 ± 1.2) years.<BR/>Gender: aripiprazole group: 13 male, 17 female; clozapine group: 14 male, 16 female .<BR/>History: aripiprazole group: 1 month &#65374;2 years, mean = (1.1 ± 0.8) years; clozapine group: 2 months &#65374;2 years, mean = (1.2 ± 0.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:24:46 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose:not reported. N = 30.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean dose:not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:24:52 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: Laboratory tests (urine routine), use of alprazolam, propranolol and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-29 10:25:00 +0100" MODIFIED_BY="[Empty name]">
<P>Efficacy and side effects of aripiprazole for first-episode schizophrenia</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:25:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2006a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:25:33 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 90.<BR/>Age: aripiprazole group: 18&#65374; 56 years, mean = (28 ± 4.6) years, risperidone group: 18&#65374;58 years, mean = (30.1 ± 5) years.</P>
<P>Gender: aripiprazole group: 26 male, 19 female; risperidone group: 23 male, 22 female.<BR/>History: aripiprazole group: 1 month&#65374;5 years, mean = (3.6 ± 2.1) years; risperidone group: 1 month&#65374;5.2 years, mean = (3.8 ± 2.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:25:50 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 45.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 45.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:25:54 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score. agitation/excitement labelled as "adverse effect".</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS score, blood routine, blood glucose, use of benzodiazepines, benzhexol (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:40 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:04:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2007">
<CHAR_METHODS MODIFIED="2013-09-29 11:04:28 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:26:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS score of 70 or more.<BR/>N = 68.<BR/>Age: aripiprazole group: 25&#65374;54 years, mean = (35.5 ± 9.8) years; clozapine group: 21&#65374;56 years, mean = (33.6 ± 8.9) years.<BR/>Gender: aripiprazole group: 19 male, 15 female; clozapine group: 21 male, 13 female .<BR/>History: aripiprazole group: 5.5&#65374; 21 years; clozapine group: 5.3 &#65374;23 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:26:47 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (18 ± 4.2) mg/day. N = 34.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean = (425 ± 5.5) mg/day. N = 34.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:26:53 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate(recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score,PANSS general pathological subscale score.</P>
<P>Adverse effects.<BR/>
</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score(no data); use of benzodiazepines, benzhexol, or propranolol medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:28:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2008">
<CHAR_METHODS MODIFIED="2013-09-29 10:27:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:27:33 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 62.<BR/>Age: aripiprazole group: mean = (26.68 ± 5.69) years; clozapine group: mean = (26.5 ± 5.58) years.<BR/>Gender: aripiprazole group: 18 male, 13 female; clozapine group: 20 male, 11 female .<BR/>History: aripiprazole group: 1&#65374;12 months, mean = (6.35 ± 6.49) months; clozapine group: 1&#65374;12 months, mean = (6.05 ± 5.76) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:27:44 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose:not reported. N = 31.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean dose:not reported. N = 31.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:28:01 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:28:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2008a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 66.<BR/>Age: aripiprazole group: 17&#65374;65 years, mean = (32.5 ± 6.8) years; ziprasidone group: 18&#65374;63 years, mean = (30.4 ± 7.7) years.</P>
<P>Gender: aripiprazole group: 19 male, 14 female; ziprasidone group: 18 male, 15 female.<BR/>History: aripiprazole group: 1.5&#65374;22 months, mean = (5.1 ± 1.9) months; ziprasidone group: 1&#65374;20 months, mean = (4.5 ± 2.1) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:28:39 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (13.12 ± 4.27) mg/day. N = 33.<BR/>2. Ziprasidone: Dose range: 20-80 mg/day. Mean = (38.71 ± 12.63) mg/day. N = 33.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:28:56 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. SANS total score score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Mental state: SANS subscale scores - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:29:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2008b">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:29:22 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 78.<BR/>Age: mean = (33 ± 11) years.</P>
<P>Gender: 33 male, 45 female.<BR/>History: 1 month&#65374;20 years, mean = (13 ± 8.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:29:30 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (15.4 ± 5.8) mg/day.<BR/>2. Risperidone: Dose range: 3-6mg/day. Mean = (3.8 ±1.5) mg/day.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:29:35 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>PANSS subscale scores - unvalidated subscales.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:31:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2008c">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:30:22 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 63.<BR/>Age: aripiprazole group: mean = (27.5 ± 9.179) years; risperidone group: mean = (28.29 ± 11.25) years.</P>
<P>Gender: aripiprazole group: 12 male, 20 female; risperidone group: 14 male, 17 female.<BR/>History: aripiprazole group: 1&#65374;20 years, mean = (4. 31 ± 6. 214) years; risperidone group: 1&#65374;29 years, mean = (2.87 ± 2.952) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:30:36 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (21.67 ± 1.12) mg/day. N = 37.<BR/>2. Risperidone: Dose range: 1-6mg/day. Mean = (4.56 ± 1.24) mg/day. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:31:02 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-79%, improved: 30%-49%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, hepatorenal function, use of benzodiazepines, propranolol and other medicine (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:31:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2008d">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, lottery.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:31:24 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 72.<BR/>Age: aripiprazole group: 16&#65374;49 years, mean = (33.27 ± 8.21) years; risperidone group: 15&#65374;42 years, mean = (30.94 ± 8.77) years.</P>
<P>Gender: aripiprazole group: 20 male, 17 female; risperidone group: 19 male, 16 female.<BR/>History: aripiprazole group: 0.25&#65374;3 years, mean = (1.54 ± 0.74) years; risperidone group: 0.25&#65374;2.5 years, mean = (1.98 ± 0.81) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:31:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean= (21.67 ± 1.12) mg/day. N = 37.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean= (4.56 ± 1.24) mg/day. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:31:55 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &gt; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. WAI-RC (Wechsler adult intelligence scale) score. WMS (Wechsler memory scale ) score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Cognitive functioning: WMS subscale scores - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:35:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:35:14 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 68.<BR/>Age: aripiprazole group: mean = (26.1 ± 7.5) years; olanzapine group: mean = (27.4 ± 8.4) years.</P>
<P>Gender: aripiprazole group: 18 male, 16 female; olanzapine group: 17 male, 17 female.<BR/>History: aripiprazole group: mean = (6.9 ± 3.4) years; olanzapine group: mean = (6.5 ± 3.6) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:35:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (19.7 ± 5.3) mg/day. N = 34.<BR/>2. Olanzapine: Dose range: 10-20 mg/day. Mean = (15.4 ± 4.5) mg/day. N = 34.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score.</P>
<P>Quality of life: GQOLI- 74 total score, GQOLI- 74 material life score, GQOLI- 74 physical health score, GQOLI- 74 mental health score, GQOLI- 74 social function score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:36:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2009a">
<CHAR_METHODS MODIFIED="2013-09-29 10:36:00 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:36:04 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: not reported.</P>
<P>Gender: aripiprazole group: 16 male, 14 female; risperidone group: 17 male, 13 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:36:20 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:36:42 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:37:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2009b">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:37:33 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 120.<BR/>
</P>
<P>Age: aripiprazole group:16&#65374;60 years. mean = (28.4 ± 7.9) years; quetiapine group: 18&#65374;63 years, mean = (29 ± 8.5) years.</P>
<P>Gender: aripiprazole group: 28 male, 32 female; quetiapine group: 30 male, 30 female.<BR/>History: aripiprazole group: mean = (2.3 ± 1.5) years; quetiapine group: mean = (2.3 ± 1.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:37:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 60.<BR/>2. Quetiapine: Dose range: 50-600 mg/day. Mean dose: not reported. N = 60.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:37:51 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 20%-50%, no effect: &lt; 20%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, headache, insomnia, somnolence, nausea/vomiting, weight gain, extrapyramidal side-effects, blood routine, urine routine, hepatorenal function, use of benzodiazepines and propranolol (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:39:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2010">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: not reported.<BR/>Design: trial with three arms.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:38:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 112.<BR/>Age: not reported.</P>
<P>Gender: not reported.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:38:57 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (19.83 ± 6.50) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 2-6.5 mg/day. Mean = (3.82 ± 0.86) mg/day. N = 54.</P>
<P>3.Clozapine: Dose range: 150-500 mg/day. Mean = (265.18 ± 82.59) mg/day. N = 28.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &gt; 75%, markedly improved: 50%- 5%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Adverse effects.</P>
<P>Cost-effect analysis.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, ECG, blood glucose and serum lipids, use of benzodiazepines and other medicine (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:40:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lou-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table method.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:39:59 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 45.<BR/>Age: aripiprazole group: 50&#65374;67 years, mean = (56.1 ± 5.9) year, risperidone group: 49&#65374;70 years, mean = (54.6 ± 6.1) years.</P>
<P>Gender: aripiprazole group: 11 male, 10 female; risperidone group: 11 male, 13 female.<BR/>History: aripiprazole group:5&#65374;14 years, mean = (10.3 ± 2.6) years; risperidone group: 3&#65374;12 years, mean = (12.1 ± 2.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:40:09 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 21.<BR/>2. Risperidone: Dose range: 0.5-4 mg/day. Mean dose: not reported. N = 24.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:40:14 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS score, ECG, use of benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:41:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luo-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:40:45 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 70.<BR/>
</P>
<P>Age: aripiprazole group: mean = (28. 5 ± 8. 2) years; quetiapine group: mean = (27. 1 ± 7. 6) years.</P>
<P>Gender: aripiprazole group: 19 male, 16 female; quetiapine group: 18 male, 17 female.<BR/>History: aripiprazole group: mean =(1.2 ± 0.7) years; quetiapine group: mean =(1.1 ± 0.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:40:55 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 35.<BR/>2. Quetiapine: Dose range: 200-800 mg/day. Mean dose: not reported. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:41:00 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:41:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luo-2009">
<CHAR_METHODS MODIFIED="2013-09-29 10:41:15 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:41:32 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: 18&#65374;56 years, aripiprazole group: mean = (31.6 ± 7.8&#65289;years; risperidone group: mean = (32.2 ± 7.4&#65289;years.</P>
<P>Gender: aripiprazole group: 23 male, 17 female; risperidone group: 21 male, 19 female.<BR/>History: 1 month&#65374;26 years, aripiprazole group: mean = (6.2 ± 5.8&#65289;years; risperidone group: mean = (6.5 ± 5.6&#65289;years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:41:45 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (20.4 ± 3.2)mg/d. N = 40.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.2 ± 2.3)mg/d. N = 40.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:41:53 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effect.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, EPS, tachycardia, menstrual changes, etc. and use of benzhexol, benzodiazepine, propranolol (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:42:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lv-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:42:29 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80; complete study N = 77.<BR/>Age: aripiprazole group: 18&#65374; 46 years, mean = (28. 8 ± 7. 50) years, risperidone group: 19&#65374;45 years, mean = (28. 6 ± 16. 5) years.</P>
<P>Gender: aripiprazole group: 21 male, 18 female; risperidone group: 20 male, 18 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:42:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (18. 6 ± 6. 8) mg/day. N = 40.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4. 3 ± 1. 8) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:42:46 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score. agitation/excitement labelled as "adverse effect".</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS score, use of benzodiazepines, anticholinergic drug (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:05:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2009">
<CHAR_METHODS MODIFIED="2013-09-29 10:43:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.</P>
<P>Blindness: unclear.<BR/>Duration: 1 week wash-out period + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:43:55 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more, Excited subscales (PEC) of 14 or more.<BR/>N = 89.<BR/>Age: aripiprazole group: mean = (30.93 ± 8.21) years; olanzapine group: mean = (31.29 ± 7.38) years.</P>
<P>Gender: aripiprazole group: 25 male, 15 female; olanzapine group: 22 male, 13 female.<BR/>History: aripiprazole group: mean = (4.52 ± 3.81) years; olanzapine group: mean = (4.73 ± 4.71) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:44:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (19.54 ± 8.35) mg/day. N = 45.<BR/>2. Olanzapine: Dose range: 5-20 mg/day. Mean = (15.36 ± 8.21) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:05:00 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-75%, no effect: &lt; 50%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score,PANSS general psychogenic pathological subscale score. SANS total score. Cognitive function total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Mental state: SANS subscale score - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:45:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2009a">
<CHAR_METHODS MODIFIED="2013-09-29 10:44:38 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:44:44 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 98.<BR/>Age: 18&#65374;55 years, mean = (32 ± 18.79) years.</P>
<P>Gender: 43 male, 55 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:45:01 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 49.<BR/>2. Risperidone: Dose range: 1-5 mg/day. Mean dose: not reported. N = 49.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:45:38 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effect.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, tremor, dry mouth, dystonia, use of benzhexol, benzodiazepine and propranolol (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:46:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mai-2005">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:46:15 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 72.<BR/>Age: aripiprazole group: 18&#65374;60 years, mean = (27. 8 ± 8. 9) year, risperidone group: 17&#65374;60 years, mean = (28. 1 ± 8. 5) years.</P>
<P>Gender: aripiprazole group: 19 male, 17 female; risperidone group: 18 male, 18 female.<BR/>History: aripiprazole group:1 month&#65374;9 years, mean= (4.7 ± 2.5) years; risperidone group: 1 month&#65374;10 years, mean = (4.8 ± 2.9) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:46:29 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (23.2 ± 3.3) mg/day. N = 36.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.1 ± 1.6) mg/day. N = 36.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:46:33 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS score, use of benzodiazepines, anticholinergic drug (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:47:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mao-2010">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:47:13 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 70.<BR/>Age: aripiprazole group: mean = (28.7 ± 9.9) years; olanzapine group: mean = (30.2 ± 8.7) years.</P>
<P>Gender: aripiprazole group: 19 male, 16 female; olanzapine group: 18 male, 17 female.<BR/>History: aripiprazole group: mean = (6 ± 4.8) years; olanzapine group: mean = (6.3 ± 3.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:47:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (20.5 ± 5.2) mg/day. N = 35.<BR/>2. Olanzapine: Dose range: 10-20 mg/day. Mean = (14.5 ± 4.6) mg/day. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:47:59 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychopathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Mental state: PANSS cognitive subscale score - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:12:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McQuade-2004">
<CHAR_METHODS MODIFIED="2013-09-29 11:12:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: double, no further details.<BR/>Duration: 26 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:49:42 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: (DSM-IV) schizophrenia disorganised (n = 17), paranoid (n = 271), residual (n = 3) or undifferentiated (n = 26), in acute relapse and hospitalised. PANSS total score of 60 or more.<BR/>N = 317.<BR/>Age: &gt; 17 years (mean = 38.4 years).<BR/>Gender: 229 M, 88 F.<BR/>History: duration of illness not reported, age at first hospitalisation mean = 24.5 years.<BR/>Setting: originally inpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:49:01 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: flexible dose. Allowed dose range: 15-30 mg/day. Mean dose: 25.1 mg/day. N = 156.<BR/>2. Olanzapine: flexible dose. Allowed dose range: 10-20 mg/day. Mean dose: 16.5 mg/day. N = 161.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early: any reason, adverse events, inefficacy.<BR/>Global state: CGI.<BR/>Mental state: PANSS total score.<BR/>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: use of antiparkinson medication (no data), metabolic syndrome (&gt; 70% incomplete).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:50:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mu-2008">
<CHAR_METHODS MODIFIED="2013-09-29 10:49:57 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:50:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 100.<BR/>Age: 25&#65374;45 years.</P>
<P>Gender: 100 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:50:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (25.2 ± 3.2) mg/day. N = 50.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.8 ± 0.5) mg/day. N = 50.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:50:33 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychopathological subscale score.</P>
<P>Lveaing the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:51:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mu-2010">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Simple randomisation.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:51:11 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), BPRS total score of 35 or more.<BR/>N = 258, complete study: N=257.<BR/>
</P>
<P>Age: aripiprazole group: mean = (38.12 ± 10.34) years; risperidone group: mean = (39.56 ± 10.67) years.</P>
<P>Gender: aripiprazole group: 58 male, 71 female; risperidone group: 61 male, 66 female.<BR/>History: aripiprazole group: mean = (6.92 ± 4.18) years; risperidone group: mean = (7.48 ± 4.37) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:51:24 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (22.5 ± 3.6) mg/day. N = 129.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.7 ± 1.7) mg/day. N = 129.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: BPRS total score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>BPRS and TESS subscale scores - unvalidated subscales.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:52:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pan-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: two weeks wash-out period and six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:52:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;60 years. mean = (26.8 ± 8.7) year, risperidone group: 17&#65374;60 years, mean = (27.1 ± 8.5) years.</P>
<P>Gender: aripiprazole group: 13 male, 17 female; risperidone group: 12 male, 18 female.<BR/>History aripiprazole group:1 month&#65374;7 years, mean = (4.7 ± 3.5) years; risperidone group: 1 month&#65374;8 years, mean = (4.8 ± 3.7) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:52:39 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (25.2 ± 3.3) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4 ± 1.5) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:52:51 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>Adverse effects (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:53:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peng-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:53:18 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 35 or more.<BR/>N = 85.<BR/>Age: aripiprazole group: 17&#65374;56 years. mean = (31. 7 ± 10. 8) years; quetiapine group, 17&#65374;57 years, mean = (29. 5 ± 11. 3) years.</P>
<P>Gender: aripiprazole group: 24 male, 20 female; quetiapine group: 21 male, 20 female.<BR/>History: aripiprazole group: mean = (2.7 ± 1.5) months; clozapine group: mean = (2.7 ± 1.9) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:53:25 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 44.<BR/>2. Quetiapine: Dose range: 100-600 mg/day. Mean dose: not reported. N = 41.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:53:48 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, EEG, liver function, use of benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:54:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peng-2007a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:54:25 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 46.<BR/>Age: aripiprazole group: 18&#65374;50 years, mean = (22.35 ± 7.15) years; clozapine group: 16&#65374;49 years, mean = (23.25 ± 9.75) years.</P>
<P>Gender: aripiprazole group: 23 male, 11 female; clozapine group: 23 male, 11 female.<BR/>History: aripiprazole group: 1&#65374;36 months, mean = (22.55 ± 12.45) months; clozapine group: 1&#65374;30 months, mean = (22.25 ± 11.25) months. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:54:43 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 23.<BR/>2. Clozapine: Dose range: 50-400 mg/day. Mean dose: not reported. N = 23 .</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805;80%, markedly improved: &#8805;50%, improved: &#8805;25%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychopathological subscale score.</P>
<P>Adverse events: TESS total score.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:42 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:12:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Potkin-2003">
<CHAR_METHODS MODIFIED="2013-09-29 11:12:52 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: double, identical capsules.<BR/>Duration: four weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:55:41 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: (DSM-IV) schizophrenia (n = 289) or schizoaffective disorder (n = 115), hospitalised due to an acute relapse, response to previous antipsychotic treatment other than clozapine, PANSS of 60 or more.<BR/>N = 404.<BR/>Age: 18-65 years (mean = 38.9 years).<BR/>Gender: 283 M, 121 F.<BR/>History: duration of illness not reported, age at onset not reported.<BR/>Setting: inpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:55:58 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: fixed dose: 20 mg/day. N = 101.<BR/>2. Aripiprazole: fixed dose: 30 mg/day. N = 101.<BR/>3. Risperidone: fixed dose: 6 mg/day. N = 99.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early: any reason, adverse events, inefficacy.<BR/>Global state: CGI.<BR/>Mental state: PANSS total score, PANSS positive sub score, PANSS negative sub score.<BR/>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-29 10:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Note: There is a placebo group (n = 103), which is not relevant for this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:58:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pu-2007">
<CHAR_METHODS MODIFIED="2013-09-29 10:57:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:58:07 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (27.43 ± 7.17) years; risperidone group: mean = (27.06 ± 2.33) years.</P>
<P>Gender: aripiprazole group: 32 female; risperidone group: 32 female.<BR/>History: aripiprazole group: total = (2.2 ± 1.5) years; risperidone group: total = (2.12 ± 1.61) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:58:32 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 15-30 mg/day. Mean = (19.50 ± 5.14) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 3-6 mg/day. Mean = (4.03 ± 0.87) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: BPRS total score, PANSS score decreased rate.</P>
<P>Change of BMI, PRL.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 10:59:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qian-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 10:59:13 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS more than 60 years.<BR/>N = 80.<BR/>Age: aripiprazole group: 16&#65374;47 years, mean = (25 ± 3.1) years; olanzapine group: 18&#65374;43 years, mean = (26 ± 2.7) years.</P>
<P>Gender: 80 female.<BR/>History: aripiprazole group: mean= (1.2 ± 2.7) years; olanzapine group: mean = (1.3 ± 0.5) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 10:59:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (20 ± 5) mg/day . N = 40.<BR/>2. Olanzapine: Dose range: 10-20 mg/day. Mean = (20 ± 5) mg/day. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 10:59:37 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-75%, no effect: &lt; 50%).</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, liver function, blood pressure change, blood glucose change (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:05:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qin-2008">
<CHAR_METHODS MODIFIED="2013-09-29 11:00:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period and eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:00:13 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 21&#65374;45 years, mean = (32.1 ± 7.2) years; risperidone group: 24&#65374;53 years, mean = (35.2 ± 5.9) years.</P>
<P>Gender: aripiprazole group: 18 male, 12 female; risperidone group: 17 male, 13 female.<BR/>History: aripiprazole group: 5&#65374;14 years; risperidone group: 5&#65374;16 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:00:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:05:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, liver function, blood and urine routines, use of benzodiazepines, propranolol, and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:01:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qu-2009">
<CHAR_METHODS MODIFIED="2013-09-29 11:01:33 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:01:41 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-5). PANSS of 60 or more.<BR/>N = 120.<BR/>Age: 19&#65374;64 years. aripiprazole group: mean = (31.6 ± 7.8&#65289;years; risperidone group: mean = (32.2 ± 7.4&#65289;years.</P>
<P>Gender: aripiprazole group: 40 male, 20 female; risperidone group: 36 male, 24 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:01:52 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -</P>
<P>Quality of life: GQOLI - 74 score (no data).<BR/>Adverse effects: anxiety, EPS, somnolence, ECG, mouth dry, liver function, use of benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:17:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shan-2008">
<CHAR_METHODS MODIFIED="2013-09-29 11:16:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:17:06 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean= (43.37 ± 8.85) years; risperidone group: 17-59 years, mean = (42.52 ± 9.85) years.</P>
<P>Gender: aripiprazole group: 16 male, 14 female; risperidone group: 15 male, 15 female.<BR/>History: aripiprazole group: mean = (10.46 ± 4.65) years; risperidone group: mean = (11.35 ± 3.28) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:17:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:17:32 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: &#8805;50%,</P>
<P>improved: &#8805; 30%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and other medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:49:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shuai-2008">
<CHAR_METHODS MODIFIED="2013-09-29 11:17:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:18:10 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 84.<BR/>Age: aripiprazole group: 19&#65374;52 years, mean = (30 ± 6) years; risperidone group: 18&#65374;55 years, mean = (32 ± 7) years.</P>
<P>Gender: aripiprazole group: 19 male, 23 female; risperidone group: 21 male, 21 female.<BR/>History: aripiprazole group: 1&#65374;9 months, mean = (3.4 ± 2.6) months; risperidone group: 2&#65374;9 months, mean = (4.3 ± 2.9) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:18:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (15 ± 5) mg/day. N = 42.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.2± 1.8) mg/day. N = 42.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:49:38 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: agitation.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, use of benzodiazepines and other medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:19:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Song-2008">
<CHAR_METHODS MODIFIED="2013-09-29 11:18:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:18:58 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 20&#65374;60 years, mean = (45.5 ±3.05) years; risperidone group: 19&#65374;60 years, mean = (43.7 ± 3.3) years.<BR/>Gender: 60 female .<BR/>History: aripiprazole group: mean = (8.4 ± 1.5) years; risperidone group: mean = (8.5 ± 1.4) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:19:08 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (15.2 ± 5.1) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean = (4.12 ± 1.43) mg/day. N = 30<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:19:21 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>Adverse effects: (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:19:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Song-2009">
<CHAR_METHODS MODIFIED="2013-09-29 11:19:35 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:19:39 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 17&#65374;62 years; risperidone group: 16&#65374;60 years.</P>
<P>Gender: aripiprazole group: 10 male, 20 female; risperidone group: 21 male, 9 female.<BR/>History: aripiprazole group: 1 month&#65374;10 years; risperidone group: 1.5 months&#65374;13 years.</P>
<P>Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:19:49 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-8 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzhexol and benzodiazepines.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:51:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Song-2010">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:20:24 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS more than 60.<BR/>N = 80.<BR/>Age: aripiprazole group: 19&#65374;56 years, mean = (27.6 ± 4.3) years; olanzapine group: 18&#65374;58 years, mean = (28.2 ± 3.6) years.</P>
<P>Gender: aripiprazole group: 20 male, 20 female; olanzapine group: 20 male, 20 female.<BR/>History: aripiprazole group: 5 months&#65374;4 years, mean = (3.1 ± 1.9) years; olanzapine group: 3 months&#65374;4 years, mean = (3.5 ± 1.1) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:20:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 40.<BR/>2. Olanzapine: Dose range: 5-20 mg/day. Mean dose: not reported. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:51:02 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI - SI.</P>
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, excitement, insomnia, myotonia, akathisia, tremor, use of benzodiazepines (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:21:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Su-2007">
<CHAR_METHODS MODIFIED="2013-09-29 11:20:54 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient , China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:21:08 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 78.<BR/>Age: aripiprazole group: 18 &#65374;60 years, mean = (27. 6 ± 8. 5) years; risperidone group: 15 &#65374;65 years, mean = (28. 7 ± 8. 4) years.</P>
<P>Gender: aripiprazole group: 23 male, 18 female; risperidone group: 25 male, 14 female.<BR/>History: aripiprazole group: 6 months &#65374;6 years; risperidone group: 1 month &#65374;10 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:21:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 39.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 39.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:21:33 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:22:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Su-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week washout + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:21:55 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS more than 60.<BR/>N = 100.<BR/>Age: aripiprazole group: 17&#65374;55 years, mean = (28.5 ± 3.5) years; olanzapine group: 18&#65374;56 years, mean = (28.2 ± 4.5) years.</P>
<P>Gender: aripiprazole group: 20 male, 30 female; olanzapine group: 20 male, 30 female.<BR/>History: aripiprazole group: 7 months&#65374;4 years, mean = (2.5 ± 2.6) years; olanzapine group: 6 months&#65374;5 years, mean = (2.5 ± 1.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:22:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 50.<BR/>2. Olanzapine: Dose range: 5-20 mg/day. Mean dose: not reported. N = 50.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:22:11 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: 75&#8805; %, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%). CGI-SI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychopathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, lactation, menstrual disorders, excitement, insomnia, myotonia, akathisia, tremor, use of benzodiazepines (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:23:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, stratified random.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:22:43 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: 18&#65374;47 years. mean = (27.1 ± 3.4) years; risperidone group: 19&#65374;48 years, mean = (26.3 ± 3.8) years.</P>
<P>Gender: aripiprazole group: 24 male, 16 female; risperidone group: 23 male, 17 female.<BR/>History: aripiprazole group: 5&#65374;14 months, mean = (7.4 ± 4.6) months; risperidone group: 2&#65374;16 months, mean = (7.3 ± 4.7) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:22:55 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 40.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:23:15 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Mental state: PANSS subscale score decreased rate - unvalidated subscales.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:24:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:23:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 84.<BR/>Age: 18&#65374;60 years, aripiprazole group: mean = (27.3 ± 6.68) years; risperidone group: mean = (26.8 ± 7.32) years.</P>
<P>Gender: aripiprazole group: 23 male, 19 female; risperidone group: 24 male, 18 female.<BR/>History: &lt; 2 years, aripiprazole group: mean = (1.2 ± 0.77) years; risperidone group: mean = (1.1 ± 0.84) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:23:50 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (19.32 ±6.94) mg/ day. N = 42.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.25 ±1.7) mg/ day. N = 42.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:24:02 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of anticholinergic medicine and benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:24:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2009a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:24:41 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>
</P>
<P>Age: aripiprazole group: 17&#65374;50 years. mean = (27. 5 ± 7. 9) years; quetiapine group: 18&#65374;51 years, mean = (26. 7 ± 8. 4) years.</P>
<P>Gender: aripiprazole group: 23 male, 21 female; quetiapine group: 22 male, 22 female.<BR/>History: aripiprazole group: mean = (4. 1 ± 2.7) years; quetiapine group: mean = (4. 5± 2. 9) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean= (11. 6±4. 6) mg/day. N=30.<BR/>2. Quetiapine: Dose range: 50-600 mg/day. Mean= (407±65) mg/day. N=30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:24:53 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score and use of benzodiazepine (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-30 17:09:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tandon-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: open label. <BR/>Duration: 8 weeks. <BR/>Design: prospective, parallel group. <BR/>Location: multicentric in USA. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-30 17:09:22 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: Schizophrenia or schizoaffective disorder (DSM IV), required initiation of antipsychotics, antipsychotic switch clinically appropriate.</P>
<P>N = 1599.<BR/>Age: 18-75 years.<BR/>History: duration of illness not reported, age at onset not reported.<BR/>Setting: Outpatients.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:26:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 10 mg-30 mg/day (mean 19.9 mg/day); N = 1295.<BR/>2. Other antipsychotic: recommended dose; N = 304.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: CGI-I. <BR/>Adverse effects: At least one adverse effect, extrapyramidal adverse effects, gastrointestinal disorders, sleep disturbances. <BR/>Others: POM. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Primary goal was evaluating the effectiveness of aripiprazole in general psychiatric outpatient practice setting. The other antipsychotic treatment group was primarily included for interpreting the safety data and not for direct comparison. Unable to use data from CGI-I and POM.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:28:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tang-2006">
<CHAR_METHODS MODIFIED="2013-09-29 11:27:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: simple randomisation.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:27:31 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 72.<BR/>Age: aripiprazole group: 18&#65374;61 years, mean = (31.3 ± 6.2) years; risperidone group: 16&#65374;60 years, mean = (30.8 ± 6.1) years.</P>
<P>Gender: aripiprazole group: 37 female; risperidone group: 35 female.<BR/>History: aripiprazole group: 1 month&#65374;4.5 years; risperidone group: 1 month&#65374;4.6 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:27:48 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (10 ± 5.22) mg/day. N = 37.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.5 ± 0.81) mg/day. N = 35.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:28:00 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines, propranolol and benzhexol (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:49:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tang-2007">
<CHAR_METHODS MODIFIED="2013-09-29 11:28:15 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;63 years, mean = (29.7 ± 12.5) years; risperidone group: 18&#65374;62 years, mean = (29.5 ± 11.4) years.</P>
<P>Gender: aripiprazole group: 16 male, 14 female; risperidone group: 18 male, 12 female.<BR/>History: aripiprazole group: mean = (3 ± 1.7) years; risperidone group: mean = (3 ± 2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:28:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (23. 3 ± 3. 2) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4. 6 ± 2. 4) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:49:45 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, EEG, use of benzodiazepines and other medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:29:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tang-2010">
<CHAR_METHODS MODIFIED="2013-09-29 11:29:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: simple randomisation.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:29:11 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 78.<BR/>Age: aripiprazole group: 18&#65374;59 years. mean = (28.3 ± 6.2) years; risperidone group: 18&#65374;58 years, mean = (27.8 ± 6.1) years.</P>
<P>Gender: aripiprazole group: 18 male, 20 female; risperidone group: 19 male, 21 female.<BR/>History: aripiprazole group: 1 month&#65374;4.5 years; risperidone group: 1 month&#65374;4.6 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:29:35 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (10 ± 5.22) mg/day. N = 38.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.3 ± 0.81) mg/day. N = 40.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:29:46 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score. agitation-labelled as "adverse effect".</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and other medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:30:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tang-2010a">
<CHAR_METHODS MODIFIED="2013-09-29 11:30:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:30:27 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 70.<BR/>Age: 18&#65374;65 years, aripiprazole group: mean = (28.5 ± 7.3) years; risperidone group: mean = (30.1 ± 8.9) years.</P>
<P>Gender: aripiprazole group: 18 male, 17 female; risperidone group: 20 male, 15 female.<BR/>History: aripiprazole group: mean = (2.9 ± 2.4) years; risperidone group: mean = (3.3 ± 2.9) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:30:39 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 35.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 35.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:30:44 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, insomnia, anxiety, nausea, endocrine, weight gain, headache, dizziness, use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:32:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tao-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: four arms intervention.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:31:30 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 70 or more.<BR/>N = 360.<BR/>Age: aripiprazole group: mean = (30. 72 ± 11. 59) years; risperidone group: mean = (32. 51 ± 14. 30) years; quetiapine group: mean = (35. 53 ± 14. 23) years; ziprasidone group: mean = (26. 03 ± 7. 23) years.<BR/>Gender: aripiprazole group: 22 male, 68 female; risperidone group: 43 male, 47 female; quetiapine group: 4 male, 86 female; ziprasidone group: 65 male, 25 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:31:58 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose:not reported. N = 90.<BR/>2. Risperidone: Dose range: 2-5 mg/day. Mean dose:not reported. N = 90.</P>
<P>3.Quetiapine: Dose range: 200-600 mg/day. Mean dose:not reported. N = 90.</P>
<P>4.Ziprasidone: Dose range: 40-80 mg/day. Mean dose:not reported. N = 90.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:32:04 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:33:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tong-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, stratified random.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:32:39 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 60 or more.<BR/>N = 68; complete study: N = 50.<BR/>Age: aripiprazole group: mean = (41 ± 19) years; risperidone group: mean = (36 ± 20) years.</P>
<P>Gender: aripiprazole group: 11 male, 14 female; risperidone group: 8 male, 17 female.<BR/>History: aripiprazole group: mean = (3.4 ± 6.7) months; risperidone group: mean = (2.9 ± 5.7) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:32:54 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean = (17 ± 6) mg/day. N = 36.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean = (4 ± 1) mg/day. N = 32.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:33:09 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: GAS score (recovery: &gt; 80%, markedly improved: &gt; 70%, improved: &gt; 60%, no effect: &#8806; 60%).</P>
<P>Mental state:BPRS total score, SANS total score</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>
</P>
<P>Mental state: BPRS &amp; SANS subscale scores are not reported, as these subscale scores are unvalidated.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:49:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tu-2009">
<CHAR_METHODS MODIFIED="2013-09-29 11:35:10 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:35:30 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 68.<BR/>Age: aripiprazole group: 18~59 years, mean = (25 ± 11) years; risperidone group: 20~56 years, mean = (28 ± 10) years.</P>
<P>Gender: aripiprazole group: 27 male, 8 female; risperidone group: 23 male, 10 female.<BR/>History: aripiprazole group: mean = (2.9 ± 4) years; risperidone group: mean = (2.1 ± 3.6) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:35:38 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 35.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose:not reported. N = 33.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:49:53 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: CGI scale: markedly improved, improved, slight improved, no effect.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:36:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2005">
<CHAR_METHODS MODIFIED="2013-09-29 11:36:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Location: outpatient and inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:36:31 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (27 ± 9) years; clozapine group: mean = (28 ± 10) years.<BR/>Gender: aripiprazole group: 14 male, 17 female; clozapine group: 15 male, 14 female .<BR/>History: aripiprazole group: 1&#65374;11 months, mean = (7.3 ± 4.7) months; clozapine group: 1&#65374;12 months, mean = (7.7 ± 4.5) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:36:42 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 31.<BR/>2. Clozapine: Dose range: 50-270.3 mg/day. Mean dose: not reported. N = 29.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:36:52 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect or deteriorate: &lt; 25%).</P>
<P>Mental state: PANSS total score. anxiety and agitation, as binary outcomes.</P>
<P>Adverse effects.<BR/>
</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score (no data); Laboratory tests (hepatorenal function, glucose, electrolyte) (unclear data), weight and ECG (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:38:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006">
<CHAR_METHODS MODIFIED="2013-09-29 11:37:59 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:38:17 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 64.<BR/>Age: aripiprazole group: 15&#65374;50 years, mean = (24.4 ± 6.8) years; clozapine group: 18&#65374;40 years, mean = (25.5 ± 9.3) years.<BR/>Gender: aripiprazole group: 18 male, 14 female; clozapine group: 21 male, 11 female.<BR/>History: aripiprazole group: 1&#65374;60 months, mean = (24.7 ± 13.9) months; clozapine group: 1&#65374;60 months, mean = (25 ± 14) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose:not reported. N=32.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean dose:not reported. N=32.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:38:27 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%- 80%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects: TESS total score, central nervous system (somnolence), ECG abnormal, liver function.<BR/>
</P>
<P>Unable to use -<BR/>Adverse effects: gastrointestinal (dry mouth, constipation), blurred vision, weight gain and EEG abnormal (unclear data). blood and urine routine, blood pressure (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:39:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006a">
<CHAR_METHODS MODIFIED="2013-09-29 11:38:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:39:01 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (38.7 ± 8.47) years; clozapine group: mean = (35.56 ± 3.78) years.<BR/>Gender: aripiprazole group: 16 male, 14 female; clozapine group: 14 male, 16 female.<BR/>History: aripiprazole group: 1 month&#65374;10 years, mean = (12.6 ± 8.38) months; clozapine group: 3 months&#65374;9 years, mean = (12.15 ± 7.22) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose:not reported. N = 30.<BR/>2. Clozapine: Dose range: 50-400 mg/day. Mean dose:not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:39:13 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score,PANSS general psychopathological subscale score. anxiety - labelled as "adverse effect".</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, hepatorenal function (no data) .<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:39:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006b">
<CHAR_METHODS MODIFIED="2013-09-29 11:39:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:39:50 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;60 years. mean = (26.2 ± 7.5) years; risperidone group: 18-60 years, mean = (27.1 ± 8.5) years.</P>
<P>Gender: aripiprazole group: 20 male,10 female; risperidone group: 18 male,12 female.<BR/>History: aripiprazole group: 1&#65374;60 months, mean = (22.4 ± 13.8) months; risperidone group: 1&#65374;60 months, mean = (24.9 ± 14) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:39:58 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score.</P>
<P>Adverse effect: TESS score.</P>
<P>Unable to use -<BR/>Quality of life: GQOLI-74 score (no data).</P>
<P>Adverse effects: EPS, ECG, liver function, mouth dry (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:40:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006c">
<CHAR_METHODS MODIFIED="2013-09-29 11:40:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:40:27 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 50.<BR/>Age: aripiprazole group: 25&#65374;39 years. mean = (32.5 ± 6.2) years; risperidone group: 20&#65374;58 years, mean = (22.5 ± 6.2) years.</P>
<P>Gender: aripiprazole group: 8 male, 17 female; risperidone group: 10 male, 15 female.<BR/>History: aripiprazole group: 5&#65374;16 years; risperidone group: 5&#65374;18 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:40:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 25.<BR/>2. Risperidone: Dose range: 0.5-5 mg/day. Mean dose: not reported. N = 25.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:40:50 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 60%-79%, improved: 30%-59%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score.</P>
<P>Unable to use:</P>
<P>Adverse effects - the N numbers reported in these outcomes are greater than that of the people randomised. Since we are unable to reach the authors, we are unable to use these data.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:41:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006d">
<CHAR_METHODS MODIFIED="2013-09-29 11:41:10 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:41:28 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 35 or more.<BR/>N = 120.<BR/>Age: aripiprazole group: 18&#65374;45 years, mean = (28.9± 7.9) years; risperidone group: 16-50 years, mean = (31.53 ± 9.03) years.</P>
<P>Gender: aripiprazole group: 32 male, 28female; risperidone group: 46 male, 14 female.<BR/>History: aripiprazole group: 3 months&#65374;10 years, mean = (3.3 ± 4.5) years; risperidone group: 3 months&#65374;10 years, mean = (5.03 ± 3.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:41:45 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean= 20 mg/day. N = 60.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean= 20 mg/day. N = 60.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:41:56 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: BPRS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood, urine, and stool routine, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:50:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007">
<CHAR_METHODS MODIFIED="2013-09-29 11:42:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:42:22 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 35 or more.<BR/>N = 95.<BR/>Age: aripiprazole group: 16&#65374;54 years. mean = (24.4 ± 13.2) years; risperidone group: 13&#65374;67 years, mean = (25. 4 ± 14. 6) years.</P>
<P>Gender: aripiprazole group: 22 male, 24 female; risperidone group: 23 male, 26 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:42:32 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 46.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 49.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:50:02 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:50:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007a">
<CHAR_METHODS MODIFIED="2013-09-29 11:43:01 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:43:13 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (37. 5 ± 9. 8) years; risperidone group: mean = (36. 7 ± 10. 5) years.</P>
<P>Gender: 60 female.<BR/>History: aripiprazole group: 1 month&#65374;3 years, mean = (2 ± 1.5) years; risperidone group: 3 months&#65374;3 years, mean = (2.3 ± 1.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:43:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:50:08 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychopathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood and urine routine, kidney function, electrolyte, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:50:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007d">
<CHAR_METHODS MODIFIED="2013-09-29 11:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:44:05 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 64.<BR/>Age: aripiprazole group: 16&#65374;52 years, mean = (29. 1 ± 3. 2) years; risperidone group: 19&#65374;54 years, mean = (28. 3 ± 2. 8) years.</P>
<P>Gender: aripiprazole group: 19 male, 13 female; risperidone group: 15 male, 17 female.<BR/>History: aripiprazole group: 8 months&#65374;5 years, mean = (2. 7 ± 1. 1) years; risperidone group: 7 month&#65374;6 years, mean = (2. 6 ± 1. 7) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean= (20. 4 ± 3. 5) mg/day. N=32.<BR/>2. Risperidone: Dose range: 1-7 mg/day. Mean= (4. 1 ± 1. 2) mg/day. N=32.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:50:14 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (markedly improved: &#8805; 60%, improved: 40%-60%, no effect: &lt; 40%).</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:45:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007e">
<CHAR_METHODS MODIFIED="2013-09-29 11:44:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period and six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:44:40 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;54 years, mean = (29. 4 ± 3. 1) years; risperidone group: 19&#65374;53 years, mean = (27. 4 ± 2. 9) years.</P>
<P>Gender: aripiprazole group: 17 male, 13 female; risperidone group: 16 male, 14 female.<BR/>History: aripiprazole group: 1 month&#65374;16 years, mean = (2. 7 ± 3. 2) years; risperidone group: 1 month&#65374;18 years, mean = (3.1 ± 3.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:44:53 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (3.1 ± 3.2) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean = (4.0 ± 1.5) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:45:09 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychopathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, ECG, EPS, use of benzodiazepines, propranolol, and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:46:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2008">
<CHAR_METHODS MODIFIED="2013-09-29 11:45:29 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: two weeks wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:45:52 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 16&#65374;61 years, mean = (30.1 ± 12.5) years; risperidone group: 18&#65374;65 years, mean = (32.7 ± 11.3) years.</P>
<P>Gender: aripiprazole group: 17 male, 13 female; risperidone group: 16 male, 14 female.<BR/>History: aripiprazole group: 1 month&#65374;410 months, mean = (91.7 ± 115.5) months; risperidone group: 1 month&#65374;379 months, mean = (85.7 ± 98.4) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:46:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (21.60 ± 6.89) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (5.25 ± 1.03) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:46:17 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 51%-74%, improved: 26%-50%, no effect: &#8804;25%) - no data reported.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:47:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2008c">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week washout period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:47:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more. SANA of 60 or more.<BR/>N = 86.<BR/>Age: aripiprazole group: mean = (29.4 ± 7.6) years; ziprasidone group: mean = (30.3 ± 8.1) years.</P>
<P>Gender: not reported.<BR/>History: aripiprazole group: mean = (5.5 ± 2.8) years; ziprasidone group: mean = (5.2 ± 2.7) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:47:14 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day, mean = (16.7 ± 1.4) mg/day. N = 43.<BR/>2. Ziprasidone: Dose range: 20-80 mg/day, mean = (46. 3 ±10. 3) mg/day. N = 43.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 11:47:24 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI-GI total score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score. SANS total score score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Mental state: SANS subscale score - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 11:47:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, stratified random.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 11:47:46 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), PANSS total score of 60 or more.<BR/>N = 60.<BR/>Age: mean = (35.2 ± 9.7) years.<BR/>Gender: 36 male, 24 female.<BR/>History: duration of illness not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 11:47:52 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 20-30 mg/day. mean dose: not reported. N = 30.<BR/>2. Clozapine: Dose range: 400-600 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early.</P>
<P>Adverse events: Fasting plasma glucose (FPG), glucose tolerance test (OGTT) 2h postprandial blood glucose (PBG) value.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:33:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wei-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:33:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more, CGI of 4 or more.<BR/>N = 108; complete study: N = 101.<BR/>Age: aripiprazole group: 19&#65374;58 years. mean = (32.2 ± 8.8) years; quetiapine group: 18&#65374;57 years, mean = (32.1 ± 7.1) years.</P>
<P>Gender: 104 female.<BR/>History: aripiprazole group: 1 month&#65374;5 years, mean = (2.8 ± 2.6) years; quetiapine group: 1 month&#65374;6 years, mean = (2.7 ± 2.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:33:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Initial dose: 5&#65374;10 mg/day. Mean dose: not reported. N = 54.<BR/>2. Quetiapine: Initial dose: 75&#65374;100 mg/day. Mean dose: not reported. N = 54.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:33:28 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-75%, no effect: &lt; 50%). CGI-SI subscale score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:34:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wei-2007">
<CHAR_METHODS MODIFIED="2013-09-29 13:33:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: six months.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:34:07 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 90.<BR/>Age: aripiprazole group: mean = (25.2 ± 6.1) years; clozapine group: mean = (24.5 ± 7.2) years.<BR/>Gender: aripiprazole group: 23 male, 22 female; clozapine group: 22 male, 23 female.<BR/>History: aripiprazole group: mean = (1.4 ± 0.9) years; clozapine group: mean = (1.4 ± 0.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:34:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 45.<BR/>2. Clozapine: Dose range: 50-450 mg/day. Mean dose: not reported. N = 45.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score, anxiety - labelled as "adverse effect".</P>
<P>Quality of life: WHO-QOL-100.</P>
<P>Adverse effects: central nervous system (headache, dizziness, somnolence, insomnia), gastrointestinal (salivate, constipation), ECG(QTc) abnormal, weight gain, appetite decrease, blood glucose increase.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, urine routine, hepatorenal function and EEG (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:33:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wei-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:35:15 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS more than 60 years.<BR/>N = 102.<BR/>Age: aripiprazole group: 19&#65374;57 years, mean = (28.2 ± 3.9) years; olanzapine group: 20&#65374;58 years, mean = (28.4 ± 4.7) years.</P>
<P>Gender: 80 female.<BR/>History: aripiprazole group: 3 months&#65374;8 years, mean = (2.4 ± 1.4) years; olanzapine group: 3 months&#65374;6 years, mean = (2.1 ± 1.1) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:35:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 51.<BR/>2. Olanzapine: Dose range: 10-20 mg/day. Mean dose: not reported. N = 51.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:33:08 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, improved: 50%-75%, no effect: &lt; 50%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:33:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wen-2009">
<CHAR_METHODS MODIFIED="2013-09-29 13:36:56 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random permutation table.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:37:18 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;45 years, mean = (26.2 ± 3.7) years; risperidone group: 19&#65374;44 years, mean = (26.3 ± 3.3) years.</P>
<P>Gender: 60 female.<BR/>History: aripiprazole group: 5-13 weeks, mean = (7.4 ± 4.3) weeks; risperidone group: 4-17 weeks, mean = (7.2 ± 4.7) weeks. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:37:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean =(24.11 ± 6.32) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.01 ± 1.89) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:33:16 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:38:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wen-2009a">
<CHAR_METHODS MODIFIED="2013-09-29 13:38:10 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:38:25 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: mean = (44.5 ± 3.0) years; risperidone group: mean = (43.9 ± 3.5) years.</P>
<P>Gender: 80 female.<BR/>History: aripiprazole group: mean = (6.5 ± 1.6) years; risperidone group: mean = (6.9 ± 1.7) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:38:46 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (16.5 ± 5.5) mg/day. N = 40.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean = (4.22 ± 1.51) mg/day. N = 40.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:38:57 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score,PANSS general pathological subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood and urine routine, renal unction, use of benzodiazepines and anticholinergic medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:39:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wlodzmierz-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Blindness: open label.<BR/>Duration: 52 weeks optional extension to a 26 week multicentre, randomised, double blind placebo controlled trial of aripiprazole.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:39:32 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia -chronic stable or acutely psychotic meeting criteria for relapse and had completed at least 2 weeks of double-blind therapy.<BR/>N = 214.<BR/>Gender: M = 116, F = 98.<BR/>History: duration of illness not reported.<BR/>Setting: not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:39:45 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 15-30 mg/day. Mean dose: 22.0 mg/day. N = 104.<BR/>2. Olanzapine: 10-20 mg/day. Mean dose: 14.2 mg/day. N = 110.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early: any reason, adverse events, inefficacy.<BR/>Global state: CGI.<BR/>Mental state: PANSS total score.<BR/>Adverse effects<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-30 17:09:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolf-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: open label. <BR/>Duration: 8 weeks. <BR/>Design: prospective<BR/>Location: multicentric</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-30 17:09:42 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: Schizophrenia (DSM IV), required initiation of antipsychotics, antipsychotic switch clinically appropriate.</P>
<P>N = 833.<BR/>Age: 18-65 years.<BR/>History: duration of illness not reported, age at onset not reported.<BR/>Setting: outpatient.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:41:00 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 10 mg-30 mg/day (mean 19.1 mg/day). N = 680.<BR/>2. Other antipsychotic: recommended dose N = 153.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: CGI-I.<BR/>Adverse effects: At least one adverse effect, extrapyramidal adverse effects, prolactin-associated adverse effects.<BR/>Others: POM, IAQ.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Primary goal was evaluating the effectiveness of aripiprazole in general psychiatric setting in Europe. Data from patients in UK was not reported. Unable to use data from CGI-I, POM and IAQ. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:42:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wu-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + twelve weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:41:51 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 98.<BR/>Age: aripiprazole group: mean = (63.5 ± 4.2) years; risperidone group: mean = (27.8 ± 9.6) years.</P>
<P>Gender: not reported.<BR/>History: aripiprazole group: mean = (26.7 ± 6.2) years; risperidone group: mean = (26.5 ± 6.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:42:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 2.5-30 mg/day. Mean dose: not reported. N = 49.<BR/>2. Risperidon: Dose range: 0.5-6 mg/day. Mean dose: not reported. N = 49.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:42:10 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Adverse effects: TESS score, blood routine, hepatorenal function, electrolyte (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:43:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xiao-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:42:56 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3 and ICD- 10). PANSS score of 60 or more.<BR/>N = 72.<BR/>Age: aripiprazole: 16&#65374;55 years, mean = (29.7 ± 19.6) years; clozapine: 18&#65374;58 years, mean = (28.6 ± 18.1) years.<BR/>Gender: aripiprazole group: 16 male, 20 female; clozapine group: 16 male, 20 female .<BR/>History: aripiprazole group: 1 months&#65374; 21 years, mean = (5.4 ± 3.4) years; clozapine group: 1.5 months &#65374;20years, mean = (5.5 ± 2.7) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:43:09 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-25 mg/day. Mean dose:not reported. N = 36.<BR/>2. Clozapine: Dose range: 50-450 mg/day. Mean dose:not reported. N = 36.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:43:15 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score; BPRS score.</P>
<P>Quality of life: WHO-QOL-100.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:44:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xie-2008">
<CHAR_METHODS MODIFIED="2013-09-29 13:43:35 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:43:41 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 84.<BR/>Age: 25&#65374;40 years.</P>
<P>Gender: 84 male.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:43:53 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range:10-20 mg/day. Mean dose: not reported. N = 42.<BR/>2. Risperidon: Dose range: 2-4 mg/day. Mean dose: not reported. N = 42.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:44:01 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -</P>
<P>Sexual desire - unvalidated scale.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:45:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xie-2010">
<CHAR_METHODS MODIFIED="2013-09-29 13:44:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:44:41 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: aripiprazole group 18&#65374;65 years, mean = (33.4 ± 9.1) years; risperidone group 18&#65374;63 years, mean = (32.4 ± 8.2) years.</P>
<P>Gender: aripiprazole group: 22 male, 18 female; risperidone group: 21 male, 19 female.<BR/>History: aripiprazole group 1&#65374;22 months, mean = (13.1 ± 2.1) months; risperidone group 1&#65374;23 months, mean = (12.6 ± 3.6) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:45:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: (21 ± 10.4) mg/day. N = 40.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: (4 ± 1.6) mg/day. N = 40.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:45:12 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:46:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xu-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:46:08 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS score of 35 or more.<BR/>N = 70.<BR/>Age: Aripiprazole: mean = (28 ± 6) years; Clozapine: mean = (29 ± 5) years.<BR/>Gender: Aripiprazole group: 18 male, 17 female; Clozapine group: 19 male, 16 female .<BR/>History: Aripiprazole group: mean = (3.5 ± 1.5) years; Clozapine group: 1.5 months -20 years, mean = (3.8 ± 1.4) years. Age at onset not reported.</P>
<P>Setting: inpatient.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:46:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 35.<BR/>2. Clozapine: Dose range: 25-400 mg/day. Mean dose: not reported. N = 35.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:46:28 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: BPRS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzhexol and benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:47:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xu-2010">
<CHAR_METHODS MODIFIED="2013-09-29 13:46:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: double.<BR/>Duration: 3-7 days wash-out period + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: not reported, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:47:01 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 52.<BR/>Age: 18&#65374;65 years, aripiprazole group: mean = (35.4 ± 8.8) years; risperidone group: mean= (40.1 ± 13.3) years.</P>
<P>Gender: aripiprazole group: 11 male, 15 female; risperidone group: 12 male, 14 female.<BR/>History: aripiprazole group: mean = (6.5 ± 6.7) years; risperidone group: mean = (8.5 ± 9.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:47:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 26.<BR/>2. Risperidone: Dose range: 2-6 mg/day. Mean dose: not reported. N = 26.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:47:27 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%). CGI-I, CGI-S score.</P>
<P>Mental state: PANSS total score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, Extrapyramidal reaction scale score, BARS score (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:49:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yan-2007">
<CHAR_METHODS MODIFIED="2013-09-29 13:48:38 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: six months.<BR/>Design: parallel.<BR/>Location: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:48:59 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 86, completed study: N = 74.<BR/>Age: aripiprazole group: mean = (32.5 ± 6.8) years; clozapine group: mean = (28.2 ± 2.8) years.<BR/>Gender: aripiprazole group: 19 female, 19 male; clozapine group: 18 male, 18 female.<BR/>History: Not reported. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:49:12 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 15-30 mg/day. Mean dose:not reported. N = 43.<BR/>2. Clozapine: Dose range: 200-500 mg/day. Mean dose:not reported. N = 43.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:49:18 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Quality of life: WHO-QOL-100</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score and use of benzodiazepine (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:33:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yan-2008">
<CHAR_METHODS MODIFIED="2013-09-29 13:49:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:50:06 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (13. 0 ± 2. 3) years; risperidone group: mean = (13. 0 ± 2. 6) years.</P>
<P>Gender: aripiprazole group: 14 male, 16 female; risperidone group: 13 male, 17 female.<BR/>History: aripiprazole group: mean = (10. 6 ± 6. 0) years; risperidone group: mean = (8. 2 ±<BR/>5. 2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:50:17 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 2.5-25 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:33:24 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI-SI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Leaving the study early: no patient.</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Adverse effects: TESS score, blood routine, hepatorenal function, EEG, and weight (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:51:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yan-2008a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: not reported, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:50:58 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3), BPRS total score of 35 or more.<BR/>N = 100.<BR/>
</P>
<P>Age: 18&#65374;56 years, mean = (28.6 ± 11.3) years.<BR/>Gender: 54 male, 46 female.<BR/>History: mean = (14.5 ± 6.3) years. Age at onset not reported.</P>
<P>Setting: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:51:08 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: (22.5 ± 7.5) mg/day. N = 50.<BR/>2. Clozapine: Initial dose: 25-50 mg/day. Mean dose:not reported. N = 50.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:51:13 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: BPRS total score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:34:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yan-2010">
<CHAR_METHODS MODIFIED="2013-09-29 13:52:05 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:52:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 100.<BR/>Age: aripiprazole group: 18&#65374;43 years, mean = (33.40 ± 7.09) years; risperidone group: 21&#65374;44 years, mean = (32.17 ± 5.13) years.</P>
<P>Gender: aripiprazole group: 27 male, 23 female; risperidone group: 24 male, 26 female.<BR/>History: aripiprazole group: 1&#65374;13 months, mean = (5.94 ± 2.79) months; risperidone group: 1&#65374;11 months, mean = (5.46 ± 2.47) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:52:37 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 50.<BR/>2. Risperidone: Dose range: 1-8 mg/day. Mean dose: not reported. N = 50.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:34:19 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-79%, improved: 30%-49%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS total score decreased rate.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:46 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:53:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further detail.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:53:18 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 100*.<BR/>Age: Aripiprazole: 20&#65374;62 years, mean = (43 ± 22) years; Clozapine: 22&#65374;59 years, mean = (40 ± 20) years.<BR/>Gender: Aripiprazole group: 29 male, 18 female; Clozapine group: 26 male, 17 female .<BR/>History: Aripiprazole group: mean = (25 ± 31) months; Clozapine group: mean = (28.4 ± 33) months. Age at onset not reported.</P>
<P>Setting: inpatient.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:53:25 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose:not reported. N = 47.<BR/>2. Clozapine: Dose range: 50-450 mg/day. Mean dose:not reported. N = 43.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:53:40 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). GGI-SI.</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score. anxiety - labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>* There is a discrepancy of 10 people between the number of people selected for the study (100) and the numbers randomised into each group (47:43). Since the report consistently reported the N numbers in each group as 47:43 in the result and discussion sections of the paper, we assume these are the N numbers of the trial.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:54:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2007">
<CHAR_METHODS MODIFIED="2013-09-29 13:54:06 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:54:11 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 60.<BR/>Age: not reported.<BR/>Gender: not reported.<BR/>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:54:27 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Started dose: 5 mg/day. Maximum dose: (15 ± 5. 5) mg/day. N = 30.<BR/>2. Clozapine: Started dose: 50 mg/day. Maximum dose: (269. 8 ± 132. 5) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Global state:markedly improved, improved, no effect.</P>
<P>Mental state: PANSS total score, anxiety - labelled as "adverse effect".</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score and hepatorenal function (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:34:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash-out period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:55:00 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (32.7 ± 5. 9) years; ziprasidone group: mean = (31.2 ± 6. 8) years.</P>
<P>Gender:aripiprazole group: 20 male, 10 female; ziprasidone group:10 male, 11 female.<BR/>History: aripiprazole group: mean = (5.5 ± 4.1) years; ziprasidone group: mean = (5.2 ± 3.9) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:55:09 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day, mean dose: not reported. N = 30.<BR/>2. Ziprasidone: Dose range: 20-160 mg/day, mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:34:27 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:56:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2008a">
<CHAR_METHODS MODIFIED="2013-09-29 13:56:11 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:56:25 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (28.2 ± 10.3) years; risperidone group: mean = (27.8 ± 9.6) years.</P>
<P>Gender: aripiprazole group: 21 male, 9 female; risperidone group: 20 male, 10 female.<BR/>History: aripiprazole group: mean = (2.6 ± 1.8) years; risperidone group: mean = (2.8 ± 2.0) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean = (16.5 ± 5.5) mg/day. N = 30.<BR/>2. Risperidon: Dose range: 1-5 mg/day. Mean = (3.8 ± 1.6) mg/day. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:56:57 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI-SI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Leaving the study early: no patient.</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Adverse effects: Blood and urine routine, liver function, ECG, weight and other adverse effect, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:58:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2008b">
<CHAR_METHODS MODIFIED="2013-09-29 13:57:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:57:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 90.<BR/>Age: aripiprazole group: 18&#65374;52 years. mean = (26.7± 8.5) years; risperidone group: 18&#65374;51 years, mean = (26.2 ± 8.3) years.</P>
<P>Gender: aripiprazole group: 45 female; risperidone group: 45 female.<BR/>History: aripiprazole group: 1&#65374;52 months, mean = (15.2 ± 16.7) months; risperidone group: 1&#65374;49 months, mean = (14.9 ± 17.1) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:57:48 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 45.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 45.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:58:05 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score. z</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood routine, liver function, blood glucose, weight, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:58:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:58:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 60.<BR/>Age: 18&#65374;45 years, aripiprazole group: mean = (29.6 ± 7.3) years; olanzapine group: mean = (28.9 ± 6.6) years.</P>
<P>Gender: aripiprazole group: 16 male, 14 female; olanzapine group: 15 male, 15 female.<BR/>History: aripiprazole group: mean = (10.2 ± 5.0) years; olanzapine group: mean = (10.4 ± 5.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:58:49 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Initial dose: 10 mg/day. Mean = (20.8 ± 6.2) mg/day. N = 30.<BR/>2. Olanzapine: Initial dose: 5 mg/day. Mean = (14.3 ± 5) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse effects: weight gain, blood glucose.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 13:59:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ye-2005">
<CHAR_METHODS MODIFIED="2013-09-29 13:59:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 13:59:20 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 68.<BR/>Age: aripiprazole group: 18&#65374;52 years, mean = (28. 6 ± 16. 8) years; risperidone group: 19&#65374;55 years, mean = (31.9 ± 15.7) years.</P>
<P>Gender: aripiprazole group: 20 male, 14 female; risperidone group: 24 male, 10 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 13:59:35 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (17.5 ± 6.5) mg/day. N = 34.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.1 ±1.8) mg/day. N = 34.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 13:59:52 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score, agitation labelled as "adverse effect".</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Adverse effects: TESS score, blood and urine routine, liver function, blood glucose (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:00:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ye-2005a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week washout + six weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:00:21 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more. BPRS of 40 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;65 years, mean = (28.3 ± 10.6) years; olanzapine group: 18&#65374;56 years, mean = (26.5 ± 11.3) years.</P>
<P>Gender: aripiprazole group: 20 male, 10 female; olanzapine group: 19 male, 11 female.<BR/>History: aripiprazole group: 0.3&#65374;18 years, mean = (6.3 ± 6.9) years; olanzapine group: 0.5&#65374;15 years, mean = (5.7 ± 6.1) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:00:30 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Olanzapine: Dose range: 5-10 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:00:37 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: 80&#8805; %, markedly improved: 60%-70%, improved: 30%-59%, no effect: &lt; 30%). CGI score.</P>
<P>Mental state: PANSS total decreased score, PANSS positive decreased subscale score, PANSS negative decreased subscale score, PANSS psychopathological decreased subscale score.</P>
<P>Leaving the study early.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood and urine routine, weight gain, extrapyramidal effects, constipation, somnolence, use of benzodiazepines and other medicine (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:01:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yi-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:01:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 60.<BR/>Age: mean = (30.1 ± 9.7) years.<BR/>Gender: 34 male, 26 female.<BR/>History: mean = (32 ± 10.5) years. Age at onset: mean = (29.7 ± 9.5) years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:01:49 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (17.6 ± 4.5) mg/day. N = 30.<BR/>2. Clozapine: Dose range: 300-600 mg/day. Mean = (370 ± 82) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse events: Fasting plasma glucose (FPG), C-peptide.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:03:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:02:44 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: treatment resistant schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 53.<BR/>Age: aripiprazole group: 18&#65374;59 years, mean = (32.8 ± 6.2) years; clozapine group: 17&#65374;58 years, mean = (30.6 ± 7.8) years.<BR/>Gender: aripiprazole group: 17 male, 9 female; clozapine group: 10 male, 12 female .<BR/>History: aripiprazole group: 1 month~9 years, mean = (4.2 ± 3.9) years; clozapine group: 1 month&#65374;11years, mean = (5.2 ± 3.4) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:02:59 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (15 ± 5) mg/day. N = 26.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean = (400 ± 125) mg/day. N = 22.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:03:30 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS positive subscale score, PANSS negative subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Leaving the study early: 5 people dropped out, but it did not report which group they were from.</P>
<P>Adverse effects: TESS total score and hepatorenal function (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:04:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2006a">
<CHAR_METHODS MODIFIED="2013-09-29 14:03:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:04:00 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 74.<BR/>Age: aripiprazole group: mean = (23.69 ± 11.67) years; clozapine group: mean = (25.61 ± 6.4) years.<BR/>Gender: aripiprazole group: 18 male, 18 female; clozapine group: 19 male, 19 female .<BR/>History: aripiprazole group: mean = (7.5 ± 2.3) months; clozapine group: mean = (8.92 ± 3.3) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:04:10 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-40 mg/day. Mean dose: not reported. N = 36.<BR/>2. Clozapine: Dose range: 75-550 mg/day. Mean dose: not reported. N = 38.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse effect: change of ECG and blood glucose.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:05:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:04:42 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS score of 60 or more.<BR/>N = 74.<BR/>Age: aripiprazole group: mean = (23.69 ± 11.67) years; clozapine group: mean = (25.61 ± 6.4) years.<BR/>Gender: aripiprazole group: 18 male, 18 female; clozapine group: 19 male, 19 female .<BR/>History: aripiprazole group: mean = (7.5 ± 2.3) months; clozapine group: mean = (8.92 ± 3.3) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:05:01 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-40 mg/day. Mean dose: not reported. N = 36.<BR/>2. Clozapine: Dose range: 75-550 mg/day. Mean dose: not reported. N = 38.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:05:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score.</P>
<P>Adverse effect.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, liver function and blood glucose (no data).</P>
<P>Mental state: BPRS and PANSS subscale scores - unvalidated subscales.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:34:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2008">
<CHAR_METHODS MODIFIED="2013-09-29 14:05:27 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:05:44 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 100.<BR/>Age: aripiprazole group: 18&#65374;65 years, mean = (36.3 ± 4.1) years; risperidone group: 16&#65374;60 years, mean = (34.5 ± 12.7) years.</P>
<P>Gender: aripiprazole group: 32 male, 18 female; risperidone group: 30 male, 20 female.<BR/>History: aripiprazole group: 3 months&#65374;10 years, mean = (3.0 ± 1.9) years. risperidone group: 2 months&#65374;15 years, mean = (3. 2 ±2. 5) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:05:54 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean= (22.3 ± 3.2) mg/day. N = 50.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean= (3.8 ±1.33) mg/day. N = 50.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:34:40 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use-</P>
<P>Adverse effects: TESS score, blood and urine routine, renal function (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:06:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, stratified random.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:06:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 22&#65374;57 years, mean = (34. 63 ±9. 86) years; clozapine group: 23&#65374;59 years, mean = (9. 49 ± 4.33) years.<BR/>Gender: aripiprazole group: 19 M, 11 F; clozapine group: 22 M, 8 F.<BR/>History: aripiprazole group: 5&#65374;21 years, mean = (9.15 ± 4.31) years; clozapine group: 5.25&#65374;23 years, mean = (9.49 ± 4.33) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:06:37 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (16.75 ± 3.55) mg/day. N = 30.<BR/>2. Clozapine: Dose range: 50-600 mg/day. Mean = (398.33 ± 74.84) mg/day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscore, PANSS negative subscore.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, EEG, and drugs for adverse events (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:07:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-ZG-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:06:59 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18&#65374;54 years, mean = (34. 5 ± 4.7) years; clozapine group: 18&#65374;51 years, mean = (33.6 ± 5.2) years.<BR/>Gender: aripiprazole group: 17 M, 13 F; clozapine group: 18 M, 12 F.<BR/>History: aripiprazole group: 4 months&#65374;6 years; clozapine group: 2 months&#65374;4 years . Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:07:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (22.1 ± 3.4) mg/ day. N = 30.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean = (336 ± 4.7) mg/ day. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:07:26 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: blood routine, urine routine, blood glucose, and hepatorenal function (no data) .</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:08:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2006">
<CHAR_METHODS MODIFIED="2013-09-29 14:07:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:08:08 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more.<BR/>N = 112.<BR/>Age: aripiprazole group: 15&#65374;60 years, mean = (25.7 ± 7.9) years; risperidone group: 15&#65374;60 years, mean = (26.1 ± 8.2) years.<BR/>Gender: aripiprazole group: 30 Male, 26 Female; Risperidon group: 29 Male, 27 Female .<BR/>History: aripiprazole group: 1 month&#65374;10 years, mean = (4.8 ± 2.6) years; risperidone group: 1 month&#65374;9 years, mean = (4.6 ± 2.8) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:08:27 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (21.4 ± 3.1) mg/day. N = 56.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.9 ± 1.7) mg/day. N = 56<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:08:33 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS score decreased rate: PANSS positive subscore, PANSS negative subscore, PANSS cognitive score, PANSS excited subscore, PANSS depressed subscore.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzhexol and benzodiazepines (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:09:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2006a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week washout + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:09:15 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 104.<BR/>Age: aripiprazole group: 18&#65374;62 years, mean = (28.1 ± 6.3) years; olanzapine group: 19&#65374;65 years, mean = (32.6 ± 5.4) years.</P>
<P>Gender: aripiprazole group: 29 male, 23 female; olanzapine group: 27 male, 25 female.<BR/>History: aripiprazole group: mean = (2.8 ± 4.6) years; olanzapine group: mean = (3.5 ± 5.2) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:09:28 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean = (16.53 ± 4.7) mg/day. N = 52.<BR/>2. Olanzapine: Dose range: 5-25 mg/day. Mean = (17.3 ± 6.4) mg/day. N = 52.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:09:32 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: 80&#8805; %, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS psychopathological subscale score.</P>
<P>Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:10:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2007">
<CHAR_METHODS MODIFIED="2013-09-29 14:09:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:10:04 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 97.<BR/>Age: aripiprazole group: 18&#65374;74 years, mean = (31.7 ± 11.6) years; clozapine group: 18&#65374;67 years, mean = (34.3 ± 11.4) years.</P>
<P>Gender: aripiprazole group: 24 male, 26 female; clozapine group: 23 male, 24 female.<BR/>History: aripiprazole group: mean = (7.4 ± 6.1) years; clozapine group: mean =(7.4 ± 4.2) months. Age at onset not reported.<BR/>Setting: inpatient.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:10:10 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose:not reported. N = 50.<BR/>2. Clozapine: Dose range: 25-400 mg/day. Mean dose:not reported. N = 47.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse effect: change of ECG (ECG abnormal, tachycardia and others).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:11:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2007a">
<CHAR_METHODS MODIFIED="2013-09-29 14:10:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:10:49 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more.<BR/>N = 50.<BR/>Age: aripiprazole group: mean = (10.07 ± 2.35) years; risperidone group: mean = (9.37 ± 4.08) years.<BR/>Gender: aripiprazole group: 11 Male, 14 Female; risperidone group: 10 Male, 15 Female .<BR/>History: aripiprazole group: mean = (1.64 ± 3.74) months; risperidone group: mean = (1.87 ± 2.96) months. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:10:57 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 25.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 25.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:11:09 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: blood and urine routines, EEG, use of anticholinergic drug and benzodiazepines (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:34:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2007b">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:11:35 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS of 35 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (28.2 ± 10.3) years; risperidone group: mean = (27.8 ± 9.6) years.</P>
<P>Gender: aripiprazole group: 20 male, 10 female; risperidone: 20 male, 10 female.<BR/>History: aripiprazole group: mean= (2.6 ± 10.8) years; risperidone group: mean = (2.8 ± 2.0) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:11:38 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. mean= (16.5 ± 5.5) mg/day.N=30.<BR/>2. Risperidone: Dose range: 1-5mg/day. mean = (3.8 ± 1.6) mg/day. N=30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:34:47 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: BPRS score decreased rate (recovery: &#8805;75%, markedly improved: 50%-75%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: BPRS score.</P>
<P>Leaving the study early: no patient.</P>
<P>Adverse effect: TESS total score.</P>
<P>Unable to use -<BR/>Various specific adverse effects (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:12:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week washout period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:12:01 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (36.3 ± 8.2) years; risperidone group: mean = (37.3 ± 8.7) years.</P>
<P>Gender: aripiprazole group: 23 male, 7 female; risperidone: 21 male, 9 female.<BR/>History: aripiprazole group:1 month-30 years; risperidone group: 2 months - 29 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:12:29 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805;75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%). CGI score.</P>
<P>Mental state: PANSS total score, PANSS positive subscore, PANSS negative subscore.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score(no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:13:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008a">
<CHAR_METHODS MODIFIED="2013-09-29 14:12:45 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:13:06 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: 18-58 years, mean = (32.8 ± 6.9) years; risperidone group: 20-56 years, mean = (33.4 ± 5.8) years.<BR/>Gender: aripiprazole group: 18 Male, 12 Female; risperidone group: 16 Male, 14 Female .<BR/>History: aripiprazole group: 1 month-8 years, mean = (4.8 ± 3.2) years; risperidone group: 2 months-7 years, mean = (4.6 ± 3.8) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:13:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (15 ± 5) mg/day. N = 30.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.5 ± 1.6) mg/day. N = 30<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:13:31 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood and urine routine, liver function (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:14:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008b">
<CHAR_METHODS MODIFIED="2013-09-29 14:13:52 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Location: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:14:04 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).<BR/>N = 40.<BR/>Age: aripiprazole group: 18-58 years, mean = (33.2 ± 7.8) years; risperidone group: 18-65 years, mean = (34.5 ± 8.7) years.<BR/>Gender: aripiprazole group: 8 Male, 12 Female; risperidone group: 10 Male, 10 Female .<BR/>History: aripiprazole group: 1 month-5 years, mean = (2.8 ± 3.6) years; risperidone group: 2 months-7 years, mean = (3.7 ± 4.2) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:14:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (10 ± 5.22) mg/day. N = 20.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (3.5 ± 0.8) mg/day. N = 20<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:14:28 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 20%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, endocrine change, laboratory tests (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:15:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2009">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: twelve weeks.<BR/>Design: parallel.<BR/>Setting: not reported, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more. Refractory schizophrenia (TRS).<BR/>N = 72.<BR/>Age: aripiprazole group: 25-54 years, mean = 34.4years; clozapine group: 24-58 years, mean = 33.8 years.<BR/>Gender: aripiprazole group: 21 female, 15 male; clozapine group: 22 male, 14 female.<BR/>History: aripiprazole group: 5.8-26 years, mean = 8.6 years; clozapine group: 5.5-28 years, mean = 8.9 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:15:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 36.<BR/>2. Clozapine: Dose range: 200-500 mg/day. Mean dose: not reported. N = 36.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:15:33 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &gt; 75%, markedly improved: 51%-74%, improved: 26%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:16:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2009a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, random number table.</P>
<P>Blindness: single.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:15:59 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (31.3 ± 8.7) years; risperidone group: mean = (30.4 ± 8.7) years.</P>
<P>Gender: 60 male.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:16:12 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score.</P>
<P>Adverse effects: blood glucose and cholesterol.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:34:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2009b">
<CHAR_METHODS MODIFIED="2013-09-29 14:16:26 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: one week wash out + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: aripiprazole group: mean = (37 ± 7) years; risperidone group: mean = (36 ± 7) years.</P>
<P>Gender: aripiprazole group: 18 male, 12 female; risperidone group: 19 male, 11 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:16:51 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidone: Dose range: 4-6 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:34:55 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score,PANSS general pathological subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, blood and urine routine, blood glucose, use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:18:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2010">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Random permutation table.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:17:44 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.Refractory schizophrenia(TRS).<BR/>N = 120.<BR/>Age: aripiprazole group 18&#65374;55 years, mean= 33 years; clozapine group: 21&#65374;53 years, mean = 34 years.<BR/>Gender: aripiprazole group: 21 female, 15 male; clozapine group: 22 male, 14 female.<BR/>History: aripiprazole group: 2&#65374;16 years, mean = 7 years; clozapine group: 4&#65374;19 years, mean = 6 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:18:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 20-30 mg/day. Mean= (22. 1 ± 5. 4) mg/day. N = 60.<BR/>2. Clozapine: Dose range: 300-600 mg/day. Mean= (354. 5 ± 84. 9) mg/day. N = 60.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:18:30 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects: central nervous system (headache, insomnia, somnolence), gastrointestinal(nausea, constipation), weight gain, extrapyramidal side-effects (tremor, akathisia), tachycardia.<BR/>
</P>
<P>Unable to use -</P>
<P>Adverse effects: TESS total score, use of benzhexol and benzodiazepines (no data). The data of at least one adverse effect.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:19:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2010a">
<CHAR_METHODS MODIFIED="2013-09-29 14:19:00 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:19:05 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 100.<BR/>Age: 19&#65374;64 years.</P>
<P>Gender: not reported.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:19:17 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 50.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose: not reported. N = 50.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score.</P>
<P>Adverse effects: TESS total score,</P>
<P>Unable to use -</P>
<P>Quality of life: GQOLI - 74<BR/>Adverse effects: anxiety, EPS, ECG abnormal, mouth dry, liver function, use of benzodiazepines and other medicines.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:48 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:20:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:20:16 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 68.<BR/>
</P>
<P>Age: aripiprazole group: mean = (24.3 &#22763; 9.4) years; quetiapine group: 18-51 years, mean = (26.7 ± 8.4) years.</P>
<P>Gender: male and female<BR/>History: aripiprazole group: mean = (23 &#22303; 13) months; quetiapine group: mean =(4. 5 ± 2.9) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:20:33 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose = not reported. N = 34.<BR/>2. Quetiapine: Dose range: 100-750 mg/day. Mean dose = (465 ± 132) mg/day. N = 34.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:20:45 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score.</P>
<P>Unable to use -<BR/>Mental state: PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:21:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2007">
<CHAR_METHODS MODIFIED="2013-09-29 14:21:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:21:20 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: 17&#65374;62 years, mean = (29.5 ± 11.7) years; risperidone group: 16&#65374;60 years, mean = (29.3 ± 10.6) years.<BR/>Gender: aripiprazole group: 19 Male, 21 Female; risperidone group: 21 Male, 19 Female.<BR/>History: aripiprazole group: 1 month&#65374;10 years, mean =6.4 years; risperidone group: 1.5 months&#65374;13 years, mean = 6.3 years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:21:29 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean: not reported. N = 40.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean: not reported. N = 40.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:21:49 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. agitation labelled as "adverse effect".</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:35:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhi-2005">
<CHAR_METHODS MODIFIED="2013-09-29 14:21:59 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:22:26 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: 18&#65374;35 years, mean = ( 22.0 ± 6.08) years; risperidone group: 18&#65374;33 years, mean = (24.56 ± 8.68) years.<BR/>Gender: 80 female.<BR/>History: aripiprazole group: 1 month&#65374;15 years, mean = (8.42 ± 6.83) years; risperidone group: 1 month&#65374;14 years, mean = (8.02 ± 7.32) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:22:40 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = (21.0 ± 6. 17) mg/day. N = 40.<BR/>2. Risperidone: Dose range: 1-6 mg/day. Mean = (4.46 ± 1.03) mg/day. N = 40.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:35:03 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:23:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhou-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Random permutation table.</P>
<P>Blindness: unclear.<BR/>Duration: one week washout period + eight weeks intervention.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient patient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:23:21 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 92,complete study: N = 90.<BR/>Age: aripiprazole group: mean = (35.2 ± 8.5) years; clozapine group: mean =(34. 3 ±7. 9) years.<BR/>Gender: aripiprazole group: 20 female, 25 male; clozapine: 23 male, 22 female.<BR/>History: aripiprazole group: mean = (3.3 ± 2.8) years; clozapine group: mean = (3.4 ± 2.9) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:23:29 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean dose: not reported. N = 45.<BR/>2. Clozapine: Dose range: 50-400 mg/day. Mean dose: not reported. N = 47.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:23:34 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-74%, improved: 25%-49%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. anxiety - labelled as "adverse effect".</P>
<P>Leaving the study early.</P>
<P>Adverse effects.<BR/>
</P>
<P>Unable to use -</P>
<P>Mental state: PANSS negative subscore, cognitive factor, affective symptoms (no data).</P>
<P>Adverse effects: TESS total score, hepatorenal function, use of benzhexol and benzodiazepines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:24:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhou-2007a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:23:58 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 62.<BR/>Age: aripiprazole group: mean = (37.5 ± 8.1) years; risperidone group: mean = (39.2 ± 10.3) years.<BR/>Gender: aripiprazole group: 9 Male, 22 Female; risperidone group: 7 Male, 24 Female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:24:28 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-30 mg/day. Mean = 10.2 mg/day. N = 31.<BR/>2. Risperidone: Dose range: 0.5-6 mg/day. Mean = 3.5 mg/day. N = 31.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:24:46 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>Adverse effects: TESS total score, use of benzodiazepines and anticholinergic medication (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:25:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhou-2007b">
<CHAR_METHODS MODIFIED="2013-09-29 14:24:56 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:25:01 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 60.<BR/>Age: 18&#65374;60 years.</P>
<P>Gender: aripiprazole group: 20 male, 10 female; risperidone group: 18 male, 12 female.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:25:11 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-25 mg/day. Mean dose: not reported. N = 30.<BR/>2. Risperidon: Dose range: 1-4 mg/day. Mean dose: not reported. N = 30.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -</P>
<P>Quality of life: GQOLI - 74 (no data).<BR/>Adverse effects: use of benzodiazepines and other medicines (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:26:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhou-2008">
<CHAR_METHODS MODIFIED="2013-09-29 14:25:28 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: eight weeks.<BR/>Design: multi-centre, parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:25:44 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more.<BR/>N = 140.<BR/>Age: aripiprazole group: 10&#65374;50 years, mean = (28.7 ± 7.8) years; risperidone group: 18&#65374;49 years, mean = (28.1 ± 7.8) years.<BR/>Gender: aripiprazole group: 36 Male, 34 Female; risperidone group: 35 Male, 35 Female.<BR/>History: aripiprazole group: 1 month&#65374;3 years, mean = (3.0 ± 1.4) years; risperidone group: 1 month&#65374;3 years, mean = (3.1 ± 2.3) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:25:59 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (22. 4 ± 3. 4) mg/day. N = 70.<BR/>2. Risperidone: Dose range: 1-4 mg/day. Mean dose = (4. 3 ± 1. 7) mg/day. N = 70.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:26:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 75%, markedly improved: 50%-75%, improved: 25%-50%, no effect: &lt; 25%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score.</P>
<P>Adverse effects.</P>
<P>Unable to use:</P>
<P>Adverse effects: TESS total score, EEG, use of benzodiazepines, benzhexol and propranolol (no data).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:26:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2005">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: single.<BR/>Duration: eight weeks.<BR/>Design: parallel.<BR/>Setting: inpatient and outpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:26:34 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). BPRS total score of 40 or more.<BR/>N = 80.<BR/>Age: aripiprazole group: 16&#65374;57 years, mean = (28.3 ± 10.2) years; clozapine group: 17&#65374;58 years, mean = (27.8 ± 8.2) years.<BR/>Gender: aripiprazole group: 22 M, 18 F; clozapine group: 20 M, 20 F.<BR/>History: aripiprazole group: 2 months&#65374;8 years, mean = (6.2 ± 3.7) years; clozapine group: 3 months&#65374;9 years, mean = (6.7 ± 5.8) years. Age at onset not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:26:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-20 mg/day. Mean dose: not reported. N = 40.<BR/>2. Clozapine: Dose range: 50-500 mg/day. Mean dose: not reported. N = 40.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (markedly improved: &#8805;60%, improved: 20%-59%, no effect: &lt; 20%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. BPRS total score.</P>
<P>Adverse effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:27:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:27:32 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more. BPRS of 40 or more.<BR/>N = 60.<BR/>
</P>
<P>Age: aripiprazole group: 18&#65374;65 years. mean = (28.3 ± 10.6) years; quetiapine group: 18-56 years, mean = (26.5 ± 11.3) years.</P>
<P>Gender: aripiprazole group: 20 male, 10 female; quetiapine group: 19 male, 11 female.<BR/>History: aripiprazole group: mean = (6.3 ± 6.9) years; quetiapine group: mean = (5.7 ± 6.1) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:27:39 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean dose: not reported. N = 30.<BR/>2. Quetiapine: Dose range: 200-700 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-29 14:27:49 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: PANSS score decreased rate (recovery: &#8805; 80%, markedly improved: 50%-80%, improved: 30%-50%, no effect: &lt; 30%).</P>
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score. BPRS total score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:28:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2010">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six months.<BR/>Design: trial with three arms.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:28:22 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS of 60 or more. SANS of 60 or more.<BR/>N = 81; Number of people completed study: N = 76.<BR/>Age: 40&#65374;65 years.</P>
<P>Gender: not reported.<BR/>History: not reported. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:28:53 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 10-30 mg/day. Mean = (18.3 ± 2.9) mg/day. N: not reported, complete study: N = 22.<BR/>2. Risperidone: Dose range: 1-5 mg/day. Mean = (4.2 ± 0.4) mg/day. N: not reported, complete study: N = 28.</P>
<P>3.Olanzapine: Dose range: 5-20 mg/day. Mean = (12.6 ± 2.6) mg/day. N: not reported, complete study: N = 26.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score, PANSS positive subscale score, PANSS negative subscale score, PANSS general psychogenic pathological subscale score. SANS total score.</P>
<P>Adverse effects.</P>
<P>Unable to use -<BR/>BPRS and SANS subscale score - unvalidated subscales.</P>
<P>Leaving the study early - unclear from which group people were dropped out.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:29:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zimbroff-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, computer-generated, centre blocked<BR/>Blindness: double, dummy administration.<BR/>Duration: four weeks.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:29:24 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia or schizoaffective disorder (DSM-IV).<BR/>N = 256.<BR/>Age: 18-70 years.<BR/>Gender: 169 M, 57 F.<BR/>History: duration of illness not reported, age at onset not reported, hospitalised &gt; 14 consecutive days prior to screening, PANSS &#8805; 80, 4/more on 2+ PANSS positive items, score of &#8805; 4 on CGI-S<BR/>Setting: inpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:29:38 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: dose 15 mg/day first 14 days, up to 30 mg/day thereafter, mean 21 mg/day (SD 7). N = 129.<BR/>2. Ziprasidone: dose 80 mg/day on first 14 days, up to 160 mg/day thereafter mean 149 mg/day ( SD 25): N = 127.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-09 12:13:38 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early.<BR/>Global state: CGI-S.<BR/>Mental state: BPRS, PANSS.<BR/>Adverse effects: system-specific effects, AIMS, BAS, SAS.</P>
<P>Unable to use -<BR/>Global state: ORDQ.<BR/>Mental state: CDSS (no numerical data).<BR/>Adverse effects: SAS (reported as zero difference with P value - not credible data), weight, glucose, blood lipids (median reported with no other data).<BR/>Adverse effects: AIMS, BAS (P values, and numbers that did allow calculation of SD).*</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>* These data, although possible to report, carried assumptions on numbers of people from which they were derived, identical SDs per group, normality of data on top of other assumptions usually associated with scale-derived numbers. We feel that these are assumptions too far. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-29 14:30:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zou-2006">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.</P>
<P>Blindness: unclear.<BR/>Duration: six weeks.<BR/>Design: parallel.<BR/>Setting: inpatient, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-29 14:30:39 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3). PANSS total score of 60 or more, BPRS total score of 36 or more, TESS total score of 1 or less.<BR/>N = 62.<BR/>Age: aripiprazole group: mean = (45.99 ± 6.89) years; clozapine group: mean = (45.81 ± 9.2) years.<BR/>Gender: aripiprazole group: 20 M, 11 F; clozapine group: 18 M, 13 F.<BR/>History: aripiprazole group: mean = (16.99 ± 8.64) years; clozapine group: mean = (15.98 ± 3.5) years. Age at onset not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-29 14:30:51 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: Dose range: 5-15 mg/day. Mean dose: not reported. N = 30.<BR/>2. Clozapine: Dose range: 25-400 mg/day. Mean dose: not reported. N = 30.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS total score. PANSS positive subscale score, PANSS negative subscale score, PANSS general pathological subscale score. BPRS total score.</P>
<P>Adverse effects: TESS scale (poisoning symptoms, laboratory abnormalities, nervous system, autonomic nervous system, cardiovascular system, other).</P>
<P>Unable to use:</P>
<P>Mental state: BPRS and PANSS subscale scores - unvalidated subscale.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Diagnostic tools and scales</B>
<BR/>CCMD: Classification of Mental Disorders<BR/>DSM IV: Diagnostic and Statistical Manual, 4th edition</P>
<P>
<B>Rating Scales</B>
</P>
<P>Global rating scales:<BR/>CGI: Clinical Global Impressions.<BR/>CGI-S: Clinical Global Impression-Severity.<BR/>CGI-I: Clinical Global Impression-Improvement<BR/>ORDQ: Outcome Resourse Discharge Questionnaire<BR/>ASEX: Arizona Sexual Experience Scale. .</P>
<P>
<B>Mental state<BR/>
</B>BPRS: Brief Psychiatric Rating Scale.<BR/>MADRS: Montgomery-Asberg Depression Rating Scale.<BR/>MMSE: Wiing Mini Mental State Examination.<BR/>PANSS: Positive and Negative Syndrome Scale.<BR/>PANSS-EC: Positive and Negative Syndrome Scale-Excited Component.<BR/>SANS: Scale for the Assessment of Negative Symptoms.<BR/>SAPS: Scale for the Assessment of Positive Symptoms.<BR/>CDSS:Calgary Depression Scale for Schizophrenia<BR/>
<B>Side effects<BR/>
</B>AIMS: Abnormal Involuntary Movement Scale.<BR/>BAS: Barnes Akathisia Scale.<BR/>ESRS: Extrapyramidal Syndrome Rating Scale.<BR/>SAS: Simpson-Angus Index - for neurological side effects.<BR/>TESS: Treatment Emergent Symptom Scale<BR/> UKU: Udvalg for kliniske ndersogelser Side Effect Rating Scale -side effect rating scale.</P>
<P>
<B>Quality of Life<BR/>
</B>QLS: Quality of Life Scale.<BR/>IWQoL-Lite: Impact of Wieght on Quality of Life</P>
<P>
<B>Other<BR/>
</B>BMI: body mass index<BR/>ECG: electrocardiogram<BR/>EPS: extrapyramidal symptoms<BR/>LOCF: last observation carried forward<BR/>SD: standard deviation<BR/>TG: triglyceride<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-09-28 15:59:40 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ai-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Allen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Anon-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole + psychosocial intervention vs aripiprazole, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-28 15:52:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bao-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-28 15:52:09 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: people with schizophrenia</P>
<P>Intervention: aripiprazole + clonazepam vs clozapine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bergman-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: aripiprazole + guanfacine vs aripiprazole, not aripiprazole vs other atypical antipsychotics. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bristol_x002d_Myers-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: aripiprazole as augmenter of atypical antipsychotics, not aripiprazole vs other atypical antipsychotics. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carson-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: aripiprazole vs haloperidol vs placebo, not aripiprazole vs other atypical antipsychotics. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Casey-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: pooled analysis. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-28 15:52:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-28 15:52:57 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-LJ-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-YH-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Colombo-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: metabolic syndrome incidence not schizophrenia.<BR/>Interventions: aripiprazole vs olanzapine.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cornblatt-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised open label. <BR/>Participants: people with schizophrenia. <BR/>Interventions: aripiprazole vs olanzapine. <BR/>Outcome: No usable data available. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fawzi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised open label.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs olanzapine vs olanzapine + clomipramine.<BR/>Outcome: No usable data available.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fleischhacker-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised double blind then open label extension.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole + clozapine vs placebo + clozapine, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Geng-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guan-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-HF-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hatta-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: aripiprazole vs olanzapine vs risperidone vs quetiapine. <BR/>Outcome: No usable data available. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Henderson-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs placebo, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Janssen-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: switch treatment with aripiprazole in patients while on risperidone, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiang-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ju-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole + clozapine vs clozapine, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs other atypical antipsychotics.<BR/>Outcome: No usable data available.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lan-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: shift from other antipsychotics to aripiprazole, not aripiprazole vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007e">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007f">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-C-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs risperidone.<BR/>Outcome: no usable data available.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liemburg-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs risperidone.</P>
<P>Outcome: no usable data available.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-Y-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-XH-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lv-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole + clozapine vs clozapine, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-09 17:17:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Medori-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-09 17:17:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: risperidone (RLAI) vs quetiapine, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Millar-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: clozapine + placebo vs clozapine + aripiprazole, not aripiprazole vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mortimer-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs placebo, not aripiprazole vs other atypical antipsychotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mossner-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: risperidone vs haloperidol, not aripiprazole vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Namey-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: clozapine + placebo vs clozapine + aripiprazole, not aripiprazole vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Newcomer-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - pooled analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Newcomer-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:20 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, pooled analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Newcomer-2008c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, pooled analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pae-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole vs aripiprazole + another antipsychotic (reducing dose over 4 weeks) vs aripiprazole + another antipsychotic (reducing dose over 6 weeks), not aripiprazole alone vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ray-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, cohort study. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Remington-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: aripiprazole + clozapine vs clozapine + placebo, not aripiprazole alone vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schreiner-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia, schizo-affective disorder.<BR/>Interventions: switching treatment for patients on oral risperidone, olanzapine and conventional antipsychotics to RLAI vs quetiapine and aripiprazole, not aripiprazole vs other drugs.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shen-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shim-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation:"double blind", unclear if randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: aripiprazole + haloperidol vs haloperidol + placebo, not aripiprazole alone vs other drugs. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-28 15:57:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-28 15:57:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: open lablel controlled clinical trial, not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-P-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Takeuchi-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: two switching strategies of aripiprazole, not aripiprazole vs other drugs. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Talbott-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Participants: people with schizophrenia. <BR/>Interventions: pooled post-hoc analysis aripiprazole vs haloperidol and aripiprazole vs olanzapine. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taylor-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, open label.<BR/>Participants: schizophrenia.<BR/>Interventions: aripiprazole vs olanzapine vs risperidone vs haloperidol vs quetiapine vs ziprasidone, not aripiprazole vs other atypicals.<BR/>Outcome: no usable data.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006e">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Watts-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, open label. <BR/>Participants: schizophrenia. <BR/>Interventions: aripiprazole vs ziprasidone. <BR/>Outcome: no usable data, study terminated. <BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zeng-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2006b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-F-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-RK-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-XL-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-GW-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-JY-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhe-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-25 15:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised - randomisation allocation according to admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial<BR/>RLAI: Risperidone Long-acting Injection<BR/>vs: versus<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-10-24 15:28:33 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2013-09-28 15:16:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006f">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised (no further description).</P>
<P>Blinding: not stated.</P>
<P>Duration: 8 weeks.</P>
<P>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 15:15:35 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: chronic schizophrenia (CCMD-3).</P>
<P>N = 50.</P>
<P>Sex: male and female.</P>
<P>Age: 20 to 58 years.</P>
<P>History: 5 to 18 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 15:16:38 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 5~30 mg/day, n = 25*.</P>
<P>2. Risperidone: 0.5~5 mg/day, n = 25.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: curative effect.</P>
<P>Mental state: PANSS score.</P>
<P>Adverse events*.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 23:08:47 +0100" MODIFIED_BY="[Empty name]">
<P>N number in various outcomes are inconsistent. We, therefore, decided not to include this trial, until we acquire further clarification from authors.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-10-03 10:52:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2006a">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised (no further description).</P>
<P>Blinding: not stated.</P>
<P>Duration: 8 weeks.</P>
<P>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 15:16:24 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: first episode schizophrenia (CCMD-3).</P>
<P>N = 68.</P>
<P>Sex: male and female.</P>
<P>Age: 24.3 ± 9.4 years in aripiprazole group; 28 ± 10 years in quetiapine group.</P>
<P>History: mean~24 months, SD ~14 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-03 10:52:40 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 10~30 mg/day, n = 34*.</P>
<P>2. Quetiapine: 100~750 mg/day, n = 34.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: curative effect*.</P>
<P>Mental state: PANSS score.</P>
<P>Adverse events.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-25 23:08:52 +0100" MODIFIED_BY="[Empty name]">
<P>* reported N numbers and their corresponding percentage of the same outcome are inconsistent. We, therefore, decided not to include this trial, until we acquire further clarification from authors.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-09-28 15:17:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zheng-XR-2008">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised (no further description).</P>
<P>Blinding: not stated.</P>
<P>Duration: 8 weeks.</P>
<P>Setting: inpatients, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-28 15:16:53 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-3).</P>
<P>N = 68.</P>
<P>Sex: male and female.</P>
<P>Age: 16 to 58 years.</P>
<P>History: median~ 5 months; range 1~32 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-28 15:17:06 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole: 5~30 mg/day, n = 30*.</P>
<P>2. Risperidone: 1~5 mg/day, n = 34.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Global state: curative effect*.</P>
<P>Adverse events*.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-28 15:17:14 +0100" MODIFIED_BY="[Empty name]">
<P>The total number of participants (n = 64) is inconsistent with the total number of people randomised (n = 68). We, therefore, decided not to include this trial, until we acquire further clarification from authors.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x9676__x5efa__x9752__x002c_-2007">
<CHAR_METHODS MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: schizophrenia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>Aripiprazole vs Risperidone</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2013-06-25 15:56:07 +0100" MODIFIED_BY="[Empty name]">
<P>No full-text article.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>CCMD-3: Chinese Classification of Mental Disorders third version<BR/>PANSS: Positive And Negative Symptom Scale<BR/>vs: versus<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-10-24 15:28:33 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bristol_x002d_Myers-2009">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>NCT 00857818</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: open label. <BR/>Duration: 16 weeks. <BR/>Design: parallel. <BR/>Location: not reported. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, bipolar 1 disorder. <BR/>Age 18-65 years. <BR/>Gender: both. <BR/>History: duration of illness not reported. <BR/>Setting: not reported<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Risperidone.<BR/>4. Quetiapine</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>Long-time effectiveness and tolerability.<BR/>Global state: CGI, PG-I.<BR/>Quality of life: IWQoL -Lite.<BR/>Percent change in fasting lipids from baseline.<BR/>Change in fasting glucose, levels weight, BMI.<BR/>Change in fasting non- HDL Cholesterol level from baseline.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>April 2009.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>Bristol-Myers Squibb.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:01 +0100" MODIFIED_BY="[Empty name]">
<P>Not open for participant recruitment. </P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eli-Lilly-2003">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Trial 8047<BR/>F1D-MC-HGLB</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details. <BR/>Blindness: double, no further details. <BR/>Duration: 28 weeks. <BR/>Design: parallel. <BR/>Location: not reported. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia. <BR/>Age 18-65 years. <BR/>Gender: not reported. <BR/>History: duration of illness not reported. <BR/>Setting: in- and outpatient. <BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Long-time effectiveness and tolerability. <BR/>Global state: CGI, PG-I. <BR/>General Mental State: PANSS. <BR/>Depression: MADRS. <BR/>Quality of life: SWN-S, SF-36. <BR/>Cognitive functioning: MOS. <BR/>Sexual functioning: GISF. <BR/>Health resource utilisation and resource utilisation costs, hospitalisation time. <BR/>Treatment-emergent adverse events: EPS (SAS, BAS, AIMS). <BR/>Laboratory values. <BR/>Vital signs. </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>October 2003. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Eli Lilly and Company. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Essock-2002">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT 00044655</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details<BR/>Blindness: single, no further details. <BR/>Duration: unclear. <BR/>Design: parallel. <BR/>Location: multiple. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, schizoaffective disorder or schizophreniform disorder.<BR/>Age 18-65 years.<BR/>Gender: male/female participants.<BR/>History: duration of illness not reported.<BR/>Setting: outpatient.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Risperidone.<BR/>4. Quetiapine.<BR/>5. Ziprasidone.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Efficacy, safety, adverse effects. </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>July 2001.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NIMH. <BR/>United States Federal Government<BR/>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glorioso-2005">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT 00245206<BR/>ID: R01MH71536</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details<BR/>Blindness: open label. <BR/>Duration: 5 years<BR/>Design: parallel. <BR/>Location: unclear. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age &#8805; 45 years.<BR/>Gender: male/female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Risperidone.<BR/>4. Quetiapine.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Metabolic, cardiovascular and cerebrovascular effects. </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>August 2005.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>University of California</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:14:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hanssens-2007">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT 00508157<BR/>CN 138-489</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:14:26 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details<BR/>Blindness: open label.<BR/>Duration: 16 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-65 years.<BR/>Gender: male/female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Risperidone.<BR/>4. Quetiapine.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Change from baseline in fasting non- HDL cholesterol. </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>July 2007.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Bristol -Myers Squibb. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:06:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Johnson-2006">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Study ID- CR006121<BR/>NCT- 00299702</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:06:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: open label.<BR/>Duration: 2 years.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-65 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Risperidal Consta.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Time to relapse, long-time effectiveness and tolerability. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>February 2006.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Johnson and Johnson.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lehrer-2008">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT- 00712270</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: double blind. <BR/>Duration: 16 weeks. <BR/>Design: parallel. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-55 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Risperidone.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Predict differential antipsychotic drug treatment response using PET and MRI. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>April 2005</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Kettring Health Network</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-2009">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT- 00956189</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: single blind. <BR/>Duration: 1 year. <BR/>Design: parallel. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-65 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Amisulpiride.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Metabolic profile and clinical efficacy. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>August 2009. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>National Taiwan University Hospital. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Livingston-2007">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT 00423878<BR/>
</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: single blind. <BR/>Duration: 6 months. <BR/>Design: parallel. <BR/>Location: unclear. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age: 16-65 years.<BR/>Gender: male/female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Risperidone.<BR/>3. Quetiapine.<BR/>4. Olanzapine.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Metabolic effects, adverse events, clinical efficacy and tolerability. </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>January 2007. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McCormack-2006">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT - 00320671<BR/>
</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random. <BR/>Blindness: double blind. <BR/>Duration: 12 weeks. <BR/>Design: parallel. <BR/>Location: unclear. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age: 16-40 years.<BR/>Gender: male/female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Risperidone.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Metabolic effects, adverse events, substance use. </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>2005 - December. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>United States Health Authority</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P> </P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:12:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McEvoy-2007">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>NCT00466310</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:12:58 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: open label.<BR/>Duration: 4 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-60 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Risperidone.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Metabolic adverse effects. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>February 2007</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]">
<P>Duke University. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:02 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:13:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Montoya-2006">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>NCT00330863</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:13:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: open label.<BR/>Duration: 30 months.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-65 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Risperidone.<BR/>3. Quetiapine.<BR/>4. Ziprasidone.<BR/>5. Olanzapine.<BR/>6. Risperidone microspheres.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Time to relapse, long-time effectiveness and tolerability. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>May 2006</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>United States of America</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:13:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schweiger-2005">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>NCT-00205660</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:13:09 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: open label.<BR/>Duration: 12 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age: 18-60 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Quetiapine.<BR/>4. Risperidone.<BR/>5. Ziprasidone.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Metabolic adverse effects. Long-time effectiveness, safety and tolerability. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>February 2005. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Bristol-Myers Squibb</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:14:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stroup-2007">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>NCT-00423878</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:14:32 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: single blind.<BR/>Duration: 6 months.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age: 18-65 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Quetiapine.<BR/>4. Risperidone.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Changes in cholesterol level. Long-time effectiveness, safety and tolerability. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>January 2007. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Duke University , U. S. A. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-09-29 11:15:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Swartz-2008b">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>NCT- 00802100</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-29 11:15:34 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: single blind.<BR/>Duration: 28- 30 weeks.<BR/>Design: parallel.<BR/>Location: multicentre.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age: 18-40 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>3. Perphenazine.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P> Long-time effectiveness, safety and tolerability, use other medication to limit side effects. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>December 2008. </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Duke University , U. S. A. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vontur-2005">
<CHAR_STUDY_NAME MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>NCT00223418</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Blindness: open label.<BR/>Duration: unspecified.<BR/>Design: parallel.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.<BR/>Age 18-52 years.<BR/>Gender: male and female participants.<BR/>History: duration of illness not reported.<BR/>Setting: not specified.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Aripiprazole.<BR/>2. Olanzapine.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Improvement in cognitive functions, long-time effectiveness and tolerability, social and occupational functioning. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>September 2005.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>United States of America.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-25 15:55:03 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>
<B>Global rating scales<BR/>
</B>CGI: Clinical Global Impressions<BR/>PGI-I: Patient&#8217;s Global Impressions of Improvement<BR/>
<BR/>
<B>Mental state:<BR/>
</B>MADRS: Montgomery-Asberg Depression Rating Scale<BR/>PANSS: Positive and Negative Syndrome Scale<BR/>
</P>
<P>
<B>Depression:<BR/>
</B>MADRS: Montgomery&#8211;Åsberg Depression Rating Scale<BR/>
</P>
<P>
<B>Sexual functioning:</B>
<BR/>GISF: Global Impressions of Sexual Function<BR/>
</P>
<P>
<B>Side effects:<BR/>
</B>AIMS: Abnormal Involuntary Movement Scale<BR/>BAS: Barnes Akathisia Scale<BR/>SAS: Simpson-Angus Index - for neurological side effects</P>
<P>
<B>Quality of Life:</B>
<BR/>IWQoL-Lite: Impact of Wieght on Quality of Life<BR/>SF-36: Short form 36<BR/>SWN-S: subjective well-being<BR/>
<BR/>
<B>Other<BR/>
</B>BMI: body mass index<BR/>EPS: extrapyramidal symptoms<BR/>HDL:high-density lipoprotein<BR/>MOS: Medical Outcomes Study<BR/>MRI: magnetic resonance imaging<BR/>PET: positron emission tomography<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-10-24 15:37:38 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-09-29 11:26:58 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:38:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:40:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:41:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:41:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Random, permuted block randomisation stratified by centre.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:42:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:44:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:45:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:14:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>Randomised, random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:16:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:45:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:46:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:17:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:50:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:52:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:54:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:55:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:55:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:56:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:57:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>1:1 randomisation using SARA (System for Automated Randomisation). QTONE an automated touch tone system was used. Statistical blocking factor of four was used and stratified by the study centre.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:59:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:03:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:05:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:06:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:07:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-28 17:22:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>Randomised, random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:09:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:09:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:10:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>Random 1:1, no further details available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:15:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:17:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:19:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>Randomisation, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:20:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:20:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>Randomisation, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:21:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:22:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>Randomised, no further details..</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:24:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>Randomised, no further details..</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:26:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>Randomised, lottery.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:28:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>Randomised, random number table method.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:30:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:32:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:34:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:35:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>Random, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:36:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:37:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>Simple randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:37:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:38:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:39:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>Random, no further details.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:44:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:45:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:48:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:49:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:52:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:54:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:55:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:56:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:57:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:58:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>Randomisation, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:01:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:28:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>Randomised, stratified randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:04:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 11:26:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>4:1 computer-generated randomised schedule using Interactive Voice Response System.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:08:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>Simple randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:10:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:16:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>Simple randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:17:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:18:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:20:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:20:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:21:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:23:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:24:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:26:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:27:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:28:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:31:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Stratified random.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:35:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>Random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:41:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:19:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:45:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>Random permutation table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:46:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:46:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>4:1 computer-generated using Interactive Voice Response System.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:50:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:51:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:52:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:53:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:53:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:54:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:55:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:00:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:00:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:01:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:02:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:03:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>Randomisation, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:03:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:04:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:07:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>Stratified randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:10:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:10:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:12:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:13:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:14:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:15:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:16:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:17:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:18:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>Randomised, random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:19:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:20:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>Random permutation table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:21:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:22:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:23:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:25:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Random permutation table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:26:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:27:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:28:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:29:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:31:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:33:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:36:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>Random, computer-generated, blocked by centre.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:40:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-09-28 16:36:09 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:38:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:40:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:41:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:41:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:42:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:44:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:45:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-28 16:36:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>Low riskUnclear riskHigh risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:45:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:46:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:17:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:50:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:52:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:54:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:55:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:55:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:56:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:57:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:59:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:03:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:05:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:06:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:07:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:07:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:09:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>No further information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:10:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:11:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>Not defined.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:15:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:17:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:19:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:20:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:20:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:21:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:22:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:24:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:26:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:28:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:30:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:32:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:34:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:35:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:36:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:36:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:37:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:38:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:39:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>No further details.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:44:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:45:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:48:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:49:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:52:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:54:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:55:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:56:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:57:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:58:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:01:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:02:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:04:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:07:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:08:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:10:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:16:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:17:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:18:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:20:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:20:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:21:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:23:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:24:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:26:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:27:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:28:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:31:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:35:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>Sealed envelope.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:41:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:19:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:45:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:46:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:50:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:51:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:52:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:53:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:53:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:54:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:55:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:00:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:00:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:01:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:02:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:03:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:03:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:04:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:07:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:10:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:10:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:12:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:13:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:14:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:15:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:16:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:17:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:18:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:19:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:20:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:21:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:22:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:23:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:25:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:26:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:27:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:28:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:29:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:31:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:33:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:35:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>No further details.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:40:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-06-25 15:44:14 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>Objective outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Subjective outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-10-24 15:08:17 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:38:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:40:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:41:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:42:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Double, identical capsules. Whether blinding was successful has not been examined, but both compounds differ quite substantially in adverse effects. This can be a problem for blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:42:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:43:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:43:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:44:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:45:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 23:14:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 23:16:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>Low riskUnclear riskHigh risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:45:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:46:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:47:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 23:17:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:50:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:52:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:54:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:55:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:55:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:56:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:57:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>Double, no further details. Whether blinding was successful has not been examined, but both compounds differ quite substantially in adverse effects. This can be a problem for blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:59:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 17:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:01:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:01:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>Double.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:02:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:02:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:03:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:05:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:06:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:07:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:07:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:09:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:10:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:11:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:12:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>Double. No further details available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:12:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:13:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:13:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:14:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:14:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:15:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:16:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:16:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:17:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:18:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:18:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:19:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:20:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:20:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:21:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:22:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:23:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:23:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:24:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:25:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:25:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:26:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:27:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:27:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:28:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:29:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:29:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:30:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:31:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:31:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:32:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:33:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:33:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:34:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:35:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>Double, no further details. Whether blinding was successful has not been examined, but both compounds differ quite substantially in adverse effects. This can be a problem for blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:36:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:36:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:37:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:38:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:39:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>Double, identical capsules. Whether blinding was successful has not been examined, but both compounds differ quite substantially in adverse effects. This can be a problem for blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:44:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:45:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:48:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:49:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:52:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:54:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:55:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:56:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:57:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 18:58:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:01:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:02:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:04:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:07:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:08:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:10:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:16:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:17:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:18:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:19:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:19:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:20:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:20:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:21:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:23:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:24:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:26:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:27:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:28:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:29:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:29:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:30:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:31:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-10-24 15:08:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:41:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 23:19:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:45:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:46:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:47:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:48:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:48:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:49:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:49:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:50:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:51:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>Double.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:52:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>Double.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:53:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:53:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:54:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 19:55:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:00:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:00:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:01:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:02:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:03:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:03:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:04:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:06:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:06:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:07:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:08:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:08:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:10:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:10:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:12:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:13:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:14:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:15:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:16:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:17:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:18:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>Single, if the blinding was performed well was unknown.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:19:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:20:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:21:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:22:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:23:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:25:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:26:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:27:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:28:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:29:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>Single blind, but whether the blindness was performed well was unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:31:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:33:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:36:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>Double, double dummy administration. Whether blinding was successful has not been examined, but both compounds have similar adverse effects.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-25 20:40:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2013-09-29 10:36:55 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:38:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:39:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:40:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:41:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:42:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Objective outcomes such as laboratory measures or death are unlikely to have been much affected by problems of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:42:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:43:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:43:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:44:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:45:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 23:14:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 23:16:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:45:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:46:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:47:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 23:18:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:50:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:52:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:54:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:55:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:55:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:56:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>Blinded evaluation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:57:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>Objective outcomes such as laboratory measures or death are unlikely to have been much affected by problems of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:59:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 17:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:01:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:01:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:02:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:02:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:03:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:05:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:06:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:07:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:07:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:09:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>Objective outcomes such as death are unlikely to have been much affected by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:09:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:11:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:12:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>Objective outcomes such as laboratory measures or death are unlikely to have been much affected by problems of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:12:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:13:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:13:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:14:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:14:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:15:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:16:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:16:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:17:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:18:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:18:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:19:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:20:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:20:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:21:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:22:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:23:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:23:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:24:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:25:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:25:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:26:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:27:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-09-29 10:36:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>Unclear if outcome were assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:28:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:29:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:29:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:30:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:31:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:31:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:32:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:33:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:33:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:34:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:35:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>Objective outcomes such as laboratory measures or death are unlikely to have been much affected by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:36:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:36:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:37:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:38:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:39:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:43:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>Objective outcomes such as laboratory measures or death are unlikely to have been much affected by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:44:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:45:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:48:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:49:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:52:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:54:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:55:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:56:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:57:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 18:58:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:01:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:02:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:04:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:07:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:08:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:10:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:16:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:17:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:18:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:19:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:19:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:20:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:20:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:21:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:23:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:24:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:26:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:27:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:28:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:29:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:29:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:30:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:31:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:36:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>There was no blinding on outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:41:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 23:19:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:45:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:46:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:47:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:47:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>Open label.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:48:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:48:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:49:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:49:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:50:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:51:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:52:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:53:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:53:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:54:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 19:55:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:00:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:00:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:01:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:02:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:03:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:03:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:04:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:06:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:06:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:07:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:08:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:08:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:10:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:10:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:12:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:13:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:14:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:15:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:16:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:17:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:18:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:19:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:20:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:21:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:22:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:23:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:25:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:26:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:27:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:28:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:29:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:31:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:33:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:37:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>Objective outcomes such as laboratory measures or death are unlikely to have been much affected by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-25 20:40:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>Unclear if outcome was assessed blindly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-10-24 15:37:38 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-28 16:17:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>There was no drop-out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:39:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:41:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-28 17:18:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Total number of drop-out = 25%.<BR/>The LOCF method was used to account for people leaving the study early.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:43:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:43:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:44:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:45:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 23:15:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>4% patients were lost to follow up (2/40 vs 1/35), and there were no difference between the two groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 23:16:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:46:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:46:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:47:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:47:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 23:18:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:33:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:33:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:34:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:55:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:55:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:34:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>The total proportion of loss to follow-up was 13.4% (5/35 vs. 4/34), there no no difference between the two groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:57:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>Leaving the study early data within the first six weeks were 25% overall, but data on reason for dropout were not available. The LOCF method was used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:59:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 17:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:01:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:01:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:02:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-28 17:12:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>One patient was lost to follow-up in olanzapine.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-28 17:14:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:05:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:06:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:07:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:07:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>LOCF.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:09:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>LOCF.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:11:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>LOCF.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:12:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>The LOCF method was used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-28 17:35:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>The total rate of loss to follow-up was 5% (6/120), and there was no difference between the two group. All 6 participants dropped out because of economic issue.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:09:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>The total proportion of loss to follow-up was 4.29% (1/35: 2/35), and there was no difference between the two groups. All because of adverse effects.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:36:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>The total proportion of loss to follow-up was 2.63% (1/38: 0/38), all because of adverse effects.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:14:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:14:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:15:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:16:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:16:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:17:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:18:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:18:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:19:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:22:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:24:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>Six patients were lost to follow-up in risperidone group, four because of adverse effect, two due to progressive disease. No patient was lost to follow-up in aripiprazole group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:21:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:22:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:23:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:24:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:24:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:29:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:25:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:26:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:35:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:27:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:28:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:29:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:29:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:30:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:31:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:31:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>The total proportion of loss to follow-up was 7.5% (1/40: 2/40 ), and there was no difference between the two groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:32:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:45:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:33:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:34:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 23:25:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>Quote:"Because of the high number of participants who discontinued the study (72%) results of analysis by time point are described on the observed case (OC) basis (except for primary outcome), as the last observation-carried-forward analysis would have included a large amount of data carried forward from patients who discontinued the study."<BR/>Due to the high number of participants leaving the study early, the validity is definitely limited.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:36:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:37:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>Two cases lost in risperidone group because of lactation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:37:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:54:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>The total rate of lost to follow-up was 3.5%(3/85), and there was no difference between the two groups (2/44: 1/41).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:40:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:57:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>The overall drop out rate was 36.9 %. The LOCF method was used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:58:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 10:59:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>One patient was lost to follow-up because of economic issues in aripiprazole group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:48:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:49:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:52:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:54:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:55:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:56:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:57:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 18:58:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:01:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:03:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:04:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:05:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:06:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>LOCF method used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:09:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:11:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 11:29:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>One patient lose to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:17:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:18:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>The total rate of loss to follow-up was 4.4%(3/90 vs. 1/90), 1 participant dropped out because of adverse effect, 1 dropped out because of no effect, 2 dropped out because of incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:37:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>The total rate of lost to follow-up was 26.5% (18/68, 11/36 vs. 7/32). 8 participants dropped out because of progressive disease, 10 dropped out because the trialists could not insist on follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:19:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:37:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>One patient discontinued therapy due to leucopenia.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:21:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:21:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:23:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>Unclear if there was drop-out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:24:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>No incomplete outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:27:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 11:42:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Total proportion of drop-out was 3.15% and the data of the two groups were balanced (2/46: 1/49). Two because of adverse effect, one due to economic issue.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:28:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:29:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:29:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:30:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:30:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 11:48:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Total proportion of drop-out was 8.3% and the data of the two groups were balanced.The proportion of missing outcomes was not enough to have a clinically relevant impact on the intervention effect estimate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:36:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:34:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:45:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:46:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:46:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>LOCF method used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:47:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>LOCF method used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:48:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>Unclear if there was drop-out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:43:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:49:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:49:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:51:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:47:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>Total proportion of drop-out was 7.7% (2/26 vs. 2/26). Aripiprazole group: 1 because of violation of study scheme, 1 because of bad compliance; risperidone group: 1 because of violation of study scheme, 1 because of drug combination; 1 because of effect.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:49:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>Total proportion of drop-out was 7.7% (2/26 vs. 2/26). Aripiprazole group: 1 because of violation of study scheme, 1 because of bad compliance; risperidone group: 1 because of violation of study scheme, 1 because of drug combination; 1 because of effect.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:53:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:53:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:52:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>The total proportion of loss to follow up was 6% (4/50 vs. 2/50). Aripiprazole group: 2 cases because of drug combination, 1 case because of adverse effect, 1 case due to family demanded; risperidone group: 2 cases because of drug combination.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 19:55:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>No incomplete outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:00:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>Unclear if there was drop-out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:55:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:57:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:02:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>There was no drop-out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 13:59:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:04:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 14:00:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>Two people were lost to follow-up (1/30 VS.1/30) in the two groups, one because of early discharge, one due to refusing further therapy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 14:02:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:06:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>Five people were excluded from analysis due to incomplete outcome data. It is unclear which group these 5 people belonged to.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:06:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>Unclear if there was incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:07:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:08:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:08:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:09:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 14:08:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:10:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 14:10:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:12:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:13:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:14:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:15:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:16:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:17:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:18:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>unclear if there were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:19:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:20:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:21:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>Unclear if there were incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:22:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>No incomplete outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:23:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:24:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:25:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>No incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:26:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:27:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>Unclear if there were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:28:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>There were no incomplete data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:29:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>There were drop-outs, but specific digital was not obtained.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 14:28:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>Total proportion of drop-out was 3.3% and the data of the two groups were balanced (1/30: 1/30).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-29 14:29:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>The total proportion of loss to follow-up was 6.2% (5 people), but it was unclear proportion in every group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:36:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>LOCF method used to account for people leaving the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-25 20:40:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>Unclear if there was drop-out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-10-24 15:35:44 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:38:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of use of alprazolam, propranolol and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-28 16:09:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>The outcome did not include missing data. There were no data on other adverse events. This procedure may have missed important data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:40:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>Data on liver function, insomnia, somnolence, and sleep disorder were missing or incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:41:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on renal function, EEG, use of benzodiazepines and other medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:42:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Only adverse events with an incidence of at least 5% in any treatment group were reported, therefore important side effects may have been missed by this procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:42:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>Data on TESS total score, blood glucose, liver function, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on blood routine, blood glucose, electrolyte, ECG, liver function were deficient.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on blood routine, blood glucose, use of propranolol, benzodiazepines and other medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:45:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on EEG, ECG, urine routine, use of benzhexol, benzodiazepine and propranolol were also missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:15:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, ECG, EEG, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:16:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>Data on TESS total score, nausea/vomiting, dizziness, blurred vision, insomnia, constipation, excitement, use of benzodiazepines and other medicines was missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:46:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of benzodiazepines and other medicines was missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:46:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Data on CGI-GI score, TESS score, blood routine, urine routine, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>Although GQL I - 74 was used to assess Quality of life, no data on score were available. Data on anxiety, somnolence, ECG, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:48:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:18:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:50:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>Data on TESS total score, ESRS score, blood and urine routines, liver function, use of benzodiazepine and anticholinergic medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:52:46 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>Data on TESS total score, use of benzhexol, benzodiazepine and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>Data on BPRS score, TESS score, ECG, EEG were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:54:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-28 16:53:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on laboratory tests (urine routine, glucose, liver function) and ECG were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-24 15:34:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on blood and urine routine, renal function, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:56:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, ECG, liver function and other adverse effects were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:58:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>Data for the predefined primary outcome are available but secondary outcome measures like 30% PANSS total reduction are missing in the six-week interim report. Treatment emergent adverse events are hardly addressed in the interim report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:59:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on blood routine, liver function were incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:00:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>Data on TESS total score and use of benzodiazepine were missing. Data on weight-average endpoint level were incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, use of benzodiazepines and anticholinergic medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on laboratory tests (urine routine, hepatorenal function) and EEG were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>Data on CGI score, TESS total score, blood and urine routine, use of benzodiazepines anticholinergic medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:04:40 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>Data of TESS total score, blood routine, blood glucose, electrolyte, ECG, liver function was missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-24 15:35:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, ECG, liver function, blood glucose, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:05:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>Although PANSS was used to assess mental state, no end data on score were available. Data on use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:06:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, use of benzodiazepines and anticholinergic medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:07:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of use of alprazolam, propranolol and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:07:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>Data on somnolence, weight gain, EGG abnormal, salivation, dry mouth, blurred vision (no data) and use of alprazolam, propranolol, anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:09:29 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>Only adverse events with an incidence of more than 5% were reported. This procedure may have missed important adverse events.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:10:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>Few neuro-cognitive tests were mentioned but usable data was not available from them.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:11:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>Only adverse events with an incidence of more than 5% were reported. This may have missed important adverse events. Some scales used had no reported usable data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>Adverse effects were reported if &#8805; 1% of patients in either treatment group experienced them. Some scales used had no data published.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-28 17:35:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on laboratory tests (blood routine, urine routine, glucose, liver function, etc) were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines, benzhexol, and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, renal function, use of benzodiazepines and anticholinergic drug were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>Although ESRS was used to assess adverse effects, no data on score were available. Data on laboratory tests(blood routine, urine routine, glucose, liver function, etc) and ECG were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of anti-psychotic drugs and benzhexol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:15:42 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>Data onTESS total score, menstrual disorder, lactation, weight gain, EEG, ECG, blood routine, urine routine, hepatorenal function, use of benzhexol, benzodiazepine and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>Data on TESS score, blood routine, EEG, weight, and use of alprazolam, propranolol and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, renal function, PRL, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:17:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>Data on laboratory tests (urine routine, hepatorenal function), use of alprazolam, propranolol and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>Data on TESS total score, ECG, EPS, use of benzodiazepines, propranolol, and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:19:40 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>Data on TESS total score were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:20:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>Data of TESS total score, blood and urine routines, liver function, ECG were missing (no data) .</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:21:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:21:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of benzodiazepines, benzhexol and propranolol medication were also missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:22:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>Data on TESS score,blood routine, blood glucose, use of benzodiazepines, benzhexol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of benzodiazepines, benzhexol and propranolol medication were also missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on use of benzodiazepines, benzhexol and propranolol medication were also missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:24:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>Data on TESS score, blood routine, liver function, use of alprazolam, propranolol and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>Data on blood and urine routines, ECG, hepatorenal function, use of benzodiazepines and other medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>Data on TESS total score, hepatorenal function, use of benzodiazepines, propranolol and other medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:26:40 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>Data on TESS total score were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and benzhexol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:28:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>The data on TESS total score, headache, insomnia, somnolence, nausea/vomiting, weight gain, extrapyramidal side-effects, blood routine, urine routine, hepatorenal function, use of benzodiazepines and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>Data on TESS total score, ECG, blood glucose and serum lipids, use of benzodiazepines and other medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>Data on TESS total score, ECG, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:30:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>Data on TESS total score were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>Data on TESS total score, EPS, tachycardia, menstrual changes, etc. and use of benzhexol, benzodiazepine, propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>Data on TESS score, use of benzodiazepines, anticholinergic drug were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:32:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, use of benzodiazepines and anticholinergic medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>Data of TESS total score, tremor, dry mouth, dystonia, use of benzhexol, benzodiazepine and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>Data on TESS score, use of benzodiazepines, anticholinergic drug were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:34:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:25:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>Although inclusion criteria required participants in acute relapse, no data on PANSS positive sub score were available. Data on use of antiparkinson medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:36:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 10:51:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>Data on blood and urine routine, ECG, liver function, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:37:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>The data on adverse effects were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:39:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>The data on TESS total score, EEG, liver function, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:40:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>Data on somnolence, ECG abnormal, mouth dry, constipation blurred vision, use of benzodiazepines were incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:43:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>For efficacy outcomes there was no standard deviation or standard error indicated which had to be back calculated.<BR/>Only adverse events with an incidence of more than 5% were reported. This procedure may have missed important adverse events.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:45:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:45:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, liver function, blood pressure change, blood glucose change were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:48:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>Data on TESS total score, liver function, blood and urine routines, use of benzodiazepines, propranolol, and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:49:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>Data on GQOLI - 74 score, anxiety, EPS, somnolence, ECG, anxiety, EPS, somnolence, ECG, mouth dry, liver function, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:52:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and other medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:54:40 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, use of benzodiazepines and other medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>Data on adverse effects were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:56:50 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>Data on TESS total score and use of benzhexol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:57:42 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>Data on TESS total score, excitement, insomnia, myotonia, akathisia, tremor, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:58:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:01:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>Data on TESS total score, lactation, menstrual disorders, excitement, insomnia, myotonia, akathisia, tremor, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:03:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:04:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>Data on TESS total score, use of anticholinergic medicine and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:05:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepine and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:07:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>Adverse events were reported if they were &gt; 5%. Scales if used were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:09:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>Data on TESS score, use of benzodiazepines, propranolol and benzhexol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:11:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>Data on TESS score, EEG, use of benzodiazepines and other medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:17:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>Data on TESS score, use of benzodiazepines and other medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:17:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>Data on TESS total score, insomnia, anxiety, nausea, endocrine, weight gain, headache, dizziness, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:18:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>Data on TESS total score and use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>Data on adverse effects were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 11:37:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on ECG and weight were missing. Data on laboratory tests (hepatorenal function, glucose, electrolytes) were unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:21:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Data on gastrointestinal (dry mouth, constipation), blurred vision, weight gain and EEG abnormal were unclear. Data on blood and urine routine, blood pressure were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:21:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on score were available. Data on hepatorenal function were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:23:46 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>Although GQOLI-74 was used to assess quality of life, no data on score were available. Data on EPS, ECG, liver function, and mouth dry were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:25:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>Data on TESS score were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:27:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>Data TESS total score, blood, urine, and stool routine, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:28:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:28:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, kidney function, electrolyte, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>Data on TESS total score were missing. Data on extrapyramidal symptoms were incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>Data on TESS total score, ECG, EPS, use of benzodiazepines, propranolol, and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Although PANSS score decreased rate was used to assess effect, no data were available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>Data on TESS score, blood and urine routine, ECG. were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:32:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>No data on efficacy were available. Data on other adverse effects were also missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:36:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, ECG, liver function, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:35:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on urine routine, hepatorenal function and EEG were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-24 15:28:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>Data on Global state, TESS total score, excitement or agitation insomnia, somnolence, myotonia, akathisia, tremors, use of benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:45:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:46:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, renal unction, use of benzodiazepines and anticholinergic medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>Adverse events were reported if they were &gt; 5%. Scales if used were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:50 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>Adverse events were reported if they were &gt; 5%. Scales if used were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>The data on TESS score, blood routine, hepatorenal function, electrolyte were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>The data on use of benzhexol, propranolol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>No imported outcome were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on blood routine, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on use of benzhexol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 13:48:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>Data on TESS total score, Extrapyramidal reaction scale score, BARS scores were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 13:49:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>Data on TESS total score, Extrapyramidal reaction scale score, BARS scores were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 13:50:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on blood routine, hepatorenal function, EEG, and weight were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 13:51:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on dizziness, salivate, constipation, weight gain, and renal function were deficient. Data on use of benzodiazepines were also missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:54:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>Data on number of no effect, blood and urine routine, renal function, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:59:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>No evidence of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:00:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>Data on TESS total score and hepatorenal function were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:01:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>Data on TESS score, RSESE score, blood and urine routine,hepatorenal function, drugs for adverse events were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:01:48 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>Although blood and urine routine, liver function, ECG, weight and other adverse effect, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:02:39 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>Data on TESS total score, blood routine, liver function, blood glucose, weight, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:03:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:04:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>Data on TESS total score and blood and urine routine, liver function, blood glucose were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:04:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, weight gain, extrapyramidal effects, constipation, somnolence, use of benzodiazepines and other medicine were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:05:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>Data on TESS total score and hepatorenal function were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on liver function and blood glucose were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>Data on TESS score, blood and urine routine, and renal function were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:06:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on EEG and drugs for adverse events were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:09:36 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>Data on blood routine, urine routine, blood glucose,and hepatorenal function were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on use of benzhexol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:11:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>Data on blood and urine routine, liver function, ECG, use of benzodiazepines and benzhexol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:11:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:12:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>Data on blood and urine routines, EEG, use of anticholinergic drug and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:13:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>Data on various specific adverse effects were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>Although ESRS was used to assess adverse effects, no data on scores were available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>Although ESRS was used to assess adverse effects, no data on scores were available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>Data on TESS score, endocrine change, laboratory tests were missing. No data of Quality of life GQOLI - 74.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:17:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>Data on TESS, use of benzhexol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:18:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>No evidence of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:19:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>Data on TESS total score, blood and urine routine, blood glucose, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:36:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>Although TESS was used to assess adverse effects, no data on scores were available. Data on use of benzhexol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:21:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>Data on GQOLI - 74 score, anxiety, EPS, ECG abnormal, mouth dry, liver function, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 14:20:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>TESS score was measured, but not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:23:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>Data on TESS score, use of benzodiazepines, benzhexol and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:24:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines, benzhexol and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:25:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Data on TESS score, PANSS negative subscore, cognitive factor, affective symptoms, hepatorenal function, use of benzhexol and benzodiazepines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:26:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and anticholinergic medication were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:27:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>Data on GQOLI - 74 score, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:28:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>Data on TESS total score, EEG, use of benzodiazepines, benzhexol and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>Data on blood and urine routine, liver function were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:31:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>Data on CGI score, TESS total score, akathisia, tremor, insomnia, constipation, drowsiness sleepiness, weight gain, EEG, blood routine, urine routine, use of benzodiazepine and propranolol were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:33:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>Data on TESS total score, use of benzodiazepines and other medicines were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:36:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>Only adverse events with an incidence of more than 5% were reported. This procedure may have missed important adverse events.</P>
<P>CDSS and ORDQ - no numerical data reported because"no statistically significant differences were observed. . ."</P>
<P>AIMS, BAS, SAS were portrayed very differently to other scales - allowing computation of data but not giving clear person-based numbers for the ratings.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:40:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>No selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-09-29 10:39:37 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:38:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-An-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:39:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:40:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:41:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ban-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:42:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>The study was industry sponsored by the manufacturer of aripiprazole.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:42:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chang-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:43:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:44:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2008a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:45:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:15:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:16:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:46:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2010a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:46:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-CuiMeng-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:47:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dai-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:18:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dai-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:50:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deng-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:52:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deng-2008a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:54:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Du-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:55:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fan-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:55:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fan-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:56:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feng-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-28 17:04:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fleischhacker-2008">
<DESCRIPTION>
<P>The study was industry sponsored by the manufacturer of aripiprazole.<BR/>Baseline data reporting is insufficient in terms of missing data on history of illness.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 17:59:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fu-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:00:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ge-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ge-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:01:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guo-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Han-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:02:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Han-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:04:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Han-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:05:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hu-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:06:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:06:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ji-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:07:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jiang-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:08:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jie-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:09:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kane-2009">
<DESCRIPTION>
<P>Drug company involvement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:10:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kern-2006">
<DESCRIPTION>
<P>Drug company involvement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:11:39 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kerwin-2007">
<DESCRIPTION>
<P>Drug company involvement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kinon-2004">
<DESCRIPTION>
<P>The study was industry sponsored by the manufacturer of olanzapine.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:12:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuang-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:13:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2006a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:14:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:15:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:15:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007c">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:16:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2007d">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:17:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:18:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2009b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:19:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-X-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:20:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lian-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:21:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liang-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:21:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:22:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2006a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:23:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:24:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:25:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008c">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:26:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2008d">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:27:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-29 10:39:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2009b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:29:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lou-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:30:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luo-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luo-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:31:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lv-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:32:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ma-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ma-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:33:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mai-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:34:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mao-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:25:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McQuade-2004">
<DESCRIPTION>
<P>The study was industry sponsored by the manufacturer of aripiprazole.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:36:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mu-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:37:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mu-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:37:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pan-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:39:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peng-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:40:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peng-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:43:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Potkin-2003">
<DESCRIPTION>
<P>The study was industry sponsored by the manufacturer of aripiprazole. The study used a fixed dose regimen, where it is difficult to say which comparator doses may be appropriate.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:45:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pu-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:46:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qian-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:48:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qin-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:49:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qu-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:52:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shan-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:54:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shuai-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:55:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:56:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:57:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 18:58:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Su-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:01:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Su-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:03:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:04:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:05:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:07:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tandon-2006">
<DESCRIPTION>
<P>Industry sponsored.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:09:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:11:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:17:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:17:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2010a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:18:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tao-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:19:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tong-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:20:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tu-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:20:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:21:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:21:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:23:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:24:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006c">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:27:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006d">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:28:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:28:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007d">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:29:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007e">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:30:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2008c">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:31:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:36:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wei-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:42:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wei-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 23:19:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wei-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:45:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wen-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:46:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wen-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wlodzmierz-2006">
<DESCRIPTION>
<P>Industry sponsored.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:47:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wolf-2007">
<DESCRIPTION>
<P>Industry sponsored.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wu-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:48:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiao-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xie-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:49:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xie-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:51:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xu-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:52:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xu-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:52:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:53:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:54:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2008a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:54:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 19:55:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:00:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:01:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:01:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2008a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:02:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2008b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:03:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:04:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ye-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:04:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ye-2005a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:05:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yi-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:06:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2006a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:07:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:08:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:09:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-ZG-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:10:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:11:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2006a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:11:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:12:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:13:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2007b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:14:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:15:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2008a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:16:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2008b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:17:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:18:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2009a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:19:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2009b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:20:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:21:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2010a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:22:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhao-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:23:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhao-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:24:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhi-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:25:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:26:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007a">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:27:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007b">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:28:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:30:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhu-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:31:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhu-2008">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:33:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhu-2010">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:38:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimbroff-2007">
<DESCRIPTION>
<P>Random sequence generation (selection bias)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-25 20:40:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zou-2006">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-09-29 15:25:19 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-09-29 15:23:51 +0100" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2013-06-27 21:44:46 +0100" MODIFIED_BY="Grade Profiler">COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE for schizophrenia</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE for schizophrenia</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia<BR/>
<B>Settings: </B>inpatient and outpatient<BR/>
<B>Intervention:</B> COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Global state: No clinically significant response </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.05 </B>
<BR/>(0.87 to 1.27)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>2132<BR/>(29 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>105 per 1000</B>
<BR/>(87 to 127)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>157 per 1000</B>
<BR/>(131 to 190)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>210 per 1000</B>
<BR/>(174 to 254)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Mental state: as measured by BPRS</B>
<BR/>BPRS (high score = poor)</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean mental state: as measured by BPRS in the intervention groups was<BR/>
<B>0.22 lower</B>
<BR/>(1.44 lower to 1 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>426<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Leaving the study early - Any reason </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.41 </B>
<BR/>(0.46 to 4.29)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>240<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>70 per 1000</B>
<BR/>(23 to 214)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>141 per 1000</B>
<BR/>(46 to 429)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life: as measured by WHO-QOL-100</B>
<BR/>WHO-QOL-100 (low score = poor)<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life: as measured by WHO-QOL-100 in the intervention groups was<BR/>
<B>2.59 higher</B>
<BR/>(1.43 to 3.74 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>132<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>6</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Adverse effects: extrapyramidal effects </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.91 </B>
<BR/>(0.75 to 4.85)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>520<BR/>(8 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>96 per 1000</B>
<BR/>(38 to 242)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>191 per 1000</B>
<BR/>(75 to 485)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>General functioning</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Service use</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Risk: moderate risk approximately equates to that of the control group risk in the study population.<BR/>
<SUP>2</SUP> Risk of bias: rated 'serious' - majority of the included studies had inadequate study design - unclear randomisation, allocation concealment and blinding. Some also had selective reporting concerns.<BR/>
<SUP>3</SUP> Imprecision: rated 'serious' - most of these included studies are of small samples with small effect size and wide confidence interval. The combined effect was not statistically significant.<BR/>
<SUP>4</SUP> Imprecision: rated 'serious' - we were unable to obtain direct binary measure of mental state, thus used BPRS score as an indicator.<BR/>
<SUP>5</SUP> Publication bias: rated 'strongly suspected' - only a small number of studies favouring intervention group were identified.<BR/>
<SUP>6</SUP> Indirectness: rated 'serious' - we were unable to obtain direct binary measure of quality of life, thus employed WHO-QOL-100 rating score as an indicator.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2013-09-29 15:24:19 +0100" MODIFIED_BY="Grade Profiler" NO="2" READONLY="YES">
<TITLE MODIFIED="2013-06-27 21:46:55 +0100" MODIFIED_BY="Grade Profiler">COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE for schizophrenia</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE for schizophrenia</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia<BR/>
<B>Settings: </B>inpatient and outpatient<BR/>
<B>Intervention:</B> COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Global state: No clinically significant response (as defined by original studies)</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.92 </B>
<BR/>(0.64 to 1.32)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>991<BR/>(12 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>46 per 1000</B>
<BR/>(32 to 66)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>92 per 1000</B>
<BR/>(64 to 132)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>138 per 1000</B>
<BR/>(96 to 198)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Mental state: as assessed by PANSS positive symptom scale score</B>
<BR/>PANSS positive symptom subscale (high score = poor)<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean mental state: as assessed by PANSS positive symptom scale score in the intervention groups was<BR/>
<B>0.97 lower</B>
<BR/>(2.34 lower to 0.41 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>583<BR/>(7 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>4,5,6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Leaving the study early </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.8 </B>
<BR/>(0.22 to 2.87)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>168<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>40 per 1000</B>
<BR/>(11 to 143)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>80 per 1000</B>
<BR/>(22 to 287)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life: as measured by WHO-QOL-100</B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life: as measured by WHO-QOL-100 in the intervention groups was<BR/>
<B>2.6 higher</B>
<BR/>(1.31 to 3.89 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>100<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>8,9,10,11</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Adverse effects: extrapyramidal symptoms</B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 2.8 </B>
<BR/>(0.64 to 12.31)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>348<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,7,12,13</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>140 per 1000</B>
<BR/>(32 to 616)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>280 per 1000</B>
<BR/>(64 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>General functioning </B>- not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Service use</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Risk: moderate risk approximately equates to that of the control group risk in the study population.<BR/>
<SUP>2</SUP> Risk of bias: rated 'serious' &#8211; majority of the included studies had inadequate study design - unclear randomisation, allocation concealment and blinding. A large proportion of them also had selective reporting concerns.<BR/>
<SUP>3</SUP> Imprecision: rated 'serious' &#8211; most of these included studies are of small samples with small effect size and wide confidence interval. The 95% confidence interval of the combined estimated effect was not statistically significant.<BR/>
<SUP>4</SUP> Imprecision and risk of bias: rated 'serious' - most of the studies included are of small sample size, the overall pooled estimate of effect is not significant.<BR/>
<SUP>5</SUP> Inconsistency: rated 'serious' - unexplained heterogeneity is high (70%).<BR/>
<SUP>6</SUP> Indirectness: rated 'serious' - we were unable to obtain direct binary measure of mental state, thus used the best approximate measure available as an indicator.<BR/>
<SUP>7</SUP> Publication bias: rated 'strongly suspected' - only small number of studies were identified - publication bias likely.<BR/>
<SUP>8</SUP> Imprecision and publication bias: rated 'serious' - only small number of studies with poor methodological design favouring intervention group were identified - publication bias likely<BR/>
<SUP>9</SUP> Risk of bias: rated 'serious' &#8211; the only included study has unclear study design (randomisation, allocation concealment, blinding were unclear) and concerns of selective reporting.<BR/>
<SUP>10</SUP> Indirectness: rated 'serious' - we are unable to obtain a direct binary measure of quality of life, thus used the best available proximate measure of WHO-QOL-100 as an indicator.<BR/>
<SUP>11</SUP> Imprecision: rated 'very serious' - only one study is available on this outcome. The sample size is small and the CI of effect estimate is wide.<BR/>
<SUP>12</SUP> Inconsistency: rated 'serious' - unexplained heterogeneity is around 53%.<BR/>
<SUP>13</SUP> Imprecision: rated 'serious' - overall event rate is small (&lt;300).</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2013-09-29 15:24:42 +0100" MODIFIED_BY="Grade Profiler" NO="3" READONLY="YES">
<TITLE MODIFIED="2013-06-27 21:48:01 +0100" MODIFIED_BY="Grade Profiler">COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE for schizophrenia</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE for schizophrenia</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia<BR/>
<B>Settings: </B>inpatient and outpatient<BR/>
<B>Intervention:</B> COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Global state: No clinically significant response (as defined by the original studies)</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.08 </B>
<BR/>(0.96 to 1.21)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>6381<BR/>(80 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>54 per 1000</B>
<BR/>(48 to 61)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>108 per 1000</B>
<BR/>(96 to 121)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>162 per 1000</B>
<BR/>(144 to 182)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Mental state: as measured by BPRS</B>
<BR/>BPRS (high score = poor)<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean mental state: as measured by BPRS in the intervention groups was<BR/>
<B>1.33 lower</B>
<BR/>(2.24 to 0.42 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>570<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>4,5,6</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Leaving the study early </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.02 </B>
<BR/>(0.79 to 1.32)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>1239<BR/>(12 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>102 per 1000</B>
<BR/>(79 to 132)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>153 per 1000</B>
<BR/>(119 to 198)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Adverse effects: extrapyramidal symptoms</B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.39 </B>
<BR/>(0.31 to 0.5)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>2605<BR/>(31 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>39 per 1000</B>
<BR/>(31 to 50)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>300 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>117 per 1000</B>
<BR/>(93 to 150)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>400 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>156 per 1000</B>
<BR/>(124 to 200)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>General functioning </B>- not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Service use</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Risk: moderate risk approximately equates to that of the control group risk of the study population.<BR/>
<SUP>2</SUP> Risk of bias: rated 'serious' - majority of the included studies had inadequate study design - unclear randomisation, allocation concealment and blinding. A large proportion of them also had selective reporting concerns.<BR/>
<SUP>3</SUP> Imprecision: rated 'serious' - 95% CI around the pool estimate of effect was not statistically significant.<BR/>
<SUP>4</SUP> Risk of bias: rated 'serious' - only a small number of publications with poor methodological design favouring intervention group were identified - publication bias likely.<BR/>
<SUP>5</SUP> Indirectness: rated 'serious' - we were unable to find direct binary measure of mental state, thus used the best available data as an indicator.<BR/>
<SUP>6</SUP> Publication bias: rated 'strongly suspected' - overall event number is small (&lt;300) and the pooled effect estimate is not statistically significant.<BR/>
<SUP>7</SUP> Imprecision: rated 'serious' - overall event number is small (&lt;300).<BR/>
<SUP>8</SUP> Publication bias: rated 'strongly suspected' - most of the studies identified were of poor methodological quality favouring intervention group - publication bias likely.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2013-09-29 15:24:55 +0100" MODIFIED_BY="Grade Profiler" NO="4" READONLY="YES">
<TITLE MODIFIED="2013-06-27 21:49:13 +0100" MODIFIED_BY="Grade Profiler">COMPARISON 4. ARIPIPRAZOLE versus ZIPRASIDONE for schizophrenia</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>COMPARISON 4. ARIPIPRAZOLE versus ZIPRASIDONE for schizophrenia</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia<BR/>
<B>Settings: </B>inpatient and outpatient<BR/>
<B>Intervention:</B> COMPARISON 4. ARIPIPRAZOLE versus ZIPRASIDONE<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>COMPARISON 4. ARIPIPRAZOLE versus ZIPRASIDONE</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Global state: No clinically significant response (as defined by the original studies)</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.97 </B>
<BR/>(0.62 to 1.52)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>442<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>97 per 1000</B>
<BR/>(62 to 152)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>146 per 1000</B>
<BR/>(93 to 228)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>194 per 1000</B>
<BR/>(124 to 304)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Mental state: as measured with BPRS</B>
<BR/>BPRS (high score = poor)<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean mental state: as measured with BPRS in the intervention groups was<BR/>
<B>2.2 lower</B>
<BR/>(4.97 lower to 0.57 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>247<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>5,6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Leaving the study early </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.94 </B>
<BR/>(0.66 to 1.34)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>316<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>141 per 1000</B>
<BR/>(99 to 201)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>250 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>235 per 1000</B>
<BR/>(165 to 335)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>350 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>329 per 1000</B>
<BR/>(231 to 469)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life </B>- not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Adverse effects: weight gain </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 4.01 </B>
<BR/>(1.1 to 14.6)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>232<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>40 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>160 per 1000</B>
<BR/>(44 to 584)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>401 per 1000</B>
<BR/>(110 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>General functioning </B>- not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Service use</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Risk: moderate risk approximately equates to that of the control group risk in the study population.<BR/>
<SUP>2</SUP> Risk of bias: rated 'serious' - majority of the included studies had inadequate study design - unclear randomisation, allocation concealment and blinding. A large proportion of them also had selective reporting concerns.<BR/>
<SUP>3</SUP> Imprecision: rated 'serious' - the total event number is small (&lt;300) and that the 95% CI of the pooled best estimate of effect is not statistically significant.<BR/>
<SUP>4</SUP> Publication bias: rated 'strongly suspected' - only a small number of trials with small sample size were identified. It is likely that these trials with low methodological quality would have exaggerated intervention effect.<BR/>
<SUP>5</SUP> Risk of bias: rated 'serious' - the only included study has serious concern with selective reporting and unclear allocation concealment and incomplete outcome.<BR/>
<SUP>6</SUP> Indirectness: rated 'serious' - we were unable to find direct binary measure of mental state, thus used BPRS score as an indicator.<BR/>
<SUP>7</SUP> Imprecision: rated 'serious' - only one study is identified, the estimate of effect is not statistically significant.<BR/>
<SUP>8 </SUP>Publication bias: rated 'strongly suspected' - only small number of trials with poor methodological quality were identified - publication bias likely.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-05" MODIFIED="2013-09-29 15:25:19 +0100" MODIFIED_BY="Grade Profiler" NO="5" READONLY="YES">
<TITLE MODIFIED="2013-06-27 21:50:33 +0100" MODIFIED_BY="Grade Profiler">COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE for schizophrenia</TITLE>
<TABLE COLS="7" ROWS="29">
<TR>
<TD COLSPAN="7">
<P>
<B>COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE for schizophrenia</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia<BR/>
<B>Settings: </B>inpatient and outpatient<BR/>
<B>Intervention:</B> COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Global state: No clinically significant response </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.06 </B>
<BR/>(0.96 to 1.17)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>1739<BR/>(11 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>212 per 1000</B>
<BR/>(192 to 234)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>350 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>371 per 1000</B>
<BR/>(336 to 409)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>500 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>530 per 1000</B>
<BR/>(480 to 585)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Mental state: as measured with PANSS</B>
<BR/>PANSS (high score = poor)<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean mental state: as measured with PANSS in the intervention groups was<BR/>
<B>0.61 higher</B>
<BR/>(0.23 lower to 1.46 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1500<BR/>(11 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,5,6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Leaving the study early</B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.15 </B>
<BR/>(1.05 to 1.25)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>2331<BR/>(9 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>230 per 1000</B>
<BR/>(210 to 250)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>350 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>402 per 1000</B>
<BR/>(367 to 438)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>500 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>575 per 1000</B>
<BR/>(525 to 625)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life: as measured with GQOLI-74</B>
<BR/>GQOLI-74 (low score = poor)</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life: as measured with gqoli-74 in the intervention groups was<BR/>
<B>1.26 lower</B>
<BR/>(6.37 lower to 3.85 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>68<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>7,8,9,10</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Adverse effects: weight gain </B>
<BR/>Follow-up: up to 12 weeks</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.25 </B>
<BR/>(0.15 to 0.43)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>1538<BR/>(9 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>25 per 1000</B>
<BR/>(15 to 43)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
<BR/>(30 to 86)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>300 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>75 per 1000</B>
<BR/>(45 to 129)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>General functioning</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Service use</B> - not measured</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No study measured or reported this outcome.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Risk: moderate risk approximately equates to that of the control group risk of the study population.<BR/>
<SUP>2</SUP> Risk of bias: rated 'serious' - majority of the included studies had inadequate study design - unclear randomisation, allocation concealment and blinding. Some of them also had selective reporting concerns.<BR/>
<SUP>3</SUP> Imprecision: rated 'serious' - total number of events is small (&lt;300) and that the 95% CI of pooled estimate of effect is not statistically significant.<BR/>
<SUP>4 </SUP>Publication bias: rated 'strongly suspected' - only small number of trials with small sample size were identified. It is likely that these small studies with poor methodological quality have negatively affected on the estimate of treatment effect.<BR/>
<SUP>5</SUP> Indirectness: rated 'serious' - we are unable to find direct binary measure of mental state, thus used PANSS score as an indicator.<BR/>
<SUP>6</SUP> Imprecision: rated 'serious' - the overall pooled estimate of effect was not statistically significant and with wide confidence interval.<BR/>
<SUP>7</SUP> Publication bias: rated 'strongly suspected' - only a small number of studies with poor methodological deign were identified - publication bias likely.<BR/>
<SUP>8</SUP> Risk of bias: rated 'serious' - unclear randomisation, allocation concealment, blinding and serious concern with selective reporting.<BR/>
<SUP>9</SUP> Indirectness: rated 'serious' - we are unable to find direct binary measure of quality of life, thus used GQOLI-74 score as an indicator.<BR/>
<SUP>10</SUP> Imprecision: rated 'very serious' - only one study with serious methodological concerns was identified and the estimate of effect is not significant.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2013-09-29 15:27:18 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-07-09 12:11:15 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-06-25 16:41:36 +0100" MODIFIED_BY="[Empty name]">Titles for reviews suggested by excluded studies</TITLE>
<TABLE COLS="3" ROWS="10">
<TR>
<TH>
<P>Suggested title/ongoing title</P>
</TH>
<TH>
<P>Excluded study</P>
</TH>
<TH>
<P>Reference to relevant ongoing Cochrane title*</P>
</TH>
</TR>
<TR>
<TD>
<P>Alpha-receptor agonists for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Bergman-2007" TYPE="STUDY">Bergman 2007</LINK>  </P>
</TD>
<TD>
<P>Currently no review.</P>
</TD>
</TR>
<TR>
<TD>
<P>Antidepressant augmentation of antipsychotic drugs for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Fawzi-2009" TYPE="STUDY">Fawzi 2009</LINK>  </P>
</TD>
<TD>
<P>
<LINK REF="REF-Whitehead-2002" TYPE="REFERENCE">Whitehead 2002</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Aripiprazole augmentation of other antipsychotics for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Bristol_x002d_Myers-2006" TYPE="STUDY">Bristol-Myers 2006</LINK>, <LINK REF="STD-Shim-2006" TYPE="STUDY">Shim 2006</LINK>
</P>
</TD>
<TD>
<P>
<LINK REF="REF-Maayan-2011" TYPE="REFERENCE">Maayan 2011</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Aripiprazole for people with metabolic syndrome</P>
</TD>
<TD>
<P>
<LINK REF="STD-Colombo-2008" TYPE="STUDY">Colombo 2008</LINK>
</P>
</TD>
<TD>
<P>
<LINK REF="REF-Mukundan-2010" TYPE="REFERENCE">Mukundan 2010</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Aripiprazole versus first generation antipsychotics for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Carson-2000" TYPE="STUDY">Carson 2000</LINK>, <LINK REF="STD-Mossner-2009" TYPE="STUDY">Mossner 2009</LINK>, <LINK REF="STD-Talbott-2007" TYPE="STUDY">Talbott 2007</LINK>, <LINK REF="STD-Taylor-2007" TYPE="STUDY">Taylor 2007</LINK>
</P>
</TD>
<TD>
<P>
<LINK REF="REF-Bhattacharjee-2008" TYPE="REFERENCE">Bhattacharjee 2008</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Aripiprazole versus placebo for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Carson-2000" TYPE="STUDY">Carson 2000</LINK>, <LINK REF="STD-Henderson-2009" TYPE="STUDY">Henderson 2009</LINK>, <LINK REF="STD-Mortimer-2004" TYPE="STUDY">Mortimer 2004</LINK>
</P>
</TD>
<TD>
<P>
<LINK REF="REF-Belgamwar-2011" TYPE="REFERENCE">Belgamwar 2011</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Augmentation of clozapine for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Fleischhacker-2008a" TYPE="STUDY">Fleischhacker 2008a</LINK>, <LINK REF="STD-Kim-2006" TYPE="STUDY">Kim 2006</LINK>, <LINK REF="STD-Ma-2007" TYPE="STUDY">Ma 2007</LINK>, <LINK REF="STD-Millar-2008" TYPE="STUDY">Millar 2008</LINK>, <LINK REF="STD-Namey-2006" TYPE="STUDY">Namey 2006</LINK>, <LINK REF="STD-Remington-2009" TYPE="STUDY">Remington 2009</LINK>    </P>
</TD>
<TD>
<P>
<LINK REF="REF-Cipriani-2009" TYPE="REFERENCE">Cipriani 2009</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Psychosocial intervention for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Anon-2008" TYPE="STUDY">Anon 2008</LINK>
</P>
</TD>
<TD>
<P>Unclear which of the many reviews would be relevant.</P>
</TD>
</TR>
<TR>
<TD>
<P>Switching from other antipsychotics to aripiprazole for schizophrenia</P>
</TD>
<TD>
<P>
<LINK REF="STD-Janssen-2005" TYPE="STUDY">Janssen 2005</LINK>, <LINK REF="STD-Lan-2008" TYPE="STUDY">Lan 2008</LINK>, <LINK REF="STD-Pae-2009a" TYPE="STUDY">Pae 2009a</LINK>, <LINK REF="STD-Schreiner-2009" TYPE="STUDY">Schreiner 2009</LINK>, <LINK REF="STD-Takeuchi-2008" TYPE="STUDY">Takeuchi 2008</LINK>  </P>
</TD>
<TD>
<P>
<LINK REF="REF-Mukundan-2010" TYPE="REFERENCE">Mukundan 2010</LINK>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* It is possible that these studies could also contribute to other titles not referenced in this column. </P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2013-09-29 15:27:18 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-06-25 16:41:36 +0100" MODIFIED_BY="[Empty name]">Suggested design of future study</TITLE>
<TABLE COLS="2" ROWS="4">
<TR>
<TH>
<P>Methods</P>
</TH>
<TD>
<P>Allocation: randomised - clearly described generation of sequence and concealment of allocation.<BR/>Blindness: double - described and tested.<BR/>Duration: six months minimum.</P>
</TD>
</TR>
<TR>
<TH>
<P>Participants</P>
</TH>
<TD>
<P>Diagnosis: schizophrenia (operational criteria).<BR/>N = 2700.*<BR/>Age: any.<BR/>Gender: both.<BR/>History: any.</P>
</TD>
</TR>
<TR>
<TH>
<P>Interventions</P>
</TH>
<TD>
<P>1. Aripiprazole: dose ~ 10-30 mg/day. N = 300.<BR/>2. Amisulpride: dose ~ 400-800 mg/day. N = 300.<BR/>3. Clozapine: dose ~ 300-800 mg/day. N = 300.<BR/>4. Olanzapine: dose ~ 10-20 mg/day. N = 300.<BR/>5. Quetiapine: dose ~300-800 mg/day. N = 300.<BR/>6. Risperidone: dose ~ 4-8 mg/day. N = 300.<BR/>7. Sertindole: dose ~ 12-24 mg/day. N = 300.<BR/>8. Ziprasidone: dose ~ 120-160 mg/day. N = 300.<BR/>9. Zotepine: dose ~ 100-300 mg/day. N = 300.</P>
</TD>
</TR>
<TR>
<TH>
<P>Outcomes</P>
</TH>
<TD>
<P>Leaving study early (any reason, adverse events, inefficacy).<BR/>Service outcomes: hospitalised, time in hospital, attending out patient clinics.<BR/>Global impression: CGI**, relapse.<BR/>Mental state: PANSS.<BR/>Adverse events/effects: UKU, major adverse event/effect.<BR/>Employment, living independently, family satisfaction, patient satisfaction.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* power calculation suggested 300/group would allow good chance of showing a 10% difference between groups for primary outcome.<BR/>
<BR/>** Primary outcome<BR/>CGI: Clinical Global Impression Scale<BR/>PANSS: Positive and Negative Syndrome Scale<BR/>UKU: Udvalg for kliniske ndersogelser Side Effect Rating Scale -side effect rating scale<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-10-10 22:30:56 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-11-04 16:56:57 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE</NAME>
<DICH_OUTCOME CHI2="5.853563288749803" CI_END="1.272445087181759" CI_START="0.8683258112201852" CI_STUDY="95" CI_TOTAL="95" DF="28" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0511407672430177" ESTIMABLE="YES" EVENTS_1="157" EVENTS_2="147" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.10463904928106978" LOG_CI_START="-0.06131728926421394" LOG_EFFECT_SIZE="0.021660880008427905" METHOD="MH" MODIFIED="2013-07-08 12:13:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9999974252280328" P_Q="1.0" P_Z="0.608906410911361" Q="0.0" RANDOM="YES" SCALE="185.31902742930964" SORT_BY="STUDY" STUDIES="29" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1072" TOTAL_2="1060" WEIGHT="100.00000000000001" Z="0.5116351091148954">
<NAME>Global state: 1. No clinically significant response (as defined by the original studies)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.8706145204307787" CI_START="0.2837009939670349" EFFECT_SIZE="0.9024390243902439" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4579748773137451" LOG_CI_START="-0.5471391426192261" LOG_EFFECT_SIZE="-0.04458213265274048" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="576" O_E="0.0" SE="0.590408950703268" STUDY_ID="STD-An-2008" TOTAL_1="41" TOTAL_2="37" VAR="0.34858272907053395" WEIGHT="2.7261956933607605"/>
<DICH_DATA CI_END="2.273370387444043" CI_START="0.5234882319225213" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3566701986456137" LOG_CI_START="-0.2810930768668142" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.37462530501512903" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" VAR="0.14034411915767847" WEIGHT="6.771247277588815"/>
<DICH_DATA CI_END="5.537609425839804" CI_START="0.3210370470481798" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7433223211848708" LOG_CI_START="-0.4934448479682711" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="0.7264831572567788" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.5277777777777777" WEIGHT="1.800577392199637"/>
<DICH_DATA CI_END="5.26531901349033" CI_START="0.047480503908589836" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7214246892159656" LOG_CI_START="-1.323484680543928" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="0.6586270439014072"/>
<DICH_DATA CI_END="1.669861922264878" CI_START="0.5216665518844816" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" LOG_CI_END="0.22268056164002456" LOG_CI_START="-0.28260700839491093" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.29680841985233186" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.08809523809523812" WEIGHT="10.787242935250074"/>
<DICH_DATA CI_END="8.220339253228541" CI_START="0.2737113312101215" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9148897412340661" LOG_CI_START="-0.5627072231227036" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Jie-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="1.2614664620867664"/>
<DICH_DATA CI_END="8.65822892263761" CI_START="0.2598683888014557" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9374290643281381" LOG_CI_START="-0.5852465462167757" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.8944271909999157" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.7999999999999998" WEIGHT="1.1878809184650383"/>
<DICH_DATA CI_END="1.9656607751511364" CI_START="0.2861633131773464" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2935085713844867" LOG_CI_START="-0.5433860446010865" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="455" O_E="0.0" SE="0.49159604012508745" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.2416666666666666" WEIGHT="3.932295454229093"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="103" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.6630033033293237"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.2395279149200398"/>
<DICH_DATA CI_END="4.398193957832168" CI_START="0.5820570953768949" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6432743775847651" LOG_CI_START="-0.2350344122729154" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="117" O_E="0.0" SE="0.5159229308610301" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="0.2661764705882353" WEIGHT="3.5702056333976837"/>
<DICH_DATA CI_END="5.470794638979733" CI_START="0.32495787085682326" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.738050412669661" LOG_CI_START="-0.4881729394530612" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="155" O_E="0.0" SE="0.7202896669403742" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.5188172043010753" WEIGHT="1.8316754473326182"/>
<DICH_DATA CI_END="4.246832637986444" CI_START="0.20512018847159758" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6280651463612595" LOG_CI_START="-0.6879915931161459" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2238" O_E="0.0" SE="0.7730582433549542" STUDY_ID="STD-Liu-2010" TOTAL_1="30" TOTAL_2="28" VAR="0.5976190476190476" WEIGHT="1.5901513490209276"/>
<DICH_DATA CI_END="15.042527544933725" CI_START="0.06647818971997141" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1773208154172596" LOG_CI_START="-1.1773208154172596" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2198" O_E="0.0" SE="1.3831281496162493" STUDY_ID="STD-Peng-2007a" TOTAL_1="23" TOTAL_2="23" VAR="1.9130434782608696" WEIGHT="0.49675020226719774"/>
<DICH_DATA CI_END="3.9346632651678948" CI_START="0.3475242089758317" EFFECT_SIZE="1.1693548387096775" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5949075706627871" LOG_CI_START="-0.4590149365173074" LOG_EFFECT_SIZE="0.06794631707273985" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.6190792977181366" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.3832591768631813" WEIGHT="2.479535500101743"/>
<DICH_DATA CI_END="8.383428283463806" CI_START="0.2683866222650336" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9234216534894845" LOG_CI_START="-0.5712391353781221" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="196" O_E="0.0" SE="0.8779711460710615" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" VAR="0.7708333333333333" WEIGHT="1.23282776402858"/>
<DICH_DATA CI_END="4.206513090488437" CI_START="0.3714477921233738" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6239222447595453" LOG_CI_START="-0.43010221874343246" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="198" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="0.38333333333333336" WEIGHT="2.4790558298400796"/>
<DICH_DATA CI_END="100.52959945656309" CI_START="0.24868297630890304" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.002293952184388" LOG_CI_START="-0.6043539435123508" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="435" O_E="0.0" SE="1.531157877047447" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="2.3444444444444446" WEIGHT="0.4053432517984964"/>
<DICH_DATA CI_END="4.116851171324752" CI_START="0.47609202238158543" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6145651670604648" LOG_CI_START="-0.3223090957039887" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="445" O_E="0.0" SE="0.550324579550235" STUDY_ID="STD-Yan-2008a" TOTAL_1="50" TOTAL_2="50" VAR="0.3028571428571428" WEIGHT="3.1377986525491575"/>
<DICH_DATA CI_END="2.623058766101521" CI_START="0.3191046808723607" EFFECT_SIZE="0.9148936170212766" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.41880802048273663" LOG_CI_START="-0.49606682519499856" LOG_EFFECT_SIZE="-0.038629402356130944" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="501" O_E="0.0" SE="0.5374020130546258" STUDY_ID="STD-Yang-2006" TOTAL_1="47" TOTAL_2="43" VAR="0.28880092363516413" WEIGHT="3.2905183363351345"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.6630033033293237"/>
<DICH_DATA CI_END="6.924944683980589" CI_START="0.23262954710507916" EFFECT_SIZE="1.2692307692307692" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8404163086335346" LOG_CI_START="-0.6333351248193956" LOG_EFFECT_SIZE="0.10354059190706949" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.865688887197502" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="0.7494172494172494" WEIGHT="1.2680582619508587"/>
<DICH_DATA CI_END="2.057929593571371" CI_START="0.30454691602129164" EFFECT_SIZE="0.7916666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.31343051248351106" LOG_CI_START="-0.5163457940010652" LOG_EFFECT_SIZE="-0.10145764075877708" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="460" O_E="0.0" SE="0.48741470988800145" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.23757309941520463" WEIGHT="4.000051929748117"/>
<DICH_DATA CI_END="2.6921683779126004" CI_START="0.23772658695895926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4301022187434325" LOG_CI_START="-0.6239222447595453" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1349" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.38333333333333336" WEIGHT="2.4790558298400796"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1367" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.4915369317786365"/>
<DICH_DATA CI_END="2.143066607100852" CI_START="0.5553176185401195" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3310356692437978" LOG_CI_START="-0.25545854746499824" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="346" O_E="0.0" SE="0.3445096060879416" STUDY_ID="STD-Zhang-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.11868686868686869" WEIGHT="8.006822871696256"/>
<DICH_DATA CI_END="1.5083471930816699" CI_START="0.7543208771802796" EFFECT_SIZE="1.0666666666666667" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="30" LOG_CI_END="0.17850131944116324" LOG_CI_START="-0.12244387224067613" LOG_EFFECT_SIZE="0.028028723600243534" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="0.17677669529663687" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.031249999999999997" WEIGHT="30.409751512704982"/>
<DICH_DATA CI_END="5.5607447385134" CI_START="0.04904308005614795" EFFECT_SIZE="0.5222222222222223" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7451329595977649" LOG_CI_START="-1.3094222626049794" LOG_EFFECT_SIZE="-0.2821446515036074" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="369" O_E="0.0" SE="1.206855907734265" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="1.456501182033097" WEIGHT="0.6524572355276236"/>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="447" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="0.48733576142155405"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="16.112368735844157" CI_END="4.1797006967686015" CI_START="1.0322940818513462" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="2.077180852305397" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="17" I2="25.523055009879666" I2_Q="32.29048621179517" ID="CMP-001.02" LOG_CI_END="0.6211451835942312" LOG_CI_START="0.013803437534653424" LOG_EFFECT_SIZE="0.31747431056444236" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1861435339661488" P_Q="0.22834512811987562" P_Z="0.040456771228577604" Q="2.953794656177852" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.42572533926554423" TOTALS="SUB" TOTAL_1="444" TOTAL_2="438" WEIGHT="300.0" Z="2.0490546508948584">
<NAME>Mental state: 1. Specific - binary outcomes</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="13.33936710717212" CI_END="5.700555378126753" CI_START="1.2081253369756522" DF="10" EFFECT_SIZE="2.6243066488403657" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="13" I2="25.033924625829187" ID="CMP-001.02.01" LOG_CI_END="0.7559171689893447" LOG_CI_START="0.08211199250797918" LOG_EFFECT_SIZE="0.419014580748662" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2053116046323029" P_Z="0.014782728411663395" STUDIES="11" TAU2="0.4121070194074204" TOTAL_1="368" TOTAL_2="364" WEIGHT="100.0" Z="2.4376585871694916">
<NAME>anxiety (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="3.05118976192878" CI_START="0.03641566725790049" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4844692184571428" LOG_CI_START="-1.4387117278964678" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.1296860077873303" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="1.2761904761904763" WEIGHT="9.278866236403282"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="5.948982583238358"/>
<DICH_DATA CI_END="190.5337733482898" CI_START="0.63505801556145" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2799719683515804" LOG_CI_START="-0.19718659803513053" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="6.19333851575199"/>
<DICH_DATA CI_END="3.9346632651678948" CI_START="0.3475242089758317" EFFECT_SIZE="1.1693548387096775" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5949075706627871" LOG_CI_START="-0.4590149365173074" LOG_EFFECT_SIZE="0.06794631707273985" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.6190792977181366" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.3832591768631813" WEIGHT="19.695942199155002"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="199" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="5.948982583238358"/>
<DICH_DATA CI_END="3.0849022616839066" CI_START="0.03601770872651914" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48924140892557627" LOG_CI_START="-1.4434839183649013" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="247" O_E="0.0" SE="1.1352924243950935" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="1.288888888888889" WEIGHT="9.209596891151753"/>
<DICH_DATA CI_END="130.82359964630137" CI_START="0.3745501586294664" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.116686094689066" LOG_CI_START="-0.42649001466055253" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="422" O_E="0.0" SE="1.493874235556739" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.231660231660231" WEIGHT="5.925440911101851"/>
<DICH_DATA CI_END="160.170939238357" CI_START="0.5057097147907748" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.204583722276951" LOG_CI_START="-0.29609870339830113" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="6.095963380416399"/>
<DICH_DATA CI_END="237.529193492062" CI_START="0.8828948678491577" EFFECT_SIZE="14.481481481481481" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.3757169941434073" LOG_CI_START="-0.0540910076696485" LOG_EFFECT_SIZE="1.1608129932368796" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="1.427281248008579" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.037131760916927" WEIGHT="6.396063444182849"/>
<DICH_DATA CI_END="33.72924445563291" CI_START="0.4743657991226642" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.52800661298213" LOG_CI_START="-0.32388663032620535" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1392" O_E="0.0" SE="1.0878112581387145" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.1833333333333331" WEIGHT="9.818910874352857"/>
<DICH_DATA CI_END="16.670115434422325" CI_START="0.8016193092556207" EFFECT_SIZE="3.6555555555555554" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2219386071680811" LOG_CI_START="-0.09603183014678221" LOG_EFFECT_SIZE="0.5629533885106494" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="376" O_E="0.0" SE="0.7741823589376341" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.5993583248902397" WEIGHT="15.487912381007304"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.0849022616839066" CI_START="0.03601770872651914" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.48924140892557627" LOG_CI_START="-1.4434839183649013" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.33319871452903094" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="0.9676910239698573">
<NAME>anxiety (medium term, 12 to 26 weeks)</NAME>
<DICH_DATA CI_END="3.0849022616839066" CI_START="0.03601770872651914" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48924140892557627" LOG_CI_START="-1.4434839183649013" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="247" O_E="0.0" SE="1.1352924243950935" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="1.288888888888889" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="19.54855216614242" CI_START="0.17906800777941861" DF="0" EFFECT_SIZE="1.8709677419354838" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="1.2911145975610654" LOG_CI_START="-0.7469819981037364" LOG_EFFECT_SIZE="0.2720662997286646" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.6007845018833395" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="29" WEIGHT="100.0" Z="0.5232726947383235">
<NAME>agitation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="19.54855216614242" CI_START="0.17906800777941861" EFFECT_SIZE="1.8709677419354838" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2911145975610654" LOG_CI_START="-0.7469819981037364" LOG_EFFECT_SIZE="0.2720662997286646" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="1.1971880290343624" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="1.4332591768631813" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="67.13733338046066" CI_END="0.6104515039458365" CI_START="-1.1370703615715514" CI_STUDY="95" CI_TOTAL="95" DF="28" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2633094288128574" ESTIMABLE="YES" I2="58.29444127408701" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="4.6278512501496394E-5" P_Q="0.5961413731873846" P_Z="0.5547625504285975" Q="1.0345551431005502" RANDOM="YES" SCALE="32.16" SORT_BY="STUDY" STUDIES="27" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="4.076220163451195" TOTALS="SUB" TOTAL_1="1057" TOTAL_2="1057" UNITS="" WEIGHT="300.0" Z="0.5906386723352605">
<NAME>Mental state: 2. Average endpoint scores of various scales (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.8375155991636745" CI_END="1.0049241160265079" CI_START="-1.4426793077344402" DF="4" EFFECT_SIZE="-0.2188775958539661" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5853744021534752" P_Z="0.7259330154792543" STUDIES="5" TAU2="0.0" TOTAL_1="212" TOTAL_2="214" WEIGHT="100.0" Z="0.3505406151436939">
<NAME>BPRS</NAME>
<CONT_DATA CI_END="3.2170589722878145" CI_START="-1.9970589722878085" EFFECT_SIZE="0.610000000000003" ESTIMABLE="YES" MEAN_1="29.42" MEAN_2="28.81" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="383" SD_1="7.1" SD_2="7.1" SE="1.3301565706573997" STUDY_ID="STD-Kuang-2006" TOTAL_1="56" TOTAL_2="58" WEIGHT="22.035372803334745"/>
<CONT_DATA CI_END="5.515464572192188" CI_START="-1.6354645721921863" EFFECT_SIZE="1.9400000000000013" ESTIMABLE="YES" MEAN_1="17.85" MEAN_2="15.91" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="436" SD_1="8.69" SD_2="6.4" SE="1.8242501394898047" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" WEIGHT="11.715400892202782"/>
<CONT_DATA CI_END="0.9804145955567523" CI_START="-3.000414595556748" EFFECT_SIZE="-1.009999999999998" ESTIMABLE="YES" MEAN_1="26.35" MEAN_2="27.36" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="446" SD_1="5.24" SD_2="4.91" SE="1.0155363115122964" STUDY_ID="STD-Yan-2008a" TOTAL_1="50" TOTAL_2="50" WEIGHT="37.803761743625834"/>
<CONT_DATA CI_END="1.7648302053327298" CI_START="-4.164830205332736" EFFECT_SIZE="-1.2000000000000028" ESTIMABLE="YES" MEAN_1="23.9" MEAN_2="25.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="448" SD_1="6.3" SD_2="7.2" SE="1.512696268257445" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="17.038150874627217"/>
<CONT_DATA CI_END="3.673425732555021" CI_START="-3.5734257325550267" EFFECT_SIZE="0.04999999999999716" ESTIMABLE="YES" MEAN_1="35.43" MEAN_2="35.38" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1406" SD_1="7.62" SD_2="6.92" SE="1.8487205689166453" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" WEIGHT="11.407313686209426"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="61.84335807611115" CI_END="1.2158803012456336" CI_START="-1.411316668394682" DF="22" EFFECT_SIZE="-0.09771818357452425" ESTIMABLE="YES" I2="64.42625257683386" ID="CMP-001.03.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.1877368603974148E-5" P_Z="0.8840783976967475" STUDIES="23" TAU2="5.860477384774644" TOTAL_1="820" TOTAL_2="818" WEIGHT="99.99999999999999" Z="0.14580111248146135">
<NAME>PANSS</NAME>
<CONT_DATA CI_END="3.7233056435819334" CI_START="-3.5233056435819305" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="57.4" MEAN_2="57.3" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="585" SD_1="8.1" SD_2="8.2" SE="1.8486592979065455" STUDY_ID="STD-An-2008" TOTAL_1="41" TOTAL_2="37" WEIGHT="4.841432235736486"/>
<CONT_DATA CI_END="10.567496636250233" CI_START="2.512503363749766" EFFECT_SIZE="6.539999999999999" ESTIMABLE="YES" MEAN_1="48.26" MEAN_2="41.72" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="11.74" SD_2="10.55" SE="2.054882981533647" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" WEIGHT="4.454904561108406"/>
<CONT_DATA CI_END="3.562106083626512" CI_START="-0.5621060836265119" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="45.3" MEAN_2="43.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="283" SD_1="4.1" SD_2="4.8" SE="1.052114273472442" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="6.44698991389303"/>
<CONT_DATA CI_END="3.033508785564666" CI_START="-8.033508785564667" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="42.7" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="79" SD_1="12.3" SD_2="11.3" SE="2.823270646405892" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" WEIGHT="3.2476185265475346"/>
<CONT_DATA CI_END="3.9543453736628114" CI_START="-2.7543453736628085" EFFECT_SIZE="0.6000000000000014" ESTIMABLE="YES" MEAN_1="37.9" MEAN_2="37.3" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="340" SD_1="6.15" SD_2="5.95" SE="1.7114321488157223" STUDY_ID="STD-Jie-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="5.110531183187665"/>
<CONT_DATA CI_END="-5.708700537180122" CI_START="-14.09129946281989" EFFECT_SIZE="-9.900000000000006" ESTIMABLE="YES" MEAN_1="40.8" MEAN_2="50.7" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="456" SD_1="8.4" SD_2="10.6" SE="2.1384573879317776" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="4.305266269552929"/>
<CONT_DATA CI_END="0.5562077132614753" CI_START="-9.336207713261476" EFFECT_SIZE="-4.390000000000001" ESTIMABLE="YES" MEAN_1="47.97" MEAN_2="52.36" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="104" SD_1="10.9" SD_2="8.5" SE="2.523621736050525" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.6731023912928316"/>
<CONT_DATA CI_END="5.407007488010484" CI_START="1.9929925119895222" EFFECT_SIZE="3.700000000000003" ESTIMABLE="YES" MEAN_1="49.43" MEAN_2="45.73" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="169" SD_1="1.98" SD_2="4.34" SE="0.870938191454097" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" WEIGHT="6.7863462036594955"/>
<CONT_DATA CI_END="3.839753817198331" CI_START="-2.039753817198334" EFFECT_SIZE="0.8999999999999986" ESTIMABLE="YES" MEAN_1="50.3" MEAN_2="49.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="118" SD_1="6.8" SD_2="5.5" SE="1.4999019575802084" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" WEIGHT="5.538579928382147"/>
<CONT_DATA CI_END="5.462761465352097" CI_START="-2.6227614653520934" EFFECT_SIZE="1.4200000000000017" ESTIMABLE="YES" MEAN_1="50.89" MEAN_2="49.47" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="8.01" SD_2="8.23" SE="2.062671302759072" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="4.440780752308356"/>
<CONT_DATA CI_END="4.455180055593453" CI_START="-4.215180055593444" EFFECT_SIZE="0.12000000000000455" ESTIMABLE="YES" MEAN_1="40.49" MEAN_2="40.37" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2199" SD_1="7.39" SD_2="7.61" SE="2.2118672025551467" STUDY_ID="STD-Peng-2007a" TOTAL_1="23" TOTAL_2="23" WEIGHT="4.177400920477618"/>
<CONT_DATA CI_END="7.953423791041085" CI_START="-7.533423791041083" EFFECT_SIZE="0.21000000000000085" ESTIMABLE="YES" MEAN_1="49.12" MEAN_2="48.91" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="15.21" SD_2="15.37" SE="3.95079902085968" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" WEIGHT="2.0922395503646207"/>
<CONT_DATA CI_END="6.366795673556779" CI_START="-5.9867956735567835" EFFECT_SIZE="0.18999999999999773" ESTIMABLE="YES" MEAN_1="43.0" MEAN_2="42.81" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="12.07" SD_2="13.12" SE="3.1514842733226516" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" WEIGHT="2.8443489218396922"/>
<CONT_DATA CI_END="1.9814047663299026" CI_START="-3.1814047663299054" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="46.8" MEAN_2="47.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="5.0" SD_2="5.2" SE="1.3170674495509587" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.914160146875614"/>
<CONT_DATA CI_END="5.882795282496857" CI_START="-5.142795282496848" EFFECT_SIZE="0.37000000000000455" ESTIMABLE="YES" MEAN_1="38.13" MEAN_2="37.76" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="404" SD_1="12.21" SD_2="11.65" SE="2.812702338400643" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="3.261664426033455"/>
<CONT_DATA CI_END="3.7341549954663753" CI_START="-6.134154995466381" EFFECT_SIZE="-1.2000000000000028" ESTIMABLE="YES" MEAN_1="42.3" MEAN_2="43.5" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="314" SD_1="9.7" SD_2="9.8" SE="2.5174722772389506" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.6824371043155577"/>
<CONT_DATA CI_END="2.178446000079135" CI_START="-8.178446000079134" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="43.2" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="461" SD_1="12.2" SD_2="10.4" SE="2.642112835198022" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" WEIGHT="3.4980193959985524"/>
<CONT_DATA CI_END="1.4393885036228928" CI_START="-4.159388503622892" EFFECT_SIZE="-1.3599999999999994" ESTIMABLE="YES" MEAN_1="44.9" MEAN_2="46.26" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1350" SD_1="4.2" SD_2="6.6" SE="1.42828568570857" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.685592916875982"/>
<CONT_DATA CI_END="0.4479942320771175" CI_START="-4.447994232077118" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="40.8" MEAN_2="42.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1371" SD_1="4.2" SD_2="5.4" SE="1.2489995996796797" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="6.0533704140084446"/>
<CONT_DATA CI_END="6.985791343038754" CI_START="-4.1657913430387605" EFFECT_SIZE="1.4099999999999966" ESTIMABLE="YES" MEAN_1="50.12" MEAN_2="48.71" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="347" SD_1="11.73" SD_2="12.4" SE="2.844843776222363" STUDY_ID="STD-Zhang-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="3.219158841690576"/>
<CONT_DATA CI_END="6.232146015547919" CI_START="-1.4521460155479176" EFFECT_SIZE="2.3900000000000006" ESTIMABLE="YES" MEAN_1="45.44" MEAN_2="43.05" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="352" SD_1="10.34" SD_2="11.12" SE="1.9603146006019883" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" WEIGHT="4.629234244244856"/>
<CONT_DATA CI_END="4.4741717573321385" CI_START="-6.274171757332136" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="41.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="371" SD_1="12.9" SD_2="13.4" SE="2.741974750415272" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" WEIGHT="3.3574425749647547"/>
<CONT_DATA CI_END="6.862189213914815" CI_START="-5.862189213914815" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="48.6" MEAN_2="48.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1369" SD_1="13.8" SD_2="15.2" SE="3.246074552440224" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.739378576641404"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7265986966771427" CI_START="-6.266598696677149" DF="0" EFFECT_SIZE="-2.270000000000003" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.2656113253408885" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.1132261661910208">
<NAME>SANS</NAME>
<CONT_DATA CI_END="1.7265986966771427" CI_START="-6.266598696677149" EFFECT_SIZE="-2.270000000000003" ESTIMABLE="YES" MEAN_1="42.15" MEAN_2="44.42" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="485" SD_1="7.65" SD_2="6.74" SE="2.039118436972213" STUDY_ID="STD-Jie-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.8609359441110207" CI_END="-2.4112412584312026" CI_START="-8.416684081327405" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.413962669879304" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.650204765827451" P_Q="1.0" P_Z="4.0955096813527416E-4" Q="0.0" RANDOM="YES" SCALE="21.55514588279871" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="118" TOTAL_2="118" UNITS="" WEIGHT="100.0" Z="3.533851594141188">
<NAME>Mental state: 3. Average endpoint scores of various scales (medium term, 12 to 26 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.8609359441110207" CI_END="-2.4112412584312026" CI_START="-8.416684081327405" DF="2" EFFECT_SIZE="-5.413962669879304" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.650204765827451" P_Z="4.0955096813527416E-4" STUDIES="3" TAU2="0.0" TOTAL_1="118" TOTAL_2="118" WEIGHT="100.0" Z="3.533851594141188">
<NAME>PANSS</NAME>
<CONT_DATA CI_END="3.890727092782444" CI_START="-9.77072709278244" EFFECT_SIZE="-2.9399999999999977" ESTIMABLE="YES" MEAN_1="43.81" MEAN_2="46.75" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="22" SD_1="12.69" SD_2="14.26" SE="3.4851288833174205" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="19.323963693989025"/>
<CONT_DATA CI_END="-0.3045799900283379" CI_START="-9.975420009971664" EFFECT_SIZE="-5.140000000000001" ESTIMABLE="YES" MEAN_1="38.62" MEAN_2="43.76" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="237" SD_1="11.15" SD_2="12.23" SE="2.4670963589702866" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="38.5621886465493"/>
<CONT_DATA CI_END="-2.172967181173611" CI_START="-11.427032818826383" EFFECT_SIZE="-6.799999999999997" ESTIMABLE="YES" MEAN_1="37.6" MEAN_2="44.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="689" SD_1="9.4" SD_2="12.3" SE="2.3607744097972363" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="42.11384765946166"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-001.05" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES">
<NAME>Mental state: 4. Average endpoint scores of various scales (skewed data, high=poor)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Notes</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.05.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>BPRS</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2530" STUDY_ID="STD-Xiao-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>15.33</P>
</TD>
<TD>
<P>7.96</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>15.91 </P>
</TD>
<TD>
<P>11.22</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.05.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="1">
<NAME>PANSS</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2531" STUDY_ID="STD-Jiang-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>53.2</P>
</TD>
<TD>
<P>13.9</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>11.2</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.05.03" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="3">
<NAME>PANSS negative symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2532" STUDY_ID="STD-Jiang-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>16.4</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>11.2</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2533" STUDY_ID="STD-Liu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.71</P>
</TD>
<TD>
<P>7.60</P>
</TD>
<TD>
<P>31</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>11.82</P>
</TD>
<TD>
<P>6.77</P>
</TD>
<TD>
<P>31</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2534" STUDY_ID="STD-Xiao-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>6.31</P>
</TD>
<TD>
<P>5.24</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>13.37 </P>
</TD>
<TD>
<P>5.15</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="74.66845976129645" CI_END="1.0163651116282457" CI_START="-0.4817331127648877" CI_STUDY="95" CI_TOTAL="95" DF="21" EFFECT_MEASURE="MD" EFFECT_SIZE="0.26731599943167905" ESTIMABLE="YES" I2="71.87567539609928" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="6.156093612652569E-8" P_Q="0.5243564235517971" P_Z="0.4842647413261022" Q="0.4053162636476953" RANDOM="YES" SCALE="18.72384443250752" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="2.136756318554569" TOTALS="YES" TOTAL_1="765" TOTAL_2="758" UNITS="" WEIGHT="100.00000000000003" Z="0.6994597855419793">
<NAME>Mental state: 5. Specific - average endpoint positive score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="66.47273593826768" CI_END="1.195034828182311" CI_START="-0.49694465613404887" DF="18" EFFECT_SIZE="0.34904508602413115" ESTIMABLE="YES" I2="72.92122891298419" ID="CMP-001.06.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.768742026175829E-7" P_Z="0.4187122917106555" STUDIES="19" TAU2="2.3714697966926757" TOTAL_1="647" TOTAL_2="640" WEIGHT="84.31113017497906" Z="0.8086573199371827">
<NAME>by up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="5.521430967388337" CI_START="2.878569032611665" EFFECT_SIZE="4.200000000000001" ESTIMABLE="YES" MEAN_1="16.6" MEAN_2="12.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="587" SD_1="2.7" SD_2="3.2" SE="0.6742118619584925" STUDY_ID="STD-An-2008" TOTAL_1="41" TOTAL_2="37" WEIGHT="5.636424593740812"/>
<CONT_DATA CI_END="2.2040424824941427" CI_START="-1.4040424824941455" EFFECT_SIZE="0.3999999999999986" ESTIMABLE="YES" MEAN_1="12.2" MEAN_2="11.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="284" SD_1="4.1" SD_2="3.7" SE="0.9204467514322717" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="4.894729651346228"/>
<CONT_DATA CI_END="2.337702833901027" CI_START="-1.7377028339010292" EFFECT_SIZE="0.29999999999999893" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="8.9" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="341" SD_1="3.6" SD_2="3.75" SE="1.0396634070698074" STUDY_ID="STD-Jie-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="4.53925677465833"/>
<CONT_DATA CI_END="2.7877986969624198" CI_START="-3.387798696962421" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="16.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="457" SD_1="6.2" SD_2="7.8" SE="1.5754364474646383" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.1622729659597755"/>
<CONT_DATA CI_END="1.6860921560323126" CI_START="-1.8060921560323135" EFFECT_SIZE="-0.0600000000000005" ESTIMABLE="YES" MEAN_1="9.74" MEAN_2="9.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="105" SD_1="3.4" SD_2="3.5" SE="0.8908797150382686" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.984184302464557"/>
<CONT_DATA CI_END="2.8186924307374217" CI_START="-1.4186924307374231" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="14.6" MEAN_2="13.9" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="119" SD_1="4.2" SD_2="4.7" SE="1.0809853892466381" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" WEIGHT="4.418912443345756"/>
<CONT_DATA CI_END="3.8128008697666886" CI_START="-3.1528008697666885" EFFECT_SIZE="0.33000000000000007" ESTIMABLE="YES" MEAN_1="12.62" MEAN_2="12.29" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="7.11" SD_2="6.88" SE="1.7769718715438534" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="2.758727836136668"/>
<CONT_DATA CI_END="0.9495131944486275" CI_START="-1.4895131944486266" EFFECT_SIZE="-0.2699999999999996" ESTIMABLE="YES" MEAN_1="9.83" MEAN_2="10.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2199" SD_1="2.12" SD_2="2.1" SE="0.6222120427048616" STUDY_ID="STD-Peng-2007a" TOTAL_1="23" TOTAL_2="23" WEIGHT="5.786974229401843"/>
<CONT_DATA CI_END="1.6600988315409742" CI_START="-1.880098831540973" EFFECT_SIZE="-0.10999999999999943" ESTIMABLE="YES" MEAN_1="11.39" MEAN_2="11.5" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="4.03" SD_2="3.14" SE="0.9031282439388107" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" WEIGHT="4.947088254649201"/>
<CONT_DATA CI_END="1.541589678702075" CI_START="-3.141589678702073" EFFECT_SIZE="-0.7999999999999989" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="12.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="5.1" SD_2="4.1" SE="1.1947105646696747" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.098036152032349"/>
<CONT_DATA CI_END="2.252184019388182" CI_START="-2.8321840193881838" EFFECT_SIZE="-0.2900000000000009" ESTIMABLE="YES" MEAN_1="11.45" MEAN_2="11.74" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="405" SD_1="5.32" SD_2="5.68" SE="1.2970564966706561" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="3.824388686158674"/>
<CONT_DATA CI_END="-1.544173635994036" CI_START="-13.295826364005968" EFFECT_SIZE="-7.420000000000002" ESTIMABLE="YES" MEAN_1="47.78" MEAN_2="55.2" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="328" SD_1="11.3" SD_2="9.47" SE="2.997925681468504" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" WEIGHT="1.312958921341686"/>
<CONT_DATA CI_END="0.23479911446524815" CI_START="-3.834799114465246" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="9.8" MEAN_2="11.6" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1372" SD_1="4.7" SD_2="4.2" SE="1.0381818903385382" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" WEIGHT="4.543603683756862"/>
<CONT_DATA CI_END="1.518755134280492" CI_START="-0.918755134280494" EFFECT_SIZE="0.29999999999999893" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="10.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1351" SD_1="2.6" SD_2="2.2" SE="0.621825270205921" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.788077673882518"/>
<CONT_DATA CI_END="2.5827414088946297" CI_START="-0.9827414088946285" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" MEAN_1="9.4" MEAN_2="8.6" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1376" SD_1="3.1" SD_2="3.9" SE="0.9095786570348566" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.92757303518746"/>
<CONT_DATA CI_END="2.785250767121655" CI_START="-1.4452507671216552" EFFECT_SIZE="0.6699999999999999" ESTIMABLE="YES" MEAN_1="15.91" MEAN_2="15.24" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="348" SD_1="4.92" SD_2="4.21" SE="1.0792294061556658" STUDY_ID="STD-Zhang-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="4.423989620960615"/>
<CONT_DATA CI_END="6.973538764431776" CI_START="2.6664612355682245" EFFECT_SIZE="4.82" ESTIMABLE="YES" MEAN_1="13.84" MEAN_2="9.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="353" SD_1="5.21" SD_2="6.73" SE="1.0987644576219842" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" WEIGHT="4.367701870483269"/>
<CONT_DATA CI_END="2.2448001912995634" CI_START="-2.4448001912995627" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="11.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1374" SD_1="5.3" SD_2="5.4" SE="1.19634861140054" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="4.093537661793698"/>
<CONT_DATA CI_END="0.4386978836249078" CI_START="-1.978697883624907" EFFECT_SIZE="-0.7699999999999996" ESTIMABLE="YES" MEAN_1="22.38" MEAN_2="23.15" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1375" SD_1="2.24" SD_2="2.56" SE="0.616693925581777" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="30" WEIGHT="5.80269181767875"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.866109206863971" CI_END="1.3367659355756578" CI_START="-1.794890026084041" DF="2" EFFECT_SIZE="-0.2290620452541916" ESTIMABLE="YES" I2="65.90585122998073" ID="CMP-001.06.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05323427226162969" P_Z="0.7743271335085489" STUDIES="3" TAU2="1.2604014766997882" TOTAL_1="118" TOTAL_2="118" WEIGHT="15.68886982502097" Z="0.28671946370850115">
<NAME>from 12-26 weeks - medium term</NAME>
<CONT_DATA CI_END="3.1728223830719617" CI_START="-0.25282238307196003" EFFECT_SIZE="1.4600000000000009" ESTIMABLE="YES" MEAN_1="11.24" MEAN_2="9.78" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="23" SD_1="3.12" SD_2="3.63" SE="0.873905029165069" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.035662075813971"/>
<CONT_DATA CI_END="0.674678295525194" CI_START="-2.154678295525194" EFFECT_SIZE="-0.7400000000000002" ESTIMABLE="YES" MEAN_1="9.57" MEAN_2="10.31" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="238" SD_1="3.26" SD_2="3.58" SE="0.7217879035961865" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="5.495571683667249"/>
<CONT_DATA CI_END="0.33409319245893543" CI_START="-2.9340931924589366" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="10.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="690" SD_1="3.5" SD_2="4.2" SE="0.8337363366615176" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="5.157636065539749"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="114.65711712082158" CI_END="0.3048936317769796" CI_START="-1.5298004731979176" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6124534207104689" ESTIMABLE="YES" I2="80.81235552362861" I2_Q="81.8085652615007" ID="CMP-001.07" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.5765166949677223E-14" P_Q="0.019048213338938025" P_Z="0.19068972342765267" Q="5.497092529396035" RANDOM="YES" SCALE="17.914358947471076" SORT_BY="STUDY" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="3.762574266003063" TOTALS="YES" TOTAL_1="823" TOTAL_2="817" UNITS="" WEIGHT="99.99999999999999" Z="1.3085414549988985">
<NAME>Mental state: 6. Specific - average endpoint negative score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="51.61074347542448" CI_END="0.7082125230236409" CI_START="-0.7856304127720879" DF="19" EFFECT_SIZE="-0.03870894487422353" ESTIMABLE="YES" I2="63.18595951045107" ID="CMP-001.07.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="7.564442193741527E-5" P_Z="0.9190944599179828" STUDIES="20" TAU2="1.6408588283369216" TOTAL_1="705" TOTAL_2="699" WEIGHT="85.12830039847391" Z="0.10157445072043213">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.95645685891174" CI_START="0.2435431410882627" EFFECT_SIZE="1.6000000000000014" ESTIMABLE="YES" MEAN_1="19.8" MEAN_2="18.2" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="3.4" SD_2="2.7" SE="0.6920825431545158" STUDY_ID="STD-An-2008" TOTAL_1="41" TOTAL_2="37" WEIGHT="5.164714385591261"/>
<CONT_DATA CI_END="2.2158088978377712" CI_START="-2.0158088978377684" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="15.21" MEAN_2="15.11" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="47" SD_1="6.41" SD_2="5.26" SE="1.0795141719577503" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" WEIGHT="4.445361237111795"/>
<CONT_DATA CI_END="2.040148848848945" CI_START="-1.2401488488489483" EFFECT_SIZE="0.3999999999999986" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="12.3" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="285" SD_1="3.6" SD_2="3.5" SE="0.8368260140422128" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="4.9086115927359355"/>
<CONT_DATA CI_END="-1.1083273258594604" CI_START="-7.691672674140544" EFFECT_SIZE="-4.400000000000002" ESTIMABLE="YES" MEAN_1="20.2" MEAN_2="24.6" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="6.4" SD_2="7.6" SE="1.6794556941376657" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" WEIGHT="3.32765038100586"/>
<CONT_DATA CI_END="2.030153013544865" CI_START="-2.830153013544866" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.85" MEAN_2="11.25" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="342" SD_1="4.2" SD_2="4.56" SE="1.239896769896591" STUDY_ID="STD-Jie-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="4.133348134685222"/>
<CONT_DATA CI_END="0.3904412294930921" CI_START="-5.790441229493091" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="22.8" MEAN_2="25.5" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="458" SD_1="7.2" SD_2="6.9" SE="1.5767847031221478" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.5056846450220145"/>
<CONT_DATA CI_END="5.659555495072841" CI_START="2.360444504927159" EFFECT_SIZE="4.01" ESTIMABLE="YES" MEAN_1="11.58" MEAN_2="7.57" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="106" SD_1="3.0" SD_2="3.5" SE="0.8416254115301731" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.899767394436736"/>
<CONT_DATA CI_END="2.8063721421486703" CI_START="-0.80637214214867" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="17.9" MEAN_2="16.9" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="120" SD_1="3.8" SD_2="3.8" SE="0.9216353751380653" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" WEIGHT="4.749885869754139"/>
<CONT_DATA CI_END="3.4728798088575146" CI_START="-3.6928798088575134" EFFECT_SIZE="-0.10999999999999943" ESTIMABLE="YES" MEAN_1="11.71" MEAN_2="11.82" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="158" SD_1="7.6" SD_2="6.77" SE="1.8280334930227353" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="3.0835503479540414"/>
<CONT_DATA CI_END="1.4249161785593796" CI_START="-1.4649161785593787" EFFECT_SIZE="-0.019999999999999574" ESTIMABLE="YES" MEAN_1="11.49" MEAN_2="11.51" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2199" SD_1="2.49" SD_2="2.51" SE="0.7372156784291413" STUDY_ID="STD-Peng-2007a" TOTAL_1="23" TOTAL_2="23" WEIGHT="5.087342270977598"/>
<CONT_DATA CI_END="1.9147961465680672" CI_START="-1.5347961465680646" EFFECT_SIZE="0.19000000000000128" ESTIMABLE="YES" MEAN_1="11.88" MEAN_2="11.69" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="204" SD_1="3.54" SD_2="3.5" SE="0.8800142044308149" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" WEIGHT="4.828391188625136"/>
<CONT_DATA CI_END="2.536940755725916" CI_START="-2.9369407557259146" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="13.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="203" SD_1="5.7" SD_2="5.1" SE="1.396424004376894" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.834769800567552"/>
<CONT_DATA CI_END="3.0449567738076215" CI_START="-5.724956773807621" EFFECT_SIZE="-1.3399999999999999" ESTIMABLE="YES" MEAN_1="12.85" MEAN_2="14.19" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="329" SD_1="4.68" SD_2="9.57" SE="2.2372639540295642" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" WEIGHT="2.4984713159200367"/>
<CONT_DATA CI_END="1.234948539884508" CI_START="-5.834948539884506" EFFECT_SIZE="-2.299999999999999" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="14.7" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1378" SD_1="7.2" SD_2="8.3" SE="1.803578314585232" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" WEIGHT="3.122586283238314"/>
<CONT_DATA CI_END="1.9297937974711952" CI_START="-0.7297937974711959" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="13.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1352" SD_1="1.5" SD_2="3.4" SE="0.6784786904047417" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.1875175488590735"/>
<CONT_DATA CI_END="0.07841275469797271" CI_START="-4.278412754697972" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="8.3" MEAN_2="10.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1382" SD_1="4.1" SD_2="4.5" SE="1.1114555021832107" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.383115702594532"/>
<CONT_DATA CI_END="3.5048279715820625" CI_START="-2.2648279715820605" EFFECT_SIZE="0.620000000000001" ESTIMABLE="YES" MEAN_1="14.56" MEAN_2="13.94" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="349" SD_1="6.72" SD_2="5.73" SE="1.4718780520138208" STUDY_ID="STD-Zhang-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="3.694790013616538"/>
<CONT_DATA CI_END="-0.5940787077510454" CI_START="-4.465921292248957" EFFECT_SIZE="-2.530000000000001" ESTIMABLE="YES" MEAN_1="10.04" MEAN_2="12.57" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="354" SD_1="5.43" SD_2="5.39" SE="0.9877330948523829" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" WEIGHT="4.623369465279178"/>
<CONT_DATA CI_END="2.633098186730164" CI_START="-2.0330981867301627" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="13.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1380" SD_1="5.8" SD_2="4.8" SE="1.1903780911962383" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="4.229383758922812"/>
<CONT_DATA CI_END="1.535644768413907" CI_START="-0.535644768413907" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="11.44" MEAN_2="10.94" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1381" SD_1="1.77" SD_2="2.35" SE="0.5283998974383921" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" WEIGHT="5.41998906157614"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="15.989149677226273" CI_END="-0.6706370233051921" CI_START="-5.815789246079786" DF="2" EFFECT_SIZE="-3.243213134692489" ESTIMABLE="YES" I2="87.49151743292111" ID="CMP-001.07.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="3.3728958342726933E-4" P_Z="0.013477311567206702" STUDIES="3" TAU2="4.5112820898355475" TOTAL_1="118" TOTAL_2="118" WEIGHT="14.871699601526071" Z="2.470901020206029">
<NAME>from 12-26 weeks - medium term</NAME>
<CONT_DATA CI_END="-1.504131102001937" CI_START="-5.155868897998063" EFFECT_SIZE="-3.33" ESTIMABLE="YES" MEAN_1="11.62" MEAN_2="14.95" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="24" SD_1="3.23" SD_2="3.95" SE="0.9315828823388" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.730975347016123"/>
<CONT_DATA CI_END="-3.8319267538102286" CI_START="-6.808073246189772" EFFECT_SIZE="-5.32" ESTIMABLE="YES" MEAN_1="10.03" MEAN_2="15.35" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="239" SD_1="3.14" SD_2="4.01" SE="0.7592349950955749" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="5.048708567234014"/>
<CONT_DATA CI_END="0.3396530964582902" CI_START="-2.5396530964582933" EFFECT_SIZE="-1.1000000000000014" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="9.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="691" SD_1="3.2" SD_2="3.6" SE="0.7345303831162672" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="5.092015687275933"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="15.682637141103697" CI_END="0.23357421116206667" CI_START="-0.7769946965743575" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2717102427061454" ESTIMABLE="YES" I2="0.0" I2_Q="78.49286567686772" ID="CMP-001.08" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6146854717733278" P_Q="0.03106049466230376" P_Z="0.2919078729469552" Q="4.649619912051403" RANDOM="YES" SCALE="8.24075029140948" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="667" TOTAL_2="663" UNITS="" WEIGHT="99.99999999999997" Z="1.0539455268370068">
<NAME>Mental state: 7. Specific - average endpoint general psychopathological score (PANSS, high=poor )</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.20000789039906" CI_END="0.4528650352403453" CI_START="-0.6153701743474651" DF="15" EFFECT_SIZE="-0.08125256955355992" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8668295242846706" P_Z="0.7655816143445786" STUDIES="16" TAU2="0.0" TOTAL_1="549" TOTAL_2="545" WEIGHT="89.4948588428978" Z="0.29815926033324114">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.7985786541959987" CI_START="-2.398578654196" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="26.7" MEAN_2="26.5" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="453" SD_1="5.3" SD_2="6.3" SE="1.3258297982479557" STUDY_ID="STD-An-2008" TOTAL_1="41" TOTAL_2="37" WEIGHT="3.7809430824233843"/>
<CONT_DATA CI_END="3.0846228478570654" CI_START="-1.6846228478570668" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="27.4" MEAN_2="26.7" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="286" SD_1="5.5" SD_2="4.8" SE="1.2166666666666668" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="4.48985661011404"/>
<CONT_DATA CI_END="3.7772058743299963" CI_START="-2.3772058743299906" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" MEAN_1="17.85" MEAN_2="17.15" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="110" SD_1="5.65" SD_2="5.45" SE="1.5700318468107581" STUDY_ID="STD-Jie-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="2.6962413652578006"/>
<CONT_DATA CI_END="1.672158326761095" CI_START="-2.672158326761095" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="15.8" MEAN_2="16.3" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="459" SD_1="4.7" SD_2="5.2" SE="1.1082644088844502" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="5.411141840309772"/>
<CONT_DATA CI_END="2.4857661502226134" CI_START="-4.745766150222618" EFFECT_SIZE="-1.1300000000000026" ESTIMABLE="YES" MEAN_1="30.9" MEAN_2="32.03" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="277" SD_1="6.3" SD_2="7.9" SE="1.8448125469362282" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.9528604207719324"/>
<CONT_DATA CI_END="1.2679573351731057" CI_START="-2.867957335173107" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="17.8" MEAN_2="18.6" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="121" SD_1="4.4" SD_2="4.3" SE="1.0550996607513659" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" WEIGHT="5.970197855277576"/>
<CONT_DATA CI_END="4.573006452453317" CI_START="-2.1530064524533157" EFFECT_SIZE="1.2100000000000009" ESTIMABLE="YES" MEAN_1="26.62" MEAN_2="25.41" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="159" SD_1="6.69" SD_2="6.82" SE="1.7158511477661234" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="2.2574413288941395"/>
<CONT_DATA CI_END="1.7064753237754446" CI_START="-1.2064753237754446" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="19.03" MEAN_2="18.78" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2199" SD_1="2.51" SD_2="2.53" SE="0.7431133098689242" STUDY_ID="STD-Peng-2007a" TOTAL_1="23" TOTAL_2="23" WEIGHT="12.035540839563106"/>
<CONT_DATA CI_END="3.6073404535547904" CI_START="-3.207340453554792" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="19.87" MEAN_2="19.67" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="6.13" SD_2="7.69" SE="1.7384709517274082" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" WEIGHT="2.199078912778378"/>
<CONT_DATA CI_END="2.0521114824958855" CI_START="-2.452111482495884" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="23.8" MEAN_2="24.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="206" SD_1="4.5" SD_2="4.4" SE="1.1490575848639326" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.033755338571429"/>
<CONT_DATA CI_END="0.2393887317287562" CI_START="-4.559388731728756" EFFECT_SIZE="-2.16" ESTIMABLE="YES" MEAN_1="20.54" MEAN_2="22.7" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1353" SD_1="2.0" SD_2="6.4" SE="1.2242004193213898" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.434765323861528"/>
<CONT_DATA CI_END="5.105785025599046" CI_START="-0.5057850255990437" EFFECT_SIZE="2.3000000000000007" ESTIMABLE="YES" MEAN_1="19.1" MEAN_2="16.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1388" SD_1="6.2" SD_2="4.8" SE="1.431549277298317" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.243120510097826"/>
<CONT_DATA CI_END="3.3546855172771237" CI_START="-2.3746855172771197" EFFECT_SIZE="0.490000000000002" ESTIMABLE="YES" MEAN_1="24.12" MEAN_2="23.63" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="350" SD_1="6.56" SD_2="5.82" SE="1.4616011007719507" STUDY_ID="STD-Zhang-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="3.111128634345528"/>
<CONT_DATA CI_END="2.717859458764695" CI_START="-2.517859458764699" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="21.56" MEAN_2="21.46" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="355" SD_1="7.6" SD_2="7.02" SE="1.3356671241992395" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" WEIGHT="3.7254541081837202"/>
<CONT_DATA CI_END="4.039524381176991" CI_START="-2.0395243811769914" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="25.5" MEAN_2="24.5" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1386" SD_1="7.6" SD_2="6.2" SE="1.5508062419270823" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.7635072621041483"/>
<CONT_DATA CI_END="0.5635980927647677" CI_START="-1.403598092764771" EFFECT_SIZE="-0.4200000000000017" ESTIMABLE="YES" MEAN_1="36.03" MEAN_2="36.45" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1387" SD_1="2.03" SD_2="1.92" SE="0.5018449831340094" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" WEIGHT="26.389825410343505"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.833009338653235" CI_END="-0.3352874019597032" CI_START="-3.4532075321312474" DF="2" EFFECT_SIZE="-1.8942474670454752" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.39991448441131516" P_Z="0.01724248841301564" STUDIES="3" TAU2="0.0" TOTAL_1="118" TOTAL_2="118" WEIGHT="10.505141157102173" Z="2.3814957780917174">
<NAME>from 12-26 weeks - medium term</NAME>
<CONT_DATA CI_END="0.922432517337874" CI_START="-5.602432517337874" EFFECT_SIZE="-2.34" ESTIMABLE="YES" MEAN_1="22.12" MEAN_2="24.46" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="187" SD_1="5.58" SD_2="7.21" SE="1.6645369726543575" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3987710487883773"/>
<CONT_DATA CI_END="1.537269735795518" CI_START="-3.077269735795517" EFFECT_SIZE="-0.7699999999999996" ESTIMABLE="YES" MEAN_1="19.69" MEAN_2="20.46" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="240" SD_1="5.37" SD_2="5.79" SE="1.177200067957864" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="4.795955379824274"/>
<CONT_DATA CI_END="-0.42287944006192024" CI_START="-5.977120559938078" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="18.8" MEAN_2="22.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="692" SD_1="5.2" SD_2="7.7" SE="1.4169242811825378" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="3.3104147284895227"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.14668121489337554" CI_START="-0.026681214893375674" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.05999999999999994" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.17488595951050603" Q="0.0" RANDOM="YES" SCALE="0.53" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="59" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="1.3566704068125637">
<NAME>Mental state: 8. Specific - average total score decreased rate (PANSS, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours clozapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14668121489337554" CI_START="-0.026681214893375674" DF="0" EFFECT_SIZE="0.05999999999999994" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.17488595951050603" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="59" WEIGHT="100.0" Z="1.3566704068125637">
<NAME>by up to 12 weeks</NAME>
<CONT_DATA CI_END="0.14668121489337554" CI_START="-0.026681214893375674" EFFECT_SIZE="0.05999999999999994" ESTIMABLE="YES" MEAN_1="0.73" MEAN_2="0.67" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="452" SD_1="0.25" SD_2="0.23" SE="0.044225922301177965" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.08028679768635062" CI_START="-0.10028679768635064" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.8281444309502421" Q="0.0" RANDOM="YES" SCALE="0.92" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="59" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="0.21708201362383234">
<NAME>Mental state: 9. Specific - average positive score decreased rate (PANSS, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours clozapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.08028679768635062" CI_START="-0.10028679768635064" DF="0" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8281444309502421" STUDIES="1" TAU2="0.0" TOTAL_1="59" TOTAL_2="59" WEIGHT="100.0" Z="0.21708201362383234">
<NAME>by up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="0.08028679768635062" CI_START="-0.10028679768635064" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.66" MEAN_2="0.67" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="452" SD_1="0.24" SD_2="0.26" SE="0.0460655391622098" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.5857108429961904" CI_END="2.6666134440885814" CI_START="0.5793067824011207" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2428947076090262" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.4259600643337908" LOG_CI_START="-0.2370913868433601" LOG_EFFECT_SIZE="0.09443433874521537" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.7325335824656276" P_Q="0.6452278699151399" P_Z="0.5766455398361379" Q="0.8763035465804436" RANDOM="YES" SCALE="209.19849188836758" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="287" TOTAL_2="285" WEIGHT="300.0" Z="0.5582912231498205">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.0530984229528642" CI_END="4.289729931839671" CI_START="0.4602838012154088" DF="2" EFFECT_SIZE="1.4051666090591108" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.6324299512048241" LOG_CI_START="-0.33697430897861386" LOG_EFFECT_SIZE="0.14772782111310512" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5906397214275154" P_Z="0.5502676840192404" STUDIES="3" TAU2="0.0" TOTAL_1="121" TOTAL_2="119" WEIGHT="100.0" Z="0.5973590601746946">
<NAME>Any reason</NAME>
<DICH_DATA CI_END="10.510529570116088" CI_START="0.3805707384500341" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0216245983864845" LOG_CI_START="-0.4195646070585221" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="0.8465616732800195" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.7166666666666666" WEIGHT="45.244713942591645"/>
<DICH_DATA CI_END="7.377700948278992" CI_START="0.013236677751594202" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8679210473201091" LOG_CI_START="-1.8782210039599212" LOG_EFFECT_SIZE="-0.5051499783199059" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="194" O_E="0.0" SE="1.6130974345442786" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="2.6020833333333333" WEIGHT="12.46131432846399"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Wang-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="42.293971728944356"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6508730797724205" CI_END="2.9228265446498036" CI_START="0.1970652959432332" DF="2" EFFECT_SIZE="0.7589385205747243" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="0.46580304288509444" LOG_CI_START="-0.705389850136481" LOG_EFFECT_SIZE="-0.11979340362569327" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4380439610520519" P_Z="0.6884621408411102" STUDIES="3" TAU2="0.0" TOTAL_1="106" TOTAL_2="106" WEIGHT="100.00000000000001" Z="0.40094293278383725">
<NAME>Adverse events</NAME>
<DICH_DATA CI_END="7.377700948278992" CI_START="0.013236677751594202" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8679210473201091" LOG_CI_START="-1.8782210039599212" LOG_EFFECT_SIZE="-0.5051499783199059" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="194" O_E="0.0" SE="1.6130974345442786" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="2.6020833333333333" WEIGHT="18.189085304504683"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Wang-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="61.73415093838682"/>
<DICH_DATA CI_END="4.230981711453745" CI_START="0.010294035334255788" EFFECT_SIZE="0.20869565217391303" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6264411480843349" LOG_CI_START="-1.9874143453683464" LOG_EFFECT_SIZE="-0.6804865986420057" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="370" O_E="0.0" SE="1.5353916556474716" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="2.3574275362318837" WEIGHT="20.07676375710851"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.510529570116088" CI_START="0.3805707384500341" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-001.11.03" LOG_CI_END="1.0216245983864845" LOG_CI_START="-0.4195646070585221" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.41291234661537835" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.8187793074476585">
<NAME>Economic issues</NAME>
<DICH_DATA CI_END="10.510529570116088" CI_START="0.3805707384500341" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0216245983864845" LOG_CI_START="-0.4195646070585221" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.8465616732800195" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.7166666666666666" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="162.32489702395196" CI_END="4.015549499189602" CI_START="2.3242300896882453" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="MD" EFFECT_SIZE="3.1698897944389235" ESTIMABLE="YES" I2="92.6074186893035" I2_Q="87.65031509782891" ID="CMP-001.12" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="8.881784197001252E-16" P_Q="9.030064695991769E-9" P_Z="2.0304936709664053E-13" Q="48.584235529322605" RANDOM="YES" SCALE="25.23" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="21.232900897196327" TOTALS="SUB" TOTAL_1="460" TOTAL_2="460" UNITS="" WEIGHT="700.0" Z="7.346772936157668">
<NAME>Quality of life: 1a. Average scores (short term, up to 12 weeks, WHO-QOL-100, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours clozapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0857712409762097" CI_END="3.7439393354441064" CI_START="1.4266165986644834" DF="1" EFFECT_SIZE="2.585277967054295" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7696236160479193" P_Z="1.2244145668535035E-5" STUDIES="2" TAU2="0.0" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="4.3731946569453815">
<NAME>endpoint scale score</NAME>
<CONT_DATA CI_END="3.8360580859991003" CI_START="1.1239419140009006" EFFECT_SIZE="2.4800000000000004" ESTIMABLE="YES" MEAN_1="15.6" MEAN_2="13.12" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="2.03" SD_2="3.2" SE="0.6918790838482304" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="73.00564947325782"/>
<CONT_DATA CI_END="5.100078165836601" CI_START="0.6399218341634012" EFFECT_SIZE="2.870000000000001" ESTIMABLE="YES" MEAN_1="18.14" MEAN_2="15.27" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="407" SD_1="4.47" SD_2="5.16" SE="1.1378158902036832" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="26.99435052674219"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.044357621308229" CI_END="13.939275868483872" CI_START="1.512080366277539" DF="1" EFFECT_SIZE="7.725678117380705" ESTIMABLE="YES" I2="83.45564470780666" ID="CMP-001.12.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.01395086569120596" P_Z="0.01481288862854861" STUDIES="2" TAU2="16.985059722222235" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="2.4369216471290023">
<NAME>physical health</NAME>
<CONT_DATA CI_END="6.951754176024088" CI_START="2.828245823975913" EFFECT_SIZE="4.890000000000001" ESTIMABLE="YES" MEAN_1="42.57" MEAN_2="37.68" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="3.29" SD_2="4.73" SE="1.051934725478091" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="55.553634523813415"/>
<CONT_DATA CI_END="15.919583976961283" CI_START="6.6204160230387235" EFFECT_SIZE="11.270000000000003" ESTIMABLE="YES" MEAN_1="49.38" MEAN_2="38.11" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="410" SD_1="4.91" SD_2="13.36" SE="2.3722803141468947" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="44.44636547618658"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.3118163442726436" CI_END="13.678871702846191" CI_START="4.7434851441323715" DF="1" EFFECT_SIZE="9.211178423489281" ESTIMABLE="YES" I2="56.74396876389307" ID="CMP-001.12.03" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.12839407453782736" P_Z="5.324258894924252E-5" STUDIES="2" TAU2="5.899556944444423" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="4.040917054138081">
<NAME>mental health</NAME>
<CONT_DATA CI_END="11.032254175055265" CI_START="2.9277458249447434" EFFECT_SIZE="6.980000000000004" ESTIMABLE="YES" MEAN_1="67.34" MEAN_2="60.36" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="8.87" SD_2="7.04" SE="2.067514610992306" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="51.070648607691254"/>
<CONT_DATA CI_END="15.798072816414226" CI_START="7.281927183585771" EFFECT_SIZE="11.54" ESTIMABLE="YES" MEAN_1="68.56" MEAN_2="57.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="411" SD_1="9.68" SD_2="8.73" SE="2.1725260514996005" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="48.92935139230874"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="23.227433926225977" CI_END="16.537210209995187" CI_START="-0.98428484335337" DF="1" EFFECT_SIZE="7.776462683320908" ESTIMABLE="YES" I2="95.69474612143485" ID="CMP-001.12.04" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.4393265407308675E-6" P_Z="0.08190139606596332" STUDIES="2" TAU2="38.241343055555525" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="1.739758706665371">
<NAME>social function</NAME>
<CONT_DATA CI_END="6.073799097527466" CI_START="0.46620090247254" EFFECT_SIZE="3.270000000000003" ESTIMABLE="YES" MEAN_1="37.57" MEAN_2="34.3" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="5.61" SD_2="5.47" SE="1.4305360300717118" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="49.59214000759614"/>
<CONT_DATA CI_END="14.524484744046791" CI_START="9.89551525595321" EFFECT_SIZE="12.21" ESTIMABLE="YES" MEAN_1="49.1" MEAN_2="36.89" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="414" SD_1="5.23" SD_2="4.78" SE="1.1808812622594855" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="50.407859992403864"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.632296395909311" CI_END="18.944274392928474" CI_START="8.690261534095121" DF="2" EFFECT_SIZE="13.817267963511798" ESTIMABLE="YES" I2="73.79556694008973" ID="CMP-001.12.05" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.02201245039483002" P_Z="1.2771323226821682E-7" STUDIES="3" TAU2="15.129421601205447" TOTAL_1="124" TOTAL_2="124" WEIGHT="100.0" Z="5.282097447321398">
<NAME>external environmental</NAME>
<CONT_DATA CI_END="16.3705996697063" CI_START="6.6294003302937" EFFECT_SIZE="11.5" ESTIMABLE="YES" MEAN_1="101.26" MEAN_2="89.76" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="415" SD_1="12.32" SD_2="11.23" SE="2.4850454947769287" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="32.11830354690055"/>
<CONT_DATA CI_END="22.730683403228277" CI_START="14.569316596771705" EFFECT_SIZE="18.64999999999999" ESTIMABLE="YES" MEAN_1="99.41" MEAN_2="80.76" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="418" SD_1="8.59" SD_2="9.07" SE="2.0820195857761656" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="35.155588932005166"/>
<CONT_DATA CI_END="15.611978206772132" CI_START="6.18802179322785" EFFECT_SIZE="10.899999999999991" ESTIMABLE="YES" MEAN_1="98.8" MEAN_2="87.9" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="693" SD_1="13.7" SD_2="7.8" SE="2.404114689830846" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="32.726107521094285"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.779420513832798" CI_START="-1.6194205138328015" DF="0" EFFECT_SIZE="0.0799999999999983" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.06" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.9264874559158707" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="100.0" Z="0.09226505004907087">
<NAME>independence</NAME>
<CONT_DATA CI_END="1.779420513832798" CI_START="-1.6194205138328015" EFFECT_SIZE="0.0799999999999983" ESTIMABLE="YES" MEAN_1="51.25" MEAN_2="51.17" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="417" SD_1="3.29" SD_2="4.03" SE="0.8670672151313044" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="8.966258416719132" CI_START="4.253741583280867" DF="0" EFFECT_SIZE="6.609999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.07" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="3.835197051812114E-8" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="99.99999999999999" Z="5.498277203333611">
<NAME>spiritual support</NAME>
<CONT_DATA CI_END="8.966258416719132" CI_START="4.253741583280866" EFFECT_SIZE="6.609999999999999" ESTIMABLE="YES" MEAN_1="18.38" MEAN_2="11.77" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="419" SD_1="5.17" SD_2="5.03" SE="1.2021947522020808" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="152.6783165055019" CI_END="3.1034249342937206" CI_START="1.9923360600845252" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="MD" EFFECT_SIZE="2.547880497189123" ESTIMABLE="YES" I2="90.17542219267301" I2_Q="92.00468823285028" ID="CMP-001.13" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="3.68594044175552E-14" P_Z="2.4963280238366034E-19" Q="75.04397795533322" RANDOM="YES" SCALE="22.13" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="9.08247076101695" TOTALS="SUB" TOTAL_1="688" TOTAL_2="688" UNITS="" WEIGHT="700.0" Z="8.988937118026556">
<NAME>Quality of life: 1b. Average scores (medium term, 12 to 24 weeks, WHO-QOL-100, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours clozapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.027297951897850635" CI_END="3.531832795751587" CI_START="1.9774763341558879" DF="1" EFFECT_SIZE="2.7546545649537375" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8687701262482076" P_Z="3.73249451458007E-12" STUDIES="2" TAU2="0.0" TOTAL_1="88" TOTAL_2="88" WEIGHT="100.0" Z="6.946956982590145">
<NAME>endpoint scale score</NAME>
<CONT_DATA CI_END="4.025582235922857" CI_START="1.2944177640771428" EFFECT_SIZE="2.66" ESTIMABLE="YES" MEAN_1="16.23" MEAN_2="13.57" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2209" SD_1="2.03" SD_2="4.21" SE="0.6967384333050993" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="32.389596461616534"/>
<CONT_DATA CI_END="3.7451785632569625" CI_START="1.854821436743039" EFFECT_SIZE="2.8000000000000007" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="13.2" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SD_1="1.8" SD_2="2.6" SE="0.48224282217041214" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="67.61040353838347"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="33.89941850802103" CI_END="9.561232208584451" CI_START="0.22469355658621915" DF="2" EFFECT_SIZE="4.892962882585335" ESTIMABLE="YES" I2="94.10019378495599" ID="CMP-001.13.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="4.353526816824882E-8" P_Z="0.03994655387618081" STUDIES="3" TAU2="15.908820363403823" TOTAL_1="128" TOTAL_2="128" WEIGHT="100.0" Z="2.0543011462831697">
<NAME>physical health</NAME>
<CONT_DATA CI_END="11.395395888295035" CI_START="6.004604111704971" EFFECT_SIZE="8.700000000000003" ESTIMABLE="YES" MEAN_1="50.6" MEAN_2="41.9" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2210" SD_1="6.1" SD_2="6.2" SE="1.3752272539475066" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="31.87086909302503"/>
<CONT_DATA CI_END="7.542262846302966" CI_START="4.11773715369703" EFFECT_SIZE="5.829999999999998" ESTIMABLE="YES" MEAN_1="43.37" MEAN_2="37.54" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2211" SD_1="3.46" SD_2="4.73" SE="0.8736195459758849" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="34.02726975808946"/>
<CONT_DATA CI_END="2.070855428777888" CI_START="-1.270855428777891" EFFECT_SIZE="0.3999999999999986" ESTIMABLE="YES" MEAN_1="38.3" MEAN_2="37.9" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2212" SD_1="3.8" SD_2="4.1" SE="0.8524929243380919" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="34.10186114888552"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.602626247582275" CI_END="9.531943960032333" CI_START="5.256084184785486" DF="2" EFFECT_SIZE="7.394014072408909" ESTIMABLE="YES" I2="23.154544304703307" ID="CMP-001.13.03" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.27217429835350904" P_Z="1.2141286464595562E-11" STUDIES="3" TAU2="0.8302078020089682" TOTAL_1="128" TOTAL_2="128" WEIGHT="99.99999999999999" Z="6.778520365423896">
<NAME>mental health</NAME>
<CONT_DATA CI_END="10.252332986665792" CI_START="4.347667013334203" EFFECT_SIZE="7.299999999999997" ESTIMABLE="YES" MEAN_1="50.5" MEAN_2="43.2" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SD_1="7.4" SD_2="6.0" SE="1.5063200191194432" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="38.39193826220644"/>
<CONT_DATA CI_END="12.710695862953756" CI_START="6.029304137046239" EFFECT_SIZE="9.369999999999997" ESTIMABLE="YES" MEAN_1="66.6" MEAN_2="57.23" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2215" SD_1="10.57" SD_2="4.36" SE="1.7044679847715272" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="31.853079229898935"/>
<CONT_DATA CI_END="8.888848561703671" CI_START="1.9111514382963395" EFFECT_SIZE="5.400000000000006" ESTIMABLE="YES" MEAN_1="66.2" MEAN_2="60.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="10.4" SD_2="5.3" SE="1.780057485353434" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="29.75498250789461"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.192547621510586" CI_END="10.561892904572943" CI_START="2.7915686889219744" DF="2" EFFECT_SIZE="6.676730796747458" ESTIMABLE="YES" I2="84.83992586284867" ID="CMP-001.13.04" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0013654554260957852" P_Z="7.565017237049788E-4" STUDIES="3" TAU2="9.99317249054706" TOTAL_1="128" TOTAL_2="128" WEIGHT="100.0" Z="3.3682383213138896">
<NAME>social function</NAME>
<CONT_DATA CI_END="13.470594717466273" CI_START="7.929405282533719" EFFECT_SIZE="10.699999999999996" ESTIMABLE="YES" MEAN_1="52.8" MEAN_2="42.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2217" SD_1="7.2" SD_2="5.3" SE="1.4135947085356537" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="32.768110698214244"/>
<CONT_DATA CI_END="7.995445213728329" CI_START="3.204554786271673" EFFECT_SIZE="5.600000000000001" ESTIMABLE="YES" MEAN_1="38.25" MEAN_2="32.65" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2218" SD_1="5.63" SD_2="5.96" SE="1.222188383369947" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="34.207286587259766"/>
<CONT_DATA CI_END="6.505258903447238" CI_START="1.0947410965527702" EFFECT_SIZE="3.8000000000000043" ESTIMABLE="YES" MEAN_1="36.6" MEAN_2="32.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2219" SD_1="6.4" SD_2="6.4" SE="1.3802594970040118" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="33.02460271452599"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.399607437975762" CI_START="-3.9996074379757705" DF="0" EFFECT_SIZE="-0.8000000000000043" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.05" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.6240977318938246" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.4900511134653537">
<NAME>material life</NAME>
<CONT_DATA CI_END="2.399607437975762" CI_START="-3.9996074379757705" EFFECT_SIZE="-0.8000000000000043" ESTIMABLE="YES" MEAN_1="48.9" MEAN_2="49.7" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2220" SD_1="7.4" SD_2="7.2" SE="1.6324827717314507" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.1611479217594519" CI_END="8.6598347753698" CI_START="4.760443160581936" DF="1" EFFECT_SIZE="6.710138967975868" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.06" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.6881020588829128" P_Z="1.5252375921795796E-11" STUDIES="2" TAU2="0.0" TOTAL_1="88" TOTAL_2="88" WEIGHT="100.0" Z="6.745478273388011">
<NAME>independence</NAME>
<CONT_DATA CI_END="9.479033101462147" CI_START="2.8409668985378618" EFFECT_SIZE="6.160000000000004" ESTIMABLE="YES" MEAN_1="53.35" MEAN_2="47.19" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2221" SD_1="4.98" SD_2="10.21" SE="1.693415352344355" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="34.50726571715869"/>
<CONT_DATA CI_END="9.409185810458357" CI_START="4.590814189541643" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="50.8" MEAN_2="43.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2222" SD_1="4.9" SD_2="6.4" SE="1.2291990207277828" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="65.49273428284131"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.43764874702877365" CI_END="0.7483040422751794" CI_START="-1.368304428500191" DF="1" EFFECT_SIZE="-0.3100001931125059" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.07" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.5082595163342982" P_Z="0.5658894251753722" STUDIES="2" TAU2="0.0" TOTAL_1="88" TOTAL_2="88" WEIGHT="100.00000000000001" Z="0.5741158292524428">
<NAME>spiritual support</NAME>
<CONT_DATA CI_END="1.8090866547796116" CI_START="-1.5490866547796136" EFFECT_SIZE="0.129999999999999" ESTIMABLE="YES" MEAN_1="11.02" MEAN_2="10.89" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2223" SD_1="3.79" SD_2="4.32" SE="0.8566926066111591" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="39.72600094349252"/>
<CONT_DATA CI_END="0.7631559097169422" CI_START="-1.963155909716945" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="8.8" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2224" SD_1="3.6" SD_2="2.8" SE="0.6955004890239532" STUDY_ID="STD-Yan-2007" TOTAL_1="43" TOTAL_2="43" WEIGHT="60.27399905650749"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.20139596458502" CI_END="6.572730528867571" CI_START="3.358789464164393" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="4.965759996515982" ESTIMABLE="YES" I2="62.96615419365388" I2_Q="62.96615419365388" ID="CMP-001.14" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.012712869586804842" P_Q="0.012712869586804842" P_Z="1.3906473645800672E-9" Q="16.20139596458502" RANDOM="YES" SCALE="31.07" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="8.23838087796587" TOTALS="SUB" TOTAL_1="386" TOTAL_2="388" UNITS="" WEIGHT="700.0" Z="6.056558320829028">
<NAME>Quality of life: 2. Average endpoint general quality of life score (GQOLI - 74, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours clozapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.399733215925647" CI_START="-3.399733215925646" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.01" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8015863314919133" STUDIES="1" TAU2="0.0" TOTAL_1="56" TOTAL_2="58" WEIGHT="100.0" Z="0.25129462401889385">
<NAME>Total score</NAME>
<CONT_DATA CI_END="4.399733215925647" CI_START="-3.399733215925646" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="62.6" MEAN_2="62.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="11.6" SD_2="9.5" SE="1.9896963651813218" STUDY_ID="STD-Kuang-2006" TOTAL_1="56" TOTAL_2="58" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="12.447066218763805" CI_START="2.9529337812361867" DF="0" EFFECT_SIZE="7.699999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.02" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0014769828083532903" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="3.17916835061308">
<NAME>Physical health</NAME>
<CONT_DATA CI_END="12.447066218763805" CI_START="2.9529337812361867" EFFECT_SIZE="7.699999999999996" ESTIMABLE="YES" MEAN_1="69.1" MEAN_2="61.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="13.9" SD_2="12.6" SE="2.4220170657257283" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.695665868708215" CI_START="-2.295665868708209" DF="0" EFFECT_SIZE="2.700000000000003" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.03" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.2894637462242907" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001" Z="1.0592987796492765">
<NAME>Mental health</NAME>
<CONT_DATA CI_END="7.695665868708215" CI_START="-2.295665868708209" EFFECT_SIZE="2.700000000000003" ESTIMABLE="YES" MEAN_1="66.8" MEAN_2="64.1" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="15.2" SD_2="12.6" SE="2.548855952514121" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="10.054303307501058" CI_START="3.145696692498945" DF="0" EFFECT_SIZE="6.600000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.04" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="1.8051936927603415E-4" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001" Z="3.744825264728264">
<NAME>Social function</NAME>
<CONT_DATA CI_END="10.054303307501058" CI_START="3.145696692498945" EFFECT_SIZE="6.600000000000001" ESTIMABLE="YES" MEAN_1="67.0" MEAN_2="60.4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="9.9" SD_2="9.4" SE="1.7624320317863797" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.503840251954457" CI_START="-5.303840251954454" DF="0" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.05" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.9710672016755412" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.03626983576783574">
<NAME>Material life</NAME>
<CONT_DATA CI_END="5.503840251954456" CI_START="-5.303840251954453" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="49.1" MEAN_2="49.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="15.3" SD_2="14.9" SE="2.757112015618275" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="17.45344092380522" CI_START="5.546559076194779" DF="0" EFFECT_SIZE="11.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.06" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="1.5310631069952627E-4" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="3.7859762296598296">
<NAME>Environmental area (medium term)</NAME>
<CONT_DATA CI_END="17.45344092380522" CI_START="5.546559076194779" EFFECT_SIZE="11.5" ESTIMABLE="YES" MEAN_1="101.26" MEAN_2="89.76" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="245" SD_1="12.32" SD_2="16.23" SE="3.0375256743313668" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.7508914161351726E-31" CI_END="9.479033101462145" CI_START="2.840966898537861" DF="0" EFFECT_SIZE="6.160000000000003" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-001.14.07" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="2.751699797885686E-4" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="3.637619082330943">
<NAME>Independence (medium term)</NAME>
<CONT_DATA CI_END="9.479033101462147" CI_START="2.8409668985378618" EFFECT_SIZE="6.160000000000004" ESTIMABLE="YES" MEAN_1="53.35" MEAN_2="47.19" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="246" SD_1="4.98" SD_2="10.21" SE="1.693415352344355" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="29.922047695777977" CI_END="0.8144849264815887" CI_START="0.4729546856724375" CI_STUDY="95" CI_TOTAL="95" DF="21" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6206564769572924" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="183" I2="29.817637437416703" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="-0.08911694868689542" LOG_CI_START="-0.3251804675183231" LOG_EFFECT_SIZE="-0.20714870810260927" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.09356570743831871" P_Q="0.8752062876501044" P_Z="5.821740658973364E-4" Q="2.439226578897631" RANDOM="YES" SCALE="336.30381831822956" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.09247652051419357" TOTALS="YES" TOTAL_1="788" TOTAL_2="794" WEIGHT="99.99999999999999" Z="3.4397861163379595">
<NAME>Adverse effects: 1. At least one adverse effect</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="18.17176407540918" CI_END="0.9475571142858752" CI_START="0.4776646265640908" DF="7" EFFECT_SIZE="0.6727663154049184" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="141" I2="61.47869865054706" ID="CMP-001.15.01" LOG_CI_END="-0.02339460334233695" LOG_CI_START="-0.3208769191873213" LOG_EFFECT_SIZE="-0.17213576126482913" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.011218628279155984" P_Z="0.023314890468975297" STUDIES="7" TAU2="0.13600303451778142" TOTAL_1="288" TOTAL_2="286" WEIGHT="78.92341119314615" Z="2.2682349474935246">
<NAME>Non-specific</NAME>
<DICH_DATA CI_END="1.528373662036375" CI_START="0.16357256488371105" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18422954502603905" LOG_CI_START="-0.7862895363540015" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="465" O_E="0.0" SE="0.5700877125495689" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.32499999999999996" WEIGHT="4.6057557396610695"/>
<DICH_DATA CI_END="3.3951028335734126" CI_START="1.13151211857599" EFFECT_SIZE="1.96" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="10" LOG_CI_END="0.5308529330722291" LOG_CI_START="0.05365920964072278" LOG_EFFECT_SIZE="0.292256071356476" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="0.2803059552906941" STUDY_ID="STD-Liu-2010" TOTAL_1="30" TOTAL_2="28" VAR="0.07857142857142858" WEIGHT="11.241262410983238"/>
<DICH_DATA CI_END="1.1073628266019147" CI_START="0.44249272978001986" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="20" LOG_CI_END="0.04428994045762505" LOG_CI_START="-0.3540938604291114" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="207" O_E="0.0" SE="0.23401261667248788" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="0.054761904761904755" WEIGHT="13.059056268269616"/>
<DICH_DATA CI_END="0.7803726372115218" CI_START="0.3203597718306939" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="28" LOG_CI_END="-0.10769796700225465" LOG_CI_START="-0.4943620243257077" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="421" O_E="0.0" SE="0.22712838128974897" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="0.051587301587301584" WEIGHT="13.346826791651695"/>
<DICH_DATA CI_END="0.9350110948187904" CI_START="0.2962620569791132" EFFECT_SIZE="0.5263157894736842" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="19" LOG_CI_END="-0.029183235769203446" LOG_CI_START="-0.5283239661364545" LOG_EFFECT_SIZE="-0.278753600952829" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1389" O_E="0.0" SE="0.2931977358041869" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.08596491228070177" WEIGHT="10.775495636947074"/>
<DICH_DATA CI_END="0.8501982055329425" CI_START="0.39423754745701456" EFFECT_SIZE="0.5789473684210527" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="38" LOG_CI_END="-0.07047981600964343" LOG_CI_START="-0.40424201557956446" LOG_EFFECT_SIZE="-0.23736091579460392" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="356" O_E="0.0" SE="0.196053568176905" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.03843700159489634" WEIGHT="14.68751928414025"/>
<DICH_DATA CI_END="1.2828452881010146" CI_START="0.26525238930525147" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.10817428336209944" LOG_CI_START="-0.5763406954288354" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2200" O_E="0.0" SE="0.4020874869455876" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" VAR="0.1616743471582181" WEIGHT="7.565564887271483"/>
<DICH_DATA CI_END="1.8225864286313116" CI_START="0.13716770632805594" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2606881320998397" LOG_CI_START="-0.862748123427802" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2204" O_E="0.0" SE="0.6599120175960899" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" VAR="0.435483870967742" WEIGHT="3.6419301742217316"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.8698689779204765" CI_START="0.01411854649967386" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.15.02" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.7135662334857849" Z="0.6810488185180525">
<NAME>epilepsy</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2377" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.7135662334857849"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.279103051674055" CI_END="1.559195322125789" CI_START="0.15679822667160134" DF="4" EFFECT_SIZE="0.4944482394993231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" I2="24.229552618194095" ID="CMP-001.15.03" LOG_CI_END="0.19290052314778694" LOG_CI_START="-0.8046588533294704" LOG_EFFECT_SIZE="-0.30587916509084173" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2598396599179126" P_Z="0.22937989229535072" STUDIES="5" TAU2="0.42917712059478874" TOTAL_1="182" TOTAL_2="182" WEIGHT="7.911205285480105" Z="1.2019578209295678">
<NAME>liver function abnormal</NAME>
<DICH_DATA CI_END="71.50812704867249" CI_START="0.12585982001561988" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8543554030852154" LOG_CI_START="-0.9001128936458906" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2386" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.709423458703395"/>
<DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2385" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.7919383229140643"/>
<DICH_DATA CI_END="0.9896227750419018" CI_START="0.09094374368676922" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.004530318470683675" LOG_CI_START="-1.0412271720899915" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2384" O_E="0.0" SE="0.6089608635481704" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" VAR="0.37083333333333335" WEIGHT="4.150127316663465"/>
<DICH_DATA CI_END="2.0109804706541157" CI_START="0.006139134214630123" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30340785302919543" LOG_CI_START="-2.2118928719078457" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2383" O_E="0.0" SE="1.4775000967674123" STUDY_ID="STD-Yan-2008a" TOTAL_1="50" TOTAL_2="50" VAR="2.1830065359477127" WEIGHT="0.8450051408080737"/>
<DICH_DATA CI_END="3.0260386806300987" CI_START="0.036718338011454264" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48087447513357967" LOG_CI_START="-1.4351169845729046" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2382" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.4147110463911075"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9603318760340067" CI_END="1.1962684404590398" CI_START="0.20844156982076173" DF="2" EFFECT_SIZE="0.49935165130028025" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" I2="0.0" ID="CMP-001.15.04" LOG_CI_END="0.0778286454790511" LOG_CI_START="-0.6810156647226671" LOG_EFFECT_SIZE="-0.301593509621808" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.3752489184816937" P_Z="0.11925030587713555" STUDIES="3" TAU2="0.0" TOTAL_1="126" TOTAL_2="132" WEIGHT="8.057628334523244" Z="1.5579280463278342">
<NAME>stuffy nose</NAME>
<DICH_DATA CI_END="74.89810334321228" CI_START="0.13083938699035758" EFFECT_SIZE="3.130434782608696" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8744708201292886" LOG_CI_START="-0.8832614993019376" LOG_EFFECT_SIZE="0.4956046604136756" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2378" O_E="0.0" SE="1.619905615429044" STUDY_ID="STD-Yu-2006" TOTAL_1="45" TOTAL_2="47" VAR="2.6240942028985503" WEIGHT="0.7078022537607382"/>
<DICH_DATA CI_END="2.4597721284746283" CI_START="0.1630684023401188" EFFECT_SIZE="0.6333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3908948762375836" LOG_CI_START="-0.7876301837712506" LOG_EFFECT_SIZE="-0.1983676537668335" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2377" O_E="0.0" SE="0.6922714540423225" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.47923976608187135" WEIGHT="3.3631976657164793"/>
<DICH_DATA CI_END="1.065292823627939" CI_START="0.09216036717813003" EFFECT_SIZE="0.31333333333333335" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.027469001395366118" LOG_CI_START="-1.0354558036352937" LOG_EFFECT_SIZE="-0.5039934011199637" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2376" O_E="0.0" SE="0.6243672920376517" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.3898345153664303" WEIGHT="3.9866284150460265"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.229225892741939" CI_START="0.038337276413468575" DF="0" EFFECT_SIZE="0.35185185185185186" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.15.05" LOG_CI_END="0.5090984261072614" LOG_CI_START="-1.4163787438475404" LOG_EFFECT_SIZE="-0.45364015887013953" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.3557308639795569" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="38" WEIGHT="1.4017438586396203" Z="0.9235304237311448">
<NAME>sweating</NAME>
<DICH_DATA CI_END="3.229225892741939" CI_START="0.038337276413468575" EFFECT_SIZE="0.35185185185185186" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5090984261072614" LOG_CI_START="-1.4163787438475404" LOG_EFFECT_SIZE="-0.45364015887013953" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2381" O_E="0.0" SE="1.1310348208971601" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="1.2792397660818713" WEIGHT="1.4017438586396203"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9257976126882719" CI_END="9.394010776061286" CI_START="0.10692109234590153" DF="1" EFFECT_SIZE="1.0022065124941282" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.15.06" LOG_CI_END="0.9728510540355704" LOG_CI_START="-0.9709366129778457" LOG_EFFECT_SIZE="9.57220528862382E-4" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.33595744583148557" P_Z="0.9984597860226175" STUDIES="2" TAU2="0.0" TOTAL_1="66" TOTAL_2="66" WEIGHT="1.4243727119064886" Z="0.0019303731510091706">
<NAME>urinary retention</NAME>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2413" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.7135662334857849"/>
<DICH_DATA CI_END="7.9199970308142" CI_START="0.014029185955349858" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.898725018773679" LOG_CI_START="-1.8529675282130038" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2412" O_E="0.0" SE="1.6163578231977633" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.612612612612612" WEIGHT="0.7108064784207038"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.26082983416286737" CI_END="1.536467983800081" CI_START="0.021755158020481204" DF="1" EFFECT_SIZE="0.1828280716437739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" I2="0.0" ID="CMP-001.15.07" LOG_CI_END="0.18652351506176074" LOG_CI_START="-1.66243775782409" LOG_EFFECT_SIZE="-0.7379571213811646" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.6095506624287661" P_Z="0.11769526261202039" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="1.5680723828185954" Z="1.5645210110695817">
<NAME>urinary incontinence</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2379" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.7135662334857849"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2380" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.8545061493328105"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="24.876762782140027" CI_END="0.39536545544518037" CI_START="0.2736122255661704" CI_STUDY="95" CI_TOTAL="95" DF="36" EFFECT_MEASURE="RR" EFFECT_SIZE="0.32890245085182684" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="411" I2="0.0" I2_Q="20.450776532883133" ID="CMP-001.16" LOG_CI_END="-0.4030012792937969" LOG_CI_START="-0.5628645013331185" LOG_EFFECT_SIZE="-0.4829328903134577" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.91867198657932" P_Q="0.2735720892246918" P_Z="2.3741356242835291E-32" Q="7.542499773715843" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1371" TOTAL_2="1394" WEIGHT="700.0" Z="11.84176147446086">
<NAME>Adverse effects: 2. Cardiac effects</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.032639681383794" CI_END="0.508521081941949" CI_START="0.29016320801431844" DF="11" EFFECT_SIZE="0.384127724174119" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="134" I2="0.0" ID="CMP-001.16.01" LOG_CI_END="-0.2936910376649995" LOG_CI_START="-0.5373576558863529" LOG_EFFECT_SIZE="-0.4155243467756761" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9689524946600928" P_Z="2.3148077003862714E-11" STUDIES="12" TAU2="0.0" TOTAL_1="461" TOTAL_2="460" WEIGHT="99.99999999999999" Z="6.68464773980671">
<NAME>abnormal ECG (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.6225879107733399" CI_START="0.22995980928446583" EFFECT_SIZE="0.3783783783783784" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="37" LOG_CI_END="-0.2057993165725573" LOG_CI_START="-0.6383480602049567" LOG_EFFECT_SIZE="-0.422073688388757" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="517" O_E="0.0" SE="0.2540812731604844" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" VAR="0.0645572933708527" WEIGHT="31.733791352174965"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.9494563159262602"/>
<DICH_DATA CI_END="1.5203128826587635" CI_START="0.12081294020645411" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.1819329755952601" LOG_CI_START="-0.9178865461844489" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.6460394312878367" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="0.41736694677871145" WEIGHT="4.90850483945482"/>
<DICH_DATA CI_END="0.9243960330499997" CI_START="0.12019860226412413" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03414192691879562" LOG_CI_START="-0.9201005825205295" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="209" O_E="0.0" SE="0.5204164998665332" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" VAR="0.2708333333333333" WEIGHT="7.5642375806466005"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.8771833980779753"/>
<DICH_DATA CI_END="3.1149053020348907" CI_START="0.18058333896460121" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4934448479682711" LOG_CI_START="-0.7433223211848708" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="427" O_E="0.0" SE="0.7264831572567788" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="0.5277777777777777" WEIGHT="3.8816482321739136"/>
<DICH_DATA CI_END="1.8425677190843581" CI_START="0.13568022353296982" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.265423458259286" LOG_CI_START="-0.8674834495872482" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="441" O_E="0.0" SE="0.6654751256486924" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="0.44285714285714284" WEIGHT="4.625978627949198"/>
<DICH_DATA CI_END="1.3589657467134286" CI_START="0.2503946685931693" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.13320851030069047" LOG_CI_START="-0.6013749223674265" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="448" O_E="0.0" SE="0.4314979445958882" STUDY_ID="STD-Yan-2008a" TOTAL_1="50" TOTAL_2="50" VAR="0.18619047619047618" WEIGHT="11.002967069035178"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1366" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="3.234706860144928"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1399" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.9494563159262602"/>
<DICH_DATA CI_END="0.5844443456188094" CI_START="0.19035948823675125" EFFECT_SIZE="0.3335483870967742" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="31" LOG_CI_END="-0.2332568387218756" LOG_CI_START="-0.7204254714308223" LOG_EFFECT_SIZE="-0.47684115507634894" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="462" O_E="0.0" SE="0.28616526637685974" STUDY_ID="STD-Zhang-2007" TOTAL_1="50" TOTAL_2="47" VAR="0.08189055968053909" WEIGHT="25.016896771541287"/>
<DICH_DATA CI_END="1.065292823627939" CI_START="0.09216036717813003" EFFECT_SIZE="0.31333333333333335" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.027469001395366118" LOG_CI_START="-1.0354558036352937" LOG_EFFECT_SIZE="-0.5039934011199637" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="385" O_E="0.0" SE="0.6243672920376517" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.3898345153664303" WEIGHT="5.255172636948611"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2082062038856774" CI_END="1.4341498709980212" CI_START="0.2288788216639581" DF="2" EFFECT_SIZE="0.5729280343669216" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" I2="0.0" ID="CMP-001.16.02" LOG_CI_END="0.15659453818422953" LOG_CI_START="-0.6403943910738097" LOG_EFFECT_SIZE="-0.24189992644479014" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9011324775665944" P_Z="0.23413841900691612" STUDIES="3" TAU2="0.0" TOTAL_1="97" TOTAL_2="97" WEIGHT="100.00000000000001" Z="1.1897659460240098">
<NAME>blood pressure- decrease (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="2.870075466838292" CI_START="0.1715148858142134" EFFECT_SIZE="0.7016129032258065" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4578933163857471" LOG_CI_START="-0.7656981814729802" LOG_EFFECT_SIZE="-0.15390243254361652" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2394" O_E="0.0" SE="0.7187437027178148" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.5165925101965146" WEIGHT="42.42595981901632"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2396" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="8.422623043295026"/>
<DICH_DATA CI_END="1.9536707051404467" CI_START="0.14257744766461286" EFFECT_SIZE="0.5277777777777778" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.29085136440213655" LOG_CI_START="-0.8459491640310532" LOG_EFFECT_SIZE="-0.2775488998144583" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2395" O_E="0.0" SE="0.6677622576550265" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.44590643274853803" WEIGHT="49.15141713768867"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5956264582462302" CI_START="0.1719198309314664" DF="0" EFFECT_SIZE="0.32" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" I2="0.0" ID="CMP-001.16.03" LOG_CI_END="-0.22502601875209446" LOG_CI_START="-0.7646740246080935" LOG_EFFECT_SIZE="-0.494850021680094" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.249881213630546E-4" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="31" WEIGHT="100.0" Z="3.594521650101887">
<NAME>general adverse cardiac events (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.5956264582462302" CI_START="0.1719198309314664" EFFECT_SIZE="0.32" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="-0.22502601875209446" LOG_CI_START="-0.7646740246080935" LOG_EFFECT_SIZE="-0.494850021680094" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2199" O_E="0.0" SE="0.31699190994052506" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" VAR="0.10048387096774195" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.023138035298369" CI_END="0.49174208189208257" CI_START="0.05421952580493762" DF="3" EFFECT_SIZE="0.1632850957635801" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="24" I2="0.0" ID="CMP-001.16.04" LOG_CI_END="-0.3082626244300013" LOG_CI_START="-1.2658442850070917" LOG_EFFECT_SIZE="-0.7870534547185464" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7956534944740182" P_Z="0.0012736190707284857" STUDIES="4" TAU2="0.0" TOTAL_1="166" TOTAL_2="168" WEIGHT="100.0" Z="3.2218587482691046">
<NAME>QTc prolongation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="4.078648376316569" CI_START="0.009807170491152772" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6105162660408545" LOG_CI_START="-2.008456274712892" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="513" O_E="0.0" SE="1.5383974345619102" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" VAR="2.3666666666666667" WEIGHT="13.368717617272974"/>
<DICH_DATA CI_END="0.9577136057950641" CI_START="0.051563135106957904" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.01876434271496278" LOG_CI_START="-1.2876606848357246" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.7453559924999299" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.5555555555555556" WEIGHT="56.95073704958286"/>
<DICH_DATA CI_END="0.7824292625750973" CI_START="0.0028981197465470336" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10655491545813395" LOG_CI_START="-2.537883674009705" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="1.42817454804465" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.03968253968254" WEIGHT="15.511873904555644"/>
<DICH_DATA CI_END="2.8167461177671838" CI_START="0.008049742376892705" EFFECT_SIZE="0.15057915057915058" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44974770441508055" LOG_CI_START="-2.0942180185245856" LOG_EFFECT_SIZE="-0.8222351570547526" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="477" O_E="0.0" SE="1.4943380584881831" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="2.233046233046233" WEIGHT="14.168671428588517"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.381817206571798" CI_END="0.384802252690231" CI_START="0.21583040280306945" DF="14" EFFECT_SIZE="0.28818748272203126" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="202" I2="0.0" ID="CMP-001.16.05" LOG_CI_END="-0.4147623942016022" LOG_CI_START="-0.6658873787467422" LOG_EFFECT_SIZE="-0.5403248864741722" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6558152526947798" P_Z="3.335181315932037E-17" STUDIES="15" TAU2="0.0" TOTAL_1="541" TOTAL_2="563" WEIGHT="99.99999999999999" Z="8.434185227393906">
<NAME>tachycardia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="1.0107601156765436" CI_START="0.14635420589763304" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.004648096442041392" LOG_CI_START="-0.8345947923836773" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="0.4929754272155268" STUDY_ID="STD-Bai-2007" TOTAL_1="59" TOTAL_2="59" VAR="0.24302477183833116" WEIGHT="8.953740554482879"/>
<DICH_DATA CI_END="1.5022476497886328" CI_START="0.12226577250002559" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.1767415332480145" LOG_CI_START="-0.9126951038372033" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="134" O_E="0.0" SE="0.6399404734221844" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.4095238095238095" WEIGHT="5.313441379349895"/>
<DICH_DATA CI_END="0.43744416772826833" CI_START="0.028222296519483065" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.3590773693727725" LOG_CI_START="-1.5494076495058775" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.6992058987801011" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.48888888888888893" WEIGHT="4.450869726858029"/>
<DICH_DATA CI_END="0.44226002623983995" CI_START="0.027914978247775318" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.354322312649378" LOG_CI_START="-1.554162706229272" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.7047921864945659" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="0.49673202614379086" WEIGHT="4.380592836433954"/>
<DICH_DATA CI_END="2.533456273050193" CI_START="0.09867942172888139" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4037134128552686" LOG_CI_START="-1.005773404183231" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.8279395334006838" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.685483870967742" WEIGHT="3.17437192545587"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.8362240092884782"/>
<DICH_DATA CI_END="0.7391312969236045" CI_START="0.15032662204073247" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.13127840806721597" LOG_CI_START="-0.822964101372109" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="439" O_E="0.0" SE="0.40629960014669597" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="0.16507936507936505" WEIGHT="13.181421883387243"/>
<DICH_DATA CI_END="0.5094455474961359" CI_START="0.010014889405555604" EFFECT_SIZE="0.07142857142857142" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="14" LOG_CI_END="-0.29290222909769104" LOG_CI_START="-1.9993538422587853" LOG_EFFECT_SIZE="-1.146128035678238" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="1.0023781246425445" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.0047619047619045" WEIGHT="2.1656680503511425"/>
<DICH_DATA CI_END="0.8310531798697679" CI_START="0.1139211767745765" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.08037118441683451" LOG_CI_START="-0.9433955375409142" LOG_EFFECT_SIZE="-0.5118833609788743" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.506944777064531" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="0.25699300699300703" WEIGHT="8.467081578651765"/>
<DICH_DATA CI_END="1.8874318744863978" CI_START="0.1927590642252142" EFFECT_SIZE="0.6031746031746031" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2758712850331038" LOG_CI_START="-0.714985190706647" LOG_EFFECT_SIZE="-0.21955695283677157" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="476" O_E="0.0" SE="0.5820339986681885" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.3387635756056808" WEIGHT="6.423302007786236"/>
<DICH_DATA CI_END="0.8235102234711112" CI_START="0.01499153096158102" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.08433100491009908" LOG_CI_START="-1.824154013968551" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1400" O_E="0.0" SE="1.021980647783726" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.0444444444444443" WEIGHT="2.0833858295931202"/>
<DICH_DATA CI_END="0.5363897724003024" CI_START="0.0617098274324675" EFFECT_SIZE="0.18193548387096775" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="31" LOG_CI_END="-0.2705195116415766" LOG_CI_START="-1.2096456680602838" LOG_EFFECT_SIZE="-0.7400825898509303" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="463" O_E="0.0" SE="0.5516473530297971" STUDY_ID="STD-Zhang-2007" TOTAL_1="25" TOTAL_2="47" VAR="0.30431480210478157" WEIGHT="7.150426927322389"/>
<DICH_DATA CI_END="0.50732607180757" CI_START="0.15209250640764954" EFFECT_SIZE="0.2777777777777778" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="36" LOG_CI_END="-0.2947128184410979" LOG_CI_START="-0.8178921830934766" LOG_EFFECT_SIZE="-0.5563025007672873" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.3073181485764296" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.09444444444444444" WEIGHT="23.03979623314744"/>
<DICH_DATA CI_END="1.4009264883704453" CI_START="0.1538120304307064" EFFECT_SIZE="0.4641975308641975" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.14641534689699198" LOG_CI_START="-0.8130096947989695" LOG_EFFECT_SIZE="-0.33329717395098873" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="372" O_E="0.0" SE="0.5635710187227587" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.3176122931442081" WEIGHT="6.851059616778863"/>
<DICH_DATA CI_END="1.5535004046793537" CI_START="0.07152306544396729" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.19131137072262336" LOG_CI_START="-1.1455538801619483" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="0.7852812659593164" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.6166666666666666" WEIGHT="3.5286174411126723"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7889306824524717" CI_START="0.002874236921672434" DF="0" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" I2="0.0" ID="CMP-001.16.06" LOG_CI_END="-0.10296115338230424" LOG_CI_START="-2.5414774360855343" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.03354703218769666" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="2.125474589384008">
<NAME>QTc prolongation (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.7889306824524717" CI_START="0.002874236921672434" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10296115338230424" LOG_CI_START="-2.5414774360855343" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2436" O_E="0.0" SE="1.4323965353101529" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.05175983436853" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5746592838701632" CI_START="0.00524841335174752" DF="0" EFFECT_SIZE="0.0909090909090909" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" I2="0.0" ID="CMP-001.16.07" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.09936700350020851" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="1.6479301602810232">
<NAME>tachycardia (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2435" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="315.6179354123406" CI_END="0.5197371712273037" CI_START="0.34772502715911924" CI_STUDY="95" CI_TOTAL="95" DF="95" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4251183623187994" ESTIMABLE="YES" EVENTS_1="304" EVENTS_2="845" I2="69.90031638224654" I2_Q="91.27418422325779" ID="CMP-001.17" LOG_CI_END="-0.28421622163853616" LOG_CI_START="-0.4587640502832486" LOG_EFFECT_SIZE="-0.37149013596089236" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="6.661338147750939E-16" P_Q="-2.220446049250313E-16" P_Z="7.256254081443621E-17" Q="171.90369798983141" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="26" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.5173811463885918" TOTALS="SUB" TOTAL_1="3452" TOTAL_2="3428" WEIGHT="1600.0" Z="8.342782522689305">
<NAME>Adverse effects: 3. Central / peripheral nervous system</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.47969826305808705" CI_START="0.09572343884300973" DF="0" EFFECT_SIZE="0.2142857142857143" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="28" I2="0.0" ID="CMP-001.17.01" LOG_CI_END="-0.31903185407038365" LOG_CI_START="-1.0189817078467673" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.792207622574807E-4" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.00000000000001" Z="3.746637531296033">
<NAME>activity- decrease (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.47969826305808694" CI_START="0.09572343884300968" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="28" LOG_CI_END="-0.3190318540703837" LOG_CI_START="-1.0189817078467676" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="362" O_E="0.0" SE="0.41115400891590376" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.16904761904761906" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="84.2755600806104" CI_START="0.21526157073573174" DF="0" EFFECT_SIZE="4.2592592592592595" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-001.17.02" LOG_CI_END="1.9257016474476552" LOG_CI_START="-0.6670334950584065" LOG_EFFECT_SIZE="0.6293340761946244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3413590924659169" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="22" WEIGHT="100.0" Z="0.9514833222748793">
<NAME>activity- increase (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="84.2755600806104" CI_START="0.21526157073573174" EFFECT_SIZE="4.2592592592592595" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9257016474476552" LOG_CI_START="-0.6670334950584065" LOG_EFFECT_SIZE="0.6293340761946244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="1.5229854569540042" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.3194847020933973" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.111617878539388" CI_END="0.6636874074858488" CI_START="0.12475244461769443" DF="5" EFFECT_SIZE="0.287744029557243" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="64" I2="45.125003411561956" ID="CMP-001.17.03" LOG_CI_END="-0.17803642239304943" LOG_CI_START="-0.9039509352951718" LOG_EFFECT_SIZE="-0.5409936788441106" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.10469423873660766" P_Z="0.0034850897699807183" STUDIES="6" TAU2="0.44012777241665685" TOTAL_1="235" TOTAL_2="237" WEIGHT="100.00000000000003" Z="2.9213581146331298">
<NAME>blurred vision (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="7.607203673049617"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="203" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="7.246946002447735"/>
<DICH_DATA CI_END="0.8235102234711112" CI_START="0.01499153096158102" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.08433100491009908" LOG_CI_START="-1.824154013968551" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1356" O_E="0.0" SE="1.021980647783726" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.0444444444444443" WEIGHT="12.247426270598895"/>
<DICH_DATA CI_END="0.8368732970249826" CI_START="0.047796960593911655" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.07734028940003874" LOG_CI_START="-1.3205997192719987" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1393" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.5333333333333333" WEIGHT="18.677879025662424"/>
<DICH_DATA CI_END="1.0244840487603406" CI_START="0.3696477512854479" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.01050520081501346" LOG_CI_START="-0.43221193144479975" LOG_EFFECT_SIZE="-0.21085336531489315" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="361" O_E="0.0" SE="0.2600542349745628" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.06762820512820514" WEIGHT="35.80891131464707"/>
<DICH_DATA CI_END="0.8096599704283242" CI_START="0.04453922347869001" EFFECT_SIZE="0.1898989898989899" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.09169733170298897" LOG_CI_START="-1.3512573589647512" LOG_EFFECT_SIZE="-0.7214773453338701" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.7398717949362497" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.5474102729421878" WEIGHT="18.41163371359427"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.36287998268994" CI_END="1.0049444295096428" CI_START="0.36045703420113606" DF="8" EFFECT_SIZE="0.6018631809622503" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="51" I2="14.556204770429904" ID="CMP-001.17.04" LOG_CI_END="0.0021420472046916076" LOG_CI_START="-0.4431464949429434" LOG_EFFECT_SIZE="-0.22050222386912588" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.3126145355597785" P_Z="0.05224526521415608" STUDIES="9" TAU2="0.08825355054379645" TOTAL_1="347" TOTAL_2="351" WEIGHT="100.0" Z="1.941107288366685">
<NAME>dizziness (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="4.021183978262525" CI_START="0.009947319052356126" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6043539435123508" LOG_CI_START="-2.002293952184388" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="86" O_E="0.0" SE="1.531157877047447" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.3444444444444446" WEIGHT="2.8123543991470927"/>
<DICH_DATA CI_END="1.3757153755427283" CI_START="0.1817236358947965" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.13852859115431085" LOG_CI_START="-0.7405885824822732" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.2666666666666667" WEIGHT="19.276469967740677"/>
<DICH_DATA CI_END="0.9754758873898897" CI_START="0.0035471995332609684" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.010783461382678439" LOG_CI_START="-2.4501143813738695" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="201" O_E="0.0" SE="1.4328750572856208" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.0531309297912714" WEIGHT="3.194946526805391"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="18.411868676892702"/>
<DICH_DATA CI_END="5.454794518074456" CI_START="0.32591104429087336" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.736778395374003" LOG_CI_START="-0.4869009221574032" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="11.309935944199346"/>
<DICH_DATA CI_END="4.052347097392378" CI_START="0.009870822769781833" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6077066370895764" LOG_CI_START="-2.005646645761614" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="1.5350966546541733" STUDY_ID="STD-Wang-2009" TOTAL_1="45" TOTAL_2="45" VAR="2.3565217391304345" WEIGHT="2.7984612479100868"/>
<DICH_DATA CI_END="4.025049578857407" CI_START="0.009937765788056413" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6047712341924788" LOG_CI_START="-2.002711242864516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="428" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="2.8106196381469526"/>
<DICH_DATA CI_END="1.8297856538215025" CI_START="0.237860325106847" EFFECT_SIZE="0.6597222222222222" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2624002182469874" LOG_CI_START="-0.6236779918597912" LOG_EFFECT_SIZE="-0.1806388868064019" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="474" O_E="0.0" SE="0.5204867267746008" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.270906432748538" WEIGHT="19.048917547233643"/>
<DICH_DATA CI_END="3.697110700043166" CI_START="0.5245485694872799" EFFECT_SIZE="1.3925925925925926" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.567862454548797" LOG_CI_START="-0.2802142930114495" LOG_EFFECT_SIZE="0.14382408076867373" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="377" O_E="0.0" SE="0.49816447956449444" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.24816784869976358" WEIGHT="20.3364260519241"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3568726825723132" CI_END="1.234253465115221" CI_START="0.26765842595451045" DF="3" EFFECT_SIZE="0.5747680747063466" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="16" I2="0.0" ID="CMP-001.17.05" LOG_CI_END="0.09140435515695843" LOG_CI_START="-0.5724190803659241" LOG_EFFECT_SIZE="-0.2405073626044828" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.7156745745522852" P_Z="0.15554530104262881" STUDIES="4" TAU2="0.0" TOTAL_1="153" TOTAL_2="147" WEIGHT="100.00000000000001" Z="1.4202143024679423">
<NAME>fatigue (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="1.379871372147832" CI_START="0.21561477914707403" EFFECT_SIZE="0.5454545454545454" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" LOG_CI_END="0.13983860453891506" LOG_CI_START="-0.6663214740880778" LOG_EFFECT_SIZE="-0.26324143477458145" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="149" O_E="0.0" SE="0.4735424207422438" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.22424242424242424" WEIGHT="67.80513506472623"/>
<DICH_DATA CI_END="3.4691002044580004" CI_START="0.11211745874060706" EFFECT_SIZE="0.6236559139784946" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5402168445565759" LOG_CI_START="-0.9503267545385717" LOG_EFFECT_SIZE="-0.20505495499099782" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="228" O_E="0.0" SE="0.8755526884183011" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.7665925101965146" WEIGHT="19.834250479568986"/>
<DICH_DATA CI_END="4.025049578857407" CI_START="0.009937765788056413" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6047712341924788" LOG_CI_START="-2.002711242864516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="429" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="6.481303582154044"/>
<DICH_DATA CI_END="59.75116774707509" CI_START="0.10930103031920343" EFFECT_SIZE="2.5555555555555554" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7763463973382545" LOG_CI_START="-0.9613757441817185" LOG_EFFECT_SIZE="0.40748532657826797" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="1.6081515378719955" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.586151368760064" WEIGHT="5.8793108735507555"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.2903457145252455" CI_START="0.5486708253122237" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-001.17.06" LOG_CI_END="0.862748123427802" LOG_CI_START="-0.2606881320998397" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.2935512556662263" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="31" WEIGHT="100.0" Z="1.0503630212477773">
<NAME>general central nervous system adverse reaction (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="7.2903457145252455" CI_START="0.5486708253122237" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.862748123427802" LOG_CI_START="-0.2606881320998397" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2201" O_E="0.0" SE="0.6599120175960899" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" VAR="0.435483870967742" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8378407593046749" CI_START="0.27064494905057934" DF="0" EFFECT_SIZE="0.47619047619047616" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="21" I2="0.0" ID="CMP-001.17.07" LOG_CI_END="-0.0768385158887084" LOG_CI_START="-0.5676000735791301" LOG_EFFECT_SIZE="-0.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.010061545771160989" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="31" WEIGHT="100.0" Z="2.57370693733416">
<NAME>general vegetative nervous system adverse reaction (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.8378407593046749" CI_START="0.27064494905057934" EFFECT_SIZE="0.47619047619047616" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="21" LOG_CI_END="-0.0768385158887084" LOG_CI_START="-0.5676000735791301" LOG_EFFECT_SIZE="-0.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2202" O_E="0.0" SE="0.2882757682962437" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" VAR="0.08310291858678956" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="45.69423512927392" CI_END="4.860424463305796" CI_START="1.0711465827333824" DF="15" EFFECT_SIZE="2.2817158137033053" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="48" I2="67.17310190757459" ID="CMP-001.17.08" LOG_CI_END="0.686674198073384" LOG_CI_START="0.029848906607971747" LOG_EFFECT_SIZE="0.35826155234067786" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="5.9460752927842364E-5" P_Z="0.032508464429950555" STUDIES="16" TAU2="1.3683014530849238" TOTAL_1="553" TOTAL_2="549" WEIGHT="100.00000000000001" Z="2.1381020151235033">
<NAME>headache (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="2.555603603168496" CI_START="0.09782424773937723" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4074934917762285" LOG_CI_START="-1.0095534831041908" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="85" O_E="0.0" SE="0.8323804075404123" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="0.6928571428571428" WEIGHT="7.222100516152988"/>
<DICH_DATA CI_END="190.5337733482898" CI_START="0.63505801556145" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2799719683515804" LOG_CI_START="-0.19718659803513053" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="4.270679248099751"/>
<DICH_DATA CI_END="1.278618826086831" CI_START="0.10998195641337302" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.10674109459607413" LOG_CI_START="-0.9586785591406364" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="0.6258327785172862" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.39166666666666666" WEIGHT="8.458047843348112"/>
<DICH_DATA CI_END="312.4173614293384" CI_START="1.1555055658507298" EFFECT_SIZE="19.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.494735160171501" LOG_CI_START="0.06277204173415661" LOG_EFFECT_SIZE="1.2787536009528289" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="1.4285471741816855" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.0407470288624787" WEIGHT="4.366583414244339"/>
<DICH_DATA CI_END="191.48144766915857" CI_START="0.6319150052022988" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.282126702246043" LOG_CI_START="-0.19934133192959255" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="1.4576266067396426" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="2.1246753246753247" WEIGHT="4.261664335819443"/>
<DICH_DATA CI_END="10.13382509220077" CI_START="0.39471768691552545" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.005773404183231" LOG_CI_START="-0.4037134128552686" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="0.8279395334006838" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.685483870967742" WEIGHT="7.248028499031501"/>
<DICH_DATA CI_END="2.5181844897074526" CI_START="0.22241549374453232" EFFECT_SIZE="0.7483870967741936" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.40108754464667423" LOG_CI_START="-0.6528349625334201" LOG_EFFECT_SIZE="-0.125873708943373" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="187" O_E="0.0" SE="0.6190792977181366" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.3832591768631813" WEIGHT="8.498646467103686"/>
<DICH_DATA CI_END="160.170939238357" CI_START="0.5057097147907748" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.204583722276951" LOG_CI_START="-0.29609870339830113" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="211" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="4.221742116052142"/>
<DICH_DATA CI_END="100.62623947143514" CI_START="0.24844414470141024" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.002711242864516" LOG_CI_START="-0.6047712341924787" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="423" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="4.007782185836741"/>
<DICH_DATA CI_END="6.445158746541576" CI_START="0.43098671219980617" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.809233618647991" LOG_CI_START="-0.3655361194152783" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="437" O_E="0.0" SE="0.6900655593423543" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="0.47619047619047616" WEIGHT="8.070457952870644"/>
<DICH_DATA CI_END="190.5337733482898" CI_START="0.63505801556145" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2799719683515804" LOG_CI_START="-0.19718659803513053" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="4.270679248099751"/>
<DICH_DATA CI_END="109.51886855598049" CI_START="0.3246648524267137" EFFECT_SIZE="5.962962962962963" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.0394889484346215" LOG_CI_START="-0.48856472468889656" LOG_EFFECT_SIZE="0.7754621118728624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="1.4849912416602609" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.205198987807683" WEIGHT="4.1656338947891935"/>
<DICH_DATA CI_END="0.5791925594324194" CI_START="0.08526130946463703" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="18" LOG_CI_END="-0.237177025916915" LOG_CI_START="-1.0692480016337726" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1391" O_E="0.0" SE="0.48876260995383936" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.23888888888888893" WEIGHT="9.262060734725916"/>
<DICH_DATA CI_END="33.28792310588217" CI_START="1.922619197251474" EFFECT_SIZE="8.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="2" LOG_CI_END="1.5222866995786413" LOG_CI_START="0.2838932744052456" LOG_EFFECT_SIZE="0.9030899869919435" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="358" O_E="0.0" SE="0.727438428093173" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.5291666666666666" WEIGHT="7.845135528061033"/>
<DICH_DATA CI_END="6.48081979463777" CI_START="1.1969560582741996" EFFECT_SIZE="2.785185185185185" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.8116299456496495" LOG_CI_START="0.07807820721566028" LOG_EFFECT_SIZE="0.44485407643265495" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="373" O_E="0.0" SE="0.4308919222957928" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.18566784869976358" WEIGHT="9.579271960218495"/>
<DICH_DATA CI_END="192.55995067495985" CI_START="0.6283757322115613" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.284565966020632" LOG_CI_START="-0.20178059570418203" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="456" O_E="0.0" SE="1.4604922779711311" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.1330376940133036" WEIGHT="4.251486055546265"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.526027621991644" CI_END="0.09848666152737814" CI_START="0.03235279763385458" DF="15" EFFECT_SIZE="0.056447489138394785" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="261" I2="0.0" ID="CMP-001.17.09" LOG_CI_END="-1.0066225838913487" LOG_CI_START="-1.4900881587538006" LOG_EFFECT_SIZE="-1.2483553713225746" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.9866581166806194" P_Z="4.429436033460925E-24" STUDIES="16" TAU2="0.0" TOTAL_1="538" TOTAL_2="536" WEIGHT="100.00000000000001" Z="10.121637175079023">
<NAME>hyper-salivation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.2868325531508368" CI_START="0.0011525139276044878" EFFECT_SIZE="0.01818181818181818" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="27" LOG_CI_END="-0.5423715613323667" LOG_CI_START="-2.9383538176561212" LOG_EFFECT_SIZE="-1.7403626894942439" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2386" O_E="0.0" SE="1.4074118376680227" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="1.9808080808080808" WEIGHT="4.071588848039608"/>
<DICH_DATA CI_END="0.8747964383884039" CI_START="0.00316654593106971" EFFECT_SIZE="0.05263157894736842" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" LOG_CI_END="-0.058092993800166" LOG_CI_START="-2.4994142081054918" LOG_EFFECT_SIZE="-1.278753600952829" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2387" O_E="0.0" SE="1.4340441660178596" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.0564826700898586" WEIGHT="3.921762244450383"/>
<DICH_DATA CI_END="0.5157260549254755" CI_START="0.002017704392455238" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2875809271069153" LOG_CI_START="-2.69514246056163" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2388" O_E="0.0" SE="1.4142135623730951" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0" WEIGHT="4.03251804596246"/>
<DICH_DATA CI_END="0.38570209070465933" CI_START="0.0015423406093901103" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4137480070270461" LOG_CI_START="-2.811819706412425" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2382" O_E="0.0" SE="1.4086391868653307" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="1.98426435877262" WEIGHT="4.0644967774926934"/>
<DICH_DATA CI_END="0.3225976707630456" CI_START="0.0012910605550196695" EFFECT_SIZE="0.02040816326530612" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="24" LOG_CI_END="-0.49133877265198056" LOG_CI_START="-2.889053387405047" LOG_EFFECT_SIZE="-1.6901960800285136" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2383" O_E="0.0" SE="1.408429433584713" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="1.9836734693877554" WEIGHT="4.065707494900423"/>
<DICH_DATA CI_END="0.2587258397945941" CI_START="0.0054119376621094735" EFFECT_SIZE="0.03741935483870968" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="25" LOG_CI_END="-0.5871601947090686" LOG_CI_START="-2.2666472145056398" LOG_EFFECT_SIZE="-1.4269037046073543" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2384" O_E="0.0" SE="0.9865389890233337" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.9732591768631814" WEIGHT="8.286627327695555"/>
<DICH_DATA CI_END="0.9754758873898897" CI_START="0.0035471995332609684" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.010783461382678439" LOG_CI_START="-2.4501143813738695" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2385" O_E="0.0" SE="1.4328750572856208" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.0531309297912714" WEIGHT="3.9281645290613985"/>
<DICH_DATA CI_END="1.1254244888243425" CI_START="0.003949127185856124" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.051316361009522325" LOG_CI_START="-2.403498879120885" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2378" O_E="0.0" SE="1.441970623584017" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.079279279279279" WEIGHT="3.8787651915236845"/>
<DICH_DATA CI_END="1.3135688446672225" CI_START="0.021146800101531762" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11845283926564747" LOG_CI_START="-1.6747553400329347" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2379" O_E="0.0" SE="1.0533393610436335" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="1.1095238095238098" WEIGHT="7.26891664937439"/>
<DICH_DATA CI_END="0.4289694886687454" CI_START="0.001702825513736522" EFFECT_SIZE="0.02702702702702703" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="18" LOG_CI_END="-0.36757359679904494" LOG_CI_START="-2.768829851334945" LOG_EFFECT_SIZE="-1.568201724066995" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2380" O_E="0.0" SE="1.4105098103245493" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.989537925021796" WEIGHT="4.053723224118266"/>
<DICH_DATA CI_END="0.3828444008905578" CI_START="0.0015472830040578677" EFFECT_SIZE="0.02433862433862434" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="17" LOG_CI_END="-0.41697770009182883" LOG_CI_START="-2.8104302448915113" LOG_EFFECT_SIZE="-1.61370397249167" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2381" O_E="0.0" SE="1.4059258725965087" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="1.9766275592362545" WEIGHT="4.080200164284442"/>
<DICH_DATA CI_END="0.345671472949198" CI_START="0.0223839207418795" EFFECT_SIZE="0.08796296296296297" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="24" LOG_CI_END="-0.46133645977477666" LOG_CI_START="-1.6500638406214274" LOG_EFFECT_SIZE="-1.0557001501981018" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2391" O_E="0.0" SE="0.6982643478047584" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.48757309941520466" WEIGHT="16.541183468895486"/>
<DICH_DATA CI_END="0.4289694886687454" CI_START="0.001702825513736522" EFFECT_SIZE="0.02702702702702703" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="18" LOG_CI_END="-0.36757359679904494" LOG_CI_START="-2.768829851334945" LOG_EFFECT_SIZE="-1.568201724066995" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2390" O_E="0.0" SE="1.4105098103245493" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.989537925021796" WEIGHT="4.053723224118266"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2393" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="3.8091098439700803"/>
<DICH_DATA CI_END="0.4213821056099002" CI_START="0.025887767491976653" EFFECT_SIZE="0.10444444444444445" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="20" LOG_CI_END="-0.37532391106272095" LOG_CI_START="-1.5869054006165313" LOG_EFFECT_SIZE="-0.9811146558396262" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2392" O_E="0.0" SE="0.7116889643890068" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.5065011820330969" WEIGHT="15.923035084640567"/>
<DICH_DATA CI_END="0.39654293070291996" CI_START="0.007783318057430428" EFFECT_SIZE="0.05555555555555555" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="18" LOG_CI_END="-0.4017097880233186" LOG_CI_START="-2.1088352221832936" LOG_EFFECT_SIZE="-1.255272505103306" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2389" O_E="0.0" SE="1.002773930432755" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.0055555555555558" WEIGHT="8.020477881472294"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.39428716730527" CI_END="10.907840839063102" CI_START="2.8979150897876647" DF="13" EFFECT_SIZE="5.622276813224612" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="6" I2="0.0" ID="CMP-001.17.10" LOG_CI_END="1.0377387923406478" LOG_CI_START="0.46208565629840237" LOG_EFFECT_SIZE="0.7499122243195251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.8169987653072928" P_Z="3.2809267732017755E-7" STUDIES="14" TAU2="0.0" TOTAL_1="497" TOTAL_2="493" WEIGHT="100.00000000000001" Z="5.106550661177071">
<NAME>insomnia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="4.378966281631378"/>
<DICH_DATA CI_END="27.631151946828567" CI_START="0.3257193191698617" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4413989910953926" LOG_CI_START="-0.48715648165606773" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="1.132843031197762" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.2833333333333334" WEIGHT="8.909585075180726"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="196" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="5.147657573346983"/>
<DICH_DATA CI_END="40.28498862817757" CI_START="0.6205785542288472" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6051432453855428" LOG_CI_START="-0.20720323671350535" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.133333333333333" WEIGHT="10.088794864542884"/>
<DICH_DATA CI_END="251.4242022543601" CI_START="0.8949019147025976" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.400407080826505" LOG_CI_START="-0.04822456271514261" LOG_EFFECT_SIZE="1.1760912590556813" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="5.526813818725674"/>
<DICH_DATA CI_END="60.53480313572841" CI_START="1.0572430516789175" EFFECT_SIZE="8.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.7820051343880947" LOG_CI_START="0.02417483959579243" LOG_EFFECT_SIZE="0.9030899869919435" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="122" O_E="0.0" SE="1.0325582165612919" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="1.0661764705882355" WEIGHT="10.724272977849717"/>
<DICH_DATA CI_END="7.805475460030501" CI_START="0.2522642821663659" EFFECT_SIZE="1.403225806451613" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8923993626679385" LOG_CI_START="-0.5981442364272093" LOG_EFFECT_SIZE="0.14712756312036468" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="189" O_E="0.0" SE="0.8755526884183011" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.7665925101965146" WEIGHT="14.91531336539868"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="212" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="5.147657573346983"/>
<DICH_DATA CI_END="130.82359964630137" CI_START="0.3745501586294664" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.116686094689066" LOG_CI_START="-0.42649001466055253" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="1.493874235556739" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.231660231660231" WEIGHT="5.123525235130601"/>
<DICH_DATA CI_END="190.5337733482898" CI_START="0.63505801556145" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2799719683515804" LOG_CI_START="-0.19718659803513053" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="5.400253354548022"/>
<DICH_DATA CI_END="211.8496982221339" CI_START="0.7706954803734202" EFFECT_SIZE="12.777777777777779" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.326027849689119" LOG_CI_START="-0.11311718786054555" LOG_EFFECT_SIZE="1.1064553309142868" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="1.4327658690193352" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.0528180354267307" WEIGHT="5.569888473223471"/>
<DICH_DATA CI_END="662.7782331742626" CI_START="2.536293311790188" EFFECT_SIZE="41.0" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="0" LOG_CI_END="2.8213682369718995" LOG_CI_START="0.4041994764675714" LOG_EFFECT_SIZE="1.6127838567197355" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="1.4198568950985788" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="2.015993602558977" WEIGHT="5.671628867589178"/>
<DICH_DATA CI_END="298.6058401293754" CI_START="1.0538198062231214" EFFECT_SIZE="17.73913043478261" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.4750982973982443" LOG_CI_START="0.02276635674633009" LOG_EFFECT_SIZE="1.2489323270722872" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="375" O_E="0.0" SE="1.4405119211778197" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="2.0750745950554133" WEIGHT="5.510147702831504"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="457" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="7.885494836654205"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.48252403655962006" CI_END="55.80299079588224" CI_START="0.8203844975403864" DF="1" EFFECT_SIZE="6.7660851727812785" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-001.17.11" LOG_CI_END="1.7466574758433175" LOG_CI_START="-0.08598255490566736" LOG_EFFECT_SIZE="0.8303374604688252" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.4872812927684962" P_Z="0.07572443276094995" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="1.7760514778979595">
<NAME>irritability (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="202" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="44.5345557122708"/>
<DICH_DATA CI_END="220.96011924822866" CI_START="0.7648439029404385" EFFECT_SIZE="13.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.344313895615592" LOG_CI_START="-0.11642719100191873" LOG_EFFECT_SIZE="1.1139433523068367" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="55.46544428772919"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9537939361791632" CI_START="0.01638194520568325" DF="0" EFFECT_SIZE="0.12500000000000003" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" I2="0.0" ID="CMP-001.17.12" LOG_CI_END="-0.020545442955097762" LOG_CI_START="-1.7856345310287896" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Z="0.04489984790845507" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="2.005591515196153">
<NAME>memory decline (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.9537939361791632" CI_START="0.01638194520568325" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.020545442955097762" LOG_CI_START="-1.7856345310287896" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="203" O_E="0.0" SE="1.0368220676663862" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.0750000000000002" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5213691864691807" CI_START="0.0019958654123266918" DF="0" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" I2="0.0" ID="CMP-001.17.13" LOG_CI_END="-0.2828546397228208" LOG_CI_START="-2.6998687479457244" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.015576108797214465" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="2.418699334764708">
<NAME>sedation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.5213691864691807" CI_START="0.0019958654123266918" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2828546397228208" LOG_CI_START="-2.6998687479457244" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="458" O_E="0.0" SE="1.419766051582929" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.01573564122738" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="35.59962596926614" CI_END="0.24408020177442977" CI_START="0.09105789196106524" DF="20" EFFECT_SIZE="0.14908195277434166" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="320" I2="43.81963446114183" ID="CMP-001.17.14" LOG_CI_END="-0.6124674463461262" LOG_CI_START="-1.0406824080611499" LOG_EFFECT_SIZE="-0.8265749272036379" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.01713361498829835" P_Z="3.8323738891855314E-14" STUDIES="21" TAU2="0.5123054109121631" TOTAL_1="751" TOTAL_2="741" WEIGHT="99.99999999999999" Z="7.566559941551475">
<NAME>somnolence (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.7628571861465668" CI_START="0.04333425946559551" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.11755675834103713" LOG_CI_START="-1.3631686206474507" LOG_EFFECT_SIZE="-0.7403626894942439" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="526" O_E="0.0" SE="0.7316785737969477" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.5353535353535354" WEIGHT="6.039193609857197"/>
<DICH_DATA CI_END="0.2579759356996738" CI_START="0.0010417443018593943" EFFECT_SIZE="0.01639344262295082" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="30" LOG_CI_END="-0.5884208036502111" LOG_CI_START="-2.982238866371323" LOG_EFFECT_SIZE="-1.785329835010767" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="84" O_E="0.0" SE="1.4061405796328994" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="1.9772313296903463" WEIGHT="2.5414427955243943"/>
<DICH_DATA CI_END="0.9537939361791632" CI_START="0.01638194520568325" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.020545442955097762" LOG_CI_START="-1.7856345310287896" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="1.0368220676663862" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.0750000000000002" WEIGHT="3.986009982767991"/>
<DICH_DATA CI_END="0.7776279549049671" CI_START="0.0029160136050178946" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10922813537249078" LOG_CI_START="-2.5352104540953477" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="197" O_E="0.0" SE="1.4250340228239595" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.0307219662058373" WEIGHT="2.4879854894711766"/>
<DICH_DATA CI_END="0.45194868175770997" CI_START="0.0497844133818323" EFFECT_SIZE="0.15" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="20" LOG_CI_END="-0.34491087601769754" LOG_CI_START="-1.3029066058709398" LOG_EFFECT_SIZE="-0.8239087409443188" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="135" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.31666666666666665" WEIGHT="7.632362276998253"/>
<DICH_DATA CI_END="0.38570209070465933" CI_START="0.0015423406093901103" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.4137480070270461" LOG_CI_START="-2.811819706412425" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="1.4086391868653307" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="1.98426435877262" WEIGHT="2.534283355676609"/>
<DICH_DATA CI_END="0.3115602049323663" CI_START="0.020541776191825636" EFFECT_SIZE="0.08" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="25" LOG_CI_END="-0.5064580191701522" LOG_CI_START="-1.6873620068459607" LOG_EFFECT_SIZE="-1.0969100130080565" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="123" O_E="0.0" SE="0.6936688479297851" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="0.4811764705882353" WEIGHT="6.368526020869353"/>
<DICH_DATA CI_END="160.38647265962425" CI_START="0.5050301229075597" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.205167736161226" LOG_CI_START="-0.2966827172825762" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="1.4695993407123664" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="2.1597222222222223" WEIGHT="2.367870427363699"/>
<DICH_DATA CI_END="0.9489818069491464" CI_START="0.05203757931686988" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.022742113407618957" LOG_CI_START="-1.2836829141430686" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="208" O_E="0.0" SE="0.7406828681096325" STUDY_ID="STD-Wang-2006" TOTAL_1="32" TOTAL_2="32" VAR="0.5486111111111112" WEIGHT="5.963725780734641"/>
<DICH_DATA CI_END="3.633535878489302" CI_START="0.27521401561494013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5603294528884348" LOG_CI_START="-0.5603294528884348" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="214" O_E="0.0" SE="0.6582805886043833" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="0.43333333333333335" WEIGHT="6.690731795941495"/>
<DICH_DATA CI_END="0.20274502559651014" CI_START="8.118568524260689E-4" EFFECT_SIZE="0.012829650748396294" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="30" LOG_CI_END="-0.6930497925174902" LOG_CI_START="-3.090520539332618" LOG_EFFECT_SIZE="-1.8917851659250537" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="1.408286184350802" STUDY_ID="STD-Wang-2009" TOTAL_1="45" TOTAL_2="35" VAR="1.9832699770333413" WEIGHT="2.535293160911592"/>
<DICH_DATA CI_END="4.025049578857407" CI_START="0.009937765788056413" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6047712341924788" LOG_CI_START="-2.002711242864516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="430" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="2.213596504875768"/>
<DICH_DATA CI_END="0.3099439051011815" CI_START="0.0012404422418620697" EFFECT_SIZE="0.0196078431372549" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="25" LOG_CI_END="-0.5087168994219423" LOG_CI_START="-2.9064234527739305" LOG_EFFECT_SIZE="-1.7075701760979363" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="443" O_E="0.0" SE="1.408424698277815" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="1.9836601307189543" WEIGHT="2.534896859779088"/>
<DICH_DATA CI_END="0.7067717440314661" CI_START="0.03930233206456692" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.1507208214410385" LOG_CI_START="-1.4055816793262488" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="447" O_E="0.0" SE="0.7371114795831993" STUDY_ID="STD-Yan-2008a" TOTAL_1="50" TOTAL_2="50" VAR="0.5433333333333333" WEIGHT="5.993542059807287"/>
<DICH_DATA CI_END="0.4061877459440316" CI_START="0.001618616520288443" EFFECT_SIZE="0.02564102564102564" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="19" LOG_CI_END="-0.3912731827262969" LOG_CI_START="-2.7908560313267015" LOG_EFFECT_SIZE="-1.5910646070264993" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="1.409526843394546" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.986765922249793" WEIGHT="2.531746545062505"/>
<DICH_DATA CI_END="0.46587130049563585" CI_START="0.0018521075021446297" EFFECT_SIZE="0.02937420178799489" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="14" LOG_CI_END="-0.3317340429758779" LOG_CI_START="-2.7323338091048233" LOG_EFFECT_SIZE="-1.5320339260403506" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="1.410124185784634" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="1.988450219334777" WEIGHT="2.5300413751233903"/>
<DICH_DATA CI_END="1.7206675610228856" CI_START="0.025901517669150238" EFFECT_SIZE="0.2111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.23569697122271097" LOG_CI_START="-1.5866747881957026" LOG_EFFECT_SIZE="-0.6754889084864959" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="475" O_E="0.0" SE="1.0704701923680724" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="1.145906432748538" WEIGHT="3.81556508463351"/>
<DICH_DATA CI_END="0.7279854498586522" CI_START="0.07315316244323636" EFFECT_SIZE="0.23076923076923078" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="-0.13787730078208202" LOG_CI_START="-1.1357668943922667" LOG_EFFECT_SIZE="-0.6368220975871743" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1354" O_E="0.0" SE="0.5861652869197762" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.3435897435897436" WEIGHT="7.392278341941981"/>
<DICH_DATA CI_END="0.7971088533451651" CI_START="0.07840836259403103" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.09848236721230207" LOG_CI_START="-1.1056376154436227" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1390" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="7.337325190740359"/>
<DICH_DATA CI_END="0.3210403057590744" CI_START="0.04576490261558593" EFFECT_SIZE="0.12121212121212122" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="33" LOG_CI_END="-0.49344043965156764" LOG_CI_START="-1.3394674574482823" LOG_EFFECT_SIZE="-0.9164539485499251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="0.4969604581550699" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.24696969696969695" WEIGHT="8.332968047968704"/>
<DICH_DATA CI_END="0.6330171517116713" CI_START="0.08510012212061072" EFFECT_SIZE="0.23209876543209876" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="18" LOG_CI_END="-0.1985845225374339" LOG_CI_START="-1.070069816692506" LOG_EFFECT_SIZE="-0.6343271696149699" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="374" O_E="0.0" SE="0.5119147757084694" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.26205673758865256" WEIGHT="8.170615293951013"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.73802435585941" CI_START="0.12545647975131194" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.17.15" LOG_CI_END="1.8557494121620408" LOG_CI_START="-0.901506902722716" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Z="0.4975736880191908" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="0.678312328426518">
<NAME>insomnia (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="71.73802435585941" CI_START="0.12545647975131194" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8557494121620408" LOG_CI_START="-0.901506902722716" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2437" O_E="0.0" SE="1.6196260080021871" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.623188405797101" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5939212184173286" CI_START="0.09637917999396164" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-001.17.16" LOG_CI_END="0.41395678172254163" LOG_CI_START="-1.016016773050504" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Z="0.40925737769856985" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="99.99999999999999" Z="0.8252012043135907">
<NAME>headache (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="2.5939212184173286" CI_START="0.09637917999396164" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41395678172254163" LOG_CI_START="-1.016016773050504" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2438" O_E="0.0" SE="0.8399735445569435" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="0.7055555555555555" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="65.53678401302403" CI_END="2.3713671993728593" CI_START="1.0457835423996809" CI_STUDY="95" CI_TOTAL="95" DF="38" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5747815055081638" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="92" I2="42.01729521477845" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.3749988084336133" LOG_CI_START="0.0194418030116673" LOG_EFFECT_SIZE="0.19722030572264027" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.003622316933122094" P_Q="0.5957551538488732" P_Z="0.02968223341398647" Q="7.398006133061598" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="21" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.5808137214155374" TOTALS="SUB" TOTAL_1="1405" TOTAL_2="1397" WEIGHT="1000.0" Z="2.1743050500587615">
<NAME>Adverse effects: 4. Extrapyramidal effects</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="25.426140674562088" CI_END="2.683101548861673" CI_START="0.5420274024939181" DF="12" EFFECT_SIZE="1.2059496519991626" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" I2="52.80447727560339" ID="CMP-001.18.01" LOG_CI_END="0.4286371099718566" LOG_CI_START="-0.2659787569098245" LOG_EFFECT_SIZE="0.0813291765310161" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.012927742107116003" P_Z="0.6462591543362834" STUDIES="13" TAU2="1.0591177903643096" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="0.45896520506705857">
<NAME>akathisia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="6.510623893834799" CI_START="0.4266530862592416" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.813622607718267" LOG_CI_START="-0.3699251084855542" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="0.695221787153807" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.4833333333333333" WEIGHT="10.793273740790287"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="136" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="9.836678280839045"/>
<DICH_DATA CI_END="40.57638819608976" CI_START="0.6161218657309964" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6082733867998966" LOG_CI_START="-0.21033337812785904" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="1.0682586159672365" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="1.1411764705882355" WEIGHT="7.56630488262556"/>
<DICH_DATA CI_END="251.76972362638108" CI_START="0.8936737776059743" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.401003503164353" LOG_CI_START="-0.04882098505299036" LOG_EFFECT_SIZE="1.1760912590556813" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="1.4390390312056631" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="2.0708333333333333" WEIGHT="5.3189639556385835"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="218" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="4.547084703556333"/>
<DICH_DATA CI_END="71.27997327732777" CI_START="0.1262626735981487" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8529675282130038" LOG_CI_START="-0.898725018773679" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="426" O_E="0.0" SE="1.6163578231977633" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.612612612612612" WEIGHT="4.5341284306605125"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="5.241151369129905"/>
<DICH_DATA CI_END="1.5762534140740458" CI_START="0.07267626638895903" EFFECT_SIZE="0.3384615384615385" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.1976260402389735" LOG_CI_START="-1.1386073918802722" LOG_EFFECT_SIZE="-0.4704906758206493" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.7849101324890105" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="0.6160839160839161" WEIGHT="9.937965766018502"/>
<DICH_DATA CI_END="3.229225892741939" CI_START="0.038337276413468575" EFFECT_SIZE="0.35185185185185186" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5090984261072614" LOG_CI_START="-1.4163787438475404" LOG_EFFECT_SIZE="-0.45364015887013953" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="472" O_E="0.0" SE="1.1310348208971601" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="1.2792397660818713" WEIGHT="7.11956867501474"/>
<DICH_DATA CI_END="33.72924445563291" CI_START="0.4743657991226642" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.52800661298213" LOG_CI_START="-0.32388663032620535" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1360" O_E="0.0" SE="1.0878112581387145" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.1833333333333331" WEIGHT="7.424062461797033"/>
<DICH_DATA CI_END="1.3019564567260682" CI_START="0.021335412282242117" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11459645971618479" LOG_CI_START="-1.670898960483472" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1394" O_E="0.0" SE="1.0488088481701514" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.0999999999999999" WEIGHT="7.710601655988948"/>
<DICH_DATA CI_END="17.357609846759765" CI_START="1.6387304874094932" EFFECT_SIZE="5.333333333333333" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="3" LOG_CI_END="1.2394899223480447" LOG_CI_START="0.21450753352448007" LOG_EFFECT_SIZE="0.7269987279362623" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="364" O_E="0.0" SE="0.6020797289396148" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.3625" WEIGHT="11.71067028191307"/>
<DICH_DATA CI_END="7.101791709032733" CI_START="0.15360408221257735" EFFECT_SIZE="1.0444444444444445" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8513679305755287" LOG_CI_START="-0.8135972422547812" LOG_EFFECT_SIZE="0.018885344160373813" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="388" O_E="0.0" SE="0.9780087842310502" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.9565011820330969" WEIGHT="8.259545796027489"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.1167347910089784" CI_END="8.116847290525522" CI_START="1.2925588140265423" DF="4" EFFECT_SIZE="3.239058892251918" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="5" I2="0.0" ID="CMP-001.18.02" LOG_CI_END="0.9093873752752276" LOG_CI_START="0.11145031348826792" LOG_EFFECT_SIZE="0.5104188443817478" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5384837891062142" P_Z="0.012159810139039615" STUDIES="5" TAU2="0.0" TOTAL_1="186" TOTAL_2="188" WEIGHT="100.0" Z="2.5074723306582705">
<NAME>dystonia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="8.44267479733438"/>
<DICH_DATA CI_END="8.355122068096664" CI_START="0.014775100960857985" EFFECT_SIZE="0.35135135135135137" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9219527993058354" LOG_CI_START="-1.8304695428261517" LOG_EFFECT_SIZE="-0.4542583717601582" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="473" O_E="0.0" SE="1.6167865084786592" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="2.6139986139986138" WEIGHT="8.404407961544457"/>
<DICH_DATA CI_END="220.96011924822866" CI_START="0.7648439029404385" EFFECT_SIZE="13.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.344313895615592" LOG_CI_START="-0.11642719100191873" LOG_EFFECT_SIZE="1.1139433523068367" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1362" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="10.514906932863799"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1398" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="15.327286578806604"/>
<DICH_DATA CI_END="13.460841889562998" CI_START="1.1886329347947961" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="1.1290722230794512" LOG_CI_START="0.0750477595764735" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="366" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.3833333333333333" WEIGHT="57.31072372945077"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.495703465574314" CI_END="4.8548698487177235" CI_START="0.7475053219611274" DF="7" EFFECT_SIZE="1.9050042124218813" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="12" I2="33.30604258247337" ID="CMP-001.18.03" LOG_CI_END="0.6861775916608399" LOG_CI_START="-0.12638571097661272" LOG_EFFECT_SIZE="0.2798959403421136" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.16217892228511133" P_Z="0.17693251927909473" STUDIES="8" TAU2="0.5757413000169436" TOTAL_1="263" TOTAL_2="257" WEIGHT="100.00000000000003" Z="1.3502602460851743">
<NAME>general extrapyramidal symptoms (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="15.379557597192587" CI_START="0.06502137617941245" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.186943842886646" LOG_CI_START="-1.186943842886646" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="527" O_E="0.0" SE="1.3944333775567928" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.9444444444444446" WEIGHT="9.039763377535632"/>
<DICH_DATA CI_END="4.021183978262525" CI_START="0.009947319052356126" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6043539435123508" LOG_CI_START="-2.002293952184388" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="1.531157877047447" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.3444444444444446" WEIGHT="7.801518393334743"/>
<DICH_DATA CI_END="190.5337733482898" CI_START="0.63505801556145" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2799719683515804" LOG_CI_START="-0.19718659803513053" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="8.459530654661942"/>
<DICH_DATA CI_END="292.8777736412457" CI_START="1.083336411313518" EFFECT_SIZE="17.8125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.4666864145248106" LOG_CI_START="0.034763340180360196" LOG_EFFECT_SIZE="1.2507248773525854" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="191" O_E="0.0" SE="1.428523652083298" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="2.0406798245614035" WEIGHT="8.707269094932444"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Wang-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="16.970908518705816"/>
<DICH_DATA CI_END="2.3202571487549672" CI_START="0.1551552163919302" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3655361194152783" LOG_CI_START="-0.8092336186479911" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="442" O_E="0.0" SE="0.6900655593423543" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="0.47619047619047616" WEIGHT="21.657186628115795"/>
<DICH_DATA CI_END="84.2755600806104" CI_START="0.21526157073573174" EFFECT_SIZE="4.2592592592592595" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9257016474476552" LOG_CI_START="-0.6670334950584065" LOG_EFFECT_SIZE="0.6293340761946244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.5229854569540042" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.3194847020933973" WEIGHT="7.868775280673645"/>
<DICH_DATA CI_END="15.829585532656859" CI_START="0.7738673874137717" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1994695438429925" LOG_CI_START="-0.11133345514244114" LOG_EFFECT_SIZE="0.5440680443502757" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="451" O_E="0.0" SE="0.7699721701835351" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.5928571428571427" WEIGHT="19.495048052039998"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.717678397266763" CI_START="0.14886095178460348" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.18.04" LOG_CI_END="0.8272192085506513" LOG_CI_START="-0.8272192085506513" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="100.0" Z="0.0">
<NAME>tardive dyskinesia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="6.717678397266763" CI_START="0.14886095178460348" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8272192085506513" LOG_CI_START="-0.8272192085506513" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="528" O_E="0.0" SE="0.97182531580755" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.9444444444444444" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.173255201714013" CI_END="5.48420911914655" CI_START="0.7218307997846093" DF="5" EFFECT_SIZE="1.9896409361137508" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="11" I2="30.29663856368479" ID="CMP-001.18.05" LOG_CI_END="0.7391140065769688" LOG_CI_START="-0.14156459097819954" LOG_EFFECT_SIZE="0.29877470779938464" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.20807081418698292" P_Z="0.1835658643810432" STUDIES="6" TAU2="0.4715948982832168" TOTAL_1="231" TOTAL_2="229" WEIGHT="100.0" Z="1.329855564570114">
<NAME>tremor (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="131.2766945785389" CI_START="0.3732574175280195" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1181876330635214" LOG_CI_START="-0.42799155303500774" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="1.4956382577045184" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.2369337979094075" WEIGHT="9.880448234260864"/>
<DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="219" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="9.53356844378198"/>
<DICH_DATA CI_END="3.371022403224418" CI_START="0.008610462829429271" EFFECT_SIZE="0.17037037037037037" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5277616387756177" LOG_CI_START="-2.064973503730444" LOG_EFFECT_SIZE="-0.7686059324774133" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="1.5229854569540042" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.3194847020933973" WEIGHT="9.588217251177731"/>
<DICH_DATA CI_END="251.4242022543601" CI_START="0.8949019147025976" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.400407080826505" LOG_CI_START="-0.04822456271514261" LOG_EFFECT_SIZE="1.1760912590556813" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1361" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="10.534305653211767"/>
<DICH_DATA CI_END="5.322304494011197" CI_START="0.8820322944180968" EFFECT_SIZE="2.1666666666666665" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.7260997173190856" LOG_CI_START="-0.05451551347269939" LOG_EFFECT_SIZE="0.3357921019231931" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="365" O_E="0.0" SE="0.45853725067480644" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.21025641025641026" WEIGHT="39.248260197752494"/>
<DICH_DATA CI_END="3.9744708951859695" CI_START="0.12198567935751709" EFFECT_SIZE="0.6962962962962963" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5992793210187235" LOG_CI_START="-0.9136911508093385" LOG_EFFECT_SIZE="-0.15720591489530744" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="387" O_E="0.0" SE="0.8887263444764255" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.7898345153664301" WEIGHT="21.215200219815163"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.942110692196106" CI_END="117.07106602280199" CI_START="0.06895886505314694" DF="1" EFFECT_SIZE="2.8413179764845853" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" I2="85.59515910450494" ID="CMP-001.18.06" LOG_CI_END="2.068449572960251" LOG_CI_START="-1.1614098948807288" LOG_EFFECT_SIZE="0.4535198390397611" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.008419044327585001" P_Z="0.5820343399621828" STUDIES="2" TAU2="6.275190941444591" TOTAL_1="71" TOTAL_2="69" WEIGHT="100.0" Z="0.5504156200248016">
<NAME>use of antiparkinson medication (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="292.8777736412457" CI_START="1.083336411313518" EFFECT_SIZE="17.8125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.4666864145248106" LOG_CI_START="0.034763340180360196" LOG_EFFECT_SIZE="1.2507248773525854" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="192" O_E="0.0" SE="1.428523652083298" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="2.0406798245614035" WEIGHT="43.28473125752221"/>
<DICH_DATA CI_END="1.181928545164485" CI_START="0.4145766696342953" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="20" LOG_CI_END="0.07259122157163136" LOG_CI_START="-0.38239514154311777" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="452" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.07142857142857142" WEIGHT="56.71526874247779"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.070127994092063" CI_START="0.036191035463317964" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.18.07" LOG_CI_END="0.4871564816560677" LOG_CI_START="-1.4413989910953926" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.33215451544622665" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.9697833313292665">
<NAME>akathisia (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="3.070127994092063" CI_START="0.036191035463317964" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4871564816560677" LOG_CI_START="-1.4413989910953926" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2431" O_E="0.0" SE="1.132843031197762" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.2833333333333334" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.296053860021452" CI_START="0.0472049579947035" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.18.08" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.5648670580356441" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="99.99999999999999" Z="0.5756274021886759">
<NAME>dystonia (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2432" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.9453474498525" CI_START="0.01398442444617999" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.18.09" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.4971385617323206" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.6789989027057508">
<NAME>spasmodic torticollis (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2433" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.755362190128105" CI_START="0.14803055289342473" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.18.10" LOG_CI_END="0.8296486387699221" LOG_CI_START="-0.8296486387699221" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.0">
<NAME>tremor (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="6.755362190128103" CI_START="0.14803055289342476" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.829648638769922" LOG_CI_START="-0.829648638769922" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2434" O_E="0.0" SE="0.9746794344808963" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.95" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.2500190238651903" CI_END="0.43206542020651306" CI_START="0.13694998490993465" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="0.24325162440852585" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="54" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="-0.36445049049146894" LOG_CI_START="-0.8634380112634881" LOG_EFFECT_SIZE="-0.6139442508774785" METHOD="MH" MODIFIED="2013-11-04 16:56:57 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.9997115073269016" P_Q="0.6445129472522952" P_Z="1.4141436279186188E-6" Q="0.8785208082062859" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="624" TOTAL_2="622" WEIGHT="300.0" Z="4.823000857310248">
<NAME>Adverse effects: 6. Haematological</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8100121704120298" CI_END="0.598818877569634" CI_START="0.04178375039659592" DF="4" EFFECT_SIZE="0.15817995610424007" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="16" I2="0.0" ID="CMP-001.19.01" LOG_CI_END="-0.2227045171214099" LOG_CI_START="-1.3789925815063306" LOG_EFFECT_SIZE="-0.8008485493138703" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9371007880154997" P_Z="0.0066285024868686275" STUDIES="5" TAU2="0.0" TOTAL_1="182" TOTAL_2="186" WEIGHT="100.0" Z="2.714953759487764">
<NAME>abnormal blood routine (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.9824718042703416" CI_START="0.003521940881577318" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.007679904489954488" LOG_CI_START="-2.4532179382665937" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2399" O_E="0.0" SE="1.4365211466489016" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.063593004769475" WEIGHT="22.35544104928006"/>
<DICH_DATA CI_END="4.021183978262525" CI_START="0.009947319052356126" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6043539435123508" LOG_CI_START="-2.002293952184388" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2401" O_E="0.0" SE="1.531157877047447" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.3444444444444446" WEIGHT="19.677383218505987"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2400" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="19.752879624347404"/>
<DICH_DATA CI_END="8.355122068096664" CI_START="0.014775100960857985" EFFECT_SIZE="0.35135135135135137" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9219527993058354" LOG_CI_START="-1.8304695428261517" LOG_EFFECT_SIZE="-0.4542583717601582" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2397" O_E="0.0" SE="1.6167865084786592" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="2.6139986139986138" WEIGHT="17.64826175529685"/>
<DICH_DATA CI_END="2.806986333547635" CI_START="0.007916449271910887" EFFECT_SIZE="0.14906832298136646" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4482402981779739" LOG_CI_START="-2.1014695668184613" LOG_EFFECT_SIZE="-0.8266146343202436" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2398" O_E="0.0" SE="1.497712195966291" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="2.2431418219461694" WEIGHT="20.5660343525697"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2940442538749284" CI_END="0.560960688217465" CI_START="0.08096076611776483" DF="9" EFFECT_SIZE="0.2131098474497004" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="21" I2="0.0" ID="CMP-001.19.02" LOG_CI_END="-0.25106757276958475" LOG_CI_START="-1.091725390831061" LOG_EFFECT_SIZE="-0.6713964818003229" MODIFIED="2013-11-04 16:56:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9984058476580681" P_Z="0.0017440545355440974" STUDIES="10" TAU2="0.0" TOTAL_1="366" TOTAL_2="360" WEIGHT="100.00000000000001" Z="3.1306743252801197">
<NAME>leucopenia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="8.022569637689829" CI_START="0.013849815723520037" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9043134955566555" LOG_CI_START="-1.8585560049959806" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2402" O_E="0.0" SE="1.6229232210492168" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="2.6338797814207653" WEIGHT="9.258012610388688"/>
<DICH_DATA CI_END="1.3074563269125963" CI_START="0.004525703567694904" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11642719100191871" LOG_CI_START="-2.344313895615592" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2403" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="11.670962433430429"/>
<DICH_DATA CI_END="4.017100178657409" CI_START="0.009957431535443751" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.603912662325553" LOG_CI_START="-2.0018526709975903" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2404" O_E="0.0" SE="1.5306394555404428" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="2.342857142857143" WEIGHT="10.408014976493213"/>
<DICH_DATA CI_END="7.377700948278992" CI_START="0.013236677751594202" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8679210473201091" LOG_CI_START="-1.8782210039599212" LOG_EFFECT_SIZE="-0.5051499783199059" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2405" O_E="0.0" SE="1.6130974345442786" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="2.6020833333333333" WEIGHT="9.371141930110326"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2406" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="9.370899906816677"/>
<DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2407" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="9.338741705351966"/>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2408" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yan-2008a" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="9.28066495345301"/>
<DICH_DATA CI_END="6.639018638563896" CI_START="0.012144558924355935" EFFECT_SIZE="0.2839506172839506" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8221038878989294" LOG_CI_START="-1.9156182536210433" LOG_EFFECT_SIZE="-0.5467571828610569" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2409" O_E="0.0" SE="1.6081515378719955" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.586151368760064" WEIGHT="9.428872774114705"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2410" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="10.440873745164069"/>
<DICH_DATA CI_END="1.5914045510327255" CI_START="0.005193187869517035" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20178059570418194" LOG_CI_START="-2.284565966020632" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2411" O_E="0.0" SE="1.4604922779711311" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.1330376940133036" WEIGHT="11.431814964676924"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.10381842509685694" CI_END="0.745816820226396" CI_START="0.13742651682593396" DF="1" EFFECT_SIZE="0.32014841526065274" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" I2="0.0" ID="CMP-001.19.03" LOG_CI_END="-0.1273678263258321" LOG_CI_START="-0.8619294608712535" LOG_EFFECT_SIZE="-0.4946486435985429" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7472946493039803" P_Z="0.00829912093709934" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="76" WEIGHT="100.0" Z="2.63965195256814">
<NAME>abnormal blood routine (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="4.052347097392378" CI_START="0.009870822769781833" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6077066370895764" LOG_CI_START="-2.005646645761614" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2428" O_E="0.0" SE="1.5350966546541733" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.3565217391304345" WEIGHT="7.900602959985384"/>
<DICH_DATA CI_END="0.804616219153575" CI_START="0.13809205987420398" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.09441121733037487" LOG_CI_START="-0.85983129210895" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2427" O_E="0.0" SE="0.44961154081541166" STUDY_ID="STD-Zou-2006" TOTAL_1="31" TOTAL_2="31" VAR="0.2021505376344086" WEIGHT="92.09939704001462"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="149.05251969770828" CI_END="0.7806818826136552" CI_START="0.33298940953547523" CI_STUDY="95" CI_TOTAL="95" DF="39" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5098615489783126" ESTIMABLE="YES" EVENTS_1="126" EVENTS_2="375" I2="73.83472612264761" I2_Q="82.72458432403506" ID="CMP-001.20" LOG_CI_END="-0.1075258992470908" LOG_CI_START="-0.4775695786661815" LOG_EFFECT_SIZE="-0.2925477389566361" METHOD="MH" MODIFIED="2013-10-24 15:24:20 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="9.658940314238862E-15" P_Q="1.0008082854673361E-6" P_Z="0.0019417377730362984" Q="40.52000907705517" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.702205587886469" TOTALS="SUB" TOTAL_1="1477" TOTAL_2="1473" WEIGHT="800.0" Z="3.099001896282903">
<NAME>Adverse effects: 5. Gastrointestinal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.43018743859725267" CI_END="79.11655351955994" CI_START="1.3176315806556511" DF="1" EFFECT_SIZE="10.210116036069579" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="0" I2="0.0" ID="CMP-001.20.01" LOG_CI_END="1.8982673602367695" LOG_CI_START="0.119793995345153" LOG_EFFECT_SIZE="1.0090306777909612" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5118970096951495" P_Z="0.026148337863466733" STUDIES="2" TAU2="0.0" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="2.2240015811390537">
<NAME>abdominal discomfort / pain (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="312.4173614293384" CI_START="1.1555055658507298" EFFECT_SIZE="19.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.494735160171501" LOG_CI_START="0.06277204173415661" LOG_EFFECT_SIZE="1.2787536009528289" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="1.4285471741816855" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.0407470288624787" WEIGHT="53.47869019824433"/>
<DICH_DATA CI_END="100.62623947143514" CI_START="0.24844414470141024" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.002711242864516" LOG_CI_START="-0.6047712341924787" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2376" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="46.52130980175566"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="74.05490154475322" CI_END="0.30660069869212686" CI_START="0.07626016036563624" DF="18" EFFECT_SIZE="0.1529098376510737" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="263" I2="75.69370882341643" ID="CMP-001.20.02" LOG_CI_END="-0.5134268597954418" LOG_CI_START="-1.117702285794086" LOG_EFFECT_SIZE="-0.8155645727947638" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="9.199804140713752E-9" P_Z="1.2194353243437588E-7" STUDIES="19" TAU2="1.490766812115944" TOTAL_1="694" TOTAL_2="696" WEIGHT="100.00000000000003" Z="5.29055831487054">
<NAME>constipation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.5167615470464438" CI_START="0.0537535695845443" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="18" LOG_CI_END="-0.28670981027392173" LOG_CI_START="-1.2695926904933654" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="532" O_E="0.0" SE="0.5773502691896257" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.33333333333333326" WEIGHT="6.907110317956346"/>
<DICH_DATA CI_END="0.35254922176248277" CI_START="0.0014007325219016521" EFFECT_SIZE="0.022222222222222223" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="22" LOG_CI_END="-0.4527802396726071" LOG_CI_START="-2.85364478787808" LOG_EFFECT_SIZE="-1.6532125137753437" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="1.4102797200870787" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="1.988888888888889" WEIGHT="3.6208355131170125"/>
<DICH_DATA CI_END="3.4205061867027573" CI_START="1.0655230250253815" EFFECT_SIZE="1.9090909090909092" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" LOG_CI_END="0.5340903802739257" LOG_CI_START="0.02756283887746276" LOG_EFFECT_SIZE="0.2808266095756942" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="288" O_E="0.0" SE="0.2975367851680503" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.08852813852813854" WEIGHT="7.977775734975932"/>
<DICH_DATA CI_END="1.3650431156485663" CI_START="0.14470668503659606" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.13514636902698354" LOG_CI_START="-0.8395114052497086" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="151" O_E="0.0" SE="0.5725188012439223" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.3277777777777778" WEIGHT="6.928211167126064"/>
<DICH_DATA CI_END="0.5960600182779132" CI_START="0.002301348975638353" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.22471000822189063" LOG_CI_START="-2.638017520096084" LOG_EFFECT_SIZE="-1.4313637641589874" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="199" O_E="0.0" SE="1.4175887785397485" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.009557945041816" WEIGHT="3.5994548533973423"/>
<DICH_DATA CI_END="0.7776279549049671" CI_START="0.0029160136050178946" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10922813537249078" LOG_CI_START="-2.5352104540953477" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="1.4250340228239595" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0307219662058373" WEIGHT="3.5778222589204844"/>
<DICH_DATA CI_END="0.5529947992497327" CI_START="0.0021502202981040445" EFFECT_SIZE="0.034482758620689655" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="14" LOG_CI_END="-0.2572789530854714" LOG_CI_START="-2.667517042712441" LOG_EFFECT_SIZE="-1.462397997898956" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="1.415785784717844" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.0044493882091214" WEIGHT="3.6047157639194403"/>
<DICH_DATA CI_END="0.31847098229954396" CI_START="0.006487610543230012" EFFECT_SIZE="0.045454545454545456" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" LOG_CI_END="-0.4969301325634766" LOG_CI_START="-2.187915229080936" LOG_EFFECT_SIZE="-1.3424226808222062" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="207" O_E="0.0" SE="0.9932930162055811" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="0.9866310160427808" WEIGHT="5.085683370031253"/>
<DICH_DATA CI_END="0.647285425612035" CI_START="0.002471861618832426" EFFECT_SIZE="0.04" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" LOG_CI_END="-0.18890417151988623" LOG_CI_START="-2.6069758458241887" LOG_EFFECT_SIZE="-1.3979400086720375" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="1.4203872711341792" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="2.0175" WEIGHT="3.5913063658973443"/>
<DICH_DATA CI_END="0.34682946138610354" CI_START="0.022886428689749768" EFFECT_SIZE="0.0890937019969278" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="21" LOG_CI_END="-0.4598840185373289" LOG_CI_START="-1.6404219714731803" LOG_EFFECT_SIZE="-1.0501529950052546" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.6934538373116331" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="0.480878224482229" WEIGHT="6.390227805587572"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="3.2928477455283365"/>
<DICH_DATA CI_END="4.025049578857407" CI_START="0.009937765788056413" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6047712341924788" LOG_CI_START="-2.002711242864516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="431" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="3.2838686996164066"/>
<DICH_DATA CI_END="0.5157260549254755" CI_START="0.002017704392455238" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2875809271069153" LOG_CI_START="-2.69514246056163" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="1.4142135623730951" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.0" WEIGHT="3.609310393317643"/>
<DICH_DATA CI_END="0.7219922061772626" CI_START="0.07086244294819037" EFFECT_SIZE="0.2261904761904762" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.14146749056398564" LOG_CI_START="-1.1495838796541198" LOG_EFFECT_SIZE="-0.6455256851090527" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="470" O_E="0.0" SE="0.5921725572081527" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.3506683375104428" WEIGHT="6.842087780378617"/>
<DICH_DATA CI_END="0.9171435836951519" CI_START="0.12114909059653102" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03756266790137051" LOG_CI_START="-0.9166798415379545" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="7.169125368173815"/>
<DICH_DATA CI_END="1.081365033803065" CI_START="0.05779731917185545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.033972322450725845" LOG_CI_START="-1.2380923051066506" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1395" O_E="0.0" SE="0.7472170590486632" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.5583333333333333" WEIGHT="6.148679928406285"/>
<DICH_DATA CI_END="0.5675748741709719" CI_START="0.11011763001540655" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="24" LOG_CI_END="-0.24597683846196863" LOG_CI_START="-0.9581431441939562" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="0.4183300132670378" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.175" WEIGHT="7.563640267039618"/>
<DICH_DATA CI_END="0.46213883750539575" CI_START="0.06556857118590999" EFFECT_SIZE="0.17407407407407408" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="24" LOG_CI_END="-0.33522753244314657" LOG_CI_START="-1.183304280003393" LOG_EFFECT_SIZE="-0.7592659062232698" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="380" O_E="0.0" SE="0.4981644795644945" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.24816784869976363" WEIGHT="7.245390651830617"/>
<DICH_DATA CI_END="0.7860721385905642" CI_START="0.0028846890569240993" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10453759651249254" LOG_CI_START="-2.539900992955346" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="453" O_E="0.0" SE="1.430544514313769" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.0464576074332173" WEIGHT="3.561906014779865"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.296654617177953" CI_END="5.381801741758265" CI_START="0.07614250266524471" DF="3" EFFECT_SIZE="0.6401436194055575" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="27" I2="77.4379339287019" ID="CMP-001.20.03" LOG_CI_END="0.730927694905568" LOG_CI_START="-1.118372852819215" LOG_EFFECT_SIZE="-0.1937225789568235" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.004037099463339189" P_Z="0.6813437557090483" STUDIES="4" TAU2="3.559973872500528" TOTAL_1="135" TOTAL_2="133" WEIGHT="99.99999999999999" Z="0.4106301468571211">
<NAME>dry mouth (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="47.214566724834555" CI_START="0.7624765511416678" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6740760086387871" LOG_CI_START="-0.11777350787149997" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="205" O_E="0.0" SE="1.0525412757962997" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="1.1078431372549022" WEIGHT="25.279959762436857"/>
<DICH_DATA CI_END="84.2755600806104" CI_START="0.21526157073573174" EFFECT_SIZE="4.2592592592592595" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9257016474476552" LOG_CI_START="-0.6670334950584065" LOG_EFFECT_SIZE="0.6293340761946244" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="1.5229854569540042" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.3194847020933973" WEIGHT="20.070253865711713"/>
<DICH_DATA CI_END="0.6012904850246734" CI_START="0.011549233885115417" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.22091566848773703" LOG_CI_START="-1.9374468236075126" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1355" O_E="0.0" SE="1.0082988974836113" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.0166666666666664" WEIGHT="25.783590643653284"/>
<DICH_DATA CI_END="0.6198119073356558" CI_START="0.03591821063778123" EFFECT_SIZE="0.1492063492063492" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.2077400846948387" LOG_CI_START="-1.4446853070129273" LOG_EFFECT_SIZE="-0.826212695853883" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="378" O_E="0.0" SE="0.7265877465672458" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="0.5279297534616683" WEIGHT="28.86619572819813"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.67563811992631" CI_END="3.394026963278285" CI_START="0.4055527386738821" DF="1" EFFECT_SIZE="1.1732250125574837" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-001.20.04" LOG_CI_END="0.5307152881750745" LOG_CI_START="-0.39195266148798436" LOG_EFFECT_SIZE="0.06938131334354504" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.41109312536065956" P_Z="0.7681737924952361" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="100.0" Z="0.29476449334366867">
<NAME>general gastrointestinal aderse reaction (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="6.445158746541576" CI_START="0.43098671219980617" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.809233618647991" LOG_CI_START="-0.3655361194152783" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="438" O_E="0.0" SE="0.6900655593423543" STUDY_ID="STD-Xu-2007" TOTAL_1="35" TOTAL_2="35" VAR="0.47619047619047616" WEIGHT="61.685823754789276"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1395" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Yu-ZG-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="38.31417624521073"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.887138041535607" CI_START="0.04476700194485466" DF="0" EFFECT_SIZE="0.4677419354838709" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.20.05" LOG_CI_END="0.6890546062331032" LOG_CI_START="-1.3490419894316987" LOG_EFFECT_SIZE="-0.32999369159929787" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.5256331898298985" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="29" WEIGHT="100.0" Z="0.6346860615299456">
<NAME>indigestion (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="4.887138041535607" CI_START="0.04476700194485466" EFFECT_SIZE="0.46774193548387094" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6890546062331032" LOG_CI_START="-1.3490419894316987" LOG_EFFECT_SIZE="-0.3299936915992978" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="190" O_E="0.0" SE="1.1971880290343624" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="1.4332591768631813" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="17.010989430137844" CI_END="3.3762797999328242" CI_START="0.7135595005559208" DF="9" EFFECT_SIZE="1.5521522244216608" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="28" I2="47.093024559435804" ID="CMP-001.20.06" LOG_CI_END="0.5284384304096568" LOG_CI_START="-0.14656980715241286" LOG_EFFECT_SIZE="0.1909343116286219" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.04854421494167216" P_Z="0.26751673455794267" STUDIES="10" TAU2="0.6521527309227152" TOTAL_1="396" TOTAL_2="394" WEIGHT="100.0" Z="1.1087994290458858">
<NAME>nausea / vomiting (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="34.23769854353973" CI_START="0.46732113081879495" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5345045637319326" LOG_CI_START="-0.330384581076008" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="289" O_E="0.0" SE="1.0954451150103324" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.2000000000000002" WEIGHT="8.488218557552205"/>
<DICH_DATA CI_END="2.171888679665419" CI_START="0.028776797165142073" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3368375616875298" LOG_CI_START="-1.5409575443434547" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="150" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="1.2166666666666668" WEIGHT="8.412518193207195"/>
<DICH_DATA CI_END="2.38743048059155" CI_START="0.5171115604290479" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.37793073425157514" LOG_CI_START="-0.28641575313022477" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="0.39024041525621916" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="0.1522875816993464" WEIGHT="19.543373119623084"/>
<DICH_DATA CI_END="2.295994708530964" CI_START="0.1567947864437097" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.36097088282939777" LOG_CI_START="-0.8046683820621104" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="0.6847022742046907" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.4688172043010753" WEIGHT="14.02488745507751"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="215" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="5.4714783529779005"/>
<DICH_DATA CI_END="190.5337733482898" CI_START="0.63505801556145" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2799719683515804" LOG_CI_START="-0.19718659803513053" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="5.676740878573292"/>
<DICH_DATA CI_END="59.75116774707509" CI_START="0.10930103031920343" EFFECT_SIZE="2.5555555555555554" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7763463973382545" LOG_CI_START="-0.9613757441817185" LOG_EFFECT_SIZE="0.40748532657826797" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="1.6081515378719955" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.586151368760064" WEIGHT="4.85484892650423"/>
<DICH_DATA CI_END="29.477912175604136" CI_START="1.6622615505501197" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="2" LOG_CI_END="1.4694967206142888" LOG_CI_START="0.22069935941422472" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="367" O_E="0.0" SE="0.7335497516155519" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.538095238095238" WEIGHT="13.208572995936825"/>
<DICH_DATA CI_END="1.7191106082473118" CI_START="0.025382059590523615" EFFECT_SIZE="0.2088888888888889" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.23530382026243468" LOG_CI_START="-1.5954731406137248" LOG_EFFECT_SIZE="-0.680084660175645" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="381" O_E="0.0" SE="1.0754074493107704" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="1.156501182033097" WEIGHT="8.692363458493942"/>
<DICH_DATA CI_END="10.308519609286225" CI_START="0.3880285580867189" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0131963013959688" LOG_CI_START="-0.41113631006800627" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="455" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.7" WEIGHT="11.626998062053818"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.35551586510438965" CI_START="0.0013890439470228017" DF="0" EFFECT_SIZE="0.022222222222222227" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="22" I2="0.0" ID="CMP-001.20.07" LOG_CI_END="-0.4491410138553092" LOG_CI_START="-2.857284013695378" LOG_EFFECT_SIZE="-1.6532125137753435" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.007122390572549675" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="2.69106692252561">
<NAME>constipation (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.35551586510438965" CI_START="0.0013890439470228017" EFFECT_SIZE="0.022222222222222223" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="22" LOG_CI_END="-0.4491410138553092" LOG_CI_START="-2.857284013695378" LOG_EFFECT_SIZE="-1.6532125137753437" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2430" O_E="0.0" SE="1.414555118606157" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.000966183574879" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.28925112559943034" CI_START="0.0011428771857382367" DF="0" EFFECT_SIZE="0.018181818181818177" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="27" I2="0.0" ID="CMP-001.20.08" LOG_CI_END="-0.5387249423479664" LOG_CI_START="-2.9420004366405212" LOG_EFFECT_SIZE="-1.7403626894942439" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.004530255170859571" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="2.8386659786168904">
<NAME>hyper-salivation (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.28925112559943034" CI_START="0.0011428771857382367" EFFECT_SIZE="0.01818181818181818" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="27" LOG_CI_END="-0.5387249423479664" LOG_CI_START="-2.9420004366405212" LOG_EFFECT_SIZE="-1.7403626894942439" MODIFIED="2013-06-25 17:02:47 +0100" MODIFIED_BY="[Empty name]" ORDER="2429" O_E="0.0" SE="1.4116959217530065" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="1.9928853754940707" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.3343994959214236" CI_END="0.4661206461289885" CI_START="0.025229026569665434" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.10844247399362425" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="-0.33150166020555966" LOG_CI_START="-1.5980995058668273" LOG_EFFECT_SIZE="-0.9648005830361934" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.5131435385875824" P_Q="1.0" P_Z="0.0028273466118962465" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="107" TOTAL_2="107" WEIGHT="100.0" Z="2.985911276403509">
<NAME>Adverse effects: 7. Hormonal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3343994959214236" CI_END="0.4661206461289885" CI_START="0.025229026569665434" DF="2" EFFECT_SIZE="0.10844247399362425" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="23" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="-0.33150166020555966" LOG_CI_START="-1.5980995058668273" LOG_EFFECT_SIZE="-0.9648005830361934" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5131435385875824" P_Z="0.0028273466118962465" STUDIES="3" TAU2="0.0" TOTAL_1="107" TOTAL_2="107" WEIGHT="100.0" Z="2.985911276403509">
<NAME>lactation/menstrual changes (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.600380984886725" CI_START="0.0022847860725330295" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.22157307107490626" LOG_CI_START="-2.6411544572430685" LOG_EFFECT_SIZE="-1.4313637641589874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2390" O_E="0.0" SE="1.4212740833562045" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.0200200200200196" WEIGHT="27.402931202130873"/>
<DICH_DATA CI_END="2.1398561589712335" CI_START="0.029207570676174695" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.33038458107600793" LOG_CI_START="-1.5345045637319326" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2391" O_E="0.0" SE="1.0954451150103324" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.2000000000000002" WEIGHT="46.12872469627968"/>
<DICH_DATA CI_END="1.3092442635902237" CI_START="0.004519523153828845" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11702067973100334" LOG_CI_START="-2.3449073843446766" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2389" O_E="0.0" SE="1.446148731578517" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="2.0913461538461537" WEIGHT="26.468344101589448"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="30.464880735481067" CI_END="0.17463141917934535" CI_START="0.08192917113114025" CI_STUDY="95" CI_TOTAL="95" DF="34" EFFECT_MEASURE="RR" EFFECT_SIZE="0.11961357542862126" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="360" I2="0.0" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="-0.7578776165947005" LOG_CI_START="-1.086561438830253" LOG_EFFECT_SIZE="-0.9222195277124767" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.6416416983422213" P_Q="0.872939885556429" P_Z="3.8847424039525325E-28" Q="3.820553439824153" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1291" TOTAL_2="1289" WEIGHT="900.0" Z="10.998515520855968">
<NAME>Adverse effects: 8a. Metabolic - binary measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.5937087919218929" CI_END="0.3670782436434995" CI_START="0.04017012273326035" DF="4" EFFECT_SIZE="0.12143137197556907" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="32" I2="0.0" ID="CMP-001.22.01" LOG_CI_END="-0.43524135492825344" LOG_CI_START="-1.396096841350323" LOG_EFFECT_SIZE="-0.9156690981392882" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.809922430626824" P_Z="1.872796416977023E-4" STUDIES="5" TAU2="0.0" TOTAL_1="205" TOTAL_2="205" WEIGHT="99.99999999999999" Z="3.7355845482906247">
<NAME> blood glucose - increased (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="1.3154148248882045" CI_START="0.004498322241287272" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11906273210348776" LOG_CI_START="-2.346949436717161" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="1.4485477549223562" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.0982905982905984" WEIGHT="15.181885715639082"/>
<DICH_DATA CI_END="4.038645960707643" CI_START="0.009904309609993965" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6062357833382839" LOG_CI_START="-2.0041757920103214" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="291" O_E="0.0" SE="1.5333686811054679" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.351219512195122" WEIGHT="13.548717121570132"/>
<DICH_DATA CI_END="3.114568067741974" CI_START="0.035674645310181115" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49339782666037824" LOG_CI_START="-1.4476403360997032" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="153" O_E="0.0" SE="1.140175425099138" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="1.3" WEIGHT="24.50462158572909"/>
<DICH_DATA CI_END="0.4143887968498253" CI_START="0.008350147587871998" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="17" LOG_CI_END="-0.382591994411641" LOG_CI_START="-2.0783058483449066" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2204" O_E="0.0" SE="0.9960707117193528" STUDY_ID="STD-Yi-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.992156862745098" WEIGHT="32.10783421213121"/>
<DICH_DATA CI_END="1.9982491776052522" CI_START="0.006178248013664149" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30064964290473245" LOG_CI_START="-2.2091346617833825" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="462" O_E="0.0" SE="1.4742597242064726" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.1734417344173442" WEIGHT="14.65694136493048"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.4544558756306209" CI_START="0.0017962723652312303" DF="0" EFFECT_SIZE="0.028571428571428577" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="17" I2="0.0" ID="CMP-001.22.02" LOG_CI_END="-0.34250827723937655" LOG_CI_START="-2.7456278114611745" LOG_EFFECT_SIZE="-1.5440680443502754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.01178031182378045" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="2.5186576976377895">
<NAME> C-peptide (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.4544558756306209" CI_START="0.0017962723652312303" EFFECT_SIZE="0.02857142857142857" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="17" LOG_CI_END="-0.34250827723937655" LOG_CI_START="-2.7456278114611745" LOG_EFFECT_SIZE="-1.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2204" O_E="0.0" SE="1.4116043100354287" STUDY_ID="STD-Yi-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.992626728110599" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04574925204789772" CI_END="0.5405479830668983" CI_START="0.009836184695614893" DF="1" EFFECT_SIZE="0.07291728051901089" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" I2="0.0" ID="CMP-001.22.03" LOG_CI_END="-0.2671657487851415" LOG_CI_START="-2.007173325039736" LOG_EFFECT_SIZE="-1.1371695369124388" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8306324082551937" P_Z="0.01041189861764932" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="99.99999999999999" Z="2.561840956419326">
<NAME>decreased appetite (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.9814657798759212" CI_START="0.003525550949819354" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.008124838061060551" LOG_CI_START="-2.452773004695487" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="1.4359984342846528" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="2.062091503267974" WEIGHT="50.66050909991446"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="49.33949090008553"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1432025984628673" CI_END="0.3853576635293658" CI_START="0.06786752800174331" DF="4" EFFECT_SIZE="0.16171973293406594" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="37" I2="0.0" ID="CMP-001.22.04" LOG_CI_END="-0.4141359998661876" LOG_CI_START="-1.1683379692077347" LOG_EFFECT_SIZE="-0.7912369845369611" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8873584602798442" P_Z="3.9154053707480484E-5" STUDIES="5" TAU2="0.0" TOTAL_1="171" TOTAL_2="173" WEIGHT="100.0" Z="4.112415655139261">
<NAME>postural hypotension (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.5838099805517241" CI_START="0.03495685915821374" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.23372848478224634" LOG_CI_START="-1.4564675952462673" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="531" O_E="0.0" SE="0.7182430061427788" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.5158730158730158" WEIGHT="38.04588726248646"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="8.83615293152492"/>
<DICH_DATA CI_END="1.081365033803065" CI_START="0.05779731917185545" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.033972322450725845" LOG_CI_START="-1.2380923051066506" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.7472170590486632" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.5583333333333333" WEIGHT="35.15256108118862"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="8.403760286099075"/>
<DICH_DATA CI_END="0.8237422801412428" CI_START="0.002997345900287972" EFFECT_SIZE="0.049689440993788817" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.08420864245288906" LOG_CI_START="-2.523263135626923" LOG_EFFECT_SIZE="-1.3037358890399062" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="386" O_E="0.0" SE="1.432712682804888" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="2.052665631469979" WEIGHT="9.561638438700918"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8219003235019445" CI_START="0.0030549995427306487" DF="0" EFFECT_SIZE="0.05010893246187363" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" I2="0.0" ID="CMP-001.22.05" LOG_CI_END="-0.0851808486131404" LOG_CI_START="-2.5149888504261964" LOG_EFFECT_SIZE="-1.3000848495196684" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.035959649526251226" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="22" WEIGHT="100.0" Z="2.097383398197215">
<NAME>PRL- increase (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.8219003235019445" CI_START="0.0030549995427306487" EFFECT_SIZE="0.05010893246187364" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.0851808486131404" LOG_CI_START="-2.5149888504261964" LOG_EFFECT_SIZE="-1.3000848495196684" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="390" O_E="0.0" SE="1.427281248008579" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="2.037131760916927" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="22.345786759486483" CI_END="0.21659542919086688" CI_START="0.07921706436846514" DF="17" EFFECT_SIZE="0.13098875545682628" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="219" I2="23.923018764228697" ID="CMP-001.22.06" LOG_CI_END="-0.6643507125220083" LOG_CI_START="-1.1011812557489362" LOG_EFFECT_SIZE="-0.8827659841354722" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.17178404024708993" P_Z="2.3455026479305724E-15" STUDIES="18" TAU2="0.2599756546038603" TOTAL_1="659" TOTAL_2="659" WEIGHT="99.99999999999999" Z="7.921559343819836">
<NAME>weight gain (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.6078012133891135" CI_START="0.011425519218235945" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.21623843724773373" LOG_CI_START="-1.942124054847516" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="529" O_E="0.0" SE="1.0137937550497034" STUDY_ID="STD-Fan-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.027777777777778" WEIGHT="5.112913921664071"/>
<DICH_DATA CI_END="0.38811127204520424" CI_START="0.001532766607075448" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.41104374371723296" LOG_CI_START="-2.814523969722238" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="1.4118161821743378" STUDY_ID="STD-Han-2005" TOTAL_1="35" TOTAL_2="35" VAR="1.9932249322493227" WEIGHT="2.922142169903398"/>
<DICH_DATA CI_END="0.8367241573312947" CI_START="0.01475477778927983" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07741769217811331" LOG_CI_START="-1.8310673267005368" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="290" O_E="0.0" SE="1.030102476024163" STUDY_ID="STD-Jiang-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.0611111111111113" WEIGHT="4.983906146793787"/>
<DICH_DATA CI_END="0.4536948108962831" CI_START="0.04498213948047892" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="21" LOG_CI_END="-0.3432361879193435" LOG_CI_START="-1.3469598921091703" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="152" O_E="0.0" SE="0.5895922723535711" STUDY_ID="STD-Kuang-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.3476190476190476" WEIGHT="10.836454676129218"/>
<DICH_DATA CI_END="0.7059719098553454" CI_START="0.002677669099652002" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.1512125788880248" LOG_CI_START="-2.5722430931471605" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="200" O_E="0.0" SE="1.4221253083701424" STUDY_ID="STD-Li-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.0224403927068724" WEIGHT="2.8847380651098216"/>
<DICH_DATA CI_END="1.816767939244651" CI_START="0.1376070078074701" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2592994572244536" LOG_CI_START="-0.861359448552416" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="126" O_E="0.0" SE="0.6582805886043833" STUDY_ID="STD-Li-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.43333333333333335" WEIGHT="9.496736039272616"/>
<DICH_DATA CI_END="0.5749786199924476" CI_START="0.03549377760441629" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.24034830381807687" LOG_CI_START="-1.4498477762104367" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.7104659772022196" STUDY_ID="STD-Liu-2006" TOTAL_1="30" TOTAL_2="30" VAR="0.5047619047619047" WEIGHT="8.60971502113137"/>
<DICH_DATA CI_END="0.55582170094965" CI_START="0.0021392843065702093" EFFECT_SIZE="0.034482758620689655" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="14" LOG_CI_END="-0.2550645010658433" LOG_CI_START="-2.669731494732069" LOG_EFFECT_SIZE="-1.462397997898956" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="125" O_E="0.0" SE="1.418387344873932" STUDY_ID="STD-Liu-2007" TOTAL_1="34" TOTAL_2="34" VAR="2.0118226600985225" WEIGHT="2.8982205020067244"/>
<DICH_DATA CI_END="1.5767983443841436" CI_START="0.005241293434478607" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.1977761552685912" LOG_CI_START="-2.2805615255850418" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="1.4557878217027993" STUDY_ID="STD-Liu-2008" TOTAL_1="31" TOTAL_2="31" VAR="2.1193181818181817" WEIGHT="2.767280085924983"/>
<DICH_DATA CI_END="1.3074563269125963" CI_START="0.004525703567694904" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11642719100191871" LOG_CI_START="-2.344313895615592" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="223" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Wang-2006a" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="2.802603556352262"/>
<DICH_DATA CI_END="0.9824718042703416" CI_START="0.003521940881577318" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.007679904489954488" LOG_CI_START="-2.4532179382665937" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="433" O_E="0.0" SE="1.4365211466489016" STUDY_ID="STD-Xiao-2007" TOTAL_1="36" TOTAL_2="36" VAR="2.063593004769475" WEIGHT="2.8336466088635044"/>
<DICH_DATA CI_END="0.6463854475521095" CI_START="0.002475303251425713" EFFECT_SIZE="0.04" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" LOG_CI_END="-0.1895084296452276" LOG_CI_START="-2.606371587698847" LOG_EFFECT_SIZE="-1.3979400086720375" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="1.419677382706276" STUDY_ID="STD-Yang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.015483870967742" WEIGHT="2.893557269686353"/>
<DICH_DATA CI_END="0.34217654874384873" CI_START="0.0013942757952651874" EFFECT_SIZE="0.02184235517568851" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="19" LOG_CI_END="-0.46574975838387517" LOG_CI_START="-2.855651311951912" LOG_EFFECT_SIZE="-1.6607005351678936" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="1.40384000276935" STUDY_ID="STD-Yu-2006" TOTAL_1="26" TOTAL_2="22" VAR="1.9707667533754487" WEIGHT="2.9515610715712186"/>
<DICH_DATA CI_END="1.2566204627555961" CI_START="0.2216654837095592" EFFECT_SIZE="0.5277777777777778" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.09920412747086656" LOG_CI_START="-0.6543019270997832" LOG_EFFECT_SIZE="-0.2775488998144583" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="467" O_E="0.0" SE="0.442613186369925" STUDY_ID="STD-Yu-2007" TOTAL_1="36" TOTAL_2="38" VAR="0.195906432748538" WEIGHT="14.442709276719581"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1363" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Yu-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="4.994407617896368"/>
<DICH_DATA CI_END="0.40910958885558435" CI_START="0.024443328321815512" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="20" LOG_CI_END="-0.38816034123429677" LOG_CI_START="-1.611839658765703" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="363" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Zhang-2010" TOTAL_1="60" TOTAL_2="60" VAR="0.5166666666666666" WEIGHT="8.477741003507989"/>
<DICH_DATA CI_END="0.6422345840965679" CI_START="0.011795449830598811" EFFECT_SIZE="0.08703703703703704" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.19230631154140734" LOG_CI_START="-1.9282854922330945" LOG_EFFECT_SIZE="-1.060295901887251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="382" O_E="0.0" SE="1.0197227639738315" STUDY_ID="STD-Zhou-2007" TOTAL_1="45" TOTAL_2="47" VAR="1.0398345153664303" WEIGHT="5.065487718291404"/>
<DICH_DATA CI_END="0.7451128111300469" CI_START="0.013420786558258051" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.12777796947685374" LOG_CI_START="-1.872222030523146" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="461" O_E="0.0" SE="1.02469507659596" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.0500000000000003" WEIGHT="5.026179249175312"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3261910580228389" CI_START="0.0044617702159259354" DF="0" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" I2="0.0" ID="CMP-001.22.07" LOG_CI_END="0.1226060953114518" LOG_CI_START="-2.3504927999251257" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.07745793674334193" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="1.7656300405490735">
<NAME>blood glucose - increased (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="1.3261910580228389" CI_START="0.0044617702159259354" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.1226060953114518" LOG_CI_START="-2.3504927999251257" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2439" O_E="0.0" SE="1.4527105330989338" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.1103678929765883" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9895765631237873" CI_START="0.003496654772758503" DF="0" EFFECT_SIZE="0.0588235294117647" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" I2="0.0" ID="CMP-001.22.08" LOG_CI_END="-0.004550598975685801" LOG_CI_START="-2.456347243780862" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.04915560920678997" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="1.967239473817949">
<NAME>decreased appetite (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.9895765631237873" CI_START="0.003496654772758503" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.004550598975685801" LOG_CI_START="-2.456347243780862" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2440" O_E="0.0" SE="1.4401974857476887" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.074168797953964" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.391373605797274" CI_START="0.0015199900780447774" DF="0" EFFECT_SIZE="0.024390243902439032" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" I2="0.0" ID="CMP-001.22.09" LOG_CI_END="-0.4074084664734098" LOG_CI_START="-2.818159246966061" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.008730824234239563" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="2.622418127660894">
<NAME>weight gain (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.39137360579727376" CI_START="0.0015199900780447774" EFFECT_SIZE="0.024390243902439025" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.40740846647341006" LOG_CI_START="-2.818159246966061" LOG_EFFECT_SIZE="-1.6127838567197355" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2441" O_E="0.0" SE="1.4160869418702062" STUDY_ID="STD-Wei-2007" TOTAL_1="45" TOTAL_2="45" VAR="2.0053022269353127" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="25.010478106544962" CI_END="-0.21921073391725507" CI_START="-0.5950568196012607" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.4071337767592579" ESTIMABLE="YES" I2="72.0117305627669" I2_Q="75.67957372827779" ID="CMP-001.23" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="7.555644976490195E-4" P_Q="3.928761833383865E-4" P_Z="2.1738159194949697E-5" Q="24.6706202143188" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.20633964164228127" TOTALS="SUB" TOTAL_1="186" TOTAL_2="192" UNITS="" WEIGHT="700.0" Z="4.246246374420465">
<NAME>Adverse effects: 8b. Metabolic - continuous measures (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Clozapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clozapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.39199279690801087" CI_START="-0.39199279690801087" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.23.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="18" WEIGHT="100.0" Z="0.0">
<NAME>blood glucose - FPG in HbA1c normal group (in mmol/l)</NAME>
<CONT_DATA CI_END="0.39199279690801087" CI_START="-0.39199279690801087" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.4" MEAN_2="4.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="345" SD_1="0.6" SD_2="0.6" SE="0.2" STUDY_ID="STD-Wang-2009" TOTAL_1="18" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6076239589947808" CI_START="-0.6076239589947808" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.23.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="10" WEIGHT="100.0" Z="0.0">
<NAME>blood glucose - FPG in HbA1c abnormal group (in mmol/l)</NAME>
<CONT_DATA CI_END="0.6076239589947808" CI_START="-0.6076239589947808" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="4.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="346" SD_1="0.8" SD_2="0.5" SE="0.31001792062897127" STUDY_ID="STD-Wang-2009" TOTAL_1="9" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.26196794144989255" CI_START="-0.6619679414498929" DF="0" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-001.23.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.3961439176656336" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="18" WEIGHT="99.99999999999999" Z="0.8485281374238577">
<NAME>blood glucose - PBG in HbA1c normal group (in mmol/l)</NAME>
<CONT_DATA CI_END="0.26196794144989255" CI_START="-0.6619679414498929" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="6.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="347" SD_1="0.8" SD_2="0.6" SE="0.23570226039551587" STUDY_ID="STD-Wang-2009" TOTAL_1="18" TOTAL_2="18" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.1692724337507971" CI_START="-2.6307275662492033" DF="0" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-001.23.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="3.465446608392057E-7" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="10" WEIGHT="100.0" Z="5.096196917465291">
<NAME>blood glucose - PBG in HbA1c abnormal group (in mmol/l)</NAME>
<CONT_DATA CI_END="-1.1692724337507971" CI_START="-2.6307275662492033" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="7.1" MEAN_2="9.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="348" SD_1="0.9" SD_2="0.7" SE="0.372827037646145" STUDY_ID="STD-Wang-2009" TOTAL_1="9" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.33985789222616636" CI_END="-0.21504083624217873" CI_START="-0.829355136709556" DF="1" EFFECT_SIZE="-0.5221979864758673" ESTIMABLE="YES" I2="0.0" ID="CMP-001.23.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5599114364561331" P_Z="8.618228186201408E-4" STUDIES="2" TAU2="0.0" TOTAL_1="66" TOTAL_2="68" WEIGHT="100.00000000000001" Z="3.3321355062493327">
<NAME>blood glucose - FPG average endpoint (in mmol/l)</NAME>
<CONT_DATA CI_END="0.012521517047309416" CI_START="-1.452521517047309" EFFECT_SIZE="-0.7199999999999998" ESTIMABLE="YES" MEAN_1="5.09" MEAN_2="5.81" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2211" SD_1="0.71" SD_2="1.92" SE="0.3737423354843994" STUDY_ID="STD-Yi-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="17.582494364944562"/>
<CONT_DATA CI_END="-0.1416619075942654" CI_START="-0.8183380924057355" EFFECT_SIZE="-0.4800000000000004" ESTIMABLE="YES" MEAN_1="4.84" MEAN_2="5.32" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="481" SD_1="0.61" SD_2="0.86" SE="0.17262464773562305" STUDY_ID="STD-Yu-2006a" TOTAL_1="36" TOTAL_2="38" WEIGHT="82.41750563505545"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.012521517047309416" CI_START="-1.452521517047309" DF="0" EFFECT_SIZE="-0.7199999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-001.23.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.05404684818239398" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="1.9264609107416832">
<NAME>blood glucose - C-peptide average endpoint (in mg/dlmmol/l)</NAME>
<CONT_DATA CI_END="0.012521517047309416" CI_START="-1.452521517047309" EFFECT_SIZE="-0.7199999999999998" ESTIMABLE="YES" MEAN_1="5.09" MEAN_2="5.81" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2211" SD_1="0.71" SD_2="1.92" SE="0.3737423354843994" STUDY_ID="STD-Yi-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4885723115462735E-32" CI_END="1.5770019619584283" CI_START="-5.557001961958432" DF="0" EFFECT_SIZE="-1.9900000000000018" ESTIMABLE="YES" I2="100.0" ID="CMP-001.23.07" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.274197513851544" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="38" WEIGHT="100.0" Z="1.0934472060377762">
<NAME>weight gain - average endpoint level (in kg)</NAME>
<CONT_DATA CI_END="1.5770019619584281" CI_START="-5.5570019619584325" EFFECT_SIZE="-1.990000000000002" ESTIMABLE="YES" MEAN_1="58.69" MEAN_2="60.68" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="480" SD_1="6.93" SD_2="8.67" SE="1.8199324018678333" STUDY_ID="STD-Yu-2006a" TOTAL_1="36" TOTAL_2="38" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-001.24" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="24" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Cost effectiveness analysis (high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-001.24.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>Cost of hospitalisation (in RMB)</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2941" STUDY_ID="STD-Liu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>3413.66 </P>
</TD>
<TD>
<P>1815.05</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>4582.00 </P>
</TD>
<TD>
<P>3372.42</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.24.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="1">
<NAME>Cost of drug (in RMB)</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2942" STUDY_ID="STD-Liu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>418.13 </P>
</TD>
<TD>
<P>326.43</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>210.39 </P>
</TD>
<TD>
<P>300.32</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-001.24.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="1">
<NAME>Length of hospitalisation (day)</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2943" STUDY_ID="STD-Liu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>33.19 </P>
</TD>
<TD>
<P>16.71</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Clozapine</P>
</TD>
<TD>
<P>49.50 </P>
</TD>
<TD>
<P>30.83</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-11-04 16:58:21 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE</NAME>
<DICH_OUTCOME CHI2="2.7596495719739296" CI_END="1.3246366304147106" CI_START="0.638370982594757" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9195703275654596" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="54" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.12209676050025323" LOG_CI_START="-0.19492686223594313" LOG_EFFECT_SIZE="-0.03641505086784495" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9935360850751029" P_Q="1.0" P_Z="0.6525199769366796" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="497" TOTAL_2="494" WEIGHT="100.00000000000001" Z="0.4502641637879513">
<NAME>Global state: 1.No clinically significant response (as defined by original studies)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1844236592731723" CI_START="0.20346073553896835" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.33933687168887666" LOG_CI_START="-0.6915193898002392" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1182" O_E="0.0" SE="0.6055300708194983" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.3666666666666666" WEIGHT="9.457732417205754"/>
<DICH_DATA CI_END="2.8062406427651023" CI_START="0.2280631212615402" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.44812491022187245" LOG_CI_START="-0.6419449362379852" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1184" O_E="0.0" SE="0.6403124237432849" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="0.41" WEIGHT="8.458134682053926"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1183" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="6.71193913479118"/>
<DICH_DATA CI_END="2.7633577414555113" CI_START="0.23160229687195705" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4414371118737813" LOG_CI_START="-0.6352571378898941" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1186" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.39999999999999997" WEIGHT="8.669588049105274"/>
<DICH_DATA CI_END="4.317746471024236" CI_START="0.36187858886243285" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6352571378898941" LOG_CI_START="-0.4414371118737813" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1992" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.39999999999999997" WEIGHT="8.669588049105274"/>
<DICH_DATA CI_END="2.438041198591854" CI_START="0.2848370424771889" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.38704104015436036" LOG_CI_START="-0.54540353224961" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="890" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Li-2007b" TOTAL_1="30" TOTAL_2="30" VAR="0.30000000000000004" WEIGHT="11.559450732140364"/>
<DICH_DATA CI_END="10.510529570116088" CI_START="0.3805707384500341" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0216245983864845" LOG_CI_START="-0.4195646070585221" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="891" O_E="0.0" SE="0.8465616732800195" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" VAR="0.7166666666666666" WEIGHT="4.838839841361084"/>
<DICH_DATA CI_END="3.5706400111640093" CI_START="0.4032890449604769" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5527460672059874" LOG_CI_START="-0.3943835751107378" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="0.5563486402641868" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.30952380952380953" WEIGHT="11.203775324997585"/>
<DICH_DATA CI_END="2.409529651189094" CI_START="0.09008865314631492" EFFECT_SIZE="0.4659090909090909" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3819322750109861" LOG_CI_START="-1.0453299058718526" LOG_EFFECT_SIZE="-0.33169881543043317" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="905" O_E="0.0" SE="0.8383808701123185" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="0.7028824833702882" WEIGHT="4.933734019112276"/>
<DICH_DATA CI_END="5.61321686747023" CI_START="0.3167128261301238" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7492118215758435" LOG_CI_START="-0.49933434835924373" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="719" O_E="0.0" SE="0.7334022006230877" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="0.5378787878787878" WEIGHT="6.447242943559979"/>
<DICH_DATA CI_END="3.794628737819284" CI_START="0.2635303923236203" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.579169291429445" LOG_CI_START="-0.579169291429445" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1185" O_E="0.0" SE="0.6804138174397717" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.462962962962963" WEIGHT="7.490524074426955"/>
<DICH_DATA CI_END="2.438041198591854" CI_START="0.2848370424771889" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.38704104015436036" LOG_CI_START="-0.54540353224961" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="720" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.30000000000000004" WEIGHT="11.559450732140364"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="30.054785002607822" CI_END="0.5723450366046499" CI_START="-2.5764791468054518" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.002067055100401" ESTIMABLE="YES" I2="63.40017072474303" I2_Q="73.26640754674254" ID="CMP-002.02" MODIFIED="2013-11-04 16:57:33 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0015535077613708648" P_Q="0.02373966180764797" P_Z="0.2122290815497676" Q="7.481224244354419" RANDOM="YES" SCALE="13.35" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="3.537458315774767" TOTALS="YES" TOTAL_1="497" TOTAL_2="494" UNITS="" WEIGHT="100.0" Z="1.2474595110381286">
<NAME>Global state: 2a. Average endpoint total score (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.110608158232587E-33" CI_END="0.692058373294677" CI_START="-0.49205837329467683" DF="0" EFFECT_SIZE="0.10000000000000007" ESTIMABLE="YES" I2="100.0" ID="CMP-002.02.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.7406124930771522" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="17.782326951824153" Z="0.3310423554409474">
<NAME>CGI</NAME>
<CONT_DATA CI_END="0.692058373294677" CI_START="-0.49205837329467683" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="3.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="839" SD_1="1.4" SD_2="1.3" SE="0.3020761493398643" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="17.782326951824153"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="21.13910381549704" CI_END="1.3980194652505915" CI_START="-3.148564382678594" DF="9" EFFECT_SIZE="-0.8752724587140013" ESTIMABLE="YES" I2="57.42487440076758" ID="CMP-002.02.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.012046912093047757" P_Z="0.4504688563163761" STUDIES="10" TAU2="7.0151294177989945" TOTAL_1="417" TOTAL_2="414" WEIGHT="67.86531682740839" Z="0.754633612012068">
<NAME>PANSS</NAME>
<CONT_DATA CI_END="-2.579450541309121" CI_START="-9.020549458690887" EFFECT_SIZE="-5.800000000000004" ESTIMABLE="YES" MEAN_1="40.3" MEAN_2="46.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2225" SD_1="7.2" SD_2="5.4" SE="1.6431676725154984" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="10.345059544641632"/>
<CONT_DATA CI_END="6.576475519786073" CI_START="-9.37647551978607" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" MEAN_1="49.5" MEAN_2="50.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2226" SD_1="18.3" SD_2="18.1" SE="4.069705149024927" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.2102990797383066"/>
<CONT_DATA CI_END="3.2713394548382944" CI_START="-4.271339454838294" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="47.1" MEAN_2="47.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2227" SD_1="8.9" SD_2="8.3" SE="1.924188140489386" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="8.91260348050842"/>
<CONT_DATA CI_END="2.5650758977944985" CI_START="-6.005075897794496" EFFECT_SIZE="-1.7199999999999989" ESTIMABLE="YES" MEAN_1="42.0" MEAN_2="43.72" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2228" SD_1="12.0" SD_2="6.87" SE="2.1863033869982456" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="7.75807662449797"/>
<CONT_DATA CI_END="1.8814047663299012" CI_START="-3.281404766329907" EFFECT_SIZE="-0.7000000000000028" ESTIMABLE="YES" MEAN_1="46.8" MEAN_2="47.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2229" SD_1="5.0" SD_2="5.2" SE="1.3170674495509587" STUDY_ID="STD-Li-2007b" TOTAL_1="30" TOTAL_2="30" WEIGHT="12.239254171479967"/>
<CONT_DATA CI_END="11.46051513519852" CI_START="2.339484864801478" EFFECT_SIZE="6.899999999999999" ESTIMABLE="YES" MEAN_1="49.8" MEAN_2="42.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="16.2" SD_2="7.9" SE="2.3268361924868426" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" WEIGHT="7.208398230542411"/>
<CONT_DATA CI_END="5.606308295397482" CI_START="-8.406308295397494" EFFECT_SIZE="-1.4000000000000057" ESTIMABLE="YES" MEAN_1="49.8" MEAN_2="51.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2231" SD_1="14.6" SD_2="15.3" SE="3.5747127756746315" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" WEIGHT="3.9548149087108535"/>
<CONT_DATA CI_END="2.4304251851503658" CI_START="-8.030425185150374" EFFECT_SIZE="-2.8000000000000043" ESTIMABLE="YES" MEAN_1="40.47" MEAN_2="43.27" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2232" SD_1="14.14" SD_2="10.28" SE="2.668633314901343" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" WEIGHT="6.053710651863984"/>
<CONT_DATA CI_END="8.056604333373022" CI_START="-5.596604333373028" EFFECT_SIZE="1.2299999999999969" ESTIMABLE="YES" MEAN_1="43.12" MEAN_2="41.89" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2233" SD_1="16.58" SD_2="16.09" SE="3.4830253959870734" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" WEIGHT="4.118143451195562"/>
<CONT_DATA CI_END="5.484045729319845" CI_START="-8.284045729319843" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" MEAN_1="49.5" MEAN_2="50.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2234" SD_1="18.4" SD_2="18.1" SE="3.5123327691836774" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" WEIGHT="4.064956684229287"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.7111862501289268" CI_START="-4.548813749871071" DF="0" EFFECT_SIZE="-2.629999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.007222611157625334" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="14.352356220767446" Z="2.686402095923428">
<NAME>BPRS</NAME>
<CONT_DATA CI_END="-0.7111862501289268" CI_START="-4.548813749871071" EFFECT_SIZE="-2.629999999999999" ESTIMABLE="YES" MEAN_1="19.48" MEAN_2="22.11" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2236" SD_1="5.08" SD_2="3.54" SE="0.9790045965162779" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" WEIGHT="14.352356220767446"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.269405538503917" CI_START="-5.669405538503908" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.1999999999999957" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.598725071816365" Q="0.0" RANDOM="YES" SCALE="7.7239665777456175" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="50" TOTAL_2="50" UNITS="" WEIGHT="100.0" Z="0.5262348115842157">
<NAME>Global state: 2b. Average endpoint scale score (medium term, 12 to 24 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.269405538503917" CI_START="-5.669405538503908" DF="0" EFFECT_SIZE="-1.1999999999999957" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.598725071816365" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.5262348115842157">
<NAME>PANSS</NAME>
<CONT_DATA CI_END="3.269405538503917" CI_START="-5.669405538503908" EFFECT_SIZE="-1.1999999999999957" ESTIMABLE="YES" MEAN_1="38.6" MEAN_2="39.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2235" SD_1="11.2" SD_2="11.6" SE="2.2803508501982757" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.849321013613993E-33" CI_END="0.6095627155006529" CI_START="-0.4095627155006527" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1000000000000001" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2013-11-04 16:57:44 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.7005067790403103" Q="0.0" RANDOM="YES" SCALE="1.91" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="54" TOTAL_2="54" UNITS="" WEIGHT="100.0" Z="0.3846364588536198">
<NAME>Global state: 3. Average endpoint SI score (CGI, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.849321013613993E-33" CI_END="0.6095627155006529" CI_START="-0.4095627155006527" DF="0" EFFECT_SIZE="0.1000000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-002.04.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.7005067790403103" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0" Z="0.3846364588536198">
<NAME>up to 12 weeks -short term</NAME>
<CONT_DATA CI_END="0.6095627155006529" CI_START="-0.4095627155006527" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="2.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="807" SD_1="1.4" SD_2="1.3" SE="0.259985754595502" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="7.188563385975751" CI_END="3.3282887386833564" CI_START="0.4819513882431317" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2665201846328489" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.5222209955566169" LOG_CI_START="-0.31699676442182173" LOG_EFFECT_SIZE="0.10261211556739766" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5164317054920777" P_Q="0.5958272239853333" P_Z="0.6317294367778624" Q="1.8886932494322652" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="401" TOTAL_2="398" WEIGHT="400.0" Z="0.4792940771289881">
<NAME>Mental state: 2a. Specific - binary outcomes</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.3056686650903195" CI_END="6.268036146810761" CI_START="0.2674403851868783" DF="4" EFFECT_SIZE="1.2947300882687274" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" I2="24.608937110626997" ID="CMP-002.05.01" LOG_CI_END="0.7971314923139723" LOG_CI_START="-0.5727730109128881" LOG_EFFECT_SIZE="0.11217924070054208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.25734688196068345" P_Z="0.7482130480324629" STUDIES="5" TAU2="0.7967714219696472" TOTAL_1="213" TOTAL_2="210" WEIGHT="100.0" Z="0.32099649438074973">
<NAME>agitation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="131.2766945785389" CI_START="0.3732574175280195" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1181876330635214" LOG_CI_START="-0.42799155303500774" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="867" O_E="0.0" SE="1.4956382577045184" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="2.2369337979094075" WEIGHT="21.34432434858379"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="841" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="18.963069145007005"/>
<DICH_DATA CI_END="161.13031491754117" CI_START="0.5026987009952284" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2071772558931313" LOG_CI_START="-0.2986922370144813" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.4719601443879746" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.166666666666667" WEIGHT="21.850427191103343"/>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="932" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="18.947816472342403"/>
<DICH_DATA CI_END="8.005255503084177" CI_START="0.01387977074164633" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="18.894362842963464"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0496621318405908" CI_END="9.350582290312877" CI_START="0.5074894470742446" DF="1" EFFECT_SIZE="2.1783759630360193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.9708386566046671" LOG_CI_START="-0.2945729842030732" LOG_EFFECT_SIZE="0.33813283620079687" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8236522367914634" P_Z="0.29489175455944605" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="84" WEIGHT="99.99999999999999" Z="1.0474507418327672">
<NAME>anxiety (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="10.308519609286225" CI_START="0.3880285580867189" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0131963013959688" LOG_CI_START="-0.41113631006800627" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.7" WEIGHT="78.92976588628761"/>
<DICH_DATA CI_END="71.69609429811867" CI_START="0.1255298505184566" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8554954977741351" LOG_CI_START="-0.9012529883348099" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.6193277068654826" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="2.6222222222222222" WEIGHT="21.07023411371237"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.005255503084177" CI_START="0.01387977074164633" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.05.03" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.49815579659730713" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0" Z="0.6773943343281656">
<NAME>depression (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="8.005255503084177" CI_START="0.01387977074164633" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.99146782835324" CI_START="0.013903717501920699" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.05.04" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.497922686342418" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6777618841839292">
<NAME>agitation (medium term, 12 to 26 weeks)</NAME>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1212" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="21.90777975315945" CI_END="0.3184346762982" CI_START="-1.9874039251455886" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8344846244236943" ESTIMABLE="YES" I2="68.04788034720639" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0026350887163894" P_Q="0.3551729566543832" P_Z="0.1560084577037372" Q="0.8548892104222019" RANDOM="YES" SCALE="11.874283346710302" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="1.8340472146085238" TOTALS="YES" TOTAL_1="343" TOTAL_2="340" UNITS="" WEIGHT="99.99999999999997" Z="1.418624710765773">
<NAME>Mental state: 3. Specific - average endpoint positive score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="20.252556690866545" CI_END="0.4071583626754969" CI_START="-2.3385336972207407" DF="6" EFFECT_SIZE="-0.965687667272622" ESTIMABLE="YES" I2="70.37411082667964" ID="CMP-002.06.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.002496764904076465" P_Z="0.16799395905034914" STUDIES="7" TAU2="2.395900995393569" TOTAL_1="293" TOTAL_2="290" WEIGHT="84.41382936880105" Z="1.3786783127022377">
<NAME>by up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.1288475491448944" CI_START="-1.728847549144892" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="10.8" MEAN_2="10.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="908" SD_1="4.5" SD_2="4.3" SE="0.9841239759298621" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="12.346637557376454"/>
<CONT_DATA CI_END="-2.4580362282613257" CI_START="-6.521963771738674" EFFECT_SIZE="-4.49" ESTIMABLE="YES" MEAN_1="11.39" MEAN_2="15.88" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1993" SD_1="4.02" SD_2="5.18" SE="1.0367352603244475" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="11.8953641205871"/>
<CONT_DATA CI_END="1.541589678702075" CI_START="-3.141589678702073" EFFECT_SIZE="-0.7999999999999989" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="12.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="894" SD_1="5.1" SD_2="4.1" SE="1.1947105646696747" STUDY_ID="STD-Li-2007b" TOTAL_1="30" TOTAL_2="30" WEIGHT="10.609628096924322"/>
<CONT_DATA CI_END="2.367802144855565" CI_START="-1.3678021448555648" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="12.5" MEAN_2="12.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="892" SD_1="6.0" SD_2="4.3" SE="0.9529777891780409" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" WEIGHT="12.618284420657828"/>
<CONT_DATA CI_END="1.9817690663018288" CI_START="-2.3817690663018274" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="11.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="746" SD_1="4.9" SD_2="4.4" SE="1.1131679375291301" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" WEIGHT="11.259321385379526"/>
<CONT_DATA CI_END="-0.7036809208340746" CI_START="-3.8563190791659276" EFFECT_SIZE="-2.280000000000001" ESTIMABLE="YES" MEAN_1="12.43" MEAN_2="14.71" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="907" SD_1="4.53" SD_2="2.72" SE="0.8042592065975346" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" WEIGHT="13.947483754412616"/>
<CONT_DATA CI_END="2.5187054591800573" CI_START="-1.6187054591800587" EFFECT_SIZE="0.4499999999999993" ESTIMABLE="YES" MEAN_1="11.43" MEAN_2="10.98" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="721" SD_1="5.03" SD_2="4.87" SE="1.055481363687161" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" WEIGHT="11.737110033463217"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.989455814474704E-34" CI_END="1.1177040300450407" CI_START="-1.31770403004504" DF="0" EFFECT_SIZE="-0.09999999999999966" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-002.06.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.8721282959001613" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="15.586170631198932" Z="0.16095569499491205">
<NAME>from 12-26 weeks - medium term</NAME>
<CONT_DATA CI_END="1.1177040300450407" CI_START="-1.31770403004504" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="9.6" MEAN_2="9.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1192" SD_1="3.3" SD_2="2.9" SE="0.6212889826803627" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="15.586170631198932"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.220879403244199" CI_END="0.21344146907721595" CI_START="-1.1748946873891712" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.48072660915597765" ESTIMABLE="YES" I2="3.55061381079032" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.398907743304482" P_Q="0.3767440830505592" P_Z="0.17468018456636716" Q="0.781299374708217" RANDOM="YES" SCALE="10.944737015892745" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.03227622459008808" TOTALS="YES" TOTAL_1="273" TOTAL_2="270" UNITS="" WEIGHT="100.0" Z="1.357318018359325">
<NAME>Mental state: 4. Specific - average endpoint negative score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.402886468910818" CI_END="0.17179335076848268" CI_START="-1.5225701799583455" DF="5" EFFECT_SIZE="-0.6753884145949315" ESTIMABLE="YES" I2="7.456874602660995" ID="CMP-002.07.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3687123425538005" P_Z="0.11816595033272013" STUDIES="6" TAU2="0.08467706964429622" TOTAL_1="223" TOTAL_2="220" WEIGHT="70.7789202777912" Z="1.5625182485057747">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="0.7532483384403217" CI_START="-3.7532483384403217" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="10.4" MEAN_2="11.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="880" SD_1="3.4" SD_2="5.3" SE="1.149637624065369" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="9.26472960019184"/>
<CONT_DATA CI_END="2.216610288318614" CI_START="-1.6166102883186126" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="11.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="908" SD_1="4.8" SD_2="3.9" SE="0.9778803607803973" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="12.689511385292143"/>
<CONT_DATA CI_END="2.536940755725916" CI_START="-2.9369407557259146" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="13.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="894" SD_1="5.7" SD_2="5.1" SE="1.396424004376894" STUDY_ID="STD-Li-2007b" TOTAL_1="30" TOTAL_2="30" WEIGHT="6.328035732855402"/>
<CONT_DATA CI_END="2.028555019586901" CI_START="-2.428555019586903" EFFECT_SIZE="-0.20000000000000107" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="12.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="746" SD_1="5.0" SD_2="4.5" SE="1.137038760490223" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" WEIGHT="9.46615268300177"/>
<CONT_DATA CI_END="-0.4578593941450422" CI_START="-3.762140605854957" EFFECT_SIZE="-2.1099999999999994" ESTIMABLE="YES" MEAN_1="10.21" MEAN_2="12.32" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="907" SD_1="4.1" SD_2="3.67" SE="0.8429443698388498" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" WEIGHT="16.8866235146059"/>
<CONT_DATA CI_END="1.7414066962165315" CI_START="-1.6414066962165301" EFFECT_SIZE="0.05000000000000071" ESTIMABLE="YES" MEAN_1="11.22" MEAN_2="11.17" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="721" SD_1="3.79" SD_2="4.29" SE="0.8629784575421441" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" WEIGHT="16.143867361844148"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.2349328531606762" CI_START="-1.2349328531606762" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="29.2210797222088" Z="0.0">
<NAME>from 12-26 weeks - medium term</NAME>
<CONT_DATA CI_END="1.2349328531606762" CI_START="-1.2349328531606762" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="829" SD_1="3.1" SD_2="3.2" SE="0.6300793600809347" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="29.2210797222088"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="84.1209551270324" CI_END="0.42865359506835543" CI_START="-3.805243146716511" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.6882947758240776" ESTIMABLE="YES" I2="88.11235561353429" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="7.760458942129844E-14" P_Q="0.37885542606299916" P_Z="0.11802963583125398" Q="0.7744127507098879" RANDOM="YES" SCALE="17.75651261557923" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="11.104835165808113" TOTALS="YES" TOTAL_1="467" TOTAL_2="464" UNITS="" WEIGHT="100.0" Z="1.5630976179675826">
<NAME>Mental state: 5. Specific - average endpoint general pathological score (PANSS, high=poor )</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="83.2892606238126" CI_END="0.5406277503965975" CI_START="-4.191477660813597" DF="9" EFFECT_SIZE="-1.8254249552084993" ESTIMABLE="YES" I2="89.19428515442137" ID="CMP-002.08.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.574918139293004E-14" P_Z="0.1305020960152973" STUDIES="10" TAU2="12.782508310970918" TOTAL_1="417" TOTAL_2="414" WEIGHT="90.4931624756176" Z="1.5121248821776851">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="1.4087498876603766" CI_START="-4.208749887660374" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="21.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="880" SD_1="5.5" SD_2="5.6" SE="1.4330619898199333" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="8.865799498306917"/>
<CONT_DATA CI_END="1.7583447328271897" CI_START="-4.158344732827196" EFFECT_SIZE="-1.2000000000000028" ESTIMABLE="YES" MEAN_1="25.4" MEAN_2="26.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1188" SD_1="6.8" SD_2="6.7" SE="1.5093872929106036" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="8.71702133696922"/>
<CONT_DATA CI_END="1.668338776684242" CI_START="-1.2683387766842433" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="20.9" MEAN_2="20.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="908" SD_1="3.3" SD_2="3.4" SE="0.7491662031885848" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="9.999981766526426"/>
<CONT_DATA CI_END="-10.154419066933462" CI_START="-15.385580933066537" EFFECT_SIZE="-12.77" ESTIMABLE="YES" MEAN_1="18.97" MEAN_2="31.74" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1993" SD_1="6.35" SD_2="5.56" SE="1.33450458972609" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="9.05346996581971"/>
<CONT_DATA CI_END="2.0521114824958855" CI_START="-2.452111482495884" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="23.8" MEAN_2="24.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="894" SD_1="4.5" SD_2="4.4" SE="1.1490575848639326" STUDY_ID="STD-Li-2007b" TOTAL_1="30" TOTAL_2="30" WEIGHT="9.389058905147769"/>
<CONT_DATA CI_END="0.4041416837566234" CI_START="-5.60414168375662" EFFECT_SIZE="-2.599999999999998" ESTIMABLE="YES" MEAN_1="24.8" MEAN_2="27.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="892" SD_1="10.0" SD_2="6.4" SE="1.532753513560916" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" WEIGHT="8.670966098891212"/>
<CONT_DATA CI_END="2.96586168336318" CI_START="-2.5658616833631744" EFFECT_SIZE="0.20000000000000284" ESTIMABLE="YES" MEAN_1="24.1" MEAN_2="23.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="746" SD_1="6.1" SD_2="5.7" SE="1.411179850844169" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" WEIGHT="8.907932925413197"/>
<CONT_DATA CI_END="2.135280999587572" CI_START="-2.155280999587568" EFFECT_SIZE="-0.00999999999999801" ESTIMABLE="YES" MEAN_1="17.67" MEAN_2="17.68" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="907" SD_1="4.21" SD_2="5.71" SE="1.0945512348743511" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" WEIGHT="9.482386398315512"/>
<CONT_DATA CI_END="4.1092460450148" CI_START="-2.649246045014799" EFFECT_SIZE="0.7300000000000004" ESTIMABLE="YES" MEAN_1="20.47" MEAN_2="19.74" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="721" SD_1="8.66" SD_2="7.47" SE="1.7241368064259655" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" WEIGHT="8.287038231967228"/>
<CONT_DATA CI_END="1.2461377516844765" CI_START="-3.846137751684478" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="25.4" MEAN_2="26.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="831" SD_1="6.8" SD_2="6.7" SE="1.2990737440933031" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" WEIGHT="9.1195073482604"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7167611033032566" CI_START="-2.516761103303261" DF="0" EFFECT_SIZE="-0.40000000000000213" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7111065483683545" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="9.506837524382409" Z="0.3703703703703723">
<NAME>from 12-26 weeks - medium term</NAME>
<CONT_DATA CI_END="1.7167611033032566" CI_START="-2.516761103303261" EFFECT_SIZE="-0.40000000000000213" ESTIMABLE="YES" MEAN_1="19.7" MEAN_2="20.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="829" SD_1="5.4" SD_2="5.4" SE="1.08" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="9.506837524382409"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-002.09" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES">
<NAME>Mental state: 6. average scores of various scales (high=poor, skewed data)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-002.09.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>BPRS endpoint scale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3005" STUDY_ID="STD-Zhu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>23.8 </P>
</TD>
<TD>
<P>14.3</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>23.9 </P>
</TD>
<TD>
<P>13.7</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-002.09.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="1">
<NAME>PANSS general pathology subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3006" STUDY_ID="STD-Zhu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>19.4</P>
</TD>
<TD>
<P>11.7</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>19.5</P>
</TD>
<TD>
<P>11.3</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-002.09.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="4">
<NAME>PANSS negative subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3007" STUDY_ID="STD-Dai-2005">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.8</P>
</TD>
<TD>
<P>7.1</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>11.7</P>
</TD>
<TD>
<P>7. 6</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3008" STUDY_ID="STD-Ge-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.88</P>
</TD>
<TD>
<P>3.54</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>15.12</P>
</TD>
<TD>
<P>8.15</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3009" STUDY_ID="STD-Wei-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.9</P>
</TD>
<TD>
<P>7.2</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>11.8</P>
</TD>
<TD>
<P>7.6</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3010" STUDY_ID="STD-Zhu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.9</P>
</TD>
<TD>
<P>8.1</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>11.4</P>
</TD>
<TD>
<P>7.4</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-002.09.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" STUDIES="4">
<NAME>PANSS positive subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3011" STUDY_ID="STD-Chen-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.1</P>
</TD>
<TD>
<P>5.1</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>10.7</P>
</TD>
<TD>
<P>6.2</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3012" STUDY_ID="STD-Dai-2005">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.3</P>
</TD>
<TD>
<P>6.9</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>12.6</P>
</TD>
<TD>
<P>7.1</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3013" STUDY_ID="STD-Wei-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12 .4</P>
</TD>
<TD>
<P>6.9</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>12.5</P>
</TD>
<TD>
<P>7.1</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3014" STUDY_ID="STD-Zhu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.8</P>
</TD>
<TD>
<P>8.3</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>14.3</P>
</TD>
<TD>
<P>7.9</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-002.09.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" STUDIES="1">
<NAME>PANSS total endpoint scale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3015" STUDY_ID="STD-Zhu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>44.2 </P>
</TD>
<TD>
<P>23.6</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Quetiapine</P>
</TD>
<TD>
<P>4.38</P>
</TD>
<TD>
<P>24.2</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="4.2244380946382085" CI_END="2.475868855937966" CI_START="0.38686393531234997" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9786850202825459" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="0.39372763685418904" LOG_CI_START="-0.41244175470594147" LOG_EFFECT_SIZE="-0.009357058925876191" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.7535942299021386" P_Q="0.7549425949480385" P_Z="0.9637104658940885" Q="2.642206237112385" RANDOM="YES" SCALE="204.1915759763056" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="360" TOTAL_2="360" WEIGHT="600.0" Z="0.04549787845565574">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.03337949482296054" CI_END="2.871545238743199" CI_START="0.22236083006617507" DF="1" EFFECT_SIZE="0.7990739533106498" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" I2="0.0" ID="CMP-002.10.01" LOG_CI_END="0.4581156626097948" LOG_CI_START="-0.6529417134224388" LOG_EFFECT_SIZE="-0.09741302540632199" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8550330268811877" P_Z="0.7310843522142079" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="84" WEIGHT="100.0" Z="0.3436834596306884">
<NAME>any reason</NAME>
<DICH_DATA CI_END="3.1930090641636517" CI_START="0.17616611437566843" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5042001513959027" LOG_CI_START="-0.7540776246125026" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="0.7391185942027817" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.5462962962962963" WEIGHT="77.96863330843914"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="744" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="22.03136669156087"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.005255503084177" CI_START="0.01387977074164633" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.10.02" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.49815579659730713" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0" Z="0.6773943343281656">
<NAME>no effect</NAME>
<DICH_DATA CI_END="8.005255503084177" CI_START="0.01387977074164633" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="70.82882080128432" CI_START="0.12706691849706483" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.10.03" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.6810488185180525">
<NAME>early discharge</NAME>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="744" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.482647982032752" CI_END="19.23940048197515" CI_START="0.09457091158176886" DF="1" EFFECT_SIZE="1.3488838503989562" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="32.55310686566531" ID="CMP-002.10.04" LOG_CI_END="1.284191534883364" LOG_CI_START="-1.0242424247204645" LOG_EFFECT_SIZE="0.12997455508144973" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2233610201211782" P_Z="0.8253194474744988" STUDIES="2" TAU2="1.1983635135515056" TOTAL_1="84" TOTAL_2="84" WEIGHT="100.00000000000003" Z="0.2207084554500127">
<NAME>early treatment termination</NAME>
<DICH_DATA CI_END="101.769506068854" CI_START="0.24565315255716974" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.00761766670477" LOG_CI_START="-0.6096776580327322" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="1.5374122295716148" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.3636363636363638" WEIGHT="51.619787591021435"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="744" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="48.380212408978586"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="101.769506068854" CI_START="0.24565315255716974" DF="0" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.10.05" LOG_CI_END="2.00761766670477" LOG_CI_START="-0.6096776580327322" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.29516940481750475" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0" Z="1.0468486470167826">
<NAME>violation of test scheme</NAME>
<DICH_DATA CI_END="101.769506068854" CI_START="0.24565315255716974" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.00761766670477" LOG_CI_START="-0.6096776580327322" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="1.5374122295716148" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.3636363636363638" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.005255503084177" CI_START="0.01387977074164633" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.10.06" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.49815579659730713" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0" Z="0.6773943343281656">
<NAME>withdrew informed consent</NAME>
<DICH_DATA CI_END="8.005255503084177" CI_START="0.01387977074164633" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="53.62786115460262" CI_END="4.5485146911732" CI_START="3.0579292478015327" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="3.8032219694873666" ESTIMABLE="YES" I2="88.81178575684247" I2_Q="88.81178575684247" ID="CMP-002.11" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="8.768330506114808E-10" P_Q="8.768330506114808E-10" P_Z="1.4983575638610623E-23" Q="53.62786115460262" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="8.853609576142647" TOTALS="SUB" TOTAL_1="350" TOTAL_2="350" UNITS="" WEIGHT="700.0" Z="10.001678358733413">
<NAME>Quality of life: Average score (medium term, 12 to 24 weeks, WHO-QOL-100, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours quetiapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.8894120278624738" CI_START="1.3105879721375255" DF="0" EFFECT_SIZE="2.5999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="7.7463057923326E-5" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="3.95211635201813">
<NAME>Total score</NAME>
<CONT_DATA CI_END="3.8894120278624738" CI_START="1.3105879721375255" EFFECT_SIZE="2.5999999999999996" ESTIMABLE="YES" MEAN_1="16.2" MEAN_2="13.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1194" SD_1="2.0" SD_2="4.2" SE="0.657875368135941" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.624288742204638" CI_START="4.375711257795362" DF="0" EFFECT_SIZE="6.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="4.4882038185708874E-13" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="7.239959005859287">
<NAME>Physical health</NAME>
<CONT_DATA CI_END="7.624288742204638" CI_START="4.375711257795362" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="43.4" MEAN_2="37.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1194" SD_1="3.5" SD_2="4.7" SE="0.8287339742040265" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="12.281185174936626" CI_START="5.918814825063363" DF="0" EFFECT_SIZE="9.099999999999994" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="2.063249993307649E-8" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="5.606612403400807">
<NAME>Mental health</NAME>
<CONT_DATA CI_END="12.281185174936626" CI_START="5.918814825063363" EFFECT_SIZE="9.099999999999994" ESTIMABLE="YES" MEAN_1="66.3" MEAN_2="57.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1194" SD_1="10.6" SD_2="4.4" SE="1.6230834852218785" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.87389612178179" CI_START="3.326103878218198" DF="0" EFFECT_SIZE="5.599999999999994" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="1.3869640589809428E-6" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="4.826868830236535">
<NAME>Social function</NAME>
<CONT_DATA CI_END="7.87389612178179" CI_START="3.326103878218198" EFFECT_SIZE="5.599999999999994" ESTIMABLE="YES" MEAN_1="38.3" MEAN_2="32.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1194" SD_1="5.7" SD_2="5.9" SE="1.1601724009818541" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.6905925874683152" CI_START="-1.490592587468316" DF="0" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.9019311064082322" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.1232222506241932">
<NAME>Spiritual pillar</NAME>
<CONT_DATA CI_END="1.6905925874683152" CI_START="-1.490592587468316" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="10.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1201" SD_1="3.8" SD_2="4.3" SE="0.8115417426109393" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="17.137954873685636" CI_START="5.8620451263143645" DF="0" EFFECT_SIZE="11.5" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="6.392580144882524E-5" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="3.99783012230392">
<NAME>Environmental area</NAME>
<CONT_DATA CI_END="17.137954873685636" CI_START="5.8620451263143645" EFFECT_SIZE="11.5" ESTIMABLE="YES" MEAN_1="101.3" MEAN_2="89.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1194" SD_1="12.3" SD_2="16.2" SE="2.8765604460883485" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.348656368111225" CI_START="3.051343631888766" DF="0" EFFECT_SIZE="6.199999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.07" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="1.1368757375272747E-4" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="3.8593530965202656">
<NAME>Independence</NAME>
<CONT_DATA CI_END="9.348656368111225" CI_START="3.051343631888766" EFFECT_SIZE="6.199999999999996" ESTIMABLE="YES" MEAN_1="53.4" MEAN_2="47.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1194" SD_1="5.0" SD_2="10.2" SE="1.6064868502418561" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.597527394797847" CI_END="1.1973027869075894" CI_START="0.6591402272685571" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8883639068937601" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="67" I2="0.0" I2_Q="0.0" ID="CMP-002.12" LOG_CI_END="0.07820399339250138" LOG_CI_START="-0.18102218259797834" LOG_EFFECT_SIZE="-0.051409094602738487" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.9857447768907961" P_Q="0.5603446820752336" P_Z="0.43692846496375737" Q="3.924444836434109" RANDOM="YES" SCALE="230.465538087146" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="681" TOTAL_2="681" WEIGHT="100.0" Z="0.7773904276000309">
<NAME>Adverse effects:1. At least one adverse effect</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.1420420545287556" CI_END="1.3692759297466026" CI_START="0.6989416805954081" DF="2" EFFECT_SIZE="0.9782862666601889" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="45" I2="0.0" ID="CMP-002.12.01" LOG_CI_END="0.13649097383981554" LOG_CI_START="-0.15555906009443757" LOG_EFFECT_SIZE="-0.009534043127311032" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9314423204309745" P_Z="0.8981751003625457" STUDIES="3" TAU2="0.0" TOTAL_1="129" TOTAL_2="129" WEIGHT="78.78493564910559" Z="0.12796698500495934">
<NAME>non-specific</NAME>
<DICH_DATA CI_END="1.669861922264878" CI_START="0.5216665518844816" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" LOG_CI_END="0.22268056164002456" LOG_CI_START="-0.28260700839491093" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="0.29680841985233186" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.08809523809523812" WEIGHT="26.319672262548863"/>
<DICH_DATA CI_END="2.032796853955517" CI_START="0.5773381185766008" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.3080939799098768" LOG_CI_START="-0.2385697673914529" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="765" O_E="0.0" SE="0.3211129911939925" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.1031135531135531" WEIGHT="22.486256409033764"/>
<DICH_DATA CI_END="1.6289182775106663" CI_START="0.5475875131102975" EFFECT_SIZE="0.9444444444444444" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="18" LOG_CI_END="0.21189929639171756" LOG_CI_START="-0.2615464638417819" LOG_EFFECT_SIZE="-0.024823583725032152" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.27810438315546776" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.07734204793028322" WEIGHT="29.979006977522968"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.005255503084177" CI_START="0.01387977074164633" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.12.02" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.49815579659730713" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="0.8815097606038009" Z="0.6773943343281656">
<NAME>abnormal urinary test result</NAME>
<DICH_DATA CI_END="8.005255503084177" CI_START="0.01387977074164633" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2416" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="0.8815097606038009"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.4399975095672386" CI_END="1.1296821360263316" CI_START="0.2597399528041605" DF="7" EFFECT_SIZE="0.5416858727114661" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="19" I2="0.0" ID="CMP-002.12.03" LOG_CI_END="0.052956261191964074" LOG_CI_START="-0.5854612427163225" LOG_EFFECT_SIZE="-0.2662524907621792" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9843145619322019" P_Z="0.10208912495323001" STUDIES="8" TAU2="0.0" TOTAL_1="329" TOTAL_2="329" WEIGHT="16.487246648647744" Z="1.6348088499870508">
<NAME>liver function abnormal</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2412" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.8856908345671394"/>
<DICH_DATA CI_END="2.288930488946035" CI_START="0.15727869489202628" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35963260406574094" LOG_CI_START="-0.8033301032984537" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2413" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="4.968509559766878"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2414" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="1.5990605479709492"/>
<DICH_DATA CI_END="4.038645960707643" CI_START="0.009904309609993965" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6062357833382839" LOG_CI_START="-2.0041757920103214" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2408" O_E="0.0" SE="1.5333686811054679" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.351219512195122" WEIGHT="0.9861426304654871"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2409" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="0.9794799547647539"/>
<DICH_DATA CI_END="6.706930006003608" CI_START="0.1490995133548233" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2410" O_E="0.0" SE="0.9710083124552245" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.9428571428571428" WEIGHT="2.459161297258354"/>
<DICH_DATA CI_END="5.352095533713907" CI_START="0.0467106759259435" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7285238568887824" LOG_CI_START="-1.330583848216745" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2411" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="1.5848916570395615"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2415" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="3.024310166814622"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="28.32201916736412" CI_START="0.3177739534323468" DF="1" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-002.12.04" LOG_CI_END="1.4521242123646438" LOG_CI_START="-0.4978817029253189" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.33750056113905935" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="94" WEIGHT="1.7672005951709404" Z="0.9591155269598718">
<NAME>stuffy nose</NAME>
<DICH_DATA CI_END="71.50812704867249" CI_START="0.12585982001561988" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8543554030852154" LOG_CI_START="-0.9001128936458906" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2407" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.8856908345671394"/>
<DICH_DATA CI_END="72.04729952775764" CI_START="0.12491793667481706" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8576177072572597" LOG_CI_START="-0.9033751978179345" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2406" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="0.8815097606038009"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.362407364476699" CI_START="0.06509396452487991" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.12.05" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="1.1934165119047893" Z="0.0">
<NAME>sweating</NAME>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2417" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="1.1934165119047893"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.9453474498525" CI_START="0.01398442444617999" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.12.06" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.4971385617323206" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.8856908345671394" Z="0.6789989027057508">
<NAME>urine routine abnormal</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2426" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.8856908345671394"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.850683174907156" CI_END="0.7684092693186053" CI_START="0.31830153635975833" CI_STUDY="95" CI_TOTAL="95" DF="20" EFFECT_MEASURE="RR" EFFECT_SIZE="0.49455621619507667" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="64" I2="0.0" I2_Q="14.171788689132722" ID="CMP-002.13" LOG_CI_END="-0.1144074048857725" LOG_CI_START="-0.49716126514602493" LOG_EFFECT_SIZE="-0.3057843350158987" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.8836982308877168" P_Q="0.32136528922822627" P_Z="0.0017382473561625843" Q="3.495354213003563" RANDOM="YES" SCALE="298.16" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="875" TOTAL_2="869" WEIGHT="400.0" Z="3.131653764433265">
<NAME>Adverse effects: 2. Cardiac effects (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.455665753033856" CI_END="2.2633541875607737" CI_START="0.4019135057594612" DF="5" EFFECT_SIZE="0.9537675902954071" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" I2="0.0" ID="CMP-002.13.01" LOG_CI_END="0.3547525211076038" LOG_CI_START="-0.39586739968441176" LOG_EFFECT_SIZE="-0.02055743928840397" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6301064369524679" P_Z="0.9145064232713104" STUDIES="6" TAU2="0.0" TOTAL_1="264" TOTAL_2="264" WEIGHT="99.99999999999999" Z="0.10735617188823508">
<NAME>abnormal ECG</NAME>
<DICH_DATA CI_END="4.914953233364638" CI_START="0.4577866549626788" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6915193898002392" LOG_CI_START="-0.33933687168887666" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="0.6055300708194983" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.3666666666666666" WEIGHT="53.02051546669377"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="7.426165365055556"/>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="9.969669574933869"/>
<DICH_DATA CI_END="2.7072889297538767" CI_START="0.007538228757564284" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4325346074150209" LOG_CI_START="-2.1227306874435348" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="901" O_E="0.0" SE="1.5009754829671218" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" VAR="2.2529274004683844" WEIGHT="8.629153192898842"/>
<DICH_DATA CI_END="72.04729952775764" CI_START="0.12491793667481706" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8576177072572597" LOG_CI_START="-0.9033751978179345" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2240" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="7.391108722891641"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="723" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="13.563387677526313"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9301732404595577" CI_END="1.3212821862041688" CI_START="0.2042422305678108" DF="3" EFFECT_SIZE="0.5194820698733047" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" ID="CMP-002.13.02" LOG_CI_END="0.12099557978235737" LOG_CI_START="-0.6898544551661939" LOG_EFFECT_SIZE="-0.2844294376919182" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8181410278113945" P_Z="0.16912222656285364" STUDIES="4" TAU2="0.0" TOTAL_1="174" TOTAL_2="174" WEIGHT="100.0" Z="1.3750297342085234">
<NAME>blood pressure- decrease</NAME>
<DICH_DATA CI_END="2.577129902321556" CI_START="0.0970071395216797" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41113631006800627" LOG_CI_START="-1.0131963013959688" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2402" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.7" WEIGHT="32.40844873378122"/>
<DICH_DATA CI_END="3.7781065604215764" CI_START="0.11763682080868876" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.57727420291097" LOG_CI_START="-0.9294567210223325" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2403" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="28.96074142167684"/>
<DICH_DATA CI_END="2.6791162158885493" CI_START="0.0076174983168983594" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4279915530350077" LOG_CI_START="-2.1181876330635214" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2404" O_E="0.0" SE="1.4956382577045184" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.2369337979094075" WEIGHT="10.141522352985431"/>
<DICH_DATA CI_END="3.832499842571054" CI_START="0.1159672440185376" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5834821456867457" LOG_CI_START="-0.9356646637981083" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2405" O_E="0.0" SE="0.8923543557893895" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.7962962962962963" WEIGHT="28.489287491556514"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.1863107879818529" CI_END="1.3873567747926832" CI_START="0.0815095238107181" DF="2" EFFECT_SIZE="0.33627784653307935" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-002.13.03" LOG_CI_END="0.14218815927014722" LOG_CI_START="-1.0887916440601104" LOG_EFFECT_SIZE="-0.47330174239498163" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9110519714006186" P_Z="0.1317644008133609" STUDIES="3" TAU2="0.0" TOTAL_1="114" TOTAL_2="111" WEIGHT="100.0" Z="1.5071804856660829">
<NAME>QTc prolongation</NAME>
<DICH_DATA CI_END="2.1398561589712335" CI_START="0.029207570676174695" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.33038458107600793" LOG_CI_START="-1.5345045637319326" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2238" O_E="0.0" SE="1.0954451150103324" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.2000000000000002" WEIGHT="43.570827988731835"/>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="19.95126950907406"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="36.477902502194105"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.817300330179422" CI_END="0.6921029661541194" CI_START="0.1777901238709369" DF="7" EFFECT_SIZE="0.3507835117048459" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="33" I2="0.0" ID="CMP-002.13.04" LOG_CI_END="-0.15982928949410014" LOG_CI_START="-0.7500923674798783" LOG_EFFECT_SIZE="-0.45496082848698916" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6822476548472782" P_Z="0.002516188537509814" STUDIES="8" TAU2="0.0" TOTAL_1="323" TOTAL_2="320" WEIGHT="100.0" Z="3.0213878233884333">
<NAME>tachycardia</NAME>
<DICH_DATA CI_END="2.1398561589712335" CI_START="0.029207570676174695" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.33038458107600793" LOG_CI_START="-1.5345045637319326" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2240" O_E="0.0" SE="1.0954451150103324" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="1.2000000000000002" WEIGHT="10.018096121280239"/>
<DICH_DATA CI_END="3.070127994092063" CI_START="0.036191035463317964" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4871564816560677" LOG_CI_START="-1.4413989910953926" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2241" O_E="0.0" SE="1.132843031197762" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.2833333333333334" WEIGHT="9.367570399119185"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2242" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="8.29083816933537"/>
<DICH_DATA CI_END="1.0095631417172248" CI_START="0.08914747010960969" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.004133486471151205" LOG_CI_START="-1.0498909770318265" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2243" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.3833333333333333" WEIGHT="31.360996553572924"/>
<DICH_DATA CI_END="0.9557155547622298" CI_START="0.051670934728763" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.019671345567648324" LOG_CI_START="-1.2867536819830392" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2244" O_E="0.0" SE="0.7442904365691219" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.553968253968254" WEIGHT="21.701090738360634"/>
<DICH_DATA CI_END="2.505014678707804" CI_START="0.007096875690544191" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3988102750588027" LOG_CI_START="-2.1489328018422027" LOG_EFFECT_SIZE="-0.8750612633917001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2245" O_E="0.0" SE="1.4965568949032775" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.2396825396825397" WEIGHT="5.367597921819887"/>
<DICH_DATA CI_END="3.1046620619644876" CI_START="0.03578847194750886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49201433475049966" LOG_CI_START="-1.4462568441898247" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2246" O_E="0.0" SE="1.138550085106622" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.296296296296296" WEIGHT="9.273894695127995"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2247" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="4.61991540138378"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="69.83134046411452" CI_END="1.2101783412024534" CI_START="0.6269111764892336" CI_STUDY="95" CI_TOTAL="95" DF="38" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8710191316182551" ESTIMABLE="YES" EVENTS_1="140" EVENTS_2="170" I2="45.583172616416064" I2_Q="54.237476371281524" ID="CMP-002.14" LOG_CI_END="0.08284937601300814" LOG_CI_START="-0.2027939875476519" LOG_EFFECT_SIZE="-0.0599723057673219" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0012502516091437155" P_Q="0.02546761285478849" P_Z="0.4105027642883038" Q="17.48155338832661" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.5537114324349683" TOTALS="SUB" TOTAL_1="1681" TOTAL_2="1669" WEIGHT="900.0" Z="0.82300920916591">
<NAME>Adverse effects: 3. Central / peripheral nervous system</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.66576983916224" CI_END="2.4867386559019597" CI_START="0.31071121123066087" DF="5" EFFECT_SIZE="0.8790094310013992" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" I2="0.0" ID="CMP-002.14.01" LOG_CI_END="0.3956301454373619" LOG_CI_START="-0.5076430760409124" LOG_EFFECT_SIZE="-0.056006465301775256" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5984662784271466" P_Z="0.8079660182662246" STUDIES="6" TAU2="0.0" TOTAL_1="262" TOTAL_2="259" WEIGHT="100.0" Z="0.24305083397296748">
<NAME>blurred vision (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="10.753818798426977"/>
<DICH_DATA CI_END="131.2766945785389" CI_START="0.3732574175280195" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1181876330635214" LOG_CI_START="-0.42799155303500774" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.4956382577045184" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.2369337979094075" WEIGHT="12.585206423496576"/>
<DICH_DATA CI_END="3.7781065604215764" CI_START="0.11763682080868876" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.57727420291097" LOG_CI_START="-0.9294567210223325" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="35.93907268389711"/>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="10.742539291037685"/>
<DICH_DATA CI_END="7.966232699790958" CI_START="0.013947761168717392" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9012529883348099" LOG_CI_START="-1.8554954977741351" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.6193277068654826" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="2.6222222222222222" WEIGHT="10.73603654328282"/>
<DICH_DATA CI_END="21.408382134855636" CI_START="0.18684270370377404" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.330583848216745" LOG_CI_START="-0.7285238568887824" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2240" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="19.24332625985883"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.66718494329318" CI_END="1.217084520605359" CI_START="0.33760452130850765" DF="7" EFFECT_SIZE="0.6410095451480943" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="52" I2="40.002665304247934" ID="CMP-002.14.02" LOG_CI_END="0.08532073891858553" LOG_CI_START="-0.4715917457958276" LOG_EFFECT_SIZE="-0.19313550343862107" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.11204879644252153" P_Z="0.17401393979792407" STUDIES="8" TAU2="0.3228985715001907" TOTAL_1="337" TOTAL_2="334" WEIGHT="100.0" Z="1.3594187283117745">
<NAME>dizziness (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="2.510826009765055" CI_START="0.2765800743435127" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.39981661887899633" LOG_CI_START="-0.558179110974246" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.31666666666666665" WEIGHT="16.732632048685097"/>
<DICH_DATA CI_END="2.510826009765055" CI_START="0.2765800743435127" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.39981661887899633" LOG_CI_START="-0.558179110974246" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.31666666666666665" WEIGHT="16.732632048685097"/>
<DICH_DATA CI_END="0.602566620368426" CI_START="0.002276498674360905" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.21999493006610987" LOG_CI_START="-2.642732598251865" LOG_EFFECT_SIZE="-1.4313637641589874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.4231280990371864" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.025293586269196" WEIGHT="4.557382480802351"/>
<DICH_DATA CI_END="5.579155313499883" CI_START="0.31864640395941085" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.74656845154428" LOG_CI_START="-0.49669097832768017" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="12.498494556163934"/>
<DICH_DATA CI_END="1.3135688446672225" CI_START="0.021146800101531762" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11845283926564747" LOG_CI_START="-1.6747553400329347" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="750" O_E="0.0" SE="1.0533393610436335" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.1095238095238098" WEIGHT="7.4709875684331175"/>
<DICH_DATA CI_END="1.2354513254051973" CI_START="0.019522445543043564" EFFECT_SIZE="0.1553030303030303" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.09182563964149931" LOG_CI_START="-1.7094657799416904" LOG_EFFECT_SIZE="-0.8088200701500956" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.0580874963994966" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="1.119549150036955" WEIGHT="7.419062501600746"/>
<DICH_DATA CI_END="3.644220492043633" CI_START="0.39514623309537067" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5616046459027394" LOG_CI_START="-0.40324215380748973" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="0.5667557862184746" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="0.3212121212121213" WEIGHT="16.614550763490403"/>
<DICH_DATA CI_END="2.3844195633238416" CI_START="0.30812273513092187" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.3773826764055266" LOG_CI_START="-0.5112762556667529" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.5220026556319158" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.27248677248677255" WEIGHT="17.974258032139264"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.419568032228831" CI_END="18.938115916867517" CI_START="0.5240497777962347" DF="4" EFFECT_SIZE="3.1503198945684483" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="12" I2="70.19278124010042" ID="CMP-002.14.03" LOG_CI_END="1.277336770464049" LOG_CI_START="-0.28062745882644324" LOG_EFFECT_SIZE="0.4983546558188029" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.009397679223972943" P_Z="0.20988234456429" STUDIES="5" TAU2="2.9152803113739987" TOTAL_1="218" TOTAL_2="218" WEIGHT="100.0" Z="1.2538890926623267">
<NAME>headache (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="54.31784079453405" CI_START="0.9020977138128584" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7349424978398802" LOG_CI_START="-0.04474641781136677" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="1.0453980786557544" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="1.092857142857143" WEIGHT="20.89524951369544"/>
<DICH_DATA CI_END="54.31784079453405" CI_START="0.9020977138128584" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7349424978398802" LOG_CI_START="-0.04474641781136677" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.0453980786557544" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.092857142857143" WEIGHT="20.89524951369544"/>
<DICH_DATA CI_END="34.23769854353973" CI_START="0.46732113081879495" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5345045637319326" LOG_CI_START="-0.330384581076008" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="1.0954451150103324" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.2000000000000002" WEIGHT="20.351233902554053"/>
<DICH_DATA CI_END="347.688498912777" CI_START="1.2683767262334191" EFFECT_SIZE="21.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="0" LOG_CI_END="2.541190325019388" LOG_CI_START="0.1032482644484501" LOG_EFFECT_SIZE="1.3222192947339193" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.4320592343871992" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="2.050793650793651" WEIGHT="16.864636497437726"/>
<DICH_DATA CI_END="0.8470750171382957" CI_START="0.014574481318140547" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07207812675720042" LOG_CI_START="-1.8364068921214496" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2240" O_E="0.0" SE="1.0363754503432017" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.074074074074074" WEIGHT="20.99363057261734"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.763291226010622" CI_END="5.096912114524386" CI_START="0.8821882611997585" DF="6" EFFECT_SIZE="2.1204801427507527" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="12" I2="22.71319179812268" ID="CMP-002.14.04" LOG_CI_END="0.7073071451629357" LOG_CI_START="-0.05443872544005049" LOG_EFFECT_SIZE="0.3264342098614426" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2559633827790122" P_Z="0.09299166788818199" STUDIES="7" TAU2="0.3166519618393844" TOTAL_1="297" TOTAL_2="294" WEIGHT="100.00000000000001" Z="1.679823466962183">
<NAME>insomnia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="1.9656607751511364" CI_START="0.2861633131773464" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2935085713844867" LOG_CI_START="-0.5433860446010865" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="0.49159604012508745" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.2416666666666666" WEIGHT="35.86024916044207"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="11.332987799304602"/>
<DICH_DATA CI_END="161.85818338602556" CI_START="0.5004380891067964" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2091346617833825" LOG_CI_START="-0.3006496429047325" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="1.4742597242064726" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.1734417344173442" WEIGHT="8.040438461910421"/>
<DICH_DATA CI_END="130.6947820808326" CI_START="0.37491932898816327" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1162582489521014" LOG_CI_START="-0.4260621689235878" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="750" O_E="0.0" SE="1.4933715981492115" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.2301587301587302" WEIGHT="7.861379407605418"/>
<DICH_DATA CI_END="19.7861751948056" CI_START="0.17553369772949146" EFFECT_SIZE="1.8636363636363635" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.296361850177582" LOG_CI_START="-0.7556394983825236" LOG_EFFECT_SIZE="0.2703611758975292" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.2053557497147007" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="1.4528824833702882" WEIGHT="11.314526927318974"/>
<DICH_DATA CI_END="61.30535442136281" CI_START="1.0439544898495545" EFFECT_SIZE="8.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.7874984075379656" LOG_CI_START="0.01868156644592124" LOG_EFFECT_SIZE="0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.0390117682420419" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="1.0795454545454546" WEIGHT="14.33998150561303"/>
<DICH_DATA CI_END="21.408382134855636" CI_START="0.18684270370377404" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.330583848216745" LOG_CI_START="-0.7285238568887824" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2240" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="11.250436737805492"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.371505374180913" CI_END="0.770814928924802" CI_START="0.14926245996624962" DF="8" EFFECT_SIZE="0.33919571410916416" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="68" I2="56.45430335152011" ID="CMP-002.14.05" LOG_CI_END="-0.1130498826428482" LOG_CI_START="-0.8260494051317819" LOG_EFFECT_SIZE="-0.469549643887315" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.018607385378549335" P_Z="0.009837498343640689" STUDIES="9" TAU2="0.7771455611738395" TOTAL_1="367" TOTAL_2="364" WEIGHT="100.0" Z="2.58148950159228">
<NAME>somnolence (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="4.914953233364638" CI_START="0.4577866549626788" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6915193898002392" LOG_CI_START="-0.33933687168887666" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="0.6055300708194983" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.3666666666666666" WEIGHT="15.335535546797184"/>
<DICH_DATA CI_END="1.6113995451271035" CI_START="0.0248231421691539" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20720323671350532" LOG_CI_START="-1.6051432453855428" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="889" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.133333333333333" WEIGHT="9.181453471871109"/>
<DICH_DATA CI_END="1.9656607751511364" CI_START="0.2861633131773464" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2935085713844867" LOG_CI_START="-0.5433860446010865" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="0.49159604012508745" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.2416666666666666" WEIGHT="17.21708142047877"/>
<DICH_DATA CI_END="0.6110696264007713" CI_START="0.011364407825909376" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.21390930262344088" LOG_CI_START="-1.944453189471809" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.0333333333333334" WEIGHT="9.688581917263473"/>
<DICH_DATA CI_END="1.1294626656610136" CI_START="0.003935007840071765" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.0528718799085443" LOG_CI_START="-2.405054398019907" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="1.4437980625864737" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.084552845528455" WEIGHT="6.129567335896471"/>
<DICH_DATA CI_END="3.05118976192878" CI_START="0.03641566725790049" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4844692184571428" LOG_CI_START="-1.4387117278964678" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="750" O_E="0.0" SE="1.1296860077873303" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.2761904761904763" WEIGHT="8.542670444446658"/>
<DICH_DATA CI_END="0.7818143136830156" CI_START="0.013711145017532726" EFFECT_SIZE="0.10353535353535354" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.1068963826417563" LOG_CI_START="-1.8629262757697973" LOG_EFFECT_SIZE="-0.9849113292057768" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.0315006517115728" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="1.0639935944813994" WEIGHT="9.527239168767089"/>
<DICH_DATA CI_END="0.7884092945867962" CI_START="0.0028761377012095687" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10324826444845014" LOG_CI_START="-2.541190325019388" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.4320592343871992" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="2.050793650793651" WEIGHT="6.202740499045426"/>
<DICH_DATA CI_END="1.8712241976778183" CI_START="0.34202208414910273" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.272125824903065" LOG_CI_START="-0.4659458509191778" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.43354695589170383" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.18796296296296297" WEIGHT="18.175130195433812"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3711569500113296" CI_START="0.30984616077291294" DF="0" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" I2="0.0" ID="CMP-002.14.06" LOG_CI_END="0.374960301455169" LOG_CI_START="-0.5088538807163955" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.7665237116586479" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.29692507588910944">
<NAME>dizziness (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="2.3711569500113296" CI_START="0.30984616077291294" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.374960301455169" LOG_CI_START="-0.5088538807163955" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2445" O_E="0.0" SE="0.519156825558337" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="0.2695238095238095" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="68.42097732363833" CI_START="1.1838474568532047" DF="0" EFFECT_SIZE="9.000000000000002" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" I2="0.0" ID="CMP-002.14.07" LOG_CI_END="1.8351892733455617" LOG_CI_START="0.07329574553308822" LOG_EFFECT_SIZE="0.954242509439325" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.03375090592966302" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="2.123035156772836">
<NAME>headache (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="68.42097732363833" CI_START="1.1838474568532047" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.8351892733455617" LOG_CI_START="0.07329574553308822" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2444" O_E="0.0" SE="1.0349449797506682" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.0711111111111111" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.357023897403046" CI_START="0.1872920131201609" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-002.14.08" LOG_CI_END="1.3295407336099563" LOG_CI_START="-0.7274807422819939" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.5662028528062903" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.5736526882995394">
<NAME>insomnia (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="21.357023897403046" CI_START="0.1872920131201609" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3295407336099563" LOG_CI_START="-0.7274807422819939" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2443" O_E="0.0" SE="1.2083045973594573" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.46" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8586842297199586" CI_START="0.3443296014280094" DF="0" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" I2="0.0" ID="CMP-002.14.09" LOG_CI_END="0.2692056141190852" LOG_CI_START="-0.46302564013519804" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.603901462232881" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.518798218823743">
<NAME>somnolence (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="1.8586842297199586" CI_START="0.3443296014280094" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.2692056141190852" LOG_CI_START="-0.46302564013519804" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2442" O_E="0.0" SE="0.4301162633521314" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="0.18500000000000003" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.365043432705246" CI_END="1.9905914928095803" CI_START="0.5603131650311448" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="1.056103508004877" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="30" I2="25.1113153577424" I2_Q="15.81145815487611" ID="CMP-002.15" LOG_CI_END="0.2989821436931196" LOG_CI_START="-0.25156917329682393" LOG_EFFECT_SIZE="0.02370648519814788" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.1649017757431842" P_Q="0.3126282818846896" P_Z="0.8659615992321241" Q="3.5634302890278136" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.41190010348488454" TOTALS="SUB" TOTAL_1="708" TOTAL_2="699" WEIGHT="400.0" Z="0.16879028622594466">
<NAME>Adverse effects: 4. Extrapyramidal symptoms - various (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.795169124983032" CI_END="2.70438414382599" CI_START="0.49079409828028087" DF="6" EFFECT_SIZE="1.1520832336565645" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="16" I2="23.02925178659212" ID="CMP-002.15.01" LOG_CI_END="0.43206838094361577" LOG_CI_START="-0.3091006682345974" LOG_EFFECT_SIZE="0.06148385635450919" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2534973245027512" P_Z="0.7450459307220493" STUDIES="7" TAU2="0.3006390035932419" TOTAL_1="287" TOTAL_2="284" WEIGHT="100.00000000000001" Z="0.3251785654543613">
<NAME>akathisia</NAME>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="882" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="10.931193689724134"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="10.827125083277311"/>
<DICH_DATA CI_END="2.838485111047003" CI_START="0.35230059728273166" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.45308662052476206" LOG_CI_START="-0.453086620524762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2054" O_E="0.0" SE="0.532290647422377" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.28333333333333327" WEIGHT="32.45768038829412"/>
<DICH_DATA CI_END="283.64361038414125" CI_START="1.0188842244977934" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.452773004695487" LOG_CI_START="0.00812483806106053" LOG_EFFECT_SIZE="1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.4359984342846528" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.062091503267974" WEIGHT="8.022238428176925"/>
<DICH_DATA CI_END="1.8162338025665838" CI_START="0.07649104407064226" EFFECT_SIZE="0.37272727272727274" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2591717542229007" LOG_CI_START="-1.1163894110998798" LOG_EFFECT_SIZE="-0.4286088284384895" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="0.808011437648186" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="0.6528824833702882" WEIGHT="19.87830135629964"/>
<DICH_DATA CI_END="4.049848137779348" CI_START="0.009876913562969599" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6074387382366481" LOG_CI_START="-2.0053787469086855" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.5347819244295118" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="2.3555555555555556" WEIGHT="7.135918339371233"/>
<DICH_DATA CI_END="21.408382134855636" CI_START="0.18684270370377404" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.330583848216745" LOG_CI_START="-0.7285238568887824" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="10.747542714856644"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6721172629472618" CI_END="3.5341150370181436" CI_START="0.06227346755253955" DF="1" EFFECT_SIZE="0.46912855176879975" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-002.15.02" LOG_CI_END="0.5482806818795954" LOG_CI_START="-1.2056969509317956" LOG_EFFECT_SIZE="-0.32870813452610015" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.412314739101559" P_Z="0.4625691670609635" STUDIES="2" TAU2="0.0" TOTAL_1="74" TOTAL_2="71" WEIGHT="100.0" Z="0.7346229427838794">
<NAME>dystonia</NAME>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="882" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="54.90559052202888"/>
<DICH_DATA CI_END="3.776028608569197" CI_START="0.009227802026014743" EFFECT_SIZE="0.18666666666666668" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5770352760118023" LOG_CI_START="-2.034901731438726" LOG_EFFECT_SIZE="-0.728933227713462" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.5342647274731482" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.353968253968254" WEIGHT="45.09440947797112"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.437016903853371" CI_END="12.311485959621681" CI_START="0.6370403535113561" DF="3" EFFECT_SIZE="2.8005201959577963" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="6" I2="53.39456079097572" ID="CMP-002.15.03" LOG_CI_END="1.090310474143088" LOG_CI_START="-0.1958330562796845" LOG_EFFECT_SIZE="0.44723870893170176" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.09217990721955593" P_Z="0.17285068375605767" STUDIES="4" TAU2="1.1986539416049087" TOTAL_1="174" TOTAL_2="174" WEIGHT="100.0" Z="1.3631009934174094">
<NAME>general extrapyramidal symptoms</NAME>
<DICH_DATA CI_END="8.500739760948548" CI_START="0.26468284681954973" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9294567210223326" LOG_CI_START="-0.57727420291097" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="28.797395909071138"/>
<DICH_DATA CI_END="3.820037874641474" CI_START="0.1163455596591846" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5820676688452829" LOG_CI_START="-0.9342501869566455" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1202" O_E="0.0" SE="0.8906926143924925" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="0.7933333333333332" WEIGHT="28.652829745063066"/>
<DICH_DATA CI_END="94.73866802787167" CI_START="1.7838545075415353" EFFECT_SIZE="13.0" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="1" LOG_CI_END="1.9765272744998983" LOG_CI_START="0.2513594301137753" LOG_EFFECT_SIZE="1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.0133721315109652" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.026923076923077" WEIGHT="25.645516541543078"/>
<DICH_DATA CI_END="162.3251455021821" CI_START="0.49899847463196106" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2103858008302795" LOG_CI_START="-0.3019007819516295" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.4757295747452437" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="2.177777777777778" WEIGHT="16.904257804322725"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.109326964135668" CI_END="2.06801810827238" CI_START="0.09250339215531157" DF="3" EFFECT_SIZE="0.4373770570729626" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" I2="0.0" ID="CMP-002.15.04" LOG_CI_END="0.31555433726926463" LOG_CI_START="-1.0338423411277589" LOG_EFFECT_SIZE="-0.3591440019292471" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5500282171254784" P_Z="0.2968117661584698" STUDIES="4" TAU2="0.0" TOTAL_1="173" TOTAL_2="170" WEIGHT="100.0" Z="1.0432948595680502">
<NAME>tremor</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="23.999584191633073"/>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="24.061856075887434"/>
<DICH_DATA CI_END="2.505014678707804" CI_START="0.007096875690544191" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3988102750588027" LOG_CI_START="-2.1489328018422027" LOG_EFFECT_SIZE="-0.8750612633917001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.4965568949032775" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.2396825396825397" WEIGHT="28.052270194780178"/>
<DICH_DATA CI_END="8.005255503084177" CI_START="0.01387977074164633" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9033751978179345" LOG_CI_START="-1.8576177072572597" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.62182089957647" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="2.6303030303030304" WEIGHT="23.886289537699316"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="45.66124049299537" CI_END="1.0758132836390777" CI_START="0.48240329771573726" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7203998027164409" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="87" I2="51.81909259917085" I2_Q="87.83238333473864" ID="CMP-002.16" LOG_CI_END="0.03173690244399934" LOG_CI_START="-0.31658973201456275" LOG_EFFECT_SIZE="-0.14242641478528167" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0021857414581013535" P_Q="1.267494178947004E-6" P_Z="0.10897668833608233" Q="32.87414544723478" RANDOM="YES" SCALE="776.4723166285547" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.0470953870085333" TOTALS="SUB" TOTAL_1="1011" TOTAL_2="1002" WEIGHT="500.0" Z="1.602809637914862">
<NAME>Adverse effects: 5. Gastrointestinal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2079037741397718" CI_END="0.7518747013606011" CI_START="0.19286863186448955" DF="6" EFFECT_SIZE="0.3808057838123533" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="29" I2="0.0" ID="CMP-002.16.01" LOG_CI_END="-0.12385452781479164" LOG_CI_START="-0.714738400225074" LOG_EFFECT_SIZE="-0.41929646401993287" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9764925380988912" P_Z="0.005408902428761136" STUDIES="7" TAU2="0.0" TOTAL_1="297" TOTAL_2="294" WEIGHT="100.00000000000001" Z="2.7816158358556082">
<NAME>constipation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="3.070127994092063" CI_START="0.036191035463317964" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4871564816560677" LOG_CI_START="-1.4413989910953926" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.132843031197762" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.2833333333333334" WEIGHT="9.387284976427916"/>
<DICH_DATA CI_END="6.755362190128103" CI_START="0.14803055289342476" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.829648638769922" LOG_CI_START="-0.829648638769922" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="0.9746794344808963" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.95" WEIGHT="12.681069178683325"/>
<DICH_DATA CI_END="1.0095631417172248" CI_START="0.08914747010960969" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.004133486471151205" LOG_CI_START="-1.0498909770318265" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2003" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.3833333333333333" WEIGHT="31.42699752978042"/>
<DICH_DATA CI_END="3.05118976192878" CI_START="0.03641566725790049" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4844692184571428" LOG_CI_START="-1.4387117278964678" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.1296860077873303" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.2761904761904763" WEIGHT="9.439825750549714"/>
<DICH_DATA CI_END="2.8679394782010643" CI_START="0.03363952608432697" EFFECT_SIZE="0.3106060606060606" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.45756998222566214" LOG_CI_START="-1.473150131197891" LOG_EFFECT_SIZE="-0.5077900744861144" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.1341145518436935" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="1.2862158167036215" WEIGHT="9.366247532722662"/>
<DICH_DATA CI_END="1.9530616275027282" CI_START="0.08192265812143532" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29071594736470874" LOG_CI_START="-1.0865959647087837" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="0.8090398349558905" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="0.6545454545454545" WEIGHT="18.405162905172325"/>
<DICH_DATA CI_END="3.1046620619644876" CI_START="0.03578847194750886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49201433475049966" LOG_CI_START="-1.4462568441898247" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.138550085106622" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.296296296296296" WEIGHT="9.29341212666364"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.893317016512615" CI_END="0.5348371985771219" CI_START="0.09764107055300854" DF="6" EFFECT_SIZE="0.22852150148430714" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="36" I2="0.0" ID="CMP-002.16.02" LOG_CI_END="-0.27177839465058995" LOG_CI_START="-1.0103674675514962" LOG_EFFECT_SIZE="-0.6410729311010431" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4352464929710539" P_Z="6.680200747263234E-4" STUDIES="7" TAU2="0.0" TOTAL_1="307" TOTAL_2="304" WEIGHT="100.0" Z="3.4023786771894184">
<NAME>dry mouth (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="0.8447034237486211" CI_START="0.01461540070189141" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07329574553308825" LOG_CI_START="-1.8351892733455617" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1202" O_E="0.0" SE="1.0349449797506682" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.0711111111111111" WEIGHT="17.573021318913053"/>
<DICH_DATA CI_END="1.3223130190345596" CI_START="0.021006960816326796" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12133427386971721" LOG_CI_START="-1.6776367746370044" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.0567244989431572" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.116666666666667" WEIGHT="16.856111991474805"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="12.981143717572554"/>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="9.688132995100103"/>
<DICH_DATA CI_END="1.488052051260373" CI_START="0.004838046743718287" EFFECT_SIZE="0.08484848484848485" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.17261812286294193" LOG_CI_START="-2.315329939934278" LOG_EFFECT_SIZE="-1.0713559085356683" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.4614330076286206" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.135786435786436" WEIGHT="8.812987139114101"/>
<DICH_DATA CI_END="1.3278931112135148" CI_START="0.02091868505319125" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12316311789462225" LOG_CI_START="-1.6794656186619095" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.0588730430094635" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="1.1212121212121213" WEIGHT="16.78777640232018"/>
<DICH_DATA CI_END="0.9655165544419958" CI_START="0.01618304722805112" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.015240275544684944" LOG_CI_START="-1.790939698439202" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.0430546308621436" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.0879629629629628" WEIGHT="17.30082643550521"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.904424708919636" CI_END="5.261376727584092" CI_START="1.364108323197235" DF="6" EFFECT_SIZE="2.6790087318957534" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="12" I2="0.0" ID="CMP-002.16.03" LOG_CI_END="0.7210993994693405" LOG_CI_START="0.13484885880938557" LOG_EFFECT_SIZE="0.42797412913936306" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.43398141530822176" P_Z="0.004214785417573632" STUDIES="7" TAU2="0.0" TOTAL_1="307" TOTAL_2="304" WEIGHT="100.0" Z="2.8616225359341243">
<NAME>nausea / vomiting (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="54.828253342758615" CI_START="0.8936998173856948" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7390044108354357" LOG_CI_START="-0.04880833080692219" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1202" O_E="0.0" SE="1.0501700542565202" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.1028571428571428" WEIGHT="10.752821989013066"/>
<DICH_DATA CI_END="47.60326868524414" CI_START="0.7562505893877647" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6776367746370044" LOG_CI_START="-0.12133427386971714" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.0567244989431572" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.116666666666667" WEIGHT="10.619844659511408"/>
<DICH_DATA CI_END="3.138274863843685" CI_START="0.17923860222716867" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49669097832768017" LOG_CI_START="-0.7465684515442799" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2003" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="22.235299755852022"/>
<DICH_DATA CI_END="27.460707857359033" CI_START="0.3277410053211045" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4387117278964678" LOG_CI_START="-0.48446921845714286" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.1296860077873303" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.2761904761904763" WEIGHT="9.292364077072483"/>
<DICH_DATA CI_END="38.21698440672134" CI_START="0.5679968850539618" EFFECT_SIZE="4.659090909090909" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5822564151316099" LOG_CI_START="-0.24565404599247628" LOG_EFFECT_SIZE="0.6683011845695669" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.073723653167" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="1.1528824833702882" WEIGHT="10.286240538399728"/>
<DICH_DATA CI_END="7.49738752131488" CI_START="0.5335191743294718" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8749099590279366" LOG_CI_START="-0.27284996769997416" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="0.6741998624632421" STUDY_ID="STD-Sun-2009a" TOTAL_1="44" TOTAL_2="44" VAR="0.4545454545454546" WEIGHT="26.089418380199696"/>
<DICH_DATA CI_END="54.97995762110186" CI_START="0.8912338626684083" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7402044007506525" LOG_CI_START="-0.05000832072213886" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.0515798142890085" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.1058201058201056" WEIGHT="10.724010599951596"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8447034237486211" CI_START="0.01461540070189141" DF="0" EFFECT_SIZE="0.11111111111111109" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" I2="0.0" ID="CMP-002.16.04" LOG_CI_END="-0.07329574553308825" LOG_CI_START="-1.8351892733455617" LOG_EFFECT_SIZE="-0.954242509439325" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.03375090592966302" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="2.123035156772836">
<NAME>dry mouth (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.8447034237486211" CI_START="0.01461540070189141" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07329574553308825" LOG_CI_START="-1.8351892733455617" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2447" O_E="0.0" SE="1.0349449797506682" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.0711111111111111" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="54.828253342758615" CI_START="0.8936998173856946" DF="0" EFFECT_SIZE="6.999999999999998" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-002.16.05" LOG_CI_END="1.7390044108354357" LOG_CI_START="-0.0488083308069223" LOG_EFFECT_SIZE="0.8450980400142567" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.06388986038245123" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.8529476642075289">
<NAME>nausea / vomiting (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="54.828253342758615" CI_START="0.8936998173856948" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7390044108354357" LOG_CI_START="-0.04880833080692219" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2446" O_E="0.0" SE="1.0501700542565202" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.1028571428571428" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3013657540770516" CI_END="4.8145214174295585" CI_START="0.07707143543809533" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6091486490083922" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.17" LOG_CI_END="0.6825531230079088" LOG_CI_START="-1.1131065523019308" LOG_EFFECT_SIZE="-0.21527671464701106" METHOD="MH" MODIFIED="2013-11-04 16:58:21 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.5830275720625542" P_Q="0.5842804439449059" P_Z="0.6383911596852292" Q="0.29936568153121557" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="114" TOTAL_2="111" WEIGHT="200.0" Z="0.4699494154931598">
<NAME>Adverse effects: 6. Haematological</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.4280106598243405" CI_START="0.013030423338013766" DF="0" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-002.17.01" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.47074865216936024" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="41" WEIGHT="99.99999999999999" Z="0.7212614884031853">
<NAME>blood routine abnormal (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2393" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.259760455310136" CI_START="0.0655318281652329" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.17.02" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-04 16:58:21 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.0" Z="0.0">
<NAME>leucopenia (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2395" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2394" O_E="0.0" SE="0.0" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.482346825782887" CI_END="1.4630052358818584" CI_START="0.21623024441342412" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5624464238777356" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-002.18" LOG_CI_END="0.1652458804045521" LOG_CI_START="-0.6650835607841334" LOG_EFFECT_SIZE="-0.2499188401897907" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.4835931140334414" P_Q="0.9152193817337361" P_Z="0.23806006266437618" Q="0.011333197495953202" RANDOM="YES" SCALE="355.71200000619893" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="309" TOTAL_2="309" WEIGHT="200.0" Z="1.1798495910942917">
<NAME>Adverse events: 7. Hormonal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.509244867848295" CI_END="1.6360870309056952" CI_START="0.2024202749717715" DF="5" EFFECT_SIZE="0.5754799620088262" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" I2="9.243460402717355" ID="CMP-002.18.01" LOG_CI_END="0.21380640204727389" LOG_CI_START="-0.6937459895231257" LOG_EFFECT_SIZE="-0.2399697937379259" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.35693330970795756" P_Z="0.29997601756407355" STUDIES="6" TAU2="0.16121538873008115" TOTAL_1="259" TOTAL_2="259" WEIGHT="100.0" Z="1.0364848519433516">
<NAME>menstrual disorder (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2418" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="30.628507837375345"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2419" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="17.638636649491573"/>
<DICH_DATA CI_END="0.9860104274367028" CI_START="0.0035093012367547953" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.00611849220455492" LOG_CI_START="-2.454779350551993" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2420" O_E="0.0" SE="1.43835550926002" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.0688665710186513" WEIGHT="12.743766067271054"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2421" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="11.24004209204132"/>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2422" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="10.251188958987044"/>
<DICH_DATA CI_END="5.352095533713907" CI_START="0.0467106759259435" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7285238568887824" LOG_CI_START="-1.330583848216745" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2423" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="17.49785839483366"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.33925597435076" CI_START="0.046823003280040215" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.18.02" LOG_CI_END="0.7274807422819939" LOG_CI_START="-1.3295407336099563" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5662028528062903" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.5736526882995394">
<NAME>menstrual disorder (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="5.33925597435076" CI_START="0.046823003280040215" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7274807422819939" LOG_CI_START="-1.3295407336099563" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2424" O_E="0.0" SE="1.2083045973594573" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.46" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="18.255101294364362" CI_END="0.6881456490436534" CI_START="0.2548895309534679" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="0.41880917099844717" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="81" I2="0.0" I2_Q="0.0" ID="CMP-002.19" LOG_CI_END="-0.16231963170427552" LOG_CI_START="-0.5936480018885606" LOG_EFFECT_SIZE="-0.377983816796418" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.5054629292640211" P_Q="0.7513997082490435" P_Z="5.922680570119248E-4" Q="1.914941868558367" RANDOM="YES" SCALE="902.4253097924746" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="920" TOTAL_2="914" WEIGHT="500.0" Z="3.4351307211414994">
<NAME>Adverse effects: 8a. Metabolic - binary measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.127097975341272" CI_END="1.3888037728526208" CI_START="0.057770536125508504" DF="3" EFFECT_SIZE="0.283252428993689" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="22" I2="51.03717923112036" ID="CMP-002.19.01" LOG_CI_END="0.14264088764725583" LOG_CI_START="-1.2382936020748319" LOG_EFFECT_SIZE="-0.5478263572137879" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10558780312983074" P_Z="0.11993111250222531" STUDIES="4" TAU2="1.331464962874685" TOTAL_1="164" TOTAL_2="164" WEIGHT="100.0" Z="1.5550628040825958">
<NAME>decreased appetite (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="1.1085273631537562" CI_START="0.018410157424752212" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.04474641781136666" LOG_CI_START="-1.7349424978398804" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="1.0453980786557544" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="1.092857142857143" WEIGHT="27.141324380699057"/>
<DICH_DATA CI_END="1.1085273631537562" CI_START="0.018410157424752212" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.04474641781136666" LOG_CI_START="-1.7349424978398804" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.0453980786557544" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.092857142857143" WEIGHT="27.141324380699057"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Sun-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="18.52112357987298"/>
<DICH_DATA CI_END="0.9655165544419958" CI_START="0.01618304722805112" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.015240275544684944" LOG_CI_START="-1.790939698439202" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.0430546308621436" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.0879629629629628" WEIGHT="27.196227658728898"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3356253117553205" CI_END="1.92175896919128" CI_START="0.16997982513882182" DF="3" EFFECT_SIZE="0.5715419963065673" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-002.19.02" LOG_CI_END="0.28369891667570857" LOG_CI_START="-0.7696026218619143" LOG_EFFECT_SIZE="-0.24295185259310284" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7206915256495134" P_Z="0.36591025339261773" STUDIES="5" TAU2="0.0" TOTAL_1="193" TOTAL_2="190" WEIGHT="100.0" Z="0.9041606104950302">
<NAME>lactation (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="2.5270106054871775" CI_START="0.09893112417381524" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.402607064593003" LOG_CI_START="-1.0046670559209654" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="884" O_E="0.0" SE="0.8266397845091497" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.6833333333333333" WEIGHT="56.02063596825537"/>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="14.660719625734917"/>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="14.607440208560833"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Sun-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="14.711204197448879"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="0.0" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.673219090802993" CI_END="0.8464353318098834" CI_START="0.2425866533922801" DF="9" EFFECT_SIZE="0.45313785370099435" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="43" I2="0.0" ID="CMP-002.19.03" LOG_CI_END="-0.07240621665835635" LOG_CI_START="-0.6151330967816209" LOG_EFFECT_SIZE="-0.34376965671998866" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.46796916365256047" P_Z="0.01303070687314851" STUDIES="10" TAU2="0.0" TOTAL_1="413" TOTAL_2="410" WEIGHT="100.00000000000001" Z="2.482928967866294">
<NAME>weight gain (short term, up to 12 weeks)</NAME>
<DICH_DATA CI_END="8.500739760948548" CI_START="0.26468284681954973" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9294567210223326" LOG_CI_START="-0.57727420291097" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="868" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Ban-2008" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="12.974518812573411"/>
<DICH_DATA CI_END="1.5022476497886328" CI_START="0.12226577250002559" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.1767415332480145" LOG_CI_START="-0.9126951038372033" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="884" O_E="0.0" SE="0.6399404734221844" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.4095238095238095" WEIGHT="24.81753889149216"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="7.00922280679253"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="933" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="7.00922280679253"/>
<DICH_DATA CI_END="0.5213691864691807" CI_START="0.0019958654123266918" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2828546397228208" LOG_CI_START="-2.6998687479457244" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2003" O_E="0.0" SE="1.419766051582929" STUDY_ID="STD-Ge-2010" TOTAL_1="40" TOTAL_2="40" VAR="2.01573564122738" WEIGHT="5.0420168508112"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="902" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="4.293391670781158"/>
<DICH_DATA CI_END="21.061276053961322" CI_START="0.18992201563435934" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.323484680543928" LOG_CI_START="-0.7214246892159657" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="745" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="7.043921929598434"/>
<DICH_DATA CI_END="1.5286793762688535" CI_START="0.02271987540215848" EFFECT_SIZE="0.18636363636363637" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.18431640645957237" LOG_CI_START="-1.6435940546645138" LOG_EFFECT_SIZE="-0.7296388241024707" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.073723653167" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="1.1528824833702882" WEIGHT="8.815619298974855"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Sun-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="16.047431162919743"/>
<DICH_DATA CI_END="5.352095533713907" CI_START="0.0467106759259435" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7285238568887824" LOG_CI_START="-1.330583848216745" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="815" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="6.94711576926399"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9628306644915527" CI_START="0.016228191078907096" DF="0" EFFECT_SIZE="0.12500000000000003" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" I2="0.0" ID="CMP-002.19.04" LOG_CI_END="-0.016450086648564448" LOG_CI_START="-1.7897298873353225" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.04589825793770323" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.9963277635232275">
<NAME>decreased appetite (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.9628306644915527" CI_START="0.016228191078907096" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.016450086648564448" LOG_CI_START="-1.7897298873353225" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2450" O_E="0.0" SE="1.041633332799983" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.085" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.19.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>lactation (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2449" O_E="0.0" SE="0.0" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.33925597435076" CI_START="0.046823003280040215" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.19.06" LOG_CI_END="0.7274807422819939" LOG_CI_START="-1.3295407336099563" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.5662028528062903" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.5736526882995394">
<NAME>weight gain (medium term, 12 to 24 weeks)</NAME>
<DICH_DATA CI_END="5.33925597435076" CI_START="0.046823003280040215" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7274807422819939" LOG_CI_START="-1.3295407336099563" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2448" O_E="0.0" SE="1.2083045973594573" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.46" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="7.273558918411345" CI_END="-0.005348590086204266" CI_START="-0.1371416693529457" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07124512971957499" ESTIMABLE="YES" I2="31.257860751720212" I2_Q="31.2578607517202" ID="CMP-002.20" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.20107747140503607" P_Q="0.20107747140503618" P_Z="0.03408646472854545" Q="7.273558918411344" RANDOM="YES" SCALE="12.2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.003808390795863635" TOTALS="SUB" TOTAL_1="540" TOTAL_2="540" UNITS="" WEIGHT="600.0" Z="2.1190473597119976">
<NAME>Adverse effects: 8b. Metabolic - continuous measure</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Quetiapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours quetiapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.017518220027485515" CI_START="-0.3624817799725135" DF="0" EFFECT_SIZE="-0.1899999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-002.20.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.030847920693696185" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="2.1590289543739196">
<NAME>cholesterol - TC average endpoint level (in mmol/L, high=poor)</NAME>
<CONT_DATA CI_END="-0.017518220027485515" CI_START="-0.3624817799725135" EFFECT_SIZE="-0.1899999999999995" ESTIMABLE="YES" MEAN_1="4.62" MEAN_2="4.81" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.57" SD_2="0.61" SE="0.0880025252162939" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13300067196628393" CI_START="-0.213000671966284" DF="0" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-002.20.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.650426980047156" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="0.4531691032788665">
<NAME>cholesterol-TG average endpoint level (in mmol/L, high=poor)</NAME>
<CONT_DATA CI_END="0.13300067196628393" CI_START="-0.213000671966284" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.84" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.54" SD_2="0.64" SE="0.0882672708942058" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.018667355716345396" CI_START="-0.2586673557163447" DF="0" EFFECT_SIZE="-0.11999999999999966" ESTIMABLE="YES" I2="0.0" ID="CMP-002.20.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.08986424534224378" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="1.696114250753559">
<NAME>cholesterol - LDL average endpoint level (in mmol/L, high=poor)</NAME>
<CONT_DATA CI_END="0.018667355716345396" CI_START="-0.2586673557163447" EFFECT_SIZE="-0.11999999999999966" ESTIMABLE="YES" MEAN_1="2.64" MEAN_2="2.76" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.56" SD_2="0.37" SE="0.07074995092263708" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.3977627273222906E-32" CI_END="0.27525954202263203" CI_START="-3.8752595420226257" DF="0" EFFECT_SIZE="-1.799999999999997" ESTIMABLE="YES" I2="100.0" ID="CMP-002.20.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.08913147381285483" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="1.6999970850555053">
<NAME>waistline- average endpoint level (in cm, high=poor)</NAME>
<CONT_DATA CI_END="0.2752595420226318" CI_START="-3.875259542022626" EFFECT_SIZE="-1.7999999999999972" ESTIMABLE="YES" MEAN_1="72.3" MEAN_2="74.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" SD_1="6.9" SD_2="7.3" SE="1.0588253449512395" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.9005143413280896" CI_START="-1.3005143413280953" DF="0" EFFECT_SIZE="1.2999999999999972" ESTIMABLE="YES" I2="0.0" ID="CMP-002.20.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.32719070694172603" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="0.979788167059604">
<NAME>weight- average endpoint level (in Kg, high=poor)</NAME>
<CONT_DATA CI_END="3.9005143413280896" CI_START="-1.3005143413280953" EFFECT_SIZE="1.2999999999999972" ESTIMABLE="YES" MEAN_1="53.8" MEAN_2="52.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" SD_1="9.0" SD_2="8.8" SE="1.3268174118711453" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.07496784536607165" CI_START="-0.11496784536607169" DF="0" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-002.20.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.679779746883324" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="0.41276370480661134">
<NAME>cholesterol - HDL average endpoint (in mmol/L, low=poor))</NAME>
<CONT_DATA CI_END="0.07496784536607165" CI_START="-0.11496784536607169" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="1.78" MEAN_2="1.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2425" SD_1="0.32" SD_2="0.33" SE="0.0484538726809094" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2016-10-10 22:30:56 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE</NAME>
<DICH_OUTCOME CHI2="29.202741853153555" CI_END="1.2066932947664228" CI_START="0.9610409718294552" CI_STUDY="95" CI_TOTAL="95" DF="79" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0768851826923844" ESTIMABLE="YES" EVENTS_1="481" EVENTS_2="374" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.08159689949515288" LOG_CI_START="-0.017258096764191103" LOG_EFFECT_SIZE="0.03216940136548086" METHOD="MH" MODIFIED="2013-07-09 11:45:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9999999457923165" P_Q="1.0" P_Z="0.20208874051577186" Q="0.0" RANDOM="YES" SCALE="21.009393665757724" SORT_BY="STUDY" STUDIES="80" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3237" TOTAL_2="3144" WEIGHT="99.99999999999996" Z="1.2756232960677787">
<NAME>Global state: 1. No clinically significant response (as defined by the original studies)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="29.202741853153555" CI_END="1.2066932947664228" CI_START="0.9610409718294552" DF="79" EFFECT_SIZE="1.0768851826923844" ESTIMABLE="YES" EVENTS_1="481" EVENTS_2="374" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.08159689949515288" LOG_CI_START="-0.017258096764191103" LOG_EFFECT_SIZE="0.03216940136548086" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9999999457923165" P_Z="0.20208874051577186" STUDIES="80" TAU2="0.0" TOTAL_1="3237" TOTAL_2="3144" WEIGHT="99.99999999999996" Z="1.2756232960677787">
<NAME>by up to 12 weeks -- short term</NAME>
<DICH_DATA CI_END="2.6605364031093544" CI_START="0.861456954811782" EFFECT_SIZE="1.5139146567717996" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="11" LOG_CI_END="0.42496920558788176" LOG_CI_START="-0.06476641845363683" LOG_EFFECT_SIZE="0.18010139356712243" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.2876731297924245" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.08275582960456909" WEIGHT="4.074495620447069"/>
<DICH_DATA CI_END="12.287383448842096" CI_START="0.5086518237199613" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0894594113883262" LOG_CI_START="-0.29357939404425104" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1687" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="0.5108913110458798"/>
<DICH_DATA CI_END="5.4998093627778335" CI_START="0.5352148044372564" EFFECT_SIZE="1.7156862745098038" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7403476360163316" LOG_CI_START="-0.2714718821675779" LOG_EFFECT_SIZE="0.23443787692437684" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="724" O_E="0.0" SE="0.5943477935686209" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="0.35324929971988794" WEIGHT="0.95453342882111"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="752" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="0.5619804421504677"/>
<DICH_DATA CI_END="8.383428283463806" CI_START="0.2683866222650336" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9234216534894845" LOG_CI_START="-0.5712391353781221" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2511" O_E="0.0" SE="0.8779711460710615" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" VAR="0.7708333333333333" WEIGHT="0.43743342524144513"/>
<DICH_DATA CI_END="4.1657466796913445" CI_START="0.47050388578722313" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6196928568366007" LOG_CI_START="-0.32743678548012456" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1571" O_E="0.0" SE="0.5563486402641868" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.30952380952380953" WEIGHT="1.0893774724762912"/>
<DICH_DATA CI_END="28.031112609677777" CI_START="0.32107180779163014" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4476403360997032" LOG_CI_START="-0.49339782666037824" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1603" O_E="0.0" SE="1.140175425099138" STUDY_ID="STD-CuiMeng-2008" TOTAL_1="60" TOTAL_2="60" VAR="1.3" WEIGHT="0.25937558868483124"/>
<DICH_DATA CI_END="8.500739760948548" CI_START="0.26468284681954973" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9294567210223326" LOG_CI_START="-0.57727420291097" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1607" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="0.43045310462589026"/>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2006" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="0.6699104608416173"/>
<DICH_DATA CI_END="2.5351291311965696" CI_START="0.2739286278946547" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4040000857749946" LOG_CI_START="-0.5623625778702442" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1616" O_E="0.0" SE="0.5676462121975467" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="0.3222222222222223" WEIGHT="1.046446340556043"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1997" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="0.4398107808134095"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2470" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="0.4398107808134095"/>
<DICH_DATA CI_END="2.1982611576833317" CI_START="0.5995753829426209" EFFECT_SIZE="1.148051948051948" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.34207928617814154" LOG_CI_START="-0.22215620649695908" LOG_EFFECT_SIZE="0.059961539840591195" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1986" O_E="0.0" SE="0.331434721408088" STUDY_ID="STD-Feng-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.1098489745548569" WEIGHT="3.0695622481381832"/>
<DICH_DATA CI_END="4.014595890972433" CI_START="0.29643896345936627" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6036418357533072" LOG_CI_START="-0.5280647139745077" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="923" O_E="0.0" SE="0.6647700293478881" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="0.44191919191919193" WEIGHT="0.7630088745997208"/>
<DICH_DATA CI_END="3.249460398915411" CI_START="0.04221445852796686" EFFECT_SIZE="0.37037037037037035" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5118112486004242" LOG_CI_START="-1.374538776918399" LOG_EFFECT_SIZE="-0.43136376415898736" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1973" O_E="0.0" SE="1.1080513425729774" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="1.2277777777777776" WEIGHT="0.27463297625452726"/>
<DICH_DATA CI_END="2.0760885769450543" CI_START="0.24575255954801975" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.31724587887671635" LOG_CI_START="-0.6095019502331924" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="0.5443762622949003" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="0.29634551495016614" WEIGHT="1.1378213884795343"/>
<DICH_DATA CI_END="6.553055387930549" CI_START="0.15260057191669785" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8164438387284481" LOG_CI_START="-0.8164438387284481" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2449" O_E="0.0" SE="0.9591663046625438" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.9199999999999999" WEIGHT="0.36650898401117465"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1589" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="0.3612731413824435"/>
<DICH_DATA CI_END="8.383428283463806" CI_START="0.2683866222650336" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9234216534894845" LOG_CI_START="-0.5712391353781221" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1947" O_E="0.0" SE="0.8779711460710615" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="0.7708333333333333" WEIGHT="0.43743342524144513"/>
<DICH_DATA CI_END="2.1514954095824685" CI_START="0.3558571385232849" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3327404238114954" LOG_CI_START="-0.4487243177668689" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1898" O_E="0.0" SE="0.45903625751598937" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="0.2107142857142857" WEIGHT="1.6002154962928574"/>
<DICH_DATA CI_END="6.486484868044777" CI_START="0.42824084759101333" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.812009409283884" LOG_CI_START="-0.3683119100511713" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1923" O_E="0.0" SE="0.6933265856621719" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="0.48070175438596496" WEIGHT="0.7014500409323354"/>
<DICH_DATA CI_END="8.177709787357301" CI_START="1.2521843237615242" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.9126316941388716" LOG_CI_START="0.09766826250094036" LOG_EFFECT_SIZE="0.505149978319906" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1875" O_E="0.0" SE="0.47871355387816905" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.22916666666666669" WEIGHT="1.4713669758121335"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1458" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.23524762694670745"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1470" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="0.6526224489489303"/>
<DICH_DATA CI_END="8.206593083103149" CI_START="0.25914969702712864" EFFECT_SIZE="1.4583333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9141628998367809" LOG_CI_START="-0.5864492945594417" LOG_EFFECT_SIZE="0.16385680263866959" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1863" O_E="0.0" SE="0.8814670311385031" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.7769841269841269" WEIGHT="0.4339705967985226"/>
<DICH_DATA CI_END="2.1967614205924293" CI_START="0.20231803066014575" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34178289290299224" LOG_CI_START="-0.6939654110143547" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1843" O_E="0.0" SE="0.6084036807578418" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.3701550387596899" WEIGHT="0.9109379313601298"/>
<DICH_DATA CI_END="2.4010002164333732" CI_START="0.3059949235000029" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.3803921992056385" LOG_CI_START="-0.5142857784668649" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1823" O_E="0.0" SE="0.5255382728122436" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.2761904761904762" WEIGHT="1.2208540639820504"/>
<DICH_DATA CI_END="10.375684873669314" CI_START="0.3855167199758466" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.016016773050504" LOG_CI_START="-0.41395678172254163" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1805" O_E="0.0" SE="0.8399735445569435" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.7055555555555555" WEIGHT="0.4779046279704765"/>
<DICH_DATA CI_END="2.661865360379047" CI_START="0.550880465530924" EFFECT_SIZE="1.2109375" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" LOG_CI_END="0.42518608467614094" LOG_CI_START="-0.25894262763129466" LOG_EFFECT_SIZE="0.08312172852242312" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1773" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="2.0879572981770185"/>
<DICH_DATA CI_END="2.5913302586116305" CI_START="0.22099876578596855" EFFECT_SIZE="0.7567567567567568" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.413522766267329" LOG_CI_START="-0.6556101517168806" LOG_EFFECT_SIZE="-0.12104369272477575" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1758" O_E="0.0" SE="0.6280139683172218" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.3944015444015444" WEIGHT="0.8549364729337512"/>
<DICH_DATA CI_END="4.206513090488437" CI_START="0.3714477921233738" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6239222447595453" LOG_CI_START="-0.43010221874343246" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="769" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.38333333333333336" WEIGHT="0.879621561626819"/>
<DICH_DATA CI_END="5.634862548259266" CI_START="0.32343291152026604" EFFECT_SIZE="1.35" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.7508833267245228" LOG_CI_START="-0.49021578973451063" LOG_EFFECT_SIZE="0.13033376849500614" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2236" O_E="0.0" SE="0.7290277645477444" STUDY_ID="STD-Liu-2010" TOTAL_1="30" TOTAL_2="54" VAR="0.5314814814814814" WEIGHT="0.6344308824277057"/>
<DICH_DATA CI_END="3.009508120292743" CI_START="0.4339986458825509" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4784955194812347" LOG_CI_START="-0.3625116255258613" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1746" O_E="0.0" SE="0.49401176002967684" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="0.24404761904761904" WEIGHT="1.3816494772870036"/>
<DICH_DATA CI_END="3.6155894540616798" CI_START="0.3982753070546583" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.558179110974246" LOG_CI_START="-0.3998166188789964" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="958" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-Luo-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.31666666666666665" WEIGHT="1.0648050482850968"/>
<DICH_DATA CI_END="3.138274863843685" CI_START="0.17923860222716867" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49669097832768017" LOG_CI_START="-0.7465684515442799" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1795" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="0.6322279974192763"/>
<DICH_DATA CI_END="3.816607523965545" CI_START="0.1164501305553829" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5816775021184052" LOG_CI_START="-0.9338600202297677" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1066" O_E="0.0" SE="0.8902342426590436" STUDY_ID="STD-Ma-2009a" TOTAL_1="49" TOTAL_2="49" VAR="0.792517006802721" WEIGHT="0.42546502143923826"/>
<DICH_DATA CI_END="2.73958965918398" CI_START="0.23361162787810777" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.43768551825920204" LOG_CI_START="-0.6315055442753148" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1770" O_E="0.0" SE="0.6280481227138924" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.39444444444444443" WEIGHT="0.8548434894683171"/>
<DICH_DATA CI_END="1.8796807452091617" CI_START="0.44703217816080554" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.27408409268501704" LOG_CI_START="-0.3496612144638167" LOG_EFFECT_SIZE="-0.0377885608893998" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1688" O_E="0.0" SE="0.3663910810082913" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.13424242424242427" WEIGHT="2.511786174848591"/>
<DICH_DATA CI_END="4.450800644191879" CI_START="0.6241074359065418" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6484381422343634" LOG_CI_START="-0.20474064300165062" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1492" O_E="0.0" SE="0.5011614417507341" STUDY_ID="STD-Mu-2010" TOTAL_1="129" TOTAL_2="129" VAR="0.2511627906976744" WEIGHT="1.3425088340261173"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1684" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Pan-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="0.4398107808134095"/>
<DICH_DATA CI_END="1.2405261482590506" CI_START="0.8525541968954098" EFFECT_SIZE="1.0284044797922416" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="61" LOG_CI_END="0.09360592292095085" LOG_CI_START="-0.06927800334489588" LOG_EFFECT_SIZE="0.012163959788027508" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.09567882457699702" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.009154437472435767" WEIGHT="36.83331349474641"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1668" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="0.5619804421504677"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1652" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.23524762694670745"/>
<DICH_DATA CI_END="5.5969892490655475" CI_START="0.3176310867623318" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7479544726962614" LOG_CI_START="-0.49807699947966155" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1634" O_E="0.0" SE="0.7319250547113998" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.5357142857142856" WEIGHT="0.629418095208524"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1629" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Song-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.23524762694670745"/>
<DICH_DATA CI_END="8.488676176282748" CI_START="0.2650589978077466" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.92883996654976" LOG_CI_START="-0.5766574484383975" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1857" O_E="0.0" SE="0.8843366338964376" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.7820512820512819" WEIGHT="0.43115876545314574"/>
<DICH_DATA CI_END="3.138274863843685" CI_START="0.17923860222716867" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49669097832768017" LOG_CI_START="-0.7465684515442799" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1674" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="0.6322279974192763"/>
<DICH_DATA CI_END="3.6305839436008545" CI_START="0.3966304105261347" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5599764826360275" LOG_CI_START="-0.4016139905407779" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1079" O_E="0.0" SE="0.5648430038936652" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.319047619047619" WEIGHT="1.056858741954611"/>
<DICH_DATA CI_END="4.377819176530504" CI_START="0.2043971430909409" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6412578193020794" LOG_CI_START="-0.6895251787355181" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1375" O_E="0.0" SE="0.7817085205293665" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.611068211068211" WEIGHT="0.5518013524232268"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1354" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.17440772342600722"/>
<DICH_DATA CI_END="7.101503173841088" CI_START="0.15602798645204474" EFFECT_SIZE="1.0526315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8513502854808354" LOG_CI_START="-0.8067974960585308" LOG_EFFECT_SIZE="0.022276394711152208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1339" O_E="0.0" SE="0.9740042148401186" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.9486842105263158" WEIGHT="0.3554272976707535"/>
<DICH_DATA CI_END="2.0367851667005463" CI_START="0.3879267532520721" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.3089452234837952" LOG_CI_START="-0.4112502683785579" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1072" O_E="0.0" SE="0.42304639694512697" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" VAR="0.17896825396825394" WEIGHT="1.8840674690277324"/>
<DICH_DATA CI_END="9.06643461324945" CI_START="0.34859279992400005" EFFECT_SIZE="1.7777777777777777" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9574365337842082" LOG_CI_START="-0.45768158735100833" LOG_EFFECT_SIZE="0.2498774732165999" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1637" O_E="0.0" SE="0.8312473893025001" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.6909722222222222" WEIGHT="0.48799105730452674"/>
<DICH_DATA CI_END="6.706930006003608" CI_START="0.1490995133548233" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8265237740363401" LOG_CI_START="-0.82652377403634" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2035" O_E="0.0" SE="0.9710083124552245" STUDY_ID="STD-Tu-2009" TOTAL_1="35" TOTAL_2="35" VAR="0.9428571428571428" WEIGHT="0.35762391773211577"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2438" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-Wang-2006c" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="0.7437976440226778"/>
<DICH_DATA CI_END="34.750218874646706" CI_START="0.46042875464227323" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5409575443434547" LOG_CI_START="-0.3368375616875298" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1220" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="1.2166666666666668" WEIGHT="0.2771410399646142"/>
<DICH_DATA CI_END="22.710273425027538" CI_START="0.1998545890665981" EFFECT_SIZE="2.130434782608696" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.356222363029327" LOG_CI_START="-0.6992858750074854" LOG_EFFECT_SIZE="0.3284682440109208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1236" O_E="0.0" SE="1.207415713952701" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="1.4578527062999111" WEIGHT="0.23129103772498252"/>
<DICH_DATA CI_END="10.108042421948712" CI_START="0.39572449669526094" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0046670559209654" LOG_CI_START="-0.402607064593003" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1251" O_E="0.0" SE="0.8266397845091497" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="0.6833333333333333" WEIGHT="0.4934462418882155"/>
<DICH_DATA CI_END="5.242335393587904" CI_START="0.04768866950134176" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7195248027465787" LOG_CI_START="-1.321584794074541" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1275" O_E="0.0" SE="1.1989578808281798" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="1.4375" WEIGHT="0.23456574976715172"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1268" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Wang-2007e" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="0.6526224489489303"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1401" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="0.4398107808134095"/>
<DICH_DATA CI_END="5.579155313499883" CI_START="0.31864640395941085" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.74656845154428" LOG_CI_START="-0.49669097832768017" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1418" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="0.6322279974192763"/>
<DICH_DATA CI_END="3.148306452599371" CI_START="0.1786674863038117" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4980769994796615" LOG_CI_START="-0.7479544726962613" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1198" O_E="0.0" SE="0.7319250547113998" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.5357142857142856" WEIGHT="0.629418095208524"/>
<DICH_DATA CI_END="2.3264027006845174" CI_START="0.31580683659576436" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.36668489334490945" LOG_CI_START="-0.500578472606136" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2490" O_E="0.0" SE="0.5094347941825426" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.2595238095238095" WEIGHT="1.299257535980898"/>
<DICH_DATA CI_END="7.156301378704515" CI_START="0.558947952066841" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8546886220507605" LOG_CI_START="-0.2526286307227981" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1303" O_E="0.0" SE="0.6504436355879909" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="0.42307692307692313" WEIGHT="0.7969904452315723"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3327" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="0.4398107808134095"/>
<DICH_DATA CI_END="4.206513090488437" CI_START="0.3714477921233738" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6239222447595453" LOG_CI_START="-0.43010221874343246" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3320" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.38333333333333336" WEIGHT="0.879621561626819"/>
<DICH_DATA CI_END="2.787165399728159" CI_START="0.2296239756931617" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4451627419669189" LOG_CI_START="-0.6389827679830317" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3302" O_E="0.0" SE="0.6368324391514267" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.4055555555555556" WEIGHT="0.8314231198938425"/>
<DICH_DATA CI_END="21.032408972995952" CI_START="0.1901826845006534" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228890179912565" LOG_CI_START="-0.7208290266632941" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3339" O_E="0.0" SE="1.200490095997562" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="1.4411764705882355" WEIGHT="0.23396736775243956"/>
<DICH_DATA CI_END="2.8062406427651023" CI_START="0.2280631212615402" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.44812491022187245" LOG_CI_START="-0.6419449362379852" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3360" O_E="0.0" SE="0.6403124237432849" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.41" WEIGHT="0.8224104031470258"/>
<DICH_DATA CI_END="3.7056499579629176" CI_START="0.3885957973190759" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5688643927203287" LOG_CI_START="-0.4105019006250791" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="896" O_E="0.0" SE="0.5752846086524313" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.330952380952381" WEIGHT="1.018842240445452"/>
<DICH_DATA CI_END="8.220339253228541" CI_START="0.2737113312101215" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9148897412340661" LOG_CI_START="-0.5627072231227036" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="985" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="0.44759504242072656"/>
<DICH_DATA CI_END="2.0008335136944777" CI_START="0.25499576958333575" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.30121095315801366" LOG_CI_START="-0.5934670245144897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1758" O_E="0.0" SE="0.5255382728122436" STUDY_ID="STD-Zhang-2007b" TOTAL_1="30" TOTAL_2="30" VAR="0.2761904761904762" WEIGHT="1.2208540639820504"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="939" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="0.4398107808134095"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="0.5619804421504677"/>
<DICH_DATA CI_END="3.5713646359076354" CI_START="0.12444667228203433" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5528341938718855" LOG_CI_START="-0.905016711983248" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1749" O_E="0.0" SE="0.8563488385776752" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" VAR="0.7333333333333332" WEIGHT="0.45980217994129186"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1288" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="0.5619804421504677"/>
<DICH_DATA CI_END="1.9423192528417736" CI_START="0.08237574732676249" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.28832061504272793" LOG_CI_START="-1.084200632386803" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1045" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.6499999999999999" WEIGHT="0.5187511773696626"/>
<DICH_DATA CI_END="6.377763079252677" CI_START="0.43554107345474924" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8046683820621104" LOG_CI_START="-0.3609708828293977" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1028" O_E="0.0" SE="0.6847022742046907" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.4688172043010753" WEIGHT="0.7192318502751398"/>
<DICH_DATA CI_END="2.079292082757925" CI_START="0.38955566017720544" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.31791549992317847" LOG_CI_START="-0.4094304810445287" LOG_EFFECT_SIZE="-0.045757490560675115" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1006" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.18253968253968253" WEIGHT="1.84720527941632"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.7842090193271274" CI_END="0.6050275863134217" CI_START="0.08956797560497476" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3472977809591982" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3758570002842634" P_Q="1.0" P_Z="0.008263642146881101" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="98" TOTAL_2="98" UNITS="" WEIGHT="100.0" Z="2.6411037002692344">
<NAME>Global state: 2. Average endpoint total score(short term, up to 12 weeks, CGI, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7150734344644891" CI_START="-0.5350734344644885" EFFECT_SIZE="0.0900000000000003" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.11" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2362" SD_1="1.37" SD_2="1.41" SE="0.3189208778298929" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" WEIGHT="17.000715819613458"/>
<CONT_DATA CI_END="0.6828964335190428" CI_START="0.11710356648095699" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="1.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2363" SD_1="1.0" SD_2="0.5" SE="0.14433756729740643" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" WEIGHT="82.99928418038654"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.18348623853211038" CI_END="0.6605722791227738" CI_START="0.21588032026560525" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.4382262996941895" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6683941898691189" P_Q="0.6683941898691189" P_Z="1.1203344749350607E-4" Q="0.18348623853211038" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="120" TOTAL_2="120" UNITS="" WEIGHT="100.0" Z="3.8629336437124193">
<NAME>Global state: 3. Average CGI subscale scores (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8596235721279066" CI_START="0.14037642787209342" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.00642972857303681" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="38.2262996941896" Z="2.725021573172848">
<NAME>CGI-EI</NAME>
<CONT_DATA CI_END="0.8596235721279066" CI_START="0.14037642787209342" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2359" SD_1="1.1" SD_2="0.9" SE="0.18348478592697182" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" WEIGHT="38.2262996941896"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6828964335190428" CI_START="0.11710356648095699" DF="0" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.005583616806205516" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="61.7737003058104" Z="2.7712812921102032">
<NAME>CGI-SI</NAME>
<CONT_DATA CI_END="0.6828964335190428" CI_START="0.11710356648095699" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="1.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2358" SD_1="1.0" SD_2="0.5" SE="0.14433756729740643" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" WEIGHT="61.7737003058104"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-003.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES">
<NAME>Global state: 4. average endpoint data of various scales (high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-003.04.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>CGI-GI</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3269" STUDY_ID="STD-Chen-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>1.7 </P>
</TD>
<TD>
<P>0.9</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>1.6</P>
</TD>
<TD>
<P>1.2</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.04.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="2">
<NAME>CGI-SI</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3270" STUDY_ID="STD-Chen-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>1.4</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>2.3</P>
</TD>
<TD>
<P>1.2</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3271" STUDY_ID="STD-Yang-2008a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>2.22 </P>
</TD>
<TD>
<P>1.28</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>2.35 </P>
</TD>
<TD>
<P>1.16</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.04.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" NOTES="&lt;p&gt;jun added today&lt;/p&gt;" NOTES_MODIFIED="2013-06-25 17:02:48 +0100" NOTES_MODIFIED_BY="[Empty name]" STUDIES="2">
<NAME>CGI</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3272" STUDY_ID="STD-Feng-2006">
<TR>
<TD/>
<TD>
<P>1.49 </P>
</TD>
<TD>
<P>1.05</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
<TR>
<TD/>
<TD>
<P>1.44</P>
</TD>
<TD>
<P>1.2</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3273" STUDY_ID="STD-Zhang-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>6.65</P>
</TD>
<TD>
<P>4.88</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>7.51</P>
</TD>
<TD>
<P>5.76</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="18.368504615917672" CI_END="1.935850075699944" CI_START="1.071215937455828" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4400393930774433" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="70" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="0.2868717198021967" LOG_CI_START="0.02987702544685059" LOG_EFFECT_SIZE="0.15837437262452367" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9906721097689755" P_Q="0.48668933589877905" P_Z="0.01570599348586168" Q="1.4402588560012357" RANDOM="YES" SCALE="404.3131824503572" SORT_BY="STUDY" STUDIES="34" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1440" TOTAL_2="1442" WEIGHT="300.0" Z="2.4156768465343648">
<NAME>Mental state: 1. Specific - binary outcomes (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.0125236057755655" CI_END="2.9391429498642347" CI_START="1.120116836176206" DF="8" EFFECT_SIZE="1.8144375167173787" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="22" I2="0.0" ID="CMP-003.05.01" LOG_CI_END="0.46822070918505393" LOG_CI_START="0.049263325045343025" LOG_EFFECT_SIZE="0.2587420171151985" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5352822593054751" P_Z="0.01548252817064372" STUDIES="9" TAU2="0.0" TOTAL_1="372" TOTAL_2="372" WEIGHT="99.99999999999999" Z="2.4208907828387765">
<NAME>anxiety</NAME>
<DICH_DATA CI_END="5.0570250995304455" CI_START="0.6406928848940934" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.7038951091715042" LOG_CI_START="-0.193350098964892" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1578" O_E="0.0" SE="0.5270462766947299" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.2777777777777778" WEIGHT="21.803057662096666"/>
<DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2005" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="2.593212045445813"/>
<DICH_DATA CI_END="191.0359474772963" CI_START="0.6333886454243398" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2811150966827576" LOG_CI_START="-0.19832972636630716" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1948" O_E="0.0" SE="1.4564381625088383" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.121212121212121" WEIGHT="2.8551623128936114"/>
<DICH_DATA CI_END="222.9484231552304" CI_START="0.7580228539330457" EFFECT_SIZE="13.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.3482044050668596" LOG_CI_START="-0.12031770045318584" LOG_EFFECT_SIZE="1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.4500221041639685" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.1025641025641026" WEIGHT="2.880485260236348"/>
<DICH_DATA CI_END="5.386835096584108" CI_START="0.7425510393916595" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7313336809961624" LOG_CI_START="-0.12927368966819996" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.5055250296034368" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.25555555555555565" WEIGHT="23.698975719670283"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="775" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="11.722074011879931"/>
<DICH_DATA CI_END="3.5641487483629146" CI_START="0.4987944957668635" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5519558208544968" LOG_CI_START="-0.3020783476378969" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1688" O_E="0.0" SE="0.501663898109747" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.2516666666666666" WEIGHT="24.06518505750185"/>
<DICH_DATA CI_END="131.47194839591478" CI_START="0.37270307923361223" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1188330991645534" LOG_CI_START="-0.4286370191360397" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.4963965576702283" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.2392026578073088" WEIGHT="2.7047149506639867"/>
<DICH_DATA CI_END="8.553099213657628" CI_START="0.2630625395303716" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.932123509757888" LOG_CI_START="-0.5799409916465255" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="7.677132979611505"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.20502718714083" CI_END="1.8362219824265131" CI_START="0.861868163910314" DF="25" EFFECT_SIZE="1.2580068634652577" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="47" I2="0.0" ID="CMP-003.05.02" LOG_CI_END="0.2639251822657647" LOG_CI_START="-0.06455916116498008" LOG_EFFECT_SIZE="0.0996830105503923" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9960636063424262" P_Z="0.2342213294743899" STUDIES="26" TAU2="0.0" TOTAL_1="1018" TOTAL_2="1020" WEIGHT="99.99999999999999" Z="1.1895550850842098">
<NAME>agitation/excitement</NAME>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="754" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="4.856215735977046"/>
<DICH_DATA CI_END="6.35814024707232" CI_START="0.43688526358896196" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8033301032984537" LOG_CI_START="-0.35963260406574094" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2034" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="7.9780687091051465"/>
<DICH_DATA CI_END="77.45728499042538" CI_START="0.1376023507612924" EFFECT_SIZE="3.264705882352941" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.889062270156631" LOG_CI_START="-0.8613741466678263" LOG_EFFECT_SIZE="0.5138440617444023" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="923" O_E="0.0" SE="1.6156199661225275" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="2.610227874933757" WEIGHT="1.4263500771978466"/>
<DICH_DATA CI_END="7.961364031061661" CI_START="0.013956290740833538" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9009874823623856" LOG_CI_START="-1.8552299918017108" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="920" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="1.4203729262453098"/>
<DICH_DATA CI_END="4.619022933127913" CI_START="0.216496002396511" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6645501184938255" LOG_CI_START="-0.6645501184938255" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1898" O_E="0.0" SE="0.7807200583588265" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="0.6095238095238095" WEIGHT="6.108208855408629"/>
<DICH_DATA CI_END="7.933315337564284" CI_START="0.014005634010915893" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8994547171933126" LOG_CI_START="-1.8536972266326377" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.6172150801252798" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.6153846153846154" WEIGHT="1.4235377500560162"/>
<DICH_DATA CI_END="28.031112609677777" CI_START="0.32107180779163014" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4476403360997032" LOG_CI_START="-0.49339782666037824" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1878" O_E="0.0" SE="1.140175425099138" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.3" WEIGHT="2.8639221007044116"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2002" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="6.2051645515262255"/>
<DICH_DATA CI_END="8.206593083103149" CI_START="0.25914969702712864" EFFECT_SIZE="1.4583333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9141628998367809" LOG_CI_START="-0.5864492945594417" LOG_EFFECT_SIZE="0.16385680263866959" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="0.8814670311385031" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.7769841269841269" WEIGHT="4.791730746633123"/>
<DICH_DATA CI_END="6.542658906961779" CI_START="0.42456405221156446" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8157542795088691" LOG_CI_START="-0.3720567802761564" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1844" O_E="0.0" SE="0.6977260962772974" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.48682170542635655" WEIGHT="7.647766501403342"/>
<DICH_DATA CI_END="6.664063596528968" CI_START="0.416829422099844" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.823739132980035" LOG_CI_START="-0.38004163374732225" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1823" O_E="0.0" SE="0.7071067811865475" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.49999999999999994" WEIGHT="7.446197461831472"/>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="1.9092814004696077"/>
<DICH_DATA CI_END="7.9199970308142" CI_START="0.014029185955349858" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.898725018773679" LOG_CI_START="-1.8529675282130038" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1794" O_E="0.0" SE="1.6163578231977633" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.612612612612612" WEIGHT="1.4250481349367126"/>
<DICH_DATA CI_END="5.454794518074456" CI_START="0.32591104429087336" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.736778395374003" LOG_CI_START="-0.4869009221574032" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1670" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="7.205997543707876"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="1.9257407228874495"/>
<DICH_DATA CI_END="4.044504981919023" CI_START="0.00988996185659807" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6068653747055984" LOG_CI_START="-2.004805383377636" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="1.534108331276844" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.353488372093023" WEIGHT="1.5819490655076742"/>
<DICH_DATA CI_END="15.803763018779694" CI_START="0.7751318458422377" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1987605087082227" LOG_CI_START="-0.11062442000767149" LOG_EFFECT_SIZE="0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1858" O_E="0.0" SE="0.7691391886876467" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.5915750915750915" WEIGHT="6.293535316037126"/>
<DICH_DATA CI_END="12.174646810603075" CI_START="0.5133619149063762" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0854563710833007" LOG_CI_START="-0.2895763537392256" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1088" O_E="0.0" SE="0.8077010290825141" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.6523809523809523" WEIGHT="5.70693966052777"/>
<DICH_DATA CI_END="14.547791543916547" CI_START="0.06150856162258902" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1627970693983896" LOG_CI_START="-1.2110644288318284" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.394417994864361" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="1.9444015444015446" WEIGHT="1.9147787357171868"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1358" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="2.5975107424993507"/>
<DICH_DATA CI_END="16.237290829528913" CI_START="0.06824003170419145" EFFECT_SIZE="1.0526315789473684" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2105135694903848" LOG_CI_START="-1.1659607800680802" LOG_EFFECT_SIZE="0.022276394711152208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="1.3959527966683958" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="1.9486842105263158" WEIGHT="1.910570584399702"/>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="1.4209459653494967"/>
<DICH_DATA CI_END="3.74127129959932" CI_START="0.1187950321838577" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.573019202356666" LOG_CI_START="-0.9252017204680286" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3343" O_E="0.0" SE="0.8800623863804024" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="0.7745098039215685" WEIGHT="4.807038867764621"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="2.5975107424993507"/>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1045" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="1.9092814004696077"/>
<DICH_DATA CI_END="3.8682013368369814" CI_START="0.11489692643761545" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5875090706854438" LOG_CI_START="-0.9396915887968063" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1006" O_E="0.0" SE="0.8970852271450604" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.8047619047619048" WEIGHT="4.626335701137895"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.548273108710726" CI_START="0.06431582420814068" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-003.05.03" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.0">
<NAME>irritability</NAME>
<DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1705" O_E="0.0" SE="1.4" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="155.69273263999548" CI_END="-0.4231183794775414" CI_START="-1.5839523793212598" CI_STUDY="95" CI_TOTAL="95" DF="83" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0035353793994006" ESTIMABLE="YES" I2="46.68986882520787" I2_Q="0.0" ID="CMP-003.06" MODIFIED="2016-10-10 22:30:56 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="2.387183871133125E-6" P_Q="0.8256262295265696" P_Z="7.020974625129018E-4" Q="0.8991782567349833" RANDOM="YES" SCALE="15.962670055552046" SORT_BY="STUDY" STUDIES="82" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="3.462670055146324" TOTALS="SUB" TOTAL_1="3191" TOTAL_2="3212" UNITS="" WEIGHT="400.00000000000006" Z="3.388758773604778">
<NAME>Mental state: 2. Average endpoint scale score</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.679846642933679" CI_END="-0.42341282922681434" CI_START="-2.2448891053227267" DF="4" EFFECT_SIZE="-1.3341509672747704" ESTIMABLE="YES" I2="29.575563365316974" ID="CMP-003.06.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.22436734069710584" P_Z="0.0040895009311552955" STUDIES="5" TAU2="0.31463751677511753" TOTAL_1="287" TOTAL_2="283" WEIGHT="99.99999999999999" Z="2.8711742009645986">
<NAME>BPRS (short term, up to 12 weeks, high=poor)</NAME>
<CONT_DATA CI_END="0.5719376623028676" CI_START="-2.7919376623028667" EFFECT_SIZE="-1.1099999999999994" ESTIMABLE="YES" MEAN_1="21.34" MEAN_2="22.45" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2352" SD_1="2.86" SD_2="3.73" SE="0.8581472290153169" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="20.543089570616104"/>
<CONT_DATA CI_END="-0.171137988690645" CI_START="-3.0888620113093532" EFFECT_SIZE="-1.629999999999999" ESTIMABLE="YES" MEAN_1="22.34" MEAN_2="23.97" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2353" SD_1="5.79" SD_2="6.16" SE="0.744331029966199" STUDY_ID="STD-Mu-2010" TOTAL_1="129" TOTAL_2="129" WEIGHT="24.85638356853578"/>
<CONT_DATA CI_END="0.9306531770202833" CI_START="-3.2706531770202867" EFFECT_SIZE="-1.1700000000000017" ESTIMABLE="YES" MEAN_1="27.63" MEAN_2="28.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2354" SD_1="4.15" SD_2="4.42" SE="1.0717815192472766" STUDY_ID="STD-Pu-2007" TOTAL_1="32" TOTAL_2="32" WEIGHT="14.755085165446348"/>
<CONT_DATA CI_END="5.774312976132618" CI_START="-1.1743129761326165" EFFECT_SIZE="2.3000000000000007" ESTIMABLE="YES" MEAN_1="23.5" MEAN_2="21.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2355" SD_1="8.6" SD_2="5.9" SE="1.772641233990805" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" WEIGHT="6.246039755115322"/>
<CONT_DATA CI_END="-0.877520566513815" CI_START="-3.122479433486185" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="20.4" MEAN_2="22.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2356" SD_1="2.55" SD_2="3.63" SE="0.5727041120858135" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" WEIGHT="33.59940194028644"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="145.74055576623064" CI_END="-0.0180889755241892" CI_START="-1.5765716975931086" DF="76" EFFECT_SIZE="-0.7973303365586488" ESTIMABLE="YES" I2="47.85253864277505" ID="CMP-003.06.02" MODIFIED="2016-10-10 22:30:49 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.6614066601649E-6" P_Z="0.044913705983458514" STUDIES="77" TAU2="5.076420289699789" TOTAL_1="2860" TOTAL_2="2873" WEIGHT="100.00000000000004" Z="2.005461749824961">
<NAME>PANSS (short term, up to 12 weeks, high=poor)</NAME>
<CONT_DATA CI_END="7.10861879877127" CI_START="-3.788618798771277" EFFECT_SIZE="1.6599999999999966" ESTIMABLE="YES" MEAN_1="48.83" MEAN_2="47.17" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2275" SD_1="13.53" SD_2="14.26" SE="2.7799586327857466" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" WEIGHT="1.2344745006542348"/>
<CONT_DATA CI_END="7.631318019345076" CI_START="-2.831318019345079" EFFECT_SIZE="2.3999999999999986" ESTIMABLE="YES" MEAN_1="47.8" MEAN_2="45.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2276" SD_1="14.1" SD_2="12.7" SE="2.6690888509222854" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" WEIGHT="1.2956024547907357"/>
<CONT_DATA CI_END="3.2649355707735097" CI_START="-1.6649355707735154" EFFECT_SIZE="0.7999999999999972" ESTIMABLE="YES" MEAN_1="41.5" MEAN_2="40.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2277" SD_1="5.3" SD_2="4.4" SE="1.2576432986608987" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3740963894808598"/>
<CONT_DATA CI_END="6.053195137449476" CI_START="-6.453195137449482" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="42.9" MEAN_2="43.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2278" SD_1="12.2" SD_2="13.3" SE="3.190464307902535" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" WEIGHT="1.0361481456772874"/>
<CONT_DATA CI_END="7.4942233312100965" CI_START="-0.3142233312100897" EFFECT_SIZE="3.5900000000000034" ESTIMABLE="YES" MEAN_1="50.81" MEAN_2="47.22" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2279" SD_1="10.42" SD_2="11.38" SE="1.9919872824225895" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" WEIGHT="1.7476981824162285"/>
<CONT_DATA CI_END="1.6587234425044102" CI_START="-4.2587234425044045" EFFECT_SIZE="-1.2999999999999972" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="41.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2280" SD_1="7.7" SD_2="8.8" SE="1.5095805156841862" STUDY_ID="STD-CuiMeng-2008" TOTAL_1="60" TOTAL_2="60" WEIGHT="2.1490680014703316"/>
<CONT_DATA CI_END="4.3095513022321645" CI_START="-5.909551302232173" EFFECT_SIZE="-0.8000000000000043" ESTIMABLE="YES" MEAN_1="42.4" MEAN_2="43.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2281" SD_1="11.2" SD_2="12.1" SE="2.606961833245742" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.3313719507289463"/>
<CONT_DATA CI_END="2.4298154362888225" CI_START="-4.24981543628883" EFFECT_SIZE="-0.9100000000000037" ESTIMABLE="YES" MEAN_1="49.8" MEAN_2="50.71" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2282" SD_1="7.88" SD_2="3.24" SE="1.7040187792392432" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="1.9807946805332528"/>
<CONT_DATA CI_END="4.658036997484479" CI_START="-5.5580369974844706" EFFECT_SIZE="-0.44999999999999574" ESTIMABLE="YES" MEAN_1="42.6" MEAN_2="43.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2283" SD_1="11.8" SD_2="12.9" SE="2.6061892145855836" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" WEIGHT="1.331823769068888"/>
<CONT_DATA CI_END="1.775023091603261" CI_START="-8.835023091603263" EFFECT_SIZE="-3.530000000000001" ESTIMABLE="YES" MEAN_1="43.37" MEAN_2="46.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2284" SD_1="10.73" SD_2="10.23" SE="2.7066941706320153" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.2744846114212451"/>
<CONT_DATA CI_END="4.132124607033484" CI_START="-6.832124607033487" EFFECT_SIZE="-1.3500000000000014" ESTIMABLE="YES" MEAN_1="47.92" MEAN_2="49.27" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2285" SD_1="12.55" SD_2="10.63" SE="2.7970537470462644" STUDY_ID="STD-Feng-2006" TOTAL_1="35" TOTAL_2="34" WEIGHT="1.225350855458748"/>
<CONT_DATA CI_END="7.033288458000538" CI_START="-8.753288458000537" EFFECT_SIZE="-0.8599999999999994" ESTIMABLE="YES" MEAN_1="47.35" MEAN_2="48.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2286" SD_1="17.26" SD_2="16.09" SE="4.027261990659925" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" WEIGHT="0.7422750708950798"/>
<CONT_DATA CI_END="4.109009174873352" CI_START="-18.50900917487334" EFFECT_SIZE="-7.199999999999996" ESTIMABLE="YES" MEAN_1="48.2" MEAN_2="55.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2287" SD_1="9.9" SD_2="23.6" SE="5.770008665504759" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.41196713644908933"/>
<CONT_DATA CI_END="5.55197746265265" CI_START="-7.3519774626526475" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="46.6" MEAN_2="47.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2288" SD_1="15.9" SD_2="14.6" SE="3.291885725219965" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" WEIGHT="0.9933392718452919"/>
<CONT_DATA CI_END="8.373869866434097" CI_START="-8.793869866434099" EFFECT_SIZE="-0.21000000000000085" ESTIMABLE="YES" MEAN_1="44.8" MEAN_2="45.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2289" SD_1="14.94" SD_2="16.01" SE="4.3796059183447085" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.6516345885168089"/>
<CONT_DATA CI_END="-1.4672268676191829" CI_START="-11.772773132380827" EFFECT_SIZE="-6.6200000000000045" ESTIMABLE="YES" MEAN_1="47.58" MEAN_2="54.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2290" SD_1="11.5" SD_2="9.43" SE="2.629014192620496" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" WEIGHT="1.3185486314496004"/>
<CONT_DATA CI_END="7.460730660324639" CI_START="-6.460730660324639" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="48.2" MEAN_2="47.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2291" SD_1="14.4" SD_2="15.3" SE="3.551458452925663" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" WEIGHT="0.8935888005728656"/>
<CONT_DATA CI_END="7.252129377346912" CI_START="-4.232129377346916" EFFECT_SIZE="1.509999999999998" ESTIMABLE="YES" MEAN_1="46.22" MEAN_2="44.71" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2292" SD_1="12.86" SD_2="12.68" SE="2.9297116797247793" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" WEIGHT="1.1572011291422288"/>
<CONT_DATA CI_END="15.32233815611214" CI_START="8.877661843887848" EFFECT_SIZE="12.099999999999994" ESTIMABLE="YES" MEAN_1="56.8" MEAN_2="44.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2293" SD_1="9.3" SD_2="8.7" SE="1.644080290010193" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" WEIGHT="2.0318917882465"/>
<CONT_DATA CI_END="2.470235817935246" CI_START="-5.07023581793524" EFFECT_SIZE="-1.2999999999999972" ESTIMABLE="YES" MEAN_1="43.5" MEAN_2="44.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2294" SD_1="7.5" SD_2="7.4" SE="1.9236250500898904" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.8010007894577944"/>
<CONT_DATA CI_END="10.343521480144544" CI_START="-6.5435214801445465" EFFECT_SIZE="1.8999999999999986" ESTIMABLE="YES" MEAN_1="50.6" MEAN_2="48.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2295" SD_1="19.7" SD_2="16.5" SE="4.307998283002119" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" WEIGHT="0.6687861209537547"/>
<CONT_DATA CI_END="-0.6832725192638733" CI_START="-12.316727480736127" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="43.6" MEAN_2="50.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2296" SD_1="13.2" SD_2="14.3" SE="2.9677726359350123" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" WEIGHT="1.1384926807294584"/>
<CONT_DATA CI_END="5.124120775081199" CI_START="-2.924120775081196" EFFECT_SIZE="1.1000000000000014" ESTIMABLE="YES" MEAN_1="40.52" MEAN_2="39.42" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2297" SD_1="10.25" SD_2="12.16" SE="2.0531605717364956" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" WEIGHT="1.701154721632834"/>
<CONT_DATA CI_END="8.004445616919991" CI_START="-6.00444561691999" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="49.8" MEAN_2="48.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2298" SD_1="17.2" SD_2="16.7" SE="3.573762412049488" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.8856322719077243"/>
<CONT_DATA CI_END="1.9107467792544863" CI_START="-7.590746779254479" EFFECT_SIZE="-2.8399999999999963" ESTIMABLE="YES" MEAN_1="37.52" MEAN_2="40.36" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2299" SD_1="10.15" SD_2="11.23" SE="2.4238949372170953" STUDY_ID="STD-Liu-2008b" TOTAL_1="39" TOTAL_2="39" WEIGHT="1.4433338230846977"/>
<CONT_DATA CI_END="-0.2891113971260726" CI_START="-13.090888602873937" EFFECT_SIZE="-6.690000000000005" ESTIMABLE="YES" MEAN_1="49.44" MEAN_2="56.13" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2300" SD_1="13.02" SD_2="12.9" SE="3.265819501461927" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" WEIGHT="1.0041254547862453"/>
<CONT_DATA CI_END="9.029084536541616" CI_START="-5.949084536541617" EFFECT_SIZE="1.5399999999999991" ESTIMABLE="YES" MEAN_1="51.22" MEAN_2="49.68" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2301" SD_1="15.13" SD_2="14.46" SE="3.821031710589868" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.8033327383889621"/>
<CONT_DATA CI_END="7.265485680787745" CI_START="-4.465485680787748" EFFECT_SIZE="1.3999999999999986" ESTIMABLE="YES" MEAN_1="41.8" MEAN_2="40.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2302" SD_1="10.2" SD_2="9.8" SE="2.992649725736773" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" WEIGHT="1.1264624005474453"/>
<CONT_DATA CI_END="1.164548329673559" CI_START="-3.2845483296735636" EFFECT_SIZE="-1.0600000000000023" ESTIMABLE="YES" MEAN_1="42.32" MEAN_2="43.38" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2303" SD_1="6.02" SD_2="3.91" SE="1.1349944933787124" STUDY_ID="STD-Luo-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.483558867612974"/>
<CONT_DATA CI_END="7.829348569292791" CI_START="-4.829348569292791" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="50.3" MEAN_2="48.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2304" SD_1="15.5" SD_2="13.3" SE="3.229318813619987" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.0194789723917548"/>
<CONT_DATA CI_END="4.671210257679785" CI_START="-6.191210257679796" EFFECT_SIZE="-0.7600000000000051" ESTIMABLE="YES" MEAN_1="40.19" MEAN_2="40.95" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2305" SD_1="13.3" SD_2="14.12" SE="2.7710765608554464" STUDY_ID="STD-Ma-2009a" TOTAL_1="49" TOTAL_2="49" WEIGHT="1.2392462783535387"/>
<CONT_DATA CI_END="4.400366842425365" CI_START="-9.000366842425374" EFFECT_SIZE="-2.3000000000000043" ESTIMABLE="YES" MEAN_1="56.3" MEAN_2="58.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2306" SD_1="15.7" SD_2="13.2" SE="3.4186173293371755" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="0.9429455514836504"/>
<CONT_DATA CI_END="1.5861052342558466" CI_START="-9.046105234255855" EFFECT_SIZE="-3.730000000000004" ESTIMABLE="YES" MEAN_1="45.97" MEAN_2="49.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2307" SD_1="14.64" SD_2="12.39" SE="2.7123484289449244" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="1.271343755677411"/>
<CONT_DATA CI_END="4.985250548401445" CI_START="-9.585250548401454" EFFECT_SIZE="-2.3000000000000043" ESTIMABLE="YES" MEAN_1="56.3" MEAN_2="58.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2308" SD_1="15.5" SD_2="13.2" SE="3.7170328668621337" STUDY_ID="STD-Pan-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.8366668257764269"/>
<CONT_DATA CI_END="4.424750166718992" CI_START="-8.024750166718986" EFFECT_SIZE="-1.7999999999999972" ESTIMABLE="YES" MEAN_1="36.5" MEAN_2="38.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2309" SD_1="12.4" SD_2="12.2" SE="3.175951301054011" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.0424618845387827"/>
<CONT_DATA CI_END="1.145675427031967" CI_START="-5.945675427031964" EFFECT_SIZE="-2.3999999999999986" ESTIMABLE="YES" MEAN_1="42.2" MEAN_2="44.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2310" SD_1="7.3" SD_2="6.7" SE="1.8090513167587776" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.893253751765742"/>
<CONT_DATA CI_END="4.106524215958749" CI_START="-6.306524215958752" EFFECT_SIZE="-1.1000000000000014" ESTIMABLE="YES" MEAN_1="52.1" MEAN_2="53.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2311" SD_1="12.7" SD_2="7.1" SE="2.6564387187862373" STUDY_ID="STD-Song-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.3027962513418745"/>
<CONT_DATA CI_END="1.8594072719248276" CI_START="-11.859407271924827" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="44.2" MEAN_2="49.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2312" SD_1="13.9" SD_2="13.2" SE="3.499761896662876" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.9123904759571305"/>
<CONT_DATA CI_END="4.13599502035791" CI_START="-11.13599502035791" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="50.2" MEAN_2="53.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2313" SD_1="21.9" SD_2="10.6" SE="3.8959874163962525" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" WEIGHT="0.7803916229995573"/>
<CONT_DATA CI_END="13.007744116022256" CI_START="-13.607744116022264" EFFECT_SIZE="-0.30000000000000426" ESTIMABLE="YES" MEAN_1="37.9" MEAN_2="38.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2314" SD_1="15.1" SD_2="40.2" SE="6.78979012930444" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.3088640048380744"/>
<CONT_DATA CI_END="5.989223047367936" CI_START="-2.489223047367936" EFFECT_SIZE="1.75" ESTIMABLE="YES" MEAN_1="41.62" MEAN_2="39.87" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2315" SD_1="10.47" SD_2="9.32" SE="2.1629086456722604" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" WEIGHT="1.6204610917862117"/>
<CONT_DATA CI_END="5.361482734480842" CI_START="-7.161482734480839" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="42.0" MEAN_2="42.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2316" SD_1="13.6" SD_2="13.5" SE="3.1946927514335046" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" WEIGHT="1.0343176020715001"/>
<CONT_DATA CI_END="6.481211031685694" CI_START="-7.081211031685703" EFFECT_SIZE="-0.30000000000000426" ESTIMABLE="YES" MEAN_1="41.8" MEAN_2="42.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2317" SD_1="13.4" SD_2="13.4" SE="3.459865122611959" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.9272516908266197"/>
<CONT_DATA CI_END="4.959703190957071" CI_START="-6.759703190957068" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="41.0" MEAN_2="41.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2318" SD_1="13.1" SD_2="13.3" SE="2.9896994216106316" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" WEIGHT="1.1278810357327385"/>
<CONT_DATA CI_END="-2.6578420818378636" CI_START="-10.342157918162137" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="50.7" MEAN_2="57.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2319" SD_1="8.3" SD_2="8.1" SE="1.960320673475935" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" WEIGHT="1.772222057614342"/>
<CONT_DATA CI_END="-2.8897209359580103" CI_START="-17.51027906404198" EFFECT_SIZE="-10.199999999999996" ESTIMABLE="YES" MEAN_1="44.7" MEAN_2="54.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2320" SD_1="15.3" SD_2="15.9" SE="3.729802752348785" STUDY_ID="STD-Tu-2009" TOTAL_1="35" TOTAL_2="35" WEIGHT="0.8324766180501331"/>
<CONT_DATA CI_END="2.536892349852807" CI_START="-5.736892349852796" EFFECT_SIZE="-1.5999999999999943" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="41.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2321" SD_1="7.67" SD_2="8.65" SE="2.1106981467435526" STUDY_ID="STD-Wang-2006b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.658395321131666"/>
<CONT_DATA CI_END="5.720332814171666" CI_START="-8.720332814171666" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="35.6" MEAN_2="37.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2439" SD_1="13.8" SD_2="12.2" SE="3.6839109652650404" STUDY_ID="STD-Wang-2006c" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.847665276233147"/>
<CONT_DATA CI_END="4.357328298184489" CI_START="-1.9573282981844833" EFFECT_SIZE="1.2000000000000028" ESTIMABLE="YES" MEAN_1="46.7" MEAN_2="45.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2322" SD_1="7.7" SD_2="8.0" SE="1.610911385662741" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" WEIGHT="2.060487690057886"/>
<CONT_DATA CI_END="7.70814323313314" CI_START="-6.108143233133132" EFFECT_SIZE="0.8000000000000043" ESTIMABLE="YES" MEAN_1="48.1" MEAN_2="47.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2323" SD_1="13.8" SD_2="13.5" SE="3.5246276399075125" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.9032836483882396"/>
<CONT_DATA CI_END="1.5571372984996676" CI_START="-5.957137298499659" EFFECT_SIZE="-2.1999999999999957" ESTIMABLE="YES" MEAN_1="54.7" MEAN_2="56.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2324" SD_1="6.8" SD_2="8.0" SE="1.9169420092080685" STUDY_ID="STD-Wang-2007e" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.80628306892318"/>
<CONT_DATA CI_END="2.222851009416141" CI_START="-5.422851009416144" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="44.3" MEAN_2="45.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2325" SD_1="8.7" SD_2="6.2" SE="1.9504700288221126" STUDY_ID="STD-Wang-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.7799097773596975"/>
<CONT_DATA CI_END="3.211694469118452" CI_START="-6.191694469118456" EFFECT_SIZE="-1.490000000000002" ESTIMABLE="YES" MEAN_1="46.53" MEAN_2="48.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2326" SD_1="9.17" SD_2="9.41" SE="2.398867788492452" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.4594182660951216"/>
<CONT_DATA CI_END="1.7315359612793948" CI_START="-3.551535961279402" EFFECT_SIZE="-0.9100000000000037" ESTIMABLE="YES" MEAN_1="49.8" MEAN_2="50.71" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2327" SD_1="7.88" SD_2="3.25" SE="1.3477471943951507" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.2932396235091947"/>
<CONT_DATA CI_END="6.320087157713529" CI_START="-5.520087157713532" EFFECT_SIZE="0.3999999999999986" ESTIMABLE="YES" MEAN_1="48.4" MEAN_2="48.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2328" SD_1="14.8" SD_2="15.1" SE="3.0205081340322693" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" WEIGHT="1.11317345155546"/>
<CONT_DATA CI_END="6.379154114241541" CI_START="-5.219154114241545" EFFECT_SIZE="0.5799999999999983" ESTIMABLE="YES" MEAN_1="47.79" MEAN_2="47.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2329" SD_1="12.93" SD_2="14.16" SE="2.958806467866007" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" WEIGHT="1.1428667837135993"/>
<CONT_DATA CI_END="4.971760240751365" CI_START="-7.451760240751369" EFFECT_SIZE="-1.240000000000002" ESTIMABLE="YES" MEAN_1="40.39" MEAN_2="41.63" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2330" SD_1="13.67" SD_2="14.66" SE="3.1693236660208752" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.0453611485272785"/>
<CONT_DATA CI_END="16.36754541234063" CI_START="-2.8075454123406267" EFFECT_SIZE="6.780000000000001" ESTIMABLE="YES" MEAN_1="54.04" MEAN_2="47.26" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2331" SD_1="19.0" SD_2="16.16" SE="4.891694688252418" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" WEIGHT="0.544971116214576"/>
<CONT_DATA CI_END="7.230165440731963" CI_START="-6.0301654407319605" EFFECT_SIZE="0.6000000000000014" ESTIMABLE="YES" MEAN_1="48.1" MEAN_2="47.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2332" SD_1="12.9" SD_2="13.3" SE="3.382799629498226" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.9568508444290568"/>
<CONT_DATA CI_END="1.184288175982649" CI_START="-3.784288175982643" EFFECT_SIZE="-1.2999999999999972" ESTIMABLE="YES" MEAN_1="38.0" MEAN_2="39.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2333" SD_1="5.2" SD_2="7.3" SE="1.2675172582651488" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" WEIGHT="2.365238996553949"/>
<CONT_DATA CI_END="-1.7777880930862966" CI_START="-9.222211906913703" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="42.9" MEAN_2="48.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2334" SD_1="8.2" SD_2="6.4" SE="1.8991226044325487" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.8204286428767749"/>
<CONT_DATA CI_END="7.858457750180627" CI_START="-7.05845775018063" EFFECT_SIZE="0.3999999999999986" ESTIMABLE="YES" MEAN_1="49.1" MEAN_2="48.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2335" SD_1="17.9" SD_2="18.2" SE="3.805405512046135" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.8082277808999873"/>
<CONT_DATA CI_END="0.6440341597435495" CI_START="-15.044034159743555" EFFECT_SIZE="-7.200000000000003" ESTIMABLE="YES" MEAN_1="40.4" MEAN_2="47.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2336" SD_1="16.7" SD_2="16.3" SE="4.002131784877831" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" WEIGHT="0.7493756776256777"/>
<CONT_DATA CI_END="1.736922204182004" CI_START="-4.536922204182002" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" MEAN_1="55.6" MEAN_2="57.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2337" SD_1="7.8" SD_2="8.2" SE="1.6004999218994045" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="2.0695074907401825"/>
<CONT_DATA CI_END="2.5250204056373384" CI_START="-3.925020405637344" EFFECT_SIZE="-0.7000000000000028" ESTIMABLE="YES" MEAN_1="39.4" MEAN_2="40.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2338" SD_1="8.24" SD_2="9.15" SE="1.6454488098127775" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" WEIGHT="2.0307166555387623"/>
<CONT_DATA CI_END="4.939735617490298" CI_START="-7.619735617490305" EFFECT_SIZE="-1.3400000000000034" ESTIMABLE="YES" MEAN_1="38.79" MEAN_2="40.13" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2339" SD_1="11.58" SD_2="11.07" SE="3.204005617972603" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" WEIGHT="1.0303002036153566"/>
<CONT_DATA CI_END="4.956878479651283" CI_START="-10.956878479651284" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="39.81" MEAN_2="42.81" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2340" SD_1="14.59" SD_2="16.78" SE="4.059706475432265" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.7332408573329771"/>
<CONT_DATA CI_END="3.559393142576109" CI_START="-6.359393142576106" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" MEAN_1="42.2" MEAN_2="43.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2341" SD_1="9.8" SD_2="9.8" SE="2.530349119522179" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.3770206867535286"/>
<CONT_DATA CI_END="11.700936687321873" CI_START="-9.700936687321873" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="48.9" MEAN_2="47.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2342" SD_1="15.7" SD_2="18.7" SE="5.4597618995703465" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.4531102125957858"/>
<CONT_DATA CI_END="7.303463527711248" CI_START="2.236536472288759" EFFECT_SIZE="4.770000000000003" ESTIMABLE="YES" MEAN_1="50.35" MEAN_2="45.58" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2344" SD_1="4.75" SD_2="5.25" SE="1.2926071844660827" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3427221039978408"/>
<CONT_DATA CI_END="5.647410424357823" CI_START="-3.047410424357829" EFFECT_SIZE="1.2999999999999972" ESTIMABLE="YES" MEAN_1="49.9" MEAN_2="48.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2345" SD_1="10.2" SD_2="6.6" SE="2.2181073012818833" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.5812600656903677"/>
<CONT_DATA CI_END="1.8790108312936158" CI_START="-4.4790108312936106" EFFECT_SIZE="-1.2999999999999972" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="41.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2346" SD_1="7.7" SD_2="8.5" SE="1.621974105835232" STUDY_ID="STD-Zhang-2010a" TOTAL_1="50" TOTAL_2="50" WEIGHT="2.0509262236975614"/>
<CONT_DATA CI_END="0.9404209523906149" CI_START="-10.940420952390614" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="44.2" MEAN_2="49.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2347" SD_1="13.9" SD_2="13.2" SE="3.0308827097068605" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.1082735478625387"/>
<CONT_DATA CI_END="7.296312351292736" CI_START="-5.89631235129273" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" MEAN_1="48.5" MEAN_2="47.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2348" SD_1="13.2" SD_2="13.3" SE="3.365527327707857" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" WEIGHT="0.9636501121840692"/>
<CONT_DATA CI_END="2.536892349852807" CI_START="-5.736892349852796" EFFECT_SIZE="-1.5999999999999943" ESTIMABLE="YES" MEAN_1="40.2" MEAN_2="41.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2349" SD_1="7.67" SD_2="8.65" SE="2.1106981467435526" STUDY_ID="STD-Zhou-2007b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.658395321131666"/>
<CONT_DATA CI_END="3.2573083241107623" CI_START="-5.457308324110765" EFFECT_SIZE="-1.1000000000000014" ESTIMABLE="YES" MEAN_1="45.4" MEAN_2="46.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2350" SD_1="13.4" SD_2="12.9" SE="2.223157342931123" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" WEIGHT="1.5777201975057016"/>
<CONT_DATA CI_END="8.18623676139705" CI_START="-10.546236761397049" EFFECT_SIZE="-1.1799999999999997" ESTIMABLE="YES" MEAN_1="49.11" MEAN_2="50.29" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2351" SD_1="16.12" SD_2="17.57" SE="4.778780036407163" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="28" WEIGHT="0.5662899081336062"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.727913579908907" CI_START="-8.027913579908919" DF="0" EFFECT_SIZE="-0.15000000000000568" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.9702307836780784" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="28" WEIGHT="100.0" Z="0.037318840159759475">
<NAME>PANSS (medium term, 12 to 24 weeks, high=poor)</NAME>
<CONT_DATA CI_END="7.727913579908907" CI_START="-8.027913579908919" EFFECT_SIZE="-0.15000000000000568" ESTIMABLE="YES" MEAN_1="43.41" MEAN_2="43.56" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2274" SD_1="13.25" SD_2="15.13" SE="4.019417520959002" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.615693877660487" CI_START="-3.7156938776604815" DF="0" EFFECT_SIZE="-0.5499999999999972" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.7334654134988474" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="28" WEIGHT="99.99999999999999" Z="0.34051940369347233">
<NAME>SANS (medium term, 12 to 24 weeks, high=poor)</NAME>
<CONT_DATA CI_END="2.615693877660487" CI_START="-3.7156938776604815" EFFECT_SIZE="-0.5499999999999972" ESTIMABLE="YES" MEAN_1="48.21" MEAN_2="48.76" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2357" SD_1="5.36" SD_2="6.04" SE="1.6151796168863681" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="28" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="52.320162891354784" CI_END="0.4136851565143924" CI_START="-0.3739418312750875" CI_STUDY="95" CI_TOTAL="95" DF="39" EFFECT_MEASURE="MD" EFFECT_SIZE="0.019871662619652446" ESTIMABLE="YES" I2="25.458947669973263" I2_Q="0.0" ID="CMP-003.07" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.07523338494748255" P_Q="0.8328571153240554" P_Z="0.9212184985636419" Q="0.04453738538302531" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="40" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.39350714686542493" TOTALS="YES" TOTAL_1="1695" TOTAL_2="1510" UNITS="" WEIGHT="99.99999999999997" Z="0.0988989550923305">
<NAME>Mental state: 3. Specific - average endpoint positive score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="52.286607140210585" CI_END="0.4317247366353658" CI_START="-0.37687917129685344" DF="38" EFFECT_SIZE="0.027422782669256174" ESTIMABLE="YES" I2="27.32364542587348" ID="CMP-003.07.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06133168748095963" P_Z="0.8942412926630656" STUDIES="39" TAU2="0.4326001046443902" TOTAL_1="1673" TOTAL_2="1482" WEIGHT="97.50267027325945" Z="0.13293941782956767">
<NAME>short term (up to 12 weeks)</NAME>
<CONT_DATA CI_END="5.044680559993171" CI_START="-0.4446805599931718" EFFECT_SIZE="2.3" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-8.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="35" SD_1="6.9" SD_2="5.8" SE="1.400372956668011" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="1.7146551889125008"/>
<CONT_DATA CI_END="1.4578036398554945" CI_START="-2.0578036398554924" EFFECT_SIZE="-0.29999999999999893" ESTIMABLE="YES" MEAN_1="10.8" MEAN_2="11.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="728" SD_1="4.3" SD_2="4.7" SE="0.8968550716854107" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" WEIGHT="3.3703913465217488"/>
<CONT_DATA CI_END="1.632727674804765" CI_START="-2.632727674804765" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="11.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2518" SD_1="4.2" SD_2="4.5" SE="1.0881463596410181" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" WEIGHT="2.5591542445565425"/>
<CONT_DATA CI_END="1.1772809572024892" CI_START="-2.6372809572024902" EFFECT_SIZE="-0.7300000000000004" ESTIMABLE="YES" MEAN_1="10.58" MEAN_2="11.31" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1573" SD_1="5.33" SD_2="5.33" SE="0.9731204105008451" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" WEIGHT="3.0118112390364584"/>
<CONT_DATA CI_END="4.286540996510736" CI_START="0.11345900348926641" EFFECT_SIZE="2.200000000000001" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="9.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1605" SD_1="3.2" SD_2="7.6" SE="1.0645812948447542" STUDY_ID="STD-CuiMeng-2008" TOTAL_1="60" TOTAL_2="60" WEIGHT="2.6441819628293226"/>
<CONT_DATA CI_END="1.4898383093447949" CI_START="-4.689838309344794" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="13.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2007" SD_1="4.34" SD_2="6.58" SE="1.5764770851490357" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="1.4024114503412253"/>
<CONT_DATA CI_END="1.911177002136037" CI_START="-2.1711770021360386" EFFECT_SIZE="-0.13000000000000078" ESTIMABLE="YES" MEAN_1="11.75" MEAN_2="11.88" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1618" SD_1="4.23" SD_2="5.56" SE="1.0414359744549295" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" WEIGHT="2.7313814259699973"/>
<CONT_DATA CI_END="4.139846847073597" CI_START="-0.7398468470735984" EFFECT_SIZE="1.6999999999999993" ESTIMABLE="YES" MEAN_1="10.66" MEAN_2="8.96" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2472" SD_1="4.71" SD_2="4.93" SE="1.2448426942121376" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.077690264291267"/>
<CONT_DATA CI_END="0.9094306346972902" CI_START="-5.5094306346972886" EFFECT_SIZE="-2.299999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="13.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1974" SD_1="3.2" SD_2="6.5" SE="1.63749469888879" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" WEIGHT="1.3129692877140893"/>
<CONT_DATA CI_END="3.199206313053035" CI_START="-2.0792063130530374" EFFECT_SIZE="0.5599999999999987" ESTIMABLE="YES" MEAN_1="11.12" MEAN_2="10.56" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2451" SD_1="4.99" SD_2="4.52" SE="1.34655857652016" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="1.8295166502999594"/>
<CONT_DATA CI_END="2.56779508299191" CI_START="-3.5477950829919105" EFFECT_SIZE="-0.4900000000000002" ESTIMABLE="YES" MEAN_1="13.57" MEAN_2="14.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1970" SD_1="6.32" SD_2="6.16" SE="1.5601281998605114" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" WEIGHT="1.42784574827155"/>
<CONT_DATA CI_END="11.629895887401243" CI_START="1.3701041125987556" EFFECT_SIZE="6.5" ESTIMABLE="YES" MEAN_1="11.6" MEAN_2="5.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1900" SD_1="4.3" SD_2="15.3" SE="2.617341914374554" STUDY_ID="STD-Li-2006" TOTAL_1="114" TOTAL_2="35" WEIGHT="0.5573235708932301"/>
<CONT_DATA CI_END="4.108749887660374" CI_START="-1.5087498876603762" EFFECT_SIZE="1.299999999999999" ESTIMABLE="YES" MEAN_1="13.6" MEAN_2="12.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1472" SD_1="5.5" SD_2="5.6" SE="1.4330619898199333" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.6497577881614067"/>
<CONT_DATA CI_END="1.3230773519566288" CI_START="-2.60307735195663" EFFECT_SIZE="-0.6400000000000006" ESTIMABLE="YES" MEAN_1="8.57" MEAN_2="9.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1790" SD_1="4.26" SD_2="4.58" SE="1.0015884819522873" STUDY_ID="STD-Liu-2008b" TOTAL_1="39" TOTAL_2="39" WEIGHT="2.8905868785806645"/>
<CONT_DATA CI_END="3.0077572150046543" CI_START="-3.2477572150046528" EFFECT_SIZE="-0.11999999999999922" ESTIMABLE="YES" MEAN_1="15.97" MEAN_2="16.09" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1759" SD_1="6.68" SD_2="6.85" SE="1.5958238210885523" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" WEIGHT="1.3731371554612157"/>
<CONT_DATA CI_END="3.061939510696832" CI_START="-1.4219395106968316" EFFECT_SIZE="0.8200000000000003" ESTIMABLE="YES" MEAN_1="11.97" MEAN_2="11.15" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="771" SD_1="4.47" SD_2="4.39" SE="1.1438677079685977" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3721417433985326"/>
<CONT_DATA CI_END="2.602436341650498" CI_START="-1.4024363416504988" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="10.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1747" SD_1="3.6" SD_2="3.2" SE="1.021669968145058" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" WEIGHT="2.8088758310744217"/>
<CONT_DATA CI_END="0.37171441882744394" CI_START="-3.0917144188274426" EFFECT_SIZE="-1.3599999999999994" ESTIMABLE="YES" MEAN_1="11.09" MEAN_2="12.45" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="960" SD_1="3.52" SD_2="4.34" SE="0.8835440000362178" STUDY_ID="STD-Luo-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.438418842517972"/>
<CONT_DATA CI_END="0.5692826130659645" CI_START="-3.7692826130659673" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="12.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1796" SD_1="4.2" SD_2="5.6" SE="1.1067971810589328" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.49442460954107"/>
<CONT_DATA CI_END="2.214412213884931" CI_START="-0.9144122138849302" EFFECT_SIZE="0.6500000000000004" ESTIMABLE="YES" MEAN_1="9.67" MEAN_2="9.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1068" SD_1="3.87" SD_2="4.03" SE="0.7981841637013815" STUDY_ID="STD-Ma-2009a" TOTAL_1="49" TOTAL_2="49" WEIGHT="3.9173530522629507"/>
<CONT_DATA CI_END="2.6042127229678527" CI_START="-3.4042127229678534" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="15.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1772" SD_1="6.7" SD_2="6.3" SE="1.532789758722456" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="1.4718612135372293"/>
<CONT_DATA CI_END="2.890950151827023" CI_START="-3.690950151827024" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="14.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1685" SD_1="6.7" SD_2="6.3" SE="1.6790870535303801" STUDY_ID="STD-Pan-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.2565964861129548"/>
<CONT_DATA CI_END="2.5832816906744673" CI_START="-1.0032816906744675" EFFECT_SIZE="0.79" ESTIMABLE="YES" MEAN_1="-4.41" MEAN_2="-5.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="36" SD_1="7.32" SD_2="7.3" SE="0.914956450638708" STUDY_ID="STD-Potkin-2003" TOTAL_1="194" TOTAL_2="95" WEIGHT="3.2805720628957484"/>
<CONT_DATA CI_END="1.732326056812603" CI_START="-3.332326056812601" EFFECT_SIZE="-0.7999999999999989" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="14.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1653" SD_1="5.2" SD_2="4.8" SE="1.2920268315067351" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.957128579069877"/>
<CONT_DATA CI_END="-0.38334798227233446" CI_START="-2.8166520177276686" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1630" SD_1="1.6" SD_2="3.0" SE="0.6207522318391883" STUDY_ID="STD-Song-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="5.18365976153284"/>
<CONT_DATA CI_END="2.982097297007608" CI_START="-0.48209729700760784" EFFECT_SIZE="1.25" ESTIMABLE="YES" MEAN_1="11.46" MEAN_2="10.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1081" SD_1="4.43" SD_2="3.63" SE="0.8837393496361006" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" WEIGHT="3.437408139443187"/>
<CONT_DATA CI_END="1.9760270767045902" CI_START="-0.9760270767045902" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="13.0" MEAN_2="12.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1074" SD_1="3.2" SD_2="3.1" SE="0.7530888773198402" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" WEIGHT="4.2026170207817035"/>
<CONT_DATA CI_END="5.989569502819967" CI_START="0.4104304971800312" EFFECT_SIZE="3.1999999999999993" ESTIMABLE="YES" MEAN_1="18.4" MEAN_2="15.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2036" SD_1="5.1" SD_2="6.7" SE="1.423275899365364" STUDY_ID="STD-Tu-2009" TOTAL_1="35" TOTAL_2="35" WEIGHT="1.6688195646291653"/>
<CONT_DATA CI_END="2.4772723613869894" CI_START="-2.0772723613869872" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="11.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1253" SD_1="4.5" SD_2="4.5" SE="1.161895003862225" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3155879028758797"/>
<CONT_DATA CI_END="3.1019660890446814" CI_START="-1.2619660890446815" EFFECT_SIZE="0.9199999999999999" ESTIMABLE="YES" MEAN_1="12.38" MEAN_2="11.46" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1403" SD_1="4.19" SD_2="4.43" SE="1.1132684611838541" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.4724776797823713"/>
<CONT_DATA CI_END="0.8644393131088655" CI_START="-4.024439313108866" EFFECT_SIZE="-1.58" ESTIMABLE="YES" MEAN_1="12.12" MEAN_2="13.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1420" SD_1="4.35" SD_2="6.58" SE="1.2471858321838007" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.0714654790532996"/>
<CONT_DATA CI_END="1.822950716359915" CI_START="-2.2229507163599136" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="11.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3374" SD_1="4.8" SD_2="5.4" SE="1.0321366781821968" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" WEIGHT="2.7674851489091497"/>
<CONT_DATA CI_END="1.0517236373867374" CI_START="-2.1917236373867377" EFFECT_SIZE="-0.5700000000000003" ESTIMABLE="YES" MEAN_1="8.84" MEAN_2="9.41" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2492" SD_1="2.13" SD_2="4.78" SE="0.8274252232075113" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.7446392678323916"/>
<CONT_DATA CI_END="2.2772723613869883" CI_START="-2.2772723613869883" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="11.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3328" SD_1="4.5" SD_2="4.5" SE="1.161895003862225" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3155879028758797"/>
<CONT_DATA CI_END="2.0004818250284115" CI_START="-3.8004818250284087" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="12.8" MEAN_2="13.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3321" SD_1="5.1" SD_2="6.3" SE="1.4798648586948742" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.5626990088870534"/>
<CONT_DATA CI_END="0.8972277681089023" CI_START="-3.4972277681089" EFFECT_SIZE="-1.299999999999999" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="12.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3340" SD_1="3.2" SD_2="5.7" SE="1.1210551752176843" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" WEIGHT="2.446411511616721"/>
<CONT_DATA CI_END="3.240370431070205" CI_START="0.15962956892979752" EFFECT_SIZE="1.700000000000001" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="9.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1290" SD_1="3.7" SD_2="2.2" SE="0.7859177225808479" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.9926311419763527"/>
<CONT_DATA CI_END="1.2661500458653636" CI_START="-2.8661500458653615" EFFECT_SIZE="-0.7999999999999989" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="11.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1029" SD_1="4.2" SD_2="4.1" SE="1.0541775574259988" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" WEIGHT="2.6829152359920996"/>
<CONT_DATA CI_END="1.073644732141849" CI_START="-2.6736447321418506" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="12.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1007" SD_1="5.4" SD_2="5.9" SE="0.9559587558347603" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" WEIGHT="3.0880788848194336"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.9576149073615778" CI_START="-2.3776149073615795" DF="0" EFFECT_SIZE="-0.21000000000000085" ESTIMABLE="YES" I2="0.0" ID="CMP-003.07.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8494010979274678" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="28" WEIGHT="2.497329726740522" Z="0.18988263798868382">
<NAME>medium term (12-26 weeks)</NAME>
<CONT_DATA CI_END="1.9576149073615778" CI_START="-2.3776149073615795" EFFECT_SIZE="-0.21000000000000085" ESTIMABLE="YES" MEAN_1="10.02" MEAN_2="10.23" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" SD_1="3.47" SD_2="4.35" SE="1.1059462951663646" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="28" WEIGHT="2.497329726740522"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="47.13266149817349" CI_END="-0.24845817189537917" CI_START="-1.0415359742219983" CI_STUDY="95" CI_TOTAL="95" DF="36" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6449970730586887" ESTIMABLE="YES" I2="23.61984480465825" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.1013809666222848" P_Q="1.0" P_Z="0.001432542689705431" Q="0.0" RANDOM="YES" SCALE="20.45" SORT_BY="STUDY" STUDIES="37" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.34499587531808723" TOTALS="SUB" TOTAL_1="1545" TOTAL_2="1431" UNITS="" WEIGHT="100.0" Z="3.1880126505120545">
<NAME>Mental state: 4. Specific - average endpoint negative score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="47.13266149817349" CI_END="-0.24845817189537917" CI_START="-1.0415359742219983" DF="36" EFFECT_SIZE="-0.6449970730586887" ESTIMABLE="YES" I2="23.61984480465825" ID="CMP-003.08.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1013809666222848" P_Z="0.001432542689705431" STUDIES="37" TAU2="0.34499587531808723" TOTAL_1="1545" TOTAL_2="1431" WEIGHT="100.0" Z="3.1880126505120545">
<NAME>short term (up to 12 weeks)</NAME>
<CONT_DATA CI_END="1.5895526600478167" CI_START="-3.1895526600478163" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-4.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="37" SD_1="5.1" SD_2="5.7" SE="1.2191819231864989" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="2.2350750060393696"/>
<CONT_DATA CI_END="3.2362028305675805" CI_START="-0.2362028305675803" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="13.1" MEAN_2="11.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="729" SD_1="4.6" SD_2="4.3" SE="0.8858340481062543" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" WEIGHT="3.623373624605624"/>
<CONT_DATA CI_END="1.4816983224122255" CI_START="-2.881698322412224" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.9" MEAN_2="12.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2513" SD_1="3.4" SD_2="5.3" SE="1.1131318430446593" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" WEIGHT="2.5840697583417827"/>
<CONT_DATA CI_END="3.079587239945452" CI_START="-0.6995872399454528" EFFECT_SIZE="1.1899999999999995" ESTIMABLE="YES" MEAN_1="13.94" MEAN_2="12.75" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1574" SD_1="5.67" SD_2="4.86" SE="0.9640928378532847" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" WEIGHT="3.211777861997718"/>
<CONT_DATA CI_END="-0.07493881813438685" CI_START="-6.125061181865616" EFFECT_SIZE="-3.1000000000000014" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="12.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1606" SD_1="8.7" SD_2="8.2" SE="1.5434269230082343" STUDY_ID="STD-CuiMeng-2008" TOTAL_1="60" TOTAL_2="60" WEIGHT="1.5009436658397644"/>
<CONT_DATA CI_END="0.7229440441867958" CI_START="-2.622944044186794" EFFECT_SIZE="-0.9499999999999993" ESTIMABLE="YES" MEAN_1="10.06" MEAN_2="11.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1619" SD_1="4.22" SD_2="3.87" SE="0.8535585640260557" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" WEIGHT="3.8128512583398337"/>
<CONT_DATA CI_END="0.6345120761752949" CI_START="-4.434512076175292" EFFECT_SIZE="-1.8999999999999986" ESTIMABLE="YES" MEAN_1="11.47" MEAN_2="13.37" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2473" SD_1="4.63" SD_2="5.36" SE="1.2931421680026782" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.02919487060101"/>
<CONT_DATA CI_END="0.7695518112635549" CI_START="-2.389551811263556" EFFECT_SIZE="-0.8100000000000005" ESTIMABLE="YES" MEAN_1="7.32" MEAN_2="8.13" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1988" SD_1="2.9" SD_2="3.73" SE="0.805908590016377" STUDY_ID="STD-Feng-2006" TOTAL_1="35" TOTAL_2="34" WEIGHT="4.116019119870946"/>
<CONT_DATA CI_END="4.298136930428063" CI_START="-0.3581369304280613" EFFECT_SIZE="1.9700000000000006" ESTIMABLE="YES" MEAN_1="10.88" MEAN_2="8.91" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2452" SD_1="5.12" SD_2="3.01" SE="1.1878467914676538" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="2.3310783483093127"/>
<CONT_DATA CI_END="2.2850500774232483" CI_START="-1.8850500774232497" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="12.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1900" SD_1="4.4" SD_2="4.5" SE="1.0638206078631331" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" WEIGHT="2.7719165555452223"/>
<CONT_DATA CI_END="2.8609763820041" CI_START="-1.8609763820040999" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="12.67" MEAN_2="12.17" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1924" SD_1="6.11" SD_2="4.22" SE="1.204601921579774" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" WEIGHT="2.279051673641756"/>
<CONT_DATA CI_END="0.16389504103417263" CI_START="-4.363895041034172" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="14.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1845" SD_1="5.6" SD_2="5.1" SE="1.1550697150006262" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" WEIGHT="2.437685452596593"/>
<CONT_DATA CI_END="-0.8916585956081409" CI_START="-3.8083414043918618" EFFECT_SIZE="-2.3500000000000014" ESTIMABLE="YES" MEAN_1="11.03" MEAN_2="13.38" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1790" SD_1="3.54" SD_2="3.01" SE="0.7440654093111259" STUDY_ID="STD-Liu-2008b" TOTAL_1="39" TOTAL_2="39" WEIGHT="4.555068212450336"/>
<CONT_DATA CI_END="-2.19127447267764" CI_START="-7.64872552732236" EFFECT_SIZE="-4.92" ESTIMABLE="YES" MEAN_1="12.63" MEAN_2="17.55" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" SD_1="5.56" SD_2="5.49" SE="1.3922324842936904" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" WEIGHT="1.7927142719577773"/>
<CONT_DATA CI_END="2.1633418252938093" CI_START="-3.80334182529381" EFFECT_SIZE="-0.8200000000000003" ESTIMABLE="YES" MEAN_1="14.45" MEAN_2="15.27" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1759" SD_1="6.31" SD_2="6.59" SE="1.5221411458710614" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" WEIGHT="1.5377372057791214"/>
<CONT_DATA CI_END="2.9459915570487456" CI_START="-1.905991557048743" EFFECT_SIZE="0.5200000000000014" ESTIMABLE="YES" MEAN_1="12.88" MEAN_2="12.36" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="772" SD_1="4.35" SD_2="5.2" SE="1.2377735387918636" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.180684397462541"/>
<CONT_DATA CI_END="1.2954915759604262" CI_START="-2.095491575960427" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="11.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1747" SD_1="2.8" SD_2="3.0" SE="0.8650626181573986" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" WEIGHT="3.7439019379683773"/>
<CONT_DATA CI_END="1.3065552566360854" CI_START="-1.9665552566360855" EFFECT_SIZE="-0.33000000000000007" ESTIMABLE="YES" MEAN_1="12.2" MEAN_2="12.53" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="961" SD_1="2.89" SD_2="4.42" SE="0.8349925149365113" STUDY_ID="STD-Luo-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.9275421691542105"/>
<CONT_DATA CI_END="1.0972456883699022" CI_START="-2.197245688369904" EFFECT_SIZE="-0.5500000000000007" ESTIMABLE="YES" MEAN_1="11.93" MEAN_2="12.48" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1069" SD_1="4.16" SD_2="4.16" SE="0.8404469170674393" STUDY_ID="STD-Ma-2009a" TOTAL_1="49" TOTAL_2="49" WEIGHT="3.8934031761989463"/>
<CONT_DATA CI_END="0.12036038445727071" CI_START="-4.120360384457271" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="12.56" MEAN_2="14.56" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1689" SD_1="4.31" SD_2="6.32" SE="1.0818364016800324" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="2.701207285830075"/>
<CONT_DATA CI_END="1.2904109260970227" CI_START="-1.8904109260970223" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-3.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="38" SD_1="6.48" SD_2="6.48" SE="0.8114490565347021" STUDY_ID="STD-Potkin-2003" TOTAL_1="194" TOTAL_2="95" WEIGHT="4.07926246184575"/>
<CONT_DATA CI_END="2.004659858362272" CI_START="-2.6046598583622735" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="12.2" MEAN_2="12.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1630" SD_1="2.8" SD_2="5.8" SE="1.1758684733704985" STUDY_ID="STD-Song-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.3692805994422077"/>
<CONT_DATA CI_END="1.3547427295989345" CI_START="-2.714742729598934" EFFECT_SIZE="-0.6799999999999997" ESTIMABLE="YES" MEAN_1="10.86" MEAN_2="11.54" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1082" SD_1="5.24" SD_2="4.22" SE="1.0381531220209785" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" WEIGHT="2.8770303704663958"/>
<CONT_DATA CI_END="2.1420529865353894" CI_START="-2.3420529865353887" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="10.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1340" SD_1="4.8" SD_2="5.3" SE="1.1439256048684654" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" WEIGHT="2.47545491061136"/>
<CONT_DATA CI_END="1.5058413807146456" CI_START="-1.5058413807146456" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="18.1" MEAN_2="18.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SD_1="3.5" SD_2="2.9" SE="0.7683005364346132" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" WEIGHT="4.376561442678962"/>
<CONT_DATA CI_END="2.1874703062078806" CI_START="-3.38747030620788" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="13.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1253" SD_1="5.8" SD_2="5.2" SE="1.422204861005146" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.7288432242865817"/>
<CONT_DATA CI_END="2.7143685465117766" CI_START="-5.514368546511781" EFFECT_SIZE="-1.4000000000000021" ESTIMABLE="YES" MEAN_1="24.2" MEAN_2="25.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1269" SD_1="8.8" SD_2="7.4" SE="2.0992061991778384" STUDY_ID="STD-Wang-2007e" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.8614495046606825"/>
<CONT_DATA CI_END="-0.3007988630924294" CI_START="-4.51920113690757" EFFECT_SIZE="-2.41" ESTIMABLE="YES" MEAN_1="10.11" MEAN_2="12.52" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1404" SD_1="4.01" SD_2="4.32" SE="1.0761428034110219" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.723287847737616"/>
<CONT_DATA CI_END="2.1422299727246537" CI_START="-1.5422299727246522" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="12.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3374" SD_1="4.5" SD_2="4.8" SE="0.9399305228340561" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" WEIGHT="3.332057866143843"/>
<CONT_DATA CI_END="2.337116443632014" CI_START="-2.3771164436320134" EFFECT_SIZE="-0.019999999999999574" ESTIMABLE="YES" MEAN_1="10.76" MEAN_2="10.78" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2493" SD_1="4.53" SD_2="6.11" SE="1.202632529079436" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.2850832586767176"/>
<CONT_DATA CI_END="1.7348530767576475" CI_START="-3.3348530767576454" EFFECT_SIZE="-0.7999999999999989" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3328" SD_1="4.7" SD_2="5.3" SE="1.293316151088614" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.028742298541624"/>
<CONT_DATA CI_END="1.3447858086585494" CI_START="-4.744785808658548" EFFECT_SIZE="-1.6999999999999993" ESTIMABLE="YES" MEAN_1="13.9" MEAN_2="15.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3321" SD_1="4.2" SD_2="7.4" SE="1.553490693030806" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.4839843374274952"/>
<CONT_DATA CI_END="1.8628985220603642" CI_START="-4.462898522060366" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="24.3" MEAN_2="25.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3361" SD_1="8.6" SD_2="7.5" SE="1.6137533888422975" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="1.3879435331388423"/>
<CONT_DATA CI_END="2.631667949710782" CI_START="-2.2916679497107824" EFFECT_SIZE="0.16999999999999993" ESTIMABLE="YES" MEAN_1="12.17" MEAN_2="12.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="986" SD_1="5.45" SD_2="3.12" SE="1.2559761144225634" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" WEIGHT="2.1291949160141637"/>
<CONT_DATA CI_END="3.0515734152444263" CI_START="-2.111573415244425" EFFECT_SIZE="0.47000000000000064" ESTIMABLE="YES" MEAN_1="12.97" MEAN_2="12.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="940" SD_1="4.18" SD_2="5.88" SE="1.3171534964966434" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.9680458584433702"/>
<CONT_DATA CI_END="-0.10810354842631908" CI_START="-2.8918964515736807" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="12.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1291" SD_1="2.7" SD_2="2.8" SE="0.7101643002385668" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="4.8194708264030215"/>
<CONT_DATA CI_END="1.6142082959639525" CI_START="-3.814208295963952" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="12.5" MEAN_2="13.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1029" SD_1="5.3" SD_2="5.6" SE="1.3848255974973422" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" WEIGHT="1.8090108909510534"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="89.52061837407203" CI_END="0.20464745484287888" CI_START="-0.7132423376150332" CI_STUDY="95" CI_TOTAL="95" DF="57" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2542974413860772" ESTIMABLE="YES" I2="36.32751757609733" I2_Q="0.0" ID="CMP-003.09" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.003841658639096579" P_Q="0.4034787621101602" P_Z="0.27747932791028695" Q="0.6979352816318185" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="58" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="1.0757265405471363" TOTALS="YES" TOTAL_1="2119" TOTAL_2="2124" UNITS="" WEIGHT="99.99999999999999" Z="1.0859992791569266">
<NAME>Mental state: 5. Specific - average endpoint general psychopathological score (PANSS, high=poor )</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="88.93361757963667" CI_END="0.1899480029161721" CI_START="-0.7359861688020845" DF="56" EFFECT_SIZE="-0.2730190829429562" ESTIMABLE="YES" I2="37.03168551548673" ID="CMP-003.09.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0033428408947268062" P_Z="0.24775396867135735" STUDIES="57" TAU2="1.0975145284060124" TOTAL_1="2097" TOTAL_2="2096" WEIGHT="99.02544717144603" Z="1.155822057344203">
<NAME>by up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="3.1712837149524153" CI_START="-0.7712837149524168" EFFECT_SIZE="1.1999999999999993" ESTIMABLE="YES" MEAN_1="23.9" MEAN_2="22.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="730" SD_1="5.3" SD_2="4.8" SE="1.0057754787851463" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" WEIGHT="2.626865130304616"/>
<CONT_DATA CI_END="2.6260631591313324" CI_START="-3.026063159131338" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="19.9" MEAN_2="20.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2514" SD_1="6.2" SD_2="5.3" SE="1.4418954539078068" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" WEIGHT="1.7380192553997742"/>
<CONT_DATA CI_END="5.307354445019454" CI_START="0.9526455549805442" EFFECT_SIZE="3.129999999999999" ESTIMABLE="YES" MEAN_1="26.29" MEAN_2="23.16" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1575" SD_1="6.32" SD_2="5.84" SE="1.1109155383436373" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" WEIGHT="2.373773474831504"/>
<CONT_DATA CI_END="2.036282142963291" CI_START="-5.07628214296329" EFFECT_SIZE="-1.5199999999999996" ESTIMABLE="YES" MEAN_1="23.2" MEAN_2="24.72" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2007" SD_1="6.45" SD_2="6.38" SE="1.8144630059607167" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" WEIGHT="1.2552840911370646"/>
<CONT_DATA CI_END="1.331042116473046" CI_START="-3.131042116473043" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="19.87" MEAN_2="20.77" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1620" SD_1="4.58" SD_2="6.11" SE="1.1383077107902084" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" WEIGHT="2.312102544748009"/>
<CONT_DATA CI_END="-0.3250720057822498" CI_START="-6.334927994217754" EFFECT_SIZE="-3.330000000000002" ESTIMABLE="YES" MEAN_1="21.24" MEAN_2="24.57" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2474" SD_1="6.12" SD_2="5.75" SE="1.5331546997395056" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.6002977859503738"/>
<CONT_DATA CI_END="2.581001463814338" CI_START="0.17899853618565986" EFFECT_SIZE="1.379999999999999" ESTIMABLE="YES" MEAN_1="13.62" MEAN_2="12.24" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1988" SD_1="2.59" SD_2="2.5" SE="0.6127671086242836" STUDY_ID="STD-Feng-2006" TOTAL_1="35" TOTAL_2="34" WEIGHT="3.7782842144627518"/>
<CONT_DATA CI_END="2.6831445810272267" CI_START="-5.683144581027227" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="24.5" MEAN_2="26.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1974" SD_1="4.3" SD_2="8.4" SE="2.1342966575015345" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.9737407194055988"/>
<CONT_DATA CI_END="1.5800864935437091" CI_START="-3.1800864935437034" EFFECT_SIZE="-0.7999999999999972" ESTIMABLE="YES" MEAN_1="22.6" MEAN_2="23.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="913" SD_1="4.6" SD_2="6.5" SE="1.2143521576506122" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" WEIGHT="2.1499106159919203"/>
<CONT_DATA CI_END="3.997207057400963" CI_START="-3.6772070574009628" EFFECT_SIZE="0.16000000000000014" ESTIMABLE="YES" MEAN_1="23.12" MEAN_2="22.96" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2453" SD_1="7.08" SD_2="6.76" SE="1.9577946776922242" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="1.1170165489084054"/>
<CONT_DATA CI_END="-0.3238815278831346" CI_START="-6.356118472116865" EFFECT_SIZE="-3.34" ESTIMABLE="YES" MEAN_1="21.42" MEAN_2="24.76" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1970" SD_1="6.08" SD_2="6.23" SE="1.5388642321530512" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" WEIGHT="1.5921472987032823"/>
<CONT_DATA CI_END="3.7843023652262264" CI_START="-1.5843023652262307" EFFECT_SIZE="1.0999999999999979" ESTIMABLE="YES" MEAN_1="24.7" MEAN_2="23.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1900" SD_1="6.6" SD_2="4.7" SE="1.369567189193099" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" WEIGHT="1.8577652143344856"/>
<CONT_DATA CI_END="4.179649341636563" CI_START="-2.3196493416365636" EFFECT_SIZE="0.9299999999999997" ESTIMABLE="YES" MEAN_1="23.16" MEAN_2="22.23" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1924" SD_1="7.77" SD_2="6.64" SE="1.6580148243893167" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" WEIGHT="1.43358359823253"/>
<CONT_DATA CI_END="6.622138125600471" CI_START="2.377861874399529" EFFECT_SIZE="4.5" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="20.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1879" SD_1="6.5" SD_2="5.3" SE="1.0827434291342217" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" WEIGHT="2.439029388363452"/>
<CONT_DATA CI_END="2.7135839488489135" CI_START="-3.7135839488489135" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="25.1" MEAN_2="25.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1474" SD_1="6.3" SD_2="6.4" SE="1.6396137756597844" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.4566941767433799"/>
<CONT_DATA CI_END="9.705800272722428" CI_START="-3.305800272722429" EFFECT_SIZE="3.1999999999999993" ESTIMABLE="YES" MEAN_1="26.2" MEAN_2="23.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1864" SD_1="17.2" SD_2="9.9" SE="3.319346847207066" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" WEIGHT="0.4533801301668121"/>
<CONT_DATA CI_END="1.2671015405163315" CI_START="-3.4671015405163272" EFFECT_SIZE="-1.0999999999999979" ESTIMABLE="YES" MEAN_1="22.1" MEAN_2="23.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1845" SD_1="5.6" SD_2="5.6" SE="1.2077270598785101" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" WEIGHT="2.1635231090280804"/>
<CONT_DATA CI_END="2.969650959266949" CI_START="-2.5696509592669434" EFFECT_SIZE="0.20000000000000284" ESTIMABLE="YES" MEAN_1="26.1" MEAN_2="25.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1807" SD_1="6.9" SD_2="6.5" SE="1.4131131904022725" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" WEIGHT="1.78450060709404"/>
<CONT_DATA CI_END="1.731507429735617" CI_START="-3.271507429735616" EFFECT_SIZE="-0.7699999999999996" ESTIMABLE="YES" MEAN_1="18.69" MEAN_2="19.46" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1790" SD_1="5.37" SD_2="5.89" SE="1.2763027532481146" STUDY_ID="STD-Liu-2008b" TOTAL_1="39" TOTAL_2="39" WEIGHT="2.0272615287072946"/>
<CONT_DATA CI_END="2.2857582368802944" CI_START="-4.48575823688029" EFFECT_SIZE="-1.0999999999999979" ESTIMABLE="YES" MEAN_1="27.19" MEAN_2="28.29" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" SD_1="6.87" SD_2="6.84" SE="1.7274594143498152" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" WEIGHT="1.3505656946821765"/>
<CONT_DATA CI_END="3.4083678036763594" CI_START="-5.1883678036763605" EFFECT_SIZE="-0.8900000000000006" ESTIMABLE="YES" MEAN_1="29.28" MEAN_2="30.17" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1759" SD_1="9.27" SD_2="9.33" SE="2.193085096247348" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" WEIGHT="0.9316498145180274"/>
<CONT_DATA CI_END="4.823346372565112" CI_START="-1.2433463725651133" EFFECT_SIZE="1.7899999999999991" ESTIMABLE="YES" MEAN_1="23.49" MEAN_2="21.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="773" SD_1="5.77" SD_2="6.21" SE="1.5476541387963052" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.5797025314110344"/>
<CONT_DATA CI_END="1.6663825130332315" CI_START="-4.06638251303323" EFFECT_SIZE="-1.1999999999999993" ESTIMABLE="YES" MEAN_1="23.6" MEAN_2="24.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1747" SD_1="4.8" SD_2="5.0" SE="1.4624669308430616" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" WEIGHT="1.7057155338813894"/>
<CONT_DATA CI_END="1.5787445317083997" CI_START="-2.1387445317084017" EFFECT_SIZE="-0.28000000000000114" ESTIMABLE="YES" MEAN_1="23.91" MEAN_2="24.19" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="962" SD_1="4.34" SD_2="4.14" SE="0.9483564730627402" STUDY_ID="STD-Luo-2009" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.7760953582160686"/>
<CONT_DATA CI_END="-1.4959590338658622" CI_START="-6.504040966134138" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="24.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1796" SD_1="4.8" SD_2="6.5" SE="1.2775953976122487" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.0247901032729274"/>
<CONT_DATA CI_END="1.84317648317391" CI_START="-3.1831764831739062" EFFECT_SIZE="-0.6699999999999982" ESTIMABLE="YES" MEAN_1="16.76" MEAN_2="17.43" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1070" SD_1="5.68" SD_2="6.95" SE="1.2822564613419039" STUDY_ID="STD-Ma-2009a" TOTAL_1="49" TOTAL_2="49" WEIGHT="2.015907799101835"/>
<CONT_DATA CI_END="2.1955299407116997" CI_START="-3.995529940711697" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="28.3" MEAN_2="29.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1772" SD_1="6.6" SD_2="6.8" SE="1.5793810320642845" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" WEIGHT="1.5358043416534104"/>
<CONT_DATA CI_END="2.034961574142284" CI_START="-3.6149615741422823" EFFECT_SIZE="-0.7899999999999991" ESTIMABLE="YES" MEAN_1="24.27" MEAN_2="25.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1689" SD_1="7.05" SD_2="7.36" SE="1.4413334104224462" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="1.7389124712768065"/>
<CONT_DATA CI_END="2.4909831519208545" CI_START="-4.290983151920852" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="28.3" MEAN_2="29.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1685" SD_1="6.6" SD_2="6.8" SE="1.7301252363147972" STUDY_ID="STD-Pan-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.3475063698107113"/>
<CONT_DATA CI_END="2.358735296340041" CI_START="-2.7587352963400398" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="25.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1653" SD_1="5.3" SD_2="4.8" SE="1.3055011809007808" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.9722899318501692"/>
<CONT_DATA CI_END="4.197146911575347" CI_START="-0.3971469115753501" EFFECT_SIZE="1.8999999999999986" ESTIMABLE="YES" MEAN_1="26.0" MEAN_2="24.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1630" SD_1="2.0" SD_2="6.1" SE="1.172035266818651" STUDY_ID="STD-Song-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="2.2385479322171133"/>
<CONT_DATA CI_END="0.49848908521890234" CI_START="-7.098489085218904" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="21.7" MEAN_2="25.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1099" SD_1="7.8" SD_2="7.2" SE="1.9380402472601028" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.1348084485290855"/>
<CONT_DATA CI_END="3.3222104634155802" CI_START="-3.522210463415576" EFFECT_SIZE="-0.09999999999999787" ESTIMABLE="YES" MEAN_1="25.1" MEAN_2="25.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1860" SD_1="8.9" SD_2="6.3" SE="1.746057830862984" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" WEIGHT="1.3294115397761377"/>
<CONT_DATA CI_END="2.755913921703713" CI_START="-2.55591392170371" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="19.1" MEAN_2="19.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1675" SD_1="5.7" SD_2="6.4" SE="1.3550830232867652" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.882942401096705"/>
<CONT_DATA CI_END="3.4890510576301064" CI_START="-0.20905105763011234" EFFECT_SIZE="1.639999999999997" ESTIMABLE="YES" MEAN_1="19.58" MEAN_2="17.94" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1083" SD_1="4.89" SD_2="3.67" SE="0.9434107321436456" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" WEIGHT="2.789308468899528"/>
<CONT_DATA CI_END="2.156942866129776" CI_START="-4.356942866129779" EFFECT_SIZE="-1.1000000000000014" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="21.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1377" SD_1="7.2" SD_2="6.9" SE="1.661736078734164" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" WEIGHT="1.4289681326944115"/>
<CONT_DATA CI_END="5.2709150173314825" CI_START="-2.270915017331482" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="21.8" MEAN_2="20.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1356" SD_1="7.6" SD_2="7.3" SE="1.9239715867617866" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.1477146346077844"/>
<CONT_DATA CI_END="2.1963534652449925" CI_START="-3.3963534652449954" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="19.5" MEAN_2="20.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1340" SD_1="6.2" SD_2="6.4" SE="1.4267371682858834" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" WEIGHT="1.7623097829806917"/>
<CONT_DATA CI_END="2.9508646591737224" CI_START="-2.7508646591737267" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="26.2" MEAN_2="26.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1076" SD_1="5.4" SD_2="6.7" SE="1.4545495129813513" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" WEIGHT="1.7180591455985725"/>
<CONT_DATA CI_END="2.093658071255395" CI_START="-4.093658071255395" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="21.3" MEAN_2="22.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2036" SD_1="6.4" SD_2="6.8" SE="1.5784259790780724" STUDY_ID="STD-Tu-2009" TOTAL_1="35" TOTAL_2="35" WEIGHT="1.5371027967881765"/>
<CONT_DATA CI_END="4.249696302971843" CI_START="-4.049696302971848" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="23.4" MEAN_2="23.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1253" SD_1="8.2" SD_2="8.2" SE="2.117230895926721" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.986451280934756"/>
<CONT_DATA CI_END="0.5416634808986722" CI_START="-4.541663480898672" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="16.6" MEAN_2="18.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1269" SD_1="5.8" SD_2="4.1" SE="1.2967909109284605" STUDY_ID="STD-Wang-2007e" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.988502794904417"/>
<CONT_DATA CI_END="3.918803038290023" CI_START="-2.7988030382900257" EFFECT_SIZE="0.5599999999999987" ESTIMABLE="YES" MEAN_1="24.02" MEAN_2="23.46" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1405" SD_1="5.31" SD_2="7.74" SE="1.7137065092949841" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.3664950770389706"/>
<CONT_DATA CI_END="1.3193402056142496" CI_START="-4.2993402056142465" EFFECT_SIZE="-1.4899999999999984" ESTIMABLE="YES" MEAN_1="23.21" MEAN_2="24.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1422" SD_1="6.46" SD_2="6.36" SE="1.4333631779838634" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.7516404895800377"/>
<CONT_DATA CI_END="3.0554964987784192" CI_START="-2.455496498778418" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="24.5" MEAN_2="24.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3374" SD_1="6.6" SD_2="7.3" SE="1.4058913941855173" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" WEIGHT="1.7964030632803933"/>
<CONT_DATA CI_END="3.0407105678444726" CI_START="-3.0207105678444695" EFFECT_SIZE="0.010000000000001563" ESTIMABLE="YES" MEAN_1="20.09" MEAN_2="20.08" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2494" SD_1="6.98" SD_2="6.85" SE="1.5463093157580083" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.5815984817884776"/>
<CONT_DATA CI_END="4.348800473495256" CI_START="-3.7488004734952547" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="23.5" MEAN_2="23.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3328" SD_1="8.1" SD_2="7.9" SE="2.0657524859801897" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.0262067483089867"/>
<CONT_DATA CI_END="2.089787442721719" CI_START="-4.289787442721722" EFFECT_SIZE="-1.1000000000000014" ESTIMABLE="YES" MEAN_1="27.2" MEAN_2="28.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3321" SD_1="6.5" SD_2="6.1" SE="1.6274724780059004" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.4722087046488215"/>
<CONT_DATA CI_END="2.2484569046132177" CI_START="-3.2484569046132177" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="25.6" MEAN_2="26.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3303" SD_1="6.8" SD_2="6.5" SE="1.4022996985111436" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" WEIGHT="1.8023589490024268"/>
<CONT_DATA CI_END="-0.2215093180556278" CI_START="-6.378490681944374" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="20.3" MEAN_2="23.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3340" SD_1="4.8" SD_2="7.8" SE="1.5706873729451738" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" WEIGHT="1.547676061551165"/>
<CONT_DATA CI_END="-0.408537701465423" CI_START="-4.391462298534574" EFFECT_SIZE="-2.3999999999999986" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="18.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3361" SD_1="5.9" SD_2="4.1" SE="1.016070863670443" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="2.6009274081678417"/>
<CONT_DATA CI_END="1.4735672259314507" CI_START="-2.093567225931448" EFFECT_SIZE="-0.3099999999999987" ESTIMABLE="YES" MEAN_1="19.75" MEAN_2="20.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="986" SD_1="3.64" SD_2="2.73" SE="0.91" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" WEIGHT="2.880033439191015"/>
<CONT_DATA CI_END="5.07865574633644" CI_START="-4.878655746336437" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="21.6" MEAN_2="21.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" SD_1="6.8" SD_2="9.1" SE="2.5401771591761073" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.7283367562948768"/>
<CONT_DATA CI_END="3.7569382428205302" CI_START="-1.5569382428205274" EFFECT_SIZE="1.1000000000000014" ESTIMABLE="YES" MEAN_1="27.3" MEAN_2="26.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1292" SD_1="5.2" SD_2="5.3" SE="1.3556056457047776" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.882026801469342"/>
<CONT_DATA CI_END="-0.010411956202517114" CI_START="-6.589588043797484" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="21.7" MEAN_2="25.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1046" SD_1="7.8" SD_2="7.2" SE="1.6783920876839238" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.4085459232963318"/>
<CONT_DATA CI_END="3.7089939288204192" CI_START="-4.508993928820416" EFFECT_SIZE="-0.3999999999999986" ESTIMABLE="YES" MEAN_1="23.1" MEAN_2="23.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1029" SD_1="8.0" SD_2="8.5" SE="2.0964639969058805" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" WEIGHT="1.0022293033055014"/>
<CONT_DATA CI_END="2.206506505728202" CI_START="-2.6065065057282006" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="23.1" MEAN_2="23.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1007" SD_1="7.7" SD_2="6.8" SE="1.2278320033992551" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" WEIGHT="2.122513223306547"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.7009894891571395" CI_START="-2.6609894891571404" DF="0" EFFECT_SIZE="1.5199999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-003.09.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4761270501862883" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="28" WEIGHT="0.9745528285539554" Z="0.7125455025005235">
<NAME>12- 26 weeks - medium term</NAME>
<CONT_DATA CI_END="5.7009894891571395" CI_START="-2.6609894891571404" EFFECT_SIZE="1.5199999999999996" ESTIMABLE="YES" MEAN_1="23.45" MEAN_2="21.93" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" SD_1="5.32" SD_2="9.56" SE="2.1331971006285073" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="28" WEIGHT="0.9745528285539554"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.998445819182823" CI_END="0.05592232501456271" CI_START="-0.07507882405721855" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.009578249521327924" ESTIMABLE="YES" I2="9.986010198377276" I2_Q="60.374589408378334" ID="CMP-003.10" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.3506112149246261" P_Q="0.055764504744326704" P_Z="0.7744120743417197" Q="7.570899468822956" RANDOM="YES" SCALE="30.54" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0014891995899490146" TOTALS="SUB" TOTAL_1="349" TOTAL_2="352" UNITS="" WEIGHT="400.0" Z="0.2866085409137012">
<NAME>Mental state: 6. PANSS average score decreased rate (short term, up to 12 weeks, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours risperidone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.1636466805684684" CI_END="5.870568672889785" CI_START="0.24151435922734565" DF="2" EFFECT_SIZE="3.0560415160585657" ESTIMABLE="YES" I2="0.0" ID="CMP-003.10.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5588786059765457" P_Z="0.033324786156966414" STUDIES="3" TAU2="0.0" TOTAL_1="108" TOTAL_2="111" WEIGHT="100.0" Z="2.1281483435667425">
<NAME>total scale score decreased rate</NAME>
<CONT_DATA CI_END="14.624038412253837" CI_START="-12.424038412253848" EFFECT_SIZE="1.0999999999999943" ESTIMABLE="YES" MEAN_1="68.3" MEAN_2="67.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="927" SD_1="28.1" SD_2="29.2" SE="6.900146389897841" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" WEIGHT="4.331098847624588"/>
<CONT_DATA CI_END="12.830176008747188" CI_START="-0.2901760087471805" EFFECT_SIZE="6.270000000000003" ESTIMABLE="YES" MEAN_1="45.14" MEAN_2="38.87" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2454" SD_1="11.37" SD_2="12.28" SE="3.3470900794570793" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="18.406868244901315"/>
<CONT_DATA CI_END="5.602007743968253" CI_START="-0.8020077439682409" EFFECT_SIZE="2.4000000000000057" ESTIMABLE="YES" MEAN_1="54.7" MEAN_2="52.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1434" SD_1="7.6" SD_2="8.7" SE="1.6337074401495513" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" WEIGHT="77.2620329074741"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0432093273528165" CI_END="0.0808399312534624" CI_START="-0.11497094345275444" DF="2" EFFECT_SIZE="-0.017065506099646015" ESTIMABLE="YES" I2="0.0" ID="CMP-003.10.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5935673930569267" P_Z="0.7326267229393344" STUDIES="3" TAU2="0.0" TOTAL_1="108" TOTAL_2="108" WEIGHT="100.0" Z="0.3416335010344843">
<NAME>negative symptom subscale score decreased rate</NAME>
<CONT_DATA CI_END="0.1216191671140919" CI_START="-0.16161916711409194" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.74" MEAN_2="0.76" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2364" SD_1="0.34" SD_2="0.33" SE="0.0722560048200711" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" WEIGHT="47.793578791334404"/>
<CONT_DATA CI_END="2.5750425032812125" CI_START="-0.8350425032812141" EFFECT_SIZE="0.8699999999999992" ESTIMABLE="YES" MEAN_1="9.78" MEAN_2="8.91" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2365" SD_1="3.14" SD_2="3.01" SE="0.8699356298025734" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.3297184157701064"/>
<CONT_DATA CI_END="0.1159316627115948" CI_START="-0.15593166271159462" EFFECT_SIZE="-0.019999999999999907" ESTIMABLE="YES" MEAN_1="0.68" MEAN_2="0.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2366" SD_1="0.32" SD_2="0.3" SE="0.06935416353759881" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="51.87670279289549"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.22069034243857882" CI_END="0.07917097561154039" CI_START="-0.09726457930833195" DF="2" EFFECT_SIZE="-0.009046801848395776" ESTIMABLE="YES" I2="0.0" ID="CMP-003.10.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8955249747770269" P_Z="0.8407018313121324" STUDIES="3" TAU2="0.0" TOTAL_1="108" TOTAL_2="108" WEIGHT="99.99999999999999" Z="0.20099583449808373">
<NAME>positive symptom subscale score decreased rate</NAME>
<CONT_DATA CI_END="0.11709049648673239" CI_START="-0.1370904964867324" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.72" MEAN_2="0.73" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2367" SD_1="0.28" SD_2="0.32" SE="0.06484328155476632" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" WEIGHT="48.182138482420434"/>
<CONT_DATA CI_END="2.4189053180712365" CI_START="-1.4989053180712386" EFFECT_SIZE="0.4599999999999991" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="11.64" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2368" SD_1="3.83" SD_2="3.21" SE="0.9994598541212149" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.20280811736260312"/>
<CONT_DATA CI_END="0.11279139168209" CI_START="-0.13279139168209003" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.73" MEAN_2="0.74" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2369" SD_1="0.29" SD_2="0.27" SE="0.06264982043070834" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="51.61505340021695"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.08814827566058" CI_START="-0.328148275660582" DF="0" EFFECT_SIZE="2.379999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-003.10.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.08498373616759383" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.722473737915068">
<NAME>general pathology subscale score decreased rate</NAME>
<CONT_DATA CI_END="5.088148275660579" CI_START="-0.3281482756605816" EFFECT_SIZE="2.379999999999999" ESTIMABLE="YES" MEAN_1="18.34" MEAN_2="15.96" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2370" SD_1="5.19" SD_2="4.56" SE="1.3817336935893254" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.8117723076287672E-4" CI_END="0.6653047671477466" CI_START="-6.614643335630717" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.974669284241485" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.11" MODIFIED="2013-06-27 22:14:17 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.9892606312348112" P_Q="1.0" P_Z="0.10921599515923641" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="68" TOTAL_2="64" UNITS="" WEIGHT="100.0" Z="1.6017269850606992">
<NAME>Mental state: 7. BPRS total score decreased rate (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.1639862855492122" CI_START="-8.063986285549218" EFFECT_SIZE="-2.950000000000003" ESTIMABLE="YES" MEAN_1="-48.64" MEAN_2="-45.69" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2376" SD_1="9.24" SD_2="11.51" SE="2.6092246214153354" STUDY_ID="STD-Pu-2007" TOTAL_1="32" TOTAL_2="32" WEIGHT="50.661431517032426"/>
<CONT_DATA CI_END="2.182090763816092" CI_START="-8.182090763816092" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-29.0" MEAN_2="-26.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2375" SD_1="13.6" SD_2="7.7" SE="2.6439724427039284" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" WEIGHT="49.338568482967574"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.955133323147018" CI_START="-2.9551333231470176" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="1.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.12" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.50931750465512" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="243" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="0.6599007849070074">
<NAME>Mental state: 8. General - average total score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.955133323147018" CI_START="-2.9551333231470176" DF="1" EFFECT_SIZE="1.5" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.50931750465512" STUDIES="2" TAU2="0.0" TOTAL_1="243" TOTAL_2="129" WEIGHT="100.0" Z="0.6599007849070074">
<NAME>up to 12 weeks (short-term)</NAME>
<CONT_DATA CI_END="9.162986088039368" CI_START="-6.162986088039367" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="-19.6" MEAN_2="-21.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="18.1" SD_2="17.1" SE="3.9097586223440954" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="33.800672109006726"/>
<CONT_DATA CI_END="6.975627740929717" CI_START="-3.975627740929717" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-15.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="34" SD_1="22.31" SD_2="22.31" SE="2.793738958532284" STUDY_ID="STD-Potkin-2003" TOTAL_1="194" TOTAL_2="95" WEIGHT="66.19932789099327"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-003.13" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="13" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="41" SUBGROUPS="YES">
<NAME>Mental state: 9. average scores of various scale (high=poor, skewed data)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-003.13.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>SANS endpoint scale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3543" STUDY_ID="STD-Tong-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10. 6 </P>
</TD>
<TD>
<P>14. 4</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>14. 2</P>
</TD>
<TD>
<P>20. 3</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.13.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="2">
<NAME>PANSS general pathology subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3544" STUDY_ID="STD-Chang-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>18.65</P>
</TD>
<TD>
<P>11.64</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>19.15</P>
</TD>
<TD>
<P>10.95</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3545" STUDY_ID="STD-Xie-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>19. 24</P>
</TD>
<TD>
<P>12. 18</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>19. 36</P>
</TD>
<TD>
<P>10. 71</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.13.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="27">
<NAME>PANSS negative symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3546" STUDY_ID="STD-Chang-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.04</P>
</TD>
<TD>
<P>6.46</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.08</P>
</TD>
<TD>
<P>6.56</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3547" STUDY_ID="STD-CuiMeng-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>9. 2</P>
</TD>
<TD>
<P>8. 7</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Ziprasidone</P>
</TD>
<TD>
<P>12. 3</P>
</TD>
<TD>
<P>8. 2</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3548" STUDY_ID="STD-Deng-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>14.89</P>
</TD>
<TD>
<P>3.89</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13.01</P>
</TD>
<TD>
<P>7.362</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3549" STUDY_ID="STD-Guo-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.4</P>
</TD>
<TD>
<P>3.9</P>
</TD>
<TD>
<P>18</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>15.8</P>
</TD>
<TD>
<P>9.2</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3550" STUDY_ID="STD-Ji-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.71</P>
</TD>
<TD>
<P>4.58</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>15.19</P>
</TD>
<TD>
<P>9.57</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3551" STUDY_ID="STD-Li-2007d">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>15.9</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.3</P>
</TD>
<TD>
<P>6.6</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3552" STUDY_ID="STD-Li-2009b">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.1</P>
</TD>
<TD>
<P>6.2</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.1</P>
</TD>
<TD>
<P>6.1</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3553" STUDY_ID="STD-Li-X-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.2</P>
</TD>
<TD>
<P>7.2</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.5</P>
</TD>
<TD>
<P>8.4</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3554" STUDY_ID="STD-Liu-2006a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.3</P>
</TD>
<TD>
<P>7.4</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10.8</P>
</TD>
<TD>
<P>7.7</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3555" STUDY_ID="STD-Lv-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11. 5</P>
</TD>
<TD>
<P>3. 8</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12. 5</P>
</TD>
<TD>
<P>6. 8</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3556" STUDY_ID="STD-Mai-2005">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12. 9</P>
</TD>
<TD>
<P>7. 1</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13. 9</P>
</TD>
<TD>
<P>6. 1</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3557" STUDY_ID="STD-Pan-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.9</P>
</TD>
<TD>
<P>7.2</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13.9</P>
</TD>
<TD>
<P>6.1</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3558" STUDY_ID="STD-Shan-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.2</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.4</P>
</TD>
<TD>
<P>5.4</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3559" STUDY_ID="STD-Song-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.7</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.8</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3560" STUDY_ID="STD-Su-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11. 4</P>
</TD>
<TD>
<P>7. 6</P>
</TD>
<TD>
<P>39</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12. 6</P>
</TD>
<TD>
<P>6. 7</P>
</TD>
<TD>
<P>39</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3561" STUDY_ID="STD-Tang-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.9</P>
</TD>
<TD>
<P>5.3</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.1</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3562" STUDY_ID="STD-Tang-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.9</P>
</TD>
<TD>
<P>5.7</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.2</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3563" STUDY_ID="STD-Tu-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.3</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13.8</P>
</TD>
<TD>
<P>6.7</P>
</TD>
<TD>
<P>33</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3564" STUDY_ID="STD-Wen-2009a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>14.89</P>
</TD>
<TD>
<P>3.88</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13.02</P>
</TD>
<TD>
<P>7.34</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3565" STUDY_ID="STD-Xie-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11. 95</P>
</TD>
<TD>
<P>5. 69</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12. 32</P>
</TD>
<TD>
<P>6. 17</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3566" STUDY_ID="STD-Xie-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.76</P>
</TD>
<TD>
<P>4.53</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10.78</P>
</TD>
<TD>
<P>6.11</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3567" STUDY_ID="STD-Yang-2008b">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.1</P>
</TD>
<TD>
<P>6.9</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.9</P>
</TD>
<TD>
<P>7.1</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3568" STUDY_ID="STD-Ye-2005a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11. 8</P>
</TD>
<TD>
<P>4. 3</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12. 3</P>
</TD>
<TD>
<P>8. 2</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3569" STUDY_ID="STD-Zhang-2008b">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>9.2</P>
</TD>
<TD>
<P>8.7</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13.5</P>
</TD>
<TD>
<P>6.9</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3570" STUDY_ID="STD-Zhi-2005">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.7</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.8</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3571" STUDY_ID="STD-Zhou-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10. 8</P>
</TD>
<TD>
<P>5. 5</P>
</TD>
<TD>
<P>70</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11. 2</P>
</TD>
<TD>
<P>5. 7</P>
</TD>
<TD>
<P>70</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3572" STUDY_ID="STD-Zhu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.40</P>
</TD>
<TD>
<P>6.57</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.67</P>
</TD>
<TD>
<P>4.31</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.13.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" STUDIES="26">
<NAME>PANSS positive symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3573" STUDY_ID="STD-Chang-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>16.82</P>
</TD>
<TD>
<P>11.66</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>17.64</P>
</TD>
<TD>
<P>11.76</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3574" STUDY_ID="STD-Chen-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.58</P>
</TD>
<TD>
<P>5.33</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.31</P>
</TD>
<TD>
<P>5.33</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3575" STUDY_ID="STD-Fan-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.66</P>
</TD>
<TD>
<P>4.71</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>8.96</P>
</TD>
<TD>
<P>4.93</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3576" STUDY_ID="STD-Feng-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>5.18</P>
</TD>
<TD>
<P>2.04</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>4.91</P>
</TD>
<TD>
<P>3.14</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3577" STUDY_ID="STD-Hu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.56</P>
</TD>
<TD>
<P>4.52</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.16</P>
</TD>
<TD>
<P>6.21</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3578" STUDY_ID="STD-Li-2007a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.39</P>
</TD>
<TD>
<P>6.02</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10.31</P>
</TD>
<TD>
<P>5.11</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3579" STUDY_ID="STD-Li-2007d">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>17.2</P>
</TD>
<TD>
<P>9.3</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.1</P>
</TD>
<TD>
<P>3.4</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3580" STUDY_ID="STD-Li-X-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>13.2</P>
</TD>
<TD>
<P>7.3</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3581" STUDY_ID="STD-Lian-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>8.9</P>
</TD>
<TD>
<P>4.1</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.5</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3582" STUDY_ID="STD-Liu-2006a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.4</P>
</TD>
<TD>
<P>7.2</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.1</P>
</TD>
<TD>
<P>7.5</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3583" STUDY_ID="STD-Liu-2008c">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>9. 59</P>
</TD>
<TD>
<P>3. 17</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10. 29</P>
</TD>
<TD>
<P>5. 47</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3584" STUDY_ID="STD-Mu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10. 95</P>
</TD>
<TD>
<P>5. 07</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11. 50</P>
</TD>
<TD>
<P>6. 02</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3585" STUDY_ID="STD-Song-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.7</P>
</TD>
<TD>
<P>5.3</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.3</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3586" STUDY_ID="STD-Su-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10. 8</P>
</TD>
<TD>
<P>7. 5</P>
</TD>
<TD>
<P>39</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12. 2</P>
</TD>
<TD>
<P>6. 8</P>
</TD>
<TD>
<P>39</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3587" STUDY_ID="STD-Tang-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.6</P>
</TD>
<TD>
<P>5.1</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.2</P>
</TD>
<TD>
<P>6.0</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3588" STUDY_ID="STD-Tang-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.1</P>
</TD>
<TD>
<P>5.3</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>8.6</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3589" STUDY_ID="STD-Tang-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.2</P>
</TD>
<TD>
<P>4.1</P>
</TD>
<TD>
<P>38</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10.6</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3590" STUDY_ID="STD-Wang-2007e">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>9.7</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10.1</P>
</TD>
<TD>
<P>5.6</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3591" STUDY_ID="STD-Xie-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>17. 21</P>
</TD>
<TD>
<P>10. 97</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>17. 33</P>
</TD>
<TD>
<P>11. 82</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3592" STUDY_ID="STD-Xie-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>8.94</P>
</TD>
<TD>
<P>2.13</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>9.41</P>
</TD>
<TD>
<P>4.78</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3593" STUDY_ID="STD-Yang-2008b">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.2</P>
</TD>
<TD>
<P>6.8</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>12.3</P>
</TD>
<TD>
<P>7.1</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3594" STUDY_ID="STD-Yu-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>9.7</P>
</TD>
<TD>
<P>5.53</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>10.1</P>
</TD>
<TD>
<P>5.8</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3595" STUDY_ID="STD-Zhang-2007a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>8.0</P>
</TD>
<TD>
<P>2.4</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>9.31</P>
</TD>
<TD>
<P>5.12</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3596" STUDY_ID="STD-Zhang-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>9.77</P>
</TD>
<TD>
<P>6.78</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.17</P>
</TD>
<TD>
<P>5.75</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3597" STUDY_ID="STD-Zhang-2008b">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>13.1</P>
</TD>
<TD>
<P>8.6</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>9.1</P>
</TD>
<TD>
<P>7.6</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3598" STUDY_ID="STD-Zhi-2005">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.7</P>
</TD>
<TD>
<P>5.3</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>11.3</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="16.427590877761165" CI_END="1.3194764702173378" CI_START="0.8588657578665471" CI_STUDY="95" CI_TOTAL="95" DF="31" EFFECT_MEASURE="RR" EFFECT_SIZE="1.064543638645354" ESTIMABLE="YES" EVENTS_1="180" EVENTS_2="106" I2="0.0" I2_Q="0.0" ID="CMP-003.14" LOG_CI_END="0.12040164999685309" LOG_CI_START="-0.06607471180764185" LOG_EFFECT_SIZE="0.02716346909460555" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.985093966325804" P_Q="0.9773767697599626" P_Z="0.5679965933670235" Q="2.112221938846436" RANDOM="YES" SCALE="192.96379805564024" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2238" TOTAL_2="1880" WEIGHT="900.0" Z="0.5710045027198773">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.5021094846802328" CI_END="1.322068920995024" CI_START="0.7854455968692827" DF="7" EFFECT_SIZE="1.019025619282099" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="62" I2="0.0" ID="CMP-003.14.01" LOG_CI_END="0.12125409601771328" LOG_CI_START="-0.10488389057015661" LOG_EFFECT_SIZE="0.008185102723778363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8350020142252876" P_Z="0.8871728516592284" STUDIES="12" TAU2="0.0" TOTAL_1="679" TOTAL_2="560" WEIGHT="100.0" Z="0.14188245672853944">
<NAME>Any reason</NAME>
<DICH_DATA CI_END="1.5936849149554626" CI_START="0.3655515102535036" EFFECT_SIZE="0.763265306122449" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.20240246183897273" LOG_CI_START="-0.43705141749503973" LOG_EFFECT_SIZE="-0.11732447782803347" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.3756183740685517" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.14108916293790244" WEIGHT="12.506292718042024"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2020" O_E="0.0" SE="0.0" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1813" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="1.2168981869275406"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.0" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.3403264275979314" CI_START="0.7168314660075765" EFFECT_SIZE="0.9801980198019802" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="37" LOG_CI_END="0.12721058078277264" LOG_CI_START="-0.14458293915295803" LOG_EFFECT_SIZE="-0.008686179185092667" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="0.1596528590098702" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.02548903539002549" WEIGHT="69.22593750783636"/>
<DICH_DATA CI_END="28.299517371364352" CI_START="0.31802662504438683" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4517790289963546" LOG_CI_START="-0.49753651955702966" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1335" O_E="0.0" SE="1.1450376024878446" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" VAR="1.3111111111111111" WEIGHT="1.3458068931698648"/>
<DICH_DATA CI_END="3.1692688808450917" CI_START="0.6156376320762526" EFFECT_SIZE="1.3968253968253967" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5009590863072588" LOG_CI_START="-0.210674840914085" LOG_EFFECT_SIZE="0.14514212269658688" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1323" O_E="0.0" SE="0.4180172914945696" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.174738455988456" WEIGHT="10.097962472333537"/>
<DICH_DATA CI_END="22.710273425027538" CI_START="0.1998545890665981" EFFECT_SIZE="2.130434782608696" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.356222363029327" LOG_CI_START="-0.6992858750074854" LOG_EFFECT_SIZE="0.3284682440109208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="1.207415713952701" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="1.4578527062999111" WEIGHT="1.210343379286452"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2003" O_E="0.0" SE="0.0" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.57367138033803" CI_START="0.15212199426199158" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8178079897862158" LOG_CI_START="-0.8178079897862158" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2005" O_E="0.0" SE="0.9607689228305228" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="0.9230769230769231" WEIGHT="1.9115442352986782"/>
<DICH_DATA CI_END="10.429540254938788" CI_START="0.38352601382461193" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0182651646927037" LOG_CI_START="-0.4162051733647413" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1437" O_E="0.0" SE="0.8426149773176358" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.71" WEIGHT="2.485214607105541"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3326" O_E="0.0" SE="0.0" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.464643744829159" CI_END="5.091911656933698" CI_START="0.14467504964763997" DF="1" EFFECT_SIZE="0.8582963193258372" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="31.724011143976625" ID="CMP-003.14.02" LOG_CI_END="0.7068808601742662" LOG_CI_START="-0.8396063599290439" LOG_EFFECT_SIZE="-0.06636274987738885" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2261930042175745" P_Z="0.866416759770563" STUDIES="2" TAU2="0.660146937987325" TOTAL_1="96" TOTAL_2="92" WEIGHT="99.99999999999999" Z="0.1682116709196382">
<NAME>Progressive disease</NAME>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="27.258615829675648"/>
<DICH_DATA CI_END="5.713699698644882" CI_START="0.38412718478941105" EFFECT_SIZE="1.4814814814814814" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7569174109419515" LOG_CI_START="-0.41552495660400146" LOG_EFFECT_SIZE="0.17069622716897506" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1323" O_E="0.0" SE="0.6886984503798128" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.47430555555555554" WEIGHT="72.74138417032434"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.25176053549345256" CI_END="4.439734252701513" CI_START="0.49253766742569977" DF="1" EFFECT_SIZE="1.4787617633735275" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="0.0" ID="CMP-003.14.03" LOG_CI_END="0.6473569755111636" LOG_CI_START="-0.3075605506900548" LOG_EFFECT_SIZE="0.16989821241055428" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6158381844340561" P_Z="0.48553332822229944" STUDIES="2" TAU2="0.0" TOTAL_1="74" TOTAL_2="72" WEIGHT="100.0" Z="0.6974306539060309">
<NAME>Not insisting follow up</NAME>
<DICH_DATA CI_END="75.11827457660985" CI_START="0.13241445731006413" EFFECT_SIZE="3.1538461538461537" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8757456038791513" LOG_CI_START="-0.8780645950533539" LOG_EFFECT_SIZE="0.49884050441289873" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1343" O_E="0.0" SE="1.6176017424332856" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="2.616635397123202" WEIGHT="12.024408460606749"/>
<DICH_DATA CI_END="4.305088557572198" CI_START="0.4129480158197567" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6339820895107801" LOG_CI_START="-0.3841046162941802" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1323" O_E="0.0" SE="0.5980291706003051" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.35763888888888884" WEIGHT="87.97559153939325"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.92321045517915" CI_START="0.12513345751728625" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.14.04" LOG_CI_END="1.8568690648743624" LOG_CI_START="-0.9026265554350377" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.497922686342418" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6777618841839292">
<NAME>Termination treatment early</NAME>
<DICH_DATA CI_END="71.92321045517915" CI_START="0.12513345751728625" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8568690648743624" LOG_CI_START="-0.9026265554350377" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1441" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2017350460909072" CI_END="5.8311286686275015" CI_START="0.29976543121936966" DF="1" EFFECT_SIZE="1.3221084675043695" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-003.14.05" LOG_CI_END="0.7657526245900367" LOG_CI_START="-0.5232184511951701" LOG_EFFECT_SIZE="0.12126708669743337" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6533240073000159" P_Z="0.7122850682994294" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="76" WEIGHT="100.0" Z="0.36878891528621444">
<NAME>Violation of study scheme</NAME>
<DICH_DATA CI_END="20.722972310630787" CI_START="0.19302250372394794" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3164520467067224" LOG_CI_START="-0.7143920553787599" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2005" O_E="0.0" SE="1.1929278784054478" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="1.423076923076923" WEIGHT="40.284054228534536"/>
<DICH_DATA CI_END="6.823446325509919" CI_START="0.14655350863704047" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8340037796584007" LOG_CI_START="-0.8340037796584007" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1440" O_E="0.0" SE="0.9797958971132712" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.96" WEIGHT="59.71594577146546"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="102.70556722052949" CI_START="0.24341426347726572" DF="0" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-003.14.06" LOG_CI_END="2.0115939854436733" LOG_CI_START="-0.6136539767716357" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.29663466646914427" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="1.043677438847619">
<NAME>Incomplete data</NAME>
<DICH_DATA CI_END="102.70556722052949" CI_START="0.24341426347726572" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0115939854436733" LOG_CI_START="-0.6136539767716357" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1335" O_E="0.0" SE="1.542083648192269" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" VAR="2.378021978021978" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.649329938683911" CI_END="2.055506889046561" CI_START="0.6418068280690621" DF="8" EFFECT_SIZE="1.1485810187065946" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="20" I2="0.0" ID="CMP-003.14.07" LOG_CI_END="0.31291893665998005" LOG_CI_START="-0.1925956668339371" LOG_EFFECT_SIZE="0.0601616349130214" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.5748957637170209" P_Z="0.6408481462394756" STUDIES="9" TAU2="0.0" TOTAL_1="694" TOTAL_2="578" WEIGHT="100.0" Z="0.46651327920337077">
<NAME>Adverse effect</NAME>
<DICH_DATA CI_END="8.425167068244779" CI_START="0.3571635819727306" EFFECT_SIZE="1.7346938775510203" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.9255785215430694" LOG_CI_START="-0.4471328301715113" LOG_EFFECT_SIZE="0.23922284568577906" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.8063374430279245" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.6501800720288115" WEIGHT="13.561538527285732"/>
<DICH_DATA CI_END="14.850735173811657" CI_START="0.06331755310657398" EFFECT_SIZE="0.9696969696969697" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1717479535876831" LOG_CI_START="-1.1984758767036463" LOG_EFFECT_SIZE="-0.01336396155798149" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1993" O_E="0.0" SE="1.392281210710311" STUDY_ID="STD-Du-2006" TOTAL_1="33" TOTAL_2="32" VAR="1.9384469696969697" WEIGHT="4.548714633070688"/>
<DICH_DATA CI_END="5.26531901349033" CI_START="0.047480503908589836" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7214246892159656" LOG_CI_START="-1.323484680543928" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1904" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="6.111098482717323"/>
<DICH_DATA CI_END="2.0195673348932908" CI_START="0.0061130316375403206" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30525833766698174" LOG_CI_START="-2.2137433565456317" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="4.0272676464011505"/>
<DICH_DATA CI_END="4.125460527883626" CI_START="0.009695887217837502" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6154724361719746" LOG_CI_START="-2.013412444844012" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2039" O_E="0.0" SE="1.5442199922988256" STUDY_ID="STD-Mu-2010" TOTAL_1="129" TOTAL_2="129" VAR="2.3846153846153846" WEIGHT="3.6976370082063807"/>
<DICH_DATA CI_END="2.5654424774543916" CI_START="0.5281199784715219" EFFECT_SIZE="1.1639851485148516" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="8" LOG_CI_END="0.40916228131679366" LOG_CI_START="-0.27726740309317055" LOG_EFFECT_SIZE="0.06594743911181156" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.4032121945041511" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.16258007379685335" WEIGHT="54.234457461925416"/>
<DICH_DATA CI_END="28.299517371364352" CI_START="0.31802662504438683" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4517790289963546" LOG_CI_START="-0.49753651955702966" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1335" O_E="0.0" SE="1.1450376024878446" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" VAR="1.3111111111111111" WEIGHT="6.7251677007143424"/>
<DICH_DATA CI_END="107.92673884706474" CI_START="0.26215325050498534" EFFECT_SIZE="5.319148936170213" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0331290544615146" LOG_CI_START="-0.5814447529888747" LOG_EFFECT_SIZE="0.7258421507363202" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="1.5358135968454372" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="2.358723404255319" WEIGHT="3.7382263984767325"/>
<DICH_DATA CI_END="71.92321045517915" CI_START="0.12513345751728625" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8568690648743624" LOG_CI_START="-0.9026265554350377" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1439" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="3.3558921412022316"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8472619447987044" CI_END="9.596021173674233" CI_START="0.10840223488757085" DF="1" EFFECT_SIZE="1.0199167325104228" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-003.14.08" LOG_CI_END="0.9820911975700465" LOG_CI_START="-0.9649617640214844" LOG_EFFECT_SIZE="0.00856471677428099" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.3573281542383474" P_Z="0.98624274241834" STUDIES="2" TAU2="0.0" TOTAL_1="79" TOTAL_2="81" WEIGHT="100.0" Z="0.017243019832039304">
<NAME>Economic issue</NAME>
<DICH_DATA CI_END="68.94634076504033" CI_START="0.12297061175900956" EFFECT_SIZE="2.911764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8385112215238748" LOG_CI_START="-0.910198666413285" LOG_EFFECT_SIZE="0.46415627755529476" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1993" O_E="0.0" SE="1.614605794507673" STUDY_ID="STD-Du-2006" TOTAL_1="33" TOTAL_2="32" VAR="2.606951871657754" WEIGHT="50.17619451735546"/>
<DICH_DATA CI_END="8.49097329838122" CI_START="0.014809633405005272" EFFECT_SIZE="0.3546099290780142" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9289574751543044" LOG_CI_START="-1.8294556917930263" LOG_EFFECT_SIZE="-0.4502491083193611" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="1.6203055486302531" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="2.6253900709219855" WEIGHT="49.82380548264454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.5988064834922862" CI_END="2.0114571950712867" CI_START="0.4866367350512305" DF="4" EFFECT_SIZE="0.9893679609249519" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="11" I2="0.0" ID="CMP-003.14.09" LOG_CI_END="0.3035107949773079" LOG_CI_START="-0.31279511030888235" LOG_EFFECT_SIZE="-0.004642157665787199" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.809006646236929" P_Z="0.9764452440702318" STUDIES="5" TAU2="0.0" TOTAL_1="400" TOTAL_2="281" WEIGHT="100.0" Z="0.029525798008618542">
<NAME>No effect</NAME>
<DICH_DATA CI_END="70.6857478355874" CI_START="0.17330226212634944" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.8493318570738875" LOG_CI_START="-0.761195768373336" LOG_EFFECT_SIZE="0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="1.5334368495078534" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="2.3514285714285714" WEIGHT="5.573603513115466"/>
<DICH_DATA CI_END="14.850735173811657" CI_START="0.06331755310657398" EFFECT_SIZE="0.9696969696969697" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1717479535876831" LOG_CI_START="-1.1984758767036463" LOG_EFFECT_SIZE="-0.01336396155798149" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1993" O_E="0.0" SE="1.392281210710311" STUDY_ID="STD-Du-2006" TOTAL_1="33" TOTAL_2="32" VAR="1.9384469696969697" WEIGHT="6.761046730415931"/>
<DICH_DATA CI_END="2.3298732314021073" CI_START="0.4655359535875854" EFFECT_SIZE="1.041460396039604" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="8" LOG_CI_END="0.3673322916696726" LOG_CI_START="-0.3320467725951594" LOG_EFFECT_SIZE="0.01764275953725653" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="0.4108187243313645" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.16877202426124965" WEIGHT="77.65463858078232"/>
<DICH_DATA CI_END="8.0750486141281" CI_START="0.013759807082363715" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9071451455893973" LOG_CI_START="-1.861387655028722" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1335" O_E="0.0" SE="1.626249871541469" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" VAR="2.6446886446886446" WEIGHT="4.955566536301028"/>
<DICH_DATA CI_END="7.824262991946792" CI_START="0.01420084054248603" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8934434396874849" LOG_CI_START="-1.84768594912681" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2005" O_E="0.0" SE="1.6101529717988263" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="2.592592592592592" WEIGHT="5.055144639385257"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="129.56614626999053" CI_END="0.8609831872336327" CI_START="0.7025958720528599" CI_STUDY="95" CI_TOTAL="95" DF="77" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7777681102084765" ESTIMABLE="YES" EVENTS_1="696" EVENTS_2="799" I2="40.57089585766713" I2_Q="72.23969547424437" ID="CMP-003.15" LOG_CI_END="-0.06500532910726271" LOG_CI_START="-0.15329440613797413" LOG_EFFECT_SIZE="-0.10914986762261844" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.6774529493390755E-4" P_Q="0.0014223523250394" P_Z="1.2589825550567741E-6" Q="21.613595753005093" RANDOM="YES" SCALE="534.59" SORT_BY="STUDY" STUDIES="51" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.054738357125736256" TOTALS="SUB" TOTAL_1="3302" TOTAL_2="3170" WEIGHT="700.0" Z="4.8461217775157195">
<NAME>Adverse effects: 1. At least one adverse effect, non-specific</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="59.21025170455379" CI_END="0.9077861282074307" CI_START="0.7287606535315387" DF="27" EFFECT_SIZE="0.8133626571581168" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="652" I2="54.39978851175283" ID="CMP-003.15.01" LOG_CI_END="-0.042016457954698855" LOG_CI_START="-0.1374150833668695" LOG_EFFECT_SIZE="-0.0897157706607842" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.344772392093187E-4" P_Z="2.2743128522173043E-4" STUDIES="28" TAU2="0.03621124958026584" TOTAL_1="1229" TOTAL_2="1132" WEIGHT="99.99999999999999" Z="3.686419559625208">
<NAME>non-specific</NAME>
<DICH_DATA CI_END="1.3013951769413403" CI_START="0.8530935654839245" EFFECT_SIZE="1.053665910808768" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="27" LOG_CI_END="0.11440919287605789" LOG_CI_START="-0.06900333372707851" LOG_EFFECT_SIZE="0.022702929574489678" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.10773742603333153" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.011607352968287583" WEIGHT="6.566932586129196"/>
<DICH_DATA CI_END="1.4710536736074922" CI_START="0.6165848974318691" EFFECT_SIZE="0.9523809523809523" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.16762851890448424" LOG_CI_START="-0.21000711704436045" LOG_EFFECT_SIZE="-0.021189299069938095" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1977" O_E="0.0" SE="0.22182504188289745" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.04920634920634921" WEIGHT="3.6763096101978383"/>
<DICH_DATA CI_END="0.9092022632486987" CI_START="0.2993962193342931" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="23" LOG_CI_END="-0.041339491870078626" LOG_CI_START="-0.5237536880698574" LOG_EFFECT_SIZE="-0.28254658996996806" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="914" O_E="0.0" SE="0.2833724868365343" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="0.08029996629592182" WEIGHT="2.695204379576261"/>
<DICH_DATA CI_END="1.4217648657407256" CI_START="0.4770132589316634" EFFECT_SIZE="0.8235294117647058" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.1528277778599635" LOG_CI_START="-0.32146954926003535" LOG_EFFECT_SIZE="-0.08432088570003593" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="0.2786045977599216" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="0.0776205218929677" WEIGHT="2.758645808943555"/>
<DICH_DATA CI_END="1.6766861387285956" CI_START="0.7481424048457821" EFFECT_SIZE="1.12" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="25" LOG_CI_END="0.22445177401018648" LOG_CI_START="-0.12601572866982322" LOG_EFFECT_SIZE="0.04921802267018165" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.2058663459163551" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.04238095238095238" WEIGHT="3.9955813867412937"/>
<DICH_DATA CI_END="1.530282677687517" CI_START="0.5743424158261774" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" LOG_CI_END="0.18477166220347044" LOG_CI_START="-0.2408291094039575" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1460" O_E="0.0" SE="0.24999999999999997" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.06249999999999999" WEIGHT="3.1812132926542827"/>
<DICH_DATA CI_END="0.9633349301606211" CI_START="0.5042553148291189" EFFECT_SIZE="0.696969696969697" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="33" LOG_CI_END="-0.016222692074493616" LOG_CI_START="-0.2973495156460956" LOG_EFFECT_SIZE="-0.15678610386029457" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1848" O_E="0.0" SE="0.16513528776617908" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.027269663265618777" WEIGHT="4.946707998065812"/>
<DICH_DATA CI_END="1.0315196795042172" CI_START="0.3843904828328861" EFFECT_SIZE="0.6296875" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="0.013477517930653564" LOG_CI_START="-0.41522737361620904" LOG_EFFECT_SIZE="-0.20087492784277775" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="0.2518233754180654" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="0.06341501240694788" WEIGHT="3.1519955987062773"/>
<DICH_DATA CI_END="1.6611810317560547" CI_START="0.6080979713019801" EFFECT_SIZE="1.0050675675675675" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.22041696346197465" LOG_CI_START="-0.21602644545071506" LOG_EFFECT_SIZE="0.002195259005629776" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1764" O_E="0.0" SE="0.25636901882503105" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.06572507381330911" WEIGHT="3.0805656790938265"/>
<DICH_DATA CI_END="1.3734169581165603" CI_START="0.7599372729430165" EFFECT_SIZE="1.0216216216216216" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="37" LOG_CI_END="0.1378024054951876" LOG_CI_START="-0.11922225395472688" LOG_EFFECT_SIZE="0.009290075770230341" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" O_E="0.0" SE="0.15097755725346332" STUDY_ID="STD-Liu-2010" TOTAL_1="30" TOTAL_2="54" VAR="0.022794222794222795" WEIGHT="5.321905353223223"/>
<DICH_DATA CI_END="1.6273096838567886" CI_START="0.5400977200092346" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" LOG_CI_END="0.21147020886306703" LOG_CI_START="-0.2675276560635541" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="963" O_E="0.0" SE="0.2813657169355689" STUDY_ID="STD-Luo-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.07916666666666666" WEIGHT="2.7216780256906823"/>
<DICH_DATA CI_END="0.9091536902162205" CI_START="0.366098977838645" EFFECT_SIZE="0.5769230769230769" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="26" LOG_CI_END="-0.04136269414787182" LOG_CI_START="-0.4364014836824018" LOG_EFFECT_SIZE="-0.23888208891513676" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="0.23204774044612855" STUDY_ID="STD-Lv-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.05384615384615384" WEIGHT="3.4869042116656592"/>
<DICH_DATA CI_END="1.351458789491978" CI_START="0.2802144081614402" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="0.13080280714232476" LOG_CI_START="-0.5525095377721111" LOG_EFFECT_SIZE="-0.21085336531489315" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1071" O_E="0.0" SE="0.4013810538533984" STUDY_ID="STD-Ma-2009a" TOTAL_1="49" TOTAL_2="49" VAR="0.1611067503924647" WEIGHT="1.5914490281811802"/>
<DICH_DATA CI_END="1.0972593698418913" CI_START="0.38505025485531263" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="0.04030929810963359" LOG_CI_START="-0.4144825848239225" LOG_EFFECT_SIZE="-0.18708664335714442" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="0.2671470032912991" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.07136752136752136" WEIGHT="2.9189916982009847"/>
<DICH_DATA CI_END="1.0457570752362568" CI_START="0.9087896316001663" EFFECT_SIZE="0.9748708566508825" ESTIMABLE="YES" EVENTS_1="183" EVENTS_2="92" LOG_CI_END="0.019430811551180826" LOG_CI_START="-0.04153663647958021" LOG_EFFECT_SIZE="-0.011052912464199658" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.03581258076700407" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.0012825409411931898" WEIGHT="8.375294546960527"/>
<DICH_DATA CI_END="0.9938710793373499" CI_START="0.2820052041315734" EFFECT_SIZE="0.5294117647058824" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.0026699467531850667" LOG_CI_START="-0.5497428771247131" LOG_EFFECT_SIZE="-0.27620641193894907" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1100" O_E="0.0" SE="0.32135334735491583" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.10326797385620917" WEIGHT="2.251385773181304"/>
<DICH_DATA CI_END="1.3960319922380053" CI_START="0.5863720236067701" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.1448953709327199" LOG_CI_START="-0.23182675849490056" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1861" O_E="0.0" SE="0.2212884436304001" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.04896857528436476" WEIGHT="3.686571788546233"/>
<DICH_DATA CI_END="1.3956495964126867" CI_START="0.5921588650303019" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="22" LOG_CI_END="0.1447763943284019" LOG_CI_START="-0.227561764644852" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1084" O_E="0.0" SE="0.21871327768450147" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.04783549783549784" WEIGHT="3.7362723597838925"/>
<DICH_DATA CI_END="1.1640167245742332" CI_START="0.41737101905841556" EFFECT_SIZE="0.6970128022759602" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.06595922029507353" LOG_CI_START="-0.3794777102776941" LOG_EFFECT_SIZE="-0.15675924499131028" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1378" O_E="0.0" SE="0.261651857966811" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.06846169477748425" WEIGHT="3.0000258541118"/>
<DICH_DATA CI_END="1.5335466633044796" CI_START="0.4790815272408504" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.18569699538685452" LOG_CI_START="-0.319590574648081" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.29680841985233186" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.08809523809523812" WEIGHT="2.526187853678193"/>
<DICH_DATA CI_END="1.4169149342292326" CI_START="0.4269404302199765" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.15134377776772012" LOG_CI_START="-0.3696327166178562" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1222" O_E="0.0" SE="0.30602417167732626" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="0.09365079365079365" WEIGHT="2.4181164217517153"/>
<DICH_DATA CI_END="1.555072243843096" CI_START="0.5651867644604941" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" LOG_CI_END="0.19175056980890243" LOG_CI_START="-0.24780801700938954" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="0.2581988897471611" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="0.06666666666666665" WEIGHT="3.0523707201215724"/>
<DICH_DATA CI_END="0.9968839384882632" CI_START="0.3362277617893513" EFFECT_SIZE="0.5789473684210527" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="19" LOG_CI_END="-0.0013554011749749777" LOG_CI_START="-0.47336643041423276" LOG_EFFECT_SIZE="-0.23736091579460392" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1272" O_E="0.0" SE="0.2772616150674173" STUDY_ID="STD-Wang-2007e" TOTAL_1="30" TOTAL_2="30" VAR="0.07687400318979268" WEIGHT="2.7768566776586745"/>
<DICH_DATA CI_END="0.7179432200624462" CI_START="0.18418086732148026" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.1439099014243399" LOG_CI_START="-0.7347554862361854" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2495" O_E="0.0" SE="0.3470656212512923" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.12045454545454548" WEIGHT="2.0044039557548614"/>
<DICH_DATA CI_END="1.3439343758619375" CI_START="0.8166363541600392" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.1283780626933575" LOG_CI_START="-0.08797129051678351" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1307" O_E="0.0" SE="0.12708468102220719" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="0.016150516150516145" WEIGHT="5.99715336021703"/>
<DICH_DATA CI_END="1.3407589231611683" CI_START="0.5289103521804296" EFFECT_SIZE="0.8421052631578947" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="19" LOG_CI_END="0.12735069600748006" LOG_CI_START="-0.2766179326012885" LOG_EFFECT_SIZE="-0.07463361829690421" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3359" O_E="0.0" SE="0.2372931721217526" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="0.056308049535603706" WEIGHT="3.3941193059188772"/>
<DICH_DATA CI_END="1.057354599864587" CI_START="0.46833758766427935" EFFECT_SIZE="0.7037037037037037" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="27" LOG_CI_END="0.024220658961487982" LOG_CI_START="-0.3294409853738047" LOG_EFFECT_SIZE="-0.15261016320615833" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="0.20774260053592453" STUDY_ID="STD-Zhang-2006" TOTAL_1="43" TOTAL_2="43" VAR="0.04315698807742871" WEIGHT="3.956513947727962"/>
<DICH_DATA CI_END="0.9455485799402955" CI_START="0.3146540193374422" EFFECT_SIZE="0.5454545454545454" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="22" LOG_CI_END="-0.02431615327265825" LOG_CI_START="-0.5021667162765047" LOG_EFFECT_SIZE="-0.26324143477458145" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.2806917861068948" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.0787878787878788" WEIGHT="2.730642777517275"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.024953540264033" CI_END="0.8563935826479461" CI_START="0.46367322516941" DF="27" EFFECT_SIZE="0.6301482162799152" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="85" I2="0.0" ID="CMP-003.15.02" LOG_CI_END="-0.06732659573424062" LOG_CI_START="-0.33378798173392815" LOG_EFFECT_SIZE="-0.20055728873408438" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.989087219833698" P_Z="0.003173533065371854" STUDIES="29" TAU2="0.0" TOTAL_1="1168" TOTAL_2="1132" WEIGHT="100.0" Z="2.950409203052536">
<NAME>liver function abnormal</NAME>
<DICH_DATA CI_END="7.839572672525566" CI_START="0.013633230112071966" EFFECT_SIZE="0.3269230769230769" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8942923903601941" LOG_CI_START="-1.8654012348732447" LOG_EFFECT_SIZE="-0.48555442225652523" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2515" O_E="0.0" SE="1.6210576961658838" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="2.6278280542986425" WEIGHT="0.9322809806827388"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2516" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="1.7092144992049898"/>
<DICH_DATA CI_END="5.167657331603573" CI_START="0.04837782073340814" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7132937077873972" LOG_CI_START="-1.3153536991153596" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2517" O_E="0.0" SE="1.1916375287812984" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="1.42" WEIGHT="1.7252634616388394"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2518" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="2.624865123779091"/>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2519" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="1.260964618286034"/>
<DICH_DATA CI_END="5.284718511186434" CI_START="0.04730620930344959" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7230218597050971" LOG_CI_START="-1.3250818510330595" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2520" O_E="0.0" SE="1.2030662579644695" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="1.4473684210526314" WEIGHT="1.692640298000578"/>
<DICH_DATA CI_END="2.399062894750428" CI_START="0.15005859195594384" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38004163374732225" LOG_CI_START="-0.823739132980035" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2521" O_E="0.0" SE="0.7071067811865475" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.49999999999999994" WEIGHT="4.899748231054304"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2507" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="2.624865123779091"/>
<DICH_DATA CI_END="3.8481017433944946" CI_START="0.11549706168953583" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5852465462167757" LOG_CI_START="-0.9374290643281383" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2508" O_E="0.0" SE="0.8944271909999157" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.7999999999999998" WEIGHT="3.06234264440894"/>
<DICH_DATA CI_END="3.8013774282922785" CI_START="0.11691668423572073" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5799409916465255" LOG_CI_START="-0.9321235097578879" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2509" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="3.1054742309499113"/>
<DICH_DATA CI_END="5.272140080731112" CI_START="0.047419073881157445" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7219869409410987" LOG_CI_START="-1.3240469322690611" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2510" O_E="0.0" SE="1.2018504251546631" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.4444444444444446" WEIGHT="1.6960666953649508"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2511" O_E="0.0" SE="0.0" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2512" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="2.624865123779091"/>
<DICH_DATA CI_END="5.306321714020261" CI_START="0.047113615320280106" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.724793577042504" LOG_CI_START="-1.3268535683704665" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2513" O_E="0.0" SE="1.2051476890327395" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.4523809523809526" WEIGHT="1.6867985713465632"/>
<DICH_DATA CI_END="6.354285749898555" CI_START="0.14082050569819843" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8030667409937645" LOG_CI_START="-0.8513341004272031" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2514" O_E="0.0" SE="0.9718032436669186" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.9444015444015444" WEIGHT="2.594102191011988"/>
<DICH_DATA CI_END="1.5335466633044796" CI_START="0.4790815272408504" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.18569699538685452" LOG_CI_START="-0.319590574648081" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2500" O_E="0.0" SE="0.29680841985233186" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.08809523809523812" WEIGHT="27.809381851929825"/>
<DICH_DATA CI_END="7.101503173841088" CI_START="0.15602798645204474" EFFECT_SIZE="1.0526315789473684" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8513502854808354" LOG_CI_START="-0.8067974960585308" LOG_EFFECT_SIZE="0.022276394711152208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2499" O_E="0.0" SE="0.9740042148401186" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.9486842105263158" WEIGHT="2.582391578086873"/>
<DICH_DATA CI_END="3.114568067741974" CI_START="0.035674645310181115" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.49339782666037824" LOG_CI_START="-1.4476403360997032" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2502" O_E="0.0" SE="1.140175425099138" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="1.3" WEIGHT="1.884518550405501"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2501" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="1.267176266651975"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2504" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="1.6895683555359666"/>
<DICH_DATA CI_END="3.7880723617701575" CI_START="0.11732733749488264" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.578418266534329" LOG_CI_START="-0.9306007846456915" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2503" O_E="0.0" SE="0.8864052604279182" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.7857142857142856" WEIGHT="3.1180216015800117"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2506" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="1.6895683555359666"/>
<DICH_DATA CI_END="6.57367138033803" CI_START="0.15212199426199158" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8178079897862158" LOG_CI_START="-0.8178079897862158" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2505" O_E="0.0" SE="0.9607689228305228" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="0.9230769230769231" WEIGHT="2.6540302918210807"/>
<DICH_DATA CI_END="8.579330192264713" CI_START="0.26225823573367574" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9334533828185837" LOG_CI_START="-0.5812708647072211" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2494" O_E="0.0" SE="0.8897565210026092" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.7916666666666665" WEIGHT="3.0945778301395603"/>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2493" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="0.9324147753125727"/>
<DICH_DATA CI_END="5.167657331603573" CI_START="0.04837782073340814" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7132937077873972" LOG_CI_START="-1.3153536991153596" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2496" O_E="0.0" SE="1.1916375287812984" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="1.42" WEIGHT="1.7252634616388394"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2495" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="3.1954879767745457"/>
<DICH_DATA CI_END="4.038645960707643" CI_START="0.009904309609993965" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6062357833382839" LOG_CI_START="-2.0041757920103214" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2498" O_E="0.0" SE="1.5333686811054679" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.351219512195122" WEIGHT="1.0419589080561538"/>
<DICH_DATA CI_END="0.4820347786267901" CI_START="0.09926993781718087" EFFECT_SIZE="0.21875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="-0.3169216264482664" LOG_CI_START="-1.0031822501630319" LOG_EFFECT_SIZE="-0.6600519383056491" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2497" O_E="0.0" SE="0.40311288741492746" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="35" VAR="0.16249999999999998" WEIGHT="15.076148403244014"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6526768195483483" CI_END="1.7967053022240564" CI_START="0.22413981710019598" DF="5" EFFECT_SIZE="0.634596878201786" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" I2="0.0" ID="CMP-003.15.03" LOG_CI_END="0.25447684944424065" LOG_CI_START="-0.6494809867899345" LOG_EFFECT_SIZE="-0.1975020686728469" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7533462984080027" P_Z="0.39174941985139444" STUDIES="7" TAU2="0.0" TOTAL_1="276" TOTAL_2="278" WEIGHT="100.00000000000001" Z="0.8564491084751367">
<NAME>hyper-salivation</NAME>
<DICH_DATA CI_END="4.318534659420911" CI_START="0.011315010711186518" EFFECT_SIZE="0.22105263157894736" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6353364094807922" LOG_CI_START="-1.9463450305906491" LOG_EFFECT_SIZE="-0.6555043105549285" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2457" O_E="0.0" SE="1.5164924574271987" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="2.299749373433584" WEIGHT="12.260016161507103"/>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2456" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="10.798071505166135"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2455" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="14.583602320195642"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2454" O_E="0.0" SE="0.0" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.6831009876717293" CI_START="0.007606185290481881" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4286370191360396" LOG_CI_START="-2.1188330991645534" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2453" O_E="0.0" SE="1.4963965576702283" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.2392026578073088" WEIGHT="12.591519748070006"/>
<DICH_DATA CI_END="15.499949390237672" CI_START="0.06451633968752372" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1903302801331048" LOG_CI_START="-1.1903302801331048" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2452" O_E="0.0" SE="1.3984117975602022" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="1.9555555555555557" WEIGHT="14.417879566557055"/>
<DICH_DATA CI_END="3.8380688295157808" CI_START="0.11579897708622293" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5841127588337569" LOG_CI_START="-0.9362952769451195" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2451" O_E="0.0" SE="0.893095206357669" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.7976190476190474" WEIGHT="35.34891069850407"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.24103147279869302" CI_END="7.464142599627155" CI_START="0.5072535696326324" DF="1" EFFECT_SIZE="1.9458193590125137" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-003.15.04" LOG_CI_END="0.8729799278498602" LOG_CI_START="-0.2947748880771696" LOG_EFFECT_SIZE="0.2891025198863452" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.623462149088423" P_Z="0.33181653448079074" STUDIES="2" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.970461468604072">
<NAME>myalgia/ostealgia</NAME>
<DICH_DATA CI_END="26.919163659736437" CI_START="0.33433430970448363" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4300615628474915" LOG_CI_START="-0.47581905340816644" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2523" O_E="0.0" SE="1.1195237082497775" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="1.2533333333333332" WEIGHT="37.541528239202655"/>
<DICH_DATA CI_END="8.220339253228541" CI_START="0.2737113312101215" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9148897412340661" LOG_CI_START="-0.5627072231227036" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2522" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="62.45847176079734"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.15.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>renal function abnormal</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2473" O_E="0.0" SE="0.0" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8348989025837081" CI_END="0.2995996953522116" CI_START="0.04280650254327742" DF="7" EFFECT_SIZE="0.11324670026565713" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="43" I2="0.0" ID="CMP-003.15.06" LOG_CI_END="-0.523458632584456" LOG_CI_START="-1.3684902542540973" LOG_EFFECT_SIZE="-0.9459744434192766" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9684106252947493" P_Z="1.1430265049651978E-5" STUDIES="8" TAU2="0.0" TOTAL_1="307" TOTAL_2="307" WEIGHT="100.0" Z="4.388180967083247">
<NAME>sexual desire change</NAME>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2485" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="11.419020109076259"/>
<DICH_DATA CI_END="2.6584101927477937" CI_START="0.0076768300546620205" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.42462199342474577" LOG_CI_START="-2.1148180734532596" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2482" O_E="0.0" SE="1.4916796657152047" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" VAR="2.225108225108225" WEIGHT="11.073119495755845"/>
<DICH_DATA CI_END="0.996792606363083" CI_START="0.003471341571324176" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.0013951920208034444" LOG_CI_START="-2.4595026507357445" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2481" O_E="0.0" SE="1.4439044890773172" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="2.084860173577628" WEIGHT="11.818005629285029"/>
<DICH_DATA CI_END="7.502975334214647" CI_START="0.013291126152980877" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8752335187236451" LOG_CI_START="-1.8764382198620155" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2484" O_E="0.0" SE="1.6163456002399996" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="2.6125730994152048" WEIGHT="9.430889904335197"/>
<DICH_DATA CI_END="1.3074563269125963" CI_START="0.004525703567694904" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11642719100191871" LOG_CI_START="-2.344313895615592" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2483" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="11.792722535448773"/>
<DICH_DATA CI_END="8.34647495295665" CI_START="0.014712717478896005" EFFECT_SIZE="0.3504273504273504" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9215030944398266" LOG_CI_START="-1.832307104492679" LOG_EFFECT_SIZE="-0.4554020050264262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2479" O_E="0.0" SE="1.6176017424332856" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="2.616635397123202" WEIGHT="9.416248551365321"/>
<DICH_DATA CI_END="0.9537939361791632" CI_START="0.01638194520568325" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.020545442955097762" LOG_CI_START="-1.7856345310287896" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2478" O_E="0.0" SE="1.0368220676663862" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.0750000000000002" WEIGHT="22.91989699312797"/>
<DICH_DATA CI_END="0.6534310065210599" CI_START="0.002448613524660515" EFFECT_SIZE="0.04" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" LOG_CI_END="-0.18480026128772897" LOG_CI_START="-2.611079756056346" LOG_EFFECT_SIZE="-1.3979400086720375" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2480" O_E="0.0" SE="1.425208585504284" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.031219512195122" WEIGHT="12.130096781605614"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3794935926774177" CI_END="2.591104846275885" CI_START="0.16147121189697636" DF="3" EFFECT_SIZE="0.6468298382730158" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-003.15.07" LOG_CI_END="0.4134849866013428" LOG_CI_START="-0.7919048951826296" LOG_EFFECT_SIZE="-0.18920995429064344" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.7103487012143419" P_Z="0.5383495012492692" STUDIES="4" TAU2="0.0" TOTAL_1="139" TOTAL_2="139" WEIGHT="100.0" Z="0.6153107828933859">
<NAME>sweating- increase</NAME>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2477" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="25.80414174810889"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2475" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="25.931255746868054"/>
<DICH_DATA CI_END="15.304614839074713" CI_START="0.06533976911636269" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1848224044743985" LOG_CI_START="-1.1848224044743985" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2476" O_E="0.0" SE="1.3919410907075054" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="1.9375" WEIGHT="25.875489605476936"/>
<DICH_DATA CI_END="2.6831009876717293" CI_START="0.007606185290481881" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4286370191360396" LOG_CI_START="-2.1188330991645534" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2474" O_E="0.0" SE="1.4963965576702283" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.2392026578073088" WEIGHT="22.389112899546117"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.05686725737471137" CI_END="34.47166058329745" CI_START="0.4401166307088324" DF="1" EFFECT_SIZE="3.8950675361101683" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-003.15.08" LOG_CI_END="1.5374622049278779" LOG_CI_START="-0.3564322204199827" LOG_EFFECT_SIZE="0.5905149922539477" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.8115176942706449" P_Z="0.2216203553806375" STUDIES="2" TAU2="0.0" TOTAL_1="83" TOTAL_2="82" WEIGHT="100.0" Z="1.2222308716454495">
<NAME>stuffy nose</NAME>
<DICH_DATA CI_END="70.55615405273014" CI_START="0.12269907100864773" EFFECT_SIZE="2.9423076923076925" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8485348997995192" LOG_CI_START="-0.9111587254339197" LOG_EFFECT_SIZE="0.4686880871827997" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2471" O_E="0.0" SE="1.6210576961658838" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="2.6278280542986425" WEIGHT="47.09662548532198"/>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2472" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="52.90337451467801"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="64.76892720382125" CI_END="0.9205120289896281" CI_START="0.6372613720279977" CI_STUDY="95" CI_TOTAL="95" DF="83" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7659025777226542" ESTIMABLE="YES" EVENTS_1="198" EVENTS_2="282" I2="0.0" I2_Q="0.0" ID="CMP-003.16" LOG_CI_END="-0.03597053188600176" LOG_CI_START="-0.19568240573717227" LOG_EFFECT_SIZE="-0.11582646881158701" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.9307676294076621" P_Q="0.710496509058703" P_Z="0.004471692690352198" Q="4.584691509596857" RANDOM="YES" SCALE="607.16" SORT_BY="STUDY" STUDIES="61" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3544" TOTAL_2="3438" WEIGHT="800.0" Z="2.842815651123219">
<NAME>Adverse effects: 2a.Cardiac effects (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="11.904608840116895" CI_END="1.0470299920212753" CI_START="0.4124379546418979" DF="11" EFFECT_SIZE="0.6571414675379856" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="57" I2="7.5988119581761255" ID="CMP-003.16.01" LOG_CI_END="0.019959122159056583" LOG_CI_START="-0.3846413755585788" LOG_EFFECT_SIZE="-0.18234112669976116" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.37085623290826764" P_Z="0.07729654859720247" STUDIES="12" TAU2="0.0532486295853763" TOTAL_1="517" TOTAL_2="515" WEIGHT="99.99999999999999" Z="1.7665921977258578">
<NAME>abnormal ECG</NAME>
<DICH_DATA CI_END="10.22970340402268" CI_START="0.3758344668565932" EFFECT_SIZE="1.9607843137254901" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0098630421321386" LOG_CI_START="-0.4250033943280115" LOG_EFFECT_SIZE="0.2924298239020636" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="736" O_E="0.0" SE="0.8428476474801037" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="0.710392156862745" WEIGHT="7.396715472953939"/>
<DICH_DATA CI_END="7.8107039169243295" CI_START="0.014225492643544472" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8926901751653994" LOG_CI_START="-1.8469326846047245" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="1.6092680291808414" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="2.58974358974359" WEIGHT="2.1371359248017856"/>
<DICH_DATA CI_END="4.03219258176421" CI_START="0.00992016110066319" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6055412662946563" LOG_CI_START="-2.0034812749666937" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.5325527556067846" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.348717948717949" WEIGHT="2.3515871003040405"/>
<DICH_DATA CI_END="5.368170063591449" CI_START="0.046570804769315244" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7298262658251348" LOG_CI_START="-1.3318862571530974" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="1.2110601416389968" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.4666666666666668" WEIGHT="3.716281844671212"/>
<DICH_DATA CI_END="1.4623451308512174" CI_START="0.11787453080459367" EFFECT_SIZE="0.41517857142857145" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.1650498833845645" LOG_CI_START="-0.9285800229450198" LOG_EFFECT_SIZE="-0.3817650697802277" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="0.6424036205333429" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="0.41268241167434716" WEIGHT="12.12289613851019"/>
<DICH_DATA CI_END="7.9199970308142" CI_START="0.014029185955349858" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.898725018773679" LOG_CI_START="-1.8529675282130038" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.6163578231977633" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.612612612612612" WEIGHT="2.118802558621705"/>
<DICH_DATA CI_END="2.2434736482605" CI_START="0.19810548913246603" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.35092097269580763" LOG_CI_START="-0.7031034908071702" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1234" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="0.3833333333333333" WEIGHT="12.937853829639906"/>
<DICH_DATA CI_END="1.3223130190345596" CI_START="0.021006960816326796" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12133427386971721" LOG_CI_START="-1.6776367746370044" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1423" O_E="0.0" SE="1.0567244989431572" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="1.116666666666667" WEIGHT="4.828070578267448"/>
<DICH_DATA CI_END="0.7912335733739333" CI_START="0.0028658714347469683" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10169529317314795" LOG_CI_START="-2.5427432962946908" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3365" O_E="0.0" SE="1.433883680416088" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.0560224089635857" WEIGHT="2.6779079206365437"/>
<DICH_DATA CI_END="7.8107039169243295" CI_START="0.014225492643544472" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8926901751653994" LOG_CI_START="-1.8469326846047245" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="1.6092680291808414" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="2.58974358974359" WEIGHT="2.1371359248017856"/>
<DICH_DATA CI_END="2.1256236089204403" CI_START="0.20908896691741605" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3274863650599791" LOG_CI_START="-0.6796688831713416" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1294" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="14.007322546160422"/>
<DICH_DATA CI_END="2.2429902156385677" CI_START="0.5935652048158981" EFFECT_SIZE="1.1538461538461537" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.3508273791097412" LOG_CI_START="-0.22653156561205232" LOG_EFFECT_SIZE="0.062147906748844434" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.3391435021024507" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.115018315018315" WEIGHT="33.568290160631015"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.120396924053236" CI_END="5.153806717771708" CI_START="0.46188633554359537" DF="4" EFFECT_SIZE="1.5428781218785685" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-003.16.02" LOG_CI_END="0.7121281272573391" LOG_CI_START="-0.3354648857417528" LOG_EFFECT_SIZE="0.1883316207577931" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7136262752276836" P_Z="0.4809924457854299" STUDIES="5" TAU2="0.0" TOTAL_1="180" TOTAL_2="183" WEIGHT="100.0" Z="0.7047072465261861">
<NAME>blood pressure decline or rise</NAME>
<DICH_DATA CI_END="109.33802671789455" CI_START="0.27077863276672415" EFFECT_SIZE="5.4411764705882355" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.038771231680444" LOG_CI_START="-0.5673856089589266" LOG_EFFECT_SIZE="0.7356928113607587" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2465" O_E="0.0" SE="1.530869428875987" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="2.3435612082670905" WEIGHT="16.157869257617115"/>
<DICH_DATA CI_END="7.961364031061661" CI_START="0.013956290740833538" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9009874823623856" LOG_CI_START="-1.8552299918017108" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2466" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="14.446353003621898"/>
<DICH_DATA CI_END="71.6064398572955" CI_START="0.12568701946272015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8549520819268552" LOG_CI_START="-0.9007095724875305" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2467" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="14.45218127944369"/>
<DICH_DATA CI_END="6.670714447920194" CI_START="0.14990898018604015" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8241723502842975" LOG_CI_START="-0.8241723502842975" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2469" O_E="0.0" SE="0.9682458365518543" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="0.9375" WEIGHT="40.39141930709637"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2468" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="14.552177152220928"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.439679023172555" CI_START="0.06476818582168423" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-003.16.03" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.0">
<NAME>blood pressure- increase</NAME>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2458" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.4875366224058544" CI_END="2.9039197083239725" CI_START="0.4549413667269284" DF="5" EFFECT_SIZE="1.1493968857492922" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-003.16.04" LOG_CI_END="0.46298460420646254" LOG_CI_START="-0.34204457201937" LOG_EFFECT_SIZE="0.06047001609354627" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.778370928475314" P_Z="0.7684166596336198" STUDIES="6" TAU2="0.0" TOTAL_1="252" TOTAL_2="252" WEIGHT="100.0" Z="0.29444660439154147">
<NAME>blood pressure- decrease</NAME>
<DICH_DATA CI_END="100.80481454410526" CI_START="0.24800402751657977" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0034812749666937" LOG_CI_START="-0.6055412662946563" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2464" O_E="0.0" SE="1.5325527556067846" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.348717948717949" WEIGHT="9.52067145413555"/>
<DICH_DATA CI_END="71.652276279555" CI_START="0.12560661666750192" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8552299918017108" LOG_CI_START="-0.9009874823623856" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2463" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="8.530928018841248"/>
<DICH_DATA CI_END="21.280120118554144" CI_START="0.18796886379003092" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3279740750646463" LOG_CI_START="-0.7259140837366839" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2462" O_E="0.0" SE="1.2064640713902572" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="1.4555555555555557" WEIGHT="15.362774607142978"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2461" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="15.42163581253433"/>
<DICH_DATA CI_END="5.272140080731112" CI_START="0.047419073881157445" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7219869409410987" LOG_CI_START="-1.3240469322690611" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2460" O_E="0.0" SE="1.2018504251546631" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.4444444444444446" WEIGHT="15.48094979642869"/>
<DICH_DATA CI_END="4.718788952018382" CI_START="0.21191878046850707" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6738305539431859" LOG_CI_START="-0.6738305539431859" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2459" O_E="0.0" SE="0.7916228058025278" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.6266666666666666" WEIGHT="35.68304031091721"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.8481017433944946" CI_START="0.11549706168953583" DF="0" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-003.16.05" LOG_CI_END="0.5852465462167757" LOG_CI_START="-0.9374290643281383" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.6503156188695827" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.45332377211707847">
<NAME>EEG abnormal</NAME>
<DICH_DATA CI_END="3.8481017433944946" CI_START="0.11549706168953583" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5852465462167757" LOG_CI_START="-0.9374290643281383" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2470" O_E="0.0" SE="0.8944271909999157" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="0.7999999999999998" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.890209470066447" CI_END="1.928871748764172" CI_START="0.46218973459997387" DF="4" EFFECT_SIZE="0.9441952772804469" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" I2="0.0" ID="CMP-003.16.06" LOG_CI_END="0.2853033522391717" LOG_CI_START="-0.33517970458623597" LOG_EFFECT_SIZE="-0.024938176173532157" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.4210683974661902" P_Z="0.8748129948701437" STUDIES="6" TAU2="0.0" TOTAL_1="202" TOTAL_2="197" WEIGHT="100.00000000000001" Z="0.15754798330936942">
<NAME>postural hypotension</NAME>
<DICH_DATA CI_END="8.220339253228541" CI_START="0.2737113312101215" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9148897412340661" LOG_CI_START="-0.5627072231227036" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2528" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="17.63387969463678"/>
<DICH_DATA CI_END="5.122375331112424" CI_START="0.046131725434176825" EFFECT_SIZE="0.4861111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7094713972989422" LOG_CI_START="-1.3360003014609279" LOG_EFFECT_SIZE="-0.31326445208099285" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2529" O_E="0.0" SE="1.2015202010997543" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="1.4436507936507939" WEIGHT="9.201802422292042"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2524" O_E="0.0" SE="0.0" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.5535004046793537" CI_START="0.07152306544396729" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.19131137072262336" LOG_CI_START="-1.1455538801619483" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2525" O_E="0.0" SE="0.7852812659593164" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="0.6166666666666666" WEIGHT="21.541928708042768"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2526" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="9.161509910317037"/>
<DICH_DATA CI_END="5.2377649569357665" CI_START="0.5846959581385349" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7191460056974361" LOG_CI_START="-0.23306990832484725" LOG_EFFECT_SIZE="0.24303804868629444" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2527" O_E="0.0" SE="0.5593363414414827" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.3128571428571429" WEIGHT="42.46087926471137"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.774776377014643" CI_END="1.0881874190633278" CI_START="0.12587974917490383" DF="4" EFFECT_SIZE="0.3701091181894573" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" I2="0.0" ID="CMP-003.16.07" LOG_CI_END="0.036703700559999275" LOG_CI_START="-0.9000441311231621" LOG_EFFECT_SIZE="-0.4316702152815814" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.4373438336888702" P_Z="0.07086006953139987" STUDIES="5" TAU2="0.0" TOTAL_1="376" TOTAL_2="273" WEIGHT="99.99999999999999" Z="1.806373170099241">
<NAME>QTc prolongation</NAME>
<DICH_DATA CI_END="4.718788952018382" CI_START="0.21191878046850707" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6738305539431859" LOG_CI_START="-0.6738305539431859" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2377" O_E="0.0" SE="0.7916228058025278" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.6266666666666666" WEIGHT="48.31522456830572"/>
<DICH_DATA CI_END="1.349251734745935" CI_START="0.0036704461687256046" EFFECT_SIZE="0.07037297677691766" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.1300929851142036" LOG_CI_START="-2.4352811409691433" LOG_EFFECT_SIZE="-1.1525940779274697" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="1.5069134604680858" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="2.2707881773399015" WEIGHT="13.333494084393196"/>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2378" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="11.555629450005426"/>
<DICH_DATA CI_END="1.9982491776052522" CI_START="0.006178248013664149" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30064964290473245" LOG_CI_START="-2.2091346617833825" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2379" O_E="0.0" SE="1.4742597242064726" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" VAR="2.1734417344173442" WEIGHT="13.930688939120964"/>
<DICH_DATA CI_END="4.044504981919023" CI_START="0.00988996185659807" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6068653747055984" LOG_CI_START="-2.004805383377636" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2380" O_E="0.0" SE="1.534108331276844" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.353488372093023" WEIGHT="12.864962958174685"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="36.751894517476394" CI_END="0.9575593935830075" CI_START="0.611159003543587" DF="48" EFFECT_SIZE="0.7649974149080454" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="181" I2="0.0" ID="CMP-003.16.08" LOG_CI_END="-0.01883427897251436" LOG_CI_START="-0.21384578586552616" LOG_EFFECT_SIZE="-0.1163400324190203" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.8815624342150408" P_Z="0.01935863212821633" STUDIES="49" TAU2="0.0" TOTAL_1="1917" TOTAL_2="1918" WEIGHT="100.00000000000001" Z="2.3385519873614506">
<NAME>tachycardia</NAME>
<DICH_DATA CI_END="5.433245432090169" CI_START="0.7362082295003559" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7350593235492655" LOG_CI_START="-0.1329993322213031" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2381" O_E="0.0" SE="0.5099019513592785" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.26" WEIGHT="5.0468724911313725"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2382" O_E="0.0" SE="0.0" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.7569283366188426" CI_START="0.25296674609948216" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24475404741121923" LOG_CI_START="-0.5969365655225819" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2383" O_E="0.0" SE="0.4944132324730442" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.24444444444444446" WEIGHT="5.368037104203369"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2384" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.5012390753614326"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2385" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.5618479596480507"/>
<DICH_DATA CI_END="2.288930488946035" CI_START="0.15727869489202628" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35963260406574094" LOG_CI_START="-0.8033301032984537" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2386" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="2.8118289593446217"/>
<DICH_DATA CI_END="4.373521068715783" CI_START="0.01083114531066897" EFFECT_SIZE="0.21764705882352942" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6408312230084063" LOG_CI_START="-1.9653256176309641" LOG_EFFECT_SIZE="-0.6622471973112789" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2387" O_E="0.0" SE="1.530869428875987" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="2.3435612082670905" WEIGHT="0.559911489857964"/>
<DICH_DATA CI_END="172.84329174620893" CI_START="0.572484691216403" EFFECT_SIZE="9.947368421052632" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.237652528719968" LOG_CI_START="-0.242236122279138" LOG_EFFECT_SIZE="0.9977082032204152" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2388" O_E="0.0" SE="1.4566988692436766" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="2.1219715956558063" WEIGHT="0.6183809672007503"/>
<DICH_DATA CI_END="2.302622448212179" CI_START="0.1563434770991285" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.36222273427339696" LOG_CI_START="-0.8059202335061098" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2389" O_E="0.0" SE="0.68617296167463" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="0.4708333333333333" WEIGHT="2.786945517226528"/>
<DICH_DATA CI_END="3.1082378709914233" CI_START="0.1809707053793092" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4925142476146918" LOG_CI_START="-0.7423917208312916" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2390" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="2.493748760323738"/>
<DICH_DATA CI_END="71.39983803807861" CI_START="0.12605070609824312" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8536972266326377" LOG_CI_START="-0.8994547171933126" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2391" O_E="0.0" SE="1.6172150801252798" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.6153846153846154" WEIGHT="0.5017185005889423"/>
<DICH_DATA CI_END="2.0195673348932908" CI_START="0.0061130316375403206" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30525833766698174" LOG_CI_START="-2.2137433565456317" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2392" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="0.5993266051448353"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2393" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.9154791960656911"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2394" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.7115480622097698"/>
<DICH_DATA CI_END="26.71629479963117" CI_START="0.3184178235883923" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.426776227020078" LOG_CI_START="-0.4970026304147763" LOG_EFFECT_SIZE="0.4648867983026508" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2395" O_E="0.0" SE="1.1300372237161602" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="1.276984126984127" WEIGHT="1.0275670777468227"/>
<DICH_DATA CI_END="2.6276323925290224" CI_START="0.09514268461250855" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41956460705852205" LOG_CI_START="-1.0216245983864845" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2396" O_E="0.0" SE="0.8465616732800195" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.7166666666666666" WEIGHT="1.8309583921313821"/>
<DICH_DATA CI_END="4.3549459370752475" CI_START="0.3587874620205651" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6389827679830317" LOG_CI_START="-0.4451627419669189" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2397" O_E="0.0" SE="0.6368324391514267" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.4055555555555556" WEIGHT="3.235529213492441"/>
<DICH_DATA CI_END="18.34435763179999" CI_START="0.9877684708230543" EFFECT_SIZE="4.256756756756757" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2635025085777092" LOG_CI_START="-0.005344840460460531" LOG_EFFECT_SIZE="0.6290788340586243" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2398" O_E="0.0" SE="0.7453272137206957" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.5555126555126556" WEIGHT="2.362118728840126"/>
<DICH_DATA CI_END="5.272140080731112" CI_START="0.047419073881157445" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7219869409410987" LOG_CI_START="-1.3240469322690611" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2399" O_E="0.0" SE="1.2018504251546631" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.4444444444444446" WEIGHT="0.9084370484036469"/>
<DICH_DATA CI_END="3.180472848141597" CI_START="0.17686049429055115" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5024916923343051" LOG_CI_START="-0.7523691655509052" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2400" O_E="0.0" SE="0.7371114795831993" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.5433333333333332" WEIGHT="2.415067817842007"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2401" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.7115480622097698"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2402" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="2.539716479408046"/>
<DICH_DATA CI_END="2.5843209551150403" CI_START="0.09673721040925096" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4123464490983779" LOG_CI_START="-1.0144064404263402" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2403" O_E="0.0" SE="0.8380817098475257" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.7023809523809523" WEIGHT="1.868198223835749"/>
<DICH_DATA CI_END="1.3074563269125963" CI_START="0.004525703567694904" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11642719100191871" LOG_CI_START="-2.344313895615592" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2404" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="0.6280419235400775"/>
<DICH_DATA CI_END="3.7727449672367777" CI_START="0.11780399902566513" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5766574484383975" LOG_CI_START="-0.9288399665497601" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2405" O_E="0.0" SE="0.8843366338964376" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.7820512820512819" WEIGHT="1.67787826426466"/>
<DICH_DATA CI_END="1.9982491776052522" CI_START="0.006178248013664149" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30064964290473245" LOG_CI_START="-2.2091346617833825" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2406" O_E="0.0" SE="1.4742597242064726" STUDY_ID="STD-Sun-2006" TOTAL_1="40" TOTAL_2="40" VAR="2.1734417344173442" WEIGHT="0.6037368413954413"/>
<DICH_DATA CI_END="4.9338978060820695" CI_START="0.45602890218488124" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.693190149873159" LOG_CI_START="-0.3410076317617965" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2407" O_E="0.0" SE="0.6074928962939559" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.36904761904761896" WEIGHT="3.555603071171265"/>
<DICH_DATA CI_END="2.0476378322372475" CI_START="0.19422135400529575" EFFECT_SIZE="0.6306306306306306" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.31125314499429" LOG_CI_START="-0.7117030225390913" LOG_EFFECT_SIZE="-0.2002249387724006" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2408" O_E="0.0" SE="0.6008895165238041" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.361068211068211" WEIGHT="3.6341799346225634"/>
<DICH_DATA CI_END="2.1256236089204403" CI_START="0.20908896691741605" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3274863650599791" LOG_CI_START="-0.6796688831713416" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2409" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="3.7491052791261628"/>
<DICH_DATA CI_END="2.2944976857274546" CI_START="0.21462615599233448" EFFECT_SIZE="0.7017543859649122" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.360687623993501" LOG_CI_START="-0.668317352682559" LOG_EFFECT_SIZE="-0.15381486434452904" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2410" O_E="0.0" SE="0.6044426169563016" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.3653508771929824" WEIGHT="3.591579847230106"/>
<DICH_DATA CI_END="4.673089416084276" CI_START="0.04226986616555006" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6696040910051549" LOG_CI_START="-1.37396912722788" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2411" O_E="0.0" SE="1.2004050242406612" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="1.4409722222222223" WEIGHT="0.9106260533395595"/>
<DICH_DATA CI_END="0.8745632810621311" CI_START="0.04573711344411945" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.05820876066010833" LOG_CI_START="-1.339731248011929" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2412" O_E="0.0" SE="0.7527726527090809" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="0.5666666666666665" WEIGHT="2.315623848872042"/>
<DICH_DATA CI_END="1.6710602390028881" CI_START="0.07544698364769252" EFFECT_SIZE="0.35507246376811596" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.22299210578507586" LOG_CI_START="-1.1223581185305214" LOG_EFFECT_SIZE="-0.44968300637272285" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2413" O_E="0.0" SE="0.7902653813539967" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.6245193729665779" WEIGHT="2.101114720366538"/>
<DICH_DATA CI_END="2.0008335136944777" CI_START="0.25499576958333575" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.30121095315801366" LOG_CI_START="-0.5934670245144897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2414" O_E="0.0" SE="0.5255382728122436" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="0.2761904761904762" WEIGHT="4.7510213450995336"/>
<DICH_DATA CI_END="4.587998708861241" CI_START="0.2179599567167716" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6616232870115933" LOG_CI_START="-0.6616232870115933" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2415" O_E="0.0" SE="0.7772815877574012" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="0.6041666666666666" WEIGHT="2.1718954720455015"/>
<DICH_DATA CI_END="2.7529106241982273" CI_START="0.47445145421675067" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.43979211184824923" LOG_CI_START="-0.3238082178928758" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2416" O_E="0.0" SE="0.4485426135725302" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.2011904761904762" WEIGHT="6.522112142385159"/>
<DICH_DATA CI_END="6.817876197174655" CI_START="0.14667324120880965" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8336491108013422" LOG_CI_START="-0.8336491108013422" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2417" O_E="0.0" SE="0.9793792286287205" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.9591836734693877" WEIGHT="1.3680245858939084"/>
<DICH_DATA CI_END="6.771543116822823" CI_START="0.1476768267953074" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8306876481172819" LOG_CI_START="-0.8306876481172819" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2418" O_E="0.0" SE="0.9759000729485332" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.9523809523809523" WEIGHT="1.377796190078865"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2419" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="0.9049564466856254"/>
<DICH_DATA CI_END="2.0008335136944777" CI_START="0.25499576958333575" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.30121095315801366" LOG_CI_START="-0.5934670245144897" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2420" O_E="0.0" SE="0.5255382728122436" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.2761904761904762" WEIGHT="4.7510213450995336"/>
<DICH_DATA CI_END="71.92321045517915" CI_START="0.12513345751728625" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8568690648743624" LOG_CI_START="-0.9026265554350377" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2422" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yan-2010" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="0.49941439725673137"/>
<DICH_DATA CI_END="1.884673713471738" CI_START="0.13264895573859178" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2752361732662593" LOG_CI_START="-0.8772961645942218" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2421" O_E="0.0" SE="0.6770032003863301" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.45833333333333337" WEIGHT="2.8629531222417968"/>
<DICH_DATA CI_END="3.8013774282922785" CI_START="0.11691668423572073" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5799409916465255" LOG_CI_START="-0.9321235097578879" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2423" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="1.6633354407390726"/>
<DICH_DATA CI_END="5.258102243248987" CI_START="0.04754567112516334" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7208290266632941" LOG_CI_START="-1.3228890179912565" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2424" O_E="0.0" SE="1.200490095997562" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="1.4411764705882355" WEIGHT="0.9104969963592108"/>
<DICH_DATA CI_END="3.8380688295157808" CI_START="0.11579897708622293" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5841127588337569" LOG_CI_START="-0.9362952769451195" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2425" O_E="0.0" SE="0.893095206357669" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.7976190476190474" WEIGHT="1.645129779198645"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2426" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="1.4059144796723109"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2427" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.9154791960656911"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2428" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="0.56933726862763"/>
<DICH_DATA CI_END="1.3214530094571706" CI_START="0.004477767821456074" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.12105172433772905" LOG_CI_START="-2.348938428951403" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2429" O_E="0.0" SE="1.4508844426904837" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.1050656660412757" WEIGHT="0.6233472280044436"/>
<DICH_DATA CI_END="2.533456273050193" CI_START="0.09867942172888139" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4037134128552686" LOG_CI_START="-1.005773404183231" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2430" O_E="0.0" SE="0.8279395334006838" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.685483870967742" WEIGHT="1.9142490484008876"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.05591118947867314" CI_END="-2.194870555064173" CI_START="-12.186712126050029" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.190791340557101" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.17" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.8130792589972158" P_Q="1.0" P_Z="0.004786824347839577" Q="0.0" RANDOM="YES" SCALE="30.80059919219455" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="250" TOTAL_2="133" UNITS="" WEIGHT="100.0" Z="2.8210399349724367">
<NAME>Adverse effects: 2b. Cardiac - QTc change from baseline (in ms)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.8066953403517445" CI_START="-24.806695340351745" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="8.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="39.0" SD_2="34.0" SE="8.064788672155682" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="9.989618933189057"/>
<CONT_DATA CI_END="-1.724140789688434" CI_START="-12.255859210311565" EFFECT_SIZE="-6.989999999999999" ESTIMABLE="YES" MEAN_1="-0.68" MEAN_2="6.31" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="21.22" SD_2="22.2" SE="2.6867122313715917" STUDY_ID="STD-Potkin-2003" TOTAL_1="201" TOTAL_2="99" WEIGHT="90.01038106681095"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="197.35951635721096" CI_END="1.2385839987366483" CI_START="0.9982486262336858" CI_STUDY="95" CI_TOTAL="95" DF="203" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1119418938118504" ESTIMABLE="YES" EVENTS_1="740" EVENTS_2="650" I2="0.0" I2_Q="55.53673964964045" ID="CMP-003.18" LOG_CI_END="0.09292546506054933" LOG_CI_START="-7.612787990795757E-4" LOG_EFFECT_SIZE="0.04608209313073487" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.5984732022087803" P_Q="0.012791877676321839" P_Z="0.0538412621884613" Q="22.490478478641606" RANDOM="YES" SCALE="364.3637830353587" SORT_BY="STUDY" STUDIES="63" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="7994" TOTAL_2="8024" WEIGHT="1100.0" Z="1.928111473353938">
<NAME>Adverse effects: 3. Central / peripheral nervous system (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.24463433907359966" CI_END="3.6383203614842645" CI_START="0.4882912100204458" DF="1" EFFECT_SIZE="1.3328765328233434" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="0.0" ID="CMP-003.18.01" LOG_CI_END="0.5609009369207736" LOG_CI_START="-0.31132109360237264" LOG_EFFECT_SIZE="0.12478992165920046" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6208788357479882" P_Z="0.5749140434117734" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.5608291089343616">
<NAME>acute onset of schizophrenia</NAME>
<DICH_DATA CI_END="6.35814024707232" CI_START="0.43688526358896196" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8033301032984537" LOG_CI_START="-0.35963260406574094" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2478" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="56.25"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1493" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="43.75"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="24.881238655329057" CI_END="1.5444187596230907" CI_START="0.7216672683645746" DF="22" EFFECT_SIZE="1.0557255644665429" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="65" I2="11.579964708517249" ID="CMP-003.18.02" LOG_CI_END="0.1887650682377599" LOG_CI_START="-0.14166299193239515" LOG_EFFECT_SIZE="0.023551038152682387" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3027878869123012" P_Z="0.7799453650359826" STUDIES="23" TAU2="0.09588497015705148" TOTAL_1="944" TOTAL_2="952" WEIGHT="100.0" Z="0.2793902343161555">
<NAME>dizziness</NAME>
<DICH_DATA CI_END="5.236229710339204" CI_START="0.0458903082183402" EFFECT_SIZE="0.49019607843137253" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7190186905419099" LOG_CI_START="-1.3382790253937076" LOG_EFFECT_SIZE="-0.3096301674258988" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="735" O_E="0.0" SE="1.2084668621285175" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="1.4603921568627451" WEIGHT="2.4207063589904347"/>
<DICH_DATA CI_END="100.96614901769104" CI_START="0.24760774024984902" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0041757920103214" LOG_CI_START="-0.6062357833382839" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1612" O_E="0.0" SE="1.5333686811054679" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="2.351219512195122" WEIGHT="1.5394887978412108"/>
<DICH_DATA CI_END="0.9269426096039015" CI_START="0.01685649126290228" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.032947153777727334" LOG_CI_START="-1.7732328202061596" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="1.0222524150130436" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="1.045" WEIGHT="3.3020769282372004"/>
<DICH_DATA CI_END="1.8770993454172435" CI_START="0.13318421351024964" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.27348725824988274" LOG_CI_START="-0.8755472495778451" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1621" O_E="0.0" SE="0.674948557710553" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="0.4555555555555556" WEIGHT="6.831724840788317"/>
<DICH_DATA CI_END="160.170939238357" CI_START="0.5057097147907748" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.204583722276951" LOG_CI_START="-0.29609870339830113" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1998" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="1.6716830302535175"/>
<DICH_DATA CI_END="4.373521068715783" CI_START="0.01083114531066897" EFFECT_SIZE="0.21764705882352942" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6408312230084063" LOG_CI_START="-1.9653256176309641" LOG_EFFECT_SIZE="-0.6622471973112789" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.530869428875987" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="2.3435612082670905" WEIGHT="1.5443218100273144"/>
<DICH_DATA CI_END="5.26531901349033" CI_START="0.047480503908589836" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7214246892159656" LOG_CI_START="-1.323484680543928" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1904" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="2.4482919560501"/>
<DICH_DATA CI_END="1.981815136256692" CI_START="0.08073406902230676" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29706314104329623" LOG_CI_START="-1.0929431583873712" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.8164965809277259" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.6666666666666665" WEIGHT="4.940373550859069"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1462" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="1.625876039616866"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1476" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="3.6603409839799657"/>
<DICH_DATA CI_END="101.18091723147054" CI_START="0.24708216414768958" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0050986120834273" LOG_CI_START="-0.6071586034113897" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1850" O_E="0.0" SE="1.5344528192634188" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="2.354545454545454" WEIGHT="1.537399266573975"/>
<DICH_DATA CI_END="2.5351291311965696" CI_START="0.2739286278946547" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4040000857749946" LOG_CI_START="-0.5623625778702442" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.5676462121975467" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.3222222222222223" WEIGHT="9.010344730713932"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="776" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="1.625876039616866"/>
<DICH_DATA CI_END="79.46792003171949" CI_START="0.14624644538082063" EFFECT_SIZE="3.409090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9001918460788256" LOG_CI_START="-0.8349146809398379" LOG_EFFECT_SIZE="0.5326385825694938" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="1.6066151129664257" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="2.581212121212121" WEIGHT="1.4072294762389235"/>
<DICH_DATA CI_END="2.4865448160209507" CI_START="0.279280888070104" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.3955962911070335" LOG_CI_START="-0.5539587832022832" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="0.5577733510227171" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.3111111111111111" WEIGHT="9.256329756271006"/>
<DICH_DATA CI_END="2.5212388497228155" CI_START="0.27543778508759353" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.40161399054077784" LOG_CI_START="-0.5599764826360275" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.5648430038936652" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.319047619047619" WEIGHT="9.079281877929152"/>
<DICH_DATA CI_END="285.39772614805565" CI_START="1.0126219430706869" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.4554505086339677" LOG_CI_START="0.0054473341225797734" LOG_EFFECT_SIZE="1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1085" O_E="0.0" SE="1.4391439924192966" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="2.0711354309165526" WEIGHT="1.7384653766350158"/>
<DICH_DATA CI_END="102.00170751967397" CI_START="0.2450939362478615" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.008607441959615" LOG_CI_START="-0.6106674332875779" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1228" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="1.529492455378236"/>
<DICH_DATA CI_END="7.012110572650388" CI_START="0.44949538808650913" EFFECT_SIZE="1.7753623188405796" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8458487557836075" LOG_CI_START="-0.3472747598570156" LOG_EFFECT_SIZE="0.24928699796329593" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="0.700846659143956" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.4911860396332446" WEIGHT="6.417094141769795"/>
<DICH_DATA CI_END="101.11262454797557" CI_START="0.24724904641495174" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.004805383377636" LOG_CI_START="-0.6068653747055983" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.534108331276844" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.353488372093023" WEIGHT="1.5380627659919863"/>
<DICH_DATA CI_END="5.579155313499883" CI_START="0.31864640395941085" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.74656845154428" LOG_CI_START="-0.49669097832768017" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2500" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="5.987254211821821"/>
<DICH_DATA CI_END="4.981310590503257" CI_START="0.4516883577365299" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6973436213421815" LOG_CI_START="-0.3451611032308191" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1444" O_E="0.0" SE="0.6123724356957945" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.375" WEIGHT="8.00044634355542"/>
<DICH_DATA CI_END="1.906973903151103" CI_START="0.33561025609341455" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.2803447497869488" LOG_CI_START="-0.4741647758030616" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.44320263021395917" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.19642857142857142" WEIGHT="12.887839260859874"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="28.4438987159479" CI_END="1.3219435630239822" CI_START="0.7029401460493272" DF="39" EFFECT_SIZE="0.9639746891184675" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="79" I2="0.0" ID="CMP-003.18.03" LOG_CI_END="0.1212129144609272" LOG_CI_START="-0.1530816527143791" LOG_EFFECT_SIZE="-0.015934369126725932" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8937510383350787" P_Z="0.8198661331075368" STUDIES="39" TAU2="0.0" TOTAL_1="1633" TOTAL_2="1639" WEIGHT="100.00000000000001" Z="0.22771715769922393">
<NAME>blurred vision</NAME>
<DICH_DATA CI_END="8.59508521794332" CI_START="0.2617775092331654" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9342501869566456" LOG_CI_START="-0.5820676688452829" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.8906926143924925" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.7933333333333332" WEIGHT="3.272306035235664"/>
<DICH_DATA CI_END="99.65501843264937" CI_START="0.2413095444545432" EFFECT_SIZE="4.903846153846154" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9984991738115128" LOG_CI_START="-0.6174255002132005" LOG_EFFECT_SIZE="0.690536836799156" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="734" O_E="0.0" SE="1.5366071025580923" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="2.361161387631976" WEIGHT="1.09947141615079"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="757" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="5.024573137974762"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2477" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.9976476829739143"/>
<DICH_DATA CI_END="4.318534659420911" CI_START="0.011315010711186518" EFFECT_SIZE="0.22105263157894736" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6353364094807922" LOG_CI_START="-1.9463450305906491" LOG_EFFECT_SIZE="-0.6555043105549285" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1977" O_E="0.0" SE="1.5164924574271987" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="2.299749373433584" WEIGHT="1.1288314651193299"/>
<DICH_DATA CI_END="5.311101367468561" CI_START="0.047071216062885626" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7251845904253741" LOG_CI_START="-1.3272445817533365" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="918" O_E="0.0" SE="1.2056070554260303" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="1.4534883720930232" WEIGHT="1.7860682647787618"/>
<DICH_DATA CI_END="5.26531901349033" CI_START="0.047480503908589836" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7214246892159656" LOG_CI_START="-1.323484680543928" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1904" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="1.7992283348853515"/>
<DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="0.994224046450325"/>
<DICH_DATA CI_END="7.933315337564284" CI_START="0.014005634010915893" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8994547171933126" LOG_CI_START="-1.8536972266326377" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.6172150801252798" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.6153846153846154" WEIGHT="0.9925994973548179"/>
<DICH_DATA CI_END="34.750218874646706" CI_START="0.46042875464227323" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5409575443434547" LOG_CI_START="-0.3368375616875298" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.2166666666666668" WEIGHT="2.1337228394139394"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1465" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.9976476829739143"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1479" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="1.3427738558380828"/>
<DICH_DATA CI_END="7.961364031061661" CI_START="0.013956290740833538" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9009874823623856" LOG_CI_START="-1.8552299918017108" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1848" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="0.9903927399129444"/>
<DICH_DATA CI_END="1.7569283366188426" CI_START="0.25296674609948216" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.24475404741121923" LOG_CI_START="-0.5969365655225819" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.4944132324730442" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.24444444444444446" WEIGHT="10.620120496173927"/>
<DICH_DATA CI_END="3.8013774282922785" CI_START="0.11691668423572073" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5799409916465255" LOG_CI_START="-0.9321235097578879" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="3.2907415621947385"/>
<DICH_DATA CI_END="68.80620475148235" CI_START="0.12299486576714651" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.46375729316168096" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="0.9965129422315628"/>
<DICH_DATA CI_END="4.131728484301274" CI_START="0.14049782516416282" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6161317742115487" LOG_CI_START="-0.8523303983675379" LOG_EFFECT_SIZE="-0.11809931207799451" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="0.8625819491779427" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="0.744047619047619" WEIGHT="3.489063587009674"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.9916510028518513"/>
<DICH_DATA CI_END="7.9199970308142" CI_START="0.014029185955349858" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.898725018773679" LOG_CI_START="-1.8529675282130038" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.6163578231977633" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.612612612612612" WEIGHT="0.9936526533201813"/>
<DICH_DATA CI_END="75.22559412382148" CI_START="1.3293347984118258" EFFECT_SIZE="10.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="1" LOG_CI_END="1.876365626437752" LOG_CI_START="0.1236343735622482" LOG_EFFECT_SIZE="1.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="1.0295630140987" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="1.06" WEIGHT="2.4490843911512195"/>
<DICH_DATA CI_END="8.523162813982854" CI_START="0.26398650936348594" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9306007846456915" LOG_CI_START="-0.578418266534329" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.8864052604279182" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.7857142857142856" WEIGHT="3.3040374876985554"/>
<DICH_DATA CI_END="5.290529762733964" CI_START="0.04725424696804059" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7234991619241479" LOG_CI_START="-1.3255591532521105" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1861" O_E="0.0" SE="1.2036269973367784" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="1.448717948717949" WEIGHT="1.7919495350476358"/>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1091" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="0.9907923066450232"/>
<DICH_DATA CI_END="14.547791543916547" CI_START="0.06150856162258902" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1627970693983896" LOG_CI_START="-1.2110644288318284" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.394417994864361" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="1.9444015444015446" WEIGHT="1.335130319195107"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="1.811183340432763"/>
<DICH_DATA CI_END="16.237290829528913" CI_START="0.06824003170419145" EFFECT_SIZE="1.0526315789473684" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2105135694903848" LOG_CI_START="-1.1659607800680802" LOG_EFFECT_SIZE="0.022276394711152208" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="1.3959527966683958" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="1.9486842105263158" WEIGHT="1.3321960739442422"/>
<DICH_DATA CI_END="102.00170751967397" CI_START="0.2450939362478615" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.008607441959615" LOG_CI_START="-0.6106674332875779" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1228" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="1.096660642187243"/>
<DICH_DATA CI_END="17.030762123653563" CI_START="0.8161660065832261" EFFECT_SIZE="3.7282608695652173" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2312340830002626" LOG_CI_START="-0.088221497605832" LOG_EFFECT_SIZE="0.5715062926972152" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="0.7750547394584811" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.600709849157054" WEIGHT="4.321602947351655"/>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="1.1097017098765503"/>
<DICH_DATA CI_END="3.7739877916386506" CI_START="0.2649717103525139" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.576800490944826" LOG_CI_START="-0.576800490944826" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3378" O_E="0.0" SE="0.6776309271789384" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.4591836734693877" WEIGHT="5.653575256728639"/>
<DICH_DATA CI_END="5.306321714020261" CI_START="0.047113615320280106" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.724793577042504" LOG_CI_START="-1.3268535683704665" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.2051476890327395" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.4523809523809526" WEIGHT="1.7874301162959392"/>
<DICH_DATA CI_END="1.6487062228191762" CI_START="0.024261447822767797" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.2171432771272964" LOG_CI_START="-1.6150832857993338" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1446" O_E="0.0" SE="1.0762589527308628" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="1.1583333333333334" WEIGHT="2.2411765075858643"/>
<DICH_DATA CI_END="7.970891595095491" CI_START="0.013939608861256886" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.901506902722716" LOG_CI_START="-1.8557494121620408" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="1.6196260080021871" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="2.623188405797101" WEIGHT="0.9896465876729295"/>
<DICH_DATA CI_END="4.017100178657409" CI_START="0.009957431535443751" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.603912662325553" LOG_CI_START="-2.0018526709975903" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.5306394555404428" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="2.342857142857143" WEIGHT="1.1080613525818324"/>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3368" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="0.988041061086828"/>
<DICH_DATA CI_END="3.8380688295157808" CI_START="0.11579897708622293" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5841127588337569" LOG_CI_START="-0.9362952769451195" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="900" O_E="0.0" SE="0.893095206357669" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.7976190476190474" WEIGHT="3.254723495344846"/>
<DICH_DATA CI_END="5.167657331603573" CI_START="0.04837782073340814" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7132937077873972" LOG_CI_START="-1.3153536991153596" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="1.1916375287812984" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="1.42" WEIGHT="1.8281897567748544"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.9916510028518513"/>
<DICH_DATA CI_END="2.295994708530964" CI_START="0.1567947864437097" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.36097088282939777" LOG_CI_START="-0.8046683820621104" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.6847022742046907" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.4688172043010753" WEIGHT="5.537402277057047"/>
<DICH_DATA CI_END="4.097127113786707" CI_START="0.7172771135938624" EFFECT_SIZE="1.7142857142857142" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="0.6124794381927723" LOG_CI_START="-0.14431302612603641" LOG_EFFECT_SIZE="0.23408320603336796" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.4445436397239843" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.19761904761904758" WEIGHT="13.136534589644858"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.5127059654141748" CI_END="1.3507612428761178" CI_START="0.2858689527859547" DF="4" EFFECT_SIZE="0.6214022062761367" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" I2="0.0" ID="CMP-003.18.04" LOG_CI_END="0.13057859101688823" LOG_CI_START="-0.5438330092657141" LOG_EFFECT_SIZE="-0.20662720912441296" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8243885202261978" P_Z="0.2297538435573938" STUDIES="5" TAU2="0.0" TOTAL_1="185" TOTAL_2="184" WEIGHT="99.99999999999999" Z="1.2009932448972516">
<NAME>fatigue</NAME>
<DICH_DATA CI_END="70.99720406421005" CI_START="0.12676555532891653" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8512412461360563" LOG_CI_START="-0.8969987366967316" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1948" O_E="0.0" SE="1.6143297699232972" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.606060606060606" WEIGHT="6.022000070709745"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1478" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="20.470039766048934"/>
<DICH_DATA CI_END="2.2274545938969066" CI_START="0.15167607161362273" EFFECT_SIZE="0.58125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3478088598150823" LOG_CI_START="-0.8190829280190615" LOG_EFFECT_SIZE="-0.23563703410198963" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="0.6854380123812833" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="0.4698252688172043" WEIGHT="33.40326328866918"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1228" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="6.629608908533392"/>
<DICH_DATA CI_END="2.295994708530964" CI_START="0.1567947864437097" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.36097088282939777" LOG_CI_START="-0.8046683820621104" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.6847022742046907" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.4688172043010753" WEIGHT="33.47508796603874"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.805575856233093" CI_END="2.7773192512132554" CI_START="1.3133145245261002" DF="19" EFFECT_SIZE="1.9098412792335184" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="39" I2="0.0" ID="CMP-003.18.05" LOG_CI_END="0.44362580451480194" LOG_CI_START="0.11836874734472959" LOG_EFFECT_SIZE="0.2809972759297658" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.7348718786702729" P_Z="7.078547217668001E-4" STUDIES="20" TAU2="0.0" TOTAL_1="741" TOTAL_2="764" WEIGHT="100.00000000000003" Z="3.386518622335246">
<NAME>headache</NAME>
<DICH_DATA CI_END="6.910530772970867" CI_START="0.7325775929977676" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.8395114052497086" LOG_CI_START="-0.13514636902698354" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1577" O_E="0.0" SE="0.5725188012439223" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.3277777777777778" WEIGHT="11.136511096073018"/>
<DICH_DATA CI_END="193.24582694708164" CI_START="0.6261454744538141" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.286110124306154" LOG_CI_START="-0.2033247539897039" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1622" O_E="0.0" SE="1.4623063704123758" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="2.1383399209486162" WEIGHT="1.7070723057207022"/>
<DICH_DATA CI_END="11.89447521234632" CI_START="0.5254540354594692" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.075345285599021" LOG_CI_START="-0.2794652682549458" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2475" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="5.763632935686913"/>
<DICH_DATA CI_END="142.14425601323842" CI_START="0.40823701456778083" EFFECT_SIZE="7.617647058823529" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1527293147323596" LOG_CI_START="-0.3890876206543663" LOG_EFFECT_SIZE="0.8818208470389967" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.493075850042916" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="2.229275493981376" WEIGHT="1.6374382031846235"/>
<DICH_DATA CI_END="160.58911584049116" CI_START="0.5043928386806436" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.205716107003693" LOG_CI_START="-0.29723108812504273" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1948" O_E="0.0" SE="1.470243572207055" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.1616161616161618" WEIGHT="1.6886905844278943"/>
<DICH_DATA CI_END="100.80481454410526" CI_START="0.24800402751657977" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0034812749666937" LOG_CI_START="-0.6055412662946563" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.5325527556067846" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.348717948717949" WEIGHT="1.5541673964133924"/>
<DICH_DATA CI_END="18.06355087199982" CI_START="0.8857616153865674" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.256803126516399" LOG_CI_START="-0.05268314386047426" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.769198717280955" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.5916666666666666" WEIGHT="6.169522579045148"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1477" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="4.761261990350059"/>
<DICH_DATA CI_END="9.947746479492718" CI_START="0.38007243201514196" EFFECT_SIZE="1.9444444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9977247086485272" LOG_CI_START="-0.42013363015458816" LOG_EFFECT_SIZE="0.28879553924696955" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="0.8328570067249201" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.6936507936507936" WEIGHT="5.262447463018486"/>
<DICH_DATA CI_END="5.620794643138402" CI_START="0.3162858440217174" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7497977185466301" LOG_CI_START="-0.4999202453300303" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.7340905181848413" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.5388888888888888" WEIGHT="6.773754171838229"/>
<DICH_DATA CI_END="3.8843813103531986" CI_START="0.009683006254130959" EFFECT_SIZE="0.19393939393939394" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5893218558533486" LOG_CI_START="-2.013989787641349" LOG_EFFECT_SIZE="-0.7123339658940003" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="1.5291981459892532" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.3384469696969696" WEIGHT="1.5609936451718667"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1670" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="13.688628222256419"/>
<DICH_DATA CI_END="4.6743560803370325" CI_START="0.2139332097968663" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6697217927449455" LOG_CI_START="-0.6697217927449455" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.7867957924694431" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.619047619047619" WEIGHT="5.896639849587381"/>
<DICH_DATA CI_END="27.688095411248863" CI_START="0.32504944331936847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4422930828371945" LOG_CI_START="-0.48805057339786945" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.1338934190276817" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.2857142857142858" WEIGHT="2.839122890542072"/>
<DICH_DATA CI_END="5.513795283467247" CI_START="0.5554250461896373" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7414506375566635" LOG_CI_START="-0.2553745401840747" LOG_EFFECT_SIZE="0.24303804868629444" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2497" O_E="0.0" SE="0.5855400437691198" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.3428571428571428" WEIGHT="10.646710839532771"/>
<DICH_DATA CI_END="19.748873627142007" CI_START="1.0253749344048295" EFFECT_SIZE="4.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.295542330774297" LOG_CI_START="0.010882696776390421" LOG_EFFECT_SIZE="0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1445" O_E="0.0" SE="0.754615428178118" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.5694444444444444" WEIGHT="6.4102844357883715"/>
<DICH_DATA CI_END="8.553099213657628" CI_START="0.2630625395303716" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.932123509757888" LOG_CI_START="-0.5799409916465255" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="4.627141934283861"/>
<DICH_DATA CI_END="8.220339253228541" CI_START="0.2737113312101215" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9148897412340661" LOG_CI_START="-0.5627072231227036" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="4.84553211407307"/>
<DICH_DATA CI_END="232.46885558627156" CI_START="0.4593207873308067" EFFECT_SIZE="10.333333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.3663647776430516" LOG_CI_START="-0.337883899413831" LOG_EFFECT_SIZE="1.0142404391146103" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="943" O_E="0.0" SE="1.588489059150055" STUDY_ID="STD-Zhang-2008" TOTAL_1="8" TOTAL_2="30" VAR="2.5232974910394264" WEIGHT="1.4466391189430081"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1753" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="1.583808224062726"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="20.219197781059506" CI_END="1.7868591272499463" CI_START="0.932612323414795" DF="19" EFFECT_SIZE="1.290909308309265" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="67" I2="6.029901850020971" ID="CMP-003.18.06" LOG_CI_END="0.2520903148617684" LOG_CI_START="-0.030298850134278944" LOG_EFFECT_SIZE="0.11089573236374473" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.38149828752547477" P_Z="0.12371237442650447" STUDIES="20" TAU2="0.0330926342108809" TOTAL_1="745" TOTAL_2="741" WEIGHT="100.0" Z="1.5393766363180037">
<NAME>headache/dizziness</NAME>
<DICH_DATA CI_END="5.654173952251728" CI_START="0.31441865651653533" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.752369165550905" LOG_CI_START="-0.5024916923343052" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.7371114795831993" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.5433333333333332" WEIGHT="4.773398862500648"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="758" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="4.346142900905823"/>
<DICH_DATA CI_END="5.311101367468561" CI_START="0.047071216062885626" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7251845904253741" LOG_CI_START="-1.3272445817533365" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="919" O_E="0.0" SE="1.2056070554260303" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="1.4534883720930232" WEIGHT="1.8508988384242089"/>
<DICH_DATA CI_END="1.8719608283890876" CI_START="0.08547187396954654" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27229675669244047" LOG_CI_START="-1.0681767740365156" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2461" O_E="0.0" SE="0.787400787401181" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.6199999999999999" WEIGHT="4.213048675883453"/>
<DICH_DATA CI_END="4.611278541353421" CI_START="0.5551605649153942" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.663821356294266" LOG_CI_START="-0.25558139098241633" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="8.472462683459407"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="777" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="1.2205661616093164"/>
<DICH_DATA CI_END="3.7781065604215764" CI_START="0.11763682080868876" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.57727420291097" LOG_CI_START="-0.9294567210223325" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="3.370190522072508"/>
<DICH_DATA CI_END="4.384751004320472" CI_START="0.35634862697115655" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6419449362379852" LOG_CI_START="-0.44812491022187245" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.6403124237432849" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.41" WEIGHT="6.209787401886402"/>
<DICH_DATA CI_END="1.484647141878634" CI_START="0.16839018036545472" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.1716232465525867" LOG_CI_START="-0.773683237880549" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="0.5552777082985894" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.30833333333333335" WEIGHT="8.058880458279935"/>
<DICH_DATA CI_END="27.600516770408536" CI_START="0.3260808511255562" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4409172135302828" LOG_CI_START="-0.4866747040909577" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1861" O_E="0.0" SE="1.1322770341445958" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="1.2820512820512822" WEIGHT="2.092174874375419"/>
<DICH_DATA CI_END="14.547791543916547" CI_START="0.06150856162258902" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1627970693983896" LOG_CI_START="-1.2110644288318284" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.394417994864361" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="1.9444015444015446" WEIGHT="1.3914129748397424"/>
<DICH_DATA CI_END="10.006924413115998" CI_START="0.8993772340484326" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="1.000300619372041" LOG_CI_START="-0.04605810993271604" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.6146362971528592" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.37777777777777777" WEIGHT="6.696785598344176"/>
<DICH_DATA CI_END="2.636919244643082" CI_START="0.2918054961423171" EFFECT_SIZE="0.8771929824561403" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.42109682977715823" LOG_CI_START="-0.5349065324501033" LOG_EFFECT_SIZE="-0.05690485133647262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="0.5615611072652579" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.3153508771929825" WEIGHT="7.8965771143381955"/>
<DICH_DATA CI_END="4.0743119183216105" CI_START="0.8904860468627992" EFFECT_SIZE="1.9047619047619047" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="7" LOG_CI_END="0.6100542743500444" LOG_CI_START="-0.05037288116195827" LOG_EFFECT_SIZE="0.2798406965940431" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="0.38793818031489463" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.1504960317460317" WEIGHT="14.987368874052137"/>
<DICH_DATA CI_END="160.58911584049116" CI_START="0.5043928386806436" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.205716107003693" LOG_CI_START="-0.29723108812504273" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.470243572207055" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="2.1616161616161618" WEIGHT="1.2537021143866707"/>
<DICH_DATA CI_END="17.301840540849035" CI_START="0.9247571067496871" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2380923051066506" LOG_CI_START="-0.033972322450725866" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1408" O_E="0.0" SE="0.7472170590486632" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.5583333333333333" WEIGHT="4.652333865583418"/>
<DICH_DATA CI_END="3.7781065604215764" CI_START="0.11763682080868876" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.57727420291097" LOG_CI_START="-0.9294567210223325" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1425" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="3.370190522072508"/>
<DICH_DATA CI_END="40.57638819608976" CI_START="0.6161218657309964" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6082733867998966" LOG_CI_START="-0.21033337812785904" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.0682586159672365" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="1.1411764705882355" WEIGHT="2.3431690798525198"/>
<DICH_DATA CI_END="1.8004229497035906" CI_START="0.18136328038845295" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2553745401840746" LOG_CI_START="-0.7414506375566636" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.5855400437691198" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.3428571428571428" WEIGHT="7.318826145476166"/>
<DICH_DATA CI_END="6.377763079252677" CI_START="0.43554107345474924" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8046683820621104" LOG_CI_START="-0.3609708828293977" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.6847022742046907" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.4688172043010753" WEIGHT="5.482082331657346"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="47.94323887941026" CI_END="1.3944342908168093" CI_START="0.9763071859837814" DF="53" EFFECT_SIZE="1.1667888491525145" ESTIMABLE="YES" EVENTS_1="245" EVENTS_2="215" I2="0.0" ID="CMP-003.18.07" LOG_CI_END="0.1443980540570492" LOG_CI_START="-0.010413514108417109" LOG_EFFECT_SIZE="0.06699226997431608" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.6708891436570068" P_Z="0.08983151399686011" STUDIES="54" TAU2="0.0" TOTAL_1="2104" TOTAL_2="2105" WEIGHT="100.00000000000001" Z="1.6962871437605274">
<NAME>insomnia</NAME>
<DICH_DATA CI_END="5.433245432090169" CI_START="0.7362082295003559" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.7350593235492655" LOG_CI_START="-0.1329993322213031" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.5099019513592785" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.26" WEIGHT="3.1805972254940076"/>
<DICH_DATA CI_END="3.3888355990086256" CI_START="0.578832724100234" EFFECT_SIZE="1.4005602240896358" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.5300505006239805" LOG_CI_START="-0.2374469241763293" LOG_EFFECT_SIZE="0.14630178822382559" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="732" O_E="0.0" SE="0.450831786501227" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="0.20324929971988795" WEIGHT="4.068674675721525"/>
<DICH_DATA CI_END="3.0260386806300987" CI_START="0.036718338011454264" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48087447513357967" LOG_CI_START="-1.4351169845729046" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="755" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="0.6528594304961386"/>
<DICH_DATA CI_END="3.016223771961138" CI_START="0.7918609269872464" EFFECT_SIZE="1.5454545454545454" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="11" LOG_CI_END="0.479463558458633" LOG_CI_START="-0.10135108601853526" LOG_EFFECT_SIZE="0.18905623622004888" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1576" O_E="0.0" SE="0.3411733972447475" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.11639928698752228" WEIGHT="7.104470311034549"/>
<DICH_DATA CI_END="2.1844236592731723" CI_START="0.20346073553896835" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.33933687168887666" LOG_CI_START="-0.6915193898002392" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1611" O_E="0.0" SE="0.6055300708194983" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.3666666666666666" WEIGHT="2.25533257807757"/>
<DICH_DATA CI_END="3.653484112546019" CI_START="0.12164948053783173" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5627072231227036" LOG_CI_START="-0.9148897412340662" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="1.0977282459669588"/>
<DICH_DATA CI_END="1.5429771261836058" CI_START="0.1620244368873757" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18835948792583612" LOG_CI_START="-0.7904194792537986" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1623" O_E="0.0" SE="0.5749396103553447" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="0.3305555555555556" WEIGHT="2.5017134479515892"/>
<DICH_DATA CI_END="1.9002975439776397" CI_START="0.29600627637637933" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2788216070530783" LOG_CI_START="-0.5286990802696782" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1998" O_E="0.0" SE="0.4743416490252569" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.22499999999999998" WEIGHT="3.675356793904187"/>
<DICH_DATA CI_END="3.691402296267391" CI_START="0.6095244623635621" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5671913780399481" LOG_CI_START="-0.21500885992858565" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2476" O_E="0.0" SE="0.45946829173634074" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.21111111111111114" WEIGHT="3.9171565829768307"/>
<DICH_DATA CI_END="3.3258629442764454" CI_START="0.03975852498258769" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5219043483799314" LOG_CI_START="-1.4005697360404568" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.1292707935887323" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="1.2752525252525253" WEIGHT="0.648463941261115"/>
<DICH_DATA CI_END="4.452684929775601" CI_START="0.7097950735355019" EFFECT_SIZE="1.7777777777777777" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6486219657126538" LOG_CI_START="-0.1488670192794541" LOG_EFFECT_SIZE="0.2498774732165999" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1977" O_E="0.0" SE="0.4684489774185066" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.2194444444444445" WEIGHT="3.7684038013447982"/>
<DICH_DATA CI_END="101.18091723147054" CI_START="0.24708216414768958" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0050986120834273" LOG_CI_START="-0.6071586034113897" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="917" O_E="0.0" SE="1.5344528192634188" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.354545454545454" WEIGHT="0.3512165276028133"/>
<DICH_DATA CI_END="3.724191980212114" CI_START="0.6041578983991716" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5710320605471474" LOG_CI_START="-0.2188495424357849" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1948" O_E="0.0" SE="0.4639803635691685" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="0.2152777777777778" WEIGHT="3.841340649112763"/>
<DICH_DATA CI_END="21.061276053961322" CI_START="0.18992201563435934" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.323484680543928" LOG_CI_START="-0.7214246892159657" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1904" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="0.5731373218216925"/>
<DICH_DATA CI_END="47.48716782243152" CI_START="0.7580995382713616" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6765762686393324" LOG_CI_START="-0.12027376787204512" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.0554786059979133" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="1.1140350877192982" WEIGHT="0.7423063130995465"/>
<DICH_DATA CI_END="68.85358478949932" CI_START="1.1764093365310613" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.8379265562671567" LOG_CI_START="0.07055846261149347" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="1.0381607668264958" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.077777777777778" WEIGHT="0.7672780935727812"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1463" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.37230144286799155"/>
<DICH_DATA CI_END="8.982866293339573" CI_START="0.7482618722878825" EFFECT_SIZE="2.5925925925925926" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.9534149354155363" LOG_CI_START="-0.12594638370499733" LOG_EFFECT_SIZE="0.4137342758552695" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="0.6340221817761007" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.40198412698412694" WEIGHT="2.0571839112968155"/>
<DICH_DATA CI_END="1.7582315729638507" CI_START="0.2221692557491295" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.24507607451311136" LOG_CI_START="-0.653316039824961" LOG_EFFECT_SIZE="-0.2041199826559248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1848" O_E="0.0" SE="0.5277199750748718" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.2784883720930233" WEIGHT="2.9694427541564092"/>
<DICH_DATA CI_END="1.981815136256692" CI_START="0.08073406902230676" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29706314104329623" LOG_CI_START="-1.0929431583873712" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.8164965809277259" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.6666666666666665" WEIGHT="1.2404329179426634"/>
<DICH_DATA CI_END="2.6534227310646625" CI_START="0.4769782760895318" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4238064452871154" LOG_CI_START="-0.3215014003923528" LOG_EFFECT_SIZE="0.05115252244738129" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.43779751788545657" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.19166666666666665" WEIGHT="4.314549279800567"/>
<DICH_DATA CI_END="3.8843813103531986" CI_START="0.009683006254130959" EFFECT_SIZE="0.19393939393939394" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5893218558533486" LOG_CI_START="-2.013989787641349" LOG_EFFECT_SIZE="-0.7123339658940003" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="1.5291981459892532" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.3384469696969696" WEIGHT="0.353634394683581"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="778" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="1.600558603796985"/>
<DICH_DATA CI_END="71.50812704867249" CI_START="0.12585982001561988" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8543554030852154" LOG_CI_START="-0.9001128936458906" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.31588664369968444"/>
<DICH_DATA CI_END="8.448516541066857" CI_START="0.2663189435758477" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9267804587026505" LOG_CI_START="-0.5745979405912879" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="1.0632282153794257"/>
<DICH_DATA CI_END="3.7784438683076322" CI_START="0.2646592181473641" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5773129748228616" LOG_CI_START="-0.5773129748228617" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.6782329983125268" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.45999999999999996" WEIGHT="1.79772886658357"/>
<DICH_DATA CI_END="3.51077932597227" CI_START="0.410165341167152" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.54540353224961" LOG_CI_START="-0.38704104015436036" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1670" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.30000000000000004" WEIGHT="2.7565175954281402"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.3177968632745666"/>
<DICH_DATA CI_END="3.148306452599371" CI_START="0.1786674863038117" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4980769994796615" LOG_CI_START="-0.7479544726962613" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.7319250547113998" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.5357142857142856" WEIGHT="1.543649853439759"/>
<DICH_DATA CI_END="13.959140620458308" CI_START="0.6447388306132354" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1448586822354845" LOG_CI_START="-0.19061617279615942" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1861" O_E="0.0" SE="0.7844645405527361" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.6153846153846153" WEIGHT="1.3438023277712186"/>
<DICH_DATA CI_END="5.5969892490655475" CI_START="0.3176310867623318" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7479544726962614" LOG_CI_START="-0.49807699947966155" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1090" O_E="0.0" SE="0.7319250547113998" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.5357142857142856" WEIGHT="1.543649853439759"/>
<DICH_DATA CI_END="7.991459001547201" CI_START="0.25193533472126156" EFFECT_SIZE="1.4189189189189189" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9026260757440279" LOG_CI_START="-0.5987109170661042" LOG_EFFECT_SIZE="0.15195757933896187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="0.8818927813146435" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.7777348777348777" WEIGHT="1.0632868633034909"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.5769455432291457"/>
<DICH_DATA CI_END="8.935114538359937" CI_START="0.27901990305111163" EFFECT_SIZE="1.5789473684210527" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9511001240558609" LOG_CI_START="-0.5543648165221938" LOG_EFFECT_SIZE="0.1983676537668335" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="0.8843175582671923" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.7820175438596491" WEIGHT="1.0574638447968863"/>
<DICH_DATA CI_END="63.447844706605935" CI_START="0.11283661965994402" EFFECT_SIZE="2.675675675675676" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8024168739023385" LOG_CI_START="-0.9475499328412286" LOG_EFFECT_SIZE="0.42743347053055497" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="1.6153441148364052" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="2.609336609336609" WEIGHT="0.31692165574555176"/>
<DICH_DATA CI_END="15.039542151025989" CI_START="0.6790228528292326" EFFECT_SIZE="3.1956521739130435" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1772346152244006" LOG_CI_START="-0.1681156090911966" LOG_EFFECT_SIZE="0.504559503066602" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="0.7902653813539967" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.6245193729665779" WEIGHT="1.3241467189404514"/>
<DICH_DATA CI_END="70.99720406421005" CI_START="0.12676555532891653" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8512412461360563" LOG_CI_START="-0.8969987366967316" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.6143297699232972" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="2.606060606060606" WEIGHT="0.3173200487760301"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1406" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.0786373199501418"/>
<DICH_DATA CI_END="34.23769854353973" CI_START="0.46732113081879495" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5345045637319326" LOG_CI_START="-0.330384581076008" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1424" O_E="0.0" SE="1.0954451150103324" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="1.2000000000000002" WEIGHT="0.6891293988570351"/>
<DICH_DATA CI_END="1.8172473253585144" CI_START="0.46888004402431005" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.259414038331026" LOG_CI_START="-0.3289382508494498" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3378" O_E="0.0" SE="0.34560104705541334" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.11944008372579801" WEIGHT="6.923599287881502"/>
<DICH_DATA CI_END="1.31686347914689" CI_START="0.1067878350541711" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.1195407534534992" LOG_CI_START="-0.9714782179980616" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="0.6408699444616557" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.4107142857142857" WEIGHT="2.0134563305735984"/>
<DICH_DATA CI_END="5.579155313499883" CI_START="0.31864640395941085" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.74656845154428" LOG_CI_START="-0.49669097832768017" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2498" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="1.5505411474283293"/>
<DICH_DATA CI_END="4.2228834310614225" CI_START="0.657791725280843" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6256090932777347" LOG_CI_START="-0.18191159404502183" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1442" O_E="0.0" SE="0.4743416490252569" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.22499999999999998" WEIGHT="3.675356793904187"/>
<DICH_DATA CI_END="8.553099213657628" CI_START="0.2630625395303716" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.932123509757888" LOG_CI_START="-0.5799409916465255" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="1.0482531700923916"/>
<DICH_DATA CI_END="8.417860424098468" CI_START="0.2672888224136799" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9252017204680284" LOG_CI_START="-0.573019202356666" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="0.8800623863804024" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="0.7745098039215685" WEIGHT="1.0677144103810268"/>
<DICH_DATA CI_END="0.7912335733739333" CI_START="0.0028658714347469683" EFFECT_SIZE="0.047619047619047616" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.10169529317314795" LOG_CI_START="-2.5427432962946908" LOG_EFFECT_SIZE="-1.3222192947339193" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3365" O_E="0.0" SE="1.433883680416088" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.0560224089635857" WEIGHT="0.40221121862446024"/>
<DICH_DATA CI_END="4.274791880429621" CI_START="0.6498042139769874" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6309149758171338" LOG_CI_START="-0.18721747658442112" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="899" O_E="0.0" SE="0.48057505236162745" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.23095238095238096" WEIGHT="3.580631103339646"/>
<DICH_DATA CI_END="3.653484112546019" CI_START="0.12164948053783173" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5627072231227036" LOG_CI_START="-0.9148897412340662" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="1.0977282459669588"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.0786373199501418"/>
<DICH_DATA CI_END="1.5422965811171738" CI_START="0.005358543169388946" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.1881678958663492" LOG_CI_START="-2.2709532661827994" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1753" O_E="0.0" SE="1.444499943433743" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" VAR="2.0865800865800868" WEIGHT="0.39632089079495875"/>
<DICH_DATA CI_END="3.633535878489302" CI_START="0.27521401561494013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5603294528884348" LOG_CI_START="-0.5603294528884348" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1295" O_E="0.0" SE="0.6582805886043833" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.43333333333333335" WEIGHT="1.9083583352964046"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="0.5703139852609945"/>
<DICH_DATA CI_END="3.5242896611794152" CI_START="0.4085929757312" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5470715958472816" LOG_CI_START="-0.388709103752032" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.5496822151338068" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.3021505376344087" WEIGHT="2.736898253111925"/>
<DICH_DATA CI_END="1.816849116480654" CI_START="0.2150013429605338" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2593188620352069" LOG_CI_START="-0.6675588273470565" LOG_EFFECT_SIZE="-0.2041199826559248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.5444525428617002" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.29642857142857143" WEIGHT="2.7897286507947445"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9437547096576521" CI_START="0.05232579561621084" DF="0" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" I2="0.0" ID="CMP-003.18.08" LOG_CI_END="-0.025140868079866475" LOG_CI_START="-1.281284159470821" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.04150807554726689" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="2.0384187218527816">
<NAME>memory decrease</NAME>
<DICH_DATA CI_END="0.9437547096576521" CI_START="0.05232579561621084" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.025140868079866475" LOG_CI_START="-1.281284159470821" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1670" O_E="0.0" SE="0.7378647873726218" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5444444444444445" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5209285808931217" CI_END="1.184499284893369" CI_START="0.03539575796437751" DF="1" EFFECT_SIZE="0.20475900467882704" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" I2="0.0" ID="CMP-003.18.09" LOG_CI_END="0.07353480286633346" LOG_CI_START="-1.4510487832582253" LOG_EFFECT_SIZE="-0.688756990195946" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.4704459123979311" P_Z="0.0765781268812127" STUDIES="2" TAU2="0.0" TOTAL_1="85" TOTAL_2="85" WEIGHT="100.0" Z="1.770895223023831">
<NAME>sedation</NAME>
<DICH_DATA CI_END="3.070127994092063" CI_START="0.036191035463317964" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4871564816560677" LOG_CI_START="-1.4413989910953926" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1613" O_E="0.0" SE="1.132843031197762" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="1.2833333333333334" WEIGHT="62.49398355826803"/>
<DICH_DATA CI_END="1.5970729499758802" CI_START="0.005174755987221601" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2033247539897039" LOG_CI_START="-2.286110124306154" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1624" O_E="0.0" SE="1.4623063704123758" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="2.1383399209486162" WEIGHT="37.50601644173197"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3606144088898357" CI_END="1.855946428449635" CI_START="0.38592679488829074" DF="1" EFFECT_SIZE="0.8463211309047755" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" I2="0.0" ID="CMP-003.18.10" LOG_CI_END="0.26856543623387275" LOG_CI_START="-0.4134950673261295" LOG_EFFECT_SIZE="-0.07246481554612837" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.5481654478045214" P_Z="0.677067061128988" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="76" WEIGHT="100.0" Z="0.4164687087888393">
<NAME>sleep disorder</NAME>
<DICH_DATA CI_END="2.024635999788516" CI_START="0.40007191420314997" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.306346954714663" LOG_CI_START="-0.3978619358360133" LOG_EFFECT_SIZE="-0.045757490560675115" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.41365578819969523" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.17111111111111113" WEIGHT="93.80863039399624"/>
<DICH_DATA CI_END="7.824262991946792" CI_START="0.01420084054248603" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8934434396874849" LOG_CI_START="-1.84768594912681" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1398" O_E="0.0" SE="1.6101529717988263" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="2.592592592592592" WEIGHT="6.191369606003754"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="36.1648132866344" CI_END="1.2249710203058317" CI_START="0.741483035225274" DF="34" EFFECT_SIZE="0.9530452403739126" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="136" I2="5.985965611039001" ID="CMP-003.18.11" LOG_CI_END="0.08812581452084808" LOG_CI_START="-0.1298987809705073" LOG_EFFECT_SIZE="-0.02088648322482963" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.36779953846037916" P_Z="0.7072706598481066" STUDIES="35" TAU2="0.03393716157427929" TOTAL_1="1391" TOTAL_2="1388" WEIGHT="100.0" Z="0.37552419067315">
<NAME>somnolence</NAME>
<DICH_DATA CI_END="20.94491884135682" CI_START="0.18356123287336082" EFFECT_SIZE="1.9607843137254901" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3210786818698723" LOG_CI_START="-0.7362190340657451" LOG_EFFECT_SIZE="0.2924298239020636" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="733" O_E="0.0" SE="1.2084668621285175" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="1.4603921568627451" WEIGHT="1.0975893023355376"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="756" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="2.0486535490175277"/>
<DICH_DATA CI_END="193.24582694708164" CI_START="0.6261454744538141" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.286110124306154" LOG_CI_START="-0.2033247539897039" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1627" O_E="0.0" SE="1.4623063704123758" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="2.1383399209486162" WEIGHT="0.7550417427310616"/>
<DICH_DATA CI_END="5.311101367468561" CI_START="0.047071216062885626" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7251845904253741" LOG_CI_START="-1.3272445817533365" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="916" O_E="0.0" SE="1.2056070554260303" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="1.4534883720930232" WEIGHT="1.1026836886677336"/>
<DICH_DATA CI_END="3.748275808525094" CI_START="0.11857303655019144" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5738315399834706" LOG_CI_START="-0.9260140580948332" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1904" O_E="0.0" SE="0.8810167286666446" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="0.7761904761904761" WEIGHT="2.024569706828225"/>
<DICH_DATA CI_END="1.7924955578972024" CI_START="0.18216536761070407" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.25345808808704917" LOG_CI_START="-0.7395341854596381" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="0.5832885768723526" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="0.34022556390977443" WEIGHT="4.383546949955961"/>
<DICH_DATA CI_END="1.5608102159044583" CI_START="0.19774471755990533" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.19335009896489205" LOG_CI_START="-0.7038951091715042" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.5270462766947299" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.2777777777777778" WEIGHT="5.261730084198511"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1464" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6221947299307165"/>
<DICH_DATA CI_END="5.303708959575646" CI_START="0.5457924206056316" EFFECT_SIZE="1.7013888888888888" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.724579684190408" LOG_CI_START="-0.2629724996518424" LOG_EFFECT_SIZE="0.2308035922692828" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="0.580093041251088" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.3365079365079365" WEIGHT="4.4275383385389535"/>
<DICH_DATA CI_END="5.047815708586125" CI_START="0.4457373505480486" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.70310349080717" LOG_CI_START="-0.35092097269580763" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.3833333333333333" WEIGHT="3.9306873936676956"/>
<DICH_DATA CI_END="1.817173431404193" CI_START="0.17969149592539244" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2593963784403529" LOG_CI_START="-0.7454724758129418" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.5902649391694365" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.34841269841269845" WEIGHT="4.289683469842763"/>
<DICH_DATA CI_END="6.755362190128103" CI_START="0.14803055289342476" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.829648638769922" LOG_CI_START="-0.829648638769922" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="0.9746794344808963" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.95" WEIGHT="1.6669355911495518"/>
<DICH_DATA CI_END="8.448516541066857" CI_START="0.2663189435758477" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9267804587026505" LOG_CI_START="-0.5745979405912879" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="0.8819171036881968" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="0.7777777777777777" WEIGHT="2.020610678167478"/>
<DICH_DATA CI_END="5.6061784025822465" CI_START="0.5462723053175387" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7486669139779994" LOG_CI_START="-0.2625908166054105" LOG_EFFECT_SIZE="0.24303804868629444" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.594017796751194" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.3528571428571428" WEIGHT="4.240393033950763"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="2.978838485963258"/>
<DICH_DATA CI_END="5.306321714020261" CI_START="0.047113615320280106" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.724793577042504" LOG_CI_START="-1.3268535683704665" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="1.2051476890327395" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.4523809523809526" WEIGHT="1.1035052716394702"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1101" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="5.4562175195193445"/>
<DICH_DATA CI_END="1.4592730588435012" CI_START="0.06813238103031363" EFFECT_SIZE="0.3153153153153153" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.16413656458241688" LOG_CI_START="-1.1666464334551805" LOG_EFFECT_SIZE="-0.5012549344363818" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="0.7817085205293665" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.611068211068211" WEIGHT="2.5428623444845804"/>
<DICH_DATA CI_END="53.472577975118114" CI_START="0.9163575397991978" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7281311224466887" LOG_CI_START="-0.03793504241817497" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.0373960074101287" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.076190476190476" WEIGHT="1.4774516175322858"/>
<DICH_DATA CI_END="1.6325792150892289" CI_START="0.0754112286971134" EFFECT_SIZE="0.3508771929824561" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.21287426305062665" LOG_CI_START="-1.1225639830676473" LOG_EFFECT_SIZE="-0.4548448600085102" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="0.7844430362958055" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.6153508771929824" WEIGHT="2.5260897724172477"/>
<DICH_DATA CI_END="9.003494880547045" CI_START="0.7898167550997759" EFFECT_SIZE="2.6666666666666665" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="0.9544111219632407" LOG_CI_START="-0.10247365741867846" LOG_EFFECT_SIZE="0.4259687322722811" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="0.6208193510729725" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.38541666666666663" WEIGHT="3.911159893216607"/>
<DICH_DATA CI_END="6.005737702167507" CI_START="0.3358826796071584" EFFECT_SIZE="1.4202898550724639" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7785663606653578" LOG_CI_START="-0.4738123907548787" LOG_EFFECT_SIZE="0.15237698495523957" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" O_E="0.0" SE="0.7356534779590487" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.5411860396332445" WEIGHT="2.8518409110242247"/>
<DICH_DATA CI_END="2.6921683779126004" CI_START="0.23772658695895926" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4301022187434325" LOG_CI_START="-0.6239222447595453" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="0.38333333333333336" WEIGHT="3.9306873936676947"/>
<DICH_DATA CI_END="17.301840540849035" CI_START="0.9247571067496871" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2380923051066506" LOG_CI_START="-0.033972322450725866" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1407" O_E="0.0" SE="0.7472170590486632" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.5583333333333333" WEIGHT="2.769274998813978"/>
<DICH_DATA CI_END="3.7781065604215764" CI_START="0.11763682080868876" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.57727420291097" LOG_CI_START="-0.9294567210223325" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2499" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="2.006875183066829"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3332" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="2.978838485963258"/>
<DICH_DATA CI_END="6.201138564557326" CI_START="0.6450428350145314" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.792471435773703" LOG_CI_START="-0.1904114444457408" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1443" O_E="0.0" SE="0.5773502691896258" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.33333333333333337" WEIGHT="4.4658089795517535"/>
<DICH_DATA CI_END="21.280120118554144" CI_START="0.18796886379003092" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3279740750646463" LOG_CI_START="-0.7259140837366839" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="1.2064640713902572" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="1.4555555555555557" WEIGHT="1.1011533357768442"/>
<DICH_DATA CI_END="40.57638819608976" CI_START="0.6161218657309964" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6082733867998966" LOG_CI_START="-0.21033337812785904" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.0682586159672365" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="1.1411764705882355" WEIGHT="1.395745763807124"/>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3368" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="0.6162798459269299"/>
<DICH_DATA CI_END="5.167657331603573" CI_START="0.04837782073340814" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7132937077873972" LOG_CI_START="-1.3153536991153596" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="1.1916375287812984" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="1.42" WEIGHT="1.1280816787892796"/>
<DICH_DATA CI_END="3.0260386806300987" CI_START="0.036718338011454264" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48087447513357967" LOG_CI_START="-1.4351169845729046" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="943" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.261075693050307"/>
<DICH_DATA CI_END="2.838485111047003" CI_START="0.35230059728273166" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.45308662052476206" LOG_CI_START="-0.453086620524762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.532290647422377" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.28333333333333327" WEIGHT="5.169594716207187"/>
<DICH_DATA CI_END="1.8225864286313116" CI_START="0.13716770632805594" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2606881320998397" LOG_CI_START="-0.862748123427802" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.6599120175960899" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.435483870967742" WEIGHT="3.494005935782203"/>
<DICH_DATA CI_END="0.8973686761685741" CI_START="0.19756129589512555" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.04702909415726398" LOG_CI_START="-0.7042981337645068" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.3860830873995128" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.14906015037593984" WEIGHT="8.962753914817103"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.40006385092943925" CI_END="-49.35923281173196" CI_START="-60.05539953830677" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-54.707316175019365" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.19" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.5270567036498739" P_Q="1.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="167.88083630692714" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="250" TOTAL_2="133" UNITS="" WEIGHT="99.99999999999999" Z="20.049120799039642">
<NAME>Adverse effects: 3a. Endocrine - Prolactin - average change (ng/ml)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="-33.892581577097445" CI_START="-94.90741842290257" EFFECT_SIZE="-64.4" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="55.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="96.4" SD_2="42.3" SE="15.56529541539599" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="3.0731617501936968"/>
<CONT_DATA CI_END="-48.96779507355001" CI_START="-59.83220492644999" EFFECT_SIZE="-54.4" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="47.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="18.31" SD_2="24.4" SE="2.771584054247187" STUDY_ID="STD-Potkin-2003" TOTAL_1="201" TOTAL_2="99" WEIGHT="96.9268382498063"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.349532224727756" CI_END="0.10030239455367303" CI_START="0.024301866354082425" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.04937140252654169" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="90" I2="88.02328114815312" I2_Q="87.8531782373835" ID="CMP-003.20" LOG_CI_END="-0.9986886987938064" LOG_CI_START="-1.614360371827451" LOG_EFFECT_SIZE="-1.3065245353106287" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.0038578754522783365" P_Q="0.004114476580072801" P_Z="8.906244064462144E-17" Q="8.232606187386699" RANDOM="YES" SCALE="165.46780978616547" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="8.725817667338234" TOTALS="SUB" TOTAL_1="265" TOTAL_2="127" WEIGHT="200.0" Z="8.318528028125879">
<NAME>Adverse effects: 3b. Endocrine - Prolactin-associated</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0791398560331683" CI_START="0.018360455680187526" DF="0" EFFECT_SIZE="0.03811881188118811" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="90" I2="0.0" ID="CMP-003.20.01" LOG_CI_END="-1.101604744113679" LOG_CI_START="-1.7361165444346052" LOG_EFFECT_SIZE="-1.418860644274142" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.8590183291905387E-18" STUDIES="1" TAU2="0.0" TOTAL_1="202" TOTAL_2="99" WEIGHT="100.0" Z="8.765528900966295">
<NAME>abnormally high prolactin value</NAME>
<DICH_DATA CI_END="0.07913985603316832" CI_START="0.018360455680187533" EFFECT_SIZE="0.03811881188118812" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="90" LOG_CI_END="-1.1016047441136787" LOG_CI_START="-1.736116544434605" LOG_EFFECT_SIZE="-1.4188606442741418" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.37271537239257907" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.13891674881773888" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="59.43303535188819" CI_START="0.16927944124101285" DF="0" EFFECT_SIZE="3.171875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-003.20.02" LOG_CI_END="1.7740279110240307" LOG_CI_START="-0.7713957831653793" LOG_EFFECT_SIZE="0.5013160639293257" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.44010145779343623" STUDIES="1" TAU2="0.0" TOTAL_1="63" TOTAL_2="28" WEIGHT="100.0" Z="0.7720219092922009">
<NAME>dysmenorrhoea</NAME>
<DICH_DATA CI_END="59.43303535188819" CI_START="0.16927944124101285" EFFECT_SIZE="3.171875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.7740279110240307" LOG_CI_START="-0.7713957831653793" LOG_EFFECT_SIZE="0.5013160639293257" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="1.4951944780173567" STUDY_ID="STD-Potkin-2003" TOTAL_1="63" TOTAL_2="28" VAR="2.235606527093596" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="195.5087296537151" CI_END="0.5050204059770336" CI_START="0.3939544058610025" CI_STUDY="95" CI_TOTAL="95" DF="146" EFFECT_MEASURE="RR" EFFECT_SIZE="0.44604373550624443" ESTIMABLE="YES" EVENTS_1="537" EVENTS_2="1109" I2="25.32302764250217" I2_Q="62.01426402084735" ID="CMP-003.21" LOG_CI_END="-0.296691073318612" LOG_CI_START="-0.4045540381459383" LOG_EFFECT_SIZE="-0.3506225557322752" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.0039021348062547867" P_Q="0.006988352652670393" P_Z="3.4438896991729663E-37" Q="21.060537051040853" RANDOM="YES" SCALE="481.97253823951814" SORT_BY="STUDY" STUDIES="64" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.13830765125632546" TOTALS="SUB" TOTAL_1="6571" TOTAL_2="6013" WEIGHT="900.0" Z="12.742234232162472">
<NAME>Adverse effects: 4. Various extrapyramidal symptoms (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="48.483893592815974" CI_END="0.7367103319453865" CI_START="0.48135164790589446" DF="41" EFFECT_SIZE="0.5954970464336581" ESTIMABLE="YES" EVENTS_1="180" EVENTS_2="278" I2="15.4358345385134" ID="CMP-003.21.01" LOG_CI_END="-0.13270323936813208" LOG_CI_START="-0.3175375370404391" LOG_EFFECT_SIZE="-0.22512038820428557" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1966692141254881" P_Z="1.8032700149456894E-6" STUDIES="42" TAU2="0.07202292791253855" TOTAL_1="1809" TOTAL_2="1692" WEIGHT="100.00000000000003" Z="4.774307134797338">
<NAME>akathisia</NAME>
<DICH_DATA CI_END="1.485037350385368" CI_START="0.020263213231856526" EFFECT_SIZE="0.17346938775510204" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.17173737679280784" LOG_CI_START="-1.6932916854212496" LOG_EFFECT_SIZE="-0.7607771543142209" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="1.0955273031872879" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="1.2001800720288116" WEIGHT="0.9265821124305106"/>
<DICH_DATA CI_END="2.1881303663821985" CI_START="0.3363121592028555" EFFECT_SIZE="0.8578431372549019" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3400731932161372" LOG_CI_START="-0.4732574306953459" LOG_EFFECT_SIZE="-0.06659211873960434" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="742" O_E="0.0" SE="0.4777544345371249" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="0.22824929971988797" WEIGHT="3.9257727976398105"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="766" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="2.002414437049282"/>
<DICH_DATA CI_END="0.9293638869079355" CI_START="0.1372455097567168" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" LOG_CI_END="-0.03181420728357814" LOG_CI_START="-0.8625018554008602" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1585" O_E="0.0" SE="0.48795003647426666" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.23809523809523814" WEIGHT="3.8011334785738695"/>
<DICH_DATA CI_END="1.2431849614993473" CI_START="0.06566412528250914" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09453574793580287" LOG_CI_START="-1.1826718366363544" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="0.7502380574571932" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.5628571428571427" WEIGHT="1.8567294791550146"/>
<DICH_DATA CI_END="1.278618826086831" CI_START="0.10998195641337302" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.10674109459607413" LOG_CI_START="-0.9586785591406364" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2480" O_E="0.0" SE="0.6258327785172862" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.39166666666666666" WEIGHT="2.5422190985239634"/>
<DICH_DATA CI_END="5.311101367468561" CI_START="0.047071216062885626" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7251845904253741" LOG_CI_START="-1.3272445817533365" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="923" O_E="0.0" SE="1.2056070554260303" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="1.4534883720930232" WEIGHT="0.7727248845169429"/>
<DICH_DATA CI_END="1.5916846764702157" CI_START="0.025130605698049202" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20185703524034426" LOG_CI_START="-1.5997970439123819" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2463" O_E="0.0" SE="1.058300524425836" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" VAR="1.1199999999999999" WEIGHT="0.9889076086735978"/>
<DICH_DATA CI_END="1.9128896710037826" CI_START="0.08364308847777954" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.28168992211510563" LOG_CI_START="-1.077569939459181" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="0.7984359711335656" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="0.6375" WEIGHT="1.6613988029875162"/>
<DICH_DATA CI_END="1.6289950819813857" CI_START="0.30079894372916166" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.2119197731534632" LOG_CI_START="-0.5217236931249496" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="0.4309458036856673" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="0.1857142857142857" WEIGHT="4.5736528557062215"/>
<DICH_DATA CI_END="1.319221438788345" CI_START="0.004485342330964766" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.12031770045318584" LOG_CI_START="-2.3482044050668596" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.4500221041639685" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.1025641025641026" WEIGHT="0.5420801865390098"/>
<DICH_DATA CI_END="1.1101701089803744" CI_START="0.15638244058882356" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.04538952989582202" LOG_CI_START="-0.805812013319034" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.5" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.25" WEIGHT="3.660610599274631"/>
<DICH_DATA CI_END="0.9437547096576521" CI_START="0.05232579561621084" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.025140868079866475" LOG_CI_START="-1.281284159470821" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1492" O_E="0.0" SE="0.7378647873726218" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.5444444444444445" WEIGHT="1.9121864286492538"/>
<DICH_DATA CI_END="1.80128068021618" CI_START="0.21685959567007587" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.2555813909824164" LOG_CI_START="-0.6638213562942659" LOG_EFFECT_SIZE="-0.2041199826559248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="3.2412270262776706"/>
<DICH_DATA CI_END="3.8659894752923827" CI_START="0.581998480435551" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5872606673778256" LOG_CI_START="-0.2350781492664631" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.483045891539648" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.23333333333333336" WEIGHT="3.8604105850540353"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="780" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.4055266104947057"/>
<DICH_DATA CI_END="23.44357047502594" CI_START="0.2228538439349045" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3700237557894768" LOG_CI_START="-0.651979870506141" LOG_EFFECT_SIZE="0.3590219426416679" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="1.1877349391654206" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="1.4107142857142856" WEIGHT="0.7950164953658269"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="0.7744959169194772"/>
<DICH_DATA CI_END="2.129235216496011" CI_START="0.029353262390077094" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3282236405757729" LOG_CI_START="-1.5323436232316976" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.0929064207170003" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.1944444444444446" WEIGHT="0.9307784541912515"/>
<DICH_DATA CI_END="0.8669836432287152" CI_START="0.0461369719168367" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.06198909597537003" LOG_CI_START="-1.3359509126966675" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.7483314773547882" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.5599999999999999" WEIGHT="1.8651230692207035"/>
<DICH_DATA CI_END="2.449261751634576" CI_START="0.8005645611064249" EFFECT_SIZE="1.4002828854314002" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="14" LOG_CI_END="0.38903520048444684" LOG_CI_START="-0.09660363888314591" LOG_EFFECT_SIZE="0.14621578080065048" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.2852666581955493" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.08137706627805637" WEIGHT="7.684488838125147"/>
<DICH_DATA CI_END="1.521306165997993" CI_START="0.07303665336702361" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.1822166255077755" LOG_CI_START="-1.1364591349471005" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="1.7541076266366704"/>
<DICH_DATA CI_END="1.8684520468046404" CI_START="0.13380059735947786" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2714819563064079" LOG_CI_START="-0.8735419476343704" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.6725927091345493" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.45238095238095233" WEIGHT="2.2478867670970604"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1105" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="0.7830708075379335"/>
<DICH_DATA CI_END="5.166910779798377" CI_START="0.5303685650930418" EFFECT_SIZE="1.6554054054054055" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7132309623825538" LOG_CI_START="-0.27542222444340364" LOG_EFFECT_SIZE="0.2189043689695751" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="0.5807397758537702" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.33725868725868724" WEIGHT="2.880169788796718"/>
<DICH_DATA CI_END="10.108042421948712" CI_START="0.39572449669526094" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0046670559209654" LOG_CI_START="-0.402607064593003" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.8266397845091497" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.6833333333333333" WEIGHT="1.5605888288816134"/>
<DICH_DATA CI_END="3.3247133785722935" CI_START="0.45361996180537567" EFFECT_SIZE="1.2280701754385965" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5217542110015646" LOG_CI_START="-0.3433078423180337" LOG_EFFECT_SIZE="0.08922318434176545" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="0.5081417322461572" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.25820802005012533" WEIGHT="3.569624683569527"/>
<DICH_DATA CI_END="1.3211295342918357" CI_START="0.18458845867230952" EFFECT_SIZE="0.49382716049382713" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.12094540146779889" LOG_CI_START="-0.7337954565691738" LOG_EFFECT_SIZE="-0.3064250275506874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="0.5020790110464023" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.2520833333333333" WEIGHT="3.637080439590253"/>
<DICH_DATA CI_END="4.833485232397585" CI_START="0.6009745292728341" EFFECT_SIZE="1.7043478260869565" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6842603960440332" LOG_CI_START="-0.22114393403830454" LOG_EFFECT_SIZE="0.23155823100286435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1242" O_E="0.0" SE="0.531838985314081" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.28285270629991127" WEIGHT="3.32172859864588"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.514037024622289"/>
<DICH_DATA CI_END="2.1256236089204403" CI_START="0.20908896691741605" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3274863650599791" LOG_CI_START="-0.6796688831713416" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1412" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="2.7932144562780428"/>
<DICH_DATA CI_END="1.9423192528417736" CI_START="0.08237574732676249" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.28832061504272793" LOG_CI_START="-1.084200632386803" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1430" O_E="0.0" SE="0.8062257748298549" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="0.6499999999999999" WEIGHT="1.6326358866942823"/>
<DICH_DATA CI_END="0.9968560220998471" CI_START="0.14839554640120672" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="-0.0013675631757215237" LOG_CI_START="-0.8285791327659144" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3378" O_E="0.0" SE="0.4859081707405883" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.23610675039246468" WEIGHT="3.825663758228603"/>
<DICH_DATA CI_END="1.328860833262457" CI_START="0.10582372245463406" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.12347950125058388" LOG_CI_START="-0.9754169657951461" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1454" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.4166666666666667" WEIGHT="2.4121662425432158"/>
<DICH_DATA CI_END="0.9086123870966706" CI_START="0.14038001486611107" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" LOG_CI_END="-0.041621346752010895" LOG_CI_START="-0.8526947159324275" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.47642851193450525" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.226984126984127" WEIGHT="3.9423837124293706"/>
<DICH_DATA CI_END="1.2777267334498414" CI_START="0.06388897635476222" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.10643798148691483" LOG_CI_START="-1.194574070187466" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="0.764220919267052" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="0.5840336134453781" WEIGHT="1.7967971795330147"/>
<DICH_DATA CI_END="2.1164687775666104" CI_START="0.2410638356873165" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3256118660864053" LOG_CI_START="-0.6178679374428814" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="908" O_E="0.0" SE="0.5542047068934521" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.30714285714285716" WEIGHT="3.108931738009714"/>
<DICH_DATA CI_END="6.553055387930549" CI_START="0.15260057191669785" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8164438387284481" LOG_CI_START="-0.8164438387284481" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.9591663046625438" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.9199999999999999" WEIGHT="1.1882795346339192"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="1.4055266104947057"/>
<DICH_DATA CI_END="6.755362190128103" CI_START="0.14803055289342476" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.829648638769922" LOG_CI_START="-0.829648638769922" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.9746794344808963" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.95" WEIGHT="1.153399313197176"/>
<DICH_DATA CI_END="0.8392893948566251" CI_START="0.04765936546455847" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.0760882645365385" LOG_CI_START="-1.3218517441354989" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.7317676345451075" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.535483870967742" WEIGHT="1.9403907006452972"/>
<DICH_DATA CI_END="0.9306865312599032" CI_START="0.18217752950701302" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.031196571078898307" LOG_CI_START="-0.739505191649136" LOG_EFFECT_SIZE="-0.38535088136401713" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.4160639899071764" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.173109243697479" WEIGHT="4.808836536566286"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="22.044793948242013" CI_END="0.4546025271635365" CI_START="0.2667274943724841" DF="35" EFFECT_SIZE="0.3482168763941938" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="221" I2="0.0" ID="CMP-003.21.02" LOG_CI_END="-0.34236815433447926" LOG_CI_START="-0.5739322147607857" LOG_EFFECT_SIZE="-0.4581501845476325" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9566499137661332" P_Z="8.793425481984327E-15" STUDIES="36" TAU2="0.0" TOTAL_1="1396" TOTAL_2="1403" WEIGHT="99.99999999999999" Z="7.755589184009042">
<NAME>tremor</NAME>
<DICH_DATA CI_END="7.839572672525566" CI_START="0.013633230112071966" EFFECT_SIZE="0.3269230769230769" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8942923903601941" LOG_CI_START="-1.8654012348732447" LOG_EFFECT_SIZE="-0.48555442225652523" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="743" O_E="0.0" SE="1.6210576961658838" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="2.6278280542986425" WEIGHT="0.7040776714756837"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="767" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="1.7482158023707701"/>
<DICH_DATA CI_END="1.5859300283128421" CI_START="0.07006053806126257" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.20028402220732086" LOG_CI_START="-1.1545265316466458" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1586" O_E="0.0" SE="0.7958224257542214" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.6333333333333332" WEIGHT="2.9213606171195763"/>
<DICH_DATA CI_END="1.2431849614993473" CI_START="0.06566412528250914" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09453574793580287" LOG_CI_START="-1.1826718366363544" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="0.7502380574571932" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.5628571428571427" WEIGHT="3.287148579330826"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2481" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="2.921360617119576"/>
<DICH_DATA CI_END="2.4023415437266507" CI_START="0.185004686617123" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38063475161440946" LOG_CI_START="-0.7328172697257719" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1981" O_E="0.0" SE="0.6540472290116194" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.42777777777777776" WEIGHT="4.325131303267944"/>
<DICH_DATA CI_END="7.961364031061661" CI_START="0.013956290740833538" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9009874823623856" LOG_CI_START="-1.8552299918017108" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="921" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="0.7058547618242677"/>
<DICH_DATA CI_END="4.008199669020626" CI_START="0.009979542763091372" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6029493478377236" LOG_CI_START="-2.0008893565097607" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="0.7908864883134603"/>
<DICH_DATA CI_END="7.9127893408891605" CI_START="0.014041965016931132" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8983296038284552" LOG_CI_START="-1.85257211326778" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="0.7085853411736843"/>
<DICH_DATA CI_END="2.674727271235896" CI_START="0.007629997826236778" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4272795057457678" LOG_CI_START="-2.1174755857742817" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.4948017374997375" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.2344322344322345" WEIGHT="0.8280381159015978"/>
<DICH_DATA CI_END="1.128971929499989" CI_START="0.05536010096166047" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.05268314386047429" LOG_CI_START="-1.256803126516399" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.769198717280955" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.5916666666666666" WEIGHT="3.1270902380434897"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1491" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="1.7482158023707701"/>
<DICH_DATA CI_END="0.9882463955100189" CI_START="0.003501361227501351" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.005134761010252241" LOG_CI_START="-2.455763081746296" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1853" O_E="0.0" SE="1.4395112064061828" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="2.0721925133689836" WEIGHT="0.8928683245269552"/>
<DICH_DATA CI_END="0.6102284711751479" CI_START="0.05761161869798999" EFFECT_SIZE="0.1875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="16" LOG_CI_END="-0.2145075335244801" LOG_CI_START="-1.2394899223480447" LOG_EFFECT_SIZE="-0.7269987279362623" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.6020797289396148" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.3625" WEIGHT="5.103986365542248"/>
<DICH_DATA CI_END="5.860892618756486" CI_START="0.055713460983726135" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7679637644615145" LOG_CI_START="-1.2540398618341033" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="1.1877349391654206" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="1.4107142857142856" WEIGHT="1.3115306736773118"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.7067515281789285"/>
<DICH_DATA CI_END="1.9912523628464711" CI_START="0.006199956993245031" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29912630414908753" LOG_CI_START="-2.2076113230277374" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.472470090755044" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.168168168168168" WEIGHT="0.8533448118428235"/>
<DICH_DATA CI_END="0.5529311385956133" CI_START="0.03215188390896462" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="15" LOG_CI_END="-0.2573289518600418" LOG_CI_START="-1.492793574923358" LOG_EFFECT_SIZE="-0.8750612633917001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.725718035235908" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.5266666666666666" WEIGHT="3.5130285902070852"/>
<DICH_DATA CI_END="3.0683219164168825" CI_START="0.18332496241361632" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4869009221574032" LOG_CI_START="-0.736778395374003" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="3.581022691953029"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1103" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.7922105909223895"/>
<DICH_DATA CI_END="1.6871545403423274" CI_START="0.17318157227527892" EFFECT_SIZE="0.5405405405405406" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.22715486500996498" LOG_CI_START="-0.7614983218159926" LOG_EFFECT_SIZE="-0.2671717284030138" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="0.5807397758537702" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.33725868725868724" WEIGHT="5.48598191064508"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="2.921360617119576"/>
<DICH_DATA CI_END="2.2944976857274546" CI_START="0.21462615599233448" EFFECT_SIZE="0.7017543859649122" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.360687623993501" LOG_CI_START="-0.668317352682559" LOG_EFFECT_SIZE="-0.15381486434452904" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="0.6044426169563016" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="0.3653508771929824" WEIGHT="5.0641593410812344"/>
<DICH_DATA CI_END="1.6605412547470806" CI_START="0.12550853386079844" EFFECT_SIZE="0.45652173913043476" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.2202496697485834" LOG_CI_START="-0.9013267436438931" LOG_EFFECT_SIZE="-0.34053853694765485" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1242" O_E="0.0" SE="0.6588195371195267" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.4340431824903874" WEIGHT="4.262698118867562"/>
<DICH_DATA CI_END="1.3019564567260682" CI_START="0.021335412282242117" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.11459645971618479" LOG_CI_START="-1.670898960483472" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="1.0488088481701514" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="1.0999999999999999" WEIGHT="1.6819955068264225"/>
<DICH_DATA CI_END="2.288930488946035" CI_START="0.15727869489202628" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35963260406574094" LOG_CI_START="-0.8033301032984537" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1411" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="3.964703694662281"/>
<DICH_DATA CI_END="0.9860104274367028" CI_START="0.0035093012367547953" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.00611849220455492" LOG_CI_START="-2.454779350551993" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1431" O_E="0.0" SE="1.43835550926002" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="2.0688665710186513" WEIGHT="0.8943037136503593"/>
<DICH_DATA CI_END="0.7060048144467438" CI_START="0.03934502599609843" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.15119233736105028" LOG_CI_START="-1.4051101634062368" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3378" O_E="0.0" SE="0.7365575380122866" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.5425170068027211" WEIGHT="3.410390889703229"/>
<DICH_DATA CI_END="1.0624305634643352" CI_START="0.12446122081381238" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.026300555767337874" LOG_CI_START="-0.9049659434278631" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1455" O_E="0.0" SE="0.5470305514707787" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.2992424242424243" WEIGHT="6.182930318764468"/>
<DICH_DATA CI_END="3.0467430499702566" CI_START="0.036468815810442506" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48383582912076384" LOG_CI_START="-1.4380783385600886" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.1289418957242967" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="1.2745098039215688" WEIGHT="1.4516915066609581"/>
<DICH_DATA CI_END="3.264013431830336" CI_START="0.3063712882576091" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5137519372625203" LOG_CI_START="-0.5137519372625203" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="906" O_E="0.0" SE="0.6035608621222174" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.3642857142857143" WEIGHT="5.078966824534686"/>
<DICH_DATA CI_END="1.2431849614993473" CI_START="0.06566412528250914" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09453574793580287" LOG_CI_START="-1.1826718366363544" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.7502380574571932" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.5628571428571427" WEIGHT="3.287148579330826"/>
<DICH_DATA CI_END="2.288930488946035" CI_START="0.15727869489202628" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35963260406574094" LOG_CI_START="-0.8033301032984537" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="3.964703694662281"/>
<DICH_DATA CI_END="4.038645960707643" CI_START="0.009904309609993965" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6062357833382839" LOG_CI_START="-2.0041757920103214" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.5333686811054679" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.351219512195122" WEIGHT="0.7869086862849757"/>
<DICH_DATA CI_END="0.8252093108783314" CI_START="0.014960663736580062" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.08343588050466831" LOG_CI_START="-1.8250491383739815" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="1.0230322487971009" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="1.0465949820788532" WEIGHT="1.76782335974325"/>
<DICH_DATA CI_END="0.9021239671730157" CI_START="0.15588212387337003" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.04473377891053913" LOG_CI_START="-0.8072036856340231" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.44787859749628367" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.20059523809523808" WEIGHT="9.223524322300383"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="37.15760906427863" CI_END="0.4886414914915302" CI_START="0.2464607783747169" DF="30" EFFECT_SIZE="0.34703164457897084" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="192" I2="19.262835377531275" ID="CMP-003.21.03" LOG_CI_END="-0.3110096590147321" LOG_CI_START="-0.608252184259892" LOG_EFFECT_SIZE="-0.45963092163731206" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.17259529084391145" P_Z="1.3490151720897884E-9" STUDIES="32" TAU2="0.1701814467705461" TOTAL_1="1373" TOTAL_2="1267" WEIGHT="100.00000000000003" Z="6.061447983239083">
<NAME>dystonia</NAME>
<DICH_DATA CI_END="8.430190271112927" CI_START="0.2565339201412786" EFFECT_SIZE="1.4705882352941178" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9258373768503501" LOG_CI_START="-0.5908552022628226" LOG_EFFECT_SIZE="0.16749108729376372" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="744" O_E="0.0" SE="0.8909127287204276" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="0.7937254901960783" WEIGHT="3.162729014120712"/>
<DICH_DATA CI_END="2.399062894750428" CI_START="0.15005859195594384" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38004163374732225" LOG_CI_START="-0.823739132980035" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1587" O_E="0.0" SE="0.7071067811865475" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.49999999999999994" WEIGHT="4.548882173845565"/>
<DICH_DATA CI_END="1.2431849614993473" CI_START="0.06566412528250914" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09453574793580287" LOG_CI_START="-1.1826718366363544" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="0.7502380574571932" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.5628571428571427" WEIGHT="4.1588212129527085"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2482" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="1.9011838707586306"/>
<DICH_DATA CI_END="8.871720928515353" CI_START="0.3131047290779274" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.948007872059943" LOG_CI_START="-0.5043103728272301" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1981" O_E="0.0" SE="0.8530989261379818" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="0.7277777777777776" WEIGHT="3.395005422423285"/>
<DICH_DATA CI_END="2.146539550629656" CI_START="0.029116630989476325" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.33173889489417746" LOG_CI_START="-1.535858877550102" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="922" O_E="0.0" SE="1.097036176291841" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="1.2034883720930232" WEIGHT="2.2192934536325772"/>
<DICH_DATA CI_END="1.0625075319530595" CI_START="0.05882311242077971" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.026332017380285656" LOG_CI_START="-1.2304520000362105" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2464" O_E="0.0" SE="0.7382411530116699" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.5449999999999999" WEIGHT="4.262661524879646"/>
<DICH_DATA CI_END="2.126205838723662" CI_START="0.029395084361878175" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3276053064217778" LOG_CI_START="-1.5317252890777027" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="1.09217999563128" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.192857142857143" WEIGHT="2.2366031744481125"/>
<DICH_DATA CI_END="1.6322886162353423" CI_START="0.024505470173684547" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.2127969518174963" LOG_CI_START="-1.6107369604895339" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.0711528467275953" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="1.1473684210526314" WEIGHT="2.3138224297296226"/>
<DICH_DATA CI_END="5.368170063591449" CI_START="0.046570804769315244" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7298262658251348" LOG_CI_START="-1.3318862571530974" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="1.2110601416389968" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.4666666666666668" WEIGHT="1.8624675138946583"/>
<DICH_DATA CI_END="0.8235102234711112" CI_START="0.01499153096158102" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.08433100491009908" LOG_CI_START="-1.824154013968551" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1490" O_E="0.0" SE="1.021980647783726" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.0444444444444443" WEIGHT="2.5098892247448115"/>
<DICH_DATA CI_END="7.508397381668973" CI_START="0.5327368540409986" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8755472495778451" LOG_CI_START="-0.27348725824988274" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.674948557710553" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.4555555555555556" WEIGHT="4.871977244631295"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="1.0934370488108764"/>
<DICH_DATA CI_END="1.585779792547136" CI_START="0.005211608098904247" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2002428793741081" LOG_CI_START="-2.2830282496905583" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.458685753602923" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.1277641277641273" WEIGHT="1.3266530200889959"/>
<DICH_DATA CI_END="0.4143498895945239" CI_START="0.04732213543367629" EFFECT_SIZE="0.14002828854314003" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="14" LOG_CI_END="-0.3826327725400721" LOG_CI_START="-1.3249356658586269" LOG_EFFECT_SIZE="-0.8537842191993494" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.5535133840098687" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.30637706627805633" WEIGHT="6.39706636852305"/>
<DICH_DATA CI_END="2.1080777784770572" CI_START="0.029647862445166522" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3238866303262053" LOG_CI_START="-1.52800661298213" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="1.0878112581387145" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.1833333333333331" WEIGHT="2.2523407067801626"/>
<DICH_DATA CI_END="0.7059719098553454" CI_START="0.002677669099652002" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.1512125788880248" LOG_CI_START="-2.5722430931471605" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1104" O_E="0.0" SE="1.4221253083701424" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0224403927068724" WEIGHT="1.3903794906937321"/>
<DICH_DATA CI_END="1.247415428384148" CI_START="0.004257356245796887" EFFECT_SIZE="0.0728744939271255" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.09601111122438284" LOG_CI_START="-2.370860007537102" LOG_EFFECT_SIZE="-1.1374244481563598" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.449052306369474" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="2.099752586594692" WEIGHT="1.343024242839767"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="1.361580291706504"/>
<DICH_DATA CI_END="2.8141991587512205" CI_START="0.0080147058991174" EFFECT_SIZE="0.15018315018315018" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44935482887913347" LOG_CI_START="-2.096112409521175" LOG_EFFECT_SIZE="-0.8233787903210206" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="1.4952200561023856" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="2.235683016170821" WEIGHT="1.267143882548326"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="0.0" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.6113995451271035" CI_START="0.0248231421691539" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20720323671350532" LOG_CI_START="-1.6051432453855428" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="1.133333333333333" WEIGHT="2.3387356115851805"/>
<DICH_DATA CI_END="0.9437547096576521" CI_START="0.05232579561621084" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.025140868079866475" LOG_CI_START="-1.281284159470821" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1410" O_E="0.0" SE="0.7378647873726218" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.5444444444444445" WEIGHT="4.265975350086249"/>
<DICH_DATA CI_END="1.1294626656610136" CI_START="0.003935007840071765" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.0528718799085443" LOG_CI_START="-2.405054398019907" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1432" O_E="0.0" SE="1.4437980625864737" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="2.084552845528455" WEIGHT="1.3520779130689222"/>
<DICH_DATA CI_END="2.0942010782201645" CI_START="0.2436270742761097" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.32101837885613893" LOG_CI_START="-0.6132744502126151" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1456" O_E="0.0" SE="0.5488082326190782" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.30119047619047623" WEIGHT="6.46745444087185"/>
<DICH_DATA CI_END="2.153264750755441" CI_START="0.20640492270563462" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.33309743099548544" LOG_CI_START="-0.685279949106848" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="0.5981999141214431" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="0.3578431372549019" WEIGHT="5.773550188166318"/>
<DICH_DATA CI_END="1.6711941162603516" CI_START="0.31649562111808593" EFFECT_SIZE="0.7272727272727273" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.22302689796306094" LOG_CI_START="-0.4996322942956239" LOG_EFFECT_SIZE="-0.13830269816628143" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="907" O_E="0.0" SE="0.4244935867534458" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.1801948051948052" WEIGHT="8.70086491123845"/>
<DICH_DATA CI_END="1.2431849614993473" CI_START="0.06566412528250914" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09453574793580287" LOG_CI_START="-1.1826718366363544" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.7502380574571932" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.5628571428571427" WEIGHT="4.1588212129527085"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="3.794051474774917"/>
<DICH_DATA CI_END="0.7136536915014502" CI_START="0.002648846619520533" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.14651248339983583" LOG_CI_START="-2.57694318863535" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.4276470270813624" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.0381760339342523" WEIGHT="1.3804723479296535"/>
<DICH_DATA CI_END="0.8252093108783314" CI_START="0.014960663736580062" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.08343588050466831" LOG_CI_START="-1.8250491383739815" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="1.0230322487971009" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="1.0465949820788532" WEIGHT="2.505453232143348"/>
<DICH_DATA CI_END="0.9357387960631399" CI_START="0.07948817084659737" EFFECT_SIZE="0.2727272727272727" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.028845364146304425" LOG_CI_START="-1.0996974967308208" LOG_EFFECT_SIZE="-0.5642714304385626" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.6290238434836914" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.3956709956709956" WEIGHT="5.387582005129396"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="128.08483523719454" CI_START="0.42627781235999473" DF="0" EFFECT_SIZE="7.389162561576356" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-003.21.04" LOG_CI_END="2.1074977139549316" LOG_CI_START="-0.3703072716699946" LOG_EFFECT_SIZE="0.8685952211424683" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.16940075914850453" STUDIES="1" TAU2="0.0" TOTAL_1="202" TOTAL_2="99" WEIGHT="100.0" Z="1.3741318307610693">
<NAME>parkinsonism</NAME>
<DICH_DATA CI_END="128.08483523719454" CI_START="0.42627781235999473" EFFECT_SIZE="7.389162561576355" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.1074977139549316" LOG_CI_START="-0.3703072716699946" LOG_EFFECT_SIZE="0.8685952211424683" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="1.455474913888573" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="2.118407224958949" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1222268401790636" CI_START="0.3152037990785014" DF="0" EFFECT_SIZE="0.5947521865889213" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" I2="0.0" ID="CMP-003.21.05" LOG_CI_END="0.05008065146623127" LOG_CI_START="-0.5014085566999748" LOG_EFFECT_SIZE="-0.22566395261687175" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.10871495207192543" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="34" WEIGHT="100.0" Z="1.6039959193715538">
<NAME>use of antiparkinson medication</NAME>
<DICH_DATA CI_END="1.1222268401790636" CI_START="0.3152037990785014" EFFECT_SIZE="0.5947521865889213" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.05008065146623127" LOG_CI_START="-0.5014085566999748" LOG_EFFECT_SIZE="-0.22566395261687175" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.32394749079243734" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.10494197679071629" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="53.909057011251086" CI_END="0.4987135556212947" CI_START="0.30778123303129734" DF="30" EFFECT_SIZE="0.39178396225285256" ESTIMABLE="YES" EVENTS_1="192" EVENTS_2="392" I2="44.350723861226406" ID="CMP-003.21.06" LOG_CI_END="-0.30214882698613515" LOG_CI_START="-0.5117578648145782" LOG_EFFECT_SIZE="-0.40695334590035664" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.004705877480675302" P_Z="2.7305550610656655E-14" STUDIES="31" TAU2="0.18085375264334602" TOTAL_1="1363" TOTAL_2="1242" WEIGHT="100.0" Z="7.610491509489078">
<NAME>extrapyramidal symptoms</NAME>
<DICH_DATA CI_END="1.364417488219936" CI_START="0.19849104744801843" EFFECT_SIZE="0.5204081632653061" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.1349472772765075" LOG_CI_START="-0.7022590764656246" LOG_EFFECT_SIZE="-0.28365589959455845" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="48" O_E="0.0" SE="0.4917791564264168" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.24184673869547813" WEIGHT="3.5864308386774795"/>
<DICH_DATA CI_END="0.5646758497138431" CI_START="0.05514999185442812" EFFECT_SIZE="0.17647058823529413" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.24820078594878725" LOG_CI_START="-1.2584545473684356" LOG_EFFECT_SIZE="-0.7533276666586115" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.593428060294673" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.352156862745098" WEIGHT="2.8441949069942467"/>
<DICH_DATA CI_END="0.9171435836951519" CI_START="0.12114909059653102" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.03756266790137051" LOG_CI_START="-0.9166798415379545" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="765" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="3.387523813994968"/>
<DICH_DATA CI_END="0.9489818069491464" CI_START="0.05203757931686988" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.022742113407618957" LOG_CI_START="-1.2836829141430686" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2520" O_E="0.0" SE="0.7406828681096325" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" VAR="0.5486111111111112" WEIGHT="2.0782167215828684"/>
<DICH_DATA CI_END="0.9783827703239931" CI_START="0.15119746439714316" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="-0.009491203988023385" LOG_CI_START="-0.8204554919536126" LOG_EFFECT_SIZE="-0.4149733479708179" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1610" O_E="0.0" SE="0.47636443708895493" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.22692307692307692" WEIGHT="3.7176856744744056"/>
<DICH_DATA CI_END="1.0184475748258677" CI_START="0.08836979165607813" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.007938678353536443" LOG_CI_START="-1.0536961689142117" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1625" O_E="0.0" SE="0.6236095644623236" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="0.38888888888888895" WEIGHT="2.6608260768136835"/>
<DICH_DATA CI_END="0.8008434869347125" CI_START="0.13874260442124225" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.09645235208343395" LOG_CI_START="-0.8577901573558909" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2003" O_E="0.0" SE="0.4472135954999579" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.2" WEIGHT="3.9804940010170795"/>
<DICH_DATA CI_END="0.6614383100712304" CI_START="0.012494684211785905" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.1795106546435124" LOG_CI_START="-1.9032747156729377" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.0125475422184014" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="1.0252525252525253" WEIGHT="1.2569257829471008"/>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="0.6015226528929813"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1461" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="3.265894557303226"/>
<DICH_DATA CI_END="0.9964024938554088" CI_START="0.265878645389223" EFFECT_SIZE="0.5147058823529411" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="-0.0015651941561178899" LOG_CI_START="-0.5753165425558036" LOG_EFFECT_SIZE="-0.2884408683559607" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="0.33702438216495473" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.11358543417366947" WEIGHT="5.148723897963413"/>
<DICH_DATA CI_END="0.6818574700465806" CI_START="0.1629535731324035" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="24" LOG_CI_END="-0.16630639725167246" LOG_CI_START="-0.7879361121876525" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="0.3651483716701107" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.13333333333333333" WEIGHT="4.825106267334636"/>
<DICH_DATA CI_END="1.244791231123726" CI_START="0.10602040189697079" EFFECT_SIZE="0.36328125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.09509652028829374" LOG_CI_START="-0.9746105538041228" LOG_EFFECT_SIZE="-0.43975701675791445" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1781" O_E="0.0" SE="0.628351230457301" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="0.39482526881720426" WEIGHT="2.6333877406466653"/>
<DICH_DATA CI_END="2.199653047137403" CI_START="0.14644716091648388" EFFECT_SIZE="0.5675675675675675" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.34235418464198275" LOG_CI_START="-0.8343190433081342" LOG_EFFECT_SIZE="-0.24598242933307574" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1764" O_E="0.0" SE="0.6911836787243154" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.47773487773487766" WEIGHT="2.3018710128522253"/>
<DICH_DATA CI_END="2.5270106054871775" CI_START="0.09893112417381524" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.402607064593003" LOG_CI_START="-1.0046670559209654" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="774" O_E="0.0" SE="0.8266397845091497" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="0.6833333333333333" WEIGHT="1.7542336633604723"/>
<DICH_DATA CI_END="1.422582431558013" CI_START="0.6973453680398237" EFFECT_SIZE="0.9960076652826573" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="31" LOG_CI_END="0.15307744099579515" LOG_CI_START="-0.15655207945532482" LOG_EFFECT_SIZE="-0.0017373192297648395" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.18187791300383302" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.03307957523862985" WEIGHT="7.086254828410983"/>
<DICH_DATA CI_END="1.7965603321473593" CI_START="0.18175321273770334" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2544418062769431" LOG_CI_START="-0.740517903649532" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1868" O_E="0.0" SE="0.5844442587408072" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.3415750915750915" WEIGHT="2.9018039383518777"/>
<DICH_DATA CI_END="2.1951942259275006" CI_START="0.3487732388128493" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.34147295169287367" LOG_CI_START="-0.45745684564824723" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1086" O_E="0.0" SE="0.46929531772445293" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.22023809523809523" WEIGHT="3.779648191976696"/>
<DICH_DATA CI_END="1.1167853562467283" CI_START="0.33546750405357084" EFFECT_SIZE="0.6120826709062003" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" LOG_CI_END="0.04796971066685843" LOG_CI_START="-0.47434954254039496" LOG_EFFECT_SIZE="-0.21318991593676828" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="0.3068129148559428" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="0.09413416472240001" WEIGHT="5.512918866341874"/>
<DICH_DATA CI_END="0.7683638924765833" CI_START="0.10624217751579515" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="14" LOG_CI_END="-0.11443305201781774" LOG_CI_START="-0.9737030366827335" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.5047394424471945" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.25476190476190474" WEIGHT="3.4801000650244496"/>
<DICH_DATA CI_END="0.8515965302783379" CI_START="0.11117301779291432" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.06976611670769504" LOG_CI_START="-0.9540006052500537" LOG_EFFECT_SIZE="-0.5118833609788743" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1077" O_E="0.0" SE="0.5194037156010917" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" VAR="0.26978021978021977" WEIGHT="3.364118487357975"/>
<DICH_DATA CI_END="1.7168212637955487" CI_START="0.2854111900482336" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.23472508363625266" LOG_CI_START="-0.544529003607739" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1222" O_E="0.0" SE="0.45773770821706344" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="0.20952380952380953" WEIGHT="3.8833842530441136"/>
<DICH_DATA CI_END="0.5749786199924476" CI_START="0.03549377760441629" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.24034830381807687" LOG_CI_START="-1.4498477762104367" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="0.7104659772022196" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="0.5047619047619047" WEIGHT="2.21113106342847"/>
<DICH_DATA CI_END="1.3234791073533203" CI_START="0.004470912861742627" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.12171708985135773" LOG_CI_START="-2.349603794465031" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.4516661206831194" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.107334525939177" WEIGHT="0.6625268085897189"/>
<DICH_DATA CI_END="0.4801215899947409" CI_START="0.0688530820703804" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="22" LOG_CI_END="-0.31864876433960554" LOG_CI_START="-1.1620766146488821" LOG_EFFECT_SIZE="-0.7403626894942439" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2496" O_E="0.0" SE="0.4954336943068623" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.24545454545454545" WEIGHT="3.5560792140939554"/>
<DICH_DATA CI_END="0.7971088533451651" CI_START="0.07840836259403103" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.09848236721230207" LOG_CI_START="-1.1056376154436227" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3332" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="2.8557508920544383"/>
<DICH_DATA CI_END="0.6468519220394404" CI_START="0.0365905058744052" EFFECT_SIZE="0.15384615384615385" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="13" LOG_CI_END="-0.18919512706157823" LOG_CI_START="-1.4366315862241328" LOG_EFFECT_SIZE="-0.8129133566428556" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3364" O_E="0.0" SE="0.732750351022145" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.5369230769230768" WEIGHT="2.1120576970664007"/>
<DICH_DATA CI_END="0.7532478029295167" CI_START="0.08297402230305383" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.12306212640134118" LOG_CI_START="-1.0810578562545836" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1753" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" VAR="0.31666666666666665" WEIGHT="3.0470831323147105"/>
<DICH_DATA CI_END="1.3940853481461768" CI_START="0.31880719859473206" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.144289362782274" LOG_CI_START="-0.4964718808936366" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1293" O_E="0.0" SE="0.3763863263545405" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.14166666666666666" WEIGHT="4.700434412509203"/>
<DICH_DATA CI_END="0.447695235169907" CI_START="0.027576078641221864" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.34901752779754347" LOG_CI_START="-1.5594674910811066" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.711024300256718" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.5055555555555555" WEIGHT="2.208574475249384"/>
<DICH_DATA CI_END="0.8973686761685741" CI_START="0.19756129589512555" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.04702909415726398" LOG_CI_START="-0.7042981337645068" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.3860830873995128" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.14906015037593984" WEIGHT="4.595096065330297"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.5475998096646206" CI_END="7.177946749096366" CI_START="0.03800982255569634" DF="1" EFFECT_SIZE="0.5223336886008696" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="60.747367141166286" ID="CMP-003.21.07" LOG_CI_END="0.8560002321165595" LOG_CI_START="-1.4201041578439313" LOG_EFFECT_SIZE="-0.282051962863686" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.11046228658032453" P_Z="0.6271426636772235" STUDIES="3" TAU2="2.252562031206831" TOTAL_1="100" TOTAL_2="100" WEIGHT="100.0" Z="0.48575249133564496">
<NAME>torsion spasm</NAME>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1489" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="40.53167610212746"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.0" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.220339253228541" CI_START="0.2737113312101215" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9148897412340661" LOG_CI_START="-0.5627072231227036" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="59.46832389787254"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.91820488337286" CI_END="21.12598921111929" CI_START="0.0691971272099343" DF="1" EFFECT_SIZE="1.2090731007170414" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="6" I2="79.66737816513637" ID="CMP-003.21.08" LOG_CI_END="1.3248170536630224" LOG_CI_START="-1.1599119353520762" LOG_EFFECT_SIZE="0.08245255915547317" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.026575256391123903" P_Z="0.8965048700305138" STUDIES="2" TAU2="3.414981267654918" TOTAL_1="247" TOTAL_2="144" WEIGHT="100.0" Z="0.13007780493754584">
<NAME>tremor</NAME>
<DICH_DATA CI_END="19.593279984104463" CI_START="1.1063886614694889" EFFECT_SIZE="4.655940594059406" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="2" LOG_CI_END="1.292107144507204" LOG_CI_START="0.04390771637234394" LOG_EFFECT_SIZE="0.668007430439774" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.7331985227732346" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.5375800737968534" WEIGHT="53.89576480362755"/>
<DICH_DATA CI_END="2.1505053392953424" CI_START="0.029062936444733234" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3325405251619664" LOG_CI_START="-1.5366605078178912" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="1.097977939466707" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="1.2055555555555557" WEIGHT="46.10423519637245"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="100.2049917255156" CI_START="0.2494885690772842" DF="0" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-003.21.09" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.2926808653233127" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="32" WEIGHT="100.0" Z="1.0522587535741466">
<NAME>increase activities</NAME>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="12.727138688132905" CI_END="0.1889212397587959" CI_START="-0.5037559307316043" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1574173454864042" ESTIMABLE="YES" I2="60.713871966665046" I2_Q="0.0" ID="CMP-003.22" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.02607449612038748" P_Q="0.7496087404687619" P_Z="0.3730149257053922" Q="0.5764078438753265" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1359424740237984" TOTALS="SUB" TOTAL_1="750" TOTAL_2="399" UNITS="" WEIGHT="300.0" Z="0.8908401802150258">
<NAME>Adverse effects: 4b. Extrapyramidal - average score</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.089700816873509" CI_END="0.7492881352592144" CI_START="-1.2426504800463678" DF="1" EFFECT_SIZE="-0.24668117239357673" ESTIMABLE="YES" I2="67.63440671864446" ID="CMP-003.22.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.07878955746547622" P_Z="0.6273622201269902" STUDIES="2" TAU2="0.3518341837503883" TOTAL_1="250" TOTAL_2="133" WEIGHT="100.0" Z="0.485442884474987">
<NAME>Abnormal Involuntary Movement Scale (high=poor)</NAME>
<CONT_DATA CI_END="0.10360721123421535" CI_START="-1.7036072112342153" EFFECT_SIZE="-0.8" ESTIMABLE="YES" MEAN_1="-0.4" MEAN_2="0.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="53" SD_1="2.5" SD_2="1.7" SE="0.461032558945855" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="45.75305611701733"/>
<CONT_DATA CI_END="0.9106769922882892" CI_START="-0.4706769922882893" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="-0.38" MEAN_2="-0.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="2.87" SD_2="2.87" SE="0.35239269585373056" STUDY_ID="STD-Potkin-2003" TOTAL_1="201" TOTAL_2="99" WEIGHT="54.24694388298267"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9774558564556692" CI_END="0.2704878328014688" CI_START="-0.49119042082985287" DF="1" EFFECT_SIZE="-0.11035129401419201" ESTIMABLE="YES" I2="49.42997100363246" ID="CMP-003.22.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15965900887739048" P_Z="0.5700921374723069" STUDIES="2" TAU2="0.04359723442520381" TOTAL_1="250" TOTAL_2="133" WEIGHT="100.0" Z="0.5679158119168147">
<NAME>Barnes Akathisia Scale (high=poor)</NAME>
<CONT_DATA CI_END="0.1475818855608686" CI_START="-0.9475818855608686" EFFECT_SIZE="-0.4" ESTIMABLE="YES" MEAN_1="0.1" MEAN_2="0.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="55" SD_1="1.0" SD_2="1.4" SE="0.279383646781331" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="31.036022384331428"/>
<CONT_DATA CI_END="0.2269624436822051" CI_START="-0.18696244368220513" EFFECT_SIZE="0.01999999999999999" ESTIMABLE="YES" MEAN_1="0.16" MEAN_2="0.14" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="56" SD_1="0.86" SD_2="0.86" SE="0.10559502384467187" STUDY_ID="STD-Potkin-2003" TOTAL_1="201" TOTAL_2="99" WEIGHT="68.96397761566857"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.105263865087851" CI_END="0.820184962588022" CI_START="-2.2158951700453358" DF="1" EFFECT_SIZE="-0.6978551037286569" ESTIMABLE="YES" I2="80.41237384734487" ID="CMP-003.22.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.023853386623795325" P_Z="0.36758245611442353" STUDIES="2" TAU2="0.9659536408412305" TOTAL_1="250" TOTAL_2="133" WEIGHT="100.0" Z="0.9010110471289103">
<NAME>Simpson-Angus Scale (high=poor)</NAME>
<CONT_DATA CI_END="-0.46776500918823927" CI_START="-2.5322349908117605" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="1.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="57" SD_1="2.3" SD_2="2.4" SE="0.5266601830206568" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="48.24871636959076"/>
<CONT_DATA CI_END="0.9115413353282493" CI_START="-0.8115413353282492" EFFECT_SIZE="0.04999999999999999" ESTIMABLE="YES" MEAN_1="-0.13" MEAN_2="-0.18" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="3.58" SD_2="3.58" SE="0.4395699829813085" STUDY_ID="STD-Potkin-2003" TOTAL_1="201" TOTAL_2="99" WEIGHT="51.75128363040923"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="85.55258614601436" CI_END="1.5055148708953912" CI_START="1.0186224408625886" CI_STUDY="95" CI_TOTAL="95" DF="91" EFFECT_MEASURE="RR" EFFECT_SIZE="1.238366356352751" ESTIMABLE="YES" EVENTS_1="285" EVENTS_2="208" I2="0.0" I2_Q="78.01004007506967" ID="CMP-003.23" LOG_CI_END="0.17768504966339965" LOG_CI_START="0.008013239713157701" LOG_EFFECT_SIZE="0.0928491446882787" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.6414910320297381" P_Q="0.0034343209718636913" P_Z="0.031945342589991196" Q="13.642589664744488" RANDOM="YES" SCALE="388.461690874322" SORT_BY="STUDY" STUDIES="46" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3593" TOTAL_2="3612" WEIGHT="400.0" Z="2.1450938684244902">
<NAME>Adverse effects: 5. Gastrointestinal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="13.633728486403944" CI_END="1.0776055494194903" CI_START="0.5203143157811637" DF="26" EFFECT_SIZE="0.7487947610181224" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="67" I2="0.0" ID="CMP-003.23.01" LOG_CI_END="0.032459819236882334" LOG_CI_START="-0.28373422488383515" LOG_EFFECT_SIZE="-0.12563720282347646" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9775174707756006" P_Z="0.11933939508725629" STUDIES="27" TAU2="0.0" TOTAL_1="1030" TOTAL_2="1037" WEIGHT="100.0" Z="1.5575523779211726">
<NAME>constipation</NAME>
<DICH_DATA CI_END="3.8481017433944946" CI_START="0.11549706168953583" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5852465462167757" LOG_CI_START="-0.9374290643281383" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1582" O_E="0.0" SE="0.8944271909999157" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.7999999999999998" WEIGHT="4.312137369700249"/>
<DICH_DATA CI_END="2.9009031839436403" CI_START="0.008331367644240426" EFFECT_SIZE="0.15546218487394958" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.462533234703846" LOG_CI_START="-2.07928370068288" LOG_EFFECT_SIZE="-0.808375232989517" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.493075850042916" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="2.229275493981376" WEIGHT="1.547457864707061"/>
<DICH_DATA CI_END="140.2560755697974" CI_START="0.42678169568479474" EFFECT_SIZE="7.7368421052631575" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1469216829712496" LOG_CI_START="-0.3697942153805555" LOG_EFFECT_SIZE="0.8885637337953471" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1981" O_E="0.0" SE="1.4783313766364663" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="2.1854636591478696" WEIGHT="1.5784796426700909"/>
<DICH_DATA CI_END="7.961364031061661" CI_START="0.013956290740833538" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9009874823623856" LOG_CI_START="-1.8552299918017108" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="925" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="1.3160742954923306"/>
<DICH_DATA CI_END="4.619022933127913" CI_START="0.216496002396511" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6645501184938255" LOG_CI_START="-0.6645501184938255" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="0.7807200583588265" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="0.6095238095238095" WEIGHT="5.659680297731577"/>
<DICH_DATA CI_END="71.39983803807861" CI_START="0.12605070609824312" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8536972266326377" LOG_CI_START="-0.8994547171933126" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.6172150801252798" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.6153846153846154" WEIGHT="1.3190067248494877"/>
<DICH_DATA CI_END="2.834903110959908" CI_START="0.22575727456988604" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.45253822051480863" LOG_CI_START="-0.6463582465309213" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.6454972243679028" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.4166666666666667" WEIGHT="8.279303749824477"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1468" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="2.7234551808633154"/>
<DICH_DATA CI_END="4.5639184979939795" CI_START="0.21910996010107084" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.659337880227438" LOG_CI_START="-0.659337880227438" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1488" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="5.749516492933665"/>
<DICH_DATA CI_END="2.587668299966842" CI_START="0.09661207350385806" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4129086055644666" LOG_CI_START="-1.0149685968924291" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1853" O_E="0.0" SE="0.8387421368293256" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.7034883720930232" WEIGHT="4.903719851824415"/>
<DICH_DATA CI_END="2.5762488864310256" CI_START="0.007448832007320471" EFFECT_SIZE="0.13852813852813853" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4109878170659824" LOG_CI_START="-2.1279118202104588" LOG_EFFECT_SIZE="-0.8584620015722383" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="1.4913622146920764" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.2241612554112553" WEIGHT="1.5510160908375032"/>
<DICH_DATA CI_END="17.16310387523164" CI_START="0.07610059686607612" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2345958309479181" LOG_CI_START="-1.1186119369925447" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="1.3822858914545448" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="1.9107142857142856" WEIGHT="1.8054556463791698"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="1.3177463266413183"/>
<DICH_DATA CI_END="7.9199970308142" CI_START="0.014029185955349858" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.898725018773679" LOG_CI_START="-1.8529675282130038" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.6163578231977633" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.612612612612612" WEIGHT="1.320406201480628"/>
<DICH_DATA CI_END="2.1928434693698087" CI_START="0.20267951208216944" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3410076317617965" LOG_CI_START="-0.693190149873159" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.6074928962939559" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.36904761904761896" WEIGHT="9.347601007866347"/>
<DICH_DATA CI_END="4.044504981919023" CI_START="0.00988996185659807" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6068653747055984" LOG_CI_START="-2.004805383377636" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1095" O_E="0.0" SE="1.534108331276844" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="2.353488372093023" WEIGHT="1.4657858252736025"/>
<DICH_DATA CI_END="15.304614839074713" CI_START="0.06533976911636269" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1848224044743985" LOG_CI_START="-1.1848224044743985" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.3919410907075054" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="1.9375" WEIGHT="1.78049543006978"/>
<DICH_DATA CI_END="3.816607523965545" CI_START="0.1164501305553829" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5816775021184052" LOG_CI_START="-0.9338600202297677" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3378" O_E="0.0" SE="0.8902342426590436" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.792517006802721" WEIGHT="4.352852829843342"/>
<DICH_DATA CI_END="6.771543116822823" CI_START="0.1476768267953074" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8306876481172819" LOG_CI_START="-0.8306876481172819" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="0.9759000729485332" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.9523809523809523" WEIGHT="3.622195390548209"/>
<DICH_DATA CI_END="3.1734279072237186" CI_START="0.17725312074037453" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5015286366186029" LOG_CI_START="-0.751406109835203" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1452" O_E="0.0" SE="0.7359800721939871" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.5416666666666665" WEIGHT="6.368695192172677"/>
<DICH_DATA CI_END="3.676017480818154" CI_START="0.27203352683117127" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5653775679493328" LOG_CI_START="-0.5653775679493328" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="0.6642111641550714" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="0.4411764705882353" WEIGHT="7.819342430389784"/>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3368" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="1.3129492886848517"/>
<DICH_DATA CI_END="6.852725287912201" CI_START="0.14592734393773824" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8358633221668504" LOG_CI_START="-0.8358633221668503" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="904" O_E="0.0" SE="0.9819805060619656" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.9642857142857142" WEIGHT="3.577476928936503"/>
<DICH_DATA CI_END="3.653484112546019" CI_START="0.12164948053783173" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5627072231227036" LOG_CI_START="-0.9148897412340662" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="0.8679477710861024" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="0.7533333333333332" WEIGHT="4.579260923575486"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="943" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="1.5530851605393428"/>
<DICH_DATA CI_END="2.1080777784770572" CI_START="0.029647862445166522" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3238866303262053" LOG_CI_START="-1.52800661298213" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1299" O_E="0.0" SE="1.0878112581387145" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.1833333333333331" WEIGHT="2.9152477992339714"/>
<DICH_DATA CI_END="1.8225864286313116" CI_START="0.13716770632805594" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2606881320998397" LOG_CI_START="-0.862748123427802" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.6599120175960899" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.435483870967742" WEIGHT="7.921556056930825"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="25.151448365070415" CI_END="1.6923195606509682" CI_START="0.8570287453652188" DF="33" EFFECT_SIZE="1.2043116331837527" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="66" I2="0.0" ID="CMP-003.23.02" LOG_CI_END="0.22848237426050408" LOG_CI_START="-0.06700461128084846" LOG_EFFECT_SIZE="0.08073888148982783" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.834357990104349" P_Z="0.28413286874784005" STUDIES="33" TAU2="0.0" TOTAL_1="1324" TOTAL_2="1334" WEIGHT="99.99999999999997" Z="1.0710813512290152">
<NAME>dry mouth</NAME>
<DICH_DATA CI_END="5.047815708586125" CI_START="0.4457373505480486" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.70310349080717" LOG_CI_START="-0.35092097269580763" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1581" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.3833333333333333" WEIGHT="7.859145578013696"/>
<DICH_DATA CI_END="160.170939238357" CI_START="0.5057097147907748" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.204583722276951" LOG_CI_START="-0.29609870339830113" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2484" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="1.3962385707119016"/>
<DICH_DATA CI_END="22.958359726025137" CI_START="0.20734628411263115" EFFECT_SIZE="2.1818181818181817" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.36094085640089" LOG_CI_START="-0.6833037432941281" LOG_EFFECT_SIZE="0.33881855655338095" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.200799397034822" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="1.441919191919192" WEIGHT="2.0893490345752697"/>
<DICH_DATA CI_END="172.84329174620893" CI_START="0.572484691216403" EFFECT_SIZE="9.947368421052632" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.237652528719968" LOG_CI_START="-0.242236122279138" LOG_EFFECT_SIZE="0.9977082032204152" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1981" O_E="0.0" SE="1.4566988692436766" STUDY_ID="STD-Guo-2006" TOTAL_1="18" TOTAL_2="20" VAR="2.1219715956558063" WEIGHT="1.4197515545163717"/>
<DICH_DATA CI_END="15.477505790203258" CI_START="0.06460989345149956" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1897009751564562" LOG_CI_START="-1.1897009751564562" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="924" O_E="0.0" SE="1.3976724838434158" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="1.9534883720930232" WEIGHT="1.542201384257053"/>
<DICH_DATA CI_END="100.2049917255156" CI_START="0.2494885690772842" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0008893565097607" LOG_CI_START="-0.6029493478377235" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="1.5295077441431735" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.3393939393939394" WEIGHT="1.2878004088325552"/>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="1.5506402427208394"/>
<DICH_DATA CI_END="71.39983803807861" CI_START="0.12605070609824312" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8536972266326377" LOG_CI_START="-0.8994547171933126" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.6172150801252798" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.6153846153846154" WEIGHT="1.1519041803069092"/>
<DICH_DATA CI_END="34.750218874646706" CI_START="0.46042875464227323" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5409575443434547" LOG_CI_START="-0.3368375616875298" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.2166666666666668" WEIGHT="2.476169154716644"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1486" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="2.101864515050175"/>
<DICH_DATA CI_END="4.341096958964587" CI_START="0.3599320666573359" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6375994859707054" LOG_CI_START="-0.44377945995459256" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1853" O_E="0.0" SE="0.6352073457486329" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.4034883720930233" WEIGHT="7.466565779688324"/>
<DICH_DATA CI_END="3.8843813103531986" CI_START="0.009683006254130959" EFFECT_SIZE="0.19393939393939394" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5893218558533486" LOG_CI_START="-2.013989787641349" LOG_EFFECT_SIZE="-0.7123339658940003" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="1.5291981459892532" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.3384469696969696" WEIGHT="1.2883219121972724"/>
<DICH_DATA CI_END="99.95416281504153" CI_START="0.25011464551267176" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9998008859974516" LOG_CI_START="-0.6018608773254143" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="781" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="1.289956445010075"/>
<DICH_DATA CI_END="4.131728484301274" CI_START="0.14049782516416282" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6161317742115487" LOG_CI_START="-0.8523303983675379" LOG_EFFECT_SIZE="-0.11809931207799451" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="0.8625819491779427" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="0.744047619047619" WEIGHT="4.0490318017926565"/>
<DICH_DATA CI_END="1.9912523628464711" CI_START="0.006199956993245031" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29912630414908753" LOG_CI_START="-2.2076113230277374" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.472470090755044" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.168168168168168" WEIGHT="1.3895012922900947"/>
<DICH_DATA CI_END="21.357023897403046" CI_START="0.1872920131201609" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3295407336099563" LOG_CI_START="-0.7274807422819939" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="1.2083045973594573" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="1.46" WEIGHT="2.0634742955972034"/>
<DICH_DATA CI_END="8.523162813982854" CI_START="0.26398650936348594" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9306007846456915" LOG_CI_START="-0.578418266534329" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="0.8864052604279182" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="0.7857142857142856" WEIGHT="3.8343104183642582"/>
<DICH_DATA CI_END="8.488676176282748" CI_START="0.2650589978077466" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.92883996654976" LOG_CI_START="-0.5766574484383975" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1869" O_E="0.0" SE="0.8843366338964376" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.7820512820512819" WEIGHT="3.8522697177476974"/>
<DICH_DATA CI_END="12.174646810603075" CI_START="0.5133619149063762" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0854563710833007" LOG_CI_START="-0.2895763537392256" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1089" O_E="0.0" SE="0.8077010290825141" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="0.6523809523809523" WEIGHT="4.617965102409508"/>
<DICH_DATA CI_END="5.704356984776904" CI_START="0.31165261615324824" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7562066963086507" LOG_CI_START="-0.506329223092051" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1222" O_E="0.0" SE="0.7416198487095662" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="0.5499999999999998" WEIGHT="5.477586311948942"/>
<DICH_DATA CI_END="10.058615961882595" CI_START="0.8021872114676944" EFFECT_SIZE="2.8405797101449277" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="1.0025382270947865" LOG_CI_START="-0.09572426585634504" LOG_EFFECT_SIZE="0.45340698061922075" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1242" O_E="0.0" SE="0.6451248248465133" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.4161860396332446" WEIGHT="7.238763881236316"/>
<DICH_DATA CI_END="15.304614839074713" CI_START="0.06533976911636269" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1848224044743985" LOG_CI_START="-1.1848224044743985" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.3919410907075054" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="1.9375" WEIGHT="1.5549277272629247"/>
<DICH_DATA CI_END="15.304614839074713" CI_START="0.06533976911636269" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1848224044743985" LOG_CI_START="-1.1848224044743985" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.3919410907075054" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="1.9375" WEIGHT="1.5549277272629247"/>
<DICH_DATA CI_END="4.714021171314743" CI_START="0.21213311600828036" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6733915286686869" LOG_CI_START="-0.6733915286686869" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3378" O_E="0.0" SE="0.7911070345636261" STUDY_ID="STD-Wu-2008" TOTAL_1="49" TOTAL_2="49" VAR="0.6258503401360543" WEIGHT="4.813726666533389"/>
<DICH_DATA CI_END="4.044504981919023" CI_START="0.00988996185659807" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6068653747055984" LOG_CI_START="-2.004805383377636" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.534108331276844" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.353488372093023" WEIGHT="1.2800881055098068"/>
<DICH_DATA CI_END="1.569685517691674" CI_START="0.07078558721399643" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.1958126513826345" LOG_CI_START="-1.1500551608219594" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1453" O_E="0.0" SE="0.7905694150420948" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.6249999999999999" WEIGHT="4.8202759545150675"/>
<DICH_DATA CI_END="6.793146423263004" CI_START="0.14720719055539838" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8320709757168574" LOG_CI_START="-0.8320709757168574" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.9775252199076786" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.9555555555555555" WEIGHT="3.152796772575262"/>
<DICH_DATA CI_END="2.6644631498311693" CI_START="0.00765939032281203" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4256097182208982" LOG_CI_START="-2.115805798249412" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.4928400545843579" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="2.2285714285714286" WEIGHT="1.351840211602783"/>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3368" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="1.1466141496281175"/>
<DICH_DATA CI_END="5.357833236457742" CI_START="0.0466606534706713" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7289891919871422" LOG_CI_START="-1.3310491833151046" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="901" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="2.0574348586344797"/>
<DICH_DATA CI_END="5.167657331603573" CI_START="0.04837782073340814" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7132937077873972" LOG_CI_START="-1.3153536991153596" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="1.1916375287812984" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="1.42" WEIGHT="2.1216003320928993"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="943" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="2.3784256354515136"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1298" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="3.929572789006848"/>
<DICH_DATA CI_END="2.533456273050193" CI_START="0.09867942172888139" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4037134128552686" LOG_CI_START="-1.005773404183231" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.8279395334006838" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.685483870967742" WEIGHT="4.394957487940208"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.568549752140947" CI_END="5.37415464298292" CI_START="0.7550172482443374" DF="2" EFFECT_SIZE="2.0143434290568463" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="12" I2="43.954823698335645" ID="CMP-003.23.03" LOG_CI_END="0.7303101592366834" LOG_CI_START="-0.12204312687177289" LOG_EFFECT_SIZE="0.30413351618245527" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.16791883612647263" P_Z="0.16190474691367523" STUDIES="3" TAU2="0.3289818344246934" TOTAL_1="150" TOTAL_2="150" WEIGHT="100.0" Z="1.3986940577907114">
<NAME>gastrointestinal reaction</NAME>
<DICH_DATA CI_END="2.642025440657429" CI_START="0.3784974908308093" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4219369952179262" LOG_CI_START="-0.42193699521792616" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.495695759225642" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.2457142857142857" WEIGHT="43.61905159929784"/>
<DICH_DATA CI_END="53.472577975118114" CI_START="0.9163575397991978" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7281311224466887" LOG_CI_START="-0.03793504241817497" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1413" O_E="0.0" SE="1.0373960074101287" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.076190476190476" WEIGHT="17.83959129345783"/>
<DICH_DATA CI_END="7.594967551396678" CI_START="0.8229133248700524" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.8805259227308035" LOG_CI_START="-0.08464590538672828" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.5669467095138409" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.3214285714285714" WEIGHT="38.54135710724434"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="30.21110307290067" CI_END="2.561888493313415" CI_START="1.3144012788554644" DF="27" EFFECT_SIZE="1.8350339266335791" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="63" I2="10.628883907853819" ID="CMP-003.23.04" LOG_CI_END="0.4085602230696529" LOG_CI_START="0.1187279729769149" LOG_EFFECT_SIZE="0.2636440980232839" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.3047524982701434" P_Z="3.628336866732422E-4" STUDIES="28" TAU2="0.08337604638719835" TOTAL_1="1089" TOTAL_2="1091" WEIGHT="100.0" Z="3.565738020505617">
<NAME>nausea / vomiting</NAME>
<DICH_DATA CI_END="4.1657466796913445" CI_START="0.47050388578722313" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6196928568366007" LOG_CI_START="-0.32743678548012456" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1580" O_E="0.0" SE="0.5563486402641868" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.30952380952380953" WEIGHT="7.37711835965713"/>
<DICH_DATA CI_END="17.68135400162296" CI_START="0.9049080742646387" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.247515519326234" LOG_CI_START="-0.043395536670309154" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1615" O_E="0.0" SE="0.758287544405155" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.575" WEIGHT="4.402451693759095"/>
<DICH_DATA CI_END="2.787165399728159" CI_START="0.2296239756931617" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4451627419669189" LOG_CI_START="-0.6389827679830317" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1626" O_E="0.0" SE="0.6368324391514267" STUDY_ID="STD-Deng-2008a" TOTAL_1="45" TOTAL_2="45" VAR="0.4055555555555556" WEIGHT="5.928168130328998"/>
<DICH_DATA CI_END="160.170939238357" CI_START="0.5057097147907748" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.204583722276951" LOG_CI_START="-0.29609870339830113" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2003" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="1.2933344518530712"/>
<DICH_DATA CI_END="5.454794518074456" CI_START="0.32591104429087336" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.736778395374003" LOG_CI_START="-0.4869009221574032" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2483" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="4.830437363027433"/>
<DICH_DATA CI_END="162.21628593010868" CI_START="0.499333340888467" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2100944536637974" LOG_CI_START="-0.3016094347851477" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="926" O_E="0.0" SE="1.4753872972096773" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.1767676767676765" WEIGHT="1.2824267372261802"/>
<DICH_DATA CI_END="430.81104752417684" CI_START="1.6921571630752779" EFFECT_SIZE="27.0" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="0" LOG_CI_END="2.6342868316205372" LOG_CI_START="0.2284406966974371" LOG_EFFECT_SIZE="1.4313637641589874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2465" O_E="0.0" SE="1.413205928784265" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" VAR="1.997150997150997" WEIGHT="1.3931415837876016"/>
<DICH_DATA CI_END="70.99720406421005" CI_START="0.12676555532891653" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8512412461360563" LOG_CI_START="-0.8969987366967316" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="1.6143297699232972" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.606060606060606" WEIGHT="1.077723373000692"/>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="1.4304714560660639"/>
<DICH_DATA CI_END="40.807215405883554" CI_START="0.6126367543421137" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6107369604895339" LOG_CI_START="-0.21279695181749625" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.0711528467275953" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="1.1473684210526314" WEIGHT="2.3550532358492537"/>
<DICH_DATA CI_END="18.06355087199982" CI_START="0.8857616153865674" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.256803126516399" LOG_CI_START="-0.05268314386047426" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.769198717280955" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.5916666666666666" WEIGHT="4.293756060909371"/>
<DICH_DATA CI_END="2.886194343367041" CI_START="0.4525414069850424" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.46032557118235495" LOG_CI_START="-0.34434167722698156" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="0.4726655248827636" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="0.2234126984126984" WEIGHT="9.447767526276971"/>
<DICH_DATA CI_END="7.645133861275818" CI_START="0.013666096196349616" EFFECT_SIZE="0.32323232323232326" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8833850940262291" LOG_CI_START="-1.8643555265815168" LOG_EFFECT_SIZE="-0.4904852162776439" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="1.0781029806973463"/>
<DICH_DATA CI_END="47.60326868524414" CI_START="0.7562505893877647" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6776367746370044" LOG_CI_START="-0.12133427386971714" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.0567244989431572" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="1.116666666666667" WEIGHT="2.415304646258567"/>
<DICH_DATA CI_END="47.35833862459427" CI_START="0.7601618013961404" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6753964585200398" LOG_CI_START="-0.11909395775275264" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.0540925533894598" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="1.1111111111111114" WEIGHT="2.4265382196474885"/>
<DICH_DATA CI_END="2.0109804706541157" CI_START="0.006139134214630123" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30340785302919543" LOG_CI_START="-2.2118928719078457" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="1.4775000967674123" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.1830065359477127" WEIGHT="1.2788964948546455"/>
<DICH_DATA CI_END="47.70843866511076" CI_START="0.754583486848142" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6785952038106073" LOG_CI_START="-0.12229270304332009" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="1.0578504710249077" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.1190476190476193" WEIGHT="2.41052203467702"/>
<DICH_DATA CI_END="17.301840540849035" CI_START="0.9247571067496871" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2380923051066506" LOG_CI_START="-0.033972322450725866" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="0.7472170590486632" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="0.5583333333333333" WEIGHT="4.516793477150106"/>
<DICH_DATA CI_END="5.302097690420089" CI_START="0.481516628554709" EFFECT_SIZE="1.5978260869565217" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7244477252868382" LOG_CI_START="-0.3173887104815965" LOG_EFFECT_SIZE="0.20352950740262082" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1242" O_E="0.0" SE="0.6119798795439094" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="0.3745193729665779" WEIGHT="6.329979768389736"/>
<DICH_DATA CI_END="27.688095411248863" CI_START="0.32504944331936847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4422930828371945" LOG_CI_START="-0.48805057339786945" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.1338934190276817" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.2857142857142858" WEIGHT="2.117076333523395"/>
<DICH_DATA CI_END="2.438041198591854" CI_START="0.2848370424771889" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.38704104015436036" LOG_CI_START="-0.54540353224961" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3332" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.30000000000000004" WEIGHT="7.56038038333874"/>
<DICH_DATA CI_END="2.3636973164858293" CI_START="0.3108240096677476" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.3735918621431128" LOG_CI_START="-0.5074854414043392" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1436" O_E="0.0" SE="0.5175491695067657" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="0.2678571428571429" WEIGHT="8.252263252181926"/>
<DICH_DATA CI_END="3.8013774282922785" CI_START="0.11691668423572073" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5799409916465255" LOG_CI_START="-0.9321235097578879" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="0.8881941729649484" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="0.7888888888888888" WEIGHT="3.322922455469704"/>
<DICH_DATA CI_END="27.42068744973231" CI_START="0.32821934229398253" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4380783385600886" LOG_CI_START="-0.48383582912076384" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.1289418957242967" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="1.2745098039215688" WEIGHT="2.134545212242001"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="943" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="1.079292514843494"/>
<DICH_DATA CI_END="10.108042421948712" CI_START="0.39572449669526094" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0046670559209654" LOG_CI_START="-0.402607064593003" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1300" O_E="0.0" SE="0.8266397845091497" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="0.6833333333333333" WEIGHT="3.7804007844592173"/>
<DICH_DATA CI_END="47.60326868524414" CI_START="0.7562505893877647" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6776367746370044" LOG_CI_START="-0.12133427386971714" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.0567244989431572" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.116666666666667" WEIGHT="2.415304646258567"/>
<DICH_DATA CI_END="10.13382509220077" CI_START="0.39471768691552545" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.005773404183231" LOG_CI_START="-0.4037134128552686" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.8279395334006838" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.685483870967742" WEIGHT="3.7698268242661874"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.1086313103149568" CI_END="1.0895873524511588" CI_START="0.24518823315571306" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5168694204693395" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-003.24" LOG_CI_END="0.037262053459541214" LOG_CI_START="-0.6105003759079661" LOG_EFFECT_SIZE="-0.28661916122421244" METHOD="MH" MODIFIED="2013-11-04 16:59:39 +0000" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.9094414606254861" P_Q="0.4875153262019336" P_Z="0.08283418623753386" Q="1.4368674039694702" RANDOM="YES" SCALE="200.92" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="328" TOTAL_2="327" WEIGHT="299.99999999999994" Z="1.73447303458787">
<NAME>Adverse effects: 6. Haematological</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6739002350306453" CI_END="1.0206828049083057" CI_START="0.20137954460164928" DF="4" EFFECT_SIZE="0.4533703104915105" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" I2="0.0" ID="CMP-003.24.01" LOG_CI_END="0.008890798423000456" LOG_CI_START="-0.6959846455887502" LOG_EFFECT_SIZE="-0.34354692358287486" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9545081225084562" P_Z="0.05606619139127382" STUDIES="6" TAU2="0.0" TOTAL_1="258" TOTAL_2="257" WEIGHT="99.99999999999999" Z="1.9105207960989603">
<NAME>blood routine abnormal</NAME>
<DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2487" O_E="0.0" SE="1.4" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="8.746693231709008"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2489" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="11.960594465685809"/>
<DICH_DATA CI_END="3.8843813103531986" CI_START="0.009683006254130959" EFFECT_SIZE="0.19393939393939394" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5893218558533486" LOG_CI_START="-2.013989787641349" LOG_EFFECT_SIZE="-0.7123339658940003" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2488" O_E="0.0" SE="1.5291981459892532" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="2.3384469696969696" WEIGHT="7.331155658565659"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2491" O_E="0.0" SE="0.0" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.824262991946792" CI_START="0.01420084054248603" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8934434396874849" LOG_CI_START="-1.84768594912681" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2490" O_E="0.0" SE="1.6101529717988263" STUDY_ID="STD-Xu-2010" TOTAL_1="26" TOTAL_2="26" VAR="2.592592592592592" WEIGHT="6.612500083172011"/>
<DICH_DATA CI_END="1.2403763061649287" CI_START="0.16657168410991996" EFFECT_SIZE="0.45454545454545453" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.0935534616929029" LOG_CI_START="-0.7783988233373155" LOG_EFFECT_SIZE="-0.3424226808222062" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2492" O_E="0.0" SE="0.5121890884601724" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.2623376623376623" WEIGHT="65.3490565608675"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.8698689779204765" CI_START="0.01411854649967386" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-003.24.02" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-11-04 16:59:39 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.6810488185180525">
<NAME>leucopenia</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2486" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.18421544008581" CI_START="0.18881983197881402" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-003.24.03" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5648670580356441" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="99.99999999999999" Z="0.5756274021886759">
<NAME>blood lipid abnormal</NAME>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2530" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="112.83021615480742" CI_END="0.22068110008540787" CI_START="0.14912292705155664" CI_STUDY="95" CI_TOTAL="95" DF="130" EFFECT_MEASURE="RR" EFFECT_SIZE="0.18140730853439602" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="876" I2="0.0" I2_Q="55.874508734979315" ID="CMP-003.25" LOG_CI_END="-0.6562348597703451" LOG_CI_START="-0.8264555803799587" LOG_EFFECT_SIZE="-0.7413452200751519" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="0.8585551484924192" P_Q="0.007242378282989015" P_Z="2.39558233158813E-65" Q="27.195164645141713" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="62" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5195" TOTAL_2="5056" WEIGHT="1300.0" Z="17.072068855713166">
<NAME>Adverse effects: 7a. Metabolic - binary measures (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.025773614372601263" CI_END="1.0287856046379111" CI_START="0.06754393989408874" DF="1" EFFECT_SIZE="0.26360620827963593" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" I2="0.0" ID="CMP-003.25.01" LOG_CI_END="0.012324878723557068" LOG_CI_START="-1.1704136102040592" LOG_EFFECT_SIZE="-0.5790443657402511" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8724544530102097" P_Z="0.054969671410438375" STUDIES="2" TAU2="0.0" TOTAL_1="102" TOTAL_2="102" WEIGHT="100.0" Z="1.9191158703742621">
<NAME>appetite- decrease</NAME>
<DICH_DATA CI_END="1.128971929499989" CI_START="0.05536010096166047" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.05268314386047429" LOG_CI_START="-1.256803126516399" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="0.769198717280955" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="0.5916666666666666" WEIGHT="81.57847100705968"/>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="18.42152899294032"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.45529102375880887" CI_END="0.8217696731430266" CI_START="0.0921086672911599" DF="4" EFFECT_SIZE="0.27512199005804" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" I2="0.0" ID="CMP-003.25.02" LOG_CI_END="-0.08524989012411528" LOG_CI_START="-1.0356995014033963" LOG_EFFECT_SIZE="-0.5604746957637559" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.977704902986661" P_Z="0.020801993450648624" STUDIES="5" TAU2="0.0" TOTAL_1="179" TOTAL_2="179" WEIGHT="100.0" Z="2.3115590872080816">
<NAME>blood glucose- increase</NAME>
<DICH_DATA CI_END="7.8107039169243295" CI_START="0.014225492643544472" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8926901751653994" LOG_CI_START="-1.8469326846047245" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2010" O_E="0.0" SE="1.6092680291808414" STUDY_ID="STD-Deng-2008" TOTAL_1="25" TOTAL_2="25" VAR="2.58974358974359" WEIGHT="12.035846272071677"/>
<DICH_DATA CI_END="1.6113995451271035" CI_START="0.0248231421691539" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20720323671350532" LOG_CI_START="-1.6051432453855428" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2487" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="1.133333333333333" WEIGHT="27.502725644326688"/>
<DICH_DATA CI_END="5.306321714020261" CI_START="0.047113615320280106" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.724793577042504" LOG_CI_START="-1.3268535683704665" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="1.2051476890327395" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.4523809523809526" WEIGHT="21.46114328967131"/>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="11.896149376333021"/>
<DICH_DATA CI_END="1.6362209810683805" CI_START="0.02444657565378593" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.21384195726782396" LOG_CI_START="-1.6117819659398616" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2503" O_E="0.0" SE="1.0723805294763609" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.1500000000000001" WEIGHT="27.104135417597305"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.744917173834105" CI_END="0.1684106135085158" CI_START="0.032660879169705385" DF="8" EFFECT_SIZE="0.07416494251799559" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="104" I2="0.0" ID="CMP-003.25.03" LOG_CI_END="-0.7736305420351017" LOG_CI_START="-1.4859721290478276" LOG_EFFECT_SIZE="-1.1298013355414647" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7844593402078822" P_Z="5.062415023967558E-10" STUDIES="9" TAU2="0.0" TOTAL_1="322" TOTAL_2="320" WEIGHT="100.0" Z="6.217157520264122">
<NAME>endocrine disorder</NAME>
<DICH_DATA CI_END="0.9754758873898897" CI_START="0.0035471995332609684" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.010783461382678439" LOG_CI_START="-2.4501143813738695" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="762" O_E="0.0" SE="1.4328750572856208" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="2.0531309297912714" WEIGHT="8.527763694481933"/>
<DICH_DATA CI_END="0.49386694765348244" CI_START="0.0018593543259158775" EFFECT_SIZE="0.030303030303030304" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="16" LOG_CI_END="-0.30639003828881833" LOG_CI_START="-2.7306378414669568" LOG_EFFECT_SIZE="-1.5185139398778875" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.4240151598070012" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="2.0278191753601593" WEIGHT="8.634209408727113"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="782" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="7.882509424213592"/>
<DICH_DATA CI_END="0.5960600182779132" CI_START="0.002301348975638353" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.22471000822189063" LOG_CI_START="-2.638017520096084" LOG_EFFECT_SIZE="-1.4313637641589874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1107" O_E="0.0" SE="1.4175887785397485" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.009557945041816" WEIGHT="8.71267009059926"/>
<DICH_DATA CI_END="0.6736301033295107" CI_START="0.0025186084117105297" EFFECT_SIZE="0.041189931350114416" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.17157851322787152" LOG_CI_START="-2.59883935050636" LOG_EFFECT_SIZE="-1.3852089318671157" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.4257850309523061" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="2.0328629544876686" WEIGHT="8.61278688976087"/>
<DICH_DATA CI_END="0.9754758873898897" CI_START="0.0035471995332609684" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.010783461382678439" LOG_CI_START="-2.4501143813738695" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.4328750572856208" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.0531309297912714" WEIGHT="8.527763694481933"/>
<DICH_DATA CI_END="0.9557155547622298" CI_START="0.051670934728763" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.019671345567648324" LOG_CI_START="-1.2867536819830392" LOG_EFFECT_SIZE="-0.6532125137753437" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1078" O_E="0.0" SE="0.7442904365691219" STUDY_ID="STD-Tang-2010a" TOTAL_1="35" TOTAL_2="35" VAR="0.553968253968254" WEIGHT="31.605810039965395"/>
<DICH_DATA CI_END="0.33500787966786005" CI_START="0.0013512921753702912" EFFECT_SIZE="0.02127659574468085" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="23" LOG_CI_END="-0.47494497787054213" LOG_CI_START="-2.869250738000893" LOG_EFFECT_SIZE="-1.6720978579357175" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1416" O_E="0.0" SE="1.4064270555052272" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.9780370624571035" WEIGHT="8.851510285324412"/>
<DICH_DATA CI_END="0.602566620368426" CI_START="0.002276498674360905" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.21999493006610987" LOG_CI_START="-2.642732598251865" LOG_EFFECT_SIZE="-1.4313637641589874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.4231280990371864" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.025293586269196" WEIGHT="8.644976472445487"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04715332451683455" CI_END="0.5962532820228628" CI_START="0.02122674260723685" DF="2" EFFECT_SIZE="0.11250117753259078" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" I2="0.0" ID="CMP-003.25.04" LOG_CI_END="-0.2245692174101175" LOG_CI_START="-1.6731166462599185" LOG_EFFECT_SIZE="-0.948842931835018" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.97669910847389" P_Z="0.010238372261026613" STUDIES="3" TAU2="0.0" TOTAL_1="108" TOTAL_2="108" WEIGHT="99.99999999999999" Z="2.567672878835174">
<NAME>lactation</NAME>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="34.19462337005167"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3332" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="33.554313297885194"/>
<DICH_DATA CI_END="2.693120783993597" CI_START="0.007577886363879708" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43025583155692676" LOG_CI_START="-2.1204519115854406" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1448" O_E="0.0" SE="1.498298354528788" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="2.2448979591836737" WEIGHT="32.251063332063126"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.301388740678946" CI_END="0.1561038122341291" CI_START="0.05810022370078689" DF="28" EFFECT_SIZE="0.095234796221489" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="195" I2="0.0" ID="CMP-003.25.05" LOG_CI_END="-0.8065864908387381" LOG_CI_START="-1.2358221954611268" LOG_EFFECT_SIZE="-1.0212043431499325" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9999941175970597" P_Z="1.099532819397178E-20" STUDIES="29" TAU2="0.0" TOTAL_1="1142" TOTAL_2="1136" WEIGHT="100.0" Z="9.325989016643197">
<NAME>menstrual disorder/lactation</NAME>
<DICH_DATA CI_END="3.9862007373059742" CI_START="0.009652381778181727" EFFECT_SIZE="0.19615384615384615" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.600559165139475" LOG_CI_START="-2.015365508885238" LOG_EFFECT_SIZE="-0.7074031718728816" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="737" O_E="0.0" SE="1.5366071025580923" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="2.361161387631976" WEIGHT="2.692410105453911"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="761" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="3.072874088368585"/>
<DICH_DATA CI_END="1.9825816770431" CI_START="0.006227072082477078" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29723108812504273" LOG_CI_START="-2.205716107003693" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2522" O_E="0.0" SE="1.470243572207055" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" VAR="2.1616161616161618" WEIGHT="2.940954501337024"/>
<DICH_DATA CI_END="0.6092263961548019" CI_START="0.0022516130639459345" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.21522128810680186" LOG_CI_START="-2.6475062402111726" LOG_EFFECT_SIZE="-1.4313637641589874" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1584" O_E="0.0" SE="1.428736220870799" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="2.0412871888281727" WEIGHT="3.1143166995122096"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2488" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="3.072874088368585"/>
<DICH_DATA CI_END="4.047236689258822" CI_START="0.009883286565907583" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6071586034113897" LOG_CI_START="-2.0050986120834273" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="1.5344528192634188" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="43" VAR="2.354545454545454" WEIGHT="2.6999753894728586"/>
<DICH_DATA CI_END="2.667240450629237" CI_START="0.00765141487730945" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.42606216892358767" LOG_CI_START="-2.116258248952102" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1911" O_E="0.0" SE="1.4933715981492115" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="2.2301587301587302" WEIGHT="2.8505660582354335"/>
<DICH_DATA CI_END="7.933315337564284" CI_START="0.014005634010915893" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8994547171933126" LOG_CI_START="-1.8536972266326377" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.6172150801252798" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.6153846153846154" WEIGHT="2.4306997690789074"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1484" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="3.002507257905482"/>
<DICH_DATA CI_END="2.0686169002387795" CI_START="0.028558213499851347" EFFECT_SIZE="0.24305555555555555" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.31568006847257196" LOG_CI_START="-1.54426896396252" LOG_EFFECT_SIZE="-0.614294447744974" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="1.0925432685485705" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="1.1936507936507939" WEIGHT="5.325858127421255"/>
<DICH_DATA CI_END="0.5271452066680693" CI_START="0.001973996373606359" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.27806973816822483" LOG_CI_START="-2.70465364950032" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.4253874013005576" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="2.0317292437863568" WEIGHT="3.12896750396747"/>
<DICH_DATA CI_END="1.9982491776052522" CI_START="0.006178248013664149" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30064964290473245" LOG_CI_START="-2.2091346617833825" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.4742597242064726" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.1734417344173442" WEIGHT="2.9249529352449617"/>
<DICH_DATA CI_END="0.7110733093068508" CI_START="0.0026584589007913623" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.1480856226370499" LOG_CI_START="-2.5753700493981357" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1793" O_E="0.0" SE="1.4257988875311538" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.032902467685076" WEIGHT="3.127161721588667"/>
<DICH_DATA CI_END="0.6577375838162001" CI_START="0.0024325810769650494" EFFECT_SIZE="0.04" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" LOG_CI_END="-0.18194734138898025" LOG_CI_START="-2.6139326759550947" LOG_EFFECT_SIZE="-1.3979400086720375" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="1.4285602240456965" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="2.0407843137254904" WEIGHT="3.115084106591693"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="2.8620655755289146"/>
<DICH_DATA CI_END="2.1444166318172884" CI_START="0.02914545572566014" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3313091668980096" LOG_CI_START="-1.5354291495539343" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="1.0965313275875672" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.2023809523809526" WEIGHT="5.28718853045648"/>
<DICH_DATA CI_END="0.7147657042663524" CI_START="0.002644725617021962" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.14583629389051386" LOG_CI_START="-2.577619378144672" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1093" O_E="0.0" SE="1.4284414212112981" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="2.0404448938321536" WEIGHT="3.115602288444284"/>
<DICH_DATA CI_END="0.741992623944269" CI_START="0.0027428346725210276" EFFECT_SIZE="0.045112781954887216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.12960041196655828" LOG_CI_START="-2.561800369200326" LOG_EFFECT_SIZE="-1.3457003905834422" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.4286862944630754" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="2.0411445279866336" WEIGHT="3.1145343671173595"/>
<DICH_DATA CI_END="1.3074563269125963" CI_START="0.004525703567694904" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11642719100191871" LOG_CI_START="-2.344313895615592" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="3.0427049365904613"/>
<DICH_DATA CI_END="1.6716113171405058" CI_START="0.005464089776733516" EFFECT_SIZE="0.09557109557109557" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.22313530274141058" LOG_CI_START="-2.262482173671388" LOG_EFFECT_SIZE="-1.0196734354649888" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="1.4600640096498225" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="2.131786912274717" WEIGHT="2.982106112043095"/>
<DICH_DATA CI_END="2.3761210576509737" CI_START="0.00683218768880523" EFFECT_SIZE="0.1274131274131274" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.37586856313176153" LOG_CI_START="-2.16544021153849" LOG_EFFECT_SIZE="-0.8947858242033644" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="1.492777353922623" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="2.228384228384228" WEIGHT="2.8528360144055784"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1289" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Wang-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="6.006817115591729"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1415" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="3.002507257905482"/>
<DICH_DATA CI_END="0.9860104274367028" CI_START="0.0035093012367547953" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.00611849220455492" LOG_CI_START="-2.454779350551993" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1429" O_E="0.0" SE="1.43835550926002" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="2.0688665710186513" WEIGHT="3.072800764303422"/>
<DICH_DATA CI_END="0.9895765631237873" CI_START="0.003496654772758503" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.004550598975685801" LOG_CI_START="-2.456347243780862" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="1.4401974857476887" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="2.074168797953964" WEIGHT="3.0649457203959973"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="2.8620655755289146"/>
<DICH_DATA CI_END="0.6110696264007713" CI_START="0.011364407825909376" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.21390930262344088" LOG_CI_START="-1.944453189471809" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.0333333333333334" WEIGHT="6.152143336130236"/>
<DICH_DATA CI_END="0.9407530590931902" CI_START="0.01660903448463005" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02652436078898345" LOG_CI_START="-1.7796556131949035" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="1.0297979758028961" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="1.060483870967742" WEIGHT="5.994635990895977"/>
<DICH_DATA CI_END="0.7237967313972767" CI_START="0.0026117265887518728" EFFECT_SIZE="0.043478260869565216" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.1403833824592805" LOG_CI_START="-2.5830722895759055" LOG_EFFECT_SIZE="-1.3617278360175928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="1.4348475555454048" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="2.0587875076546234" WEIGHT="3.0878440621150207"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1230636098679194" CI_START="0.003957428951835721" DF="0" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-003.25.06" LOG_CI_END="0.050404355221627936" LOG_CI_START="-2.4025868733329907" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.06018759886005332" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0" Z="1.879416838876949">
<NAME>menstrual disorder or sexual function change</NAME>
<DICH_DATA CI_END="1.1230636098679194" CI_START="0.003957428951835721" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.050404355221627936" LOG_CI_START="-2.4025868733329907" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.440899190155396" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="2.0761904761904764" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.0394759226265573" CI_END="0.2740948431855556" CI_START="0.06097281973749981" DF="8" EFFECT_SIZE="0.12927619836818827" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="66" I2="0.0" ID="CMP-003.25.07" LOG_CI_END="-0.5620991351906182" LOG_CI_START="-1.214863720213115" LOG_EFFECT_SIZE="-0.8884814277018664" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.931855834968919" P_Z="9.531562140806142E-8" STUDIES="9" TAU2="0.0" TOTAL_1="327" TOTAL_2="328" WEIGHT="99.99999999999999" Z="5.335435283053449">
<NAME>menstrual disorder</NAME>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1998" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="6.9439335138919756"/>
<DICH_DATA CI_END="0.9895765631237873" CI_START="0.003496654772758503" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.004550598975685801" LOG_CI_START="-2.456347243780862" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="1.4401974857476887" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="2.074168797953964" WEIGHT="7.088335673487829"/>
<DICH_DATA CI_END="1.4592730588435012" CI_START="0.06813238103031363" EFFECT_SIZE="0.3153153153153153" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.16413656458241688" LOG_CI_START="-1.1666464334551805" LOG_EFFECT_SIZE="-0.5012549344363818" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1767" O_E="0.0" SE="0.7817085205293665" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.611068211068211" WEIGHT="24.060169416555173"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1670" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="13.892035921296808"/>
<DICH_DATA CI_END="1.6343045942797216" CI_START="0.02447524172666784" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.21333300157640056" LOG_CI_START="-1.6112730102484383" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1861" O_E="0.0" SE="1.071782603291334" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="1.1487179487179489" WEIGHT="12.798968362757266"/>
<DICH_DATA CI_END="1.4129379684860779" CI_START="0.004739521443544551" EFFECT_SIZE="0.08183306055646482" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.1501230956521274" LOG_CI_START="-2.324265507465198" LOG_EFFECT_SIZE="-1.0870712059065355" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1246" O_E="0.0" SE="1.4534681138922425" STUDY_ID="STD-Wang-2007" TOTAL_1="46" TOTAL_2="49" VAR="2.1125695581014727" WEIGHT="6.959489038829676"/>
<DICH_DATA CI_END="0.6463854475521095" CI_START="0.002475303251425713" EFFECT_SIZE="0.04" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" LOG_CI_END="-0.1895084296452276" LOG_CI_START="-2.606371587698847" LOG_EFFECT_SIZE="-1.3979400086720375" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="1.419677382706276" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.015483870967742" WEIGHT="7.2947270356041285"/>
<DICH_DATA CI_END="0.8367241573312947" CI_START="0.01475477778927983" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07741769217811331" LOG_CI_START="-1.8310673267005368" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2505" O_E="0.0" SE="1.030102476024163" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.0611111111111113" WEIGHT="13.855669335115396"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3332" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="7.106671702461736"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.751375227378354" CI_END="0.8637160351768429" CI_START="0.12161736575885194" DF="8" EFFECT_SIZE="0.3241031764143751" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="15" I2="0.0" ID="CMP-003.25.08" LOG_CI_END="-0.06362901750521441" LOG_CI_START="-0.91500440767211" LOG_EFFECT_SIZE="-0.48931671258866216" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.9489785045878554" P_Z="0.024263777045135656" STUDIES="9" TAU2="0.0" TOTAL_1="390" TOTAL_2="388" WEIGHT="99.99999999999999" Z="2.2529266050767878">
<NAME>skin symptom</NAME>
<DICH_DATA CI_END="8.022569637689829" CI_START="0.013849815723520037" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9043134955566555" LOG_CI_START="-1.8585560049959806" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.6229232210492168" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="2.6338797814207653" WEIGHT="9.49557875619801"/>
<DICH_DATA CI_END="7.502975334214647" CI_START="0.013291126152980877" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8752335187236451" LOG_CI_START="-1.8764382198620155" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1767" O_E="0.0" SE="1.6163456002399996" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="2.6125730994152048" WEIGHT="9.573019374821216"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1106" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="9.611362808231313"/>
<DICH_DATA CI_END="7.502975334214647" CI_START="0.013291126152980877" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8752335187236451" LOG_CI_START="-1.8764382198620155" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.6163456002399996" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="2.6125730994152048" WEIGHT="9.573019374821216"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="23.631697227248953"/>
<DICH_DATA CI_END="8.34647495295665" CI_START="0.014712717478896005" EFFECT_SIZE="0.3504273504273504" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9215030944398266" LOG_CI_START="-1.832307104492679" LOG_EFFECT_SIZE="-0.4554020050264262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="1.6176017424332856" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="2.616635397123202" WEIGHT="9.558157367409827"/>
<DICH_DATA CI_END="71.85363283148561" CI_START="0.12525462729361522" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8564487304213015" LOG_CI_START="-0.9022062209819764" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1450" O_E="0.0" SE="1.6204475740165292" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="2.6258503401360547" WEIGHT="9.524614756811541"/>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="9.553590641481778"/>
<DICH_DATA CI_END="8.044961518532196" CI_START="0.013811266947039826" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9055239710790393" LOG_CI_START="-1.8597664805183645" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="1.6243452996768142" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="2.6384976525821595" WEIGHT="9.478959692976147"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3778911462262502" CI_END="0.3762148175894273" CI_START="0.013781446228711844" DF="2" EFFECT_SIZE="0.07200544617633672" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="29" I2="0.0" ID="CMP-003.25.09" LOG_CI_END="-0.4245641033348333" LOG_CI_START="-1.8607052050559656" LOG_EFFECT_SIZE="-1.1426346541953996" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.5021052752254096" P_Z="0.0018158545495604427" STUDIES="3" TAU2="0.0" TOTAL_1="92" TOTAL_2="92" WEIGHT="100.0" Z="3.118806037967193">
<NAME>PRL-increase</NAME>
<DICH_DATA CI_END="2.6584101927477937" CI_START="0.0076768300546620205" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.42462199342474577" LOG_CI_START="-2.1148180734532596" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1958" O_E="0.0" SE="1.4916796657152047" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.225108225108225" WEIGHT="31.982933002626044"/>
<DICH_DATA CI_END="2.6515870907376713" CI_START="0.007696584184088997" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4235058959862219" LOG_CI_START="-2.1137019760147355" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="774" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="32.03923390317134"/>
<DICH_DATA CI_END="0.33500787966786005" CI_START="0.0013512921753702912" EFFECT_SIZE="0.02127659574468085" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="23" LOG_CI_END="-0.47494497787054213" LOG_CI_START="-2.869250738000893" LOG_EFFECT_SIZE="-1.6720978579357175" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1415" O_E="0.0" SE="1.4064270555052272" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.9780370624571035" WEIGHT="35.977833094202616"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.354285749898555" CI_START="0.14082050569819843" DF="0" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-003.25.10" LOG_CI_END="0.8030667409937645" LOG_CI_START="-0.8513341004272031" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.9544000542528479" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="35" WEIGHT="100.0" Z="0.057182203822584786">
<NAME>obesity</NAME>
<DICH_DATA CI_END="6.354285749898555" CI_START="0.14082050569819843" EFFECT_SIZE="0.9459459459459459" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8030667409937645" LOG_CI_START="-0.8513341004272031" LOG_EFFECT_SIZE="-0.024133679716719363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1767" O_E="0.0" SE="0.9718032436669186" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.9444015444015444" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="67.52677800793181" CI_START="0.11962013537682785" DF="0" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.25.11" LOG_CI_END="1.8294760281629698" LOG_CI_START="-0.9221957104226909" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Z="0.5181247889033018" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="35" WEIGHT="100.0" Z="0.6462386925436842">
<NAME>vaginal bleeding</NAME>
<DICH_DATA CI_END="67.52677800793181" CI_START="0.11962013537682785" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8294760281629698" LOG_CI_START="-0.9221957104226909" LOG_EFFECT_SIZE="0.45364015887013953" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1767" O_E="0.0" SE="1.6163456002399996" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="2.6125730994152048" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="60.8044745604239" CI_END="0.28805744120881105" CI_START="0.17171142289741073" DF="57" EFFECT_SIZE="0.2224022326914732" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="423" I2="6.256898999502472" ID="CMP-003.25.12" LOG_CI_END="-0.5405209014331704" LOG_CI_START="-0.7652008129561473" LOG_EFFECT_SIZE="-0.6528608571946588" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.34059465329727256" P_Z="4.674747528793018E-30" STUDIES="58" TAU2="0.060491522875059094" TOTAL_1="2374" TOTAL_2="2249" WEIGHT="99.99999999999997" Z="11.390281920122819">
<NAME>weight gain</NAME>
<DICH_DATA CI_END="1.7885897684932468" CI_START="0.06729688163984052" EFFECT_SIZE="0.3469387755102041" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2525107420711812" LOG_CI_START="-1.1720050593716607" LOG_EFFECT_SIZE="-0.45974715865023974" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="277" O_E="0.0" SE="0.836767633234467" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" VAR="0.7001800720288115" WEIGHT="2.2898471483144633"/>
<DICH_DATA CI_END="0.5529311385956133" CI_START="0.03215188390896462" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="15" LOG_CI_END="-0.2573289518600418" LOG_CI_START="-1.492793574923358" LOG_EFFECT_SIZE="-0.8750612633917001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1692" O_E="0.0" SE="0.725718035235908" STUDY_ID="STD-Chang-2007" TOTAL_1="50" TOTAL_2="50" VAR="0.5266666666666666" WEIGHT="2.9665288050464333"/>
<DICH_DATA CI_END="1.7458609412099357" CI_START="0.21505524655983485" EFFECT_SIZE="0.6127450980392157" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.242009648951299" LOG_CI_START="-0.6674499577869837" LOG_EFFECT_SIZE="-0.2127201544178423" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="738" O_E="0.0" SE="0.5342210748957262" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="0.2853921568627451" WEIGHT="5.035859696285248"/>
<DICH_DATA CI_END="0.7332835516809254" CI_START="0.013637289391091267" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.13472805657581619" LOG_CI_START="-1.8652719434241833" LOG_EFFECT_SIZE="-1.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="759" O_E="0.0" SE="1.016530045465127" STUDY_ID="STD-Chen-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.0333333333333332" WEIGHT="1.5924136963135496"/>
<DICH_DATA CI_END="0.9780867534503261" CI_START="0.003537730779248796" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.009622622846536252" LOG_CI_START="-2.451275219910012" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2521" O_E="0.0" SE="1.4342388218903674" STUDY_ID="STD-Chen-2010" TOTAL_1="32" TOTAL_2="32" VAR="2.057040998217469" WEIGHT="0.8225713962096604"/>
<DICH_DATA CI_END="0.5579155313499884" CI_START="0.03186464039594109" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="15" LOG_CI_END="-0.25343154845571997" LOG_CI_START="-1.49669097832768" LOG_EFFECT_SIZE="-0.8750612633917001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1583" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Chen-2010a" TOTAL_1="60" TOTAL_2="60" VAR="0.5333333333333332" WEIGHT="2.9332246102261195"/>
<DICH_DATA CI_END="1.3074563269125963" CI_START="0.004525703567694904" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11642719100191871" LOG_CI_START="-2.344313895615592" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1998" O_E="0.0" SE="1.4454514951439552" STUDY_ID="STD-Ding-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.0893300248138957" WEIGHT="0.8102168685893444"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2486" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Fan-2010" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="0.8180221403142547"/>
<DICH_DATA CI_END="1.9564679498508297" CI_START="0.006026619902322997" EFFECT_SIZE="0.10858585858585859" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2914727378401041" LOG_CI_START="-2.2199261985319554" LOG_EFFECT_SIZE="-0.9642267303459258" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="927" O_E="0.0" SE="1.4752081668501775" STUDY_ID="STD-Han-2007a" TOTAL_1="43" TOTAL_2="42" VAR="2.176239135541461" WEIGHT="0.7787355513012706"/>
<DICH_DATA CI_END="1.0775759187155824" CI_START="0.01893895632860063" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.03244787736433642" LOG_CI_START="-1.7226439573928503" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2462" O_E="0.0" SE="1.0309496315810693" STUDY_ID="STD-Hu-2010" TOTAL_1="25" TOTAL_2="25" VAR="1.0628571428571427" WEIGHT="1.5505619364038843"/>
<DICH_DATA CI_END="1.310925281185334" CI_START="0.004513727706863152" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.1175779389107847" LOG_CI_START="-2.3454646435244584" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1948" O_E="0.0" SE="1.446803405179879" STUDY_ID="STD-Ji-2007" TOTAL_1="32" TOTAL_2="32" VAR="2.093240093240093" WEIGHT="0.8087459316478334"/>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1904" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Li-2006" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="0.8694550839745242"/>
<DICH_DATA CI_END="1.9949281755505845" CI_START="0.006188533082870698" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2999272641713543" LOG_CI_START="-2.2084122830500044" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1928" O_E="0.0" SE="1.4734110665188351" STUDY_ID="STD-Li-2006a" TOTAL_1="38" TOTAL_2="38" VAR="2.170940170940171" WEIGHT="0.7805848089467314"/>
<DICH_DATA CI_END="0.8500442566604848" CI_START="0.014523572055939016" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07055846261149344" LOG_CI_START="-1.8379265562671567" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1881" O_E="0.0" SE="1.0381607668264958" STUDY_ID="STD-Li-2007d" TOTAL_1="60" TOTAL_2="60" VAR="1.077777777777778" WEIGHT="1.5302368968357907"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1467" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Li-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.7852418872779925"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1480" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Li-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.8736081692284758"/>
<DICH_DATA CI_END="1.542142798664722" CI_START="0.005073312249883969" EFFECT_SIZE="0.08845208845208845" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.18812459018752375" LOG_CI_START="-2.294708407103389" LOG_EFFECT_SIZE="-1.0532919084579329" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1866" O_E="0.0" SE="1.458428392830233" STUDY_ID="STD-Li-X-2007" TOTAL_1="36" TOTAL_2="35" VAR="2.127013377013377" WEIGHT="0.7962595569423762"/>
<DICH_DATA CI_END="1.9505614529721007" CI_START="0.08202766426877019" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2901596374297934" LOG_CI_START="-1.0860396547738684" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1848" O_E="0.0" SE="0.8083862765367947" STUDY_ID="STD-Lian-2008" TOTAL_1="43" TOTAL_2="43" VAR="0.6534883720930231" WEIGHT="2.4395948606820492"/>
<DICH_DATA CI_END="0.3607742910148043" CI_START="0.006929540331069246" EFFECT_SIZE="0.05" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="20" LOG_CI_END="-0.4427644181040931" LOG_CI_START="-2.1592955732238694" LOG_EFFECT_SIZE="-1.3010299956639813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1826" O_E="0.0" SE="1.0082988974836116" STUDY_ID="STD-Liang-2008" TOTAL_1="60" TOTAL_2="60" VAR="1.0166666666666668" WEIGHT="1.6170528148103263"/>
<DICH_DATA CI_END="2.688434553592154" CI_START="0.007591095434344022" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.42949946861312105" LOG_CI_START="-2.119695548641635" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1808" O_E="0.0" SE="1.4974097718542911" STUDY_ID="STD-Liu-2006a" TOTAL_1="45" TOTAL_2="45" VAR="2.24223602484472" WEIGHT="0.7564167476605037"/>
<DICH_DATA CI_END="0.8690618470163535" CI_START="0.17277970551292016" EFFECT_SIZE="0.3875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.060949315769792914" LOG_CI_START="-0.7625072705455488" LOG_EFFECT_SIZE="-0.4117282931576709" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1777" O_E="0.0" SE="0.4120986154031633" STUDY_ID="STD-Liu-2008c" TOTAL_1="32" TOTAL_2="31" VAR="0.1698252688172043" WEIGHT="7.562721196298049"/>
<DICH_DATA CI_END="1.4592730588435012" CI_START="0.06813238103031363" EFFECT_SIZE="0.3153153153153153" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.16413656458241688" LOG_CI_START="-1.1666464334551805" LOG_EFFECT_SIZE="-0.5012549344363818" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1767" O_E="0.0" SE="0.7817085205293665" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" VAR="0.611068211068211" WEIGHT="2.5936958312953036"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="779" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Liu-2009a" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="0.7998102767227523"/>
<DICH_DATA CI_END="8.82976889241327" CI_START="0.0162496050423134" EFFECT_SIZE="0.3787878787878788" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9459493366395004" LOG_CI_START="-1.7891571903791628" LOG_EFFECT_SIZE="-0.42160392686983106" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1751" O_E="0.0" SE="1.6066151129664257" STUDY_ID="STD-Lou-2007" TOTAL_1="21" TOTAL_2="24" VAR="2.581212121212121" WEIGHT="0.6593554452230449"/>
<DICH_DATA CI_END="1.5914045510327255" CI_START="0.005193187869517035" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20178059570418194" LOG_CI_START="-2.284565966020632" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1799" O_E="0.0" SE="1.4604922779711311" STUDY_ID="STD-Lv-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.1330376940133036" WEIGHT="0.7940727066609621"/>
<DICH_DATA CI_END="1.9912523628464711" CI_START="0.006199956993245031" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29912630414908753" LOG_CI_START="-2.2076113230277374" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1775" O_E="0.0" SE="1.472470090755044" STUDY_ID="STD-Mai-2005" TOTAL_1="36" TOTAL_2="36" VAR="2.168168168168168" WEIGHT="0.7815556988779667"/>
<DICH_DATA CI_END="0.27262970447338564" CI_START="0.005426004270832534" EFFECT_SIZE="0.038461538461538464" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="26" LOG_CI_END="-0.5644268272025014" LOG_CI_START="-2.2655198687391347" LOG_EFFECT_SIZE="-1.414973347970818" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1750" O_E="0.0" SE="0.9992304731449789" STUDY_ID="STD-Mu-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.9984615384615385" WEIGHT="1.6448525869465231"/>
<DICH_DATA CI_END="1.9399314825365324" CI_START="0.4952691199008003" EFFECT_SIZE="0.9801980198019802" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="11" LOG_CI_END="0.2877863911251801" LOG_CI_START="-0.3051587494953654" LOG_EFFECT_SIZE="-0.008686179185092667" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="0.34829891072629166" STUDY_ID="STD-Potkin-2003" TOTAL_1="202" TOTAL_2="99" VAR="0.1213121312131213" WEIGHT="9.580784781969264"/>
<DICH_DATA CI_END="0.8654220538208824" CI_START="0.0032008464427998057" EFFECT_SIZE="0.05263157894736842" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" LOG_CI_END="-0.0627720417341568" LOG_CI_START="-2.4947351601715013" LOG_EFFECT_SIZE="-1.278753600952829" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1670" O_E="0.0" SE="1.4285471741816855" STUDY_ID="STD-Qin-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.0407470288624787" WEIGHT="0.8289499928288061"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1657" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-Shan-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="0.7852418872779925"/>
<DICH_DATA CI_END="1.1110029699454145" CI_START="0.018369134752455978" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.04571521990322681" LOG_CI_START="-1.7359112999317405" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1635" O_E="0.0" SE="1.0465362369445672" STUDY_ID="STD-Shuai-2008" TOTAL_1="42" TOTAL_2="42" VAR="1.0952380952380953" WEIGHT="1.5071186678058341"/>
<DICH_DATA CI_END="0.9754758873898897" CI_START="0.0035471995332609684" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.010783461382678439" LOG_CI_START="-2.4501143813738695" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1108" O_E="0.0" SE="1.4328750572856208" STUDY_ID="STD-Song-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.0531309297912714" WEIGHT="0.8240931014889334"/>
<DICH_DATA CI_END="1.5250057453009744" CI_START="0.16393380862356036" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18327147984530298" LOG_CI_START="-0.7853314711732654" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1861" O_E="0.0" SE="0.5689621680902419" STUDY_ID="STD-Su-2007" TOTAL_1="39" TOTAL_2="39" VAR="0.3237179487179487" WEIGHT="4.5335209337044935"/>
<DICH_DATA CI_END="2.001264373770802" CI_START="0.006168939583471334" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.301304464191279" LOG_CI_START="-2.209789483069929" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1094" O_E="0.0" SE="1.4750290147367426" STUDY_ID="STD-Sun-2009" TOTAL_1="42" TOTAL_2="42" VAR="2.1757105943152455" WEIGHT="0.778919610622214"/>
<DICH_DATA CI_END="1.0431111253741114" CI_START="0.01750676826636448" EFFECT_SIZE="0.13513513513513514" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.018330577425564203" LOG_CI_START="-1.7567940168875165" LOG_EFFECT_SIZE="-0.8692317197309761" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1379" O_E="0.0" SE="1.0427169737079605" STUDY_ID="STD-Tang-2006" TOTAL_1="37" TOTAL_2="35" VAR="1.0872586872586874" WEIGHT="1.5175964831158424"/>
<DICH_DATA CI_END="0.9388287955704953" CI_START="0.016643077069770976" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.02741359827499986" LOG_CI_START="-1.778766375708887" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1357" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Tang-2007" TOTAL_1="30" TOTAL_2="30" VAR="1.0583333333333331" WEIGHT="1.5568314135398609"/>
<DICH_DATA CI_END="1.165432081829262" CI_START="0.019403038270719736" EFFECT_SIZE="0.15037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.06648696910821048" LOG_CI_START="-1.71213025971442" LOG_EFFECT_SIZE="-0.8228216453031046" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1344" O_E="0.0" SE="1.0447685645076896" STUDY_ID="STD-Tang-2010" TOTAL_1="38" TOTAL_2="40" VAR="1.0915413533834586" WEIGHT="1.5119548393891284"/>
<DICH_DATA CI_END="0.8743017310720974" CI_START="0.0031482212832287413" EFFECT_SIZE="0.05246422893481717" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.058338661730199186" LOG_CI_START="-2.5019347494045636" LOG_EFFECT_SIZE="-1.2801367055673813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1644" O_E="0.0" SE="1.4353804378956374" STUDY_ID="STD-Tong-2007" TOTAL_1="36" TOTAL_2="32" VAR="2.060317001493472" WEIGHT="0.821300773917376"/>
<DICH_DATA CI_END="1.6085426237362968" CI_START="0.005137857516464679" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20643257348058153" LOG_CI_START="-2.289217943797032" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1222" O_E="0.0" SE="1.465957467518168" STUDY_ID="STD-Wang-2006d" TOTAL_1="60" TOTAL_2="60" VAR="2.1490312965722804" WEIGHT="0.7883248215694458"/>
<DICH_DATA CI_END="0.5157260549254755" CI_START="0.002017704392455238" EFFECT_SIZE="0.03225806451612903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.2875809271069153" LOG_CI_START="-2.69514246056163" LOG_EFFECT_SIZE="-1.4913616938342726" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1256" O_E="0.0" SE="1.4142135623730951" STUDY_ID="STD-Wang-2007a" TOTAL_1="30" TOTAL_2="30" VAR="2.0" WEIGHT="0.8453428044023361"/>
<DICH_DATA CI_END="7.888578229356675" CI_START="0.014085061703212953" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8969987366967316" LOG_CI_START="-1.8512412461360563" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1276" O_E="0.0" SE="1.6143297699232972" STUDY_ID="STD-Wang-2007d" TOTAL_1="32" TOTAL_2="32" VAR="2.606060606060606" WEIGHT="0.653211187395642"/>
<DICH_DATA CI_END="1.9031160339754112" CI_START="0.08407264567351506" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.27946526825494583" LOG_CI_START="-1.075345285599021" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1414" O_E="0.0" SE="0.7958224257542215" STUDY_ID="STD-Wen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.6333333333333333" WEIGHT="2.5104630755276394"/>
<DICH_DATA CI_END="0.6110696264007713" CI_START="0.011364407825909376" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.21390930262344088" LOG_CI_START="-1.944453189471809" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1427" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Wen-2009a" TOTAL_1="40" TOTAL_2="40" VAR="1.0333333333333334" WEIGHT="1.5924136963135491"/>
<DICH_DATA CI_END="0.9875353845953485" CI_START="0.0035038821559539354" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.005447334122579834" LOG_CI_START="-2.4554505086339677" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="1.4391439924192966" STUDY_ID="STD-Xie-2008" TOTAL_1="42" TOTAL_2="42" VAR="2.0711354309165526" WEIGHT="0.8171325096524013"/>
<DICH_DATA CI_END="0.9537939361791632" CI_START="0.01638194520568325" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.020545442955097762" LOG_CI_START="-1.7856345310287896" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2504" O_E="0.0" SE="1.0368220676663862" STUDY_ID="STD-Xie-2010" TOTAL_1="40" TOTAL_2="40" VAR="1.0750000000000002" WEIGHT="1.533980348866153"/>
<DICH_DATA CI_END="0.8654220538208824" CI_START="0.0032008464427998057" EFFECT_SIZE="0.05263157894736842" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" LOG_CI_END="-0.0627720417341568" LOG_CI_START="-2.4947351601715013" LOG_EFFECT_SIZE="-1.278753600952829" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3332" O_E="0.0" SE="1.4285471741816855" STUDY_ID="STD-Yan-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.0407470288624787" WEIGHT="0.8289499928288061"/>
<DICH_DATA CI_END="1.3325524885266953" CI_START="0.020845541182763928" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12468432466187462" LOG_CI_START="-1.6809868254291618" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1447" O_E="0.0" SE="1.0606601717798214" STUDY_ID="STD-Yan-2010" TOTAL_1="48" TOTAL_2="48" VAR="1.1250000000000002" WEIGHT="1.4692822755663144"/>
<DICH_DATA CI_END="0.8411523531131865" CI_START="0.014677102152366468" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07512533580274083" LOG_CI_START="-1.8333596830759094" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3305" O_E="0.0" SE="1.0327955589886446" STUDY_ID="STD-Yang-2008b" TOTAL_1="45" TOTAL_2="45" VAR="1.0666666666666669" WEIGHT="1.5453214096795265"/>
<DICH_DATA CI_END="1.3140027542922799" CI_START="0.00450315628638129" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11859627555305043" LOG_CI_START="-2.346482980166724" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3345" O_E="0.0" SE="1.447999757148908" STUDY_ID="STD-Ye-2005" TOTAL_1="34" TOTAL_2="34" VAR="2.096703296703297" WEIGHT="0.8074475548457409"/>
<DICH_DATA CI_END="1.3157787090329414" CI_START="0.06204132389497477" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.11918285468290388" LOG_CI_START="-1.2073189433834552" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="905" O_E="0.0" SE="0.7791937224739794" STUDY_ID="STD-Zhang-2006" TOTAL_1="56" TOTAL_2="56" VAR="0.607142857142857" WEIGHT="2.6089454565651646"/>
<DICH_DATA CI_END="5.167657331603573" CI_START="0.04837782073340814" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7132937077873972" LOG_CI_START="-1.3153536991153596" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="1.1916375287812984" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" VAR="1.42" WEIGHT="1.1765158094332688"/>
<DICH_DATA CI_END="1.5746592838701632" CI_START="0.00524841335174752" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19718659803513047" LOG_CI_START="-2.2799719683515804" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="943" O_E="0.0" SE="1.4550952040282188" STUDY_ID="STD-Zhang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.1173020527859236" WEIGHT="0.7998102767227523"/>
<DICH_DATA CI_END="1.6113995451271035" CI_START="0.0248231421691539" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20720323671350532" LOG_CI_START="-1.6051432453855428" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1739" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Zhang-2008a" TOTAL_1="30" TOTAL_2="30" VAR="1.133333333333333" WEIGHT="1.4590261488829255"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1753" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Zhang-2008b" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.661806445478469"/>
<DICH_DATA CI_END="1.6113995451271035" CI_START="0.0248231421691539" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20720323671350532" LOG_CI_START="-1.6051432453855428" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1297" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Zhang-2009b" TOTAL_1="30" TOTAL_2="30" VAR="1.133333333333333" WEIGHT="1.4590261488829255"/>
<DICH_DATA CI_END="1.1050846251014352" CI_START="0.05655675464153993" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.04339553667030915" LOG_CI_START="-1.2475155193262337" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1048" O_E="0.0" SE="0.758287544405155" STUDY_ID="STD-Zhi-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.575" WEIGHT="2.7409046693717958"/>
<DICH_DATA CI_END="0.7537183447784397" CI_START="0.043859687731744125" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.12279091429024776" LOG_CI_START="-1.3579344646982399" LOG_EFFECT_SIZE="-0.7403626894942439" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.7255294355688354" STUDY_ID="STD-Zhou-2007a" TOTAL_1="31" TOTAL_2="31" VAR="0.5263929618768329" WEIGHT="2.9679123024197946"/>
<DICH_DATA CI_END="0.790580940180365" CI_START="0.041814632202146845" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.10205366010976111" LOG_CI_START="-1.3786717188787267" LOG_EFFECT_SIZE="-0.7403626894942439" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1011" O_E="0.0" SE="0.7498917670821986" STUDY_ID="STD-Zhou-2008" TOTAL_1="70" TOTAL_2="70" VAR="0.5623376623376625" WEIGHT="2.7966282309001618"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="70.55615405273014" CI_START="0.12269907100864773" DF="0" EFFECT_SIZE="2.9423076923076925" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.25.13" LOG_CI_END="1.8485348997995192" LOG_CI_START="-0.9111587254339197" LOG_EFFECT_SIZE="0.4686880871827997" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.5055807556872651" STUDIES="1" TAU2="0.0" TOTAL_1="51" TOTAL_2="50" WEIGHT="100.0" Z="0.6657346036254675">
<NAME>weight loss</NAME>
<DICH_DATA CI_END="70.55615405273014" CI_START="0.12269907100864773" EFFECT_SIZE="2.9423076923076925" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8485348997995192" LOG_CI_START="-0.9111587254339197" LOG_EFFECT_SIZE="0.4686880871827997" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="739" O_E="0.0" SE="1.6210576961658838" STUDY_ID="STD-Chen-2006" TOTAL_1="51" TOTAL_2="50" VAR="2.6278280542986425" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="861.7091953426223" CI_END="0.20726668010370475" CI_START="0.051113360930312324" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="MD" EFFECT_SIZE="0.12919002051700854" ESTIMABLE="YES" I2="97.79507981315605" I2_Q="98.47196970773877" ID="CMP-003.26" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="-8.881784197001252E-16" P_Q="-1.5543122344752192E-15" P_Z="0.001182506700551138" Q="785.3247452471633" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1.4235570187903448" TOTALS="SUB" TOTAL_1="885" TOTAL_2="884" UNITS="" WEIGHT="1300.0" Z="3.243066349350741">
<NAME>Adverse effects: 7b. Metabolic - continuous measures (high=poor )</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="37.170214104774864" CI_END="-0.4394200979739187" CI_START="-4.165320418282246" DF="4" EFFECT_SIZE="-2.3023702581280823" ESTIMABLE="YES" I2="89.23869529315904" ID="CMP-003.26.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.6615827258537053E-7" P_Z="0.015424011275785288" STUDIES="5" TAU2="3.6922400736524783" TOTAL_1="233" TOTAL_2="232" WEIGHT="100.0" Z="2.4222670479997186">
<NAME>endpoint average weight (in kg)</NAME>
<CONT_DATA CI_END="-3.0139187282165683" CI_START="-5.386081271783437" EFFECT_SIZE="-4.200000000000003" ESTIMABLE="YES" MEAN_1="54.8" MEAN_2="59.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1996" SD_1="2.0" SD_2="2.8" SE="0.6051546258702161" STUDY_ID="STD-Du-2006" TOTAL_1="33" TOTAL_2="32" WEIGHT="22.26106080149561"/>
<CONT_DATA CI_END="1.1489227579295846" CI_START="-4.3489227579295875" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="53.8" MEAN_2="55.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1330" SD_1="9.0" SD_2="9.8" SE="1.4025373831421077" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="15.963923799794765"/>
<CONT_DATA CI_END="0.613385411084499" CI_START="-1.4133854110844961" EFFECT_SIZE="-0.3999999999999986" ESTIMABLE="YES" MEAN_1="56.9" MEAN_2="57.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1273" SD_1="2.1" SD_2="1.9" SE="0.517042873786433" STUDY_ID="STD-Wang-2007e" TOTAL_1="30" TOTAL_2="30" WEIGHT="22.816965815168157"/>
<CONT_DATA CI_END="0.2269097109621776" CI_START="-1.4269097109621804" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="57.9" MEAN_2="58.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3366" SD_1="2.3" SD_2="1.9" SE="0.4219004621945797" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="23.343629684600437"/>
<CONT_DATA CI_END="-2.8039472396800487" CI_START="-8.476052760319952" EFFECT_SIZE="-5.640000000000001" ESTIMABLE="YES" MEAN_1="67.42" MEAN_2="73.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1281" SD_1="6.1" SD_2="5.06" SE="1.4469922828635495" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="15.614419898941033"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.157146328715529" CI_START="-1.8428536712844714" DF="0" EFFECT_SIZE="-1.5000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="9.91477194432749E-18" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="8.574929257125444">
<NAME>weight change from baseline (in kg)</NAME>
<CONT_DATA CI_END="-1.157146328715529" CI_START="-1.8428536712844714" EFFECT_SIZE="-1.5000000000000002" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="3.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3366" SD_1="0.3" SD_2="1.2" SE="0.17492855684535902" STUDY_ID="STD-Yu-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.8396498325847714" CI_START="-4.080350167415223" DF="0" EFFECT_SIZE="-2.4599999999999973" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.002924174998915218" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="2.975598422444562">
<NAME>average endpoint BMI of male (in kg/m2)</NAME>
<CONT_DATA CI_END="-0.8396498325847714" CI_START="-4.080350167415223" EFFECT_SIZE="-2.4599999999999973" ESTIMABLE="YES" MEAN_1="21.1" MEAN_2="23.56" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1590" SD_1="3.09" SD_2="3.31" SE="0.8267244603453641" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.319960579609862" CI_END="0.6040101734553156" CI_START="-3.551871480184582" DF="1" EFFECT_SIZE="-1.4739306533646332" ESTIMABLE="YES" I2="76.85164062098201" ID="CMP-003.26.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.037667986599404735" P_Z="0.16445388645630335" STUDIES="2" TAU2="1.7433410416666646" TOTAL_1="62" TOTAL_2="62" WEIGHT="100.0" Z="1.3902469979019223">
<NAME>average endpoint BMI of female (in kg/m2)</NAME>
<CONT_DATA CI_END="-0.9535347938984964" CI_START="-4.3264652061015045" EFFECT_SIZE="-2.6400000000000006" ESTIMABLE="YES" MEAN_1="21.31" MEAN_2="23.95" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1591" SD_1="3.2" SD_2="3.46" SE="0.8604572427881974" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="45.254960251860666"/>
<CONT_DATA CI_END="0.5809647053132303" CI_START="-1.6009647053132334" EFFECT_SIZE="-0.5100000000000016" ESTIMABLE="YES" MEAN_1="21.31" MEAN_2="21.82" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1678" SD_1="2.05" SD_2="2.39" SE="0.5566248736806504" STUDY_ID="STD-Pu-2007" TOTAL_1="32" TOTAL_2="32" WEIGHT="54.74503974813934"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.6116969080198" CI_START="3.9683030919802" DF="0" EFFECT_SIZE="4.29" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="26.13716602199768">
<NAME>average endpoint blood glucose of female (in mmol/L)</NAME>
<CONT_DATA CI_END="4.6116969080198" CI_START="3.9683030919802" EFFECT_SIZE="4.29" ESTIMABLE="YES" MEAN_1="4.36" MEAN_2="0.07" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1593" SD_1="0.81" SD_2="0.39" SE="0.16413409152275465" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.599580326646559" CI_START="-0.03958032664655853" DF="0" EFFECT_SIZE="0.28000000000000025" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.08593887564959221" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="1.7172205856030438">
<NAME>average endpoint blood glucose of male (in mmol/L)</NAME>
<CONT_DATA CI_END="0.5995803266465589" CI_START="-0.03958032664655847" EFFECT_SIZE="0.28000000000000025" ESTIMABLE="YES" MEAN_1="4.33" MEAN_2="4.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1592" SD_1="0.74" SD_2="0.5" SE="0.1630541832234508" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.20647227662159934" CI_START="-0.3664722766215995" DF="0" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.07" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.58414665010947" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="0.5473378457850476">
<NAME>average endpoint blood glucose FBG (in mg/dl)</NAME>
<CONT_DATA CI_END="0.20647227662159934" CI_START="-0.3664722766215995" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" MEAN_1="4.79" MEAN_2="4.87" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1282" SD_1="0.53" SD_2="0.6" SE="0.14616201056818195" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.058995294308635704" CI_START="-0.9610047056913639" DF="0" EFFECT_SIZE="-0.5099999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.08" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.026667942877688932" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.00000000000001" Z="2.216344130119721">
<NAME>average endpoint cholesterol - TC of female (in mmol/L)</NAME>
<CONT_DATA CI_END="-0.058995294308635704" CI_START="-0.9610047056913639" EFFECT_SIZE="-0.5099999999999998" ESTIMABLE="YES" MEAN_1="4.48" MEAN_2="4.99" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1595" SD_1="0.99" SD_2="0.78" SE="0.230108669980077" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.0015653375199202735" CI_START="-0.9584346624800788" DF="0" EFFECT_SIZE="-0.47999999999999954" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.09" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.04925512737456381" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="1.9663765741856063">
<NAME>average endpoint cholesterol - TC of male (in mmol/L)</NAME>
<CONT_DATA CI_END="-0.0015653375199202735" CI_START="-0.9584346624800788" EFFECT_SIZE="-0.47999999999999954" ESTIMABLE="YES" MEAN_1="4.49" MEAN_2="4.97" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1594" SD_1="1.1" SD_2="0.76" SE="0.24410380305654125" STUDY_ID="STD-Huang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6164091383069478" CI_END="0.14361198260844443" CI_START="-0.18704974922139395" DF="1" EFFECT_SIZE="-0.021718883306474743" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.10" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.43238500582365746" P_Z="0.7968136792378587" STUDIES="2" TAU2="0.0" TOTAL_1="120" TOTAL_2="120" WEIGHT="100.0" Z="0.25747296991128515">
<NAME>average endpoint cholesterol - TC level (in mmol/L)</NAME>
<CONT_DATA CI_END="0.1933145605398448" CI_START="-0.17331456053984523" EFFECT_SIZE="0.009999999999999787" ESTIMABLE="YES" MEAN_1="4.62" MEAN_2="4.61" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.57" SD_2="0.68" SE="0.09352955563765808" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="81.34183334913261"/>
<CONT_DATA CI_END="0.2227537518542937" CI_START="-0.542753751854294" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" MEAN_1="4.18" MEAN_2="4.34" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1284" SD_1="0.8" SD_2="0.71" SE="0.1952861148844604" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="18.65816665086738"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.07442687214077981" CI_START="-0.2144268721407795" DF="0" EFFECT_SIZE="-0.06999999999999984" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.11" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Z="0.3421405849171837" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.9499442651092704">
<NAME>average endpoint cholesterol-TG level (in mmol/L)</NAME>
<CONT_DATA CI_END="0.07442687214077981" CI_START="-0.2144268721407795" EFFECT_SIZE="-0.06999999999999984" ESTIMABLE="YES" MEAN_1="1.06" MEAN_2="1.13" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1283" SD_1="0.3" SD_2="0.27" SE="0.07368853370776217" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1633752244165152" CI_END="0.2593695125958138" CI_START="-0.11219358666988738" DF="1" EFFECT_SIZE="0.07358796296296322" ESTIMABLE="YES" I2="14.043209876543072" ID="CMP-003.26.12" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.28076669675350396" P_Z="0.4375479219032684" STUDIES="2" TAU2="0.004044444444444398" TOTAL_1="120" TOTAL_2="120" WEIGHT="100.0" Z="0.7763405859629673">
<NAME>average endpoint cholesterol - LDL level (in mmol/L)</NAME>
<CONT_DATA CI_END="0.28508487571257274" CI_START="-0.045084875712572525" EFFECT_SIZE="0.1200000000000001" ESTIMABLE="YES" MEAN_1="2.64" MEAN_2="2.52" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.56" SD_2="0.57" SE="0.08422852512328852" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="80.66165123456794"/>
<CONT_DATA CI_END="0.2836605979174948" CI_START="-0.5236605979174942" EFFECT_SIZE="-0.11999999999999966" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.32" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1286" SD_1="0.73" SD_2="0.86" SE="0.2059530690877576" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="19.338348765432052"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.1329813120511272" CI_START="-5.467018687948867" DF="0" EFFECT_SIZE="-3.299999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-003.26.13" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.002838649294892902" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="2.9846909881077965">
<NAME>average endpoint waistline (in cm)</NAME>
<CONT_DATA CI_END="-1.1329813120511272" CI_START="-5.467018687948867" EFFECT_SIZE="-3.299999999999997" ESTIMABLE="YES" MEAN_1="72.3" MEAN_2="75.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" SD_1="6.9" SD_2="7.9" SE="1.1056420959987208" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.85931842948507" CI_END="0.20808207250141558" CI_START="-0.22170192533528799" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.006809926416936208" ESTIMABLE="YES" I2="53.95659467518634" I2_Q="70.67263727423753" ID="CMP-003.27" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="0.05424177977764111" P_Q="0.01671390491113156" P_Z="0.9504742386598717" Q="10.22935484534607" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.022416396356042374" TOTALS="YES" TOTAL_1="468" TOTAL_2="321" UNITS="" WEIGHT="99.99999999999999" Z="0.0621112492868296">
<NAME>Adverse effect : 7c. Metabolic - continuous measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6102961527816231" CI_END="0.13937609726227895" CI_START="-0.027192316470692902" DF="1" EFFECT_SIZE="0.05609189039579302" ESTIMABLE="YES" I2="0.0" ID="CMP-003.27.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4346765082472117" P_Z="0.18682326456384044" STUDIES="2" TAU2="0.0" TOTAL_1="120" TOTAL_2="120" WEIGHT="91.17393580239175" Z="1.3200352039945074">
<NAME>average endpoint cholesterol- HDL level (in mmol/L)</NAME>
<CONT_DATA CI_END="0.18263592813366583" CI_START="-0.02263592813366569" EFFECT_SIZE="0.08000000000000007" ESTIMABLE="YES" MEAN_1="1.78" MEAN_2="1.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.32" SD_2="0.38" SE="0.05236623169774795" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="47.78125124032311"/>
<CONT_DATA CI_END="0.152507937669227" CI_START="-0.13250793766922697" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="1.39" MEAN_2="1.38" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1284" SD_1="0.31" SD_2="0.25" SE="0.0727094675174194" STUDY_ID="STD-Zhang-2009a" TOTAL_1="30" TOTAL_2="30" WEIGHT="43.39268456206864"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-4.91072758645878" CI_START="-39.68927241354122" DF="0" EFFECT_SIZE="-22.3" ESTIMABLE="YES" I2="0.0" ID="CMP-003.27.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.011955418806770748" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="34" WEIGHT="0.01526701075394227" Z="2.5134574820512863">
<NAME>cholesterol - change from baseline (in mg/dl)</NAME>
<CONT_DATA CI_END="-4.91072758645878" CI_START="-39.68927241354122" EFFECT_SIZE="-22.3" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="19.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="273" SD_1="52.3" SD_2="27.9" SE="8.872240791517386" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="0.01526701075394227"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="19.69749606231576" CI_START="-6.09749606231576" DF="0" EFFECT_SIZE="6.8" ESTIMABLE="YES" I2="0.0" ID="CMP-003.27.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.30143552495200954" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="34" WEIGHT="0.027746290014278883" Z="1.0333598886541824">
<NAME>glucose - change from baseline (in mg/dl)</NAME>
<CONT_DATA CI_END="19.69749606231576" CI_START="-6.09749606231576" EFFECT_SIZE="6.8" ESTIMABLE="YES" MEAN_1="4.1" MEAN_2="-2.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="274" SD_1="32.0" SD_2="27.6" SE="6.580476051626235" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="0.027746290014278883"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.019667431357376565" CI_END="0.15000097098669296" CI_START="-1.2388410267205887" DF="1" EFFECT_SIZE="-0.5444200278669479" ESTIMABLE="YES" I2="0.0" ID="CMP-003.27.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8884698873338559" P_Z="0.12439258395890884" STUDIES="2" TAU2="0.0" TOTAL_1="250" TOTAL_2="133" WEIGHT="8.783050896840015" Z="1.536594729771997">
<NAME>weight gain - change from baseline (in kg)</NAME>
<CONT_DATA CI_END="0.44191773833253356" CI_START="-1.6419177383325336" EFFECT_SIZE="-0.6" ESTIMABLE="YES" MEAN_1="0.9" MEAN_2="1.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="275" SD_1="2.2" SD_2="2.5" SE="0.5316004511057589" STUDY_ID="STD-Chan-2007" TOTAL_1="49" TOTAL_2="34" WEIGHT="3.9411457040433584"/>
<CONT_DATA CI_END="0.4314588702098219" CI_START="-1.4314588702098219" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="276" SD_1="3.81" SD_2="3.9" SE="0.47524285015288575" STUDY_ID="STD-Potkin-2003" TOTAL_1="201" TOTAL_2="99" WEIGHT="4.8419051927966565"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.049543475340277" CI_END="1.3265893852885373" CI_START="0.6770695310538746" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9477305803857748" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="48" I2="40.58868856856734" I2_Q="55.609843001302046" ID="CMP-003.28" LOG_CI_END="0.12273651796683643" LOG_CI_START="-0.1693667295387243" LOG_EFFECT_SIZE="-0.023315105785943955" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="0.16820526109006073" P_Q="0.1051097228394875" P_Z="0.7543711280350047" Q="4.505503326015864" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0931619669566837" TOTALS="SUB" TOTAL_1="136" TOTAL_2="140" WEIGHT="300.0" Z="0.31288092841433846">
<NAME>Adverse effect: 8. required additional drug combination</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.3185901605940293" CI_END="1.5785500123154057" CI_START="0.7261300813696551" DF="1" EFFECT_SIZE="1.0706225520175892" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="28" I2="0.0" ID="CMP-003.28.01" LOG_CI_END="0.19825834595489555" LOG_CI_START="-0.13898557136532036" LOG_EFFECT_SIZE="0.02963638729478756" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5724562654090051" P_Z="0.730488191540253" STUDIES="2" TAU2="0.0" TOTAL_1="68" TOTAL_2="70" WEIGHT="100.0" Z="0.344476201031141">
<NAME>benzodiazepines</NAME>
<DICH_DATA CI_END="1.8430215832364572" CI_START="0.722035516523626" EFFECT_SIZE="1.1535714285714285" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="16" LOG_CI_END="0.2655304211797951" LOG_CI_START="-0.14144143920202784" LOG_EFFECT_SIZE="0.06204449098888363" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1990" O_E="0.0" SE="0.2390572853314818" STUDY_ID="STD-Feng-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.0571483856700575" WEIGHT="68.66880467811193"/>
<DICH_DATA CI_END="1.8190990128778954" CI_START="0.45431627148445364" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.25985633819280124" LOG_CI_START="-0.3426417085092513" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="0.3539103350462166" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="0.12525252525252528" WEIGHT="31.33119532188808"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9273703693656962" CI_START="0.1214946584006607" DF="0" EFFECT_SIZE="0.3356643356643357" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-003.28.02" LOG_CI_END="-0.03274678446625737" LOG_CI_START="-0.9154428157126918" LOG_EFFECT_SIZE="-0.4740948000894746" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.03525756376264934" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="36" WEIGHT="100.0" Z="2.1053878131092834">
<NAME>benzhexol</NAME>
<DICH_DATA CI_END="0.9273703693656962" CI_START="0.1214946584006607" EFFECT_SIZE="0.3356643356643357" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.03274678446625737" LOG_CI_START="-0.9154428157126918" LOG_EFFECT_SIZE="-0.4740948000894746" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="928" O_E="0.0" SE="0.5185000181699793" STUDY_ID="STD-Fu-2009" TOTAL_1="33" TOTAL_2="36" VAR="0.2688422688422688" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7249295888316616" CI_START="0.45232475287637464" DF="0" EFFECT_SIZE="1.110204081632653" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" I2="0.0" ID="CMP-003.28.03" LOG_CI_END="0.4353552847495612" LOG_CI_START="-0.34454964541022876" LOG_EFFECT_SIZE="0.045402819669666236" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8194892887690144" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="34" WEIGHT="100.0" Z="0.22820189463574853">
<NAME>benzhexol/propranolol</NAME>
<DICH_DATA CI_END="2.724929588831662" CI_START="0.45232475287637464" EFFECT_SIZE="1.110204081632653" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.43535528474956126" LOG_CI_START="-0.34454964541022876" LOG_EFFECT_SIZE="0.045402819669666236" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1990" O_E="0.0" SE="0.45812001656752777" STUDY_ID="STD-Feng-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.2098739495798319" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="48.5397111468615" CI_END="-0.39202548838957274" CI_START="-2.2955395084023125" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.3437824983959425" ESTIMABLE="YES" I2="93.8194935051772" I2_Q="0.0" ID="CMP-003.29" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="29" P_CHI2="1.6346124454003075E-10" P_Q="1.0" P_Z="0.0056528522130056096" Q="0.0" RANDOM="YES" SCALE="9.99256158241071" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.7776695807723051" TOTALS="YES" TOTAL_1="125" TOTAL_2="125" UNITS="" WEIGHT="100.0" Z="2.767266510486404">
<NAME>Adverse effects: 9. TESS score (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours risperidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5987027968416136" CI_START="-1.198702796841615" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="5.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2371" SD_1="2.0" SD_2="2.1" SE="0.458530260724415" STUDY_ID="STD-Dai-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="23.86900926673724"/>
<CONT_DATA CI_END="-0.17111519177925755" CI_START="-0.7288848082207429" EFFECT_SIZE="-0.4500000000000002" ESTIMABLE="YES" MEAN_1="2.01" MEAN_2="2.46" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2372" SD_1="0.65" SD_2="0.43" SE="0.14229078208607424" STUDY_ID="STD-Yang-2008a" TOTAL_1="30" TOTAL_2="30" WEIGHT="29.5528029463379"/>
<CONT_DATA CI_END="-4.382535293587185" CI_START="-7.437464706412812" EFFECT_SIZE="-5.909999999999998" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="18.31" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2373" SD_1="2.04" SD_2="3.32" SE="0.7793330481892834" STUDY_ID="STD-Zhang-2007a" TOTAL_1="25" TOTAL_2="25" WEIGHT="17.025384840586966"/>
<CONT_DATA CI_END="-0.17111519177925755" CI_START="-0.7288848082207429" EFFECT_SIZE="-0.4500000000000002" ESTIMABLE="YES" MEAN_1="2.01" MEAN_2="2.46" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2374" SD_1="0.65" SD_2="0.43" SE="0.14229078208607424" STUDY_ID="STD-Zhang-2007b" TOTAL_1="30" TOTAL_2="30" WEIGHT="29.5528029463379"/>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-003.30" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="30" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO">
<NAME>Adverse effects: 10. TESS score (short term, up to 12 weeks, high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4432" STUDY_ID="STD-Chen-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>0.2</P>
</TD>
<TD>
<P>0.5</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>0.1</P>
</TD>
<TD>
<P>0.4</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4433" STUDY_ID="STD-CuiMeng-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>5.35 </P>
</TD>
<TD>
<P>4.25</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>7.95</P>
</TD>
<TD>
<P>5.15</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4434" STUDY_ID="STD-Mu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>3.59</P>
</TD>
<TD>
<P>2.08</P>
</TD>
<TD>
<P>129</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>3. 62</P>
</TD>
<TD>
<P>2.14</P>
</TD>
<TD>
<P>129</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4435" STUDY_ID="STD-Qu-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>5.35</P>
</TD>
<TD>
<P>4.2</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>7.95</P>
</TD>
<TD>
<P>5.1</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4436" STUDY_ID="STD-Yan-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>3.42</P>
</TD>
<TD>
<P>2.34</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>4.45</P>
</TD>
<TD>
<P>1.92</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4437" STUDY_ID="STD-Zhang-2010a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>5.35</P>
</TD>
<TD>
<P>4.25</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>7.95</P>
</TD>
<TD>
<P>5.15</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4438" STUDY_ID="STD-Zhou-2007b">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>5.35</P>
</TD>
<TD>
<P>4.25</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>7.95</P>
</TD>
<TD>
<P>5.15</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-003.31" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="31" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO">
<NAME>Adverse effects: 11. weight gain (in KG, high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Heading 1</P>
</TH>
<TH>
<P>Heading 2</P>
</TH>
<TH>
<P>Heading 3</P>
</TH>
<TH>
<P>Heading 4</P>
</TH>
<TH>
<P>Heading 5</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4439" STUDY_ID="STD-Chen-2006">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>1.1</P>
</TD>
<TD>
<P>1.5</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>1.8</P>
</TD>
<TD>
<P>1.4</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4440" STUDY_ID="STD-Tao-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>2.06</P>
</TD>
<TD>
<P>2.67</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>2.73</P>
</TD>
<TD>
<P>2.43</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4441" STUDY_ID="STD-Wang-2007e">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>0.3</P>
</TD>
<TD>
<P>1.97</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>1.0</P>
</TD>
<TD>
<P>3.1</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="4.049353140855201E-6" CI_END="3.2589578268492585" CI_START="-6.387576400531696" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.5643092868412185" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.32" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="32" P_CHI2="0.9983944176149577" P_Q="0.9983944176149577" P_Z="0.5249937466316625" Q="4.049353140855201E-6" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="74" TOTAL_2="70" UNITS="" WEIGHT="200.0" Z="0.635666611576984">
<NAME>Cognitive functioning: 1. Specific - average endpoint total score</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Risperidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours risperidone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.833784083674741" CI_START="-7.953784083674746" DF="0" EFFECT_SIZE="-1.5600000000000023" ESTIMABLE="YES" I2="0.0" ID="CMP-003.32.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6325038273597232" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="35" WEIGHT="99.99999999999999" Z="0.47820567223865434">
<NAME>(short term, up to 12 weeks, WMS, low= poor)</NAME>
<CONT_DATA CI_END="4.833784083674741" CI_START="-7.953784083674746" EFFECT_SIZE="-1.5600000000000023" ESTIMABLE="YES" MEAN_1="78.66" MEAN_2="80.22" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2273" SD_1="13.68" SD_2="13.98" SE="3.2621946801615214" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.777483379033086" CI_START="-8.9174833790331" DF="0" EFFECT_SIZE="-1.5700000000000074" ESTIMABLE="YES" I2="0.0" ID="CMP-003.32.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6753605734400773" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="35" WEIGHT="100.0" Z="0.41880237041554796">
<NAME>(short term, up to 12 weeks, WAIS-RC, low=poor)</NAME>
<CONT_DATA CI_END="5.777483379033086" CI_START="-8.9174833790331" EFFECT_SIZE="-1.5700000000000074" ESTIMABLE="YES" MEAN_1="86.55" MEAN_2="88.12" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2271" SD_1="15.78" SD_2="16.01" SE="3.748784894512912" STUDY_ID="STD-Liu-2008d" TOTAL_1="37" TOTAL_2="35" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-003.33" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="33" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Cost effectiveness analysis (high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-003.33.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>Cost of hospitalisation (in RMB)</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4444" STUDY_ID="STD-Liu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>3413.66 </P>
</TD>
<TD>
<P>1815.05</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>4551.41 </P>
</TD>
<TD>
<P>3024.38</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.33.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="1">
<NAME>Cost of drug (in RMB)</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4445" STUDY_ID="STD-Liu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>418.13 </P>
</TD>
<TD>
<P>326.43</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>685.00 </P>
</TD>
<TD>
<P>493.02</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.33.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="1">
<NAME>Length of hospitalisation (day)</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4446" STUDY_ID="STD-Liu-2010">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>33.19 </P>
</TD>
<TD>
<P>16.71</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Risperidone</P>
</TD>
<TD>
<P>50.84 </P>
</TD>
<TD>
<P>40.85</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-11-04 17:00:31 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>COMPARISON 4. ARIPIPRAZOLE versus ZIPRASIDONE</NAME>
<DICH_OUTCOME CHI2="0.6080609768675131" CI_END="1.517241464871752" CI_START="0.620553549313252" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9703244695417114" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.18105470307828891" LOG_CI_START="-0.20722073605436347" LOG_EFFECT_SIZE="-0.013083016488037266" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9876312002650641" P_Q="1.0" P_Z="0.8949188511153776" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="221" TOTAL_2="221" WEIGHT="99.99999999999999" Z="0.13208273581753">
<NAME>Global state: 1. No clinically significant response (as defined by the original studies)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6080609768675131" CI_END="1.517241464871752" CI_START="0.620553549313252" DF="5" EFFECT_SIZE="0.9703244695417114" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.18105470307828891" LOG_CI_START="-0.20722073605436347" LOG_EFFECT_SIZE="-0.013083016488037266" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9876312002650641" P_Z="0.8949188511153776" STUDIES="6" TAU2="0.0" TOTAL_1="221" TOTAL_2="221" WEIGHT="99.99999999999999" Z="0.13208273581753">
<NAME>up to 12 weeks - short term</NAME>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="900" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="6.784978281563162"/>
<DICH_DATA CI_END="2.2002701344388558" CI_START="0.34796863713066783" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3424760038649878" LOG_CI_START="-0.4584598978203613" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="901" O_E="0.0" SE="0.47047371334662913" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.22134551495016613" WEIGHT="23.500890378117205"/>
<DICH_DATA CI_END="5.5969892490655475" CI_START="0.3176310867623318" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7479544726962614" LOG_CI_START="-0.49807699947966155" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="896" O_E="0.0" SE="0.7319250547113998" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="0.5357142857142856" WEIGHT="9.710057807392616"/>
<DICH_DATA CI_END="3.101882540574044" CI_START="0.4388016287874072" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.4916253482982286" LOG_CI_START="-0.3577317690370022" LOG_EFFECT_SIZE="0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="0.4989165751082529" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="0.24891774891774895" WEIGHT="20.897733107214535"/>
<DICH_DATA CI_END="2.2002701344388558" CI_START="0.34796863713066783" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3424760038649878" LOG_CI_START="-0.4584598978203613" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="899" O_E="0.0" SE="0.47047371334662913" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" VAR="0.22134551495016613" WEIGHT="23.500890378117205"/>
<DICH_DATA CI_END="3.1005692822786637" CI_START="0.3225214175072657" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.491441440109722" LOG_CI_START="-0.49144144010972196" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.5773502691896258" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.33333333333333337" WEIGHT="15.60545004759527"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-1.544802989489685" CI_START="-6.315197010510314" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.9299999999999997" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0012406785695312655" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="NaN" TOTALS="SUB" TOTAL_1="43" TOTAL_2="43" UNITS="" WEIGHT="0.0" Z="3.2293594303954047">
<NAME>Global state: 2. Average endpoint CGI-GI score (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.544802989489685" CI_START="-6.315197010510314" EFFECT_SIZE="-3.9299999999999997" ESTIMABLE="YES" MEAN_1="37.65" MEAN_2="41.58" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2431" SD_1="5.25" SD_2="6.01" SE="1.2169596121788178" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.21943213307638582" CI_START="-0.2794321330763854" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.029999999999999805" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.8136413095240248" Q="0.0" RANDOM="YES" SCALE="1.14" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="NaN" TOTALS="SUB" TOTAL_1="126" TOTAL_2="121" UNITS="" WEIGHT="0.0" Z="0.2357311337998091">
<NAME>Global state: 3. Average change score (CGI-S, decline=good)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.21943213307638582" CI_START="-0.2794321330763854" EFFECT_SIZE="-0.029999999999999805" ESTIMABLE="YES" MEAN_1="-1.15" MEAN_2="-1.12" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="427" SD_1="1.01" SD_2="0.99" SE="0.127263630884993" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="126" TOTAL_2="121" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.111017224584271" CI_END="-0.6222520457984994" CI_START="-2.5100693037592783" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.5661606747788888" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9954162792916159" P_Q="0.8526756064621599" P_Z="0.0011458420985060174" Q="0.31875224868625385" RANDOM="YES" SCALE="30.54" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="592" TOTAL_2="582" UNITS="" WEIGHT="300.0" Z="3.2520292985194708">
<NAME>Mental state: 1. Average endpoint total score (short term, up to 12 weeks, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.029916663499319" CI_END="0.1998991518345712" CI_START="-3.675528611703105" DF="6" EFFECT_SIZE="-1.737814729934267" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.984452754299222" P_Z="0.07878674380901944" STUDIES="7" TAU2="0.0" TOTAL_1="347" TOTAL_2="342" WEIGHT="100.00000000000003" Z="1.7577694594235733">
<NAME>PANSS</NAME>
<CONT_DATA CI_END="6.057540258479265" CI_START="-7.6575402584792736" EFFECT_SIZE="-0.8000000000000043" ESTIMABLE="YES" MEAN_1="47.4" MEAN_2="48.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="827" SD_1="13.4" SD_2="13.7" SE="3.4988093212786926" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="7.9844052094241516"/>
<CONT_DATA CI_END="3.34563371547301" CI_START="-5.84563371547301" EFFECT_SIZE="-1.25" ESTIMABLE="YES" MEAN_1="44.16" MEAN_2="45.41" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="794" SD_1="10.47" SD_2="11.26" SE="2.344754164730976" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" WEIGHT="17.778228640386427"/>
<CONT_DATA CI_END="2.0633207532813644" CI_START="-8.663320753281372" EFFECT_SIZE="-3.3000000000000043" ESTIMABLE="YES" MEAN_1="46.4" MEAN_2="49.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="904" SD_1="11.5" SD_2="13.5" SE="2.736438422127426" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" WEIGHT="13.053042729492615"/>
<CONT_DATA CI_END="3.921491221355055" CI_START="-5.821491221355046" EFFECT_SIZE="-0.9499999999999957" ESTIMABLE="YES" MEAN_1="46.63" MEAN_2="47.58" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="805" SD_1="11.06" SD_2="9.03" SE="2.485500376425665" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" WEIGHT="15.821784050077975"/>
<CONT_DATA CI_END="3.34563371547301" CI_START="-5.84563371547301" EFFECT_SIZE="-1.25" ESTIMABLE="YES" MEAN_1="44.16" MEAN_2="45.41" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2174" SD_1="10.47" SD_2="11.26" SE="2.344754164730976" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" WEIGHT="17.778228640386427"/>
<CONT_DATA CI_END="6.739496058221423" CI_START="-7.739496058221423" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="47.8" MEAN_2="48.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2194" SD_1="14.7" SD_2="13.9" SE="3.6936883102575577" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="7.164116328270265"/>
<CONT_DATA CI_END="1.2880487528469216" CI_START="-7.2880487528469216" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-24.6" MEAN_2="-21.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="428" SD_1="18.7" SD_2="15.6" SE="2.1878201776514787" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="126" TOTAL_2="121" WEIGHT="20.420194401962156"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7623483123986985" CI_END="-0.21524992012982747" CI_START="-2.563157365746001" DF="2" EFFECT_SIZE="-1.3892036429379142" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6830590866469038" P_Z="0.02037701061920916" STUDIES="3" TAU2="0.0" TOTAL_1="119" TOTAL_2="119" WEIGHT="100.0" Z="2.319332572017631">
<NAME>SANS</NAME>
<CONT_DATA CI_END="0.9017681442577063" CI_START="-3.021768144257711" EFFECT_SIZE="-1.0600000000000023" ESTIMABLE="YES" MEAN_1="47.66" MEAN_2="48.72" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2432" SD_1="4.74" SD_2="4.54" SE="1.0009205065663886" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" WEIGHT="35.8101878044003"/>
<CONT_DATA CI_END="-0.016324436634866935" CI_START="-4.423675563365131" EFFECT_SIZE="-2.219999999999999" ESTIMABLE="YES" MEAN_1="45.34" MEAN_2="47.56" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2433" SD_1="5.23" SD_2="3.79" SE="1.1243449271249082" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" WEIGHT="28.379624391199393"/>
<CONT_DATA CI_END="0.9017681442577063" CI_START="-3.021768144257711" EFFECT_SIZE="-1.0600000000000023" ESTIMABLE="YES" MEAN_1="47.66" MEAN_2="48.72" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2434" SD_1="4.74" SD_2="4.54" SE="1.0009205065663886" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" WEIGHT="35.8101878044003"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5687261495269009" CI_START="-4.9687261495268995" DF="0" EFFECT_SIZE="-2.1999999999999993" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.11938354534855358" STUDIES="1" TAU2="0.0" TOTAL_1="126" TOTAL_2="121" WEIGHT="100.0" Z="1.5573662880039283">
<NAME>BPRS</NAME>
<CONT_DATA CI_END="0.5687261495269009" CI_START="-4.9687261495268995" EFFECT_SIZE="-2.1999999999999993" ESTIMABLE="YES" MEAN_1="-15.2" MEAN_2="-13.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="463" SD_1="11.2" SD_2="11.0" SE="1.412641340027806" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="126" TOTAL_2="121" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.5534112689331372" CI_END="7.5157803000541366" CI_START="0.5914483635795279" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="2.1083633366880274" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.875974076395396" LOG_CI_START="-0.22808316547624272" LOG_EFFECT_SIZE="0.3239454554595767" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.459918799783402" P_Q="0.42980847031296887" P_Z="0.2500778577527052" Q="0.6233415159505065" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="118" TOTAL_2="118" WEIGHT="200.0" Z="1.150160338751734">
<NAME>Mental state: 2. Specific - binary outcomes (up to 12 weeks - short term)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="14.042415376985337" CI_START="0.6409153808931227" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="1.1474418153917585" LOG_CI_START="-0.19319930595243368" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.1629963642110472" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="43" WEIGHT="100.0" Z="1.3950645860713007">
<NAME>anxiety - labelled as "adverse effect"</NAME>
<DICH_DATA CI_END="14.042415376985337" CI_START="0.6409153808931227" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1474418153917585" LOG_CI_START="-0.19319930595243368" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="901" O_E="0.0" SE="0.7874992309581577" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.6201550387596898" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.923455298908857" CI_END="9.424303389524399" CI_START="0.10665911511381737" DF="1" EFFECT_SIZE="1.002590574507272" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="0.9742492585843103" LOG_CI_START="-0.9720020237168997" LOG_EFFECT_SIZE="0.0011236174337052331" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.33656950048785106" P_Z="0.9981943343565797" STUDIES="2" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="100.0" Z="0.002263068209629824">
<NAME>agitation - labelled as "adverse effect"</NAME>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="908" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="49.882250327082424"/>
<DICH_DATA CI_END="71.07405779123665" CI_START="0.12662848132908622" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8517111110810305" LOG_CI_START="-0.8974686016417053" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.6148817719123905" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="2.607843137254902" WEIGHT="50.11774967291757"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.0031098070161217" CI_END="0.3728525274949799" CI_START="-0.9214730057562475" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2743102391306338" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.06" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.981350792923741" P_Q="0.9740586347946298" P_Z="0.40610814086651936" Q="0.05256759429554028" RANDOM="YES" SCALE="7.51" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="400" TOTAL_2="400" UNITS="" WEIGHT="300.0" Z="0.8307619304026462">
<NAME>Mental state: 3. Specific - average endpoint PANSS subscale scores (short term, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.07021277936084344" CI_END="1.042951327189316" CI_START="-1.358495160829582" DF="1" EFFECT_SIZE="-0.15777191682013303" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7910272306240295" P_Z="0.7967664341471216" STUDIES="2" TAU2="0.0" TOTAL_1="73" TOTAL_2="73" WEIGHT="100.0" Z="0.25753417890598984">
<NAME>positive symptom scores</NAME>
<CONT_DATA CI_END="2.3532483384403213" CI_START="-2.153248338440322" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="11.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="827" SD_1="4.3" SD_2="4.6" SE="1.149637624065369" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="28.396689772185603"/>
<CONT_DATA CI_END="1.158980305599554" CI_START="-1.6789803055995571" EFFECT_SIZE="-0.26000000000000156" ESTIMABLE="YES" MEAN_1="9.12" MEAN_2="9.38" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="794" SD_1="3.47" SD_2="3.24" SE="0.7239828470279511" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" WEIGHT="71.60331022781439"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1156749087150564" CI_END="0.6110474666123253" CI_START="-1.2344684374042783" DF="3" EFFECT_SIZE="-0.3117104853959765" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7732915450651444" P_Z="0.5079187483765485" STUDIES="4" TAU2="0.0" TOTAL_1="136" TOTAL_2="136" WEIGHT="100.0" Z="0.6620818857750858">
<NAME>negative symptom scores</NAME>
<CONT_DATA CI_END="3.5609300582468064" CI_START="-1.960930058246805" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" MEAN_1="13.0" MEAN_2="12.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2436" SD_1="5.2" SD_2="5.7" SE="1.4086636693452887" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="11.170298611190242"/>
<CONT_DATA CI_END="0.8437205964722019" CI_START="-2.7237205964722007" EFFECT_SIZE="-0.9399999999999995" ESTIMABLE="YES" MEAN_1="9.84" MEAN_2="10.78" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2435" SD_1="4.18" SD_2="3.14" SE="0.9100782517137875" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" WEIGHT="26.76220781342641"/>
<CONT_DATA CI_END="1.158980305599554" CI_START="-1.6789803055995571" EFFECT_SIZE="-0.26000000000000156" ESTIMABLE="YES" MEAN_1="9.12" MEAN_2="9.38" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2438" SD_1="3.47" SD_2="3.24" SE="0.7239828470279511" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" WEIGHT="42.28855614753816"/>
<CONT_DATA CI_END="1.8748481514859217" CI_START="-2.274848151485924" EFFECT_SIZE="-0.20000000000000107" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="12.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2437" SD_1="4.1" SD_2="4.1" SE="1.0586154479633605" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="19.778937427845186"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.764654524644681" CI_END="1.0419037513077436" CI_START="-1.7325795341080905" DF="4" EFFECT_SIZE="-0.34533789140017335" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7789423039708281" P_Z="0.6256132048105076" STUDIES="5" TAU2="0.0" TOTAL_1="191" TOTAL_2="191" WEIGHT="100.0" Z="0.4879105476679052">
<NAME>general pathology scores</NAME>
<CONT_DATA CI_END="2.8432858487868624" CI_START="-2.6632858487868627" EFFECT_SIZE="0.08999999999999986" ESTIMABLE="YES" MEAN_1="22.71" MEAN_2="22.62" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2440" SD_1="6.84" SD_2="6.17" SE="1.404763490811275" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" WEIGHT="25.386429831521006"/>
<CONT_DATA CI_END="1.337150288465112" CI_START="-5.3371502884651125" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="22.6" MEAN_2="24.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2439" SD_1="8.0" SD_2="7.6" SE="1.7026589849548908" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" WEIGHT="17.280356711225583"/>
<CONT_DATA CI_END="4.082366724110775" CI_START="-2.5823667241107753" EFFECT_SIZE="0.75" ESTIMABLE="YES" MEAN_1="23.94" MEAN_2="23.19" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2442" SD_1="6.77" SD_2="7.04" SE="1.700218346049243" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" WEIGHT="17.330003724943037"/>
<CONT_DATA CI_END="2.8432858487868624" CI_START="-2.6632858487868627" EFFECT_SIZE="0.08999999999999986" ESTIMABLE="YES" MEAN_1="22.71" MEAN_2="22.62" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2441" SD_1="6.84" SD_2="6.17" SE="1.404763490811275" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" WEIGHT="25.386429831521006"/>
<CONT_DATA CI_END="2.428492781416595" CI_START="-4.828492781416593" EFFECT_SIZE="-1.1999999999999993" ESTIMABLE="YES" MEAN_1="23.1" MEAN_2="24.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2443" SD_1="8.1" SD_2="6.1" SE="1.8513058454327131" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" WEIGHT="14.616779900789362"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-004.07" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES">
<NAME>Mental state: endpoint scores of various scales (high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-004.07.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>PANSS negative symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4480" STUDY_ID="STD-Cheng-2009">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>14.56</P>
</TD>
<TD>
<P>9.51</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Ziprasidone</P>
</TD>
<TD>
<P>13.12</P>
</TD>
<TD>
<P>5.16</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-004.07.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="3">
<NAME>PANSS positive symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4481" STUDY_ID="STD-Liu-2008a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>14.21</P>
</TD>
<TD>
<P>5.45</P>
</TD>
<TD>
<P>33</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Ziprasidone</P>
</TD>
<TD>
<P>12.96</P>
</TD>
<TD>
<P>8.43</P>
</TD>
<TD>
<P>33</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4482" STUDY_ID="STD-Wang-2008c">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>13.12</P>
</TD>
<TD>
<P>5.16</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Ziprasidone</P>
</TD>
<TD>
<P>14.56</P>
</TD>
<TD>
<P>9.51</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4483" STUDY_ID="STD-Yang-2008">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.3</P>
</TD>
<TD>
<P>5.7</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Ziprasidone</P>
</TD>
<TD>
<P>11.5</P>
</TD>
<TD>
<P>3.9</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="2.5066986572215284" CI_END="1.2347574741521843" CI_START="0.7204105936754985" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9431502345857918" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="84" I2="0.0" I2_Q="0.0" ID="CMP-004.08" LOG_CI_END="0.0915816636841437" LOG_CI_START="-0.14241990948245348" LOG_EFFECT_SIZE="-0.025419122899154874" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6434367933101113" P_Q="0.6437649303787016" P_Z="0.6702434327842196" Q="2.5048650911597363" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="675" TOTAL_2="665" WEIGHT="500.0" Z="0.4258139355795804">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.339931609656609" CI_START="0.6560950946182011" DF="0" EFFECT_SIZE="0.9376153562200074" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="42" I2="0.0" ID="CMP-004.08.01" LOG_CI_END="0.12708263246426776" LOG_CI_START="-0.18303320929072806" LOG_EFFECT_SIZE="-0.027975288413230184" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7236286354570961" STUDIES="2" TAU2="0.0" TOTAL_1="159" TOTAL_2="157" WEIGHT="100.0" Z="0.35361339450933443">
<NAME>any reason</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2444" O_E="0.0" SE="0.0" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.339931609656609" CI_START="0.6560950946182011" EFFECT_SIZE="0.9376153562200074" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="42" LOG_CI_END="0.12708263246426776" LOG_CI_START="-0.18303320929072806" LOG_EFFECT_SIZE="-0.027975288413230184" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="422" O_E="0.0" SE="0.182163580545059" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="129" TOTAL_2="127" VAR="0.03318357007699619" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3846838017326788" CI_START="0.13826503671686552" DF="0" EFFECT_SIZE="0.43755383290267014" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="0.0" ID="CMP-004.08.02" LOG_CI_END="0.1413506117826714" LOG_CI_START="-0.8592876266919806" LOG_EFFECT_SIZE="-0.3589685074546546" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.15965489447907788" STUDIES="1" TAU2="0.0" TOTAL_1="129" TOTAL_2="127" WEIGHT="100.0" Z="1.406233180270461">
<NAME>adverse events</NAME>
<DICH_DATA CI_END="1.3846838017326788" CI_START="0.13826503671686552" EFFECT_SIZE="0.43755383290267014" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.1413506117826714" LOG_CI_START="-0.8592876266919806" LOG_EFFECT_SIZE="-0.3589685074546546" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="423" O_E="0.0" SE="0.5877798545191758" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="129" TOTAL_2="127" VAR="0.3454851573785835" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6616940808959673" CI_START="0.5832798162881327" DF="0" EFFECT_SIZE="0.9844961240310077" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="23" I2="0.0" ID="CMP-004.08.03" LOG_CI_END="0.2205510728730274" LOG_CI_START="-0.2341230515596116" LOG_EFFECT_SIZE="-0.006785989343292112" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.9533465905095788" STUDIES="1" TAU2="0.0" TOTAL_1="129" TOTAL_2="127" WEIGHT="100.0" Z="0.05850473557923185">
<NAME>defaulted</NAME>
<DICH_DATA CI_END="1.6616940808959673" CI_START="0.5832798162881327" EFFECT_SIZE="0.9844961240310077" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="23" LOG_CI_END="0.2205510728730274" LOG_CI_START="-0.2341230515596116" LOG_EFFECT_SIZE="-0.006785989343292112" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="426" O_E="0.0" SE="0.2670778313649465" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="129" TOTAL_2="127" VAR="0.07133056800660281" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.028347835870817" CI_START="0.5413567745077187" DF="0" EFFECT_SIZE="1.4767441860465116" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" I2="0.0" ID="CMP-004.08.04" LOG_CI_END="0.6051269635392733" LOG_CI_START="-0.2665164241144949" LOG_EFFECT_SIZE="0.16930526971238913" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.44642149102520146" STUDIES="1" TAU2="0.0" TOTAL_1="129" TOTAL_2="127" WEIGHT="100.0" Z="0.7613944779007084">
<NAME>inefficacy</NAME>
<DICH_DATA CI_END="4.028347835870817" CI_START="0.5413567745077187" EFFECT_SIZE="1.4767441860465116" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.6051269635392733" LOG_CI_START="-0.2665164241144949" LOG_EFFECT_SIZE="0.16930526971238913" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="0.512007640612179" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="129" TOTAL_2="127" VAR="0.26215182404525017" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.851453241333055" CI_START="0.2516537414580188" DF="0" EFFECT_SIZE="0.9844961240310077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-004.08.05" LOG_CI_END="0.5856246296659211" LOG_CI_START="-0.5991966083525055" LOG_EFFECT_SIZE="-0.006785989343292112" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.9820880854907887" STUDIES="1" TAU2="0.0" TOTAL_1="129" TOTAL_2="127" WEIGHT="100.0" Z="0.022451141633094706">
<NAME>other/withdrew</NAME>
<DICH_DATA CI_END="3.851453241333055" CI_START="0.2516537414580188" EFFECT_SIZE="0.9844961240310077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5856246296659211" LOG_CI_START="-0.5991966083525055" LOG_EFFECT_SIZE="-0.006785989343292112" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="425" O_E="0.0" SE="0.6959698601717408" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="129" TOTAL_2="127" VAR="0.4843740462674724" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="20.47764374151897" CI_END="1.8590576544460276" CI_START="0.9706574743151419" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3433198455583142" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="44" I2="56.04963093604241" I2_Q="63.318976248615655" ID="CMP-004.09" LOG_CI_END="0.26929285863661023" LOG_CI_START="-0.01293399692871058" LOG_EFFECT_SIZE="0.12817943085394984" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.015182978338904807" P_Q="0.007929960806413283" P_Z="0.07502359391581388" Q="19.083436840379406" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.45804071824090176" TOTALS="SUB" TOTAL_1="508" TOTAL_2="505" WEIGHT="800.0" Z="1.7803200728673245">
<NAME>Adverse effects: 1. At least one adverse effect, non-specific</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.36888869440414956" CI_END="1.776522627362109" CI_START="0.846946281934725" DF="1" EFFECT_SIZE="1.2266292161925898" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="27" I2="0.0" ID="CMP-004.09.01" LOG_CI_END="0.2495707434188854" LOG_CI_START="-0.07214413417832986" LOG_EFFECT_SIZE="0.08871330462027777" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5436109213838656" P_Z="0.27973034145313136" STUDIES="2" TAU2="0.0" TOTAL_1="63" TOTAL_2="63" WEIGHT="100.0" Z="1.0809253417429163">
<NAME>non-specific</NAME>
<DICH_DATA CI_END="2.223535382309631" CI_START="0.8283370479945881" EFFECT_SIZE="1.3571428571428572" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="14" LOG_CI_END="0.34704404461003535" LOG_CI_START="-0.08179291406085346" LOG_EFFECT_SIZE="0.13262556527459096" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="0.2519009523004612" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="0.06345408976987923" WEIGHT="56.28049075013284"/>
<DICH_DATA CI_END="1.8856585761492402" CI_START="0.615044169861256" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.2754630606613981" LOG_CI_START="-0.21109369391859562" LOG_EFFECT_SIZE="0.032184683371401235" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.2858058461350672" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.0816849816849817" WEIGHT="43.719509249867166"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.09.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="42" WEIGHT="0.0" Z="0.0">
<NAME>endocrine disorder</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2542" O_E="0.0" SE="0.0" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.6064398572955" CI_START="0.12568701946272015" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.09.03" LOG_CI_END="1.8549520819268552" LOG_CI_START="-0.9007095724875305" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4973248921481538" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="42" WEIGHT="100.0" Z="0.6787048576962033">
<NAME>liver function abnormal</NAME>
<DICH_DATA CI_END="71.6064398572955" CI_START="0.12568701946272015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8549520819268552" LOG_CI_START="-0.9007095724875305" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2546" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.174519805058755" CI_START="0.09021883877788416" DF="0" EFFECT_SIZE="0.3255208333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" I2="0.0" ID="CMP-004.09.04" LOG_CI_END="0.0698603443619964" LOG_CI_START="-1.0447027670809452" LOG_EFFECT_SIZE="-0.4874212113594744" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.08648014922274869" STUDIES="1" TAU2="0.0" TOTAL_1="128" TOTAL_2="125" WEIGHT="100.0" Z="1.7142645575783744">
<NAME>respiratory tract infection</NAME>
<DICH_DATA CI_END="1.174519805058755" CI_START="0.09021883877788416" EFFECT_SIZE="0.3255208333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.0698603443619964" LOG_CI_START="-1.0447027670809452" LOG_EFFECT_SIZE="-0.4874212113594744" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2548" O_E="0.0" SE="0.6546998888379655" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="128" TOTAL_2="125" VAR="0.4286319444444444" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.649201222423535" CI_START="2.9562291625665558" DF="1" EFFECT_SIZE="7.999999999999998" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="4" I2="0.0" ID="CMP-004.09.05" LOG_CI_END="1.335441877082298" LOG_CI_START="0.47073809690158896" LOG_EFFECT_SIZE="0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="4.240992241295061E-5" STUDIES="2" TAU2="0.0" TOTAL_1="86" TOTAL_2="86" WEIGHT="100.0" Z="4.093942665390103">
<NAME>sexual function change</NAME>
<DICH_DATA CI_END="32.69850476120027" CI_START="1.95727604266302" EFFECT_SIZE="8.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="2" LOG_CI_END="1.5145278936753648" LOG_CI_START="0.29165208030852224" LOG_EFFECT_SIZE="0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2544" O_E="0.0" SE="0.7183233061045863" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.5159883720930232" WEIGHT="50.0"/>
<DICH_DATA CI_END="32.69850476120027" CI_START="1.95727604266302" EFFECT_SIZE="8.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="2" LOG_CI_END="1.5145278936753648" LOG_CI_START="0.29165208030852224" LOG_EFFECT_SIZE="0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2543" O_E="0.0" SE="0.7183233061045863" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" VAR="0.5159883720930232" WEIGHT="50.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.8698689779204765" CI_START="0.01411854649967386" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.09.06" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.6810488185180525">
<NAME>skin rash</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2545" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.465490926561218" CI_START="0.06466008772360077" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.09.07" LOG_CI_END="1.1893637105217114" LOG_CI_START="-1.1893637105217114" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="42" WEIGHT="100.0" Z="0.0">
<NAME>stuffy nose</NAME>
<DICH_DATA CI_END="15.465490926561218" CI_START="0.06466008772360077" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1893637105217114" LOG_CI_START="-1.1893637105217114" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2556" O_E="0.0" SE="1.3972762620115438" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.9523809523809526" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.362407364476699" CI_START="0.06509396452487991" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.09.08" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="35" WEIGHT="100.0" Z="0.0">
<NAME>sweating</NAME>
<DICH_DATA CI_END="15.362407364476699" CI_START="0.06509396452487991" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1864592771008313" LOG_CI_START="-1.1864592771008313" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2555" O_E="0.0" SE="1.3938641048743392" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="1.942857142857143" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.9453474498525" CI_START="0.01398442444617999" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.09.09" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.4971385617323206" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.6789989027057508">
<NAME>urine routine abnormal</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2547" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Dai-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.536023753238412" CI_END="1.6900742778044247" CI_START="0.47044536399742765" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8916768522308921" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="19" I2="0.0" I2_Q="6.442194064169383" ID="CMP-004.10" LOG_CI_END="0.227905792028886" LOG_CI_START="-0.32749080686420634" LOG_EFFECT_SIZE="-0.04979250741766018" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.8727365524955947" P_Q="0.3608589848919008" P_Z="0.7252657585624884" Q="3.206573700603495" RANDOM="YES" SCALE="150.13" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="409" TOTAL_2="406" WEIGHT="400.0" Z="0.35143002831871034">
<NAME>Adverse effects: 2. Cardiac effects (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6166945973697663" CI_END="1.6842692590025448" CI_START="0.21651795687415276" DF="2" EFFECT_SIZE="0.6038828849911001" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" ID="CMP-004.10.01" LOG_CI_END="0.22641152205155987" LOG_CI_START="-0.6645060796895472" LOG_EFFECT_SIZE="-0.21904727881899366" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7346601673746009" P_Z="0.3351556915106897" STUDIES="4" TAU2="0.0" TOTAL_1="148" TOTAL_2="148" WEIGHT="100.0" Z="0.9637811096283383">
<NAME>abnormal ECG</NAME>
<DICH_DATA CI_END="3.0260386806300987" CI_START="0.036718338011454264" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48087447513357967" LOG_CI_START="-1.4351169845729046" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="830" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="21.62160558298519"/>
<DICH_DATA CI_END="2.778302053737336" CI_START="0.230356522660695" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.44377945995459256" LOG_CI_START="-0.6375994859707053" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="901" O_E="0.0" SE="0.6352073457486329" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.4034883720930233" WEIGHT="67.87647170527914"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="0.0" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.897117532359623" CI_START="0.014069831258787349" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8974686016417053" LOG_CI_START="-1.8517111110810305" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.6148817719123905" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="2.607843137254902" WEIGHT="10.501922711735663"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.05570058549843941" CI_END="2.7891127217661245" CI_START="0.06408663140753348" DF="1" EFFECT_SIZE="0.42278225950705184" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-004.10.02" LOG_CI_END="0.44546606659726534" LOG_CI_START="-1.1932325556833416" LOG_EFFECT_SIZE="-0.3738832445430381" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8134251336188226" P_Z="0.37112641585140826" STUDIES="2" TAU2="0.0" TOTAL_1="74" TOTAL_2="71" WEIGHT="100.0" Z="0.894365423591421">
<NAME>QTc prolongation</NAME>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2445" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="35.35630383711824"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2446" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Zhu-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="64.64369616288175"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6112548364426875" CI_END="3.1598666315812722" CI_START="0.42922404324977825" DF="2" EFFECT_SIZE="1.1645989574687807" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" I2="0.0" ID="CMP-004.10.03" LOG_CI_END="0.49966875274794964" LOG_CI_START="-0.3673159587511776" LOG_EFFECT_SIZE="0.06617639699838598" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7366610726569163" P_Z="0.7647831518893644" STUDIES="3" TAU2="0.0" TOTAL_1="115" TOTAL_2="115" WEIGHT="100.0" Z="0.299205633094008">
<NAME>tachycardia</NAME>
<DICH_DATA CI_END="5.6052899693918485" CI_START="0.31716071558928804" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7485980841655011" LOG_CI_START="-0.4987206109489013" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2447" O_E="0.0" SE="0.7326811758373191" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.5368217054263564" WEIGHT="48.313445983823186"/>
<DICH_DATA CI_END="5.306321714020261" CI_START="0.047113615320280106" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.724793577042504" LOG_CI_START="-1.3268535683704665" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2448" O_E="0.0" SE="1.2051476890327395" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.4523809523809526" WEIGHT="17.85737166653319"/>
<DICH_DATA CI_END="8.3444766693104" CI_START="0.26963943805788637" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9213991047351494" LOG_CI_START="-0.569216586623787" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2449" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="33.82918234964363"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.05296196107530307" CI_END="34.66244530348672" CI_START="0.44398050823570684" DF="1" EFFECT_SIZE="3.92293895982775" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-004.10.04" LOG_CI_END="1.5398591972801081" LOG_CI_START="-0.3526360959923452" LOG_EFFECT_SIZE="0.5936115506438815" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8179871354250087" P_Z="0.2188662939691195" STUDIES="2" TAU2="0.0" TOTAL_1="72" TOTAL_2="72" WEIGHT="100.0" Z="1.2295483790156883">
<NAME>blood pressure- decrease</NAME>
<DICH_DATA CI_END="101.11262454797557" CI_START="0.24724904641495174" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.004805383377636" LOG_CI_START="-0.6068653747055983" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2560" O_E="0.0" SE="1.534108331276844" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="2.353488372093023" WEIGHT="52.50888099467141"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2559" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="47.4911190053286"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.385362367813286" CI_END="4.230496596176165" CI_START="1.7433174115937073" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="2.715713235192888" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="39" I2="25.182469556460244" I2_Q="0.0" ID="CMP-004.11" LOG_CI_END="0.6263913499567002" LOG_CI_START="0.24137646774881377" LOG_EFFECT_SIZE="0.433883908852757" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.16416889278537483" P_Q="0.45280079521749617" P_Z="9.98605530314811E-6" Q="3.667976234092777" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.20111162902775137" TOTALS="SUB" TOTAL_1="644" TOTAL_2="644" WEIGHT="500.0" Z="4.417475137304935">
<NAME>Adverse effects: 3. Central / peripheral nervous system (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="54.43914552732532" CI_START="0.900087602870343" DF="0" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-004.11.01" LOG_CI_END="1.7359112999317405" LOG_CI_START="-0.0457152199032269" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.06297307798175102" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="42" WEIGHT="100.0" Z="1.859381529622451">
<NAME>blurred vision</NAME>
<DICH_DATA CI_END="54.43914552732532" CI_START="0.900087602870343" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7359112999317405" LOG_CI_START="-0.0457152199032269" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.0465362369445672" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.0952380952380953" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.5707721033332644" CI_END="6.697891413252428" CI_START="1.5651919275603778" DF="4" EFFECT_SIZE="3.237821114839217" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="9" I2="0.0" ID="CMP-004.11.02" LOG_CI_END="0.8259381024442861" LOG_CI_START="0.19456759937110102" LOG_EFFECT_SIZE="0.5102528509076936" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6320094723174143" P_Z="0.0015351437758872482" STUDIES="5" TAU2="0.0" TOTAL_1="188" TOTAL_2="188" WEIGHT="100.0" Z="3.1679567097927657">
<NAME>dizziness</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="831" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="5.285807747415673"/>
<DICH_DATA CI_END="12.229769227601054" CI_START="1.0993211886698584" EFFECT_SIZE="3.6666666666666665" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="3" LOG_CI_END="1.087418262095564" LOG_CI_START="0.04112459878156131" LOG_EFFECT_SIZE="0.5642714304385625" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.6145980770678082" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.3777307963354475" WEIGHT="36.41341295231598"/>
<DICH_DATA CI_END="47.70843866511076" CI_START="0.754583486848142" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6785952038106073" LOG_CI_START="-0.12229270304332009" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.0578504710249077" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.1190476190476193" WEIGHT="12.291226251368768"/>
<DICH_DATA CI_END="12.229769227601054" CI_START="1.0993211886698584" EFFECT_SIZE="3.6666666666666665" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="3" LOG_CI_END="1.087418262095564" LOG_CI_START="0.04112459878156131" LOG_EFFECT_SIZE="0.5642714304385625" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2189" O_E="0.0" SE="0.6145980770678082" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" VAR="0.3777307963354475" WEIGHT="36.41341295231598"/>
<DICH_DATA CI_END="20.897996678081547" CI_START="0.19140590658602802" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3201046558069978" LOG_CI_START="-0.7180446644790353" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2569" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="9.596140096583593"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2754338324303616" CI_END="25.26695736164966" CI_START="0.9589406476771724" DF="1" EFFECT_SIZE="4.92234826655041" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="2" I2="21.59530548954606" ID="CMP-004.11.03" LOG_CI_END="1.402552947475747" LOG_CI_START="-0.018208272061841987" LOG_EFFECT_SIZE="0.6921723377069525" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.25874987006554007" P_Z="0.05616840492558663" STUDIES="2" TAU2="0.3686951823159973" TOTAL_1="75" TOTAL_2="75" WEIGHT="100.0" Z="1.9097267497800399">
<NAME>headache</NAME>
<DICH_DATA CI_END="285.39772614805565" CI_START="1.0126219430706869" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.4554505086339677" LOG_CI_START="0.0054473341225797734" LOG_EFFECT_SIZE="1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.4391439924192966" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="2.0711354309165526" WEIGHT="28.546818669377977"/>
<DICH_DATA CI_END="13.796875882763622" CI_START="0.6523215890666713" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1397807573810868" LOG_CI_START="-0.1855382479417619" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="0.778498944161523" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="0.6060606060606061" WEIGHT="71.45318133062203"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.377737126718109" CI_END="7.296648726706141" CI_START="1.1730715795268236" DF="4" EFFECT_SIZE="2.925660822291189" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="12" I2="45.78283379717883" ID="CMP-004.11.04" LOG_CI_END="0.8631234390681725" LOG_CI_START="0.0693245130917123" LOG_EFFECT_SIZE="0.4662239760799423" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.11722306803254501" P_Z="0.02131817915336578" STUDIES="5" TAU2="0.4743988744965343" TOTAL_1="191" TOTAL_2="191" WEIGHT="100.00000000000001" Z="2.302301431616824">
<NAME>insomnia</NAME>
<DICH_DATA CI_END="20.79289613537594" CI_START="2.137482155207278" EFFECT_SIZE="6.666666666666667" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="3" LOG_CI_END="1.3179149841854378" LOG_CI_START="0.3299024977031998" LOG_EFFECT_SIZE="0.8239087409443188" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.5803634253003515" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.3368217054263566" WEIGHT="26.801386282208043"/>
<DICH_DATA CI_END="7.956271095255056" CI_START="0.013965224384746686" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9007095724875305" LOG_CI_START="-1.8549520819268552" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.6186892965481947" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="2.6201550387596897" WEIGHT="7.025838531833014"/>
<DICH_DATA CI_END="8.401158658013896" CI_START="0.26782020094974834" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9243391865476622" LOG_CI_START="-0.5721566684362998" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="0.8790490729915326" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="0.7727272727272727" WEIGHT="17.433550063070296"/>
<DICH_DATA CI_END="20.79289613537594" CI_START="2.137482155207278" EFFECT_SIZE="6.666666666666667" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="3" LOG_CI_END="1.3179149841854378" LOG_CI_START="0.3299024977031998" LOG_EFFECT_SIZE="0.8239087409443188" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2189" O_E="0.0" SE="0.5803634253003515" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" VAR="0.3368217054263566" WEIGHT="26.801386282208043"/>
<DICH_DATA CI_END="5.454794518074456" CI_START="0.32591104429087336" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.736778395374003" LOG_CI_START="-0.4869009221574032" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.5166666666666666" WEIGHT="21.937838840680612"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.189588699069139" CI_END="3.392532726569502" CI_START="0.6212979478344096" DF="3" EFFECT_SIZE="1.4518173511081571" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="15" I2="28.39392562170714" ID="CMP-004.11.05" LOG_CI_END="0.5305240458380363" LOG_CI_START="-0.20670008087209946" LOG_EFFECT_SIZE="0.16191198248296843" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.24170645772589627" P_Z="0.3892878572588362" STUDIES="4" TAU2="0.22613432079543178" TOTAL_1="148" TOTAL_2="148" WEIGHT="100.0" Z="0.8609095737228136">
<NAME>somnolence</NAME>
<DICH_DATA CI_END="3.5189754801485726" CI_START="0.7503959646483561" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="8" LOG_CI_END="0.5464162407274133" LOG_CI_START="-0.12470951009762694" LOG_EFFECT_SIZE="0.21085336531489318" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.3942225881606738" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.1554114490161002" WEIGHT="49.150466081902636"/>
<DICH_DATA CI_END="54.43914552732532" CI_START="0.900087602870343" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7359112999317405" LOG_CI_START="-0.0457152199032269" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.0465362369445672" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.0952380952380953" WEIGHT="14.192177913103425"/>
<DICH_DATA CI_END="2.545191816087794" CI_START="0.09822442395884887" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4057205181184749" LOG_CI_START="-1.0077805094464374" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="0.8302975005345611" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="0.6893939393939394" WEIGHT="20.483422777070977"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="16.17393322792297"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.272670022958398" CI_END="1.4207517419879996" CI_START="0.45837718421094725" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8069945371285097" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="57" I2="22.92962716642452" I2_Q="0.0" ID="CMP-004.12" LOG_CI_END="0.15251819720686963" LOG_CI_START="-0.3387770075718336" LOG_EFFECT_SIZE="-0.09312940518248196" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.21827113277514731" P_Q="0.4566797082847691" P_Z="0.45744690744634187" Q="5.708018062876269" RANDOM="YES" SCALE="394.7274384003254" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14871189717641428" TOTALS="SUB" TOTAL_1="545" TOTAL_2="540" WEIGHT="700.0" Z="0.7430574460482297">
<NAME>Adverse effects: 4. Various extrapyramidal symptoms (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.7718330298355487" CI_END="2.6093304047160535" CI_START="0.24510954231676385" DF="2" EFFECT_SIZE="0.799732318499864" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="46.97538347589051" ID="CMP-004.12.01" LOG_CI_END="0.41652907483028756" LOG_CI_START="-0.6106397809762126" LOG_EFFECT_SIZE="-0.09705535307296256" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1516900768882803" P_Z="0.7110941579271646" STUDIES="3" TAU2="0.5165042019825502" TOTAL_1="213" TOTAL_2="210" WEIGHT="100.0" Z="0.3703870020094543">
<NAME>akathisia</NAME>
<DICH_DATA CI_END="21.24440546987425" CI_START="0.18828486425154256" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3272445817533365" LOG_CI_START="-0.7251845904253741" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.2056070554260303" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="1.4534883720930232" WEIGHT="18.479673797919848"/>
<DICH_DATA CI_END="1.1084867416678226" CI_START="0.056383173249291985" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.044730502994089406" LOG_CI_START="-1.2488504856500142" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="0.7598558760587117" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="0.5773809523809523" WEIGHT="33.280294561108526"/>
<DICH_DATA CI_END="3.267692014261792" CI_START="0.4824451099927573" EFFECT_SIZE="1.2555803571428572" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5142411167680266" LOG_CI_START="-0.3165520911975144" LOG_EFFECT_SIZE="0.09884451278525612" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.4880120428516636" STUDY_ID="STD-Zimbroff-2007" TOTAL_1="128" TOTAL_2="125" VAR="0.23815575396825395" WEIGHT="48.240031640971615"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.652276279555" CI_START="0.12560661666750192" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.12.02" LOG_CI_END="1.8552299918017108" LOG_CI_START="-0.9009874823623856" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.497411635240814" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="43" WEIGHT="100.0" Z="0.6785679898446393">
<NAME>activity-decrease</NAME>
<DICH_DATA CI_END="71.652276279555" CI_START="0.12560661666750192" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8552299918017108" LOG_CI_START="-0.9009874823623856" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1312028987903366" CI_START="0.003928954256744883" DF="0" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-004.12.03" LOG_CI_END="0.05354050936569048" LOG_CI_START="-2.405723027477053" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.06084454898420908" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="42" WEIGHT="100.0" Z="1.8746234193679265">
<NAME>dystonia</NAME>
<DICH_DATA CI_END="1.1312028987903366" CI_START="0.003928954256744883" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.05354050936569048" LOG_CI_START="-2.405723027477053" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.4445835750922673" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="2.0868217054263565" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.10672653482828695" CI_END="1.6242327937945884" CI_START="0.3681616779047452" DF="1" EFFECT_SIZE="0.7732918405565441" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" I2="0.0" ID="CMP-004.12.04" LOG_CI_END="0.21064827479117287" LOG_CI_START="-0.4339614193645033" LOG_EFFECT_SIZE="-0.11165657228666523" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7439021918123216" P_Z="0.4971420554905581" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.6789933887224644">
<NAME>general extrapyramidal symptoms</NAME>
<DICH_DATA CI_END="2.1256236089204403" CI_START="0.20908896691741605" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3274863650599791" LOG_CI_START="-0.6796688831713416" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="831" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="40.96385542168675"/>
<DICH_DATA CI_END="2.2518004966804637" CI_START="0.32626952460223885" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.35252991058923017" LOG_CI_START="-0.4864234898504567" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.49280538030458115" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.24285714285714288" WEIGHT="59.03614457831325"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="28.206213581225008" CI_START="0.31907863046143503" DF="1" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-004.12.05" LOG_CI_END="1.4503447901203" LOG_CI_START="-0.4961022806809748" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.33661797387160464" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="76" WEIGHT="100.0" Z="0.9608691544066903">
<NAME>tremor</NAME>
<DICH_DATA CI_END="71.652276279555" CI_START="0.12560661666750192" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8552299918017108" LOG_CI_START="-0.9009874823623856" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="49.87216635418443"/>
<DICH_DATA CI_END="71.07405779123665" CI_START="0.12662848132908622" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8517111110810305" LOG_CI_START="-0.8974686016417053" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.6148817719123905" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="2.607843137254902" WEIGHT="50.12783364581558"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.9453474498525" CI_START="0.01398442444617999" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.12.06" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.4971385617323206" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.6789989027057508">
<NAME>spasmodic torticollis</NAME>
<DICH_DATA CI_END="7.9453474498525" CI_START="0.01398442444617999" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9001128936458906" LOG_CI_START="-1.8543554030852154" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="468" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Li-2007" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.942110692196106" CI_END="117.07106602280199" CI_START="0.06895886505314694" DF="1" EFFECT_SIZE="2.8413179764845853" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" I2="85.59515910450494" ID="CMP-004.12.07" LOG_CI_END="2.068449572960251" LOG_CI_START="-1.1614098948807288" LOG_EFFECT_SIZE="0.4535198390397611" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.008419044327585001" P_Z="0.5820343399621828" STUDIES="2" TAU2="6.275190941444591" TOTAL_1="71" TOTAL_2="69" WEIGHT="100.0" Z="0.5504156200248016">
<NAME>use of antiparkinson medication</NAME>
<DICH_DATA CI_END="292.8777736412457" CI_START="1.083336411313518" EFFECT_SIZE="17.8125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.4666864145248106" LOG_CI_START="0.034763340180360196" LOG_EFFECT_SIZE="1.2507248773525854" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="192" O_E="0.0" SE="1.428523652083298" STUDY_ID="STD-Wang-2005" TOTAL_1="31" TOTAL_2="29" VAR="2.0406798245614035" WEIGHT="43.28473125752221"/>
<DICH_DATA CI_END="1.181928545164485" CI_START="0.4145766696342953" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="20" LOG_CI_END="0.07259122157163136" LOG_CI_START="-0.38239514154311777" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="452" O_E="0.0" SE="0.2672612419124244" STUDY_ID="STD-Zhu-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.07142857142857142" WEIGHT="56.71526874247779"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="19.12102424547922" CI_END="2.8043036477422296" CI_START="0.7454079328176219" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="1.445804338441565" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="27" I2="26.78216490777152" I2_Q="0.0" ID="CMP-004.13" LOG_CI_END="0.4478250368977269" LOG_CI_START="-0.12760598968710693" LOG_EFFECT_SIZE="0.16010952360530997" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.16037630972343775" P_Q="0.42776594465007856" P_Z="0.2754086153164701" Q="3.842320601807777" RANDOM="YES" SCALE="560.7406586730405" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.4926264146943204" TOTALS="SUB" TOTAL_1="570" TOTAL_2="570" WEIGHT="500.0" Z="1.0906916219332827">
<NAME>Adverse effects: 5. Gastrointestinal (short term, up to 12 weeks)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.35067319986737" CI_START="0.3864482940154323" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-004.13.01" LOG_CI_END="1.0149685968924291" LOG_CI_START="-0.4129086055644666" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.40857001147857763" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="43" WEIGHT="100.0" Z="0.8264127317845636">
<NAME>appetite-decrease</NAME>
<DICH_DATA CI_END="10.35067319986737" CI_START="0.3864482940154323" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0149685968924291" LOG_CI_START="-0.4129086055644666" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.8387421368293256" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.7034883720930232" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.7749536359789877" CI_END="2.96912960103216" CI_START="0.1345009066453268" DF="2" EFFECT_SIZE="0.6319419461361169" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="27.92672374526317" ID="CMP-004.13.02" LOG_CI_END="0.4726291547481806" LOG_CI_START="-0.8712747881542471" LOG_EFFECT_SIZE="-0.19932281670303328" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.24970481964874147" P_Z="0.5609782548437522" STUDIES="3" TAU2="0.5326131344474272" TOTAL_1="115" TOTAL_2="115" WEIGHT="100.00000000000001" Z="0.5813890852813544">
<NAME>constipation</NAME>
<DICH_DATA CI_END="71.652276279555" CI_START="0.12560661666750192" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8552299918017108" LOG_CI_START="-0.9009874823623856" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="19.759412768875208"/>
<DICH_DATA CI_END="1.3252344073641877" CI_START="0.02096065241244839" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12229270304332002" LOG_CI_START="-1.6785952038106073" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.0578504710249077" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.1190476190476193" WEIGHT="37.73034801221199"/>
<DICH_DATA CI_END="6.64261094358732" CI_START="0.1505432138796847" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8223388166442885" LOG_CI_START="-0.8223388166442885" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.9333333333333333" WEIGHT="42.51023921891281"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.249855856503676" CI_END="2.803657127450511" CI_START="0.1032148634466796" DF="3" EFFECT_SIZE="0.5379396690718342" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" I2="29.409370545850063" ID="CMP-004.13.03" LOG_CI_END="0.4477249006066109" LOG_CI_START="-0.9862577576693816" LOG_EFFECT_SIZE="-0.2692664285313853" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2357176878357623" P_Z="0.46169091001046747" STUDIES="4" TAU2="0.8420716743420739" TOTAL_1="148" TOTAL_2="148" WEIGHT="99.99999999999999" Z="0.7360653898028794">
<NAME>dry mouth</NAME>
<DICH_DATA CI_END="71.652276279555" CI_START="0.12560661666750192" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8552299918017108" LOG_CI_START="-0.9009874823623856" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.6190157878205267" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="2.6212121212121207" WEIGHT="20.486837454728224"/>
<DICH_DATA CI_END="1.1110029699454145" CI_START="0.018369134752455978" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.04571521990322681" LOG_CI_START="-1.7359112999317405" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.0465362369445672" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.0952380952380953" WEIGHT="36.62384472179109"/>
<DICH_DATA CI_END="4.012779170210339" CI_START="0.009968153816424267" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.603445260457001" LOG_CI_START="-2.0013852691290386" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.5300903471979148" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="2.3411764705882354" WEIGHT="22.28909872832623"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="20.60021909515444"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.24440546987425" CI_START="0.18828486425154256" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-004.13.04" LOG_CI_END="1.3272445817533365" LOG_CI_START="-0.7251845904253741" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5653344259186854" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="43" WEIGHT="99.99999999999999" Z="0.5749362343562306">
<NAME>hyper-salivation</NAME>
<DICH_DATA CI_END="21.24440546987425" CI_START="0.18828486425154256" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3272445817533365" LOG_CI_START="-0.7251845904253741" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.2056070554260303" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="1.4534883720930232" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.322607261612195" CI_END="7.09100563279933" CI_START="0.9058591431225488" DF="5" EFFECT_SIZE="2.534453054685521" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="7" I2="20.918700259028018" ID="CMP-004.13.05" LOG_CI_END="0.8507078303601099" LOG_CI_START="-0.04293932784245329" LOG_EFFECT_SIZE="0.4038842512588283" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.27608124550153446" P_Z="0.0764587737850387" STUDIES="6" TAU2="0.34537966654591273" TOTAL_1="221" TOTAL_2="221" WEIGHT="100.0" Z="1.771613279635804">
<NAME>nausea / vomiting</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="831" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Bai-2009" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="9.348654229240417"/>
<DICH_DATA CI_END="34.34463281007448" CI_START="0.46586609583162103" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.535858877550102" LOG_CI_START="-0.33173889489417746" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.097036176291841" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="1.2034883720930232" WEIGHT="17.790696186964063"/>
<DICH_DATA CI_END="54.43914552732532" CI_START="0.900087602870343" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7359112999317405" LOG_CI_START="-0.0457152199032269" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="909" O_E="0.0" SE="1.0465362369445672" STUDY_ID="STD-Li-2007c" TOTAL_1="42" TOTAL_2="42" VAR="1.0952380952380953" WEIGHT="19.12751698618555"/>
<DICH_DATA CI_END="191.26516482783427" CI_START="0.63262957532762" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.281635879067217" LOG_CI_START="-0.19885050875076649" LOG_EFFECT_SIZE="1.0413926851582251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.45704998280993" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="2.122994652406417" WEIGHT="11.163396287812533"/>
<DICH_DATA CI_END="34.34463281007448" CI_START="0.46586609583162103" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.535858877550102" LOG_CI_START="-0.33173889489417746" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2189" O_E="0.0" SE="1.097036176291841" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" VAR="1.2034883720930232" WEIGHT="17.790696186964063"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="24.779040122833365"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="15.259760455310136" CI_START="0.0655318281652329" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.14" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2013-11-04 17:00:31 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.0" Z="0.0">
<NAME>Adverse effects: 6. Haematological</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.259760455310136" CI_START="0.0655318281652329" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.14.01" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-11-04 17:00:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.0" Z="0.0">
<NAME>leucopenia</NAME>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2557" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2558" O_E="0.0" SE="0.0" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.380853857232079" CI_END="1.9310851751474252" CI_START="0.2830874234774775" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7393686000555055" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-004.15" LOG_CI_END="0.2858014298025534" LOG_CI_START="-0.5480794242967039" LOG_EFFECT_SIZE="-0.1311389972470752" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.7943219229531155" P_Q="1.0" P_Z="0.5375899927365921" Q="0.0" RANDOM="YES" SCALE="255.91307899195164" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="269" TOTAL_2="269" WEIGHT="99.99999999999999" Z="0.6164614772229093">
<NAME>Adverse effects: 7. Hormonal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.380853857232079" CI_END="1.9310851751474252" CI_START="0.2830874234774775" DF="5" EFFECT_SIZE="0.7393686000555055" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" I2="0.0" ID="CMP-004.15.01" LOG_CI_END="0.2858014298025534" LOG_CI_START="-0.5480794242967039" LOG_EFFECT_SIZE="-0.1311389972470752" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7943219229531155" P_Z="0.5375899927365921" STUDIES="6" TAU2="0.0" TOTAL_1="269" TOTAL_2="269" WEIGHT="99.99999999999999" Z="0.6164614772229093">
<NAME>menstrual disorder</NAME>
<DICH_DATA CI_END="5.33925597435076" CI_START="0.046823003280040215" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7274807422819939" LOG_CI_START="-1.3295407336099563" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2551" O_E="0.0" SE="1.2083045973594573" STUDY_ID="STD-Chen-2007a" TOTAL_1="50" TOTAL_2="50" VAR="1.46" WEIGHT="16.433510754194728"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2549" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Chen-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="31.295120479727352"/>
<DICH_DATA CI_END="21.18421544008581" CI_START="0.18881983197881402" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3260123844875458" LOG_CI_START="-0.7239523931595834" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2550" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Ge-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="16.546845311120208"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2553" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Liu-2009b" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="10.135515704768576"/>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2554" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Luo-2008" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="9.188780055749733"/>
<DICH_DATA CI_END="5.352095533713907" CI_START="0.0467106759259435" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7285238568887824" LOG_CI_START="-1.330583848216745" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2552" O_E="0.0" SE="1.2095300587265134" STUDY_ID="STD-Wei-2006" TOTAL_1="54" TOTAL_2="54" VAR="1.4629629629629628" WEIGHT="16.400227694439398"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.904510149824137" CI_END="6.172039553642282" CI_START="0.7873781030154343" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="2.2044792572131606" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="13" I2="39.42153716600982" I2_Q="10.059460846095932" ID="CMP-004.16" LOG_CI_END="0.7904287005851385" LOG_CI_START="-0.10381666710712899" LOG_EFFECT_SIZE="0.34330601673900474" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.1287314007886302" P_Q="0.34272717278142206" P_Z="0.13235410063609102" Q="3.335537042830567" RANDOM="YES" SCALE="275.13" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.8707049782491821" TOTALS="SUB" TOTAL_1="269" TOTAL_2="266" WEIGHT="400.0" Z="1.5048832295788983">
<NAME>Adverse effects: 8a. Metabolic - binary measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.036682244187877" CI_END="7.928231378521738" CI_START="0.041397869265604" DF="1" EFFECT_SIZE="0.5728977972688518" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="75.22718065213513" ID="CMP-004.16.01" LOG_CI_END="0.8991763161680493" LOG_CI_START="-1.3830220112946643" LOG_EFFECT_SIZE="-0.2419228475633074" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04452135489112363" P_Z="0.6777545156239864" STUDIES="2" TAU2="2.711361646876247" TOTAL_1="76" TOTAL_2="76" WEIGHT="100.0" Z="0.4155292399925773">
<NAME>appetite-decrease</NAME>
<DICH_DATA CI_END="10.35067319986737" CI_START="0.3864482940154323" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0149685968924291" LOG_CI_START="-0.4129086055644666" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="0.8387421368293256" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="0.7034883720930232" WEIGHT="52.62720862543176"/>
<DICH_DATA CI_END="1.097533962816258" CI_START="0.01859456195135778" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.040417968217551774" LOG_CI_START="-1.7306140482460657" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.0403129732205987" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="1.0822510822510822" WEIGHT="47.37279137456823"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.4280106598243405" CI_START="0.013030423338013766" DF="0" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.16.02" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.47074865216936024" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="41" WEIGHT="99.99999999999999" Z="0.7212614884031853">
<NAME>blood routine abnormal</NAME>
<DICH_DATA CI_END="7.4280106598243405" CI_START="0.013030423338013766" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87087251831755" LOG_CI_START="-1.8850414745117612" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="915" O_E="0.0" SE="1.6188375213822173" STUDY_ID="STD-Peng-2007" TOTAL_1="44" TOTAL_2="41" VAR="2.6206349206349207" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.07405779123665" CI_START="0.12662848132908622" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.16.03" LOG_CI_END="1.8517111110810305" LOG_CI_START="-0.8974686016417053" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4963113070323152" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="33" WEIGHT="100.0" Z="0.6803050896828817">
<NAME>lactation</NAME>
<DICH_DATA CI_END="71.07405779123665" CI_START="0.12662848132908622" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8517111110810305" LOG_CI_START="-0.8974686016417053" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="897" O_E="0.0" SE="1.6148817719123905" STUDY_ID="STD-Liu-2008a" TOTAL_1="33" TOTAL_2="33" VAR="2.607843137254902" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3012241571433472" CI_END="14.598090256604221" CI_START="1.1026179578657325" DF="2" EFFECT_SIZE="4.0119965687269215" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="3" I2="0.0" ID="CMP-004.16.04" LOG_CI_END="1.164296044464756" LOG_CI_START="0.04242506136879397" LOG_EFFECT_SIZE="0.603360552916775" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5217263736050197" P_Z="0.03501357767148636" STUDIES="3" TAU2="0.0" TOTAL_1="116" TOTAL_2="116" WEIGHT="100.0" Z="2.1082013372796164">
<NAME>weight gain</NAME>
<DICH_DATA CI_END="47.75739586781628" CI_START="0.7538099459954097" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6790406374037314" LOG_CI_START="-0.12273813663644433" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="809" O_E="0.0" SE="1.0583737708199736" STUDY_ID="STD-Cheng-2009" TOTAL_1="43" TOTAL_2="43" VAR="1.12015503875969" WEIGHT="38.76884812684595"/>
<DICH_DATA CI_END="47.75739586781628" CI_START="0.7538099459954097" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6790406374037314" LOG_CI_START="-0.12273813663644433" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2189" O_E="0.0" SE="1.0583737708199736" STUDY_ID="STD-Wang-2008c" TOTAL_1="43" TOTAL_2="43" VAR="1.12015503875969" WEIGHT="38.76884812684595"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="898" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Yang-2008" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="22.4623037463081"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="19.834863858054856" CI_END="0.12856536412394504" CI_START="-0.007322448541252753" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="0.06062145779134614" ESTIMABLE="YES" I2="74.79186126115243" I2_Q="74.79186126115243" ID="CMP-004.17" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0013421084619554824" P_Q="0.0013421084619554824" P_Z="0.08033687036520624" Q="19.834863858054856" RANDOM="YES" SCALE="6.469839238073396" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.027533550372216366" TOTALS="SUB" TOTAL_1="540" TOTAL_2="540" UNITS="" WEIGHT="600.0" Z="1.7487348075002669">
<NAME>Adverse effects: 8b. Metabolic - continuous measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Ziprasidone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ziprasidone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13300067196628393" CI_START="-0.213000671966284" DF="0" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-004.17.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.650426980047156" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="0.4531691032788665">
<NAME>cholesterol - TG average endpoint level (in mmol/L, high= poor)</NAME>
<CONT_DATA CI_END="0.13300067196628393" CI_START="-0.213000671966284" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.84" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.54" SD_2="0.64" SE="0.0882672708942058" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.16948621006924122" CI_START="-0.16948621006924122" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-004.17.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="0.0">
<NAME>cholesterol - TC average endpoint level (in mmol/L, high= poor)</NAME>
<CONT_DATA CI_END="0.1694862100692412" CI_START="-0.1694862100692412" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.62" MEAN_2="4.62" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.57" SD_2="0.59" SE="0.08647414514048564" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.30260546717376113" CI_START="-0.04260546717376046" DF="0" EFFECT_SIZE="0.13000000000000034" ESTIMABLE="YES" I2="0.0" ID="CMP-004.17.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.13989778589782964" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="1.4761717700037098">
<NAME>cholesterol - LDL average endpoint level (in mmol/L, high= poor)</NAME>
<CONT_DATA CI_END="0.30260546717376113" CI_START="-0.04260546717376046" EFFECT_SIZE="0.13000000000000034" ESTIMABLE="YES" MEAN_1="2.64" MEAN_2="2.51" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2216" SD_1="0.56" SD_2="0.62" SE="0.08806563209081937" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.19349573766150213" CI_START="0.006504262338498032" DF="0" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-004.17.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.036054369667859396" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="2.0963137289060545">
<NAME>HDL (low=poor)</NAME>
<CONT_DATA CI_END="0.19349573766150213" CI_START="0.006504262338498032" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="1.78" MEAN_2="1.68" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2531" SD_1="0.32" SD_2="0.32" SE="0.04770278351999552" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.5108956502022388" CI_START="-5.289104349797773" DF="0" EFFECT_SIZE="-3.4000000000000057" ESTIMABLE="YES" I2="0.0" ID="CMP-004.17.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="4.19451796888717E-4" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="3.527532795183908">
<NAME>waistline- average endpoint level (in cm, high= poor)</NAME>
<CONT_DATA CI_END="-1.5108956502022388" CI_START="-5.289104349797773" EFFECT_SIZE="-3.4000000000000057" ESTIMABLE="YES" MEAN_1="72.3" MEAN_2="75.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" SD_1="6.9" SD_2="6.0" SE="0.9638464608017192" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.057567343028603" CI_START="-5.0575673430286034" DF="0" EFFECT_SIZE="-2.5" ESTIMABLE="YES" I2="0.0" ID="CMP-004.17.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.05538446178380255" STUDIES="1" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="99.99999999999999" Z="1.9158478757973947">
<NAME>weight- average endpoint level (in kg, high= poor)</NAME>
<CONT_DATA CI_END="0.057567343028603" CI_START="-5.0575673430286034" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="53.8" MEAN_2="56.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2237" SD_1="9.0" SD_2="8.5" SE="1.3049052754042256" STUDY_ID="STD-Tao-2008" TOTAL_1="90" TOTAL_2="90" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE</NAME>
<DICH_OUTCOME CHI2="1.9909570937457617" CI_END="1.1691334646934988" CI_START="0.9557132344759889" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0570507675018939" ESTIMABLE="YES" EVENTS_1="302" EVENTS_2="289" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.06786409171902698" LOG_CI_START="-0.01967239994907916" LOG_EFFECT_SIZE="0.024095845884973873" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9964089913325714" P_Q="0.6312418395319603" P_Z="0.280577020705821" Q="0.2303805257541241" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="873" TOTAL_2="866" WEIGHT="100.0" Z="1.0790240552622843">
<NAME>Global state: 1.No clinically significant response (as defined by the original studies)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.7377933481179162" CI_END="1.2148358609082226" CI_START="0.8581317497740683" DF="9" EFFECT_SIZE="1.021023615304494" ESTIMABLE="YES" EVENTS_1="179" EVENTS_2="171" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="0.08451760343447788" LOG_CI_START="-0.06644602939224672" LOG_EFFECT_SIZE="0.00903578702111553" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9949685340605975" P_Z="0.8145008740498176" STUDIES="10" TAU2="0.0" TOTAL_1="717" TOTAL_2="705" WEIGHT="33.62277830093725" Z="0.23462362162002584">
<NAME>up to 12 weeks- short term</NAME>
<DICH_DATA CI_END="5.668135846368685" CI_START="0.3752090932107094" EFFECT_SIZE="1.4583333333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7534402502947799" LOG_CI_START="-0.4257266450174407" LOG_EFFECT_SIZE="0.16385680263866959" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2528" O_E="0.0" SE="0.6926484712766676" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="0.4797619047619047" WEIGHT="0.551096581991044"/>
<DICH_DATA CI_END="1.2187886614690804" CI_START="0.8145112468760111" EFFECT_SIZE="0.9963518817824982" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="122" LOG_CI_END="0.08592840527797706" LOG_CI_START="-0.08910291452002982" LOG_EFFECT_SIZE="-0.0015872546210263525" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.10281426366835568" STUDY_ID="STD-Fleischhacker-2008" TOTAL_1="355" TOTAL_2="348" VAR="0.010570772813666161" WEIGHT="25.01190315451504"/>
<DICH_DATA CI_END="10.45829496408284" CI_START="0.4083945925965452" EFFECT_SIZE="2.066666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0194608864386594" LOG_CI_START="-0.3889200168814764" LOG_EFFECT_SIZE="0.31527043477859146" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="0.8272899142081558" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="0.6844086021505377" WEIGHT="0.3863118392332012"/>
<DICH_DATA CI_END="2.5580317998825457" CI_START="0.3737441351432563" EFFECT_SIZE="0.9777777777777777" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.407905939058848" LOG_CI_START="-0.42742561363716053" LOG_EFFECT_SIZE="-0.009759837289156262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="0.490677889011509" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.24076479076479076" WEIGHT="1.0981470548245271"/>
<DICH_DATA CI_END="1.946499522246717" CI_START="0.5958199836960805" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.28925430145996545" LOG_CI_START="-0.224884934717163" LOG_EFFECT_SIZE="0.032184683371401235" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2173" O_E="0.0" SE="0.30200793236071005" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="0.09120879120879122" WEIGHT="2.8987901536657423"/>
<DICH_DATA CI_END="5.579155313499883" CI_START="0.31864640395941085" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.74656845154428" LOG_CI_START="-0.49669097832768017" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2131" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="0.4957408985321223"/>
<DICH_DATA CI_END="8.500739760948548" CI_START="0.26468284681954973" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9294567210223326" LOG_CI_START="-0.57727420291097" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2117" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Song-2010" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="0.33752571814953003"/>
<DICH_DATA CI_END="3.6786074906021238" CI_START="0.39145247316513704" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5656834508483586" LOG_CI_START="-0.4073209587531089" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2192" O_E="0.0" SE="0.5715476066494082" STUDY_ID="STD-Su-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.32666666666666666" WEIGHT="0.8093728955626484"/>
<DICH_DATA CI_END="2.438041198591854" CI_START="0.2848370424771889" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.38704104015436036" LOG_CI_START="-0.54540353224961" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2156" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="0.30000000000000004" WEIGHT="0.8813171529459949"/>
<DICH_DATA CI_END="2.2371404754611532" CI_START="0.34223376153532686" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.34969325535374657" LOG_CI_START="-0.4656771493091201" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" O_E="0.0" SE="0.47895261184756516" STUDY_ID="STD-Zhang-2006a" TOTAL_1="52" TOTAL_2="52" VAR="0.2293956043956044" WEIGHT="1.152572851517397"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.217435788271004" CI_START="0.9506107020496916" DF="0" EFFECT_SIZE="1.0757822685788787" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="118" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.0854460643137881" LOG_CI_START="-0.021997300692466772" LOG_EFFECT_SIZE="0.031724381810660646" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2471000967020095" STUDIES="1" TAU2="0.0" TOTAL_1="156" TOTAL_2="161" WEIGHT="66.37722169906276" Z="1.157421787321585">
<NAME>from 12 to 26 weeks (medium-term)</NAME>
<DICH_DATA CI_END="1.217435788271004" CI_START="0.9506107020496916" EFFECT_SIZE="1.0757822685788787" ESTIMABLE="YES" EVENTS_1="123" EVENTS_2="118" LOG_CI_END="0.0854460643137881" LOG_CI_START="-0.021997300692466772" LOG_EFFECT_SIZE="0.031724381810660646" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.06311276445790849" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.0039832210375194375" WEIGHT="66.37722169906276"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.12942551625264603" CI_END="1.2498454461012432" CI_START="1.0423764356540142" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1414067816626179" ESTIMABLE="YES" EVENTS_1="377" EVENTS_2="325" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.09685631216380867" LOG_CI_START="0.018024584994334777" LOG_EFFECT_SIZE="0.05744044857907172" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7190285092498883" P_Q="0.7210226061304705" P_Z="0.0042868943509355075" Q="0.1275150807610626" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="570" TOTAL_2="562" WEIGHT="200.0" Z="2.8562411230386022">
<NAME>Global state: 2. Not responded (decline in PANSS of 30% or more)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3437130779012212" CI_START="1.0094136530206528" DF="0" EFFECT_SIZE="1.1646296950429766" ESTIMABLE="YES" EVENTS_1="176" EVENTS_2="149" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="0.12830654402503053" LOG_CI_START="0.004069174571860437" LOG_EFFECT_SIZE="0.0661878592984455" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.036765889433262686" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="99.99999999999999" Z="2.088354269085784">
<NAME>by up to 12 weeks (short-term)</NAME>
<DICH_DATA CI_END="1.3437130779012212" CI_START="1.0094136530206528" EFFECT_SIZE="1.1646296950429766" ESTIMABLE="YES" EVENTS_1="176" EVENTS_2="149" LOG_CI_END="0.12830654402503053" LOG_CI_START="0.004069174571860437" LOG_EFFECT_SIZE="0.0661878592984455" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="0.07297764580168922" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.005325736786756809" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2663159145640912" CI_START="1.0012617693710035" DF="0" EFFECT_SIZE="1.1260167464114832" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="176" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="0.10254206495188416" LOG_CI_START="5.476340539332946E-4" LOG_EFFECT_SIZE="0.05154484950290872" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.04759003157376275" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="1.9810110753070165">
<NAME>more than 26 weeks (long-term)</NAME>
<DICH_DATA CI_END="1.2663159145640912" CI_START="1.0012617693710035" EFFECT_SIZE="1.1260167464114832" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="176" LOG_CI_END="0.10254206495188416" LOG_CI_START="5.476340539332946E-4" LOG_EFFECT_SIZE="0.05154484950290872" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.05991203359003188" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.0035894517688931085" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.770918931100544" CI_END="1.267893482731289" CI_START="1.0806163128268054" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1705154336300836" ESTIMABLE="YES" EVENTS_1="425" EVENTS_2="355" I2="93.22994050224949" I2_Q="93.21046456194811" ID="CMP-005.03" LOG_CI_END="0.10308276947225356" LOG_CI_START="0.03367151929904196" LOG_EFFECT_SIZE="0.06837714438564779" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.2139394560384265E-4" P_Q="1.2415275927812885E-4" P_Z="1.1268013104996408E-4" Q="14.728548206634446" RANDOM="YES" SCALE="3.229440451522266" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.04599997897489203" TOTALS="SUB" TOTAL_1="570" TOTAL_2="562" WEIGHT="200.0" Z="3.861527923128717">
<NAME>Global state: 3. Remission not achieved (as defined in the study)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.128234647649999" CI_START="0.906621847074036" DF="0" EFFECT_SIZE="1.01137637909206" ESTIMABLE="YES" EVENTS_1="199" EVENTS_2="194" I2="0.0" ID="CMP-005.03.01" LOG_CI_END="0.05239943260986322" LOG_CI_START="-0.04257381985776267" LOG_EFFECT_SIZE="0.00491280637605028" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8393138139357059" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="0.20277127106623127">
<NAME>by up to 12 weeks (short-term)</NAME>
<DICH_DATA CI_END="1.128234647649999" CI_START="0.906621847074036" EFFECT_SIZE="1.01137637909206" ESTIMABLE="YES" EVENTS_1="199" EVENTS_2="194" LOG_CI_END="0.05239943260986322" LOG_CI_START="-0.04257381985776267" LOG_EFFECT_SIZE="0.00491280637605028" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.05578775862466523" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.0031122740123639093" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5559368157178641" CI_START="1.2311078174701926" DF="0" EFFECT_SIZE="1.3840252805927864" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="161" I2="0.0" ID="CMP-005.03.02" LOG_CI_END="0.191991956958151" LOG_CI_START="0.09029608906609082" LOG_EFFECT_SIZE="0.14114402301212092" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="5.313700552114659E-8" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="5.440480669882709">
<NAME>more than 26 weeks (long-term)</NAME>
<DICH_DATA CI_END="1.5559368157178641" CI_START="1.2311078174701926" EFFECT_SIZE="1.3840252805927864" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="161" LOG_CI_END="0.191991956958151" LOG_CI_START="0.09029608906609082" LOG_EFFECT_SIZE="0.14114402301212092" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.059736656202461005" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.0035684680942510228" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.1613584650061752" CI_START="-0.1613584650061752" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.04" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="YES" SCALE="1.75" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="90" TOTAL_2="90" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>Global state: 4. Average endpoint EI score (CGI, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1613584650061752" CI_START="-0.1613584650061752" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.04.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="2" TAU2="0.0" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="0.0">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="0.24203769750926285" CI_START="-0.24203769750926285" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="1.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2118" SD_1="0.5" SD_2="0.6" SE="0.1234908903522847" STUDY_ID="STD-Song-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="44.44444444444444"/>
<CONT_DATA CI_END="0.2164850978992973" CI_START="-0.2164850978992973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="1.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2193" SD_1="0.5" SD_2="0.6" SE="0.11045361017187261" STUDY_ID="STD-Su-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="55.555555555555564"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5578786821784637" CI_START="-0.757878682178463" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.7657628526153584" Q="0.0" RANDOM="YES" SCALE="4.51" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="NaN" TOTALS="SUB" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.2979217958621079">
<NAME>Global state: 5. Average endpoint CGI score decreased rate (short term, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5578786821784637" CI_START="-0.757878682178463" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2456" SD_1="1.3" SD_2="1.3" SE="0.3356585566713095" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3226515077598008" CI_START="-0.12265150775980108" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.06" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.3787058800830906" Q="0.0" RANDOM="YES" SCALE="0.76" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="285" TOTAL_2="281" UNITS="" WEIGHT="100.0" Z="0.8802832750876692">
<NAME>Global state: 6. Average change score (CGI-S, decline=best)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3226515077598008" CI_START="-0.12265150775980108" DF="0" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" I2="0.0" ID="CMP-005.06.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3787058800830906" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="0.8802832750876692">
<NAME>more than 26 weeks (long-term)</NAME>
<CONT_DATA CI_END="0.3226515077598008" CI_START="-0.12265150775980108" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="-1.3" MEAN_2="-1.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="117" SD_1="1.3" SD_2="1.4" SE="0.11359979546361444" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.32253514162054436" CI_START="-0.12253514162054419" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.07" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.3784566299448957" Q="0.0" RANDOM="YES" SCALE="0.7599464754486895" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="285" TOTAL_2="281" UNITS="" WEIGHT="100.0" Z="0.880743585155682">
<NAME>Global state: 7. Improvement (CGI-I, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.32253514162054436" CI_START="-0.12253514162054419" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="2.7" MEAN_2="2.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="1.4" SD_2="1.3" SE="0.11354042389343533" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.05681601220669" CI_END="1.5771031008830079" CI_START="-0.05781972521531109" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7596416878338484" ESTIMABLE="YES" I2="19.03749790670106" I2_Q="28.990801068523982" ID="CMP-005.08" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.2460754883101166" P_Q="0.24456674518240684" P_Z="0.06855608549483228" Q="2.816536491180534" RANDOM="YES" SCALE="30.54" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.412838440875967" TOTALS="SUB" TOTAL_1="1102" TOTAL_2="1103" UNITS="" WEIGHT="300.0" Z="1.8213341028000618">
<NAME>Mental state: 1. Average endpoint scale score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="12.87469336256823" CI_END="1.4560372761170726" CI_START="-0.22833938193617898" DF="10" EFFECT_SIZE="0.6138489470904468" ESTIMABLE="YES" I2="22.328247218113077" ID="CMP-005.08.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.23076258963130347" P_Z="0.15312893856709367" STUDIES="11" TAU2="0.40995163947516217" TOTAL_1="754" TOTAL_2="746" WEIGHT="100.0" Z="1.4285662562382437">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.298529403124684" CI_START="0.10147059687530757" EFFECT_SIZE="1.1999999999999957" ESTIMABLE="YES" MEAN_1="52.8" MEAN_2="51.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2664" SD_1="2.2" SD_2="2.6" SE="0.5604844843016238" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" WEIGHT="25.49922662029552"/>
<CONT_DATA CI_END="8.508538255838829" CI_START="1.9114617441611719" EFFECT_SIZE="5.210000000000001" ESTIMABLE="YES" MEAN_1="-22.15" MEAN_2="-27.36" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="9" SD_1="22.31" SD_2="22.31" SE="1.6829586063097475" STUDY_ID="STD-Fleischhacker-2008" TOTAL_1="355" TOTAL_2="348" WEIGHT="5.694674213858531"/>
<CONT_DATA CI_END="5.596938059335066" CI_START="-4.476938059335062" EFFECT_SIZE="0.5600000000000023" ESTIMABLE="YES" MEAN_1="50.79" MEAN_2="50.23" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2215" SD_1="10.83" SD_2="9.14" SE="2.5699135795687007" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" WEIGHT="2.632275043345755"/>
<CONT_DATA CI_END="10.273314776565462" CI_START="-4.793314776565458" EFFECT_SIZE="2.740000000000002" ESTIMABLE="YES" MEAN_1="52.36" MEAN_2="49.62" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="16.13" SD_2="15.56" SE="3.84359857425304" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="1.216070898760054"/>
<CONT_DATA CI_END="4.191285353314564" CI_START="-4.771285353314562" EFFECT_SIZE="-0.28999999999999915" ESTIMABLE="YES" MEAN_1="44.87" MEAN_2="45.16" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2120" SD_1="11.36" SD_2="10.19" SE="2.2864120915804422" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" WEIGHT="3.2751073531372605"/>
<CONT_DATA CI_END="4.252774402508113" CI_START="-3.852774402508121" EFFECT_SIZE="0.19999999999999574" ESTIMABLE="YES" MEAN_1="41.9" MEAN_2="41.7" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2174" SD_1="8.6" SD_2="8.7" SE="2.067780038039415" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" WEIGHT="3.9404963901742893"/>
<CONT_DATA CI_END="2.062739294638934" CI_START="-1.6627392946389423" EFFECT_SIZE="0.19999999999999574" ESTIMABLE="YES" MEAN_1="50.3" MEAN_2="50.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2118" SD_1="4.2" SD_2="4.3" SE="0.950394654867124" STUDY_ID="STD-Song-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="14.060178657065187"/>
<CONT_DATA CI_END="1.866084674869066" CI_START="-1.4660846748690746" EFFECT_SIZE="0.19999999999999574" ESTIMABLE="YES" MEAN_1="50.3" MEAN_2="50.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2193" SD_1="4.2" SD_2="4.3" SE="0.8500588214941364" STUDY_ID="STD-Su-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="16.302876637332012"/>
<CONT_DATA CI_END="1.849669647212697" CI_START="-1.4496696472127055" EFFECT_SIZE="0.19999999999999574" ESTIMABLE="YES" MEAN_1="50.3" MEAN_2="50.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="4.2" SD_2="4.3" SE="0.8416836534880665" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="16.509415348104785"/>
<CONT_DATA CI_END="0.8658928012485867" CI_START="-3.8658928012485867" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="47.3" MEAN_2="48.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2154" SD_1="6.4" SD_2="5.9" SE="1.2071103448381946" STUDY_ID="STD-Zhang-2006a" TOTAL_1="52" TOTAL_2="52" WEIGHT="9.889227020527274"/>
<CONT_DATA CI_END="10.382340095224578" CI_START="-6.44234009522458" EFFECT_SIZE="1.9699999999999989" ESTIMABLE="YES" MEAN_1="49.11" MEAN_2="47.14" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2196" SD_1="16.12" SD_2="13.11" SE="4.292089120810404" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="26" WEIGHT="0.9804518173993482"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3859338105441155" CI_END="6.8686565284187875" CI_START="-5.264050107591876" DF="1" EFFECT_SIZE="0.8023032104134553" ESTIMABLE="YES" I2="0.0" ID="CMP-005.08.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5344448920824041" P_Z="0.7954699153130267" STUDIES="2" TAU2="0.0" TOTAL_1="63" TOTAL_2="76" WEIGHT="100.0" Z="0.2592142782755489">
<NAME>12- 26 weeks - medium term</NAME>
<CONT_DATA CI_END="12.212795412393895" CI_START="-6.212795412393895" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-39.0" MEAN_2="-42.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="10" SD_1="22.31" SD_2="22.31" SE="4.700492195297081" STUDY_ID="STD-McQuade-2004" TOTAL_1="41" TOTAL_2="50" WEIGHT="43.35833016529528"/>
<CONT_DATA CI_END="7.180457211873572" CI_START="-8.940457211873577" EFFECT_SIZE="-0.8800000000000026" ESTIMABLE="YES" MEAN_1="43.41" MEAN_2="44.29" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" SD_1="13.25" SD_2="15.24" SE="4.112553738463274" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="26" WEIGHT="56.641669834704715"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="8.302713965401686" CI_START="0.09728603459831131" DF="0" EFFECT_SIZE="4.199999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-005.08.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.04480934174743884" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="2.0064398357983664">
<NAME>more than 26 weeks (long-term)</NAME>
<CONT_DATA CI_END="8.302713965401686" CI_START="0.09728603459831131" EFFECT_SIZE="4.199999999999999" ESTIMABLE="YES" MEAN_1="-27.3" MEAN_2="-31.5" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="117" SD_1="25.0" SD_2="24.8" SE="2.09325987506065" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.1570598212690367E-5" CI_END="1.9692120584243278" CI_START="-2.042316572438469" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0365522570070706" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.09" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.9962943056540122" P_Q="0.9962943056540122" P_Z="0.9715075288718338" Q="2.1570598212690367E-5" RANDOM="YES" SCALE="20.99491861912011" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="67" TOTAL_2="70" UNITS="" WEIGHT="100.0" Z="0.0357176098589139">
<NAME>Mental state: 2. Average endpoint scale score (SANS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.4379037819955185" CI_START="-2.517903781995517" DF="0" EFFECT_SIZE="-0.03999999999999915" ESTIMABLE="YES" I2="0.0" ID="CMP-005.09.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9747598894261211" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="65.52257007070766" Z="0.03163906522571437">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.4379037819955185" CI_START="-2.517903781995517" EFFECT_SIZE="-0.03999999999999915" ESTIMABLE="YES" MEAN_1="48.21" MEAN_2="48.25" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2120" SD_1="5.06" SD_2="6.73" SE="1.264259854538607" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" WEIGHT="65.52257007070766"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.3859574963026016" CI_START="-3.445957496302604" DF="0" EFFECT_SIZE="-0.030000000000001137" ESTIMABLE="YES" I2="0.0" ID="CMP-005.09.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9862666811466796" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="34.47742992929234" Z="0.01721301263257731">
<NAME>more than 26 weeks - long term</NAME>
<CONT_DATA CI_END="3.3859574963026016" CI_START="-3.445957496302604" EFFECT_SIZE="-0.030000000000001137" ESTIMABLE="YES" MEAN_1="48.21" MEAN_2="48.24" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" SD_1="5.36" SD_2="6.71" SE="1.7428674828962365" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="26" WEIGHT="34.47742992929234"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-005.10" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES">
<NAME>Mental state: 3. average endpoint score (PANSS, high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-005.10.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>PANSS total</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4613" STUDY_ID="STD-Bai-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>11.26 </P>
</TD>
<TD>
<P>5.07</P>
</TD>
<TD>
<P>59</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Olanzapine</P>
</TD>
<TD>
<P>10.24 </P>
</TD>
<TD>
<P>5.85</P>
</TD>
<TD>
<P>59</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.10.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="1">
<NAME>PANSS negative symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4614" STUDY_ID="STD-Han-2007">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.7</P>
</TD>
<TD>
<P>3.8</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Ziprasidone</P>
</TD>
<TD>
<P>12.6</P>
</TD>
<TD>
<P>6.8</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.10.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="1">
<NAME>PANSS positive symptom subscale score</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4615" STUDY_ID="STD-Han-2007">
<TR>
<TD/>
<TD>
<P>11.3 </P>
</TD>
<TD>
<P>4.3</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
<TR>
<TD/>
<TD>
<P>11.5</P>
</TD>
<TD>
<P>6.7</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="6.333420552773402" CI_END="1.2609974972849527" CI_START="0.16668102199005186" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7138392596375023" ESTIMABLE="YES" I2="5.264462544294452" I2_Q="0.0" ID="CMP-005.11" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.3868949342397541" P_Q="0.9930760182879135" P_Z="0.010557054998205707" Q="0.013896127594485413" RANDOM="YES" SCALE="11.044521081175382" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.031124914450454982" TOTALS="YES" TOTAL_1="522" TOTAL_2="521" UNITS="" WEIGHT="100.0" Z="2.5570285584217425">
<NAME>Mental state: 4. Specific - average endpoint positive score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.255724374032138" CI_END="1.7046111895708163" CI_START="-0.16127154269002497" DF="4" EFFECT_SIZE="0.7716698234403956" ESTIMABLE="YES" I2="36.058563951375106" ID="CMP-005.11.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.18084746162498078" P_Z="0.10498382600292068" STUDIES="5" TAU2="0.4039213105926192" TOTAL_1="215" TOTAL_2="214" WEIGHT="57.11443161731614" Z="1.6211576812943307">
<NAME>by up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.9326472871281806" CI_START="-1.2526472871281809" EFFECT_SIZE="0.8399999999999999" ESTIMABLE="YES" MEAN_1="11.99" MEAN_2="11.15" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="4.54" SD_2="4.26" SE="1.067696806489668" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="6.654803057279693"/>
<CONT_DATA CI_END="2.1467117139020013" CI_START="-1.2867117139020021" EFFECT_SIZE="0.4299999999999997" ESTIMABLE="YES" MEAN_1="9.02" MEAN_2="8.59" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2120" SD_1="4.29" SD_2="3.97" SE="0.8758894180929878" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" WEIGHT="9.762468887562324"/>
<CONT_DATA CI_END="1.231810483162389" CI_START="-0.8318104831623869" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="10.4" MEAN_2="10.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2174" SD_1="2.1" SD_2="2.3" SE="0.5264435935053794" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" WEIGHT="25.28142671956513"/>
<CONT_DATA CI_END="2.070302756808124" CI_START="-1.6703027568081255" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.5" MEAN_2="12.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2193" SD_1="4.3" SD_2="5.2" SE="0.9542536350467836" STUDY_ID="STD-Su-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="8.275717205685101"/>
<CONT_DATA CI_END="5.018279664559712" CI_START="0.9817203354402886" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="15.3" MEAN_2="12.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="5.2" SD_2="5.2" SE="1.0297534446957413" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="7.140015747223898"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.861606720081191" CI_START="-1.541606720081191" DF="0" EFFECT_SIZE="0.6600000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-005.11.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5568276127946443" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="6.027863992038308" Z="0.5875600841864852">
<NAME>12- 26 weeks - medium term</NAME>
<CONT_DATA CI_END="2.861606720081191" CI_START="-1.541606720081191" EFFECT_SIZE="0.6600000000000001" ESTIMABLE="YES" MEAN_1="10.02" MEAN_2="9.36" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" SD_1="3.47" SD_2="4.31" SE="1.1232893754411732" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="26" WEIGHT="6.027863992038308"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.835521677491182E-32" CI_END="1.6322858064506003" CI_START="-0.03228580645060086" DF="0" EFFECT_SIZE="0.7999999999999997" ESTIMABLE="YES" I2="100.0" ID="CMP-005.11.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.05957395892107332" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="36.85770439064556" Z="1.8839335904559946">
<NAME>more than 26 weeks</NAME>
<CONT_DATA CI_END="1.6322858064506005" CI_START="-0.03228580645060075" EFFECT_SIZE="0.7999999999999998" ESTIMABLE="YES" MEAN_1="-5.4" MEAN_2="-6.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="5.2" SD_2="4.9" SE="0.4246434184584843" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="36.85770439064556"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.158707130536374" CI_END="1.0913687294261851" CI_START="-0.25049230276710577" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="0.4204382133295397" ESTIMABLE="YES" I2="0.0" I2_Q="53.85356860624567" ID="CMP-005.12" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.6755330307368734" P_Q="0.14099978148578607" P_Z="0.21936806450394952" Q="2.167014804389283" RANDOM="YES" SCALE="8.87098795691625" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="485" TOTAL_2="482" UNITS="" WEIGHT="100.00000000000001" Z="1.2282102782332904">
<NAME>Mental state: 5. Specific - average endpoint negative subscale score (PANSS, high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9916923261470907" CI_END="0.9157093604475175" CI_START="-0.5932973420492418" DF="4" EFFECT_SIZE="0.1612060091991378" ESTIMABLE="YES" I2="0.0" ID="CMP-005.12.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.911053135478649" P_Z="0.6753894603811406" STUDIES="5" TAU2="0.0" TOTAL_1="200" TOTAL_2="201" WEIGHT="79.07382453778196" Z="0.41876284790381346">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="3.367025966147594" CI_START="-1.0070259661475944" EFFECT_SIZE="1.1799999999999997" ESTIMABLE="YES" MEAN_1="11.36" MEAN_2="10.18" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2215" SD_1="3.77" SD_2="4.89" SE="1.115850078572145" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" WEIGHT="9.41124787666397"/>
<CONT_DATA CI_END="2.542835831712735" CI_START="-2.1428358317127327" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="12.47" MEAN_2="12.27" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="4.63" SD_2="5.21" SE="1.1953463687051007" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="8.20108618179509"/>
<CONT_DATA CI_END="1.101273548068911" CI_START="-1.101273548068911" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="10.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2174" SD_1="2.3" SD_2="2.4" SE="0.5618845839799181" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" WEIGHT="37.11629990131103"/>
<CONT_DATA CI_END="2.0223640096266253" CI_START="-1.8223640096266223" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="13.3" MEAN_2="13.2" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2193" SD_1="4.7" SD_2="5.1" SE="0.9808159868191383" STUDY_ID="STD-Su-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="12.181025064136822"/>
<CONT_DATA CI_END="1.8236957479294909" CI_START="-2.0236957479294935" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="13.2" MEAN_2="13.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="4.7" SD_2="5.2" SE="0.9814954576223639" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="12.164165513875043"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.866670693693525" CI_START="-0.06667069369352396" DF="0" EFFECT_SIZE="1.4000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-005.12.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.06136316096648933" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="20.92617546221805" Z="1.8708695756686695">
<NAME>more than 26 weeks</NAME>
<CONT_DATA CI_END="2.866670693693525" CI_START="-0.06667069369352396" EFFECT_SIZE="1.4000000000000004" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-9.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="8.8" SD_2="9.0" SE="0.7483151247994532" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="20.92617546221805"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="19.510683105266246" CI_END="0.6429580701300842" CI_START="-2.244338176553469" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8006900532116924" ESTIMABLE="YES" I2="64.12221980013305" I2_Q="0.0" ID="CMP-005.13" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0067294791025117595" P_Q="0.4141129092618544" P_Z="0.2770129010759147" Q="0.6669626009633142" RANDOM="YES" SCALE="12.648317649604003" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="2.629237274873524" TOTALS="YES" TOTAL_1="319" TOTAL_2="323" UNITS="" WEIGHT="100.00000000000001" Z="1.0870541385401344">
<NAME>Mental state: 6. Specific - average endpoint general pathological score (PANSS, high=poor )</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="18.68609143295457" CI_END="0.6047125712343268" CI_START="-2.487024366228972" DF="6" EFFECT_SIZE="-0.9411558974973225" ESTIMABLE="YES" I2="67.89055634492685" ID="CMP-005.13.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0047279726878358685" P_Z="0.23276539256946815" STUDIES="7" TAU2="2.8369308521602057" TOTAL_1="297" TOTAL_2="297" WEIGHT="91.72029720151984" Z="1.193265598104671">
<NAME>up to 12 weeks - short term</NAME>
<CONT_DATA CI_END="2.9208331584269405" CI_START="-2.820833158426939" EFFECT_SIZE="0.05000000000000071" ESTIMABLE="YES" MEAN_1="25.19" MEAN_2="25.14" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2215" SD_1="5.86" SD_2="5.57" SE="1.4647377100149315" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" WEIGHT="11.362685610442565"/>
<CONT_DATA CI_END="4.38952902294762" CI_START="-1.5495290229476235" EFFECT_SIZE="1.4199999999999982" ESTIMABLE="YES" MEAN_1="23.59" MEAN_2="22.17" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="5.23" SD_2="7.12" SE="1.515093668236196" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="11.016475537613173"/>
<CONT_DATA CI_END="2.732033211017712" CI_START="-4.132033211017711" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="21.39" MEAN_2="22.09" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2120" SD_1="6.83" SD_2="9.45" SE="1.7510695288735667" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" WEIGHT="9.525681428648964"/>
<CONT_DATA CI_END="2.4025470961378215" CI_START="-2.002547096137823" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="17.8" MEAN_2="17.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2174" SD_1="4.6" SD_2="4.8" SE="1.1237691679598363" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" WEIGHT="13.939370194838423"/>
<CONT_DATA CI_END="0.9252136952487382" CI_START="-2.5252136952487394" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="23.8" MEAN_2="24.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2193" SD_1="4.5" SD_2="4.3" SE="0.8802272433866154" STUDY_ID="STD-Su-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="15.937940904018927"/>
<CONT_DATA CI_END="0.8893720536370342" CI_START="-2.4893720536370356" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="23.8" MEAN_2="24.6" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="4.5" SD_2="4.2" SE="0.8619403555180534" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="16.08851539288708"/>
<CONT_DATA CI_END="-3.0755687338363558" CI_START="-7.524431266163646" EFFECT_SIZE="-5.300000000000001" ESTIMABLE="YES" MEAN_1="25.5" MEAN_2="30.8" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2154" SD_1="4.7" SD_2="6.7" SE="1.1349347660006381" STUDY_ID="STD-Zhang-2006a" TOTAL_1="52" TOTAL_2="52" WEIGHT="13.849628133070714"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.68218070440267" CI_START="-3.082180704402669" DF="0" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-005.13.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6862941372805258" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="26" WEIGHT="8.279702798480173" Z="0.4038892846625748">
<NAME>12- 26 weeks - medium term</NAME>
<CONT_DATA CI_END="4.68218070440267" CI_START="-3.082180704402669" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" MEAN_1="23.45" MEAN_2="22.65" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2153" SD_1="5.32" SD_2="8.28" SE="1.980740837599474" STUDY_ID="STD-Zhu-2010" TOTAL_1="22" TOTAL_2="26" WEIGHT="8.279702798480173"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.924032045102433" CI_END="1.377093866988476" CI_START="0.7066593603545538" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9864766957177729" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="69" I2="32.47842061713838" I2_Q="61.105945027245745" ID="CMP-005.14" LOG_CI_END="0.13896354412455683" LOG_CI_START="-0.15078988403728452" LOG_EFFECT_SIZE="-0.005913169956363851" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.20489399757761806" P_Q="0.07645249334015758" P_Z="0.9362402038411426" Q="5.142174045367663" RANDOM="YES" SCALE="99.18752779765958" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07731387023013422" TOTALS="SUB" TOTAL_1="1057" TOTAL_2="1065" WEIGHT="300.0" Z="0.0799962935552505">
<NAME>Mental state: 7. Specific - binary outcomes</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7388275114573379" CI_END="1.8950758558677865" CI_START="0.792856233123441" DF="1" EFFECT_SIZE="1.2257743285639957" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="34" I2="0.0" ID="CMP-005.14.01" LOG_CI_END="0.2776265985391602" LOG_CI_START="-0.10080555520651278" LOG_EFFECT_SIZE="0.08841052166632377" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.390036756409479" P_Z="0.35977914687316626" STUDIES="2" TAU2="0.0" TOTAL_1="386" TOTAL_2="392" WEIGHT="100.0" Z="0.9157860219078913">
<NAME>anxiety - labelled as"adverse effect"</NAME>
<DICH_DATA CI_END="2.3390666894283396" CI_START="0.8251983322997305" EFFECT_SIZE="1.3893141945773524" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="22" LOG_CI_END="0.3690426042109673" LOG_CI_START="-0.08344165839369504" LOG_EFFECT_SIZE="0.1428004729086361" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="264" O_E="0.0" SE="0.26579149568720206" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.07064511917963996" WEIGHT="69.947001328188"/>
<DICH_DATA CI_END="2.0275675223471232" CI_START="0.41368082593019484" EFFECT_SIZE="0.9158415841584159" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.3069753260617237" LOG_CI_START="-0.38333460814894355" LOG_EFFECT_SIZE="-0.03817964104360995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="229" O_E="0.0" SE="0.40549147244463035" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.16442333422531444" WEIGHT="30.052998671812006"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9536154537649347" CI_START="0.07582401521932382" DF="0" EFFECT_SIZE="0.26889952153110047" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" I2="0.0" ID="CMP-005.14.02" LOG_CI_END="-0.02062671961049338" LOG_CI_START="-1.1201932214734922" LOG_EFFECT_SIZE="-0.5704099705419929" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.04200226159286052" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="99.99999999999999" Z="2.033497740774491">
<NAME>depression - labelled as"adverse effect"</NAME>
<DICH_DATA CI_END="0.9536154537649347" CI_START="0.07582401521932382" EFFECT_SIZE="0.26889952153110047" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.02062671961049338" LOG_CI_START="-1.1201932214734922" LOG_EFFECT_SIZE="-0.5704099705419929" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="0.6458908061362925" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.4171749334513897" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004221380699990016" CI_END="1.5639888778834292" CI_START="0.5016857856503723" DF="1" EFFECT_SIZE="0.8857939878715548" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="24" I2="0.0" ID="CMP-005.14.03" LOG_CI_END="0.19423366030245537" LOG_CI_START="-0.2995682037381638" LOG_EFFECT_SIZE="-0.05266727171785424" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9481961719057137" P_Z="0.6758838487668596" STUDIES="2" TAU2="0.0" TOTAL_1="386" TOTAL_2="392" WEIGHT="100.0" Z="0.4180865373261859">
<NAME>exacerbation of schizophrenia - labelled as"adverse effect"</NAME>
<DICH_DATA CI_END="1.683781121084742" CI_START="0.45617579657679785" EFFECT_SIZE="0.8764132553606238" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" LOG_CI_END="0.2262856358077868" LOG_CI_START="-0.34086776090941" LOG_EFFECT_SIZE="-0.057291062550811615" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="262" O_E="0.0" SE="0.3331487126862732" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.11098806476452103" WEIGHT="75.80613858987398"/>
<DICH_DATA CI_END="2.9092533495379684" CI_START="0.28830964735573983" EFFECT_SIZE="0.9158415841584159" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.463781543012387" LOG_CI_START="-0.540140825099607" LOG_EFFECT_SIZE="-0.03817964104360995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="230" O_E="0.0" SE="0.5897089685248544" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.34775666755864776" WEIGHT="24.19386141012602"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-005.15" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="15" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES">
<NAME>Mental state: 8. Various scale scores decreased rate (low=poor, data skewed)</NAME>
<TR>
<TH>
<P>Heading 1</P>
</TH>
<TH>
<P>Heading 2</P>
</TH>
<TH>
<P>Heading 3</P>
</TH>
<TH>
<P>Heading 4</P>
</TH>
<TH>
<P>Heading 5</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-005.15.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" STUDIES="1">
<NAME>PANSS positive symptom subscale</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4642" STUDY_ID="STD-Ye-2005a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>12.8 </P>
</TD>
<TD>
<P>8.4</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.15.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" STUDIES="1">
<NAME>PANSS negative symptom subscale</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4643" STUDY_ID="STD-Ye-2005a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>10.9 </P>
</TD>
<TD>
<P>8.1</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.15.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" STUDIES="1">
<NAME>PANSS general pathology subscale</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4644" STUDY_ID="STD-Ye-2005a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>19.4 </P>
</TD>
<TD>
<P>11.8</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.15.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" STUDIES="1">
<NAME>BPRS total</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4645" STUDY_ID="STD-Ye-2005a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>24.8</P>
</TD>
<TD>
<P>4.3</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-005.15.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" STUDIES="1">
<NAME>PANSS total</NAME>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4646" STUDY_ID="STD-Ye-2005a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>44.1 </P>
</TD>
<TD>
<P>23.8</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="24.138417162431008" CI_END="0.9942139465976559" CI_START="0.5961955339552255" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7698999381461993" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="97" I2="50.28671549070425" I2_Q="63.46564363072309" ID="CMP-005.16" LOG_CI_END="-0.0025201489742068023" LOG_CI_START="-0.2246112815503959" LOG_EFFECT_SIZE="-0.11356571526230136" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0194768733233065" P_Q="0.007700502628711248" P_Z="0.045022430639468" Q="19.160047406464123" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3622438751110504" TOTALS="SUB" TOTAL_1="726" TOTAL_2="745" WEIGHT="800.0" Z="2.0044448349713653">
<NAME>Adverse effects: 1. At least one adverse effect</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3046201776279502" CI_START="0.6887414608121218" DF="0" EFFECT_SIZE="0.9479166666666666" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" I2="0.0" ID="CMP-005.16.01" LOG_CI_END="0.11548409116079857" LOG_CI_START="-0.16194377259774825" LOG_EFFECT_SIZE="-0.02322984071847483" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7427400708166916" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="35" WEIGHT="100.0" Z="0.3282269528228675">
<NAME>non-specific</NAME>
<DICH_DATA CI_END="1.3046201776279502" CI_START="0.6887414608121218" EFFECT_SIZE="0.9479166666666666" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" LOG_CI_END="0.11548409116079857" LOG_CI_START="-0.16194377259774825" LOG_EFFECT_SIZE="-0.02322984071847483" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="0.16296250046184413" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="0.02655677655677655" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6110696264007713" CI_START="0.011364407825909376" DF="0" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" I2="0.0" ID="CMP-005.16.02" LOG_CI_END="-0.21390930262344088" LOG_CI_START="-1.944453189471809" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.01450534947098591" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="2.4444989706634765">
<NAME>endocrine dyscrasia</NAME>
<DICH_DATA CI_END="0.6110696264007713" CI_START="0.011364407825909376" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.21390930262344088" LOG_CI_START="-1.944453189471809" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2561" O_E="0.0" SE="1.0165300454651272" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.0333333333333334" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5964422403549541" CI_START="0.12003356759324908" DF="0" EFFECT_SIZE="0.26756885090218424" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="27" I2="0.0" ID="CMP-005.16.03" LOG_CI_END="-0.22443160716494798" LOG_CI_START="-0.9206972857697368" LOG_EFFECT_SIZE="-0.5725644464673424" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.0012663495082072328" STUDIES="1" TAU2="0.0" TOTAL_1="156" TOTAL_2="161" WEIGHT="99.99999999999999" Z="3.223498524737953">
<NAME>high prolactin level</NAME>
<DICH_DATA CI_END="0.5964422403549541" CI_START="0.12003356759324908" EFFECT_SIZE="0.26756885090218424" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="27" LOG_CI_END="-0.22443160716494798" LOG_CI_START="-0.9206972857697368" LOG_EFFECT_SIZE="-0.5725644464673424" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2562" O_E="0.0" SE="0.40898990618314757" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.16727274335969985" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3028668856438417" CI_END="1.074681893319797" CI_START="0.19683954640193546" DF="4" EFFECT_SIZE="0.4599346653682913" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" I2="0.0" ID="CMP-005.16.04" LOG_CI_END="0.03127993176753295" LOG_CI_START="-0.7058876444272446" LOG_EFFECT_SIZE="-0.33730385632985577" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.860888966931861" P_Z="0.072872041038956" STUDIES="5" TAU2="0.0" TOTAL_1="174" TOTAL_2="174" WEIGHT="100.00000000000001" Z="1.7936312762576272">
<NAME>liver function abnormal</NAME>
<DICH_DATA CI_END="4.129808085649786" CI_START="0.010320641440566405" EFFECT_SIZE="0.2064516129032258" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6159298702327053" LOG_CI_START="-1.9862933099334763" LOG_EFFECT_SIZE="-0.6851817198503856" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2533" O_E="0.0" SE="1.5285587772421023" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.336491935483871" WEIGHT="8.024969071723408"/>
<DICH_DATA CI_END="2.550548773546233" CI_START="0.09801812166579543" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4066336328581724" LOG_CI_START="-1.0086936241861348" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2537" O_E="0.0" SE="0.8313702367707394" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="0.6911764705882353" WEIGHT="27.12805819710782"/>
<DICH_DATA CI_END="1.60725335906782" CI_START="0.023793370903776916" EFFECT_SIZE="0.19555555555555557" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.20608434208516607" LOG_CI_START="-1.6235440253355162" LOG_EFFECT_SIZE="-0.708729841625175" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2536" O_E="0.0" SE="1.0747327598293936" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="1.155050505050505" WEIGHT="16.233294939574407"/>
<DICH_DATA CI_END="3.748275808525094" CI_START="0.11857303655019144" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5738315399834706" LOG_CI_START="-0.9260140580948332" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2535" O_E="0.0" SE="0.8810167286666446" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="0.7761904761904761" WEIGHT="24.156796680391032"/>
<DICH_DATA CI_END="3.7086562974712898" CI_START="0.11983975024794946" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.569216586623787" LOG_CI_START="-0.9213991047351496" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2534" O_E="0.0" SE="0.8755950357709131" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="0.7666666666666666" WEIGHT="24.45688111120334"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.411306700939454" CI_START="0.41422019779176417" DF="0" EFFECT_SIZE="1.6296296296296295" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-005.16.05" LOG_CI_END="0.806946552946687" LOG_CI_START="-0.38276872829228686" LOG_EFFECT_SIZE="0.2120889123272001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.48467691743709107" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="100.0" Z="0.6988001856186763">
<NAME>skin adverse reaction</NAME>
<DICH_DATA CI_END="6.411306700939454" CI_START="0.41422019779176417" EFFECT_SIZE="1.6296296296296295" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.806946552946687" LOG_CI_START="-0.38276872829228686" LOG_EFFECT_SIZE="0.2120889123272001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2540" O_E="0.0" SE="0.6988446453853949" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.48838383838383836" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="28.155550146917736" CI_START="0.319652784372436" DF="1" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-005.16.06" LOG_CI_END="1.4495640176808047" LOG_CI_START="-0.4953215082414795" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.33623016452126" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="99.99999999999999" Z="0.9616406344179532">
<NAME>sweating- increase</NAME>
<DICH_DATA CI_END="71.14657198220529" CI_START="0.1264994187246438" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8521539795421889" LOG_CI_START="-0.8979114701028642" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2539" O_E="0.0" SE="1.6154020581650284" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="2.6095238095238096" WEIGHT="50.01520218911522"/>
<DICH_DATA CI_END="71.21510406800243" CI_START="0.12637768515238015" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.85257211326778" LOG_CI_START="-0.8983296038284552" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2538" O_E="0.0" SE="1.6158932858054431" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="2.611111111111111" WEIGHT="49.984797810884764"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.601961306299592E-32" CI_END="1.5372857812892917" CI_START="0.15519708630160936" DF="0" EFFECT_SIZE="0.48844884488448853" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="100.0" ID="CMP-005.16.07" LOG_CI_END="0.18675461031037352" LOG_CI_START="-0.8091164365250686" LOG_EFFECT_SIZE="-0.3111809131073476" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.22062642472564598" STUDIES="1" TAU2="0.0" TOTAL_1="101" TOTAL_2="111" WEIGHT="100.0" Z="1.2248641715305733">
<NAME>flu syndrome</NAME>
<DICH_DATA CI_END="1.5372857812892915" CI_START="0.15519708630160936" EFFECT_SIZE="0.4884488448844885" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.18675461031037346" LOG_CI_START="-0.8091164365250686" LOG_EFFECT_SIZE="-0.3111809131073476" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2567" O_E="0.0" SE="0.5849795825523247" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.34220111200309217" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.694642549231856" CI_START="0.5042625907348175" DF="0" EFFECT_SIZE="1.5386138613861386" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-005.16.08" LOG_CI_END="0.6716025306157691" LOG_CI_START="-0.2973432492512633" LOG_EFFECT_SIZE="0.1871296406822529" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.44902343209382034" STUDIES="1" TAU2="0.0" TOTAL_1="101" TOTAL_2="111" WEIGHT="99.99999999999999" Z="0.7570441273349022">
<NAME>respiratory infection</NAME>
<DICH_DATA CI_END="4.694642549231856" CI_START="0.5042625907348175" EFFECT_SIZE="1.5386138613861386" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6716025306157691" LOG_CI_START="-0.2973432492512633" LOG_EFFECT_SIZE="0.1871296406822529" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2568" O_E="0.0" SE="0.5691635474528599" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.3239471437491239" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.2748750877726165" CI_END="1.3328181762542413" CI_START="0.3734159926512526" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7054754583326125" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-005.17" LOG_CI_END="0.12477090677661723" LOG_CI_START="-0.4278070860348875" LOG_EFFECT_SIZE="-0.15151808962913513" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.9340960946762944" P_Q="0.6838507481854122" P_Z="0.2824406575259354" Q="1.4931564342031798" RANDOM="YES" SCALE="288.73" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="576" TOTAL_2="591" WEIGHT="400.0" Z="1.074852790167918">
<NAME>Adverse effects: 2. Cardiac effects</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8274557989717249" CI_END="6.288708339118467" CI_START="0.14514571589809966" DF="1" EFFECT_SIZE="0.9553947215448173" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-005.17.01" LOG_CI_END="0.7985614532674732" LOG_CI_START="-0.8381957782220629" LOG_EFFECT_SIZE="-0.019817162477294932" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.36300931050118335" P_Z="0.9621459517961541" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="61" WEIGHT="100.0" Z="0.04746082556901768">
<NAME>abnormal ECG</NAME>
<DICH_DATA CI_END="73.15840614780981" CI_START="0.131085556818331" EFFECT_SIZE="3.096774193548387" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864264235230413" LOG_CI_START="-0.8824451568198217" LOG_EFFECT_SIZE="0.49090953920529573" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.613430693321079" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.6031586021505375" WEIGHT="35.509381815760115"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2162" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="64.49061818423988"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.795332307397482" CI_START="0.013640560661244014" DF="0" EFFECT_SIZE="0.32608695652173914" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.17.02" LOG_CI_END="0.891834633468784" LOG_CI_START="-1.8651677787205696" LOG_EFFECT_SIZE="-0.4866665726258928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4889709913218926" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="100.0" Z="0.691946405711585">
<NAME>blood pressure- decrease</NAME>
<DICH_DATA CI_END="7.795332307397482" CI_START="0.013640560661244014" EFFECT_SIZE="0.32608695652173914" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.891834633468784" LOG_CI_START="-1.8651677787205696" LOG_EFFECT_SIZE="-0.4866665726258928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2541" O_E="0.0" SE="1.619476864302069" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="2.6227053140096617" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.597740055920805" CI_END="1.3812895578896272" CI_START="0.11348994875455583" DF="2" EFFECT_SIZE="0.3959324199154407" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" I2="0.0" ID="CMP-005.17.03" LOG_CI_END="0.14028472869592115" LOG_CI_START="-0.945042600089617" LOG_EFFECT_SIZE="-0.4023789356968479" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7416558302422929" P_Z="0.14614297375024307" STUDIES="3" TAU2="0.0" TOTAL_1="302" TOTAL_2="316" WEIGHT="100.00000000000001" Z="1.4532910048176222">
<NAME>QTc prolongation</NAME>
<DICH_DATA CI_END="15.150142679509194" CI_START="0.06310497550687236" EFFECT_SIZE="0.9777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.180416722913026" LOG_CI_START="-1.1999363974913386" LOG_EFFECT_SIZE="-0.009759837289156262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2450" O_E="0.0" SE="1.3982312058635027" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="1.9550505050505051" WEIGHT="20.789244192238982"/>
<DICH_DATA CI_END="1.6786988090846142" CI_START="0.07049969913334275" EFFECT_SIZE="0.344017094017094" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.2249727823284192" LOG_CI_START="-1.151812736412968" LOG_EFFECT_SIZE="-0.46341997704227433" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="11" O_E="0.0" SE="0.8087306289069226" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.6540452301321866" WEIGHT="62.142525448034675"/>
<DICH_DATA CI_END="4.520299993995564" CI_START="0.010669115950591597" EFFECT_SIZE="0.2196078431372549" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.655167258132956" LOG_CI_START="-1.9718715649884653" LOG_EFFECT_SIZE="-0.6583521534277548" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="220" O_E="0.0" SE="1.543135608753424" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="2.381267507002801" WEIGHT="17.068230359726357"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3610023006916947" CI_END="2.0769260376864858" CI_START="0.3944249635669307" DF="4" EFFECT_SIZE="0.9050919714292586" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" I2="0.0" ID="CMP-005.17.04" LOG_CI_END="0.3174210309614033" LOG_CI_START="-0.404035605910661" LOG_EFFECT_SIZE="-0.043307287474628885" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8509439275931121" P_Z="0.8139729899808976" STUDIES="5" TAU2="0.0" TOTAL_1="169" TOTAL_2="170" WEIGHT="99.99999999999997" Z="0.2353037435109134">
<NAME>tachycardia</NAME>
<DICH_DATA CI_END="8.63300548799398" CI_START="0.2782924212594541" EFFECT_SIZE="1.55" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9361620169918647" LOG_CI_START="-0.5554986206512819" LOG_EFFECT_SIZE="0.1903316981702915" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2451" O_E="0.0" SE="0.8762088423908257" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="0.7677419354838709" WEIGHT="23.392702988514685"/>
<DICH_DATA CI_END="3.74127129959932" CI_START="0.1187950321838577" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.573019202356666" LOG_CI_START="-0.9252017204680286" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2452" O_E="0.0" SE="0.8800623863804024" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="0.7745098039215685" WEIGHT="23.188291455662824"/>
<DICH_DATA CI_END="3.1082378709914233" CI_START="0.1809707053793092" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4925142476146918" LOG_CI_START="-0.7423917208312916" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2453" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="34.13128872765915"/>
<DICH_DATA CI_END="5.296053860021452" CI_START="0.0472049579947035" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7239523931595834" LOG_CI_START="-1.3260123844875458" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2454" O_E="0.0" SE="1.2041594578792296" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.4500000000000002" WEIGHT="12.385902805932133"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2455" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="6.901814022231192"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.110879574565216" CI_START="-9.510879574565216" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.18" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="1.0" P_Q="1.0" P_Z="0.21203807473638037" Q="0.0" RANDOM="YES" SCALE="30.27269141572956" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="156" TOTAL_2="161" UNITS="" WEIGHT="100.0" Z="1.2479809037069578">
<NAME>Adverse effects: 3a. Cardiac - QTc change from baseline (in ms)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.110879574565216" CI_START="-9.510879574565216" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="0.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="12" SD_1="26.39" SD_2="26.39" SE="2.964788955511781" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="74.82288972419772" CI_END="0.9446959799972232" CI_START="0.6109042505922135" CI_STUDY="95" CI_TOTAL="95" DF="31" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7596833483088071" ESTIMABLE="YES" EVENTS_1="336" EVENTS_2="341" I2="58.56882818310263" I2_Q="65.78403381661033" ID="CMP-005.19" LOG_CI_END="-0.024707932710627382" LOG_CI_START="-0.21402685309303385" LOG_EFFECT_SIZE="-0.11936739290183063" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.732215158867234E-5" P_Q="0.0018218977023586325" P_Z="0.013452793368704547" Q="26.303509746771667" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.28291662975342635" TOTALS="SUB" TOTAL_1="3184" TOTAL_2="3200" WEIGHT="1000.0" Z="2.471552135871696">
<NAME>Adverse effects: 3b. Central / peripheral nervous system</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.354489142627141" CI_END="1.5259072858468192" CI_START="0.623962375822429" DF="5" EFFECT_SIZE="0.9757605932613469" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="39" I2="0.0" ID="CMP-005.19.01" LOG_CI_END="0.18352814668022832" LOG_CI_START="-0.2048415969607421" LOG_EFFECT_SIZE="-0.010656725140256876" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4995852332788492" P_Z="0.9143436143861503" STUDIES="6" TAU2="0.0" TOTAL_1="525" TOTAL_2="532" WEIGHT="99.99999999999999" Z="0.10756140410028919">
<NAME>dizziness</NAME>
<DICH_DATA CI_END="10.45829496408284" CI_START="0.4083945925965452" EFFECT_SIZE="2.066666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0194608864386594" LOG_CI_START="-0.3889200168814764" LOG_EFFECT_SIZE="0.31527043477859146" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="0.8272899142081558" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="0.6844086021505377" WEIGHT="7.604147306238309"/>
<DICH_DATA CI_END="2.2218780885865503" CI_START="0.6981005420115648" EFFECT_SIZE="1.2454293628808863" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="19" LOG_CI_END="0.34672022611401265" LOG_CI_START="-0.1560820248033192" LOG_EFFECT_SIZE="0.09531910065534673" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="253" O_E="0.0" SE="0.2953485311001234" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.08723075482300055" WEIGHT="59.661799774281945"/>
<DICH_DATA CI_END="3.0467430499702566" CI_START="0.036468815810442506" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48383582912076384" LOG_CI_START="-1.4380783385600886" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.1289418957242967" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="1.2745098039215688" WEIGHT="4.083408234598095"/>
<DICH_DATA CI_END="2.555603603168496" CI_START="0.09782424773937723" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4074934917762285" LOG_CI_START="-1.0095534831041908" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="0.8323804075404123" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="0.6928571428571428" WEIGHT="7.51142408224028"/>
<DICH_DATA CI_END="3.138274863843685" CI_START="0.17923860222716867" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49669097832768017" LOG_CI_START="-0.7465684515442799" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="9.75814467826751"/>
<DICH_DATA CI_END="1.7726733913928103" CI_START="0.1251471355447181" EFFECT_SIZE="0.471004243281471" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.24862872579708753" LOG_CI_START="-0.9025790863782466" LOG_EFFECT_SIZE="-0.32697518029057954" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.6762251674423669" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.4572804770824572" WEIGHT="11.38107592437384"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.347177161806254" CI_START="0.006703403121247933" DF="0" EFFECT_SIZE="0.1254355400696864" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-005.19.02" LOG_CI_END="0.37054587080485923" LOG_CI_START="-2.1737046627382695" LOG_EFFECT_SIZE="-0.9015793959667051" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.16481335319381588" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="35" WEIGHT="100.0" Z="1.3890637906930516">
<NAME>blurred vision</NAME>
<DICH_DATA CI_END="2.347177161806254" CI_START="0.006703403121247933" EFFECT_SIZE="0.1254355400696864" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.37054587080485923" LOG_CI_START="-2.1737046627382695" LOG_EFFECT_SIZE="-0.9015793959667051" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.494505357646492" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.233546264034069" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.65790165332531" CI_END="5.06930276080738" CI_START="0.8154475563028205" DF="4" EFFECT_SIZE="2.033162696013165" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="46" I2="58.58313592763951" ID="CMP-005.19.03" LOG_CI_END="0.7049482299532115" LOG_CI_START="-0.08860396440993977" LOG_EFFECT_SIZE="0.3081721327716359" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.04660195345037732" P_Z="0.12793769741091573" STUDIES="5" TAU2="0.4818096935694049" TOTAL_1="495" TOTAL_2="496" WEIGHT="100.0" Z="1.522284950030375">
<NAME>headache</NAME>
<DICH_DATA CI_END="168.69299916711446" CI_START="0.5530005953503516" EFFECT_SIZE="9.658536585365853" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.227097059553088" LOG_CI_START="-0.25727440114153444" LOG_EFFECT_SIZE="0.9849113292057768" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.4593320938490886" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.129650160137965" WEIGHT="8.320373920817982"/>
<DICH_DATA CI_END="2.2454800510353" CI_START="0.9938614548504985" EFFECT_SIZE="1.493886230728336" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="33" LOG_CI_END="0.3513092011205001" LOG_CI_START="-0.0026741524110981364" LOG_EFFECT_SIZE="0.17431752435470102" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.20793157411032068" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.04323553951199578" WEIGHT="41.38371533159178"/>
<DICH_DATA CI_END="222.06646547539532" CI_START="0.7610334123984379" EFFECT_SIZE="13.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.346482980166724" LOG_CI_START="-0.11859627555305047" LOG_EFFECT_SIZE="1.1139433523068367" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.447999757148908" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="2.096703296703297" WEIGHT="8.426687220122156"/>
<DICH_DATA CI_END="252.96219883682127" CI_START="0.889460959125917" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.4030556276456436" LOG_CI_START="-0.05087310953428134" LOG_EFFECT_SIZE="1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="1.4414498873626436" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="2.077777777777778" WEIGHT="8.48899391221575"/>
<DICH_DATA CI_END="1.7035502178370032" CI_START="0.33981815992047154" EFFECT_SIZE="0.7608530083777608" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.23135494037413337" LOG_CI_START="-0.46875341610112753" LOG_EFFECT_SIZE="-0.11869923786349705" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="222" O_E="0.0" SE="0.41124711418582516" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.16912418892616912" WEIGHT="33.38022961525233"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.006416507969488" CI_END="1.6173500556841685" CI_START="0.21126064205647552" DF="2" EFFECT_SIZE="0.5845360649215016" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" I2="33.475618075594404" ID="CMP-005.19.04" LOG_CI_END="0.20880402782141927" LOG_CI_START="-0.6751814046504954" LOG_EFFECT_SIZE="-0.23318868841453805" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2224155188327216" P_Z="0.30111400671245037" STUDIES="3" TAU2="0.3238792245654775" TOTAL_1="365" TOTAL_2="356" WEIGHT="100.00000000000001" Z="1.0340474268146902">
<NAME>fatigue</NAME>
<DICH_DATA CI_END="1.157647326152855" CI_START="0.003940708498389478" EFFECT_SIZE="0.0675422138836773" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.06357627300636985" LOG_CI_START="-2.4044256895249396" LOG_EFFECT_SIZE="-1.170424708259285" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.449716569597636" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.101678132165937" WEIGHT="11.116136514532673"/>
<DICH_DATA CI_END="1.4709742062171736" CI_START="0.44240243735505363" EFFECT_SIZE="0.8066985645933015" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="22" LOG_CI_END="0.16760505736671183" LOG_CI_START="-0.35418248901137284" LOG_EFFECT_SIZE="-0.09328871582233046" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="251" O_E="0.0" SE="0.3065005876324978" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.09394261021906648" WEIGHT="64.53187568610245"/>
<DICH_DATA CI_END="3.7781065604215764" CI_START="0.11763682080868876" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.57727420291097" LOG_CI_START="-0.9294567210223325" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="0.8850612031567835" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.7833333333333332" WEIGHT="24.35198779936489"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.869054499688964" CI_END="3.451222434572497" CI_START="0.9471830002477095" DF="6" EFFECT_SIZE="1.8080208018992985" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="79" I2="56.73821888770745" ID="CMP-005.19.05" LOG_CI_END="0.537972950886475" LOG_CI_START="-0.02356610513642792" LOG_EFFECT_SIZE="0.25720342287502357" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.031133619840479798" P_Z="0.07258101366304437" STUDIES="7" TAU2="0.2711494386367561" TOTAL_1="570" TOTAL_2="571" WEIGHT="100.00000000000001" Z="1.7954563983699512">
<NAME>insomnia</NAME>
<DICH_DATA CI_END="168.69299916711446" CI_START="0.5530005953503516" EFFECT_SIZE="9.658536585365853" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.227097059553088" LOG_CI_START="-0.25727440114153444" LOG_EFFECT_SIZE="0.9849113292057768" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.4593320938490886" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.129650160137965" WEIGHT="4.531888637548843"/>
<DICH_DATA CI_END="134.20790539006924" CI_START="0.3890402634957905" EFFECT_SIZE="7.225806451612903" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1277780982932244" LOG_CI_START="-0.410005449293444" LOG_EFFECT_SIZE="0.8588863244998901" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.4907066180835706" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.2222062211981566" WEIGHT="4.363660025717857"/>
<DICH_DATA CI_END="2.2584037339706784" CI_START="1.185536217863005" EFFECT_SIZE="1.6362821948488242" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="47" LOG_CI_END="0.35380158318771193" LOG_CI_START="0.07391482611495338" LOG_EFFECT_SIZE="0.21385820465133262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="248" O_E="0.0" SE="0.16440686656633033" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.027029617774159145" WEIGHT="36.4886674258075"/>
<DICH_DATA CI_END="252.689312220282" CI_START="0.8904215141630377" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.4025868733329907" LOG_CI_START="-0.05040435522162799" LOG_EFFECT_SIZE="1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.440899190155396" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="2.0761904761904764" WEIGHT="4.635100504189132"/>
<DICH_DATA CI_END="4.58568734389541" CI_START="0.20848551395218168" EFFECT_SIZE="0.9777777777777777" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6614044408322509" LOG_CI_START="-0.6809241154105634" LOG_EFFECT_SIZE="-0.009759837289156262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="0.7884904385705458" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.6217171717171717" WEIGHT="12.185645981773405"/>
<DICH_DATA CI_END="283.64361038414125" CI_START="1.0188842244977934" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.452773004695487" LOG_CI_START="0.00812483806106053" LOG_EFFECT_SIZE="1.2304489213782739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="1.4359984342846528" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="2.062091503267974" WEIGHT="4.663108823144949"/>
<DICH_DATA CI_END="1.4536598540479861" CI_START="0.5690715851840945" EFFECT_SIZE="0.9095254353021509" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="29" LOG_CI_END="0.16246279662496335" LOG_CI_START="-0.24483309899163383" LOG_EFFECT_SIZE="-0.041185151183335204" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="223" O_E="0.0" SE="0.23924762523238852" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.05723942617933742" WEIGHT="33.13192860181832"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.597601049248659" CI_END="1.013434831610307" CI_START="0.41936333861924546" DF="4" EFFECT_SIZE="0.6519182574963913" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="67" I2="12.998105813167923" ID="CMP-005.19.06" LOG_CI_END="0.005795826850438482" LOG_CI_START="-0.37740953889522405" LOG_EFFECT_SIZE="-0.1858068560223928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.33113102767566704" P_Z="0.05734437849300244" STUDIES="5" TAU2="0.03770801350357896" TOTAL_1="501" TOTAL_2="502" WEIGHT="100.0" Z="1.900676652456979">
<NAME>somnolence</NAME>
<DICH_DATA CI_END="1.394157017910037" CI_START="0.00457025285413514" EFFECT_SIZE="0.07982261640798226" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.14431168923663795" LOG_CI_START="-2.3400597714579843" LOG_EFFECT_SIZE="-1.0978740411106733" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.4593320938490886" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.129650160137965" WEIGHT="2.33780174887228"/>
<DICH_DATA CI_END="3.1298350341967227" CI_START="0.03790678231036277" EFFECT_SIZE="0.34444444444444444" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4955214475700541" LOG_CI_START="-1.4212830787801585" LOG_EFFECT_SIZE="-0.4628808156050522" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.1259404671135462" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="1.2677419354838708" WEIGHT="3.881308305003843"/>
<DICH_DATA CI_END="0.9290229489231493" CI_START="0.3585512555441914" EFFECT_SIZE="0.5771501925545571" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="41" LOG_CI_END="-0.03197355783887716" LOG_CI_START="-0.44544875238424236" LOG_EFFECT_SIZE="-0.23871115511155977" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="250" O_E="0.0" SE="0.24287737601116982" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.058989419778071164" WEIGHT="52.39905090359155"/>
<DICH_DATA CI_END="1.636856610113416" CI_START="0.286197455926457" EFFECT_SIZE="0.6844444444444444" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.21401063655059463" LOG_CI_START="-0.5433342311003935" LOG_EFFECT_SIZE="-0.16466179727489944" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="0.44486812417574706" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.1979076479076479" WEIGHT="21.504740807227176"/>
<DICH_DATA CI_END="3.082160465707319" CI_START="0.4959672608757856" EFFECT_SIZE="1.2363861386138615" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4888552455300586" LOG_CI_START="-0.30454699062726626" LOG_EFFECT_SIZE="0.09215412745139619" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="0.4660484009232219" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.2172011120030922" WEIGHT="19.877098235305148"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9950251143534597" CI_START="0.08647464591921761" DF="0" EFFECT_SIZE="0.29333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" I2="0.0" ID="CMP-005.19.07" LOG_CI_END="-0.0021659575583179995" LOG_CI_START="-1.0631112075806697" LOG_EFFECT_SIZE="-0.5326385825694938" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.04907187424650325" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="100.0" Z="1.96796665726281">
<NAME>headache/dizziness</NAME>
<DICH_DATA CI_END="0.9950251143534597" CI_START="0.08647464591921761" EFFECT_SIZE="0.29333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.0021659575583179995" LOG_CI_START="-1.0631112075806697" LOG_EFFECT_SIZE="-0.5326385825694938" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="0.6232044916268162" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.38838383838383844" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2675902135150501" CI_END="0.6021059075142334" CI_START="0.22594942361055548" DF="1" EFFECT_SIZE="0.3688434393551706" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="55" I2="0.0" ID="CMP-005.19.08" LOG_CI_END="-0.22032711172617336" LOG_CI_START="-0.6459887622021065" LOG_EFFECT_SIZE="-0.43315793696414007" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6049529259531621" P_Z="6.636320583110726E-5" STUDIES="2" TAU2="0.0" TOTAL_1="441" TOTAL_2="442" WEIGHT="100.0" Z="3.9889614444625017">
<NAME>sedation</NAME>
<DICH_DATA CI_END="0.9913352393902776" CI_START="0.19370344250150612" EFFECT_SIZE="0.4382066276803119" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.0037794555076168025" LOG_CI_START="-0.7128626609219689" LOG_EFFECT_SIZE="-0.3583210582147928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="245" O_E="0.0" SE="0.416518984878866" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.17348806476452103" WEIGHT="36.035840066595526"/>
<DICH_DATA CI_END="0.617723115899202" CI_START="0.18137095755574068" EFFECT_SIZE="0.33471933471933474" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="37" LOG_CI_END="-0.20920614656642156" LOG_CI_START="-0.7414322541175425" LOG_EFFECT_SIZE="-0.47531920034198205" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="246" O_E="0.0" SE="0.3126322501372505" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.09773892382588034" WEIGHT="63.96415993340447"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.189324823334675" CI_START="0.4151658921922654" DF="0" EFFECT_SIZE="1.3188118811881189" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" ID="CMP-005.19.09" LOG_CI_END="0.6221440351076367" LOG_CI_START="-0.38177833300435726" LOG_EFFECT_SIZE="0.12018285105163971" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.638878458957298" STUDIES="1" TAU2="0.0" TOTAL_1="101" TOTAL_2="111" WEIGHT="100.0" Z="0.46926747944374525">
<NAME>nervousness</NAME>
<DICH_DATA CI_END="4.189324823334675" CI_START="0.4151658921922654" EFFECT_SIZE="1.3188118811881189" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6221440351076367" LOG_CI_START="-0.38177833300435726" LOG_EFFECT_SIZE="0.12018285105163971" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="0.5897089685248544" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.34775666755864776" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.522003783747942" CI_START="0.21285063889058803" DF="0" EFFECT_SIZE="0.7326732673267327" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" ID="CMP-005.19.10" LOG_CI_END="0.4017457338070943" LOG_CI_START="-0.6719250419104271" LOG_EFFECT_SIZE="-0.1350896540516664" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.621866484806836" STUDIES="1" TAU2="0.0" TOTAL_1="101" TOTAL_2="111" WEIGHT="100.0" Z="0.493206786686167">
<NAME>CNS stimulation</NAME>
<DICH_DATA CI_END="2.522003783747942" CI_START="0.21285063889058803" EFFECT_SIZE="0.7326732673267327" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.4017457338070943" LOG_CI_START="-0.6719250419104271" LOG_EFFECT_SIZE="-0.1350896540516664" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="0.6306795284125272" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.3977566675586477" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-4.820239962079033" CI_START="-12.959760037920965" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-8.889999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.20" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="1.0" P_Z="1.857603178704992E-5" Q="0.0" RANDOM="YES" SCALE="19.741266410506075" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="285" TOTAL_2="281" UNITS="" WEIGHT="100.0" Z="4.281353116696817">
<NAME>Adverse effects: 4. Endocrine - Prolactin - average increase</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_DATA CI_END="-4.820239962079033" CI_START="-12.959760037920965" EFFECT_SIZE="-8.889999999999999" ESTIMABLE="YES" MEAN_1="-18.52" MEAN_2="-9.63" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="24.8" SD_2="24.6" SE="2.076446337801466" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="22.02975940185022" CI_END="1.431006339441089" CI_START="0.7469975307420227" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0339043485925932" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="96" I2="50.06754363792036" I2_Q="43.638397553350195" ID="CMP-005.21" LOG_CI_END="0.155641557713784" LOG_CI_START="-0.12668083377614925" LOG_EFFECT_SIZE="0.01448036196881741" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.02414374300678146" P_Q="0.1496315726880243" P_Z="0.8406565447373172" Q="5.322772720736089" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.26220922891994924" TOTALS="SUB" TOTAL_1="1315" TOTAL_2="1351" WEIGHT="400.0" Z="0.20105375129622025">
<NAME>Adverse effects: 5. Extrapyramidal - various</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="13.674216326170338" CI_END="3.596188137499835" CI_START="0.6738762671584567" DF="5" EFFECT_SIZE="1.5567227878135246" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="37" I2="63.43483326038383" ID="CMP-005.21.01" LOG_CI_END="0.5558424041236756" LOG_CI_START="-0.1714198385142136" LOG_EFFECT_SIZE="0.19221128280473102" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.017816824519152452" P_Z="0.30019529339814854" STUDIES="6" TAU2="0.6193674546855509" TOTAL_1="657" TOTAL_2="663" WEIGHT="99.99999999999999" Z="1.0360147128031005">
<NAME>Akathisia</NAME>
<DICH_DATA CI_END="276.64770599952647" CI_START="1.0060450224416324" EFFECT_SIZE="16.682926829268293" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.4419270733360823" LOG_CI_START="0.002617416664679154" LOG_EFFECT_SIZE="1.2222722450003807" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.4328625671063222" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.05309513621452" WEIGHT="6.828819774755034"/>
<DICH_DATA CI_END="62.151490235474135" CI_START="1.0995356268830494" EFFECT_SIZE="8.266666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.7934515463852898" LOG_CI_START="0.04120930582781786" LOG_EFFECT_SIZE="0.9173304261065539" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.029275765842438" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="1.0594086021505376" WEIGHT="10.870875429582886"/>
<DICH_DATA CI_END="3.1571434189180296" CI_START="0.9251087457215463" EFFECT_SIZE="1.7090058479532164" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="15" LOG_CI_END="0.4992943109482679" LOG_CI_START="-0.03380721332485497" LOG_EFFECT_SIZE="0.23274354881170642" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="121" O_E="0.0" SE="0.313146474253137" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.0980607143371706" WEIGHT="25.43775973125122"/>
<DICH_DATA CI_END="0.9950251143534597" CI_START="0.08647464591921761" EFFECT_SIZE="0.29333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.0021659575583179995" LOG_CI_START="-1.0631112075806697" LOG_EFFECT_SIZE="-0.5326385825694938" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="0.6232044916268162" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.38838383838383844" WEIGHT="18.109394166537555"/>
<DICH_DATA CI_END="5.420271106190829" CI_START="0.6366878413364869" EFFECT_SIZE="1.8576923076923078" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.7340210092280794" LOG_CI_START="-0.19607344366669116" LOG_EFFECT_SIZE="0.26897378278069417" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="0.5463420856721831" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.2984896745766311" WEIGHT="19.883013168619744"/>
<DICH_DATA CI_END="2.9092533495379684" CI_START="0.28830964735573983" EFFECT_SIZE="0.9158415841584159" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.463781543012387" LOG_CI_START="-0.540140825099607" LOG_EFFECT_SIZE="-0.03817964104360995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="0.5897089685248544" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.34775666755864776" WEIGHT="18.87013772925355"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="55.311137476305944" CI_START="0.9459416945370961" DF="0" EFFECT_SIZE="7.233333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-005.21.02" LOG_CI_END="1.742812589848724" LOG_CI_START="-0.02413563159098959" LOG_EFFECT_SIZE="0.8593384791288672" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.05659577181073892" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="31" WEIGHT="100.0" Z="1.906419723210288">
<NAME>Tremor</NAME>
<DICH_DATA CI_END="55.311137476305944" CI_START="0.9459416945370961" EFFECT_SIZE="7.233333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.742812589848724" LOG_CI_START="-0.02413563159098959" LOG_EFFECT_SIZE="0.8593384791288671" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.0379141318084462" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="1.0772657450076804" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8239364388856283" CI_END="1.5870002572194977" CI_START="0.6178562403852748" DF="1" EFFECT_SIZE="0.9902211936815445" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="31" I2="0.0" ID="CMP-005.21.03" LOG_CI_END="0.20057699714489194" LOG_CI_START="-0.20911256256530136" LOG_EFFECT_SIZE="-0.004267782710204706" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.3640318159047199" P_Z="0.9674279666385949" STUDIES="4" TAU2="0.0" TOTAL_1="326" TOTAL_2="341" WEIGHT="100.0" Z="0.04083433520620362">
<NAME>Extrapyramidal symptoms</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="0.0" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="0.0" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.7747909163949185" CI_START="0.6491155852795094" EFFECT_SIZE="1.0733333333333333" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="25" LOG_CI_END="0.24914719727594725" LOG_CI_START="-0.18767796332361036" LOG_EFFECT_SIZE="0.030734616976168434" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="16" O_E="0.0" SE="0.25659326165559854" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.06584010192705846" WEIGHT="87.96188003042819"/>
<DICH_DATA CI_END="2.139787012760827" CI_START="0.14111483470916725" EFFECT_SIZE="0.5495049504950495" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.33037054728093596" LOG_CI_START="-0.8504273286008686" LOG_EFFECT_SIZE="-0.2600283906599663" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="0.6936065173367253" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.48109000089198106" WEIGHT="12.038119969571817"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1365699207290216" CI_END="1.3816368766439007" CI_START="0.4596498710841108" DF="2" EFFECT_SIZE="0.7969122989604456" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="27" I2="0.0" ID="CMP-005.21.04" LOG_CI_END="0.14039391627134967" LOG_CI_START="-0.3375728573518361" LOG_EFFECT_SIZE="-0.09858947054024318" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5664963324818524" P_Z="0.4187697225231374" STUDIES="3" TAU2="0.0" TOTAL_1="302" TOTAL_2="316" WEIGHT="100.0" Z="0.8085575072466747">
<NAME>Parkinsonism</NAME>
<DICH_DATA CI_END="7.795332307397482" CI_START="0.013640560661244014" EFFECT_SIZE="0.32608695652173914" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.891834633468784" LOG_CI_START="-1.8651677787205696" LOG_EFFECT_SIZE="-0.4866665726258928" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.619476864302069" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="2.6227053140096617" WEIGHT="3.005530380446626"/>
<DICH_DATA CI_END="1.7099989080833322" CI_START="0.49865176792534976" EFFECT_SIZE="0.9234143049932524" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="19" LOG_CI_END="0.23299583307429717" LOG_CI_START="-0.302202636868631" LOG_EFFECT_SIZE="-0.03460340189716691" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="17" O_E="0.0" SE="0.3143782305196292" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.09883367182465311" WEIGHT="79.75642667814556"/>
<DICH_DATA CI_END="1.7726733913928103" CI_START="0.1251471355447181" EFFECT_SIZE="0.471004243281471" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.24862872579708753" LOG_CI_START="-0.9025790863782466" LOG_EFFECT_SIZE="-0.32697518029057954" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="228" O_E="0.0" SE="0.6762251674423669" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="0.4572804770824572" WEIGHT="17.238042941407805"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.736214980169798" CI_END="1.3548586267441194" CI_START="0.7051417214430129" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9774289459465915" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="81" I2="21.78951111999353" I2_Q="72.89835643421931" ID="CMP-005.22" LOG_CI_END="0.1318939809461545" LOG_CI_START="-0.151723588462331" LOG_EFFECT_SIZE="-0.009914803758088243" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.19507763097859665" P_Q="0.011356306142621397" P_Z="0.8910037350436746" Q="11.069439359714275" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.15801349678669338" TOTALS="SUB" TOTAL_1="1417" TOTAL_2="1394" WEIGHT="400.0" Z="0.13703423465735348">
<NAME>Adverse effects: 6. Gastrointestinal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.33198177644997" CI_END="2.2555153318202845" CI_START="0.8001697241222043" DF="5" EFFECT_SIZE="1.3434266190663482" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="24" I2="0.0" ID="CMP-005.22.01" LOG_CI_END="0.3532457835518035" LOG_CI_START="-0.09681788496828106" LOG_EFFECT_SIZE="0.12821394929176122" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5026734639570318" P_Z="0.2641194549209315" STUDIES="6" TAU2="0.0" TOTAL_1="479" TOTAL_2="469" WEIGHT="100.0" Z="1.1167074372113308">
<NAME>nausea / vomiting</NAME>
<DICH_DATA CI_END="222.62506719669574" CI_START="0.7791942564709621" EFFECT_SIZE="13.170731707317072" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.3475740635578792" LOG_CI_START="-0.10835425735141341" LOG_EFFECT_SIZE="1.119609903103233" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.4426244527433731" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.0811653116531166" WEIGHT="3.358277170544332"/>
<DICH_DATA CI_END="2.442427262719192" CI_START="0.7285495765346653" EFFECT_SIZE="1.333952528379773" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.38782163897420613" LOG_CI_START="-0.1375408899024288" LOG_EFFECT_SIZE="0.12514037453588867" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="0.308600550048595" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.0952342994902954" WEIGHT="73.38878945569027"/>
<DICH_DATA CI_END="21.032408972995952" CI_START="0.1901826845006534" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228890179912565" LOG_CI_START="-0.7208290266632941" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.200490095997562" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="1.4411764705882355" WEIGHT="4.849600376420754"/>
<DICH_DATA CI_END="15.150142679509194" CI_START="0.06310497550687236" EFFECT_SIZE="0.9777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.180416722913026" LOG_CI_START="-1.1999363974913386" LOG_EFFECT_SIZE="-0.009759837289156262" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.3982312058635027" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="1.9550505050505051" WEIGHT="3.5749101806824624"/>
<DICH_DATA CI_END="21.061276053961322" CI_START="0.18992201563435934" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.323484680543928" LOG_CI_START="-0.7214246892159657" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="4.843951453442979"/>
<DICH_DATA CI_END="2.577129902321556" CI_START="0.0970071395216797" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41113631006800627" LOG_CI_START="-1.0131963013959688" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="0.8366600265340756" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.7" WEIGHT="9.984471363219201"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.910333322157376" CI_END="1.0441194880960323" CI_START="0.20622057048930303" DF="5" EFFECT_SIZE="0.46402469384092354" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" I2="0.0" ID="CMP-005.22.02" LOG_CI_END="0.018750201780564555" LOG_CI_START="-0.6856680160437049" LOG_EFFECT_SIZE="-0.33345890713157017" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4269211946999085" P_Z="0.06350726238464577" STUDIES="6" TAU2="0.0" TOTAL_1="224" TOTAL_2="219" WEIGHT="100.0" Z="1.8556233548888967">
<NAME>constipation</NAME>
<DICH_DATA CI_END="3.5384563850724375" CI_START="0.008715321903286232" EFFECT_SIZE="0.17560975609756097" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5488138468710192" LOG_CI_START="-2.0597165674479534" LOG_EFFECT_SIZE="-0.755451360288467" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.5322636778047645" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.347831978319783" WEIGHT="7.292380968513463"/>
<DICH_DATA CI_END="2.7389368446952904" CI_START="0.007939597214199805" EFFECT_SIZE="0.14746543778801843" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43758201826471066" LOG_CI_START="-2.1002015293219576" LOG_EFFECT_SIZE="-0.8313097555286235" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.4907066180835706" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.2222062211981566" WEIGHT="7.704633833099046"/>
<DICH_DATA CI_END="2.550548773546233" CI_START="0.09801812166579543" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4066336328581724" LOG_CI_START="-1.0086936241861348" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="0.8313702367707394" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="0.6911764705882353" WEIGHT="24.77122119246217"/>
<DICH_DATA CI_END="5.1996734008264225" CI_START="0.045966799691885316" EFFECT_SIZE="0.4888888888888889" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7159760658129948" LOG_CI_START="-1.33755573171927" LOG_EFFECT_SIZE="-0.31078983295313745" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.2062547430167914" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="1.4550505050505051" WEIGHT="11.766797906009604"/>
<DICH_DATA CI_END="5.525756215095862" CI_START="0.3217256984521052" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7423917208312917" LOG_CI_START="-0.4925142476146918" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="0.7253898787483019" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="0.5261904761904761" WEIGHT="32.53818913622593"/>
<DICH_DATA CI_END="0.9537939361791632" CI_START="0.01638194520568325" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.020545442955097762" LOG_CI_START="-1.7856345310287896" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="1.0368220676663862" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="1.0750000000000002" WEIGHT="15.926776963689765"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8099307394500228" CI_END="1.1866114208323346" CI_START="0.3832269993947229" DF="4" EFFECT_SIZE="0.6743452633874463" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="30" I2="0.0" ID="CMP-005.22.03" LOG_CI_END="0.07430852399519214" LOG_CI_START="-0.41654390127647933" LOG_EFFECT_SIZE="-0.17111768864064364" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7706650143258893" P_Z="0.17176982853076614" STUDIES="5" TAU2="0.0" TOTAL_1="429" TOTAL_2="425" WEIGHT="99.99999999999997" Z="1.3665390638246326">
<NAME>dry mouth</NAME>
<DICH_DATA CI_END="2.042579782403475" CI_START="0.006440395252195581" EFFECT_SIZE="0.11469534050179211" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.31017902891602406" LOG_CI_START="-2.1910874788234076" LOG_EFFECT_SIZE="-0.9404542249536916" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.469256328115041" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.1587141577060933" WEIGHT="3.8510747331919273"/>
<DICH_DATA CI_END="1.5009248432841482" CI_START="0.4036819117481924" EFFECT_SIZE="0.778393351800554" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" LOG_CI_END="0.17635894609792485" LOG_CI_START="-0.3939607100990809" LOG_EFFECT_SIZE="-0.10880088200057803" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="272" O_E="0.0" SE="0.3350085891779501" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.11223075482300056" WEIGHT="74.07389856761338"/>
<DICH_DATA CI_END="5.258102243248987" CI_START="0.04754567112516334" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7208290266632941" LOG_CI_START="-1.3228890179912565" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.200490095997562" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="1.4411764705882355" WEIGHT="5.768460503336151"/>
<DICH_DATA CI_END="3.714831400322382" CI_START="0.11438226691144417" EFFECT_SIZE="0.6518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5699391078486201" LOG_CI_START="-0.9416413005382951" LOG_EFFECT_SIZE="-0.18585109634483746" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="0.8879098143301708" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="0.7883838383838383" WEIGHT="10.544824924325912"/>
<DICH_DATA CI_END="5.26531901349033" CI_START="0.047480503908589836" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7214246892159656" LOG_CI_START="-1.323484680543928" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="1.2011898862615948" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="1.442857142857143" WEIGHT="5.761741271532615"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.029293936674556" CI_START="1.0896526323785085" DF="0" EFFECT_SIZE="2.957894736842105" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" I2="0.0" ID="CMP-005.22.04" LOG_CI_END="0.9046773568741943" LOG_CI_START="0.03728807235827001" LOG_EFFECT_SIZE="0.4709827146162321" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.03329753833517616" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="2.1284772004161745">
<NAME>abdominal pain - upper</NAME>
<DICH_DATA CI_END="8.029293936674556" CI_START="1.0896526323785085" EFFECT_SIZE="2.957894736842105" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.9046773568741943" LOG_CI_START="0.03728807235827001" LOG_EFFECT_SIZE="0.4709827146162321" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="270" O_E="0.0" SE="0.5095087593708593" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.25959917587563214" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1296370478675377" CI_START="0.035409603531957164" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.20000000000000007" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-005.23" LOG_CI_END="0.05293892717496855" LOG_CI_START="-1.4508789358470058" LOG_EFFECT_SIZE="-0.6989700043360186" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="1.0" P_Q="1.0" P_Z="0.0684594330608583" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="99" TOTAL_2="99" WEIGHT="100.0" Z="1.8219706900135204">
<NAME>Adverse effects: 7. Hormonal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1296370478675377" CI_START="0.035409603531957164" DF="2" EFFECT_SIZE="0.20000000000000007" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" I2="0.0" ID="CMP-005.23.01" LOG_CI_END="0.05293892717496855" LOG_CI_START="-1.4508789358470058" LOG_EFFECT_SIZE="-0.6989700043360186" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0684594330608583" STUDIES="3" TAU2="0.0" TOTAL_1="99" TOTAL_2="99" WEIGHT="100.0" Z="1.8219706900135204">
<NAME>menstrual changes</NAME>
<DICH_DATA CI_END="4.017100178657409" CI_START="0.009957431535443751" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.603912662325553" LOG_CI_START="-2.0018526709975903" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2565" O_E="0.0" SE="1.5306394555404428" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="2.342857142857143" WEIGHT="33.30580036228905"/>
<DICH_DATA CI_END="4.021183978262525" CI_START="0.009947319052356126" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6043539435123508" LOG_CI_START="-2.002293952184388" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2566" O_E="0.0" SE="1.531157877047447" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="2.3444444444444446" WEIGHT="33.2832507344202"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2532" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="33.41094890329075"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="19.64712895662589" CI_END="0.3725829279930222" CI_START="0.1859311390216129" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2632010033828712" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="274" I2="18.563164952383115" I2_Q="0.0" ID="CMP-005.24" LOG_CI_END="-0.42877704865686306" LOG_CI_START="-0.7306478701917207" LOG_EFFECT_SIZE="-0.5797124594242918" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.23653595697231977" P_Q="0.7803599868529816" P_Z="5.159199349233798E-14" Q="2.474303400788313" RANDOM="YES" SCALE="924.0739142734429" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.06542110199640111" TOTALS="SUB" TOTAL_1="1393" TOTAL_2="1399" WEIGHT="600.0" Z="7.527826214429594">
<NAME>Adverse effects: 8a. Metabolic - binary measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.9654741067255674" CI_END="1.9955313255982585" CI_START="0.05572635776125778" DF="1" EFFECT_SIZE="0.3334721766116111" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="39" I2="49.12169045737387" ID="CMP-005.24.01" LOG_CI_END="0.3000585496733792" LOG_CI_START="-1.2539393412229896" LOG_EFFECT_SIZE="-0.4769403957748051" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16092938912938792" P_Z="0.22894832060037507" STUDIES="2" TAU2="1.0551434410731724" TOTAL_1="330" TOTAL_2="325" WEIGHT="100.0" Z="1.2030724159499333">
<NAME>appetite- increase</NAME>
<DICH_DATA CI_END="0.9739932742269981" CI_START="0.33086153784347166" EFFECT_SIZE="0.5676767676767677" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="33" LOG_CI_END="-0.011444042070241137" LOG_CI_START="-0.4803537159867366" LOG_EFFECT_SIZE="-0.24589887902848884" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="0.2754398635988702" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.0758671184593642" WEIGHT="73.6731763442172"/>
<DICH_DATA CI_END="1.2969380677149234" CI_START="0.004366197953304428" EFFECT_SIZE="0.07525083612040134" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11291923784826766" LOG_CI_START="-2.359896578274402" LOG_EFFECT_SIZE="-1.123488670213067" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.4525442510261604" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="2.109884801189149" WEIGHT="26.3268236557828"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.07057842633892629" CI_END="0.44485235513471255" CI_START="0.03405198188204621" DF="2" EFFECT_SIZE="0.1230776354064085" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="20" I2="0.0" ID="CMP-005.24.02" LOG_CI_END="-0.3517841058503475" LOG_CI_START="-1.467857606353596" LOG_EFFECT_SIZE="-0.9098208561019717" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9653261912773168" P_Z="0.0013958039659032785" STUDIES="3" TAU2="0.0" TOTAL_1="114" TOTAL_2="113" WEIGHT="100.00000000000003" Z="3.1955173374140573">
<NAME> blood glucose - increase</NAME>
<DICH_DATA CI_END="1.0993776829417647" CI_START="0.018563377792695433" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.0411469166631687" LOG_CI_START="-1.7313429966916825" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.0411693490712153" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="1.0840336134453783" WEIGHT="39.64770454032574"/>
<DICH_DATA CI_END="1.561848214475928" CI_START="0.005063900555365829" EFFECT_SIZE="0.08893280632411067" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19363882543207822" LOG_CI_START="-2.295514831560989" LOG_EFFECT_SIZE="-1.0509380030644555" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.4621411796270485" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="2.137856829161177" WEIGHT="20.103986306008963"/>
<DICH_DATA CI_END="0.9473656386205671" CI_START="0.016493103995993713" EFFECT_SIZE="0.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.023482371379337435" LOG_CI_START="-1.7826976026045493" LOG_EFFECT_SIZE="-0.9030899869919435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="1.033371735077529" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="1.067857142857143" WEIGHT="40.24830915366532"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5420345387783303" CI_START="0.18560153525392445" DF="0" EFFECT_SIZE="0.31717888100866826" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="47" I2="0.0" ID="CMP-005.24.03" LOG_CI_END="-0.26597303906507125" LOG_CI_START="-0.7314184357165636" LOG_EFFECT_SIZE="-0.49869573739081746" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="2.669638589256742E-5" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="115" WEIGHT="100.0" Z="4.199958541050974">
<NAME>cholesterol - abnormally high cholesterol value</NAME>
<DICH_DATA CI_END="0.5420345387783303" CI_START="0.18560153525392445" EFFECT_SIZE="0.31717888100866826" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="47" LOG_CI_END="-0.26597303906507125" LOG_CI_START="-0.7314184357165636" LOG_EFFECT_SIZE="-0.49869573739081746" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="0.27340492998495836" STUDY_ID="STD-McQuade-2004" TOTAL_1="108" TOTAL_2="115" VAR="0.07475025574007997" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.8698689779204765" CI_START="0.01411854649967386" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.24.04" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.6810488185180525">
<NAME>lactation</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2162" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.561848214475928" CI_START="0.005063900555365829" DF="0" EFFECT_SIZE="0.08893280632411069" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" I2="0.0" ID="CMP-005.24.05" LOG_CI_END="0.19363882543207822" LOG_CI_START="-2.295514831560989" LOG_EFFECT_SIZE="-1.0509380030644553" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.09792026285072067" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="100.0" Z="1.6550208784451226">
<NAME>PRL- increase</NAME>
<DICH_DATA CI_END="1.561848214475928" CI_START="0.005063900555365829" EFFECT_SIZE="0.08893280632411067" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19363882543207822" LOG_CI_START="-2.295514831560989" LOG_EFFECT_SIZE="-1.0509380030644555" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.4621411796270485" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="2.137856829161177" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.461661750131352" CI_END="0.42562055298407386" CI_START="0.14955572196253417" DF="8" EFFECT_SIZE="0.2522974218727298" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="162" I2="30.20209307862083" ID="CMP-005.24.06" LOG_CI_END="-0.3709774083632679" LOG_CI_START="-0.8251969663222947" LOG_EFFECT_SIZE="-0.5980871873427812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.17688738565290463" P_Z="2.4496608185822064E-7" STUDIES="9" TAU2="0.14474472896608895" TOTAL_1="766" TOTAL_2="772" WEIGHT="99.99999999999999" Z="5.161509786474028">
<NAME>weight gain</NAME>
<DICH_DATA CI_END="1.7506122613464035" CI_START="0.005437037185268532" EFFECT_SIZE="0.0975609756097561" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.24318996595509515" LOG_CI_START="-2.264637696738641" LOG_EFFECT_SIZE="-1.0107238653917732" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.4731103830134407" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="2.1700542005420056" WEIGHT="3.0753432203999296"/>
<DICH_DATA CI_END="0.8032693209470169" CI_START="0.0030079928466408244" EFFECT_SIZE="0.04915514592933948" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.09513881961427799" LOG_CI_START="-2.521723200882294" LOG_EFFECT_SIZE="-1.308431010248286" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.4253876773432435" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.0317300307219663" WEIGHT="3.2707942799539014"/>
<DICH_DATA CI_END="0.7056664135976082" CI_START="0.26041608177126696" EFFECT_SIZE="0.4286803966437834" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="46" LOG_CI_END="-0.151400552448737" LOG_CI_START="-0.5843321997933094" LOG_EFFECT_SIZE="-0.3678663761210232" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="0.2543061926964188" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.06467163964374809" WEIGHT="33.993528021273015"/>
<DICH_DATA CI_END="0.8698065306790718" CI_START="0.00318471177760694" EFFECT_SIZE="0.05263157894736842" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" LOG_CI_END="-0.06057733588977182" LOG_CI_START="-2.4969298660158867" LOG_EFFECT_SIZE="-1.278753600952829" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2239" O_E="0.0" SE="1.4311255363356072" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" VAR="2.04812030075188" WEIGHT="3.2463471750321564"/>
<DICH_DATA CI_END="1.1085271130532943" CI_START="0.0038369004045640683" EFFECT_SIZE="0.06521739130434782" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.04474631982798223" LOG_CI_START="-2.4160194737518057" LOG_EFFECT_SIZE="-1.1856365769619117" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2119" O_E="0.0" SE="1.445466008135898" STUDY_ID="STD-Ma-2009" TOTAL_1="45" TOTAL_2="44" VAR="2.0893719806763285" WEIGHT="3.186405241824245"/>
<DICH_DATA CI_END="1.1242764392747613" CI_START="0.0039531598183374095" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.05087310953428134" LOG_CI_START="-2.4030556276456436" LOG_EFFECT_SIZE="-1.1760912590556813" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2179" O_E="0.0" SE="1.4414498873626436" STUDY_ID="STD-Mao-2010" TOTAL_1="35" TOTAL_2="35" VAR="2.077777777777778" WEIGHT="3.203027718662439"/>
<DICH_DATA CI_END="0.5848465486698488" CI_START="0.23874991538003967" EFFECT_SIZE="0.3736737400530504" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="58" LOG_CI_END="-0.23295806863239113" LOG_CI_START="-0.6220567736708688" LOG_EFFECT_SIZE="-0.42750742115162993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="0.228558505409255" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.05223899039491244" WEIGHT="36.139033304602656"/>
<DICH_DATA CI_END="0.5454794518074457" CI_START="0.032591104429087345" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="15" LOG_CI_END="-0.2632216046259969" LOG_CI_START="-1.4869009221574032" LOG_EFFECT_SIZE="-0.8750612633917001" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="0.7187952884282608" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="0.5166666666666666" WEIGHT="10.763045876524938"/>
<DICH_DATA CI_END="1.4806506036242797" CI_START="0.004818328539361605" EFFECT_SIZE="0.08446455505279035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.17045258801473442" LOG_CI_START="-2.3171035908118798" LOG_EFFECT_SIZE="-1.0733255013985727" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="1.4612028130444297" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="101" TOTAL_2="111" VAR="2.1351136608489547" WEIGHT="3.1224751617267135"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="78.77633628444141" CI_END="-0.8857107827178141" CI_START="-1.276179974946602" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.080945378832208" ESTIMABLE="YES" I2="84.76699911929003" I2_Q="91.6516190901612" ID="CMP-005.25" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="7.060241280498758E-12" P_Q="1.6919798895287386E-13" P_Z="1.9589568705288043E-27" Q="71.87022327801121" RANDOM="YES" SCALE="33.865852839211094" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.7614842988749801" TOTALS="SUB" TOTAL_1="1453" TOTAL_2="1461" UNITS="" WEIGHT="700.0" Z="10.851632107891223">
<NAME>Adverse effects: 8b. Metabolic - continuous measures (high=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6263984377381863" CI_END="-5.651076352642083" CI_START="-9.205620964721593" DF="2" EFFECT_SIZE="-7.428348658681838" ESTIMABLE="YES" I2="0.0" ID="CMP-005.25.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.731104292921319" P_Z="2.570635150580149E-16" STUDIES="3" TAU2="0.0" TOTAL_1="121" TOTAL_2="121" WEIGHT="100.0" Z="8.191933102285764">
<NAME>weight - average endpoint level (in kg)</NAME>
<CONT_DATA CI_END="-4.585974481384143" CI_START="-10.414025518615842" EFFECT_SIZE="-7.499999999999993" ESTIMABLE="YES" MEAN_1="57.6" MEAN_2="65.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2118" SD_1="5.1" SD_2="7.9" SE="1.4867750334196497" STUDY_ID="STD-Song-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="37.19814183168102"/>
<CONT_DATA CI_END="-5.319295623870113" CI_START="-10.480704376129898" EFFECT_SIZE="-7.900000000000006" ESTIMABLE="YES" MEAN_1="57.5" MEAN_2="65.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="5.1" SD_2="7.9" SE="1.3167101010458144" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="47.427630835393295"/>
<CONT_DATA CI_END="-1.2672963631684775" CI_START="-10.332703636831532" EFFECT_SIZE="-5.800000000000004" ESTIMABLE="YES" MEAN_1="60.1" MEAN_2="65.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2171" SD_1="9.3" SD_2="8.6" SE="2.3126463917627644" STUDY_ID="STD-Yang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="15.374227332925688"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.314384735316275" CI_END="1.2899486981599613" CI_START="-7.349006415992367" DF="1" EFFECT_SIZE="-3.0295288589162026" ESTIMABLE="YES" I2="84.16314428218142" ID="CMP-005.25.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.011976248282840052" P_Z="0.16924014960839154" STUDIES="2" TAU2="8.370698004017102" TOTAL_1="326" TOTAL_2="330" WEIGHT="100.0" Z="1.3746494512682996">
<NAME>weight gain - change from baseline (in kg)</NAME>
<CONT_DATA CI_END="-0.6737068688059284" CI_START="-1.6062931311940714" EFFECT_SIZE="-1.14" ESTIMABLE="YES" MEAN_1="0.11" MEAN_2="1.25" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="239" SD_1="2.84" SD_2="2.82" SE="0.23790903040674835" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="57.63388208708067"/>
<CONT_DATA CI_END="-2.152689508076862" CI_START="-9.047310491923138" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-1.37" MEAN_2="4.23" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="240" SD_1="8.31" SD_2="8.31" SE="1.7588642031767336" STUDY_ID="STD-McQuade-2004" TOTAL_1="41" TOTAL_2="49" WEIGHT="42.36611791291933"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.28928000624121075" CI_END="-9.114244410424583" CI_START="-21.61788951312497" DF="1" EFFECT_SIZE="-15.366066961774777" ESTIMABLE="YES" I2="0.0" ID="CMP-005.25.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5906823630000542" P_Z="1.4550997048277359E-6" STUDIES="2" TAU2="0.0" TOTAL_1="393" TOTAL_2="396" WEIGHT="100.0" Z="4.817305286856723">
<NAME>cholesterol - change from baseline (in mg/dl)</NAME>
<CONT_DATA CI_END="-5.810355502362908" CI_START="-22.069644497637093" EFFECT_SIZE="-13.94" ESTIMABLE="YES" MEAN_1="-9.85" MEAN_2="4.09" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="234" SD_1="49.52" SD_2="49.16" SE="4.147854022707912" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="59.13848247063675"/>
<CONT_DATA CI_END="-7.649762595565861" CI_START="-27.21023740443414" EFFECT_SIZE="-17.43" ESTIMABLE="YES" MEAN_1="-1.13" MEAN_2="16.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="235" SD_1="37.24" SD_2="37.24" SE="4.990008735660147" STUDY_ID="STD-McQuade-2004" TOTAL_1="108" TOTAL_2="115" WEIGHT="40.86151752936325"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5589002553026428" CI_START="-1.4410997446973581" DF="1" EFFECT_SIZE="-1.0000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-005.25.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="8.856570510184894E-6" STUDIES="2" TAU2="0.0" TOTAL_1="91" TOTAL_2="91" WEIGHT="100.0" Z="4.443357784949079">
<NAME>cholesterol - TC average endpoint level (in mmol/L)</NAME>
<CONT_DATA CI_END="-0.3310232047291437" CI_START="-1.6689767952708572" EFFECT_SIZE="-1.0000000000000004" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="4.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2118" SD_1="0.5" SD_2="2.1" SE="0.34132096331752027" STUDY_ID="STD-Song-2010" TOTAL_1="40" TOTAL_2="40" WEIGHT="43.476192741283356"/>
<CONT_DATA CI_END="-0.41329322534763335" CI_START="-1.5867067746523675" EFFECT_SIZE="-1.0000000000000004" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="4.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="0.4" SD_2="2.1" SE="0.2993456916964981" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="56.523807258716644"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.6931557358072449" CI_START="-1.3068442641927551" DF="0" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.25.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="1.686330913819214E-10" STUDIES="1" TAU2="0.0" TOTAL_1="51" TOTAL_2="51" WEIGHT="100.0" Z="6.387487769068525">
<NAME>cholesterol - TG average endpoint level (in mmol/L)</NAME>
<CONT_DATA CI_END="-0.6931557358072449" CI_START="-1.3068442641927551" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="2.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2145" SD_1="0.5" SD_2="1.0" SE="0.15655607277128736" STUDY_ID="STD-Wei-2009" TOTAL_1="51" TOTAL_2="51" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.6342693293374677" CI_START="-1.2657306706625326" DF="0" EFFECT_SIZE="-0.9500000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-005.25.06" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="3.694459482675799E-9" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="5.897323124819909">
<NAME>blood glucose - PBG average endpoint level (in mg/dl)</NAME>
<CONT_DATA CI_END="-0.6342693293374677" CI_START="-1.2657306706625326" EFFECT_SIZE="-0.9500000000000002" ESTIMABLE="YES" MEAN_1="4.68" MEAN_2="5.63" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2171" SD_1="0.51" SD_2="0.72" SE="0.16109003693587012" STUDY_ID="STD-Yang-2009" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.14655831282453638" CI_END="1.1937251477083568" CI_START="-7.981649799868537" DF="1" EFFECT_SIZE="-3.3939623260800897" ESTIMABLE="YES" I2="0.0" ID="CMP-005.25.07" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.7018464370386825" P_Z="0.1470647748538209" STUDIES="2" TAU2="0.0" TOTAL_1="441" TOTAL_2="442" WEIGHT="100.0" Z="1.4499775675673043">
<NAME>glucose - change from baseline (in mg/dl)</NAME>
<CONT_DATA CI_END="1.4838277796632373" CI_START="-9.423827779663238" EFFECT_SIZE="-3.97" ESTIMABLE="YES" MEAN_1="0.9" MEAN_2="4.87" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="237" SD_1="33.2" SD_2="33.0" SE="2.78261632493369" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" WEIGHT="70.75950893807564"/>
<CONT_DATA CI_END="6.484016294353838" CI_START="-10.484016294353838" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="7.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="238" SD_1="38.53" SD_2="38.53" SE="4.328659282147363" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" WEIGHT="29.240491061924367"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-005.26" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="26" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Adverse effects: 9. Average endpoint scale score (TESS, high=poor, data skewed)</NAME>
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Mean</P>
</TH>
<TH>
<P>SD</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Note</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4770" STUDY_ID="STD-Zhang-2006a">
<TR>
<TD>
<P>Aripiprazole</P>
</TD>
<TD>
<P>4.43</P>
</TD>
<TD>
<P>4.03</P>
</TD>
<TD>
<P>52</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Olanzapine</P>
</TD>
<TD>
<P>5.54 </P>
</TD>
<TD>
<P>4.33</P>
</TD>
<TD>
<P>52</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="34.6895973696741" CI_END="1.2482835242621675" CI_START="1.0665930094353413" CI_STUDY="95" CI_TOTAL="95" DF="32" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1538676183910088" ESTIMABLE="YES" EVENTS_1="794" EVENTS_2="670" I2="7.75332541629717" I2_Q="27.954413139243595" ID="CMP-005.27" LOG_CI_END="0.09631323842156891" LOG_CI_START="0.027998732943702333" LOG_EFFECT_SIZE="0.06215598568263556" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="0.3408639555538848" P_Q="0.15585106922345604" P_Z="3.6171409947568416E-4" Q="18.044130898850607" RANDOM="YES" SCALE="341.739973638709" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.004970349394352599" TOTALS="SUB" TOTAL_1="5148" TOTAL_2="5145" WEIGHT="1400.0" Z="3.5665483489746688">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.539363651696719" CI_END="1.2525597228070562" CI_START="1.0503182179054515" DF="8" EFFECT_SIZE="1.1469901027815599" ESTIMABLE="YES" EVENTS_1="482" EVENTS_2="409" I2="0.0" ID="CMP-005.27.01" LOG_CI_END="0.09779844245719606" LOG_CI_START="0.02132089844403264" LOG_EFFECT_SIZE="0.0595596704506143" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8054822333981262" P_Z="0.002267271446606731" STUDIES="9" TAU2="0.0" TOTAL_1="1168" TOTAL_2="1163" WEIGHT="99.99999999999999" Z="3.0527865537676284">
<NAME>Any reason</NAME>
<DICH_DATA CI_END="18.482357467934268" CI_START="0.16569855903464942" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.26675736569448" LOG_CI_START="-0.7806812683218911" LOG_EFFECT_SIZE="0.24303804868629444" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2667" O_E="0.0" SE="1.2026755886059097" STUDY_ID="STD-Chen-2009a" TOTAL_1="40" TOTAL_2="35" VAR="1.4464285714285716" WEIGHT="0.13952308725793314"/>
<DICH_DATA CI_END="1.6931590153268765" CI_START="1.015539998685415" EFFECT_SIZE="1.31128589720139" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="77" LOG_CI_END="0.22869774738004667" LOG_CI_START="0.006697033468307645" LOG_EFFECT_SIZE="0.11769739042417714" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="1" O_E="0.0" SE="0.13040431827301252" STUDY_ID="STD-Fleischhacker-2008" TOTAL_1="355" TOTAL_2="348" VAR="0.01700528622424915" WEIGHT="11.867496796144453"/>
<DICH_DATA CI_END="8.128711794201093" CI_START="0.01456506186870345" EFFECT_SIZE="0.34408602150537637" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9100217257910883" LOG_CI_START="-1.8366876662591465" LOG_EFFECT_SIZE="-0.4633329702340291" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" O_E="0.0" SE="1.613430693321079" STUDY_ID="STD-Han-2007" TOTAL_1="30" TOTAL_2="31" VAR="2.6031586021505375" WEIGHT="0.07752511876036886"/>
<DICH_DATA CI_END="1.404015577075882" CI_START="0.9832423507682069" EFFECT_SIZE="1.1749415204678362" ESTIMABLE="YES" EVENTS_1="143" EVENTS_2="120" LOG_CI_END="0.14737192617026204" LOG_CI_START="-0.007339423542248738" LOG_EFFECT_SIZE="0.07001625131400664" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.09087821265466109" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.008258849535305802" WEIGHT="24.435628584959286"/>
<DICH_DATA CI_END="1.4487378047991593" CI_START="0.9447182097788224" EFFECT_SIZE="1.169892723880597" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="67" LOG_CI_END="0.1609897931782288" LOG_CI_START="-0.02469771338282185" LOG_EFFECT_SIZE="0.06814603989770347" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="0.1090737605219428" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="0.011897085234398128" WEIGHT="16.96299352385078"/>
<DICH_DATA CI_END="1.2143751804320966" CI_START="0.9242910853908921" EFFECT_SIZE="1.0594508736101655" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="113" LOG_CI_END="0.08435288247141973" LOG_CI_START="-0.03419123562964606" LOG_EFFECT_SIZE="0.025080823420886827" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.06963340177541447" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.004848810642816295" WEIGHT="41.62055288399145"/>
<DICH_DATA CI_END="71.50812704867249" CI_START="0.12585982001561988" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8543554030852154" LOG_CI_START="-0.9001128936458906" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="0.07708898171865507"/>
<DICH_DATA CI_END="2.024268887291291" CI_START="0.8996176012607535" EFFECT_SIZE="1.3494694960212201" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="29" LOG_CI_END="0.30626820011969674" LOG_CI_START="-0.045942056064729606" LOG_EFFECT_SIZE="0.1301630720274836" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="0.20689004795161844" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="104" TOTAL_2="110" VAR="0.04280349194142298" WEIGHT="4.714806447566836"/>
<DICH_DATA CI_END="15.259760455310136" CI_START="0.0655318281652329" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1835477162038213" LOG_CI_START="-1.1835477162038213" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2162" O_E="0.0" SE="1.390443574307614" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="1.9333333333333331" WEIGHT="0.1043845757502394"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.50812704867249" CI_START="0.12585982001561988" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.27.02" LOG_CI_END="1.8543554030852154" LOG_CI_START="-0.9001128936458906" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4971385617323206" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.6789989027057508">
<NAME>Economic issues</NAME>
<DICH_DATA CI_END="71.50812704867249" CI_START="0.12585982001561988" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8543554030852154" LOG_CI_START="-0.9001128936458906" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2132" O_E="0.0" SE="1.6179883123378205" STUDY_ID="STD-Qian-2009" TOTAL_1="40" TOTAL_2="40" VAR="2.6178861788617884" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="70.82882080128432" CI_START="0.12706691849706483" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-005.27.03" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.6810488185180525">
<NAME>Early discharge</NAME>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2162" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.8698689779204765" CI_START="0.01411854649967386" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.27.04" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="99.99999999999999" Z="0.6810488185180525">
<NAME>Refusing therapy</NAME>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363439" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2162" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Ye-2005a" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9049815158533772" CI_END="1.5850321178938747" CI_START="0.9155189586107368" DF="3" EFFECT_SIZE="1.2046273091453517" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="79" I2="0.0" ID="CMP-005.27.05" LOG_CI_END="0.20003806685834882" LOG_CI_START="-0.038332657878094804" LOG_EFFECT_SIZE="0.08085270449012699" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5923606181423012" P_Z="0.1836513952144868" STUDIES="4" TAU2="0.0" TOTAL_1="673" TOTAL_2="679" WEIGHT="100.00000000000001" Z="1.3295960653601284">
<NAME>adverse events</NAME>
<DICH_DATA CI_END="1.7097024959734826" CI_START="0.6131732587255361" EFFECT_SIZE="1.0238866396761133" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="26" LOG_CI_END="0.23292054571508697" LOG_CI_START="-0.21241679354560897" LOG_EFFECT_SIZE="0.010251876084738995" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.26159335753711516" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.06843108470754097" WEIGHT="28.650197078655932"/>
<DICH_DATA CI_END="1.9980611207264878" CI_START="0.6982648189855113" EFFECT_SIZE="1.1811755952380953" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.30060876916936424" LOG_CI_START="-0.15597983867695048" LOG_EFFECT_SIZE="0.07231446524620688" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="138" O_E="0.0" SE="0.26820240839898535" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="0.07193253187101613" WEIGHT="27.25559648995505"/>
<DICH_DATA CI_END="1.9532723631783295" CI_START="0.8294700105850301" EFFECT_SIZE="1.2728632478632478" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="30" LOG_CI_END="0.29076280528385284" LOG_CI_START="-0.08119931123441154" LOG_EFFECT_SIZE="0.10478174702472065" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.21849238848500044" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.04773892382588035" WEIGHT="41.0684595724879"/>
<DICH_DATA CI_END="15.369639245916602" CI_START="0.6550848070450506" EFFECT_SIZE="3.173076923076923" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1866636739183243" LOG_CI_START="-0.18370247276010998" LOG_EFFECT_SIZE="0.5014806005791071" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.80495985798074" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="104" TOTAL_2="110" VAR="0.647960372960373" WEIGHT="3.0257468589011203"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.602508628142461" CI_END="2.670977373271036" CI_START="1.2286318092149722" DF="3" EFFECT_SIZE="1.8115318828257612" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="45" I2="16.724696325103007" ID="CMP-005.27.06" LOG_CI_END="0.4266702089853732" LOG_CI_START="0.08942175499111844" LOG_EFFECT_SIZE="0.25804598198824585" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.3077086049835762" P_Z="0.002705681284848997" STUDIES="4" TAU2="0.026826486845235552" TOTAL_1="673" TOTAL_2="679" WEIGHT="100.0" Z="2.999336691167452">
<NAME>inefficacy</NAME>
<DICH_DATA CI_END="6.115016975992207" CI_START="1.5277371532977797" EFFECT_SIZE="3.0564912280701755" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="10" LOG_CI_END="0.7863976670255352" LOG_CI_START="0.1840486404361497" LOG_EFFECT_SIZE="0.48522315373084235" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="109" O_E="0.0" SE="0.35382279989437443" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.1251905737250945" WEIGHT="25.815634774860502"/>
<DICH_DATA CI_END="2.301028421238934" CI_START="0.7164947930192522" EFFECT_SIZE="1.2840073529411764" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="17" LOG_CI_END="0.36192198290637" LOG_CI_START="-0.14478696140232844" LOG_EFFECT_SIZE="0.10856751075202078" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.29764334213665633" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="0.08859155911827866" WEIGHT="34.00176187761895"/>
<DICH_DATA CI_END="3.1734605601716437" CI_START="0.9058766195499375" EFFECT_SIZE="1.6955128205128205" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.501533105263412" LOG_CI_START="-0.042930949229926116" LOG_EFFECT_SIZE="0.22930107801674296" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.31982088074992326" STUDY_ID="STD-McQuade-2004" TOTAL_1="156" TOTAL_2="161" VAR="0.10228539576365663" WEIGHT="30.39547434312763"/>
<DICH_DATA CI_END="6.138457592206981" CI_START="0.5581302086721955" EFFECT_SIZE="1.8509615384615385" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7880592598473678" LOG_CI_START="-0.2532644707558896" LOG_EFFECT_SIZE="0.26739739454573913" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="237" O_E="0.0" SE="0.6116787139919527" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="104" TOTAL_2="110" VAR="0.3741508491508491" WEIGHT="9.787129004392927"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.26608454931025727" CI_END="1.16742505270738" CI_START="0.4637183577777465" DF="1" EFFECT_SIZE="0.7357692765195251" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="39" I2="0.0" ID="CMP-005.27.07" LOG_CI_END="0.0672290089465816" LOG_CI_START="-0.33374571082457266" LOG_EFFECT_SIZE="-0.13325835093899555" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.605970513428318" P_Z="0.19266581466227278" STUDIES="2" TAU2="0.0" TOTAL_1="413" TOTAL_2="408" WEIGHT="100.00000000000001" Z="1.3027333425343777">
<NAME>lost to follow-up</NAME>
<DICH_DATA CI_END="1.3815732965786707" CI_START="0.45902980231739055" EFFECT_SIZE="0.7963562753036437" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="26" LOG_CI_END="0.14037393047963473" LOG_CI_START="-0.3381591171602928" LOG_EFFECT_SIZE="-0.098892593340329" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.0" SE="0.2810926809604824" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.07901309528955155" WEIGHT="70.21180108480274"/>
<DICH_DATA CI_END="1.4225828039035733" CI_START="0.2620614968570593" EFFECT_SIZE="0.6105769230769231" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="0.15307755466766224" LOG_CI_START="-0.5815967826812716" LOG_EFFECT_SIZE="-0.21425961400680466" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="136" O_E="0.0" SE="0.4315513424553855" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="0.18623656117504545" WEIGHT="29.788198915197267"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.064013733011328" CI_START="0.70550647497878" DF="0" EFFECT_SIZE="2.232421875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" I2="0.0" ID="CMP-005.27.08" LOG_CI_END="0.8490515348737651" LOG_CI_START="-0.1514989960348631" LOG_EFFECT_SIZE="0.348776269419451" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.17180542011711222" STUDIES="1" TAU2="0.0" TOTAL_1="128" TOTAL_2="127" WEIGHT="100.0" Z="1.366425593924929">
<NAME>medication noncompliance</NAME>
<DICH_DATA CI_END="7.064013733011328" CI_START="0.70550647497878" EFFECT_SIZE="2.232421875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.8490515348737651" LOG_CI_START="-0.1514989960348631" LOG_EFFECT_SIZE="0.348776269419451" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="0.5877283346607339" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="0.3454245953630796" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.22920392251234006" CI_END="6.34424240523933" CI_START="0.7710098958371623" DF="1" EFFECT_SIZE="2.2116676233171395" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" I2="0.0" ID="CMP-005.27.09" LOG_CI_END="0.8023797684530821" LOG_CI_START="-0.11294004778575775" LOG_EFFECT_SIZE="0.34471986033366225" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.6321147582712829" P_Z="0.1398661951525356" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="391" WEIGHT="100.0" Z="1.4762894870689813">
<NAME>others</NAME>
<DICH_DATA CI_END="14.530886226718806" CI_START="0.6021065155785653" EFFECT_SIZE="2.957894736842105" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1622921023666104" LOG_CI_START="-0.22032667313414606" LOG_EFFECT_SIZE="0.4709827146162321" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="0.8121571128024627" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.6595991758756321" WEIGHT="43.8269076974009"/>
<DICH_DATA CI_END="7.191821354404674" CI_START="0.4320930689577748" EFFECT_SIZE="1.7628205128205128" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8568388909387616" LOG_CI_START="-0.36442269998715954" LOG_EFFECT_SIZE="0.24620809547580105" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="236" O_E="0.0" SE="0.7173751038522592" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="104" TOTAL_2="110" VAR="0.5146270396270397" WEIGHT="56.17309230259911"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.519152378825936" CI_END="1.8059908718576123" CI_START="0.6007324157279597" DF="2" EFFECT_SIZE="1.041593615203966" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="61" I2="55.743913186667214" ID="CMP-005.27.10" LOG_CI_END="0.2567155508989225" LOG_CI_START="-0.22131893274059744" LOG_EFFECT_SIZE="0.017698309079162537" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.10439484624140782" P_Z="0.8846099631330321" STUDIES="3" TAU2="0.1321632657643928" TOTAL_1="517" TOTAL_2="518" WEIGHT="99.99999999999999" Z="0.14512780801217126">
<NAME>patient decision</NAME>
<DICH_DATA CI_END="1.9196469024595684" CI_START="0.8202991629493075" EFFECT_SIZE="1.2548644338118022" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="33" LOG_CI_END="0.28322135244528374" LOG_CI_START="-0.08602773161211841" LOG_EFFECT_SIZE="0.09859681041658268" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="110" O_E="0.0" SE="0.2168987397877627" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.04704506332151959" WEIGHT="43.998256351527075"/>
<DICH_DATA CI_END="3.4369659159670563" CI_START="0.6930799410566493" EFFECT_SIZE="1.5434027777777777" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.5361752253054459" LOG_CI_START="-0.15921667021144273" LOG_EFFECT_SIZE="0.1884792775470016" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.408476641672019" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="0.16685316679165102" WEIGHT="26.369299961375745"/>
<DICH_DATA CI_END="1.1405380832654721" CI_START="0.2717075451036123" EFFECT_SIZE="0.5566801619433198" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="19" LOG_CI_END="0.05710979121364482" LOG_CI_START="-0.5658983014004134" LOG_EFFECT_SIZE="-0.2543942550933843" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="238" O_E="0.0" SE="0.3659580375412934" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="104" TOTAL_2="110" VAR="0.13392528524107472" WEIGHT="29.632443687097172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6772048964265511" CI_START="0.023184449564150528" DF="0" EFFECT_SIZE="0.19719298245614036" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" I2="0.0" ID="CMP-005.27.11" LOG_CI_END="0.22458612161128744" LOG_CI_START="-1.6348032104901855" LOG_EFFECT_SIZE="-0.705108544439449" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Z="0.1371479883194025" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="1.4864959462049456">
<NAME>protocol entry or interim criteria not met</NAME>
<DICH_DATA CI_END="1.6772048964265511" CI_START="0.023184449564150528" EFFECT_SIZE="0.19719298245614036" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.22458612161128744" LOG_CI_START="-1.6348032104901855" LOG_EFFECT_SIZE="-0.705108544439449" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="1.0922144978020414" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="1.1929325092089653" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6541947382254526" CI_END="1.5326744867439004" CI_START="0.4210013841950553" DF="1" EFFECT_SIZE="0.8032795780048363" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="20" I2="0.0" ID="CMP-005.27.12" LOG_CI_END="0.18544992809510705" LOG_CI_START="-0.3757164762610392" LOG_EFFECT_SIZE="-0.09513327408296611" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.41861721364319227" P_Z="0.5063469732027743" STUDIES="2" TAU2="0.0" TOTAL_1="413" TOTAL_2="408" WEIGHT="100.00000000000001" Z="0.6645365420544855">
<NAME>protocol violation</NAME>
<DICH_DATA CI_END="1.7077503443582454" CI_START="0.4431831230424263" EFFECT_SIZE="0.8699690402476781" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.23242438157988965" LOG_CI_START="-0.3534167864319356" LOG_EFFECT_SIZE="-0.06049620242602297" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="0.34412600205069777" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="0.11842270528739685" WEIGHT="91.75369274250002"/>
<DICH_DATA CI_END="3.1373033822478784" CI_START="0.03486490414122965" EFFECT_SIZE="0.3307291666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4965565176985063" LOG_CI_START="-1.4576115245216539" LOG_EFFECT_SIZE="-0.4805275034115739" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="137" O_E="0.0" SE="1.14788798128794" STUDY_ID="STD-Kern-2006" TOTAL_1="128" TOTAL_2="127" VAR="1.3176468175853018" WEIGHT="8.246307257499991"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.03399245915659" CI_START="0.013445972577116033" DF="0" EFFECT_SIZE="0.32867132867132864" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-005.27.13" LOG_CI_END="0.9049314197595786" LOG_CI_START="-1.8714077788182675" LOG_EFFECT_SIZE="-0.4832381795293444" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.49505778930710564" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="281" WEIGHT="100.0" Z="0.6822865363982716">
<NAME>sponsor decision</NAME>
<DICH_DATA CI_END="8.03399245915659" CI_START="0.013445972577116033" EFFECT_SIZE="0.32867132867132864" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9049314197595786" LOG_CI_START="-1.8714077788182675" LOG_EFFECT_SIZE="-0.4832381795293444" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="113" O_E="0.0" SE="1.6308353883453055" STUDY_ID="STD-Kane-2009" TOTAL_1="285" TOTAL_2="281" VAR="2.659624063879383" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8618321204216265E-32" CI_END="8.554215073964745" CI_START="0.014515923965815726" DF="0" EFFECT_SIZE="0.35238095238095235" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="100.0" ID="CMP-005.27.14" LOG_CI_END="0.9321801652873879" LOG_CI_START="-1.8381553152932741" LOG_EFFECT_SIZE="-0.4529875750029431" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Z="0.5215476352537994" STUDIES="1" TAU2="0.0" TOTAL_1="104" TOTAL_2="110" WEIGHT="100.0" Z="0.6409616009854618">
<NAME>death</NAME>
<DICH_DATA CI_END="8.554215073964745" CI_START="0.014515923965815726" EFFECT_SIZE="0.3523809523809524" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9321801652873879" LOG_CI_START="-1.8381553152932741" LOG_EFFECT_SIZE="-0.45298757500294307" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="1.6273087746748764" STUDY_ID="STD-Wlodzmierz-2006" TOTAL_1="104" TOTAL_2="110" VAR="2.648133848133848" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.093151352042791" CI_END="1.526667747745929" CI_START="-2.6290076062397993" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5511699292469352" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.28" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="0.8953573003218557" P_Q="0.8953573003218557" P_Z="0.6031314652302024" Q="1.093151352042791" RANDOM="YES" SCALE="17.14" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="170" TOTAL_2="170" UNITS="" WEIGHT="500.0" Z="0.5199026000187371">
<NAME>Quality of life: 1. Average endpoint general quality of life score (GQOLI-74, low=poor)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours olanzapine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours aripiprazole</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.850838077791085" CI_START="-6.370838077791067" DF="0" EFFECT_SIZE="-1.259999999999991" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6289540619113221" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.00000000000001" Z="0.4831995424100388">
<NAME>Total score</NAME>
<CONT_DATA CI_END="3.850838077791085" CI_START="-6.370838077791067" EFFECT_SIZE="-1.259999999999991" ESTIMABLE="YES" MEAN_1="210.3" MEAN_2="211.56" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="11.6" SD_2="9.83" SE="2.6076183634519383" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.344169904158223" CI_START="-4.724169904158233" DF="0" EFFECT_SIZE="-0.19000000000000483" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.934543024484273" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.00000000000001" Z="0.08213039319966879">
<NAME>Physical health</NAME>
<CONT_DATA CI_END="4.344169904158223" CI_START="-4.724169904158233" EFFECT_SIZE="-0.19000000000000483" ESTIMABLE="YES" MEAN_1="55.23" MEAN_2="55.42" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="8.33" SD_2="10.61" SE="2.313394501084296" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.2767211706538086" CI_START="-8.19672117065381" DF="0" EFFECT_SIZE="-2.460000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4006479171559899" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0" Z="0.8404646589123019">
<NAME>Mental health</NAME>
<CONT_DATA CI_END="3.2767211706538086" CI_START="-8.19672117065381" EFFECT_SIZE="-2.460000000000001" ESTIMABLE="YES" MEAN_1="58.44" MEAN_2="60.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="11.79" SD_2="12.34" SE="2.9269523398921273" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.834475548889623" CI_START="-3.4144755488896212" DF="0" EFFECT_SIZE="1.2100000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.608072267734924" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0" Z="0.5128271079004622">
<NAME>Social function</NAME>
<CONT_DATA CI_END="5.834475548889623" CI_START="-3.4144755488896212" EFFECT_SIZE="1.2100000000000009" ESTIMABLE="YES" MEAN_1="56.88" MEAN_2="55.67" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="9.98" SD_2="9.47" SE="2.3594696562625104" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.077596565836051" CI_START="-4.617596565836058" DF="0" EFFECT_SIZE="-0.7700000000000031" ESTIMABLE="YES" I2="0.0" ID="CMP-005.28.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.6948826223695008" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0" Z="0.39223765856748966">
<NAME>Material life</NAME>
<CONT_DATA CI_END="3.077596565836051" CI_START="-4.617596565836058" EFFECT_SIZE="-0.7700000000000031" ESTIMABLE="YES" MEAN_1="49.44" MEAN_2="50.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2230" SD_1="7.52" SD_2="8.63" SE="1.9630955447066398" STUDY_ID="STD-Liu-2009" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>COMPARISON 6. ARIPIPRAZOLE versus OLANZAPINE (acutely agitated people - all data by 5 days)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.42960230226316787" CI_START="-0.7896023022631673" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.17999999999999972" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5627731699004551" Q="0.0" RANDOM="YES" SCALE="7.04" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="237" TOTAL_2="234" UNITS="" WEIGHT="100.0" Z="0.578727337327061">
<NAME>Global state: Average improvement (BPRS, high=good)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.42960230226316787" CI_START="-0.7896023022631673" EFFECT_SIZE="-0.17999999999999972" ESTIMABLE="YES" MEAN_1="-5.89" MEAN_2="-5.71" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="283" SD_1="3.38" SD_2="3.37" SE="0.31102729798691847" STUDY_ID="STD-Kinon-2004" TOTAL_1="237" TOTAL_2="234" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.9965132661052722" CI_END="1.0990838351060939" CI_START="0.7599928113535065" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9139451918772121" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="150" I2="24.934566702349663" I2_Q="24.637347170434378" ID="CMP-006.02" LOG_CI_END="0.04103082048112194" LOG_CI_START="-0.11919051561956343" LOG_EFFECT_SIZE="-0.03907984756922073" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2618409582828649" P_Q="0.26355020035037147" P_Z="0.33901362968269266" Q="3.980751588966181" RANDOM="YES" SCALE="339.01116089670603" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07044773065704828" TOTALS="SUB" TOTAL_1="1183" TOTAL_2="1207" WEIGHT="400.0" Z="0.9561160282529951">
<NAME>Mental state: Specific - binary outcomes</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1194713027885166" CI_START="0.7642206754188964" DF="0" EFFECT_SIZE="0.9249449254572468" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="131" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="0.049012965087595305" LOG_CI_START="-0.11678121697622343" LOG_EFFECT_SIZE="-0.03388412594431409" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4230541632418934" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="0.8011338597262864">
<NAME>agitation - no change - (change defined as &#8805; 40%reduction in PANSS-EC)</NAME>
<DICH_DATA CI_END="1.1194713027885166" CI_START="0.7642206754188964" EFFECT_SIZE="0.9249449254572468" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="131" LOG_CI_END="0.049012965087595305" LOG_CI_START="-0.11678121697622343" LOG_EFFECT_SIZE="-0.03388412594431409" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="0.09738832323872433" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="0.009484485503250255" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.167180326334272" CI_START="0.05354785253816937" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" I2="0.0" ID="CMP-006.02.02" LOG_CI_END="0.06713795860054844" LOG_CI_START="-1.2712579412564733" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.07784508047066903" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="1.7633286229603102">
<NAME>agitation - labelled as"adverse effect"</NAME>
<DICH_DATA CI_END="1.167180326334272" CI_START="0.05354785253816937" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.06713795860054844" LOG_CI_START="-1.2712579412564733" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.7861803767425681" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.6180795847750864" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.165311261270209" CI_START="0.40244322439567265" DF="0" EFFECT_SIZE="0.9334960341671751" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" I2="0.0" ID="CMP-006.02.03" LOG_CI_END="0.3355203345626828" LOG_CI_START="-0.3952953800684834" LOG_EFFECT_SIZE="-0.029887522752900287" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8726370229797459" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.00000000000001" Z="0.16030982095772206">
<NAME>anxiety - labelled as"adverse effect"</NAME>
<DICH_DATA CI_END="2.165311261270209" CI_START="0.40244322439567265" EFFECT_SIZE="0.9334960341671751" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3355203345626828" LOG_CI_START="-0.3952953800684834" LOG_EFFECT_SIZE="-0.029887522752900287" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.4292847683704783" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="0.1842854123548952" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="106.4873516913323" CI_START="0.2475006572618088" DF="0" EFFECT_SIZE="5.133779264214047" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-006.02.04" LOG_CI_END="2.0272980263956497" LOG_CI_START="-0.6064236434180985" LOG_EFFECT_SIZE="0.7104371914887756" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.2903350935586625" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="1.0573868336620826">
<NAME>exacerbation of schizophrenia - labelled as"adverse effect"</NAME>
<DICH_DATA CI_END="106.4873516913323" CI_START="0.2475006572618088" EFFECT_SIZE="5.133779264214047" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0272980263956497" LOG_CI_START="-0.6064236434180985" LOG_EFFECT_SIZE="0.7104371914887756" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="289" O_E="0.0" SE="1.5470611459811214" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="2.3933981894044205" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.3546712608050296E-32" CI_END="4.067773657705995" CI_START="0.11520492011945234" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6845637583892618" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="100.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="0.6093567795643554" LOG_CI_START="-0.9385289728650683" LOG_EFFECT_SIZE="-0.16458609665035648" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="0.6768214606840793" Q="0.0" RANDOM="YES" SCALE="53.36" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="0.41680443312360727">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.3546712608050296E-32" CI_END="4.067773657705995" CI_START="0.11520492011945234" DF="0" EFFECT_SIZE="0.6845637583892618" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="100.0" ID="CMP-006.03.01" LOG_CI_END="0.6093567795643554" LOG_CI_START="-0.9385289728650683" LOG_EFFECT_SIZE="-0.16458609665035648" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.6768214606840793" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="0.41680443312360727">
<NAME>adverse events</NAME>
<DICH_DATA CI_END="4.067773657705995" CI_START="0.11520492011945234" EFFECT_SIZE="0.6845637583892618" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6093567795643554" LOG_CI_START="-0.9385289728650683" LOG_EFFECT_SIZE="-0.16458609665035648" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="293" O_E="0.0" SE="0.9092357531350918" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="0.8267096547791375" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.57864119485341" CI_END="1.9047627476294278" CI_START="0.837058481041686" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2626946631214837" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="47" I2="56.817039963010075" I2_Q="56.21373844514174" ID="CMP-006.04" LOG_CI_END="0.27984088877167557" LOG_CI_START="-0.07724419898826348" LOG_EFFECT_SIZE="0.10129834489170605" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.04104050166440221" P_Q="0.043675283273821086" P_Z="0.26613383619025954" Q="11.419106866969397" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.40816142141327905" TOTALS="SUB" TOTAL_1="1743" TOTAL_2="1751" WEIGHT="600.0" Z="1.1120100753954527">
<NAME>Adverse effects: 1. Central nervous system</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.363729023463608" CI_START="0.059859878067193534" DF="0" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-006.04.01" LOG_CI_END="0.1347280834394282" LOG_CI_START="-1.2228641721399796" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.11619460713432185" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="1.570948519606237">
<NAME>dizziness</NAME>
<DICH_DATA CI_END="1.363729023463608" CI_START="0.059859878067193534" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.1347280834394282" LOG_CI_START="-1.2228641721399796" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.797456411117391" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.6359367276322292" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.767666904152188" CI_START="1.0225901186192778" DF="0" EFFECT_SIZE="2.4285714285714284" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" I2="0.0" ID="CMP-006.04.02" LOG_CI_END="0.7610001709440634" LOG_CI_START="0.009701591783970759" LOG_EFFECT_SIZE="0.3853508813640171" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.04436958498314421" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="2.0105823964916643">
<NAME>headache</NAME>
<DICH_DATA CI_END="5.767666904152188" CI_START="1.0225901186192778" EFFECT_SIZE="2.4285714285714284" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.7610001709440634" LOG_CI_START="0.009701591783970759" LOG_EFFECT_SIZE="0.3853508813640171" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="0.4413165043865843" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.19476025704399408" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.904549944233872" CI_START="0.30108607676591476" DF="0" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-006.04.03" LOG_CI_END="0.7711868004788094" LOG_CI_START="-0.5213093272622096" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.7047482981272523" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="0.3789186192057517">
<NAME>lethargy</NAME>
<DICH_DATA CI_END="5.904549944233872" CI_START="0.30108607676591476" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7711868004788094" LOG_CI_START="-0.5213093272622096" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="0.7592186233940917" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.5764129181084197" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2244814862327624" CI_START="0.22935865494511332" DF="0" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-006.04.04" LOG_CI_END="0.34722879558174385" LOG_CI_START="-0.6394848669382199" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5615610283757486" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="99.99999999999999" Z="0.5805244174474696">
<NAME>sedation</NAME>
<DICH_DATA CI_END="2.2244814862327624" CI_START="0.22935865494511332" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.34722879558174385" LOG_CI_START="-0.6394848669382199" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.5796004896756294" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.33593672763222937" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.9436786523448317" CI_START="0.8745003315936618" DF="0" EFFECT_SIZE="1.6044463087248322" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" I2="0.0" ID="CMP-006.04.05" LOG_CI_END="0.4688903983520559" LOG_CI_START="-0.05824002150918088" LOG_EFFECT_SIZE="0.20532518842143757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.12679318760354027" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="1.5268706159316505">
<NAME>sleep - insomnia</NAME>
<DICH_DATA CI_END="2.943678652344832" CI_START="0.8745003315936619" EFFECT_SIZE="1.6044463087248322" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" LOG_CI_END="0.468890398352056" LOG_CI_START="-0.058240021509180825" LOG_EFFECT_SIZE="0.20532518842143757" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="0.3096390179641517" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="0.09587632144580428" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1537597789493728" CI_START="0.017688398952414534" DF="0" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" I2="0.0" ID="CMP-006.04.06" LOG_CI_END="0.062115395009702715" LOG_CI_START="-1.7523114750382167" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.06788513848000785" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="1.8257685103501455">
<NAME>somnolence</NAME>
<DICH_DATA CI_END="1.1537597789493728" CI_START="0.017688398952414534" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.062115395009702715" LOG_CI_START="-1.7523114750382167" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="1.065803325024007" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="1.1359367276322292" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.0370927097121518E-30" CI_END="-12.341232924748814" CI_START="-19.17876707525118" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-15.759999999999998" ESTIMABLE="YES" I2="100.00000000000001" I2_Q="0.0" ID="CMP-006.05" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="1.637955934075468E-19" Q="0.0" RANDOM="YES" SCALE="32.718769911722994" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="298" TOTAL_2="306" UNITS="" WEIGHT="100.0" Z="9.035138023868377">
<NAME>Adverse effects: 2. Endocrine - Prolactin - average increase</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_DATA CI_END="-12.341232924748816" CI_START="-19.178767075251184" EFFECT_SIZE="-15.76" ESTIMABLE="YES" MEAN_1="-13.43" MEAN_2="2.33" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="325" SD_1="25.7" SD_2="15.9" SE="1.7443009678840946" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.05403852488258199" CI_END="2.5142152373533064" CI_START="0.8527445884594903" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4642347618723661" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="0.40040245409518754" LOG_CI_START="-0.069181027956495" LOG_EFFECT_SIZE="0.16561071306934622" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.816179294569771" P_Q="0.8162531395228523" P_Z="0.16682940280160352" Q="0.053994326821380105" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="596" TOTAL_2="612" WEIGHT="200.0" Z="1.3824635894419768">
<NAME>Adverse effects: 3a. Extrapyramidal - various</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5586642012191976" CI_START="0.7949357691835549" DF="0" EFFECT_SIZE="1.4261744966442953" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="18" I2="0.0" ID="CMP-006.06.01" LOG_CI_END="0.40801329287161914" LOG_CI_START="-0.09966796092350658" LOG_EFFECT_SIZE="0.1541726659740563" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.23388770157611016" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="1.190403901860894">
<NAME>akathisia</NAME>
<DICH_DATA CI_END="2.5586642012191976" CI_START="0.7949357691835549" EFFECT_SIZE="1.4261744966442953" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="18" LOG_CI_END="0.40801329287161914" LOG_CI_START="-0.09966796092350658" LOG_EFFECT_SIZE="0.1541726659740563" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.29821448154199326" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="0.08893187700135984" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.097598586142847" CI_START="0.4126638165116217" DF="0" EFFECT_SIZE="1.7114093959731544" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-006.06.02" LOG_CI_END="0.8511114336206457" LOG_CI_START="-0.3844036095772834" LOG_EFFECT_SIZE="0.23335391202168115" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4590793259736179" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="0.7403637304653258">
<NAME>parkinsonism</NAME>
<DICH_DATA CI_END="7.097598586142847" CI_START="0.4126638165116217" EFFECT_SIZE="1.7114093959731544" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8511114336206457" LOG_CI_START="-0.3844036095772834" LOG_EFFECT_SIZE="0.23335391202168115" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.7257476522725633" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" VAR="0.5267096547791376" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.5531552254325828" CI_END="0.030363439924855087" CI_START="-0.11661463176541582" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.04312559592028037" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.07" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.45703142809838326" P_Q="0.45703142809838326" P_Z="0.2500753896761816" Q="0.5531552254325828" RANDOM="YES" SCALE="0.8448833969317635" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="596" TOTAL_2="612" UNITS="" WEIGHT="200.0" Z="1.1501663322090252">
<NAME>Adverse effects: 3b. Extrapyramidal - average score</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3770404856784029" CI_START="-0.2370404856784028" DF="0" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" I2="0.0" ID="CMP-006.07.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6549917456819008" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="0.44683839857361957">
<NAME>Barnes Akathesia Scale (high=poor)</NAME>
<CONT_DATA CI_END="0.3770404856784029" CI_START="-0.2370404856784028" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.67" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="333" SD_1="1.89" SD_2="1.96" SE="0.15665618761380262" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.228577464680919E-32" CI_END="0.025688993941377615" CI_START="-0.12568899394137764" DF="0" EFFECT_SIZE="-0.05000000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-006.07.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.19540705841417758" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="1.2947483395393518">
<NAME>Simpson-Angus Scale (high=poor)</NAME>
<CONT_DATA CI_END="0.025688993941377622" CI_START="-0.1256889939413776" EFFECT_SIZE="-0.05" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="334" SD_1="0.65" SD_2="0.15" SE="0.038617543249979465" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.3428040912210325" CI_END="2.2994373021376795" CI_START="0.22658480871149142" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7218154620461756" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-006.08" LOG_CI_END="0.3616215723328199" LOG_CI_START="-0.6447692105976457" LOG_EFFECT_SIZE="-0.1415738191324129" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.5582152860934224" P_Q="0.5583959743900281" P_Z="0.5813354668574375" Q="0.3424894249266851" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="578" TOTAL_2="578" WEIGHT="200.0" Z="0.5514350714646576">
<NAME>Adverse effects: 4. Gastrointestinal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7084654743715166" CI_START="0.09230318878552848" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-006.08.01" LOG_CI_END="0.43272330387540814" LOG_CI_START="-1.0347832952033704" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.42134165467870666" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="0.804095804595396">
<NAME>nausea / dyspepsia</NAME>
<DICH_DATA CI_END="2.7084654743715166" CI_START="0.09230318878552848" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.43272330387540814" LOG_CI_START="-1.0347832952033704" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.8620206405736967" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.7430795847750864" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.913449045120992" CI_START="0.2035230223854647" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-006.08.02" LOG_CI_END="0.6913864565643887" LOG_CI_START="-0.6913864565643888" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="289" WEIGHT="100.0" Z="0.0">
<NAME>salivation - dry mouth</NAME>
<DICH_DATA CI_END="4.913449045120992" CI_START="0.2035230223854647" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6913864565643887" LOG_CI_START="-0.6913864565643888" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="0.8122476540081559" STUDY_ID="STD-Kinon-2004" TOTAL_1="289" TOTAL_2="289" VAR="0.659746251441753" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-21.992417890031586" CI_START="-49.24758210996842" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-35.620000000000005" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.09" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="3.007341284407261E-7" Q="0.0" RANDOM="YES" SCALE="62.510151723761815" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="298" TOTAL_2="306" UNITS="" WEIGHT="100.0" Z="5.122986349739083">
<NAME>Adverse effects: 5. Metabolic - continuous measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Olanzapine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aripiprazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours olanzapine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-21.992417890031586" CI_START="-49.24758210996842" DF="0" EFFECT_SIZE="-35.620000000000005" ESTIMABLE="YES" I2="0.0" ID="CMP-006.09.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="3.007341284407261E-7" STUDIES="1" TAU2="0.0" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0" Z="5.122986349739083">
<NAME>triglycerides - fasting, increase</NAME>
<CONT_DATA CI_END="-21.992417890031586" CI_START="-49.24758210996842" EFFECT_SIZE="-35.620000000000005" ESTIMABLE="YES" MEAN_1="7.84" MEAN_2="43.46" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="344" SD_1="72.62" SD_2="96.84" SE="6.952975777851556" STUDY_ID="STD-Kinon-2004" TOTAL_1="298" TOTAL_2="306" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>COMPARISON 7. ARIPIPRAZOLE versus OTHER ANTIPSYCHOTIC DRUGS</NAME>
<DICH_OUTCOME CHI2="7.360984923649022" CI_END="0.8775791513817957" CI_START="0.7744613492078131" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8244095666692576" ESTIMABLE="YES" EVENTS_1="780" EVENTS_2="909" I2="32.07430728547972" I2_Q="31.211971283459672" ID="CMP-007.01" LOG_CI_END="-0.05671370283010191" LOG_CI_START="-0.11100025155825924" LOG_EFFECT_SIZE="-0.08385697719418059" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.19514775273224083" P_Q="0.2014110751549193" P_Z="1.4028503659277886E-9" Q="7.268706624235231" RANDOM="YES" SCALE="9.7" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0029967003278985145" TOTALS="SUB" TOTAL_1="1608" TOTAL_2="1530" WEIGHT="600.0" Z="6.055152114237915">
<NAME>Global state: 1. No change (as defined in the study, measured by IAQ)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1094430316255612" CI_START="0.8160293253062745" DF="0" EFFECT_SIZE="0.9514925373134329" ESTIMABLE="YES" EVENTS_1="145" EVENTS_2="145" I2="0.0" ID="CMP-007.01.01" LOG_CI_END="0.04510500671596733" LOG_CI_START="-0.0882942339056346" LOG_EFFECT_SIZE="-0.021594613594833643" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.525717834502528" STUDIES="1" TAU2="0.0" TOTAL_1="268" TOTAL_2="255" WEIGHT="100.0" Z="0.6345563094469244">
<NAME>cognition</NAME>
<DICH_DATA CI_END="1.1094430316255612" CI_START="0.8160293253062745" EFFECT_SIZE="0.9514925373134329" ESTIMABLE="YES" EVENTS_1="145" EVENTS_2="145" LOG_CI_END="0.04510500671596733" LOG_CI_START="-0.0882942339056346" LOG_EFFECT_SIZE="-0.021594613594833643" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.0783593742780198" STUDY_ID="STD-Kerwin-2007" TOTAL_1="268" TOTAL_2="255" VAR="0.006140191537242792" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8424556242873603" CI_START="0.5618659855139105" DF="0" EFFECT_SIZE="0.6880022962112514" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="130" I2="0.0" ID="CMP-007.01.02" LOG_CI_END="-0.0744529659874171" LOG_CI_START="-0.25036725861652653" LOG_EFFECT_SIZE="-0.16241011230197178" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="2.957298896469489E-4" STUDIES="1" TAU2="0.0" TOTAL_1="268" TOTAL_2="255" WEIGHT="99.99999999999999" Z="3.6190120322752746">
<NAME>energy</NAME>
<DICH_DATA CI_END="0.8424556242873603" CI_START="0.5618659855139105" EFFECT_SIZE="0.6880022962112514" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="130" LOG_CI_END="-0.0744529659874171" LOG_CI_START="-0.25036725861652653" LOG_EFFECT_SIZE="-0.16241011230197178" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="0.1033329262801313" STUDY_ID="STD-Kerwin-2007" TOTAL_1="268" TOTAL_2="255" VAR="0.01067769365361505" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9198146507087935" CI_START="0.6518361770908976" DF="0" EFFECT_SIZE="0.7743180648481729" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="145" I2="0.0" ID="CMP-007.01.03" LOG_CI_END="-0.03629967731110888" LOG_CI_START="-0.18586153973625752" LOG_EFFECT_SIZE="-0.11108060852368318" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.0035986251947657155" STUDIES="1" TAU2="0.0" TOTAL_1="268" TOTAL_2="255" WEIGHT="100.0" Z="2.911357060643339">
<NAME>mood</NAME>
<DICH_DATA CI_END="0.9198146507087935" CI_START="0.6518361770908976" EFFECT_SIZE="0.7743180648481729" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="145" LOG_CI_END="-0.03629967731110888" LOG_CI_START="-0.18586153973625752" LOG_EFFECT_SIZE="-0.11108060852368318" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.08785337833169138" STUDY_ID="STD-Kerwin-2007" TOTAL_1="268" TOTAL_2="255" VAR="0.007718216084291301" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9869344098119537" CI_START="0.6808819518376812" DF="0" EFFECT_SIZE="0.8197474167623421" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="130" I2="0.0" ID="CMP-007.01.04" LOG_CI_END="-0.0057117089344818255" LOG_CI_START="-0.16692817752849587" LOG_EFFECT_SIZE="-0.08631994323148884" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.035830795854050766" STUDIES="1" TAU2="0.0" TOTAL_1="268" TOTAL_2="255" WEIGHT="100.0" Z="2.0988423993743517">
<NAME>negative symptoms</NAME>
<DICH_DATA CI_END="0.9869344098119538" CI_START="0.6808819518376812" EFFECT_SIZE="0.8197474167623421" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="130" LOG_CI_END="-0.005711708934481776" LOG_CI_START="-0.16692817752849587" LOG_EFFECT_SIZE="-0.08631994323148884" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="0.09469935168651394" STUDY_ID="STD-Kerwin-2007" TOTAL_1="268" TOTAL_2="255" VAR="0.00896796720984605" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9282383207094532" CI_START="0.6889967998527335" DF="0" EFFECT_SIZE="0.799720721545646" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="163" I2="0.0" ID="CMP-007.01.05" LOG_CI_END="-0.032340506452298454" LOG_CI_START="-0.16178279523247097" LOG_EFFECT_SIZE="-0.0970616508423847" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.0032891382410075278" STUDIES="1" TAU2="0.0" TOTAL_1="268" TOTAL_2="255" WEIGHT="100.0" Z="2.939338321715704">
<NAME>somnolence</NAME>
<DICH_DATA CI_END="0.9282383207094532" CI_START="0.6889967998527335" EFFECT_SIZE="0.799720721545646" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="163" LOG_CI_END="-0.032340506452298454" LOG_CI_START="-0.16178279523247097" LOG_EFFECT_SIZE="-0.0970616508423847" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.07603504117913665" STUDY_ID="STD-Kerwin-2007" TOTAL_1="268" TOTAL_2="255" VAR="0.0057813274871130055" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9436731802839046" CI_START="0.7560935170658549" DF="0" EFFECT_SIZE="0.8446923545537618" ESTIMABLE="YES" EVENTS_1="174" EVENTS_2="196" I2="0.0" ID="CMP-007.01.06" LOG_CI_END="-0.02517838766654026" LOG_CI_START="-0.12142448567087974" LOG_EFFECT_SIZE="-0.07330143666870999" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.0028317644652998096" STUDIES="1" TAU2="0.0" TOTAL_1="268" TOTAL_2="255" WEIGHT="100.00000000000001" Z="2.9854337758033083">
<NAME>weight gain</NAME>
<DICH_DATA CI_END="0.9436731802839046" CI_START="0.7560935170658549" EFFECT_SIZE="0.8446923545537618" ESTIMABLE="YES" EVENTS_1="174" EVENTS_2="196" LOG_CI_END="-0.02517838766654026" LOG_CI_START="-0.12142448567087974" LOG_EFFECT_SIZE="-0.07330143666870999" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.05653543439361785" STUDY_ID="STD-Kerwin-2007" TOTAL_1="268" TOTAL_2="255" VAR="0.003196255342075068" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.11166135019789025" CI_START="-2.9716613501978903" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.43" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.02" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.06906332347490775" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="42" TOTAL_2="43" UNITS="" WEIGHT="100.0" Z="1.8180052950879984">
<NAME>Global state: 2. Change in sexual dysfunction (ASEX)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.11166135019789025" CI_START="-2.9716613501978903" EFFECT_SIZE="-1.43" ESTIMABLE="YES" MEAN_1="-1.64" MEAN_2="-0.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="221" SD_1="3.37" SD_2="3.87" SE="0.786576366891595" STUDY_ID="STD-Kerwin-2007" TOTAL_1="42" TOTAL_2="43" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="6.16113365106399" CI_END="1.5090744594436942" CI_START="0.9596877049021473" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2034285207314839" ESTIMABLE="YES" EVENTS_1="261" EVENTS_2="101" I2="2.6153247144080867" I2_Q="22.772662308626572" ID="CMP-007.03" LOG_CI_END="0.1787106688860794" LOG_CI_START="-0.01787006915096288" LOG_EFFECT_SIZE="0.08042029986755826" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.4053843369257275" P_Q="0.2741940361736863" P_Z="0.10879674041026004" Q="3.8846347545852415" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3721" TOTAL_2="1617" WEIGHT="100.0" Z="1.6036249832028255">
<NAME>Mental state: Specific - binary outcomes</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.19699153958948473" CI_END="1.8975196556196217" CI_START="0.9365898239671707" DF="1" EFFECT_SIZE="1.3331157489996988" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="41" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="0.2781862832673482" LOG_CI_START="-0.02845056513061371" LOG_EFFECT_SIZE="0.12486785906836721" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6571602355550923" P_Z="0.1104301179772657" STUDIES="2" TAU2="0.0" TOTAL_1="951" TOTAL_2="410" WEIGHT="38.800352159703706" Z="1.5962628619440875">
<NAME>Anxiety - labelled as"adverse effects"</NAME>
<DICH_DATA CI_END="2.1761951159727313" CI_START="0.9199193274508922" EFFECT_SIZE="1.4148936170212767" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="30" LOG_CI_END="0.3376978312795488" LOG_CI_START="-0.03625025654477439" LOG_EFFECT_SIZE="0.15072378736738717" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="347" O_E="0.0" SE="0.21965895786089584" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.04825005776853481" WEIGHT="24.45926958271824"/>
<DICH_DATA CI_END="2.2106138898130827" CI_START="0.6445166689808716" EFFECT_SIZE="1.1936404402772116" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="11" LOG_CI_END="0.34451289447067474" LOG_CI_START="-0.19076584611073766" LOG_EFFECT_SIZE="0.07687352417996855" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="348" O_E="0.0" SE="0.3144253818900209" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.09886332077668548" WEIGHT="14.341082576985466"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.2318226046431136" CI_START="0.964569121557916" DF="0" EFFECT_SIZE="2.6411347517730497" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" I2="0.0" ID="CMP-007.03.02" LOG_CI_END="0.8592477644294868" LOG_CI_START="-0.015666645121636662" LOG_EFFECT_SIZE="0.4217905596539251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.05878848153861477" STUDIES="1" TAU2="0.0" TOTAL_1="282" TOTAL_2="266" WEIGHT="4.07654493045304" Z="1.8897718380585906">
<NAME>Agitation - labelled as"adverse effects"</NAME>
<DICH_DATA CI_END="7.2318226046431136" CI_START="0.964569121557916" EFFECT_SIZE="2.6411347517730497" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" LOG_CI_END="0.8592477644294868" LOG_CI_START="-0.015666645121636662" LOG_EFFECT_SIZE="0.4217905596539251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="349" O_E="0.0" SE="0.513929055066505" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.26412307364155074" WEIGHT="4.07654493045304"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2610700553342525E-31" CI_END="1.8087648325524923" CI_START="0.49190694149307695" DF="0" EFFECT_SIZE="0.9432624113475179" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" I2="100.0" ID="CMP-007.03.03" LOG_CI_END="0.25738210551992746" LOG_CI_START="-0.3081170488965156" LOG_EFFECT_SIZE="-0.025367471688294046" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.8604178510013848" STUDIES="1" TAU2="0.0" TOTAL_1="282" TOTAL_2="266" WEIGHT="13.860252763540336" Z="0.1758422819896267">
<NAME>Schizophrenia - labelled as"adverse effects"</NAME>
<DICH_DATA CI_END="1.808764832552492" CI_START="0.4919069414930769" EFFECT_SIZE="0.9432624113475178" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.2573821055199274" LOG_CI_START="-0.3081170488965156" LOG_EFFECT_SIZE="-0.025367471688294094" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="350" O_E="0.0" SE="0.33217700257017896" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.11034156103650866" WEIGHT="13.860252763540336"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9744001457188745" CI_END="1.4769676188114005" CI_START="0.7252828882235296" DF="2" EFFECT_SIZE="1.034997265882457" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="38" I2="0.0" ID="CMP-007.03.04" LOG_CI_END="0.1693709738998411" LOG_CI_START="-0.13949256883325323" LOG_EFFECT_SIZE="0.014939202533293925" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.37261863564363595" P_Z="0.84962240933389" STUDIES="3" TAU2="0.0" TOTAL_1="2206" TOTAL_2="675" WEIGHT="43.26285014630291" Z="0.18960022710293342">
<NAME>Psychotic disorder - labelled as"adverse effects"</NAME>
<DICH_DATA CI_END="2.9809759382147254" CI_START="0.7788583333291794" EFFECT_SIZE="1.5237315875613748" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="13" LOG_CI_END="0.47435847051678237" LOG_CI_START="-0.10854152903920554" LOG_EFFECT_SIZE="0.1829084707387884" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="0.34239834514072026" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.1172366267551038" WEIGHT="10.599016819177905"/>
<DICH_DATA CI_END="1.4160074909273481" CI_START="0.4881798830140394" EFFECT_SIZE="0.8314243027888446" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="16" LOG_CI_END="0.1510655508536135" LOG_CI_START="-0.3114201210187979" LOG_EFFECT_SIZE="-0.08017728508259218" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.27166637299885227" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.07380261821835152" WEIGHT="20.930220309591444"/>
<DICH_DATA CI_END="1.927074130373601" CI_START="0.47490778741177403" EFFECT_SIZE="0.9566517189835575" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="9" LOG_CI_END="0.28489842134614507" LOG_CI_START="-0.323390708914017" LOG_EFFECT_SIZE="-0.01924614378393596" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="352" O_E="0.0" SE="0.35731204619457607" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.12767189835575485" WEIGHT="11.733613017533562"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.2987248489638805" CI_END="0.7338155128445304" CI_START="0.4716347662207982" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5882966155347362" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="158" I2="52.371312099884946" I2_Q="51.73521291253898" ID="CMP-007.04" LOG_CI_END="-0.13441311150680008" LOG_CI_START="-0.3263941886886156" LOG_EFFECT_SIZE="-0.23040365009770783" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.09794748462990954" P_Q="0.10157432578668779" P_Z="2.5454907050301384E-6" Q="6.21571166275669" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="493" TOTAL_2="484" WEIGHT="400.0" Z="4.704451737922114">
<NAME>Preference: Study medication worse than or equal to previous medication</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9097766681279734" CI_START="0.49473268253473796" DF="0" EFFECT_SIZE="0.6708921310691223" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="74" I2="0.0" ID="CMP-007.04.01" LOG_CI_END="-0.041065205155223085" LOG_CI_START="-0.3056293987612459" LOG_EFFECT_SIZE="-0.17334730195823447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.010216666501255708" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="220" WEIGHT="100.0" Z="2.5684085516218906">
<NAME>patient - by up to 12 weeks (short-term)</NAME>
<DICH_DATA CI_END="0.9097766681279734" CI_START="0.49473268253473796" EFFECT_SIZE="0.6708921310691223" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="74" LOG_CI_END="-0.041065205155223085" LOG_CI_START="-0.3056293987612459" LOG_EFFECT_SIZE="-0.17334730195823447" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="208" O_E="0.0" SE="0.15540631693805732" STUDY_ID="STD-Kerwin-2007" TOTAL_1="226" TOTAL_2="220" VAR="0.024151123344251922" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4308893070007915" CI_START="0.5180637662776997" DF="0" EFFECT_SIZE="0.8609831029185868" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" I2="0.0" ID="CMP-007.04.02" LOG_CI_END="0.1556060382194821" LOG_CI_START="-0.28561678149388214" LOG_EFFECT_SIZE="-0.06500537163719998" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5635861354947742" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="59" WEIGHT="100.0" Z="0.5775231085886395">
<NAME>care giver - by up to 12 weeks (short-term)</NAME>
<DICH_DATA CI_END="1.4308893070007915" CI_START="0.5180637662776997" EFFECT_SIZE="0.8609831029185868" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.1556060382194821" LOG_CI_START="-0.28561678149388214" LOG_EFFECT_SIZE="-0.06500537163719998" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="0.2591764683878122" STUDY_ID="STD-Kerwin-2007" TOTAL_1="62" TOTAL_2="59" VAR="0.06717244176597864" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6132772422391307" CI_START="0.2466006521765971" DF="0" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="54" I2="0.0" ID="CMP-007.04.03" LOG_CI_END="-0.2123431510035973" LOG_CI_START="-0.6080057791745013" LOG_EFFECT_SIZE="-0.41017446508904926" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="4.8300827346460854E-5" STUDIES="1" TAU2="0.0" TOTAL_1="165" TOTAL_2="165" WEIGHT="100.0" Z="4.063700343239226">
<NAME>patient - from 12 to 26 weeks (medium-term)</NAME>
<DICH_DATA CI_END="0.6132772422391307" CI_START="0.2466006521765971" EFFECT_SIZE="0.3888888888888889" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="54" LOG_CI_END="-0.2123431510035973" LOG_CI_START="-0.6080057791745013" LOG_EFFECT_SIZE="-0.41017446508904926" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="209" O_E="0.0" SE="0.2324141863491857" STUDY_ID="STD-Kerwin-2007" TOTAL_1="165" TOTAL_2="165" VAR="0.05401635401635402" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3261572352111735" CI_START="0.14894980697072213" DF="0" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="0.0" ID="CMP-007.04.04" LOG_CI_END="0.12259501904329576" LOG_CI_START="-0.8269600552660208" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.14598221520391172" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="1.4538704918932226">
<NAME>care giver - from 12 to 26 weeks (medium-term)</NAME>
<DICH_DATA CI_END="1.3261572352111732" CI_START="0.14894980697072216" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.12259501904329569" LOG_CI_START="-0.8269600552660207" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="0.557773351022717" STUDY_ID="STD-Kerwin-2007" TOTAL_1="40" TOTAL_2="40" VAR="0.31111111111111106" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.6620941345818432" CI_START="0.13005709475337726" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2934451219512195" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="-0.17908025946805986" LOG_CI_START="-0.8858659515942217" LOG_EFFECT_SIZE="-0.5324731055311408" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.0031453170149570893" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="165" WEIGHT="99.99999999999999" Z="2.9531670524845404">
<NAME>Quality of life: 1. Unsatisfactory response on health dimension scale</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6620941345818431" CI_START="0.13005709475337732" EFFECT_SIZE="0.2934451219512195" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="24" LOG_CI_END="-0.17908025946805992" LOG_CI_START="-0.8858659515942215" LOG_EFFECT_SIZE="-0.5324731055311408" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="214" O_E="0.0" SE="0.41516941420050885" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="165" VAR="0.17236564248759367" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.317712266465819" CI_START="3.082287733534184" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="6.200000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.06" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="9.712738153220766E-5" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="162" UNITS="" WEIGHT="100.0" Z="3.8976581754683144">
<NAME>Quality of life: 3. Average change score (QLS, high=better))</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.317712266465819" CI_START="3.082287733534184" EFFECT_SIZE="6.200000000000001" ESTIMABLE="YES" MEAN_1="16.21" MEAN_2="10.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SD_1="14.34" SD_2="14.38" SE="1.5906987531699222" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="162" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.05442848705327246" CI_START="-0.042428487053272464" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.005999999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.07" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.8081387839196527" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="165" UNITS="" WEIGHT="100.0" Z="0.24282781938457598">
<NAME>Quality of life: 2. Average score (EQ-5D utility score, high=better)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.05442848705327246" CI_START="-0.042428487053272464" EFFECT_SIZE="0.005999999999999998" ESTIMABLE="YES" MEAN_1="0.045" MEAN_2="0.039" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="0.217" SD_2="0.231" SE="0.02470886579308099" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="165" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.829963829589672E-30" CI_END="1.0117383622672929" CI_START="0.8299802812446254" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9163639508735514" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="141" I2="100.0" I2_Q="0.0" ID="CMP-007.08" LOG_CI_END="0.005068217528971251" LOG_CI_START="-0.08093222551353761" LOG_EFFECT_SIZE="-0.037932003992283164" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="1.0" P_Z="0.08381750852763979" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="163" WEIGHT="100.0" Z="1.728952992708575">
<NAME>Quality of life: 4a. Weight related - No meaningful change (IWQOL-Lite)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0117383622672929" CI_START="0.8299802812446253" EFFECT_SIZE="0.9163639508735513" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="141" LOG_CI_END="0.005068217528971251" LOG_CI_START="-0.08093222551353767" LOG_EFFECT_SIZE="-0.03793200399228322" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="216" O_E="0.0" SE="0.050517085952228535" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="163" VAR="0.0025519759731048456" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.6203735425422717" CI_END="3.554250026903241" CI_START="0.9350218647393593" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="2.2446359458213" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.09" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.4309087118512611" P_Q="0.4309087118512608" P_Z="7.813608027740614E-4" Q="0.6203735425422722" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="388" TOTAL_2="383" UNITS="" WEIGHT="200.0" Z="3.3593145307197436">
<NAME>Quality of life: 4b. Weight related - average score (IWQOL-Lite, high=better)</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.159962685605331" CI_START="-1.8399626856053302" DF="0" EFFECT_SIZE="1.1600000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-007.09.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4485335073070531" STUDIES="1" TAU2="0.0" TOTAL_1="224" TOTAL_2="219" WEIGHT="100.0" Z="0.7578621670781569">
<NAME>short-term</NAME>
<CONT_DATA CI_END="4.159962685605331" CI_START="-1.8399626856053302" EFFECT_SIZE="1.1600000000000001" ESTIMABLE="YES" MEAN_1="2.37" MEAN_2="1.21" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="214" SD_1="21.8" SD_2="6.96" SE="1.5306213324676643" STUDY_ID="STD-Kerwin-2007" TOTAL_1="224" TOTAL_2="219" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.575437140965699E-31" CI_END="3.955639186737399" CI_START="1.0443608132626019" DF="0" EFFECT_SIZE="2.5000000000000004" ESTIMABLE="YES" I2="100.0" ID="CMP-007.09.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="7.622332625102878E-4" STUDIES="1" TAU2="0.0" TOTAL_1="164" TOTAL_2="164" WEIGHT="100.0" Z="3.3661569474043667">
<NAME>medium-term</NAME>
<CONT_DATA CI_END="3.9556391867373986" CI_START="1.0443608132626014" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="3.77" MEAN_2="1.27" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SD_1="6.66" SD_2="6.79" SE="0.7426867015002799" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="164" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="51.49041256003456" CI_END="1.0774771262426766" CI_START="0.8293391714223141" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9453010034399612" ESTIMABLE="YES" EVENTS_1="1387" EVENTS_2="488" I2="57.27359928540212" I2_Q="70.07332112013093" ID="CMP-007.10" LOG_CI_END="0.0324080592949232" LOG_CI_START="-0.08126782149721766" LOG_EFFECT_SIZE="-0.02442988110114723" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="3.6743009824002915E-4" P_Q="2.319143321234396E-4" P_Z="0.399550258621198" Q="33.4150008430329" RANDOM="YES" SCALE="7.09" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07844888140224925" TOTALS="SUB" TOTAL_1="13980" TOTAL_2="5147" WEIGHT="1100.0" Z="0.842424739024404">
<NAME>Leaving the study early</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.931589829836944" CI_END="1.192938097493021" CI_START="0.7820412478250038" DF="2" EFFECT_SIZE="0.965881358315517" ESTIMABLE="YES" EVENTS_1="745" EVENTS_2="258" I2="66.282226900794" ID="CMP-007.10.01" LOG_CI_END="0.07661790836883407" LOG_CI_START="-0.10677033999595377" LOG_EFFECT_SIZE="-0.01507621581355986" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0515196059660884" P_Z="0.7472599342749603" STUDIES="3" TAU2="0.02268162125486631" TOTAL_1="2219" TOTAL_2="689" WEIGHT="100.0" Z="0.32225445502869204">
<NAME>any reason</NAME>
<DICH_DATA CI_END="1.3349632910352176" CI_START="0.8908743850504742" EFFECT_SIZE="1.090543259557344" ESTIMABLE="YES" EVENTS_1="120" EVENTS_2="105" LOG_CI_END="0.12546932358820925" LOG_CI_START="-0.05018352797809963" LOG_EFFECT_SIZE="0.03764289780505482" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.10317935450568816" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.010645979196210471" WEIGHT="34.81882912010068"/>
<DICH_DATA CI_END="0.9542013316322481" CI_START="0.6960812382949895" EFFECT_SIZE="0.8149856713496889" ESTIMABLE="YES" EVENTS_1="440" EVENTS_2="114" LOG_CI_END="-0.02035998169856228" LOG_CI_START="-0.15734007176250628" LOG_EFFECT_SIZE="-0.08885002673053428" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="208" O_E="0.0" SE="0.08046278296594217" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.006474259442624314" WEIGHT="39.80082224677604"/>
<DICH_DATA CI_END="1.437118748981368" CI_START="0.7926594172309002" EFFECT_SIZE="1.0673076923076923" ESTIMABLE="YES" EVENTS_1="185" EVENTS_2="39" LOG_CI_END="0.15749265532739562" LOG_CI_START="-0.10091337635164155" LOG_EFFECT_SIZE="0.028289639487877074" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="88" O_E="0.0" SE="0.15178898213875283" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="0.023039895098718625" WEIGHT="25.38034863312328"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.84154363410772" CI_START="0.00308547970951139" DF="0" EFFECT_SIZE="0.07537934410181106" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-007.10.02" LOG_CI_END="0.2651820136213958" LOG_CI_START="-2.510677305213365" LOG_EFFECT_SIZE="-1.1227476457959846" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.11285564360673608" STUDIES="1" TAU2="0.0" TOTAL_1="680" TOTAL_2="153" WEIGHT="100.0" Z="1.5854873729054824">
<NAME>administrative reasons</NAME>
<DICH_DATA CI_END="1.84154363410772" CI_START="0.00308547970951139" EFFECT_SIZE="0.07537934410181106" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.2651820136213958" LOG_CI_START="-2.510677305213365" LOG_EFFECT_SIZE="-1.1227476457959846" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="95" O_E="0.0" SE="1.6305535046087742" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="2.658704731391956" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6053549287355013" CI_END="1.7631275238998234" CI_START="1.1115387338291711" DF="2" EFFECT_SIZE="1.3999230462761056" ESTIMABLE="YES" EVENTS_1="358" EVENTS_2="86" I2="0.0" ID="CMP-007.10.03" LOG_CI_END="0.24628372518819394" LOG_CI_START="0.04592460117371578" LOG_EFFECT_SIZE="0.14610416318095487" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7388373947723168" P_Z="0.004257077717370981" STUDIES="3" TAU2="0.0" TOTAL_1="2219" TOTAL_2="689" WEIGHT="99.99999999999999" Z="2.8584562767936834">
<NAME>adverse events</NAME>
<DICH_DATA CI_END="1.8115840598714943" CI_START="0.8831942057322726" EFFECT_SIZE="1.2649033737307567" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="43" LOG_CI_END="0.2580584906704983" LOG_CI_START="-0.05394378882995246" LOG_EFFECT_SIZE="0.10205735092027295" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.18327168341475666" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.03358850994167879" WEIGHT="41.23848618719554"/>
<DICH_DATA CI_END="2.083293647089242" CI_START="1.02945493270745" EFFECT_SIZE="1.4644647217581288" ESTIMABLE="YES" EVENTS_1="215" EVENTS_2="31" LOG_CI_END="0.31875048949754164" LOG_CI_START="0.012607338904625513" LOG_EFFECT_SIZE="0.16567891420108358" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="216" O_E="0.0" SE="0.17983000209131497" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.032338829652162344" WEIGHT="42.83207890257659"/>
<DICH_DATA CI_END="2.874105736674809" CI_START="0.9046835740317076" EFFECT_SIZE="1.6125" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="12" LOG_CI_END="0.4585027415329644" LOG_CI_START="-0.04350329491835364" LOG_EFFECT_SIZE="0.2074997233073054" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.29488083078146177" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="0.0869547043623651" WEIGHT="15.929434910227855"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.231386050661218" CI_START="0.04351361253961904" DF="0" EFFECT_SIZE="0.477112676056338" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-007.10.04" LOG_CI_END="0.7186167700151093" LOG_CI_START="-1.3613748596883357" LOG_EFFECT_SIZE="-0.32137904483661317" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5447357719953966" STUDIES="1" TAU2="0.0" TOTAL_1="284" TOTAL_2="271" WEIGHT="100.0" Z="0.6056672000698886">
<NAME>death</NAME>
<DICH_DATA CI_END="5.231386050661218" CI_START="0.04351361253961904" EFFECT_SIZE="0.477112676056338" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7186167700151093" LOG_CI_START="-1.3613748596883357" LOG_EFFECT_SIZE="-0.32137904483661317" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="1.2217973794124244" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="1.4927888363390676" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.532129948127915" CI_END="1.958501611725068" CI_START="0.4501226411115255" DF="2" EFFECT_SIZE="0.9389174181422278" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="48" I2="79.01833052126199" ID="CMP-007.10.05" LOG_CI_END="0.2919239332813906" LOG_CI_START="-0.34666914155497036" LOG_EFFECT_SIZE="-0.027372604136789866" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.008513853385203829" P_Z="0.8665648002226299" STUDIES="3" TAU2="0.3306100121229672" TOTAL_1="2219" TOTAL_2="689" WEIGHT="100.0" Z="0.1680234890894421">
<NAME>inefficacy</NAME>
<DICH_DATA CI_END="2.674616701440639" CI_START="0.9268474040534067" EFFECT_SIZE="1.5744718309859156" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="20" LOG_CI_END="0.4272615521977449" LOG_CI_START="-0.03299176211519619" LOG_EFFECT_SIZE="0.19713489504127435" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.2703550751180712" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.07309186664209792" WEIGHT="34.85481986692857"/>
<DICH_DATA CI_END="0.8393173191749586" CI_START="0.3059853225794577" EFFECT_SIZE="0.5067729083665339" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="20" LOG_CI_END="-0.07607381519916499" LOG_CI_START="-0.5142994051381211" LOG_EFFECT_SIZE="-0.29518661016864306" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="217" O_E="0.0" SE="0.2574158807817983" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.06626293567866898" WEIGHT="35.45456132054102"/>
<DICH_DATA CI_END="2.2444439285454667" CI_START="0.5089129418529208" EFFECT_SIZE="1.06875" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="8" LOG_CI_END="0.3511087601821036" LOG_CI_START="-0.2933565047096454" LOG_EFFECT_SIZE="0.028876127736229093" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.37856208675192476" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="0.1433092535259718" WEIGHT="29.690618812530403"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.12195681856535795" CI_END="2.1252196949129853" CI_START="0.34065880526188264" DF="1" EFFECT_SIZE="0.8508670884386588" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" I2="0.0" ID="CMP-007.10.06" LOG_CI_END="0.3274038319659124" LOG_CI_START="-0.46768038104654147" LOG_EFFECT_SIZE="-0.07013827454031453" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.7269218390177608" P_Z="0.7294959909327356" STUDIES="2" TAU2="0.0" TOTAL_1="964" TOTAL_2="424" WEIGHT="100.0" Z="0.3457960547750075">
<NAME>lost to follow-up</NAME>
<DICH_DATA CI_END="2.922452956220024" CI_START="0.3115690949538104" EFFECT_SIZE="0.954225352112676" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4657475288951294" LOG_CI_START="-0.5064456272403933" LOG_EFFECT_SIZE="-0.02034904917263197" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.5710710723477428" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.32612216967240093" WEIGHT="66.8838311225944"/>
<DICH_DATA CI_END="3.3122330815264993" CI_START="0.13755825414013967" EFFECT_SIZE="0.675" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.52012089044952" LOG_CI_START="-0.8615133447874701" LOG_EFFECT_SIZE="-0.17069622716897506" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="93" O_E="0.0" SE="0.8115787889779736" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="0.6586601307189542" WEIGHT="33.116168877405606"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.001639502477231642" CI_END="2.63433629248612" CI_START="0.16077510558182329" DF="1" EFFECT_SIZE="0.6507962012508101" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-007.10.07" LOG_CI_END="0.4206712150632942" LOG_CI_START="-0.7937811965417227" LOG_EFFECT_SIZE="-0.18655499073921425" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.9677018710504945" P_Z="0.5470745135663022" STUDIES="2" TAU2="0.0" TOTAL_1="964" TOTAL_2="424" WEIGHT="100.0" Z="0.6021496758392254">
<NAME>no longer meets criteria</NAME>
<DICH_DATA CI_END="3.777700515371753" CI_START="0.10712525238973392" EFFECT_SIZE="0.636150234741784" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5772275254024144" LOG_CI_START="-0.9701081418590408" LOG_EFFECT_SIZE="-0.1964403082283132" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.9089126303844616" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.8261221696724009" WEIGHT="61.601591191722584"/>
<DICH_DATA CI_END="6.4451221377463925" CI_START="0.07069299700801548" EFFECT_SIZE="0.675" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="0.8092311518285509" LOG_CI_START="-1.150623606166501" LOG_EFFECT_SIZE="-0.17069622716897506" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="94" O_E="0.0" SE="1.1512283862838082" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="1.3253267973856209" WEIGHT="38.398408808277416"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.16373935381621554" CI_END="3.7950896352328405" CI_START="0.10156152447267318" DF="1" EFFECT_SIZE="0.6208341878993847" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-007.10.08" LOG_CI_END="0.5792220378407974" LOG_CI_START="-0.9932707888430101" LOG_EFFECT_SIZE="-0.2070243755011063" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.685737090551176" P_Z="0.6058036269739271" STUDIES="2" TAU2="0.0" TOTAL_1="964" TOTAL_2="424" WEIGHT="100.0" Z="0.5160727133614503">
<NAME>other</NAME>
<DICH_DATA CI_END="15.179574319303" CI_START="0.05998495105733439" EFFECT_SIZE="0.954225352112676" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1812595928130913" LOG_CI_START="-1.2219576911583552" LOG_EFFECT_SIZE="-0.02034904917263197" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="1.4116617287222415" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="1.9927888363390676" WEIGHT="42.814538626551524"/>
<DICH_DATA CI_END="4.930957187272645" CI_START="0.04106707730553314" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.6929312318128324" LOG_CI_START="-1.3865062042621452" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="1.22147184333176" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="1.4919934640522876" WEIGHT="57.185461373448476"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.4366136506764263" CI_END="2.3196675942439886" CI_START="0.5259192427909093" DF="1" EFFECT_SIZE="1.1045170096885826" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="12" I2="0.0" ID="CMP-007.10.09" LOG_CI_END="0.3654257554389386" LOG_CI_START="-0.2790809385514044" LOG_EFFECT_SIZE="0.04317240844376703" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.5087614691789941" P_Z="0.7928765135631297" STUDIES="2" TAU2="0.0" TOTAL_1="964" TOTAL_2="424" WEIGHT="100.0" Z="0.26257715075618493">
<NAME>poor/non compliance</NAME>
<DICH_DATA CI_END="2.25628620616075" CI_START="0.4035596282636177" EFFECT_SIZE="0.954225352112676" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.3533941883398885" LOG_CI_START="-0.3940922866851524" LOG_EFFECT_SIZE="-0.02034904917263197" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.4390772555474351" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.19278883633906763" WEIGHT="74.34438733825796"/>
<DICH_DATA CI_END="7.302342617563443" CI_START="0.38996475502955397" EFFECT_SIZE="1.6875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="2" LOG_CI_END="0.8634622056921065" LOG_CI_START="-0.40897464268598144" LOG_EFFECT_SIZE="0.22724378150306254" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.747435703401272" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="0.5586601307189543" WEIGHT="25.655612661742037"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.726325258959768" CI_START="0.13537050135981338" DF="0" EFFECT_SIZE="0.954225352112676" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-007.10.10" LOG_CI_END="0.8277778642804327" LOG_CI_START="-0.8684759626256967" LOG_EFFECT_SIZE="-0.02034904917263197" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Z="0.9624930812413816" STUDIES="1" TAU2="0.0" TOTAL_1="284" TOTAL_2="271" WEIGHT="100.0" Z="0.04702527754438534">
<NAME>pregnancy</NAME>
<DICH_DATA CI_END="6.726325258959768" CI_START="0.13537050135981338" EFFECT_SIZE="0.954225352112676" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8277778642804327" LOG_CI_START="-0.8684759626256967" LOG_EFFECT_SIZE="-0.02034904917263197" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.996387894516522" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.9927888363390677" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.166902019244691" CI_END="0.6550372500208986" CI_START="0.35787857685013014" DF="2" EFFECT_SIZE="0.48417331485874154" ESTIMABLE="YES" EVENTS_1="117" EVENTS_2="65" I2="0.0" ID="CMP-007.10.11" LOG_CI_END="-0.18373400226999437" LOG_CI_START="-0.4462642983527794" LOG_EFFECT_SIZE="-0.3149991503113869" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.5579696807518202" P_Z="2.5591705242084347E-6" STUDIES="3" TAU2="0.0" TOTAL_1="2219" TOTAL_2="689" WEIGHT="100.0" Z="4.70335804273312">
<NAME>withdrew</NAME>
<DICH_DATA CI_END="0.9590984729077149" CI_START="0.1875312575500107" EFFECT_SIZE="0.4241001564945227" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.018136800498880827" LOG_CI_START="-0.726926334069108" LOG_EFFECT_SIZE="-0.3725315672839944" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.41634648058392804" STUDY_ID="STD-Kerwin-2007" TOTAL_1="284" TOTAL_2="271" VAR="0.17334439189462317" WEIGHT="13.719057141636767"/>
<DICH_DATA CI_END="0.6525777408509588" CI_START="0.3054213489035254" EFFECT_SIZE="0.4464428002276608" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="35" LOG_CI_END="-0.18536774389547406" LOG_CI_START="-0.515100609103623" LOG_EFFECT_SIZE="-0.3502341764995485" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="215" O_E="0.0" SE="0.1936867172272733" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.03751454443027772" WEIGHT="63.39198979223769"/>
<DICH_DATA CI_END="1.2343525499809493" CI_START="0.3488987506094971" EFFECT_SIZE="0.65625" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="12" LOG_CI_END="0.09143921856585063" LOG_CI_START="-0.457300585737824" LOG_EFFECT_SIZE="-0.18293068358598671" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.3223324773538178" STUDY_ID="STD-Wolf-2007" TOTAL_1="680" TOTAL_2="153" VAR="0.10389822595704948" WEIGHT="22.888953066125545"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.32186080260819216" CI_END="1.2322572677462302" CI_START="1.0471668673421919" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1359484947943144" ESTIMABLE="YES" EVENTS_1="1350" EVENTS_2="252" I2="0.0" I2_Q="0.0" ID="CMP-007.11" LOG_CI_END="0.09070138826541117" LOG_CI_START="0.020015892559032744" LOG_EFFECT_SIZE="0.05535864041222195" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.5704916421903105" P_Q="1.0" P_Z="0.0021408502306608577" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1924" TOTAL_2="409" WEIGHT="100.0" Z="3.0699633738656154">
<NAME>Adverse effects: 1. At least one adverse effect</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2324447355803692" CI_START="1.0162219736680072" EFFECT_SIZE="1.1191235059760956" ESTIMABLE="YES" EVENTS_1="901" EVENTS_2="170" LOG_CI_END="0.09076745405831271" LOG_CI_START="0.0069885813827671225" LOG_EFFECT_SIZE="0.04887801772053993" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="214" O_E="0.0" SE="0.049212124521723626" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.002421833199941632" WEIGHT="71.18550847502972"/>
<DICH_DATA CI_END="1.371543614315945" CI_START="1.0128102861551462" EFFECT_SIZE="1.1786065842721207" ESTIMABLE="YES" EVENTS_1="449" EVENTS_2="82" LOG_CI_END="0.13720962248052626" LOG_CI_START="0.005528103413539825" LOG_EFFECT_SIZE="0.07136886294703303" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="97" O_E="0.0" SE="0.07735037613397985" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.00598308068806816" WEIGHT="28.814491524970286"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="63.59009246237312" CI_END="1.4901981688847954" CI_START="1.1233620917551643" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="1.293843936542634" ESTIMABLE="YES" EVENTS_1="975" EVENTS_2="230" I2="82.70170780690592" I2_Q="91.23537757777224" ID="CMP-007.12" LOG_CI_END="0.17324402541258158" LOG_CI_START="0.050519764368921534" LOG_EFFECT_SIZE="0.11188189489075157" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.9824669683643492E-9" P_Q="4.9441450933329634E-11" P_Z="3.520896955284042E-4" Q="57.04752308918197" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8824" TOTAL_2="2700" WEIGHT="100.0" Z="3.5736126279050398">
<NAME>Adverse effects: 2. Central nervous system</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.103050179570109" CI_START="0.7841577304565033" DF="0" EFFECT_SIZE="1.7937219730941705" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="6" I2="0.0" ID="CMP-007.12.01" LOG_CI_END="0.6131068283432571" LOG_CI_START="-0.10559657178365359" LOG_EFFECT_SIZE="0.25375512827980173" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.16635150229957588" STUDIES="1" TAU2="0.0" TOTAL_1="669" TOTAL_2="144" WEIGHT="3.039926074004888" Z="1.3840227059811578">
<NAME>sleep disorder</NAME>
<DICH_DATA CI_END="4.103050179570109" CI_START="0.7841577304565033" EFFECT_SIZE="1.7937219730941705" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="6" LOG_CI_END="0.6131068283432571" LOG_CI_START="-0.10559657178365359" LOG_EFFECT_SIZE="0.25375512827980173" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="218" O_E="0.0" SE="0.4221699348737548" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.1782274539113104" WEIGHT="3.039926074004888"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.4745052201214435" CI_END="2.6568493223668193" CI_START="1.6500582134296171" DF="2" EFFECT_SIZE="2.0937898763286356" ESTIMABLE="YES" EVENTS_1="476" EVENTS_2="68" I2="63.467018121582264" ID="CMP-007.12.02" LOG_CI_END="0.42436692500861994" LOG_CI_START="0.21749926622923021" LOG_EFFECT_SIZE="0.3209330956189251" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.06474802729409312" P_Z="1.191748937497727E-9" STUDIES="3" TAU2="0.0" TOTAL_1="2206" TOTAL_2="675" WEIGHT="30.711044806910657" Z="6.08134990816372">
<NAME>insomnia</NAME>
<DICH_DATA CI_END="5.129151454262393" CI_START="2.0052908286916282" EFFECT_SIZE="3.2070921985815604" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="20" LOG_CI_END="0.7100455231599807" LOG_CI_START="0.3021773675479413" LOG_EFFECT_SIZE="0.506111445353961" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="219" O_E="0.0" SE="0.23958377358644395" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.05740038456592044" WEIGHT="6.336869235802471"/>
<DICH_DATA CI_END="2.789045962857302" CI_START="1.4144306521890753" EFFECT_SIZE="1.9861802788844622" ESTIMABLE="YES" EVENTS_1="301" EVENTS_2="32" LOG_CI_END="0.4454556714015171" LOG_CI_START="0.15058165938585966" LOG_EFFECT_SIZE="0.2980186653936883" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.17321045430789755" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.030001861481548264" WEIGHT="16.267706040428486"/>
<DICH_DATA CI_END="2.357970492241258" CI_START="0.878743190639007" EFFECT_SIZE="1.4394618834080717" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="16" LOG_CI_END="0.3725383660105636" LOG_CI_START="-0.05613802729714089" LOG_EFFECT_SIZE="0.15820016935671138" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="220" O_E="0.0" SE="0.25180663541131537" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.06340658163716711" WEIGHT="8.1064695306797"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.3422990879734895" CI_END="0.705426601354338" CI_START="0.3885746087608108" DF="2" EFFECT_SIZE="0.5235559813723174" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="73" I2="40.1609506702572" ID="CMP-007.12.03" LOG_CI_END="-0.15154816728892714" LOG_CI_START="-0.41052558159353675" LOG_EFFECT_SIZE="-0.28103687444123193" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.18803100508402504" P_Z="2.1015062935348676E-5" STUDIES="3" TAU2="0.0" TOTAL_1="2206" TOTAL_2="675" WEIGHT="31.156396812597126" Z="4.253823861139041">
<NAME>somnolence</NAME>
<DICH_DATA CI_END="0.6522279317478303" CI_START="0.17176222040778982" EFFECT_SIZE="0.33470601692976437" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="31" LOG_CI_END="-0.18560060641291745" LOG_CI_START="-0.7650723543157659" LOG_EFFECT_SIZE="-0.47533648036434173" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.34038457314954684" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.1158616576381992" WEIGHT="9.82214731549383"/>
<DICH_DATA CI_END="0.960447443285098" CI_START="0.45334698815983787" EFFECT_SIZE="0.6598605577689243" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="32" LOG_CI_END="-0.017526395212245117" LOG_CI_START="-0.343569265188065" LOG_EFFECT_SIZE="-0.18054783020015508" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="212" O_E="0.0" SE="0.19151919576203227" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.03667960234533564" WEIGHT="16.267706040428486"/>
<DICH_DATA CI_END="0.93910000535117" CI_START="0.21757024215112905" EFFECT_SIZE="0.45201793721973094" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="10" LOG_CI_END="-0.027288156978241107" LOG_CI_START="-0.6624005048990672" LOG_EFFECT_SIZE="-0.3448443309386542" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="222" O_E="0.0" SE="0.37306813702551894" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.13917983486369137" WEIGHT="5.066543456674812"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.47146090494191123" CI_END="1.986720213127637" CI_START="1.0944629084929793" DF="2" EFFECT_SIZE="1.474581833206101" ESTIMABLE="YES" EVENTS_1="232" EVENTS_2="51" I2="0.0" ID="CMP-007.12.04" LOG_CI_END="0.2981367103657768" LOG_CI_START="0.03920104785024242" LOG_EFFECT_SIZE="0.16866887910800962" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7899935925876596" P_Z="0.010667272346197736" STUDIES="3" TAU2="0.0" TOTAL_1="2206" TOTAL_2="675" WEIGHT="21.889283897631117" Z="2.553413656140212">
<NAME>headache</NAME>
<DICH_DATA CI_END="2.830835196302232" CI_START="1.0291509369250404" EFFECT_SIZE="1.706855791962175" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="21" LOG_CI_END="0.4519145866311213" LOG_CI_START="0.012479073758072154" LOG_EFFECT_SIZE="0.23219683019459678" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="223" O_E="0.0" SE="0.25812659550249967" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.06662933930571108" WEIGHT="6.653712697592593"/>
<DICH_DATA CI_END="2.1535606283440867" CI_START="0.8940602299169732" EFFECT_SIZE="1.3875924871940808" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="21" LOG_CI_END="0.33315710279220767" LOG_CI_START="-0.048633223218071356" LOG_EFFECT_SIZE="0.14226193978706814" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="211" O_E="0.0" SE="0.2242655273910314" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.050295026775977456" WEIGHT="10.675682089031193"/>
<DICH_DATA CI_END="2.6448194076347584" CI_START="0.6782155776810361" EFFECT_SIZE="1.3393124065769806" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="9" LOG_CI_END="0.42239602308375374" LOG_CI_START="-0.16863223929514953" LOG_EFFECT_SIZE="0.1268818918943021" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="0.34717292695845064" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.1205290412128977" WEIGHT="4.559889111007331"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2759719420075422" CI_START="0.27238548861539225" DF="0" EFFECT_SIZE="0.5895390070921985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" I2="0.0" ID="CMP-007.12.05" LOG_CI_END="0.10584112456909921" LOG_CI_START="-0.564816033257537" LOG_EFFECT_SIZE="-0.22948745434421894" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.17981249881061867" STUDIES="1" TAU2="0.0" TOTAL_1="282" TOTAL_2="266" WEIGHT="5.069495388641976" Z="1.3413325725950676">
<NAME>fatigue</NAME>
<DICH_DATA CI_END="1.2759719420075422" CI_START="0.27238548861539225" EFFECT_SIZE="0.5895390070921985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.10584112456909921" LOG_CI_START="-0.564816033257537" LOG_EFFECT_SIZE="-0.22948745434421894" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="0.39394733431383855" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.15519450221297926" WEIGHT="5.069495388641976"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.670216194449338" CI_START="0.5865623286247732" DF="0" EFFECT_SIZE="0.9897908366533864" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="16" I2="0.0" ID="CMP-007.12.06" LOG_CI_END="0.2227726902969023" LOG_CI_START="-0.23168583258584993" LOG_EFFECT_SIZE="-0.004456571144473848" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.9693367774682666" STUDIES="1" TAU2="0.0" TOTAL_1="1255" TOTAL_2="265" WEIGHT="8.133853020214243" Z="0.038440114984762644">
<NAME>Lightheadedness</NAME>
<DICH_DATA CI_END="1.6702161944493383" CI_START="0.5865623286247731" EFFECT_SIZE="0.9897908366533864" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="16" LOG_CI_END="0.22277269029690236" LOG_CI_START="-0.23168583258585002" LOG_EFFECT_SIZE="-0.004456571144473848" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="218" O_E="0.0" SE="0.2669511859472982" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.07126293567866898" WEIGHT="8.133853020214243"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.40581106944923784" CI_START="0.2303567161221626" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3057471264367816" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="145" I2="0.0" I2_Q="0.0" ID="CMP-007.13" LOG_CI_END="-0.391676110739946" LOG_CI_START="-0.6375991212351572" LOG_EFFECT_SIZE="-0.5146376159875515" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="2.3417631457873744E-16" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="282" TOTAL_2="266" WEIGHT="100.0" Z="8.203146101651988">
<NAME>Adverse effects: 3a. Endocrine - Prolactin - increase in level</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.40581106944923784" CI_START="0.2303567161221626" EFFECT_SIZE="0.3057471264367816" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="145" LOG_CI_END="-0.391676110739946" LOG_CI_START="-0.6375991212351572" LOG_EFFECT_SIZE="-0.5146376159875515" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="207" O_E="0.0" SE="0.14445639370342192" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.020867649681798037" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.9379291920762203" CI_START="-19.13792919207622" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-8.600000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.14" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="0.10970380702398465" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="47" TOTAL_2="47" UNITS="" WEIGHT="100.0" Z="1.5995258612782062">
<NAME>Adverse effects: 3b. Endocrine - Prolactin - Change in level</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9379291920762203" CI_START="-19.13792919207622" EFFECT_SIZE="-8.600000000000001" ESTIMABLE="YES" MEAN_1="-41.5" MEAN_2="-32.9" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="222" SD_1="26.74" SD_2="25.37" SE="5.376593281916434" STUDY_ID="STD-Kerwin-2007" TOTAL_1="47" TOTAL_2="47" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="66.71824187585341" CI_END="0.31991196195129684" CI_START="0.18214304114604327" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.24139125429229305" ESTIMABLE="YES" EVENTS_1="121" EVENTS_2="90" I2="97.00231909029989" I2_Q="97.72824570005622" ID="CMP-007.15" LOG_CI_END="-0.4949695207401646" LOG_CI_START="-0.7395874165143251" LOG_EFFECT_SIZE="-0.6172784686272448" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="3.552713678800501E-15" P_Q="3.2525537818628436E-11" P_Z="4.522757960505579E-23" Q="44.01884482070716" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="4.2760995710269585" TOTALS="SUB" TOTAL_1="2206" TOTAL_2="675" WEIGHT="200.0" Z="9.891701202911225">
<NAME>Adverse effects: 4. Extrapyramidal - akathisia</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3395429035083803" CI_END="5.99268883838549" CI_START="1.2759103163542493" DF="1" EFFECT_SIZE="2.7651642829309457" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="10" I2="25.347669165286735" ID="CMP-007.15.01" LOG_CI_END="0.7776217281752994" LOG_CI_START="0.10582014892957958" LOG_EFFECT_SIZE="0.44172093855243955" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.24711474707741143" P_Z="0.009954116224938522" STUDIES="2" TAU2="0.08000055004861464" TOTAL_1="951" TOTAL_2="410" WEIGHT="100.0" Z="2.5774191592465736">
<NAME>homogeneous data</NAME>
<DICH_DATA CI_END="9.429349758665367" CI_START="1.6381770148106338" EFFECT_SIZE="3.930260047281324" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="6" LOG_CI_END="0.9744817451275474" LOG_CI_START="0.2143608280726526" LOG_EFFECT_SIZE="0.5944212866000999" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.4464987893372679" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.19936116887964592" WEIGHT="55.74300161351209"/>
<DICH_DATA CI_END="4.934141373697436" CI_START="0.6391003523099846" EFFECT_SIZE="1.7757847533632287" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="4" LOG_CI_END="0.6932115887972286" LOG_CI_START="-0.1944309430425253" LOG_EFFECT_SIZE="0.24939032287735163" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="0.5214056171040681" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.271863817547674" WEIGHT="44.256998386487915"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.22499709546716162" CI_START="0.12289338577151664" DF="0" EFFECT_SIZE="0.16628486055776892" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="80" I2="0.0" ID="CMP-007.15.02" LOG_CI_END="-0.6478230882474204" LOG_CI_START="-0.9104714905898016" LOG_EFFECT_SIZE="-0.779147289418611" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="2.95314921460825E-31" STUDIES="1" TAU2="0.0" TOTAL_1="1255" TOTAL_2="265" WEIGHT="100.0" Z="11.628478317730622">
<NAME>outlying study</NAME>
<DICH_DATA CI_END="0.22499709546716162" CI_START="0.12289338577151664" EFFECT_SIZE="0.16628486055776892" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="80" LOG_CI_END="-0.6478230882474204" LOG_CI_START="-0.9104714905898016" LOG_EFFECT_SIZE="-0.779147289418611" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="210" O_E="0.0" SE="0.1542809716664745" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.02380261821835151" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.181383940493975" CI_END="4.61306932470533" CI_START="2.124719949960681" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="3.130731611740786" ESTIMABLE="YES" EVENTS_1="299" EVENTS_2="25" I2="52.16894625171095" I2_Q="0.0" ID="CMP-007.16" LOG_CI_END="0.6639899811876636" LOG_CI_START="0.32730169570315065" LOG_EFFECT_SIZE="0.49564583844540716" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.12360162774440131" P_Q="1.0" P_Z="7.898620234549228E-9" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2206" TOTAL_2="675" WEIGHT="100.0" Z="5.770607617322886">
<NAME>Adverse effects: 5. Gastrointestinal</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.181383940493975" CI_END="4.61306932470533" CI_START="2.124719949960681" DF="2" EFFECT_SIZE="3.130731611740786" ESTIMABLE="YES" EVENTS_1="299" EVENTS_2="25" I2="52.16894625171095" ID="CMP-007.16.01" LOG_CI_END="0.6639899811876636" LOG_CI_START="0.32730169570315065" LOG_EFFECT_SIZE="0.49564583844540716" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.12360162774440131" P_Z="7.898620234549228E-9" STUDIES="3" TAU2="0.0" TOTAL_1="2206" TOTAL_2="675" WEIGHT="100.0" Z="5.770607617322886">
<NAME>nausea</NAME>
<DICH_DATA CI_END="30.54218532150284" CI_START="2.9131640951530766" EFFECT_SIZE="9.432624113475176" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="3" LOG_CI_END="1.4849001080025088" LOG_CI_START="0.46436494862090305" LOG_EFFECT_SIZE="0.9746325283117059" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="0.5994674043512673" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.35936116887964586" WEIGHT="7.839872340528156"/>
<DICH_DATA CI_END="4.336771146936484" CI_START="1.6225195593847754" EFFECT_SIZE="2.6526394422310755" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="16" LOG_CI_END="0.6371665048683792" LOG_CI_START="0.21018994090025067" LOG_EFFECT_SIZE="0.42367822288431495" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="209" O_E="0.0" SE="0.2508081472429576" STUDY_ID="STD-Tandon-2006" TOTAL_1="1255" TOTAL_2="265" VAR="0.0629047267234451" WEIGHT="67.08714450012236"/>
<DICH_DATA CI_END="5.511481598100909" CI_START="1.0797412954533647" EFFECT_SIZE="2.4394618834080717" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="6" LOG_CI_END="0.7412683617166996" LOG_CI_START="0.03331971158333877" LOG_EFFECT_SIZE="0.3872940366500192" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="0.41585254149067263" STUDY_ID="STD-Wolf-2007" TOTAL_1="669" TOTAL_2="144" VAR="0.17293333626425159" WEIGHT="25.072983159349477"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="27.164085748192903" CI_END="0.8208364181510076" CI_START="0.6538862119325458" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7326210589936939" ESTIMABLE="YES" EVENTS_1="306" EVENTS_2="399" I2="74.23068066825817" I2_Q="73.91304633493601" ID="CMP-007.17" LOG_CI_END="-0.08574338340774769" LOG_CI_START="-0.18449782022210262" LOG_EFFECT_SIZE="-0.13512060181492516" METHOD="MH" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="3.113588191117067E-4" P_Q="3.570991364201248E-4" P_Z="8.165393616598874E-8" Q="26.833336271741445" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1281" TOTAL_2="1236" WEIGHT="100.00000000000001" Z="5.363435237334772">
<NAME>Adverse effects: 6a. Metabolic- binary measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6445534436677872" CI_START="0.1868512253798608" DF="0" EFFECT_SIZE="0.3470383275261324" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="35" I2="0.0" ID="CMP-007.17.01" LOG_CI_END="-0.1907410669409333" LOG_CI_START="-0.728504049679654" LOG_EFFECT_SIZE="-0.4596225583102936" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="8.071324145166313E-4" STUDIES="1" TAU2="0.0" TOTAL_1="164" TOTAL_2="166" WEIGHT="8.522168297355284" Z="3.3503371919819305">
<NAME>weight gain (7% or more of total body weight at 26 weeks - medium-term)</NAME>
<DICH_DATA CI_END="0.6445534436677871" CI_START="0.18685122537986082" EFFECT_SIZE="0.3470383275261324" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="35" LOG_CI_END="-0.19074106694093337" LOG_CI_START="-0.728504049679654" LOG_EFFECT_SIZE="-0.4596225583102936" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="229" O_E="0.0" SE="0.3158846380304208" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="166" VAR="0.09978310454360996" WEIGHT="8.522168297355284"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.189606075104525" CI_START="0.9650628725728564" DF="0" EFFECT_SIZE="1.754471544715447" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="15" I2="0.0" ID="CMP-007.17.02" LOG_CI_END="0.5037370498370128" LOG_CI_START="-0.015444392022025027" LOG_EFFECT_SIZE="0.2441463289074939" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0652771067974796" STUDIES="1" TAU2="0.0" TOTAL_1="164" TOTAL_2="166" WEIGHT="3.6523578417236933" Z="1.8433556095646426">
<NAME>weight loss (7% or more of total body weight at 26 weeks - medium-term)</NAME>
<DICH_DATA CI_END="3.189606075104525" CI_START="0.9650628725728565" EFFECT_SIZE="1.754471544715447" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="15" LOG_CI_END="0.5037370498370128" LOG_CI_START="-0.015444392022024977" LOG_EFFECT_SIZE="0.2441463289074939" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="230" O_E="0.0" SE="0.3049697489375843" STUDY_ID="STD-Kerwin-2007" TOTAL_1="164" TOTAL_2="166" VAR="0.0930065477670532" WEIGHT="3.6523578417236933"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.3705038308265135" CI_START="0.034580784860817324" DF="0" EFFECT_SIZE="0.11319148936170213" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="25" I2="0.0" ID="CMP-007.17.03" LOG_CI_END="-0.4312072972711174" LOG_CI_START="-1.4611651540102213" LOG_EFFECT_SIZE="-0.9461862256406692" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.1687293403926395E-4" STUDIES="1" TAU2="0.0" TOTAL_1="282" TOTAL_2="266" WEIGHT="6.3031945572741765" Z="3.6011005941447127">
<NAME>average weight gain</NAME>
<DICH_DATA CI_END="0.3705038308265135" CI_START="0.034580784860817324" EFFECT_SIZE="0.11319148936170213" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="25" LOG_CI_END="-0.4312072972711174" LOG_CI_START="-1.4611651540102213" LOG_EFFECT_SIZE="-0.9461862256406692" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="0.6050023434221661" STUDY_ID="STD-Kerwin-2007" TOTAL_1="282" TOTAL_2="266" VAR="0.3660278355463126" WEIGHT="6.3031945572741765"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9135030411638577" CI_START="0.6210756271100119" DF="0" EFFECT_SIZE="0.75322936357908" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="92" I2="0.0" ID="CMP-007.17.04" LOG_CI_END="-0.03929000248934873" LOG_CI_START="-0.2068555134517945" LOG_EFFECT_SIZE="-0.12307275797057164" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.003988232985930126" STUDIES="1" TAU2="0.0" TOTAL_1="138" TOTAL_2="131" WEIGHT="23.124203769324694" Z="2.8790909503375826">
<NAME>total cholesterol increase</NAME>
<DICH_DATA CI_END="0.9135030411638577" CI_START="0.6210756271100119" EFFECT_SIZE="0.75322936357908" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="92" LOG_CI_END="-0.03929000248934873" LOG_CI_START="-0.2068555134517945" LOG_EFFECT_SIZE="-0.12307275797057164" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="0.09842881060199732" STUDY_ID="STD-Kerwin-2007" TOTAL_1="138" TOTAL_2="131" VAR="0.00968823075652386" WEIGHT="23.124203769324694"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8382461363343743" CI_START="0.5074056347153612" DF="0" EFFECT_SIZE="0.6521739130434783" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="78" I2="0.0" ID="CMP-007.17.05" LOG_CI_END="-0.07662843965581187" LOG_CI_START="-0.2946447142680114" LOG_EFFECT_SIZE="-0.18563657696191163" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="8.446222800749359E-4" STUDIES="1" TAU2="0.0" TOTAL_1="138" TOTAL_2="130" WEIGHT="19.67845731213379" Z="3.3377416957136217">
<NAME>LDL increase</NAME>
<DICH_DATA CI_END="0.8382461363343743" CI_START="0.5074056347153612" EFFECT_SIZE="0.6521739130434783" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="78" LOG_CI_END="-0.07662843965581187" LOG_CI_START="-0.2946447142680114" LOG_EFFECT_SIZE="-0.18563657696191163" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.1280638389051704" STUDY_ID="STD-Kerwin-2007" TOTAL_1="138" TOTAL_2="130" VAR="0.016400346835129438" WEIGHT="19.67845731213379"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.221659435388563" CI_START="0.6149179665563899" DF="0" EFFECT_SIZE="0.8667296786389413" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="46" I2="0.0" ID="CMP-007.17.06" LOG_CI_END="0.08695015357797094" LOG_CI_START="-0.21118281763626273" LOG_EFFECT_SIZE="-0.06211633202914589" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.4140877247838358" STUDIES="1" TAU2="0.0" TOTAL_1="138" TOTAL_2="131" WEIGHT="11.562101884662347" Z="0.8167212981040811">
<NAME>HDL increase</NAME>
<DICH_DATA CI_END="1.221659435388563" CI_START="0.6149179665563899" EFFECT_SIZE="0.8667296786389413" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="46" LOG_CI_END="0.08695015357797094" LOG_CI_START="-0.21118281763626273" LOG_EFFECT_SIZE="-0.06211633202914589" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="0.17512478307324944" STUDY_ID="STD-Kerwin-2007" TOTAL_1="138" TOTAL_2="131" VAR="0.030668689646452675" WEIGHT="11.562101884662347"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0030849680920293" CI_START="0.640014695874889" DF="0" EFFECT_SIZE="0.8012422360248447" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="77" I2="0.0" ID="CMP-007.17.07" LOG_CI_END="0.0013377222632619382" LOG_CI_START="-0.1938100537284635" LOG_EFFECT_SIZE="-0.09623616573260077" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.05322471830330321" STUDIES="1" TAU2="0.0" TOTAL_1="138" TOTAL_2="129" WEIGHT="19.498926586631754" Z="1.9330931945042815">
<NAME>triglyceride increase</NAME>
<DICH_DATA CI_END="1.0030849680920293" CI_START="0.640014695874889" EFFECT_SIZE="0.8012422360248447" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="77" LOG_CI_END="0.0013377222632619382" LOG_CI_START="-0.1938100537284635" LOG_EFFECT_SIZE="-0.09623616573260077" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.11463076961461008" STUDY_ID="STD-Kerwin-2007" TOTAL_1="138" TOTAL_2="129" VAR="0.013140213342437812" WEIGHT="19.498926586631754"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4659815415764683" CI_START="0.6175447307470625" DF="0" EFFECT_SIZE="0.9514773651396042" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="31" I2="0.0" ID="CMP-007.17.08" LOG_CI_END="0.16612850206366842" LOG_CI_START="-0.20933157958562712" LOG_EFFECT_SIZE="-0.021601538760979356" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.8215691368222791" STUDIES="1" TAU2="0.0" TOTAL_1="119" TOTAL_2="117" WEIGHT="7.6585897508942615" Z="0.22552724005271074">
<NAME>fasting glucose (increase)</NAME>
<DICH_DATA CI_END="1.4659815415764683" CI_START="0.6175447307470625" EFFECT_SIZE="0.9514773651396042" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="31" LOG_CI_END="0.16612850206366842" LOG_CI_START="-0.20933157958562712" LOG_EFFECT_SIZE="-0.021601538760979356" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="236" O_E="0.0" SE="0.22054711051817477" STUDY_ID="STD-Kerwin-2007" TOTAL_1="119" TOTAL_2="117" VAR="0.048641027957916" WEIGHT="7.6585897508942615"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="8.967202389387776" CI_END="-2.458744705565228" CI_START="-3.4815217218764865" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.970133213720857" ESTIMABLE="YES" I2="55.392999663598594" I2_Q="55.39299966359858" ID="CMP-007.18" MODIFIED="2013-06-25 19:14:29 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.06192457707181187" P_Q="0.06192457707181176" P_Z="5.057213986132855E-30" Q="8.967202389387772" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="910" TOTAL_2="886" UNITS="" WEIGHT="100.0" Z="11.383427737111939">
<NAME>Adverse effects: 6b. Metabolic - continuous measures</NAME>
<GROUP_LABEL_1>Aripiprazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Others</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.7205708646987352" CI_START="-3.679429135301265" DF="0" EFFECT_SIZE="-2.7" ESTIMABLE="YES" I2="0.0" ID="CMP-007.18.01" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="6.551787033867369E-8" STUDIES="1" TAU2="0.0" TOTAL_1="279" TOTAL_2="258" WEIGHT="27.2618855949327" Z="5.403048130307456">
<NAME>weight change (no risk)</NAME>
<CONT_DATA CI_END="-1.7205708646987354" CI_START="-3.679429135301265" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-1.3" MEAN_2="1.4" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="237" SD_1="5.01" SD_2="6.42" SE="0.49971792493478284" STUDY_ID="STD-Kerwin-2007" TOTAL_1="279" TOTAL_2="258" WEIGHT="27.2618855949327"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.6622432160010217" CI_START="-3.2977567839989783" DF="0" EFFECT_SIZE="-2.48" ESTIMABLE="YES" I2="0.0" ID="CMP-007.18.02" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="2.782236078729827E-9" STUDIES="1" TAU2="0.0" TOTAL_1="222" TOTAL_2="219" WEIGHT="39.1069204086828" Z="5.94395641438715">
<NAME>% weight change from baseline- up to 12 weeks (short-term)</NAME>
<CONT_DATA CI_END="-1.6622432160010217" CI_START="-3.2977567839989783" EFFECT_SIZE="-2.48" ESTIMABLE="YES" MEAN_1="-1.45" MEAN_2="1.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="238" SD_1="4.32" SD_2="4.44" SE="0.41723051568770625" STUDY_ID="STD-Kerwin-2007" TOTAL_1="222" TOTAL_2="219" WEIGHT="39.1069204086828"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.053046663083978E-31" CI_END="-2.8252110021727694" CI_START="-4.6547889978272305" DF="0" EFFECT_SIZE="-3.7399999999999998" ESTIMABLE="YES" I2="100.0" ID="CMP-007.18.03" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="1.1188287472647186E-15" STUDIES="1" TAU2="0.0" TOTAL_1="162" TOTAL_2="165" WEIGHT="31.250722567750817" Z="8.013066750464152">
<NAME>% weight change from baseline - from 12 to 26 weeks (medium-term)</NAME>
<CONT_DATA CI_END="-2.82521100217277" CI_START="-4.6547889978272305" EFFECT_SIZE="-3.74" ESTIMABLE="YES" MEAN_1="-1.66" MEAN_2="2.08" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="239" SD_1="4.2" SD_2="4.24" SE="0.46673765693807096" STUDY_ID="STD-Kerwin-2007" TOTAL_1="162" TOTAL_2="165" WEIGHT="31.250722567750817"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.3257939565879298" CI_START="-16.074206043412072" DF="0" EFFECT_SIZE="-9.700000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-007.18.04" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.0028581950839363006" STUDIES="1" TAU2="0.0" TOTAL_1="133" TOTAL_2="129" WEIGHT="0.6436499403130812" Z="2.982591168305208">
<NAME>no change in fasting total cholesterol</NAME>
<CONT_DATA CI_END="-3.3257939565879298" CI_START="-16.074206043412072" EFFECT_SIZE="-9.700000000000001" ESTIMABLE="YES" MEAN_1="-18.8" MEAN_2="-9.1" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="240" SD_1="26.52" SD_2="26.12" SE="3.2522057005592933" STUDY_ID="STD-Kerwin-2007" TOTAL_1="133" TOTAL_2="129" WEIGHT="0.6436499403130812"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.980372093175521" CI_START="-5.7803720931755205" DF="0" EFFECT_SIZE="-1.9" ESTIMABLE="YES" I2="0.0" ID="CMP-007.18.05" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.3372142177599273" STUDIES="1" TAU2="0.0" TOTAL_1="114" TOTAL_2="115" WEIGHT="1.736821488320597" Z="0.9596841439962542">
<NAME>no change in fasting total glucose</NAME>
<CONT_DATA CI_END="1.980372093175521" CI_START="-5.7803720931755205" EFFECT_SIZE="-1.9" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="3.3" MODIFIED="2013-06-25 17:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SD_1="14.95" SD_2="15.01" SE="1.9798180598130377" STUDY_ID="STD-Kerwin-2007" TOTAL_1="114" TOTAL_2="115" WEIGHT="1.736821488320597"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-10-24 15:37:39 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-06-25 16:00:57 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: original search</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAKWCAYAAABj+x9xAAA+HElEQVR42u2dD4RV3du/H5IkSSQZ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</FILE>
</FIGURE>
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-06-25 16:00:59 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: update 2011</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAOSCAYAAABeHVbTAABdKklEQVR42u2dD4RVWxv/X5IkSSTX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</FILE>
</FIGURE>
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-07-30 11:28:17 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: update 2012</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAANMCAYAAAB2KSuMAABZHklEQVR42u29f4RVXdy/f5MkSSLJ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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2013-10-24 15:37:39 +0100" MODIFIED_BY="[Empty name]" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2013-10-24 15:37:39 +0100" MODIFIED_BY="[Empty name]" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVcAABW5CAIAAAAmjFhgAACAAElEQVR42uzdva5k17WY7QYMGA46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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2013-07-08 12:13:13 +0100" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 COMPARISON 1. ARIPIPRAZOLE versus CLOZAPINE, outcome: 1.1 Global state: 1. No clinically significant response (as defined by the original studies).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2013-06-25 23:20:49 +0100" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 2 COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE, outcome: 2.1 Global state: 1.No clinically significant response (as defined by original studies).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2013-07-09 11:45:49 +0100" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-003.01" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 3 COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE, outcome: 3.1 Global state: 1. No clinically significant response (as defined by the original studies).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGsCAMAAAA2Uyl8AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2013-07-30 19:25:00 +0100" MODIFIED_BY="[Empty name]" NO="9" REF_ID="CMP-005.01" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 5 COMPARISON 5. ARIPIPRAZOLE versus OLANZAPINE, outcome: 5.1 Global state: 1.No clinically significant response (as defined by the original studies).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGsCAMAAAA2Uyl8AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2016-10-18 13:44:33 +0100" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2016-10-18 13:44:33 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2016-10-17 11:59:48 +0100" MODIFIED_BY="[Empty name]">New Feedback</TITLE>
<DATE_SUBMITTED>
<DATE DAY="4" MONTH="8" YEAR="2016"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2016-10-18 13:39:36 +0100" MODIFIED_BY="[Empty name]">
<P>
<BR/>I would like to bring the authors attention to a possible error in their review report.<BR/>
<BR/>I believe that the a result in <LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK> (aripiprazole versus risperidone), (Mental state: 2 average endpoint scale), subgroup 2 (PANSS [short term, up to 12 weeks, high=poor]) contain an extra study in error. The study in question, <LINK REF="STD-Zhang-2009" TYPE="STUDY">Zhang 2009</LINK>, appears to compare aripiprazole with clozapine, and not with risperidone. As such, it should not be included in this analysis.<BR/>
<BR/>For this analysis the authors report no significant difference between aripiprazole and risperidone for PANSS short term (78 RCTs, n=5793, -0.69 CI -1.49 to 0.11) with considerable heterogeneity (ChI<SUP>2</SUP> = 161.78; df = 76; P=0.00001; I<SUP>2</SUP>=53%). However, after excluding <LINK REF="STD-Zhang-2009" TYPE="STUDY">Zhang 2009</LINK> and replicating the analysis, significant results in favour of aripiprazole are observed (77 RCTs, n = 5733, MD -0.80 CI -1.58 to -0.02, Z = 2.01, P = 0.04) with considerable heterogeneity (ChI<SUP>2</SUP> = 145.74; df = 76; P&lt;0.00001; I<SUP>2</SUP>=48%).<BR/>
<BR/>Conclusions elsewhere in the report may also need reconsideration.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2016-10-17 12:11:24 +0100" MODIFIED_BY="[Empty name]">
<P>Thank you for bring this to our attention. Following your query, I have checked through these data and found that <LINK REF="STD-Zhang-2009a" TYPE="STUDY">Zhang 2009a</LINK> which has the correct control group, has accidentally been entered twice. For some reason the duplicate entry was added as <LINK REF="STD-Zhang-2009" TYPE="STUDY">Zhang 2009</LINK>. My guess is the software didn't allow the same study to be entered twice in the same outcome, hence the reviewer mistook <LINK REF="STD-Zhang-2009" TYPE="STUDY">Zhang 2009</LINK> as <LINK REF="STD-Zhang-2009a" TYPE="STUDY">Zhang 2009a</LINK> . To rectify the error, I have removed study <LINK REF="STD-Zhang-2009" TYPE="STUDY">Zhang 2009</LINK> from this outcome. The result does became statistically significant and the results section has changed, but this significance is only marginal, upper CI is -0.02. As statistically significant results do not always necessarily have clinical significance, and as this is a marginal change, I feel the overall conclusions of the review should remain the same.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2016-10-18 13:44:33 +0100" MODIFIED_BY="[Empty name]">
<P>Claire Ainsworth: commentator.</P>
<P>Jun Xia: review author.</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2013-09-29 15:37:39 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-06-25 16:04:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-06-25 16:04:26 +0100" MODIFIED_BY="[Empty name]">Previous searches</TITLE>
<APPENDIX_BODY MODIFIED="2013-06-25 16:04:26 +0100" MODIFIED_BY="[Empty name]">
<P>1. Update of 2011<BR/>We searched the Cochrane Schizophrenia Group Trials Register (November 2011) using the phrase</P>
<P>[ ( (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in title, abstract or index terms of REFERENCE) or ( (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in interventions of STUDY)]</P>
<P>The Cochrane Schizophrenia Group&#8217;s Trials Register is compiled by systematic searches of major databases, handsearches of journals and conference proceedings (see <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/SCHIZ/frame.html">Group Module</A>). Incoming trials are assigned to relevant existing or new review titles.</P>
<P>2. Update of 2007<BR/>We searched the Cochrane Schizophrenia Group Trials Register (March 2007) using the phrase:</P>
<P>[ ( (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in title, abstract or index terms of REFERENCE) or ( (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in interventions of STUDY)]</P>
<P>This register is compiled by systematic searches of major databases, handsearches and conference proceedings (see <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/SCHIZ/frame.html">Group Module</A>). The Cochrane Schizophrenia Group Trials Register is maintained on Meerkat 1.5. This version of Meerkat stores references as studies. When an individual reference is selected through a search all references which have been identified as the same study are also selected</P>
<P>3. Initial search</P>
<P>We searched the Cochrane Schizophrenia Group Trials Register (August 2005) using the phrase:</P>
<P>[ (aripiprazol* AND (amisulprid* OR clozapin* OR olanzapin* OR quetiapin* OR risperidon* OR sertindol* OR ziprasidon* OR zotepin*)) in title, abstract or index terms of REFERENCE].</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-09-29 15:37:39 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-06-25 16:04:26 +0100" MODIFIED_BY="[Empty name]">Previous data collection and analysis</TITLE>
<APPENDIX_BODY MODIFIED="2013-09-29 15:37:39 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Data extraction</HEADING>
<P>We independently extracted data from selected trials. When disputes arose we attempted to resolve these by discussion. When this was not possible and further information was necessary to resolve the dilemma, we did not enter data and added the trial to the list of those awaiting assessment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Management</HEADING>
<P>We extracted the data onto standard simple forms. Where possible, we entered data in such a way that the area to the left of the line of no effect indicated a favourable outcome for aripiprazole.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Rating scales</HEADING>
<P>A wide range of instruments are available to measure outcomes in mental health studies. These instruments vary in quality and many are not validated or are even ad hoc. It is accepted generally that measuring instruments should have the properties of reliability (the extent to which a test effectively measures anything at all) and validity (the extent to which a test measures that which it is supposed to measure) (<LINK REF="REF-Rust-1989" TYPE="REFERENCE">Rust 1989</LINK>). Unpublished scales are known to be subject to bias in trials of treatments for schizophrenia (<LINK REF="REF-Marshall-2000" TYPE="REFERENCE">Marshall 2000</LINK>). Therefore continuous data from rating scales were included only if the measuring instrument had been described in a peer-reviewed journal. In addition, the following minimum standards for instruments were set: the instrument should either be (a) a self-report or (b) completed by an independent rater or relative (not the therapist) and (c) the instrument should be a global assessment of an area of functioning.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of risk of bias in included studies</HEADING>
<P>Again working independently, PK, KK and SL assessed the risk of bias using the tool described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). This tool encourages consideration of how the sequence was generated, how allocation was concealed, the integrity of blinding at outcome, the completeness of outcome data, selective reporting and other biases.</P>
<P>The risk of bias in each domain and overall were assessed and categorised into:</P>
<P>A. Low risk of bias: plausible bias unlikely to seriously alter the results (categorised as 'Yes' in Risk of Bias table)<BR/>B. High risk of bias: plausible bias that seriously weakens confidence in the results (categorised as 'No' in Risk of Bias table)<BR/>C. Unclear risk of bias: plausible bias that raises some doubt about the results (categorised as 'Unclear' in Risk of Bias table)</P>
<P>Trials with a high risk of bias (defined as at least three out of five domains were categorised as 'No') or where allocation was clearly not concealed were not included in the review. If the raters disagreed, the final rating was made by consensus with the involvement of another member of the review group.   Where inadequate details of randomisation and other characteristics of trials are provided, authors of the studies were contacted in order to obtain further information. Non-concurrence in quality assessment was reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of treatment effect  </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Data types</HEADING>
<P>We assessed outcomes using continuous (for example changes on a behaviour scale), categorical (for example, one of three categories on a behaviour scale, such as 'little change', 'moderate change' or 'much change') or dichotomous (for example, either 'no important changes' or 'important change' in a person's behaviour) measures. Currently RevMan does not support categorical data so we were unable to analyse this.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Dichotomous-yes/no-data</HEADING>
<P>We carried out an intention-to-treat analysis. Everyone allocated to the intervention were counted, whether they completed the follow-up or not. It was assumed that those who left early had no change in their outcome. This rule is conservative concerning response to treatment, because it assumes that those discontinuing the studies would not have responded. It is not conservative concerning adverse effects, but we felt that assuming that all those leaving early would have developed adverse effects would overestimate risk. Where possible, efforts were made to convert outcome measures to dichotomous data. This can be done by identifying cut-off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It was generally assumed that if there had been a 50% reduction in a scale-derived score such as the Brief Psychiatric Rating Scale (BPRS, <LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>) or the Positive and Negative Syndrome Scale (PANSS, <LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>), this could be considered as a clinically significant response (<LINK REF="REF-Leucht-2005" TYPE="REFERENCE">Leucht 2005</LINK>, <LINK REF="REF-Leucht-2005a" TYPE="REFERENCE">Leucht 2005a</LINK>). If data based on these thresholds were not available, we used the primary cut-off presented by the original authors.</P>
<P>We calculated the relative risk (RR) and its 95% confidence interval (CI) based on the random-effects model, as this takes into account any differences between studies even if there is no statistically significant heterogeneity. It has been shown that RR is more intuitive (<LINK REF="REF-Boissel-1999" TYPE="REFERENCE">Boissel 1999</LINK>) than odds ratios and that odds ratios tend to be interpreted as RR by clinicians (<LINK REF="REF-Deeks-2000" TYPE="REFERENCE">Deeks 2000</LINK>). This misinterpretation then leads to an overestimate of the impression of the effect. When the overall results were significant we calculated the number needed to treat (NNT) and the number needed to harm (NNH) as the inverse of the risk difference.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Continuous data</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Normal distribution of the data</HEADING>
<P>The meta-analytic formulas applied by RevMan Analyses (the statistical programme included in RevMan) require a normal distribution of data. The software is robust towards some skew but to which degree of skewness meta-analytic calculations can still be reliably carried out is unclear. On the other hand, excluding all studies on the basis of estimates of the normal distribution of the data also leads to a bias, because a considerable amount of data may be lost leading to a selection bias. Therefore, we included all studies in the primary
 
analysis. In a sensitivity analysis we excluded potentially skewed data applying the following rules:</P>
<P>a) When a scale started from the finite number zero the standard deviation, when multiplied by two, was more than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution, <LINK REF="REF-Altman-1996" TYPE="REFERENCE">Altman 1996</LINK>).<BR/>b) If a scale started from a positive value (such as PANSS which can have values from 30 to 210) the calculation described above was modified to take the scale starting point into account. In these cases skew is present if 2SD&gt; (S-Smin), where S is the mean score and Smin is the minimum score). In large studies (as a cut-off we used 200 participants) skewed data pose less of a problem. In these cases we entered the data in a synthesis and no sensitivity analysis was applied.<BR/>d) The rules explained in a) and b) do not apply to change data. The reason is that when continuous data are presented on a scale which includes a possibility of negative values, it is difficult to tell whether data are non-normally distributed (skewed) or not. This is also the case for change data (endpoint minus baseline). In the absence of individual patient data it is impossible to know if data are skewed, though this is likely. After consulting the ALLSTAT electronic statistics mailing list, we presented change data in RevMan Analyses in order to summarise available information. In doing this, it was assumed either that data were not skewed or that the analysis could cope with the unknown degree of skew. Without individual patient data it is impossible to test this assumption. We therefore included change data and did not apply a sensitivity analysis. For continuous outcomes we estimated a mean difference (MD) between groups. MDs were again based on the random-effects model, as this takes into account any differences between studies even if there is no statistically significant heterogeneity. We combined both endpoint data and change data in the analysis because there is no principal statistical reason why endpoint and change data should measure different effects (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). When standard errors instead of standard deviations (SD) were presented, we converted the former to standard deviations. If both were missing we estimated SDs from p-values or used the average SD of the other studies (<LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Unit of analysis issues  </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Cluster trials</HEADING>
<P>Studies increasingly employ cluster randomisation (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Authors often fail to account for intra class correlation in clustered studies, leading to a unit of analysis error (<LINK REF="REF-Divine-1992" TYPE="REFERENCE">Divine 1992</LINK>) whereby P values are spuriously low, confidence intervals unduly narrow and statistical significance overestimated. This can cause Type I errors (<LINK REF="REF-Bland-1997" TYPE="REFERENCE">Bland 1997</LINK>, <LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>).</P>
<P>Where clustering was not accounted for in primary studies, we presented the data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review we will seek to contact first authors of studies to obtain intra class correlation coefficients of their clustered data and to adjust for this using accepted methods (<LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>). Where clustering has been incorporated into the analysis of primary studies, we will also present these data as if from a non-cluster randomised study, but adjusted for the clustering effect.</P>
<P>We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a design effect. This is calculated using the mean number of participants per cluster (m) and the intra class correlation coefficient (ICC) [Design effect=1+ (m-1)*ICC] (<LINK REF="REF-Donner-2002" TYPE="REFERENCE">Donner 2002</LINK>). If the ICC was not reported it was assumed to be 0.1 (<LINK REF="REF-Ukoumunne-1999" TYPE="REFERENCE">Ukoumunne 1999</LINK>).</P>
<P>If cluster studies had been appropriately analysed taking into account intra class correlation coefficients and relevant data documented in the report, we synthesised these with other studies using the generic inverse variance technique.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Cross-over trials</HEADING>
<P>A major concern of cross-over trials is the carry-over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence on entry to the second phase the participants can differ systematically from their initial state despite a wash-out phase. For the same reason cross-over trials are not appropriate if the condition of interest is unstable (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). As both effects are very likely in schizophrenia, we will only use data of the first phase of cross-over studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Studies with multiple treatment groups</HEADING>
<P>Where a study involved more than two treatment groups, if relevant, the additional treatment groups were presented in additional relevant comparisons. Data were not double counted. Where the additional treatment groups were not relevant, these data were not reproduced.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dealing with missing data  </HEADING>
<P>At some degree of loss of follow-up, data must lose credibility (<LINK REF="REF-Xia-2007" TYPE="REFERENCE">Xia 2007</LINK>). Although high rates of premature discontinuation are a major problem in this field, we felt that it was unclear which degree of attrition leads to a high degree of bias. We, therefore, did not exclude outcomes on the basis of the percentage of participants completing them. However we addressed the drop-out problem in all parts of the review, including the abstract. For this purpose we calculated, presented and commented on frequency statistics (overall rates of leaving the studies early in all studies and comparators pooled and their ranges).</P>
<P>We assumed that the people who discontinued the studies for any reason did not show any response to the treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of heterogeneity  </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Clinical heterogeneity</HEADING>
<P>We considered all the included studies within any comparison to judge for clinical heterogeneity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Statistical</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Visual inspection</HEADING>
<P>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Employing the I<SUP>2</SUP> statistic</HEADING>
<P>Visual inspection was supplemented using, primarily, the I<SUP>2</SUP>statistic. This provides an estimate of the percentage of variability due to heterogeneity rather than chance alone. Where the I<SUP>2</SUP> estimate was greater than or equal to 50% we interpreted this as indicating the presence of considerable levels of heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of reporting biases  </HEADING>
<P>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). These are described in section 10.1 of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We are aware that funnel plots may be useful in investigating small-study effects but are of limited power to detect such effects when there are few studies. We entered data from all identified and selected trials into a funnel graph (trial effect versus trial size) in an attempt to investigate the likelihood of overt publication bias. We did not undertake a formal test for funnel plot asymmetry.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data synthesis  </HEADING>
<P>Where possible for both dichotomous and continuous data we used the random-effects model for data synthesis as this takes into account any differences between studies even if there is no statistically significant heterogeneity. We understand that there is no closed argument for preference for use of fixed or random-effects models. The random-effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This does seem true to us, however, random-effects does put added weight onto the smaller of the studies - those trials that are most vulnerable to bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis and investigation of heterogeneity  </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Subgroup</HEADING>
<P>We did not anticipate any subgroup analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Heterogeneity</HEADING>
<P>If data are clearly heterogeneous we checked that data are correctly extracted and entered and that we had made no unit of analysis errors. If inconsistency was high and clear reasons explaining the heterogeneity were found, we presented the data separately. If not, we commented on the heterogeneity of the data.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis  </HEADING>
<P>We planned sensitivity analyses a priority for examining the change in the robustness of the sensitivity to including studies with potentially skewed data. A recent report showed that some of the comparisons of atypical antipsychotics may have been biased by using inappropriate comparator doses (<LINK REF="REF-Heres-2006" TYPE="REFERENCE">Heres 2006</LINK>). We, therefore, also analysed whether the exclusion of studies with inappropriate comparator doses changed the results of the primary outcome and the general mental state.</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2009-01-23 07:58:13 +0000" MODIFIED_BY="[Empty name]">
<EXTENSION ID="FLOW_3" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="3">
<FLOWCHARTBOX TEXT="&lt;p&gt;174 total included studies&lt;/p&gt;&lt;p&gt;- 4 from original search&lt;/p&gt;&lt;p&gt;- 8 from 2011 update search&lt;/p&gt;&lt;p&gt;- 162 current 2013 update&lt;/p&gt;&lt;p&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;162 of studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;162 of studies (167 references) included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;209 of full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;212 records after duplicate removed&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;215 of records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 of additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;3 of records excluded through title and abstract screening&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;42 of full-text articles excluded, mostly due to quasi-randomisation.&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;4 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;4 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;28 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;3620 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;3620 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;3620 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;3592 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;22 full-text articles excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="FLOW_2" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="2">
<FLOWCHARTBOX TEXT="&lt;p&gt;12 total included studies&lt;/p&gt;&lt;p&gt;- 4 from original search&lt;/p&gt;&lt;p&gt;- 8 from 2011 update search&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;278 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;618 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;618 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;618 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;340 articles excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;38 of records excluded with reasons&lt;/p&gt;&lt;p&gt;216 added to 'awaiting classification'&lt;/p&gt;&lt;p&gt;16 listed as 'ongoing studies'&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>